data_1rou_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rou _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 1 N-CA-C 127.171 5.629 . . . . 0.0 127.171 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.275 8.2 p -156.68 -141.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.607 -174.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 1.157 8.1 mp 130.35 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 129.159 2.984 . . . . 0.0 111.895 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -154.83 130.33 9.83 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 122.629 2.468 . . . . 0.0 117.403 -162.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.67 119.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 123.414 0.686 . . . . 0.0 111.143 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.283 0.7 OUTLIER -87.19 135.93 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 122.201 1.0 . . . . 0.0 112.077 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -118.64 -60.65 1.75 Allowed 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.611 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -119.69 94.64 4.47 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.08 164.4 5.15 Favored 'General case' 0 CA--C 1.594 2.643 0 O-C-N 119.385 -2.072 . . . . 0.0 113.912 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.74 170.69 45.98 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 122.357 3.703 . . . . 0.0 122.357 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -99.24 -63.88 1.09 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.547 -1.826 . . . . 0.0 107.123 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.23 102.83 1.74 Allowed Glycine 0 CA--C 1.549 2.175 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 p -51.54 -22.57 3.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HE2' ' NZ ' ' A' ' 137' ' ' LYS . 10.0 mt-10 -63.29 153.62 34.24 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 p -115.79 163.52 20.72 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 111.635 -2.529 . . . . 0.0 112.303 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.68 146.16 29.98 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 CA-C-N 123.385 2.245 . . . . 0.0 114.351 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -90.32 164.36 14.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.122 -1.611 . . . . 0.0 110.854 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.3 OUTLIER -61.4 130.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 119.297 -2.127 . . . . 0.0 111.691 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.0 15.22 79.86 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.419 2.128 . . . . 0.0 118.419 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.88 154.02 19.15 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.421 2.11 . . . . 0.0 110.998 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -84.58 124.58 31.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.753 . . . . 0.0 110.208 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.23 132.06 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.008 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.26 93.5 4.72 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 125.168 2.413 . . . . 0.0 104.88 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.04 169.37 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 110.558 -3.019 . . . . 0.0 109.12 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.474 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.335 2.9 t60 -148.49 137.45 21.68 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 159.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -122.71 152.62 40.39 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.107 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.9 m -117.51 150.79 38.37 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 159.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.6 144.97 12.1 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 118.424 -2.672 . . . . 0.0 115.655 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -130.14 153.23 48.73 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 112.648 -1.776 . . . . 0.0 113.746 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.48 168.91 16.04 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 122.975 1.369 . . . . 0.0 107.388 166.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.8 -27.84 66.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -72.42 1.15 8.46 Favored 'General case' 0 CA--C 1.594 2.635 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.5 43.2 12.75 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 120.202 -1.561 . . . . 0.0 113.308 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -114.88 116.24 28.23 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -75.9 87.42 2.87 Favored 'General case' 0 CA--C 1.586 2.338 0 O-C-N 121.966 -0.459 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.91 -28.16 62.31 Favored 'General case' 0 CA--C 1.558 1.26 0 O-C-N 119.46 -2.025 . . . . 0.0 115.432 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -156.07 148.41 23.57 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 t -160.06 113.58 2.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.269 81.1 p -63.13 -38.58 91.75 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.474 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.275 65.7 mt -53.2 -42.34 66.17 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 122.318 2.326 . . . . 0.0 115.76 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.402 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 14.3 m-20 -49.92 -36.73 28.67 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 173.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 -85.79 42.51 0.97 Allowed 'General case' 0 CA--C 1.585 2.313 0 C-N-CA 124.745 1.218 . . . . 0.0 114.251 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.324 34.3 ttmt 83.26 -36.72 0.08 Allowed 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.2 -175.07 4.55 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-O 124.034 1.873 . . . . 0.0 115.469 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.89 178.09 4.48 Favored 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 125.254 1.422 . . . . 0.0 113.033 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.99 164.73 11.87 Favored 'General case' 0 CA--C 1.583 2.246 0 O-C-N 120.431 -1.418 . . . . 0.0 108.9 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.5 p -167.44 133.71 2.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 118.939 -2.35 . . . . 0.0 111.111 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -146.27 -176.3 5.11 Favored 'General case' 0 CA--C 1.573 1.827 0 CA-C-O 122.177 0.989 . . . . 0.0 112.214 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -119.26 114.31 22.19 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -40.89 113.85 0.42 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.4 95.17 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -111.5 21.17 16.46 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.27 -42.12 2.74 Favored Glycine 0 N--CA 1.51 3.586 0 O-C-N 121.147 -0.971 . . . . 0.0 112.484 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -32.81 -37.35 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 120.494 3.516 . . . . 0.0 120.494 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.254 20.6 m -123.95 -142.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 123.116 1.436 . . . . 0.0 109.662 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.7 pt -113.86 157.14 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 124.298 1.999 . . . . 0.0 108.284 170.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -64.85 -34.09 77.54 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 113.838 -1.528 . . . . 0.0 113.346 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.07 67.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.199 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -73.17 -43.44 61.45 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 120.226 1.376 . . . . 0.0 112.214 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.83 -38.58 70.23 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 121.237 1.835 . . . . 0.0 114.928 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.319 2.2 mp -69.97 -62.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 CA-C-N 119.741 1.155 . . . . 0.0 111.44 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.72 -30.59 70.86 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.284 12.6 t -77.74 -34.45 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 120.036 1.289 . . . . 0.0 110.644 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.39 -38.43 66.16 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 121.224 1.829 . . . . 0.0 112.701 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.8 p -80.88 8.41 8.34 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.504 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 9.3 tpt -100.25 127.76 46.46 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 122.071 2.214 . . . . 0.0 114.814 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -82.08 166.53 19.65 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.41 128.22 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.914 0 O-C-N 120.395 -1.44 . . . . 0.0 109.938 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.49 -0.46 64.43 Favored Glycine 1 N--CA 1.517 4.054 0 CA-C-N 123.201 2.728 . . . . 0.0 117.751 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -73.48 154.5 39.89 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.55 123.39 26.43 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.335 1.054 . . . . 0.0 112.246 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 8.7 p -151.64 174.65 13.22 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -124.86 119.85 30.01 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 124.201 1.953 . . . . 0.0 111.566 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -74.24 138.65 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-N 112.495 -2.138 . . . . 0.0 110.76 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -123.12 110.48 15.36 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 102.629 -3.101 . . . . 0.0 102.629 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 2.9 p -115.85 146.38 42.05 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -106.94 135.75 19.53 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.672 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -43.13 -24.59 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.853 1 N-CA-C 122.77 4.104 . . . . 0.0 122.77 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.39 -39.12 92.18 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 121.588 1.995 . . . . 0.0 114.293 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.44 -3.73 58.77 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 125.58 1.552 . . . . 0.0 112.79 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.27 -117.96 0.2 Allowed 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.287 6.6 m-85 -92.45 16.72 11.24 Favored 'General case' 0 N--CA 1.513 2.692 0 CA-C-N 121.005 1.73 . . . . 0.0 114.334 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.65 -63.23 4.61 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 123.008 2.64 . . . . 0.0 117.373 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -79.46 42.62 0.52 Allowed 'General case' 0 CA--C 1.584 2.264 0 CA-C-N 118.92 1.36 . . . . 0.0 114.236 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -171.77 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.99 136.88 6.45 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.22 0.914 . . . . 0.0 110.89 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.402 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.7 t -78.45 118.91 75.12 Favored Pre-proline 0 CA--C 1.581 2.157 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.241 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.272 42.4 Cg_exo -27.37 -51.15 0.11 Allowed 'Trans proline' 0 CA--C 1.579 2.761 1 N-CA-C 124.682 4.839 . . . . 0.0 124.682 -175.684 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.57 -30.14 12.44 Favored 'Trans proline' 0 CA--C 1.572 2.42 0 CA-C-N 125.607 3.038 . . . . 0.0 119.548 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -163.93 -8.95 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 117' ' ' SER . 19.6 mt -79.93 123.7 83.54 Favored Pre-proline 0 CA--C 1.583 2.248 0 O-C-N 119.631 -1.918 . . . . 0.0 113.299 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.76 171.09 7.23 Favored 'Trans proline' 0 CA--C 1.585 3.067 0 C-N-CA 122.547 2.165 . . . . 0.0 113.441 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.65 12.87 0.23 Allowed 'Trans proline' 0 CA--C 1.58 2.804 0 N-CA-C 120.536 3.245 . . . . 0.0 120.536 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -153.95 67.7 0.75 Allowed 'General case' 0 CA--C 1.582 2.211 0 O-C-N 119.974 -1.704 . . . . 0.0 111.644 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.16 133.89 33.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 119.797 -1.815 . . . . 0.0 110.529 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.291 23.3 m -66.05 152.05 45.51 Favored 'General case' 0 CA--C 1.594 2.639 0 O-C-N 120.703 -1.248 . . . . 0.0 112.447 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 11.8 tp -132.44 158.27 42.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 119.541 -1.974 . . . . 0.0 111.892 -170.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.9 t -143.69 124.59 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.862 -169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.303 15.3 m-85 -136.46 124.44 22.8 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 122.286 2.312 . . . . 0.0 112.16 173.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -93.49 113.14 25.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.481 -2.012 . . . . 0.0 107.999 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.7 t -112.34 136.25 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.886 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -119.51 114.97 23.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.28 119.95 38.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.578 1.18 . . . . 0.0 109.498 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -79.73 -56.92 3.93 Favored 'General case' 0 CA--C 1.582 2.184 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.307 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -169.89 161.65 9.04 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 126.031 1.733 . . . . 0.0 109.72 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -138.05 -84.89 0.29 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.784 -1.822 . . . . 0.0 110.862 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.468 ' NZ ' ' HE2' ' A' ' 44' ' ' GLU . 40.0 ttpt -79.83 74.36 6.56 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 125.511 2.577 . . . . 0.0 108.308 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.567 3.299 0 CA-C-N 110.909 -2.86 . . . . 0.0 111.855 -173.778 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 1 N-CA-C 123.815 4.286 . . . . 0.0 123.815 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.324 38.2 t -139.51 133.2 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 1 CA-C-N 124.419 4.109 . . . . 0.0 116.517 -174.038 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.33 134.12 54.05 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 125.912 1.685 . . . . 0.0 109.253 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -129.24 133.09 47.36 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 124.12 3.145 . . . . 0.0 111.453 176.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.9 t -105.1 153.18 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.71 142.38 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.915 0 CA-C-O 122.771 1.272 . . . . 0.0 108.97 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -114.32 -57.89 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.692 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -122.29 112.24 17.89 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.51 -62.9 1.45 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.455 -1.403 . . . . 0.0 114.241 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.1 -155.83 26.43 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 119.364 2.505 . . . . 0.0 119.364 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -91.12 -54.57 3.89 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 114.337 -0.931 . . . . 0.0 113.319 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -39.0 62.15 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.261 73.0 p 74.62 3.25 4.23 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -106.92 167.24 10.02 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 120.772 -1.205 . . . . 0.0 113.001 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.2 p -132.94 108.33 12.75 Favored Pre-proline 0 CA--C 1.577 1.982 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.59 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.353 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.6 ptm -170.83 175.47 4.48 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 120.868 1.667 . . . . 0.0 114.344 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -55.8 132.8 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 CA-C-O 122.334 1.064 . . . . 0.0 111.44 176.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.33 0.3 70.58 Favored Glycine 0 CA--C 1.563 3.079 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.08 137.88 49.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 121.437 2.618 . . . . 0.0 113.585 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -86.65 104.8 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -105.39 131.08 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.074 0.95 . . . . 0.0 110.667 -173.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.255 29.1 p90 -105.23 115.54 30.43 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 105.653 -1.981 . . . . 0.0 105.653 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.28 170.08 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 CA-C-O 125.04 2.352 . . . . 0.0 114.103 -170.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -124.43 119.32 28.84 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 111.58 -2.555 . . . . 0.0 106.358 168.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.333 3.3 p90 -114.72 150.85 34.65 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 123.977 1.846 . . . . 0.0 113.626 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -127.63 151.71 48.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.53 138.38 6.03 Favored Glycine 0 CA--C 1.546 2.001 0 O-C-N 118.742 -2.474 . . . . 0.0 115.944 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.19 150.71 49.4 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 127.323 2.249 . . . . 0.0 112.25 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.5 tp -84.22 -172.75 4.34 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-O 123.984 1.849 . . . . 0.0 109.641 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -58.35 -37.39 75.09 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.19 21.61 0.89 Allowed 'General case' 0 CA--C 1.597 2.756 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.97 33.48 50.61 Favored Glycine 1 N--CA 1.517 4.054 0 O-C-N 120.179 -1.576 . . . . 0.0 115.798 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.7 m -86.72 109.24 19.08 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -69.04 92.36 0.52 Allowed 'General case' 0 CA--C 1.588 2.437 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -73.08 -36.08 66.75 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 119.296 -2.127 . . . . 0.0 114.598 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -161.65 174.95 12.57 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 123.834 1.778 . . . . 0.0 114.442 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 t -152.42 -147.15 0.22 Allowed 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 51.6 p -148.73 -66.56 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.056 -1.653 . . . . 0.0 108.701 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.317 22.3 mt -61.38 -42.35 98.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -49.99 -42.34 48.84 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.698 ' NE ' ' HD2' ' A' ' 74' ' ' ASP 0.339 32.5 ptt180 -75.57 -75.38 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.545 1.138 . . . . 0.0 113.535 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -163.62 -36.7 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.925 1.29 . . . . 0.0 112.172 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.698 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 3.0 p30 -89.28 -157.15 0.43 Allowed 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -145.62 170.71 15.91 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 125.943 1.697 . . . . 0.0 108.498 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.285 3.7 t80 -114.05 154.68 27.28 Favored 'General case' 0 CA--C 1.573 1.856 0 CA-C-O 123.772 1.749 . . . . 0.0 109.125 173.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.2 p -170.9 124.08 0.63 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.802 -1.186 . . . . 0.0 108.171 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -143.22 164.44 30.18 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 121.813 -0.555 . . . . 0.0 111.913 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.97 128.2 49.89 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 119.168 -2.208 . . . . 0.0 106.125 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.57 110.94 1.08 Allowed 'General case' 0 CA--C 1.57 1.733 0 O-C-N 121.27 -0.894 . . . . 0.0 112.77 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 54.76 30.65 Favored Glycine 0 N--CA 1.509 3.542 0 O-C-N 120.65 -1.281 . . . . 0.0 114.606 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -99.15 -71.95 0.68 Allowed 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 124.366 2.031 . . . . 0.0 112.182 -174.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -111.23 -49.98 0.64 Allowed Glycine 0 CA--C 1.561 2.914 0 N-CA-C 104.024 -3.63 . . . . 0.0 104.024 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.778 23.8 tt0 118.89 137.78 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 127.909 3.719 . . . . 0.0 114.634 164.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.348 11.9 m -79.97 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 1 CA-C-N 105.773 -5.194 . . . . 0.0 104.454 178.25 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -132.79 157.39 43.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 124.017 1.865 . . . . 0.0 106.8 166.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -65.01 -33.11 75.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.519 -1.219 . . . . 0.0 113.123 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.26 80.49 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 117.25 -1.357 . . . . 0.0 111.938 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.453 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.0 m0 -73.94 -43.31 58.71 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.685 1.584 . . . . 0.0 112.215 172.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.41 -34.58 72.64 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 121.548 1.976 . . . . 0.0 114.267 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.303 1.5 mp -69.99 -63.25 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.004 0 CA-C-N 120.317 1.417 . . . . 0.0 111.294 174.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.16 -33.14 75.1 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.345 3.5 t -78.35 -25.92 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 CA-C-N 119.764 1.166 . . . . 0.0 111.584 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.23 90.05 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-N 121.238 1.835 . . . . 0.0 111.856 165.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.6 p -82.58 17.57 1.75 Allowed 'General case' 0 CA--C 1.596 2.718 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.505 ' SD ' HD21 ' A' ' 101' ' ' LEU . 2.2 ttt -104.68 143.31 33.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 119.26 -2.15 . . . . 0.0 116.068 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -104.13 152.95 21.5 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 119.039 2.977 . . . . 0.0 119.039 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.88 124.92 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.408 0 CA-C-O 118.478 -0.773 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.9 -55.4 0.53 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 120.683 1.583 . . . . 0.0 112.809 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.305 5.5 tt0 -158.41 -163.59 1.31 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.505 HD21 ' SD ' ' A' ' 96' ' ' MET 0.782 0.5 OUTLIER -162.66 -139.92 0.05 OUTLIER 'General case' 0 CA--C 1.594 2.667 0 C-N-CA 125.091 1.357 . . . . 0.0 111.622 178.414 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.528 ' SG ' ' HG2' ' A' ' 103' ' ' ARG 0.72 51.3 t -160.03 -115.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 127.162 2.185 . . . . 0.0 107.916 175.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.528 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 54.8 ptt85 -135.32 135.15 40.55 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -173.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -89.84 132.07 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 CA-C-N 112.66 -2.063 . . . . 0.0 108.241 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.2 m -121.0 105.99 11.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 15.6 p -124.08 149.6 45.97 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -170.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -81.45 135.98 49.51 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.521 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.265 50.5 Cg_exo -57.7 -17.2 28.0 Favored 'Trans proline' 0 CA--C 1.559 1.756 0 N-CA-C 118.882 2.608 . . . . 0.0 118.882 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.62 -33.94 76.02 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 121.692 2.042 . . . . 0.0 113.907 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.57 -2.87 51.62 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 125.734 1.614 . . . . 0.0 113.462 169.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.51 -113.97 0.22 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 121.499 1.954 . . . . 0.0 113.013 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.308 2.7 m-85 -79.04 -37.55 38.74 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 121.188 1.813 . . . . 0.0 113.12 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.22 -116.15 3.29 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 121.222 3.249 . . . . 0.0 121.222 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -77.85 -31.99 51.83 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.36 -33.76 63.18 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.12 155.99 9.75 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 t -98.9 111.09 59.82 Favored Pre-proline 0 CA--C 1.58 2.117 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.285 47.6 Cg_exo -31.26 -52.0 0.27 Allowed 'Trans proline' 0 CA--C 1.581 2.843 1 N-CA-C 124.19 4.65 . . . . 0.0 124.19 -175.36 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.71 -18.54 32.46 Favored 'Trans proline' 0 CA--C 1.577 2.629 0 N-CA-C 120.494 3.229 . . . . 0.0 120.494 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -160.2 -18.81 0.06 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . 0.289 10.7 mt -79.93 -59.01 0.58 Allowed Pre-proline 0 CA--C 1.605 3.088 1 N-CA-C 124.437 4.977 . . . . 0.0 124.437 -172.262 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . 0.89 0.1 OUTLIER 34.09 -115.29 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.486 2 C-N-CA 126.843 5.029 . . . . 0.0 123.57 -172.325 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.12 99.66 1.32 Allowed 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 125.886 3.138 . . . . 0.0 118.601 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 t30 52.46 70.69 0.54 Allowed 'General case' 0 CA--C 1.593 2.629 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.55 114.52 28.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.618 -1.926 . . . . 0.0 108.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.4 m -54.0 151.52 6.71 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.465 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 72.5 mt -126.77 164.53 21.14 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 124.566 2.127 . . . . 0.0 113.791 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -144.31 113.55 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.601 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 5.7 m-85 -127.07 125.57 41.54 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 122.227 2.285 . . . . 0.0 110.839 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 8.4 tm-20 -93.68 96.03 9.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.362 -1.461 . . . . 0.0 108.296 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.3 138.98 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -132.18 118.44 19.56 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.9 tt -90.83 114.08 26.4 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.814 -1.179 . . . . 0.0 113.877 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.31 9.8 m-30 -76.59 -51.42 11.65 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.571 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -163.74 146.85 9.9 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 121.702 2.046 . . . . 0.0 108.353 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.267 0.1 OUTLIER -100.88 -80.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 170.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -80.0 -37.03 35.07 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 177.333 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 1 N-CA-C 123.676 4.231 . . . . 0.0 123.676 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -174.93 -173.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.194 0 CA-C-O 123.687 1.708 . . . . 0.0 110.681 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.91 2.2 mm? 178.94 165.9 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.71 2.004 . . . . 0.0 113.674 160.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 125.83 53.7 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 11.2 p -114.37 109.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 O-C-N 121.43 -0.793 . . . . 0.0 112.653 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.389 8.2 mm -48.31 133.87 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 N-CA-C 119.712 3.227 . . . . 0.0 119.712 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -115.73 -59.8 1.95 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.201 -1.818 . . . . 0.0 108.867 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -143.49 103.74 4.14 Favored 'General case' 0 CA--C 1.585 2.322 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -53.26 -61.35 2.36 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 119.878 3.288 . . . . 0.0 119.878 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.74 177.42 16.23 Favored Glycine 0 CA--C 1.55 2.281 0 C-N-CA 125.22 1.391 . . . . 0.0 114.635 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 t -162.07 -12.62 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.01 -68.92 1.44 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 122.279 3.672 . . . . 0.0 122.279 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -158.83 66.83 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.768 0.794 . . . . 0.0 112.388 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.391 10.4 mt-10 60.42 -160.33 0.3 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 120.327 3.455 . . . . 0.0 120.327 174.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -97.04 170.86 6.7 Favored Pre-proline 0 CA--C 1.585 2.324 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -99.46 -166.15 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.512 0 CA-C-N 123.073 2.133 . . . . 0.0 117.149 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -130.15 169.71 14.99 Favored 'General case' 0 CA--C 1.573 1.837 0 O-C-N 121.282 -0.887 . . . . 0.0 112.999 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.95 139.18 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.166 0 O-C-N 119.211 -2.181 . . . . 0.0 109.352 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 7.01 86.89 Favored Glycine 0 CA--C 1.567 3.293 0 CA-C-O 117.497 -1.724 . . . . 0.0 117.335 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' HD2' ' HB2' ' A' ' 137' ' ' LYS . 4.8 t0 -74.43 146.85 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 121.531 2.665 . . . . 0.0 113.501 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -85.68 119.96 26.59 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.37 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 123.192 0.597 . . . . 0.0 111.332 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -114.5 111.99 22.27 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.9 m -116.16 162.3 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 124.087 1.899 . . . . 0.0 114.669 -173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.9 108.03 16.19 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.543 168.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 2.2 p90 -110.51 147.62 33.75 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 123.31 1.528 . . . . 0.0 114.747 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.8 m -131.19 144.5 51.4 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 165.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.88 144.85 12.68 Favored Glycine 0 CA--C 1.551 2.295 0 O-C-N 119.769 -1.832 . . . . 0.0 116.528 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.31 149.8 52.29 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.007 1.723 . . . . 0.0 114.398 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.97 169.55 18.13 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.369 1.081 . . . . 0.0 108.521 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.346 0.0 OUTLIER -61.59 -25.45 67.34 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.81 3.46 11.84 Favored 'General case' 0 CA--C 1.594 2.651 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.54 11.59 Favored Glycine 0 N--CA 1.507 3.387 0 CA-C-N 121.101 1.773 . . . . 0.0 114.343 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.9 m -115.52 115.53 26.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -78.2 96.74 5.29 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -70.09 -32.03 69.89 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.682 -1.886 . . . . 0.0 113.87 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.448 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 2.2 t70 -155.22 159.92 40.46 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 124.189 1.947 . . . . 0.0 115.669 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.7 t -158.82 98.75 1.51 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.6 p -54.36 -49.85 68.85 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.428 0.2 OUTLIER -66.49 -44.17 83.35 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -177.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.38 -40.2 61.78 Favored 'General case' 0 CA--C 1.583 2.215 0 C-N-CA 124.423 1.089 . . . . 0.0 113.852 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.448 ' NE ' ' HD2' ' A' ' 67' ' ' ASP . 62.1 mtp85 -68.86 -14.81 63.26 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 173.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.384 0.6 OUTLIER 118.52 -41.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 129.005 2.922 . . . . 0.0 114.11 177.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.92 155.53 20.88 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -88.6 135.33 33.55 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 117.258 -1.353 . . . . 0.0 109.276 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -83.11 151.23 25.84 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 122.872 2.578 . . . . 0.0 108.922 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.0 t -168.03 145.92 4.36 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 123.9 1.81 . . . . 0.0 108.429 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -152.46 179.28 8.71 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.007 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -116.26 121.99 43.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.72 109.59 0.24 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.83 37.77 60.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.383 13.9 tppt? -91.03 -8.85 47.92 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-N 120.993 2.397 . . . . 0.0 117.211 -174.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.29 65.75 1.41 Allowed Glycine 0 N--CA 1.504 3.183 0 N-CA-C 103.969 -3.652 . . . . 0.0 103.969 -169.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -156.91 -57.35 0.09 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.958 -1.121 . . . . 0.0 113.208 -164.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.281 13.9 m -98.99 -139.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 122.998 1.38 . . . . 0.0 109.462 -175.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.9 pt -120.67 163.69 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 123.66 1.695 . . . . 0.0 110.317 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.263 2.2 mptt -67.8 -34.68 77.23 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.426 -1.261 . . . . 0.0 113.237 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.12 -32.42 69.82 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 117.313 -1.327 . . . . 0.0 112.607 167.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 29.5 m0 -76.89 -42.66 38.89 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 120.955 1.707 . . . . 0.0 112.613 172.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -59.7 -37.1 77.92 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 120.313 1.415 . . . . 0.0 114.586 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.282 1.4 mp -66.76 -58.35 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-N 119.749 1.159 . . . . 0.0 110.801 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.36 87.94 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.4 HG21 ' SD ' ' A' ' 96' ' ' MET 0.289 92.9 t -67.22 -37.7 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.349 0.977 . . . . 0.0 112.221 172.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.75 -39.05 61.82 Favored 'General case' 0 CA--C 1.588 2.416 0 CA-C-N 121.302 1.864 . . . . 0.0 112.444 168.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.7 p -94.96 42.28 1.09 Allowed 'General case' 0 CA--C 1.597 2.769 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 133' ' ' LEU . 12.4 ttm -112.12 142.59 44.39 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 119.102 -2.249 . . . . 0.0 115.248 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -109.48 139.49 44.41 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 120.13 1.332 . . . . 0.0 113.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.7 131.55 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.399 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.393 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.46 -56.02 0.5 Allowed Glycine 0 N--CA 1.492 2.408 0 CA-C-O 117.107 -1.941 . . . . 0.0 111.329 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -150.45 -162.12 1.49 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-N 118.946 1.373 . . . . 0.0 113.737 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.799 0.6 OUTLIER -154.4 -126.94 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 CA-C-O 124.855 2.264 . . . . 0.0 114.026 176.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.5 OUTLIER -158.52 -147.78 0.18 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 124.357 2.027 . . . . 0.0 110.936 -164.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.502 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -131.76 138.56 48.64 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 124.644 2.164 . . . . 0.0 109.353 170.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.65 134.82 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 112.612 -2.085 . . . . 0.0 108.764 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.9 m -121.27 109.46 14.96 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.535 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 4.7 p -127.03 144.27 51.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -86.07 146.02 41.99 Favored Pre-proline 0 CA--C 1.574 1.902 0 CA-C-N 112.773 -2.012 . . . . 0.0 110.996 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -46.93 -26.21 4.61 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 N-CA-C 119.713 2.928 . . . . 0.0 119.713 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.57 -43.51 89.45 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.774 1.624 . . . . 0.0 114.437 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.86 -1.53 56.62 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.84 -118.35 0.23 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 120.719 1.599 . . . . 0.0 113.931 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.475 16.7 m-85 -83.8 -13.09 54.63 Favored 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 121.86 2.118 . . . . 0.0 115.595 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.82 -153.86 49.64 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.213 3.245 . . . . 0.0 121.213 171.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.8 t -85.26 62.38 7.46 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.995 1.379 . . . . 0.0 110.85 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.19 -54.69 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 126.301 1.84 . . . . 0.0 111.638 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.01 163.88 24.87 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 122.447 1.026 . . . . 0.0 113.796 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.41 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 19.7 t -72.98 143.57 84.22 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 116.827 -1.558 . . . . 0.0 110.862 176.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -49.68 126.82 17.19 Favored 'Trans proline' 0 CA--C 1.581 2.865 0 C-N-CA 122.923 2.415 . . . . 0.0 113.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.322 0.2 OUTLIER 28.58 47.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.575 2.536 0 N-CA-C 121.946 3.787 . . . . 0.0 121.946 -172.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -154.79 -47.66 0.09 Allowed 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.41 ' HB ' ' H ' ' A' ' 117' ' ' SER . 18.1 mt -104.51 150.14 38.18 Favored Pre-proline 0 N--CA 1.512 2.636 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.002 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.66 173.3 8.12 Favored 'Trans proline' 0 CA--C 1.588 3.189 0 CA-C-N 126.412 3.326 . . . . 0.0 116.015 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.18 -21.48 22.49 Favored 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 121.751 3.712 . . . . 0.0 121.751 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -158.71 92.8 1.14 Allowed 'General case' 0 CA--C 1.584 2.283 0 CA-C-N 120.852 1.66 . . . . 0.0 107.651 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.59 133.43 22.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 122.985 2.629 . . . . 0.0 112.916 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 84.7 m -66.56 150.61 48.73 Favored 'General case' 0 CA--C 1.586 2.328 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.535 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.25 0.3 OUTLIER -145.11 175.84 9.95 Favored 'General case' 0 CA--C 1.573 1.843 0 O-C-N 119.643 -1.91 . . . . 0.0 111.196 -177.703 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -145.42 146.52 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 125.805 1.642 . . . . 0.0 109.729 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.251 1.7 m-85 -135.96 125.28 24.8 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.481 -0.762 . . . . 0.0 109.745 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 55.6 mt-10 -83.42 114.0 21.15 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.37 136.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -132.41 120.67 22.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.533 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.7 OUTLIER -86.34 123.84 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.367 -1.458 . . . . 0.0 114.616 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.25 -49.48 49.5 Favored 'General case' 0 CA--C 1.587 2.383 0 O-C-N 121.701 -0.624 . . . . 0.0 112.526 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -171.29 155.73 4.38 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.74 1.616 . . . . 0.0 110.385 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.527 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.286 0.2 OUTLIER -126.6 -106.26 0.32 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.567 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.527 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 85.9 tttt -83.46 72.47 10.25 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.508 1.123 . . . . 0.0 110.904 173.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 178.45 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.11 133.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 118.291 1.045 . . . . 0.0 113.691 -173.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -109.96 141.95 42.01 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 127.119 2.168 . . . . 0.0 107.893 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -159.58 170.75 20.96 Favored 'General case' 0 N--CA 1.51 2.547 2 CA-C-N 126.276 4.125 . . . . 0.0 122.123 -170.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.615 ' O ' ' SG ' ' A' ' 102' ' ' CYS 1.237 3.7 m 106.0 -173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.672 1 N-CA-C 127.785 6.217 . . . . 0.0 127.785 158.351 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.643 34.3 mm -16.41 128.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.342 2 N-CA-C 131.351 7.538 . . . . 0.0 131.351 -153.931 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.654 ' H ' ' HB2' ' A' ' 102' ' ' CYS . 65.0 tttt -142.63 -49.17 0.35 Allowed 'General case' 0 CA--C 1.584 2.257 0 C-N-CA 127.33 2.252 . . . . 0.0 109.537 171.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' NE ' ' HE2' ' A' ' 132' ' ' GLU . 73.8 mtt180 -114.77 101.93 9.52 Favored 'General case' 0 CA--C 1.578 2.033 0 C-N-CA 124.922 1.289 . . . . 0.0 108.693 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.28 174.84 0.63 Allowed 'General case' 0 CA--C 1.597 2.762 0 O-C-N 119.469 -2.019 . . . . 0.0 115.579 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.43 8.26 Favored Glycine 0 N--CA 1.486 2.017 0 O-C-N 119.856 -1.777 . . . . 0.0 116.461 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.5 p -107.37 -76.66 0.61 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.6 70.51 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.267 10.2 t -157.6 61.56 0.48 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.362 1.077 . . . . 0.0 113.179 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.264 30.3 mt-10 59.75 168.69 0.07 Allowed 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 120.855 3.65 . . . . 0.0 120.855 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 p -90.07 165.4 24.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.275 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.43 159.61 17.14 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 CA-C-N 121.919 1.721 . . . . 0.0 114.732 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -98.33 165.54 11.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.345 0.3 OUTLIER -63.73 130.24 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 119.219 -2.176 . . . . 0.0 110.574 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.17 17.61 79.88 Favored Glycine 0 CA--C 1.569 3.431 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.02 147.29 43.06 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.575 1.688 . . . . 0.0 112.256 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -81.83 114.64 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.46 146.14 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.661 0.784 . . . . 0.0 111.307 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.25 46.3 p90 -129.85 98.68 4.86 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 124.86 2.267 . . . . 0.0 111.712 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.81 170.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 111.562 -2.563 . . . . 0.0 112.259 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.479 ' CE1' ' HG ' ' A' ' 70' ' ' LEU . 5.1 t60 -134.55 135.82 42.58 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 164.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 6.7 p90 -128.8 142.3 51.03 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.1 m -110.96 144.91 39.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 159.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.34 140.44 7.99 Favored Glycine 0 CA--C 1.548 2.112 0 O-C-N 118.92 -2.363 . . . . 0.0 116.776 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 155.97 47.25 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.675 2.39 . . . . 0.0 112.569 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.49 -174.5 4.84 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 120.475 -1.391 . . . . 0.0 111.044 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 1.9 pt? -64.83 -26.12 68.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.68 1.98 13.18 Favored 'General case' 0 CA--C 1.601 2.93 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.417 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.22 31.82 81.86 Favored Glycine 0 N--CA 1.501 2.996 0 O-C-N 120.477 -1.389 . . . . 0.0 114.821 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -90.25 114.6 26.66 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.4 95.02 1.0 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -70.45 -31.3 68.4 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 119.519 -1.988 . . . . 0.0 114.212 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.526 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 11.2 t0 -154.23 161.18 41.99 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.839 2.257 . . . . 0.0 114.179 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.0 p -151.05 96.92 2.39 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -28.09 27.93 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 120.723 3.601 . . . . 0.0 120.723 -172.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.263 36.5 mt -70.48 -51.72 27.05 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.947 1.703 . . . . 0.0 112.062 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.18 -30.24 70.29 Favored 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' NE ' ' HD2' ' A' ' 67' ' ' ASP . 60.6 ttt-85 -54.01 -19.92 5.52 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 174.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.35 39.0 ttmt 127.36 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 129.387 3.075 . . . . 0.0 111.952 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.3 2.7 p-10 -104.61 -142.8 0.37 Allowed 'General case' 0 CA--C 1.575 1.934 0 CA-C-O 123.076 1.417 . . . . 0.0 111.953 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -124.78 -136.5 0.28 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.404 3.1 t80 -140.25 142.58 35.76 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 118.337 -2.727 . . . . 0.0 109.095 167.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.4 p -155.4 148.75 24.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 118.479 -2.638 . . . . 0.0 109.05 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -157.37 -173.19 4.3 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.223 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -122.21 113.53 19.59 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -39.63 113.57 0.35 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.76 47.44 88.65 Favored Glycine 0 N--CA 1.503 3.149 0 N-CA-C 118.208 2.043 . . . . 0.0 118.208 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -109.39 6.65 24.51 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.78 58.32 2.15 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -149.97 -49.27 0.13 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.295 10.3 m -117.85 -138.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-O 123.04 1.4 . . . . 0.0 108.374 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 89' ' ' TRP . 26.7 pt -122.48 163.25 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 123.767 1.746 . . . . 0.0 110.173 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.59 71.54 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.479 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.37 75.04 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.558 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.422 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.4 m0 -75.4 -41.43 56.18 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 120.725 1.602 . . . . 0.0 112.833 172.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.61 -37.99 80.07 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 119.744 1.157 . . . . 0.0 113.863 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.257 1.2 mp -64.61 -54.68 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.709 1.595 . . . . 0.0 111.208 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.71 72.1 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.2 t -60.91 -46.62 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.07 0.85 . . . . 0.0 112.327 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.8 -34.89 55.67 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 p -87.56 6.73 32.92 Favored 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.52 ' SD ' ' HG ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.35 138.05 52.68 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 123.524 2.874 . . . . 0.0 116.806 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -80.93 149.19 29.5 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 113.51 -3.138 . . . . 0.0 111.05 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.279 1.8 t -9.61 87.91 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 123.144 2.702 . . . . 0.0 110.513 -166.003 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -3.19 -37.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 1 N-CA-C 129.839 6.696 . . . . 0.0 129.839 -140.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 61.24 -127.69 0.85 Allowed 'General case' 0 CA--C 1.605 3.075 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.52 ' HG ' ' SD ' ' A' ' 96' ' ' MET 1.672 0.6 OUTLIER 124.57 154.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 161.383 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.654 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 18.8 t -160.19 -104.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.239 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -122.29 158.36 29.7 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 124.875 2.274 . . . . 0.0 116.036 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mt -131.82 114.61 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.007 0 CA-C-N 111.524 -2.58 . . . . 0.0 105.559 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -107.15 99.19 8.76 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 7.8 p -112.39 146.82 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -90.57 141.02 26.81 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.921 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.26 -22.41 8.33 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 N-CA-C 119.882 2.993 . . . . 0.0 119.882 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.99 -42.04 98.7 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.086 1.766 . . . . 0.0 114.434 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.56 0.17 39.39 Favored 'General case' 0 CA--C 1.577 2.0 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.256 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.97 -114.5 0.15 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.38 24.7 m-85 -82.29 -14.11 55.91 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 120.945 1.702 . . . . 0.0 115.176 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.1 -152.0 52.01 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.5 p -67.66 -22.25 65.31 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.12 -33.01 13.51 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.4 169.5 45.68 Favored Glycine 0 CA--C 1.551 2.327 0 CA-C-N 121.05 1.75 . . . . 0.0 114.71 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.8 t -90.42 120.14 69.06 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 116.684 -1.627 . . . . 0.0 108.799 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -37.23 -46.07 1.52 Allowed 'Trans proline' 0 CA--C 1.582 2.887 1 N-CA-C 123.32 4.316 . . . . 0.0 123.32 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.14 -20.11 19.39 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 CA-C-N 125.595 3.034 . . . . 0.0 119.534 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -159.53 -27.17 0.07 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.9 mt -79.98 126.6 79.43 Favored Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 120.183 -1.573 . . . . 0.0 111.938 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -82.68 170.7 12.62 Favored 'Trans proline' 0 CA--C 1.581 2.841 0 C-N-CA 122.365 2.043 . . . . 0.0 115.842 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.41 130.67 22.9 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 C-N-CA 122.85 2.367 . . . . 0.0 114.931 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.9 t30 58.85 60.85 2.34 Favored 'General case' 0 CA--C 1.586 2.364 0 C-N-CA 125.031 1.332 . . . . 0.0 113.413 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.23 123.73 32.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.33 -1.481 . . . . 0.0 112.451 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -59.35 156.2 13.22 Favored 'General case' 0 CA--C 1.587 2.373 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.529 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 87.8 mt -126.62 165.05 19.92 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 124.69 2.186 . . . . 0.0 114.297 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.99 106.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.77 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 2.5 m-85 -120.92 125.82 48.4 Favored 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 122.194 2.27 . . . . 0.0 109.134 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -95.43 98.72 10.76 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.52 140.57 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.346 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.551 ' HE2' ' NE ' ' A' ' 38' ' ' ARG . 50.4 mt-10 -130.3 110.15 11.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.31 25.8 tp -85.19 121.38 27.85 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 122.822 1.296 . . . . 0.0 112.779 -177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.3 15.3 m-30 -84.04 -64.36 1.18 Allowed 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.278 -1.514 . . . . 0.0 111.782 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.17 162.17 40.96 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.912 2.142 . . . . 0.0 110.46 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -143.5 -114.8 0.1 Allowed 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -103.4 173.1 6.45 Favored 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.623 1.569 . . . . 0.0 108.196 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 O-C-N 119.583 -1.948 . . . . 0.0 117.73 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.0 t -170.25 150.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 120.029 1.914 . . . . 0.0 112.859 -167.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.69 10.2 tp -151.84 -146.67 0.2 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.962 162.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -179.02 166.42 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.16 -1.587 . . . . 0.0 113.769 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.83 123.23 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.129 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.297 0.3 OUTLIER -89.79 139.28 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 120.25 1.386 . . . . 0.0 111.8 178.826 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.34 -69.18 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.982 -0.449 . . . . 0.0 111.219 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -103.96 68.66 0.92 Allowed 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -38.1 -71.25 0.08 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.04 -178.4 39.44 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.5 p -83.7 -66.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.681 -0.759 . . . . 0.0 112.001 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.96 55.27 0.01 OUTLIER Glycine 0 CA--C 1.54 1.614 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 15.3 t -153.16 63.25 0.77 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.234 1.492 . . . . 0.0 112.527 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.361 46.8 mt-10 69.76 170.38 0.3 Allowed 'General case' 0 CA--C 1.576 1.972 1 N-CA-C 121.943 4.053 . . . . 0.0 121.943 175.126 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.7 p -114.33 160.0 34.49 Favored Pre-proline 0 CA--C 1.587 2.398 0 CA-C-N 111.042 -2.799 . . . . 0.0 110.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.83 129.18 30.91 Favored 'Trans proline' 0 CA--C 1.579 2.752 0 C-N-CA 122.853 2.369 . . . . 0.0 117.023 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -87.12 161.58 18.03 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 122.009 2.186 . . . . 0.0 111.363 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.343 0.4 OUTLIER -62.31 132.15 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 119.029 -2.294 . . . . 0.0 110.896 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.76 0.97 90.0 Favored Glycine 0 CA--C 1.569 3.428 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.56 152.65 20.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 121.504 2.652 . . . . 0.0 112.868 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -83.56 135.7 34.53 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.285 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -132.36 135.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.185 0.594 . . . . 0.0 109.831 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.265 33.4 p90 -115.96 105.31 12.51 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 124.038 1.875 . . . . 0.0 109.707 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.2 m -110.05 173.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 127.138 2.175 . . . . 0.0 114.55 -172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.257 0.1 OUTLIER -135.25 111.33 9.56 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 166.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.257 20.8 p90 -96.63 176.0 6.18 Favored 'General case' 0 CA--C 1.586 2.327 0 CA-C-O 126.291 2.948 . . . . 0.0 113.918 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.262 63.3 m -150.61 140.23 21.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.1 156.6 27.08 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 119.787 -1.82 . . . . 0.0 116.216 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -139.44 147.31 41.21 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 112.346 -1.927 . . . . 0.0 111.704 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 tp -80.64 169.11 18.07 Favored 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 122.762 1.268 . . . . 0.0 107.928 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.319 0.0 OUTLIER -59.24 -26.68 65.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.68 4.09 6.82 Favored 'General case' 0 CA--C 1.595 2.698 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.59 41.89 34.42 Favored Glycine 0 N--CA 1.506 3.339 0 O-C-N 119.804 -1.81 . . . . 0.0 114.434 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.6 m -116.67 117.31 29.46 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -77.36 97.82 5.03 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.054 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -74.0 -37.07 64.53 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.853 -2.404 . . . . 0.0 115.727 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.54 174.37 14.14 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.337 1.426 . . . . 0.0 113.93 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.4 p -159.98 -10.25 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 119.098 2.999 . . . . 0.0 119.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.3 1.6 t 71.7 -49.77 0.69 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.95 -2.344 . . . . 0.0 111.411 -168.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.6 mt -48.23 -39.33 20.9 Favored 'General case' 0 CA--C 1.581 2.14 0 C-N-CA 127.637 2.375 . . . . 0.0 113.972 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.26 -44.97 88.61 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 125.279 1.432 . . . . 0.0 113.025 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -76.69 -22.27 54.19 Favored 'General case' 0 CA--C 1.585 2.326 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.392 57.3 mtpt 106.18 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 127.648 2.379 . . . . 0.0 113.625 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.65 159.86 27.82 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.836 -1.165 . . . . 0.0 113.021 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -80.51 167.28 20.32 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -98.04 155.96 16.87 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-O 123.052 1.406 . . . . 0.0 107.708 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -168.28 118.92 0.79 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 119.622 -1.924 . . . . 0.0 108.724 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -127.92 -174.53 3.22 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.235 1.017 . . . . 0.0 111.127 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.259 9.5 t0 -126.71 121.52 32.29 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 tp -50.67 111.77 0.59 Allowed 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.58 23.42 70.46 Favored Glycine 0 CA--C 1.573 3.71 0 CA-C-O 118.218 -1.323 . . . . 0.0 116.045 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -124.65 -70.7 0.74 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 120.277 2.039 . . . . 0.0 112.952 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.81 73.35 0.3 Allowed Glycine 0 N--CA 1.508 3.443 0 N-CA-C 103.85 -3.7 . . . . 0.0 103.85 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.487 5.7 pt-20 -73.54 134.48 43.8 Favored 'General case' 0 CA--C 1.561 1.366 2 CA-C-O 129.302 4.382 . . . . 0.0 119.196 -158.503 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.353 20.8 m -80.04 -117.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 1 CA-C-N 102.564 -6.653 . . . . 0.0 108.439 -175.445 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.2 pt -121.72 156.11 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 124.285 1.993 . . . . 0.0 107.775 167.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 8.0 tmtt? -66.94 -28.72 68.52 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.927 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.17 83.37 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 117.353 -1.308 . . . . 0.0 111.485 166.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -70.18 -41.59 73.54 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.866 1.666 . . . . 0.0 111.99 172.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.83 -41.26 67.18 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.766 1.621 . . . . 0.0 114.465 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -68.26 -61.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 119.582 1.083 . . . . 0.0 112.586 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.26 -28.45 66.33 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.271 45.5 t -79.16 -43.72 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 117.209 -1.377 . . . . 0.0 109.503 175.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.49 -33.45 31.43 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.161 1.8 . . . . 0.0 115.492 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -86.4 -12.09 50.16 Favored 'General case' 0 CA--C 1.583 2.221 0 CA-C-O 115.597 -2.144 . . . . 0.0 116.645 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -89.62 146.89 24.24 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 125.244 3.656 . . . . 0.0 115.043 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -86.94 159.97 18.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.86 125.95 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.566 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.277 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.12 -49.54 0.89 Allowed Glycine 0 N--CA 1.494 2.512 0 CA-C-O 113.939 -3.701 . . . . 0.0 108.651 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.974 4.5 pt-20 154.01 -93.73 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.417 1 N-CA-C 131.351 7.538 . . . . 0.0 131.351 164.39 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.7 tp -79.09 122.2 25.94 Favored 'General case' 0 N--CA 1.484 1.225 1 N-CA-C 123.96 4.8 . . . . 0.0 123.96 -160.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.2 m -147.41 146.33 29.56 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.053 169.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -109.35 120.93 44.02 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.244 1.973 . . . . 0.0 110.905 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -75.97 146.92 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.297 -2.229 . . . . 0.0 113.521 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -136.61 117.17 13.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.8 p -133.47 154.55 50.71 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -96.62 146.61 31.61 Favored Pre-proline 0 CA--C 1.581 2.152 0 CA-C-N 113.797 -1.547 . . . . 0.0 114.022 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -43.25 -29.15 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 N-CA-C 121.62 3.661 . . . . 0.0 121.62 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -65.36 -39.09 91.88 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.22 1.827 . . . . 0.0 115.356 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -86.64 -7.71 58.1 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.958 1.303 . . . . 0.0 113.718 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.44 -133.77 0.34 Allowed 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 120.827 1.649 . . . . 0.0 112.398 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.2 4.1 49.74 Favored 'General case' 0 CA--C 1.591 2.556 0 CA-C-N 122.424 2.375 . . . . 0.0 113.411 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.69 -62.14 5.09 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 122.293 3.677 . . . . 0.0 122.293 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -70.48 -39.16 74.37 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -130.04 -7.19 4.4 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.27 158.29 27.66 Favored Glycine 0 CA--C 1.55 2.241 0 CA-C-N 124.421 3.282 . . . . 0.0 113.78 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.1 t -82.75 137.0 44.28 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 116.777 -1.582 . . . . 0.0 109.759 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.266 43.8 Cg_exo -32.82 -45.18 0.25 Allowed 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.464 4.755 . . . . 0.0 124.464 -176.357 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 -52.99 0.08 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 0 CA-C-N 125.934 3.155 . . . . 0.0 118.929 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -152.5 3.57 0.35 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 51.0 mt -79.89 137.43 53.95 Favored Pre-proline 0 CA--C 1.599 2.838 0 O-C-N 119.15 -2.219 . . . . 0.0 113.705 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -92.63 -176.1 0.64 Allowed 'Trans proline' 0 CA--C 1.595 3.545 0 CA-C-N 125.319 2.935 . . . . 0.0 115.533 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -64.18 171.97 6.96 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 N-CA-C 118.722 2.547 . . . . 0.0 118.722 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.262 28.3 t-20 59.23 54.08 5.02 Favored 'General case' 0 CA--C 1.585 2.297 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.06 105.94 13.8 Favored 'General case' 0 CA--C 1.57 1.73 0 O-C-N 120.417 -1.427 . . . . 0.0 113.491 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 85.2 m -82.44 135.37 35.16 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.8 mt -129.93 167.45 18.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 122.694 2.497 . . . . 0.0 115.585 -171.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.29 125.79 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 CA-C-N 111.147 -2.751 . . . . 0.0 107.01 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.275 60.7 m-85 -133.0 162.11 32.58 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 119.89 -1.756 . . . . 0.0 110.977 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.68 104.23 6.25 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.81 131.85 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 122.0 0.905 . . . . 0.0 111.269 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -114.14 111.07 20.99 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.996 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 117.34 29.97 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.57 -65.62 0.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.367 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -156.85 162.36 39.69 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 121.451 1.932 . . . . 0.0 109.491 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -141.38 -98.54 0.14 Allowed 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -80.34 -43.8 20.55 Favored 'General case' 0 CA--C 1.594 2.669 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.949 173.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.649 0 CA-C-N 124.868 3.485 . . . . 0.0 121.038 178.697 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.265 0 N-CA-C 120.101 2.8 . . . . 0.0 120.101 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.02 140.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.588 5.9 tp -155.73 -142.92 0.11 Allowed 'General case' 0 CA--C 1.57 1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.148 168.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -153.45 162.8 40.92 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.193 1.473 . . . . 0.0 114.958 -170.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.1 t -107.49 104.8 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.495 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.496 HD12 ' SG ' ' A' ' 102' ' ' CYS 0.376 2.1 mm -76.81 120.44 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-N 120.588 1.54 . . . . 0.0 112.512 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -95.1 -53.61 3.74 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.474 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -148.91 103.82 3.39 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -76.77 165.9 24.1 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 123.781 2.991 . . . . 0.0 114.344 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.75 -158.68 33.95 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.308 5.0 t -153.26 -77.69 0.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.887 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 13.88 -85.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 122.423 3.729 . . . . 0.0 122.423 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.3 t -143.81 60.34 1.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 121.739 0.781 . . . . 0.0 111.193 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.399 6.4 pt-20 28.01 -114.84 0.03 OUTLIER 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -139.17 121.39 10.24 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.732 1.213 . . . . 0.0 112.681 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -70.09 -114.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.524 0 C-N-CA 122.912 2.408 . . . . 0.0 114.861 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.7 ptm -170.24 179.94 3.3 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 tp -50.48 144.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.258 0 O-C-N 120.771 -1.206 . . . . 0.0 111.268 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.64 -10.59 64.23 Favored Glycine 0 CA--C 1.555 2.562 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -85.85 149.01 25.54 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 121.764 2.782 . . . . 0.0 113.354 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.9 tpt85 -79.94 130.55 35.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.033 -1.042 . . . . 0.0 109.488 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 2.4 t -127.84 146.04 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.272 1.029 . . . . 0.0 110.718 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.253 51.7 p90 -134.32 115.28 13.9 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 122.871 1.32 . . . . 0.0 108.493 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.17 -179.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 CA-C-O 124.087 1.899 . . . . 0.0 113.553 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.57 113.91 9.56 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.479 172.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -115.85 150.13 37.51 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -122.54 147.15 46.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 162.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.06 143.06 9.82 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 119.102 -2.249 . . . . 0.0 117.198 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -134.3 154.78 51.12 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.634 1.974 . . . . 0.0 114.915 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.24 162.59 23.48 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.297 1.6 tm? -61.81 -29.03 69.89 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.05 -2.06 4.99 Favored 'General case' 0 CA--C 1.598 2.808 0 O-C-N 120.323 -1.486 . . . . 0.0 114.934 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.97 50.18 4.48 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 120.17 -1.581 . . . . 0.0 113.98 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.4 m -128.43 115.89 18.89 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.28 112.61 14.17 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.108 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -87.59 -36.99 17.21 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 122.277 2.308 . . . . 0.0 114.303 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -151.44 155.85 39.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.5 1.619 . . . . 0.0 111.148 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.5 p -159.92 104.72 1.54 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.192 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -36.86 80.15 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.61 -34.55 67.34 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 -58.66 3.38 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -158.42 69.77 0.51 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.794 1.179 . . . . 0.0 113.108 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.05 -82.08 0.08 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 120.115 -1.616 . . . . 0.0 108.42 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.71 -157.68 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 127.356 2.262 . . . . 0.0 108.409 -174.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -88.84 -176.94 5.38 Favored 'General case' 0 CA--C 1.578 2.047 0 O-C-N 120.068 -1.645 . . . . 0.0 109.556 169.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.274 9.9 t80 -119.65 160.0 23.34 Favored 'General case' 0 CA--C 1.576 1.971 0 O-C-N 119.627 -1.921 . . . . 0.0 110.344 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 p -165.39 134.42 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 119.792 -1.818 . . . . 0.0 109.198 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -148.07 -178.56 6.35 Favored 'General case' 0 CA--C 1.58 2.103 0 O-C-N 121.374 -0.829 . . . . 0.0 110.977 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 -117.11 127.34 54.04 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.67 103.56 0.05 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -172.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.69 47.96 87.46 Favored Glycine 1 N--CA 1.516 4.017 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.308 0.0 OUTLIER -133.76 -78.81 0.47 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -168.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.29 71.41 0.33 Allowed Glycine 0 N--CA 1.509 3.542 1 N-CA-C 103.066 -4.014 . . . . 0.0 103.066 169.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.474 0.0 OUTLIER -66.37 141.86 57.82 Favored 'General case' 0 CA--C 1.554 1.106 2 CA-C-O 129.274 4.369 . . . . 0.0 119.564 -157.593 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.396 17.4 m -79.93 -110.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 1 CA-C-N 102.751 -6.568 . . . . 0.0 105.617 -176.959 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 89' ' ' TRP . 24.8 pt -125.28 156.76 34.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 124.031 1.872 . . . . 0.0 106.121 167.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.45 -28.94 68.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.115 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.17 -36.02 76.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 117.024 -1.465 . . . . 0.0 112.867 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.418 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.5 m0 -72.91 -45.23 59.32 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 120.785 1.63 . . . . 0.0 112.755 173.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . 0.288 2.7 p30 -56.7 -35.41 68.47 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 121.527 1.967 . . . . 0.0 115.497 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.272 1.6 mp -67.16 -57.77 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-N 119.45 1.023 . . . . 0.0 111.241 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.13 83.09 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 t -68.51 -41.14 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 120.43 1.468 . . . . 0.0 111.585 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.57 62.61 Favored 'General case' 0 CA--C 1.587 2.384 0 CA-C-N 120.16 1.345 . . . . 0.0 113.83 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.4 p -96.44 -3.15 44.0 Favored 'General case' 0 CA--C 1.593 2.606 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.2 ttp -103.02 132.64 49.14 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 121.944 2.157 . . . . 0.0 111.026 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -94.17 153.55 18.03 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.4 t -10.56 -31.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 1 N-CA-C 126.862 5.875 . . . . 0.0 126.862 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.17 17.73 0.22 Allowed Glycine 0 N--CA 1.493 2.449 0 CA-C-O 116.357 -2.357 . . . . 0.0 115.038 -169.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.35 0.9 OUTLIER -129.14 -174.24 3.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -176.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.13 127.51 53.25 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.496 ' SG ' HD12 ' A' ' 36' ' ' ILE . 1.6 m -139.68 165.9 26.04 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.708 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.251 6.0 mtt85 -127.84 116.89 20.86 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.581 1.658 . . . . 0.0 111.143 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.62 138.25 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.8 m -132.99 109.64 9.7 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 25.1 p -137.26 149.08 46.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.093 2.998 . . . . 0.0 119.093 -173.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -81.0 142.13 51.47 Favored Pre-proline 0 CA--C 1.577 2.01 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.743 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.55 -25.44 7.72 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 N-CA-C 120.727 3.318 . . . . 0.0 120.727 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.07 -38.68 89.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.364 1.893 . . . . 0.0 114.558 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -79.28 -7.65 58.45 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 124.953 1.301 . . . . 0.0 114.249 169.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.25 -115.84 0.24 Allowed 'General case' 0 CA--C 1.58 2.109 0 CA-C-N 120.7 1.591 . . . . 0.0 114.781 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.285 1.6 m-85 -103.33 29.51 5.56 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 122.178 2.263 . . . . 0.0 113.432 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -52.36 158.18 3.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 120.449 2.939 . . . . 0.0 120.449 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.284 9.9 t 71.1 -64.56 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.89 -15.6 16.81 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.17 177.8 49.85 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-N 122.619 2.463 . . . . 0.0 112.392 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.416 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.4 t -75.31 127.43 86.34 Favored Pre-proline 0 CA--C 1.579 2.093 0 CA-C-O 116.394 -1.765 . . . . 0.0 108.846 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 69.6 Cg_exo -38.3 -43.81 1.9 Allowed 'Trans proline' 0 CA--C 1.582 2.922 1 N-CA-C 123.0 4.192 . . . . 0.0 123.0 -176.961 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.6 -37.06 0.22 Allowed 'Trans proline' 0 CA--C 1.573 2.469 0 CA-C-N 125.491 2.997 . . . . 0.0 119.399 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -150.99 -7.34 0.26 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.416 ' HB ' ' H ' ' A' ' 117' ' ' SER . 1.5 mt -79.9 145.94 62.84 Favored Pre-proline 0 CA--C 1.595 2.678 0 CA-C-N 122.944 2.611 . . . . 0.0 112.797 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.4 160.65 48.81 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 CA-C-N 126.453 3.341 . . . . 0.0 115.497 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -62.2 129.32 26.64 Favored 'Trans proline' 0 CA--C 1.57 2.286 0 C-N-CA 122.721 2.281 . . . . 0.0 116.736 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.58 65.66 1.21 Allowed 'General case' 0 CA--C 1.592 2.579 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.5 140.18 51.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 119.642 -1.911 . . . . 0.0 111.748 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.6 m -59.99 146.46 42.51 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.429 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 6.2 tp -116.8 152.55 34.16 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.931 1.696 . . . . 0.0 112.336 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.26 130.39 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.302 -170.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.256 24.2 m-85 -138.35 161.28 37.33 Favored 'General case' 0 N--CA 1.521 3.085 0 O-C-N 119.444 -2.035 . . . . 0.0 110.435 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 5.9 tm-20 -126.19 104.68 8.36 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.52 135.31 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-O 122.387 1.089 . . . . 0.0 111.107 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -115.35 115.77 27.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.658 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.25 112.17 24.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -77.92 -40.09 40.79 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.23 172.11 1.95 Allowed 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.304 0.0 OUTLIER -146.13 -96.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.374 -2.079 . . . . 0.0 107.919 177.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.47 72.2 tttt -111.42 -99.42 0.41 Allowed 'General case' 0 CA--C 1.586 2.347 0 CA-C-O 116.545 -1.693 . . . . 0.0 110.019 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.22 0 CA-C-N 124.991 3.541 . . . . 0.0 113.973 -178.568 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.352 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.4 t -169.04 144.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.587 7.8 tp -157.69 -141.92 0.09 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.988 -1.482 . . . . 0.0 111.415 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 29.6 mtpt -155.87 155.75 33.45 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 122.825 2.557 . . . . 0.0 115.876 -171.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.56 108.11 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.408 1.0 OUTLIER -78.83 124.75 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-N 120.274 1.397 . . . . 0.0 113.538 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -110.64 -56.48 2.35 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.059 0.933 . . . . 0.0 110.599 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.262 46.1 ttt180 -113.63 97.98 6.77 Favored 'General case' 0 CA--C 1.597 2.787 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -37.75 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.863 1 N-CA-C 123.349 4.574 . . . . 0.0 123.349 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.18 163.73 28.03 Favored Glycine 0 CA--C 1.55 2.234 0 C-N-CA 125.072 1.32 . . . . 0.0 114.696 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.343 12.4 t -146.41 -72.07 0.24 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.85 69.54 2.64 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 120.756 3.062 . . . . 0.0 120.756 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.27 71.1 p 69.7 61.84 0.27 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.383 4.7 pt-20 30.6 -113.39 0.03 OUTLIER 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -147.52 122.19 5.11 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 115.918 -1.991 . . . . 0.0 110.898 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.42 0.2 OUTLIER -114.26 -40.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.275 1 N-CA-C 125.749 5.25 . . . . 0.0 125.749 177.579 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.526 3.367 2 N-CA-C 127.542 6.127 . . . . 0.0 127.542 -174.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 tp -65.71 141.0 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.03 82.43 Favored Glycine 0 CA--C 1.567 3.322 0 O-C-N 120.286 -1.509 . . . . 0.0 116.527 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HD2' ' HB2' ' A' ' 137' ' ' LYS . 4.0 t0 -72.66 141.38 48.27 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.932 2.366 . . . . 0.0 110.625 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 -85.97 101.03 12.54 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.25 137.2 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.35 0.66 . . . . 0.0 112.416 -169.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.05 104.56 12.26 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -108.98 160.29 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 125.754 2.692 . . . . 0.0 114.697 -172.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -125.05 115.69 20.92 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.705 -2.952 . . . . 0.0 105.106 167.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.331 5.7 p90 -113.95 143.93 43.9 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.728 1.251 . . . . 0.0 114.28 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -118.07 147.32 43.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 164.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.79 136.6 4.67 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 118.894 -2.379 . . . . 0.0 115.278 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.29 160.36 40.64 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 111.852 -2.174 . . . . 0.0 114.921 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.448 HD11 ' H ' ' A' ' 62' ' ' ASP . 1.0 OUTLIER -80.65 178.82 8.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -65.13 -22.62 66.96 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' H ' HD11 ' A' ' 60' ' ' LEU . 36.8 t70 -73.57 -6.46 46.75 Favored 'General case' 0 CA--C 1.601 2.924 0 CA-C-N 119.106 0.867 . . . . 0.0 112.704 165.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.79 47.46 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 125.59 1.567 . . . . 0.0 113.636 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -88.67 108.93 19.72 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -74.49 91.85 2.31 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -73.1 -25.94 61.05 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 119.81 -1.806 . . . . 0.0 113.592 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -151.72 154.17 35.79 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 124.693 2.187 . . . . 0.0 115.308 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.449 ' HG ' ' NE ' ' A' ' 72' ' ' ARG . 79.8 p -153.77 102.3 2.52 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 112.029 -2.35 . . . . 0.0 104.767 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.292 31.6 p -58.87 -67.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.379 32.6 mt -61.39 -45.14 95.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.05 -40.89 24.36 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.449 ' NE ' ' HG ' ' A' ' 68' ' ' SER . 60.0 mtt180 -93.91 26.83 3.0 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.339 40.3 tttp 82.44 -30.4 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.49 -170.29 2.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.19 176.66 9.36 Favored 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 126.044 1.738 . . . . 0.0 109.857 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.394 0.5 OUTLIER -132.68 146.02 51.52 Favored 'General case' 0 CA--C 1.575 1.939 0 O-C-N 119.404 -2.06 . . . . 0.0 111.853 173.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.1 p -165.42 150.29 8.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.297 -2.127 . . . . 0.0 109.647 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -159.66 -171.8 3.43 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.665 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -123.18 113.66 19.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -37.99 105.98 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.43 53.52 24.61 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 118.178 2.031 . . . . 0.0 118.178 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -7.2 23.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.59 63.06 2.17 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 -167.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -154.29 -55.45 0.1 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 112.036 -2.082 . . . . 0.0 110.307 -163.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.301 16.6 m -97.82 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 pt -125.64 163.2 27.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 124.459 2.076 . . . . 0.0 109.261 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.254 0.9 OUTLIER -68.07 -34.58 76.7 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.178 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.39 70.71 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.601 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -73.26 -46.27 50.95 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 121.136 1.789 . . . . 0.0 112.28 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.95 -35.83 69.57 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 121.361 1.891 . . . . 0.0 115.571 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.29 1.7 mp -65.22 -61.55 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.207 0 CA-C-N 119.855 1.207 . . . . 0.0 111.627 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.91 80.91 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.301 6.4 t -74.27 -32.87 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.189 0 O-C-N 121.237 -0.914 . . . . 0.0 111.084 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.99 -24.72 68.04 Favored 'General case' 0 CA--C 1.577 2.008 0 CA-C-N 120.709 1.595 . . . . 0.0 113.833 166.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.0 p -97.22 8.0 45.44 Favored 'General case' 0 CA--C 1.596 2.724 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.787 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 8.6 tpt -93.71 140.32 29.78 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 119.515 -1.991 . . . . 0.0 113.346 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.24 145.61 26.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.778 . . . . 0.0 114.203 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.05 125.23 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.32 -12.91 53.49 Favored Glycine 0 N--CA 1.496 2.675 0 CA-C-O 114.972 -3.127 . . . . 0.0 117.888 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.483 67.7 mt-10 -113.16 -159.5 0.69 Allowed 'General case' 0 CA--C 1.583 2.234 0 CA-C-N 122.805 3.303 . . . . 0.0 117.434 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.0 tp -140.26 138.75 35.26 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 119.082 2.994 . . . . 0.0 119.082 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 0.8 OUTLIER -160.02 157.82 29.41 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.909 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -104.88 128.71 53.21 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.204 1.478 . . . . 0.0 113.177 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.609 HG21 ' SG ' ' A' ' 106' ' ' CYS . 11.0 mt -71.88 131.72 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.231 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.625 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.1 m -113.98 108.78 17.48 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 104' ' ' ILE 0.315 11.4 p -160.16 162.92 34.01 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 120.09 3.366 . . . . 0.0 120.09 -163.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HD3' ' SG ' ' A' ' 106' ' ' CYS 2.574 0.0 OUTLIER 134.61 -147.52 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.165 1 N-CA-C 147.669 13.581 . . . . 0.0 147.669 157.447 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.888 21.9 Cg_exo 35.09 -63.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.577 2.631 1 C-N-CA 126.206 4.604 . . . . 0.0 120.952 -162.214 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.31 -33.37 75.69 Favored 'General case' 0 CA--C 1.579 2.07 0 O-C-N 118.818 -2.426 . . . . 0.0 114.805 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -80.76 0.99 32.26 Favored 'General case' 0 CA--C 1.598 2.82 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.69 -104.86 0.09 Allowed 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.87 -7.53 54.01 Favored 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -45.56 -21.39 0.49 Allowed Glycine 0 N--CA 1.503 3.112 1 N-CA-C 123.868 4.307 . . . . 0.0 123.868 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.9 p -71.92 -56.12 6.26 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.603 1.702 . . . . 0.0 112.79 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.19 -0.24 3.72 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.56 153.82 27.29 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-N 123.56 2.891 . . . . 0.0 115.133 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.5 t -82.97 130.77 56.26 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.635 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -34.29 -47.57 0.55 Allowed 'Trans proline' 0 CA--C 1.581 2.841 1 N-CA-C 122.666 4.064 . . . . 0.0 122.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.23 -54.71 0.36 Allowed 'Trans proline' 0 CA--C 1.571 2.351 0 CA-C-N 125.682 3.065 . . . . 0.0 116.725 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -173.0 78.3 0.04 OUTLIER 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 119.344 0.975 . . . . 0.0 113.542 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.9 mt -141.09 125.65 10.59 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 119.673 -1.892 . . . . 0.0 109.377 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -90.31 162.69 4.59 Favored 'Trans proline' 0 CA--C 1.589 3.264 0 CA-C-N 123.442 2.265 . . . . 0.0 112.223 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.28 -34.6 66.88 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.103 2.309 . . . . 0.0 118.103 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -89.68 56.71 3.63 Favored 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 125.981 1.712 . . . . 0.0 113.215 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.54 106.94 4.37 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.014 -1.678 . . . . 0.0 113.664 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 m -60.35 154.09 21.15 Favored 'General case' 0 CA--C 1.587 2.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.2 mt -124.27 172.34 9.17 Favored 'General case' 0 CA--C 1.566 1.567 0 O-C-N 120.288 -1.507 . . . . 0.0 111.834 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.46 123.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -123.78 120.82 33.78 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 119.937 1.244 . . . . 0.0 108.228 176.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.15 107.79 19.35 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.961 -1.087 . . . . 0.0 108.716 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -112.45 135.86 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.17 0.986 . . . . 0.0 110.892 -171.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -114.43 112.71 23.44 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.9 115.1 28.86 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.891 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -78.94 -50.21 11.54 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -169.94 159.67 7.92 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 123.833 1.777 . . . . 0.0 110.384 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.91 -87.97 0.08 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 102.76 -3.052 . . . . 0.0 102.76 -177.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HB2' ' HD2' ' A' ' 50' ' ' ASP . 53.6 tptt -121.89 95.45 4.67 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 170.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.635 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 177.477 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.68 146.47 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 N-CA-C 119.028 2.973 . . . . 0.0 119.028 -170.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.42 136.9 52.86 Favored 'General case' 0 CA--C 1.598 2.793 0 C-N-CA 126.548 1.939 . . . . 0.0 107.539 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -124.19 118.65 27.34 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 118.291 -2.756 . . . . 0.0 108.211 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.13 136.03 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.579 -0.701 . . . . 0.0 109.613 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.426 HD12 ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -100.22 151.43 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 122.124 0.964 . . . . 0.0 113.044 -177.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -131.18 -63.62 0.84 Allowed 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 124.22 1.008 . . . . 0.0 110.851 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -112.79 89.86 3.19 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -35.09 -56.21 0.59 Allowed 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -151.75 17.38 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 124.63 1.109 . . . . 0.0 115.495 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 t -79.66 -34.17 40.65 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.35 45.74 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 120.429 2.932 . . . . 0.0 120.429 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.25 67.2 p 68.84 -5.88 0.95 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 118.894 2.924 . . . . 0.0 118.894 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -75.86 131.94 40.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.0 p -107.93 163.61 16.57 Favored Pre-proline 0 N--CA 1.503 2.185 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.47 166.43 25.93 Favored 'Trans proline' 0 CA--C 1.577 2.639 0 CA-C-N 122.39 1.889 . . . . 0.0 114.436 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -102.39 163.34 12.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.52 -1.363 . . . . 0.0 111.546 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.355 0.3 OUTLIER -63.16 128.51 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.179 -2.2 . . . . 0.0 110.432 178.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 4.03 84.58 Favored Glycine 0 CA--C 1.572 3.594 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HD2' ' HA ' ' A' ' 137' ' ' LYS . 9.7 t0 -65.23 166.34 9.99 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 121.189 2.494 . . . . 0.0 114.35 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -108.21 101.12 10.37 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 119.926 1.239 . . . . 0.0 108.933 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.93 139.0 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 123.61 0.764 . . . . 0.0 111.05 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.28 41.6 p90 -117.32 101.12 8.16 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 124.865 2.269 . . . . 0.0 109.267 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.19 170.93 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 111.076 -2.783 . . . . 0.0 112.731 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.96 100.7 3.22 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 166.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -97.69 160.22 14.45 Favored 'General case' 0 CA--C 1.593 2.635 0 CA-C-O 122.724 1.249 . . . . 0.0 113.299 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -128.0 147.96 50.52 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.15 142.43 9.1 Favored Glycine 0 CA--C 1.55 2.222 0 O-C-N 119.098 -2.251 . . . . 0.0 116.464 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -130.27 149.11 52.11 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.49 1.916 . . . . 0.0 115.205 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.29 171.4 12.75 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.922 1.344 . . . . 0.0 108.746 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 3.3 tt -62.56 -29.46 70.6 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.05 7.01 1.81 Allowed 'General case' 0 CA--C 1.597 2.786 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.37 66.0 Favored Glycine 0 N--CA 1.509 3.557 0 O-C-N 119.841 -1.787 . . . . 0.0 114.744 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -112.62 118.53 35.31 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -77.88 93.11 4.33 Favored 'General case' 0 CA--C 1.583 2.225 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -64.66 -30.31 71.33 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 119.151 -2.218 . . . . 0.0 114.559 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.14 152.85 31.73 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 124.513 2.102 . . . . 0.0 112.492 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.6 p -159.35 86.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 t -52.91 -40.66 63.73 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.12 -38.81 54.13 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.691 1.996 . . . . 0.0 115.694 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.68 -34.26 18.49 Favored 'General case' 0 CA--C 1.578 2.025 0 C-N-CA 125.879 1.672 . . . . 0.0 114.88 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -29.78 70.88 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.312 2.708 . . . . 0.0 118.312 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.352 58.5 tptt 131.5 -56.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 127.677 2.391 . . . . 0.0 111.695 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -98.35 174.06 6.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 123.602 1.667 . . . . 0.0 113.199 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.06 175.62 6.25 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 125.298 1.439 . . . . 0.0 114.389 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.345 2.3 t80 -108.49 153.27 23.57 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-O 122.989 1.376 . . . . 0.0 108.356 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.9 p -163.53 111.79 1.22 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 118.154 -2.841 . . . . 0.0 104.514 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -125.54 177.06 6.42 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.116 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.308 33.6 t70 -86.32 -139.34 0.09 Allowed 'General case' 0 CA--C 1.584 2.251 0 O-C-N 119.117 -2.24 . . . . 0.0 105.803 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 tp -141.5 109.96 5.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 118.579 -2.576 . . . . 0.0 104.265 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 48.44 16.12 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.414 14.5 tppt? -106.82 6.58 29.6 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-N 119.902 1.851 . . . . 0.0 114.441 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.1 -51.99 1.65 Allowed Glycine 0 N--CA 1.508 3.478 0 O-C-N 120.151 -1.593 . . . . 0.0 109.953 -172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.283 52.9 tt0 -20.2 -53.82 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 120.654 3.575 . . . . 0.0 120.654 168.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.294 16.5 m -101.87 -135.61 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 123.228 1.49 . . . . 0.0 110.12 -174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.7 pt -126.55 162.51 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.774 1.75 . . . . 0.0 109.797 173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -67.16 -33.61 75.79 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.172 -1.376 . . . . 0.0 113.109 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.2 73.09 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.29 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -74.77 -42.18 58.66 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-N 120.854 1.661 . . . . 0.0 112.205 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.84 -38.5 85.7 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.21 1.368 . . . . 0.0 113.863 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.4 mp -68.6 -60.64 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-N 119.09 0.859 . . . . 0.0 111.615 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.05 72.94 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.311 15.5 t -74.16 -32.79 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 CA-C-N 120.344 1.429 . . . . 0.0 110.652 175.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.25 73.92 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 121.02 1.736 . . . . 0.0 112.749 166.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.8 p -83.85 8.24 15.51 Favored 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.544 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 tpt -91.95 130.3 37.73 Favored 'General case' 0 CA--C 1.579 2.072 0 O-C-N 119.483 -2.011 . . . . 0.0 112.209 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.33 135.35 41.89 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 116.423 -1.751 . . . . 0.0 109.461 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.288 3.6 t -9.65 82.84 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-O 124.729 2.204 . . . . 0.0 108.308 -161.044 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -54.99 46.88 0.01 OUTLIER Glycine 0 N--CA 1.502 3.037 2 CA-C-N 107.532 -4.394 . . . . 0.0 123.702 -140.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 0.4 OUTLIER -29.02 -87.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -169.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.61 121.51 17.67 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.754 0.822 . . . . 0.0 112.646 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.544 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 2.4 m -149.2 167.36 26.2 Favored 'General case' 0 CA--C 1.575 1.92 0 C-N-CA 123.949 0.899 . . . . 0.0 111.779 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -131.83 133.6 44.86 Favored 'General case' 0 CA--C 1.557 1.226 0 O-C-N 119.134 -2.229 . . . . 0.0 112.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.3 mt -90.71 129.27 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 CA-C-N 112.689 -2.05 . . . . 0.0 108.862 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 106.4 14.35 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.581 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 5.0 p -129.36 147.48 51.19 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -169.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -91.69 146.25 32.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.037 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.26 82.4 Cg_endo -61.87 -14.55 37.43 Favored 'Trans proline' 0 CA--C 1.568 2.213 0 N-CA-C 118.023 2.278 . . . . 0.0 118.023 -176.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.82 -38.46 78.7 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 120.778 1.626 . . . . 0.0 114.427 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.58 2.54 52.85 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 125.632 1.573 . . . . 0.0 113.495 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.61 -113.8 0.17 Allowed 'General case' 0 CA--C 1.58 2.132 0 CA-C-N 120.774 1.624 . . . . 0.0 115.269 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.271 4.9 m-85 -88.08 0.33 56.12 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 120.953 1.706 . . . . 0.0 115.378 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.4 -19.39 1.87 Allowed Glycine 0 N--CA 1.499 2.86 1 N-CA-C 124.219 4.447 . . . . 0.0 124.219 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -71.36 -57.41 4.48 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 120.271 2.036 . . . . 0.0 111.869 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.52 0.34 2.49 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.5 157.07 33.3 Favored Glycine 0 CA--C 1.546 1.996 0 CA-C-N 123.999 3.091 . . . . 0.0 112.483 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.7 t -86.53 125.56 66.99 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-O 116.918 -1.515 . . . . 0.0 108.423 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.274 28.1 Cg_exo -26.24 -49.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.877 1 N-CA-C 124.882 4.916 . . . . 0.0 124.882 -176.334 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -46.16 1.3 Allowed 'Trans proline' 0 CA--C 1.572 2.391 0 CA-C-N 125.861 3.129 . . . . 0.0 118.977 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -152.58 -11.78 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.91 144.13 59.03 Favored Pre-proline 0 CA--C 1.595 2.692 0 CA-C-N 121.858 2.117 . . . . 0.0 115.564 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -102.48 176.16 0.19 Allowed 'Trans proline' 0 CA--C 1.594 3.497 0 CA-C-N 125.278 2.921 . . . . 0.0 113.661 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.5 -37.87 5.1 Favored 'Trans proline' 0 CA--C 1.573 2.464 0 C-N-CA 122.239 1.959 . . . . 0.0 116.619 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -80.89 50.87 1.44 Allowed 'General case' 0 CA--C 1.582 2.177 0 O-C-N 120.06 -1.65 . . . . 0.0 115.202 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.28 127.91 17.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.218 -1.551 . . . . 0.0 112.831 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.1 m -80.26 161.73 24.98 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.973 -1.079 . . . . 0.0 112.817 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.581 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.3 0.5 OUTLIER -145.12 174.0 11.44 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 119.711 -1.868 . . . . 0.0 112.274 -176.569 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.57 125.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 125.039 1.336 . . . . 0.0 108.005 -171.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.285 4.7 m-85 -124.13 122.85 38.94 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 120.302 1.41 . . . . 0.0 110.58 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.17 121.73 32.47 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.77 128.0 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 121.369 0.604 . . . . 0.0 111.806 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.56 100.56 9.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.285 16.2 tp -103.99 126.81 51.4 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.687 1.232 . . . . 0.0 111.703 -174.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -86.04 -60.32 2.04 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 120.897 -1.127 . . . . 0.0 112.836 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -157.5 -178.06 7.06 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 119.939 1.245 . . . . 0.0 110.088 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.26 -60.65 0.08 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 50' ' ' ASP 0.28 58.3 tttm -79.82 -44.51 20.43 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.614 2.82 . . . . 0.0 118.614 -172.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.823 0 CA-C-N 124.774 3.443 . . . . 0.0 121.188 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.141 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.394 17.1 t -123.89 119.28 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.2 tp -89.93 122.42 32.94 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 125.251 1.42 . . . . 0.0 108.68 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -114.77 97.81 6.48 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 122.816 2.553 . . . . 0.0 108.568 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 109.318 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -86.17 145.48 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-O 121.591 0.71 . . . . 0.0 111.836 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -123.58 -53.67 1.78 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 123.568 0.747 . . . . 0.0 111.491 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -124.1 107.18 10.99 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -72.54 0.05 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.75 -156.82 28.83 Favored Glycine 0 CA--C 1.547 2.092 0 C-N-CA 125.1 1.334 . . . . 0.0 111.713 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -88.74 -7.48 56.18 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.6 -85.73 0.06 OUTLIER Glycine 0 CA--C 1.538 1.482 0 O-C-N 121.164 -0.96 . . . . 0.0 111.943 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -165.45 5.27 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -87.23 154.02 21.04 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 123.775 2.989 . . . . 0.0 115.1 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 p -128.23 164.29 38.48 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 112.974 -1.921 . . . . 0.0 113.284 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.48 -176.42 2.28 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-N 122.515 1.934 . . . . 0.0 115.775 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.5 ptp -133.92 167.34 20.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.461 -1.399 . . . . 0.0 112.426 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.279 1.5 tp -60.58 136.68 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 O-C-N 119.251 -2.155 . . . . 0.0 110.967 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.33 61.46 Favored Glycine 0 CA--C 1.559 2.787 0 N-CA-C 118.412 2.125 . . . . 0.0 118.412 -173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.85 149.13 26.58 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.63 2.215 . . . . 0.0 112.019 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -78.37 133.89 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.368 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 m -136.84 138.75 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 118.804 0.729 . . . . 0.0 111.57 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -116.73 102.43 9.42 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.551 -1.343 . . . . 0.0 108.543 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.2 m -102.32 167.81 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.62 117.91 17.59 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -112.18 150.85 30.26 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 m -119.05 151.6 37.94 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 157.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.07 142.32 8.86 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 118.229 -2.795 . . . . 0.0 115.459 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -130.25 155.07 46.89 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.027 -1.587 . . . . 0.0 115.01 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.1 tp -78.48 177.01 8.86 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 123.086 1.422 . . . . 0.0 107.378 166.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -63.81 -25.8 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.75 13.74 2.0 Allowed 'General case' 0 CA--C 1.604 3.023 0 CA-C-N 119.077 0.853 . . . . 0.0 113.268 168.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.66 29.7 75.48 Favored Glycine 0 N--CA 1.509 3.541 0 O-C-N 120.034 -1.666 . . . . 0.0 116.432 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -86.74 113.9 22.97 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -74.39 85.28 1.98 Allowed 'General case' 0 CA--C 1.586 2.331 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.64 -30.78 69.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 119.66 -1.9 . . . . 0.0 115.403 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -149.57 141.24 23.53 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.575 1.179 . . . . 0.0 111.496 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.9 p -160.02 93.26 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.4 p -61.01 -35.83 77.89 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -52.92 -39.13 62.57 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.65 -41.8 44.38 Favored 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 125.034 1.334 . . . . 0.0 114.223 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -68.54 -20.12 64.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 33.9 mtmm 101.8 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 127.407 2.283 . . . . 0.0 112.118 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.1 153.31 41.77 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 123.0 1.381 . . . . 0.0 114.356 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -93.29 178.77 5.62 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.506 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.302 4.5 t80 -114.35 153.25 30.14 Favored 'General case' 0 CA--C 1.587 2.372 0 O-C-N 120.95 -1.094 . . . . 0.0 110.082 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.8 p -161.63 145.94 12.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 118.491 -2.631 . . . . 0.0 111.342 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -155.22 -171.26 3.74 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -124.05 114.5 19.81 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.64 110.07 0.18 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.29 29.87 67.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -106.13 0.91 25.8 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.23 61.29 1.33 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -148.27 -51.29 0.17 Allowed 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 111.191 -2.505 . . . . 0.0 111.991 -166.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.261 13.5 m -125.9 -140.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.969 1.366 . . . . 0.0 109.756 -173.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.559 HD11 ' HZ2' ' A' ' 107' ' ' LYS . 12.6 pt -115.21 162.51 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-O 123.826 1.774 . . . . 0.0 109.88 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -65.88 -34.1 77.37 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.655 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.72 75.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -70.23 -40.78 74.29 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.641 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.26 -33.78 74.09 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 119.593 1.088 . . . . 0.0 113.921 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -67.37 -59.17 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 119.925 1.238 . . . . 0.0 110.622 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.0 87.67 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.332 5.2 t -60.4 -41.22 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.712 173.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.21 -39.29 56.23 Favored 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 121.506 1.957 . . . . 0.0 113.251 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -97.69 51.0 1.05 Allowed 'General case' 0 CA--C 1.593 2.624 0 C-N-CA 123.846 0.858 . . . . 0.0 112.618 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.1 ttt -138.37 152.3 48.31 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 119.479 -2.013 . . . . 0.0 113.881 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -118.53 146.08 44.83 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.558 2.799 . . . . 0.0 118.558 -172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -18.45 -29.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.756 1 N-CA-C 127.354 6.057 . . . . 0.0 127.354 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.37 -2.14 0.14 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-O 115.566 -2.797 . . . . 0.0 116.601 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 78.1 mm-40 -112.6 -145.43 0.4 Allowed 'General case' 0 N--CA 1.516 2.856 0 N-CA-C 121.012 3.708 . . . . 0.0 121.012 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 16.1 tp -133.94 140.6 46.88 Favored 'General case' 0 CA--C 1.601 2.932 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.47 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 58.8 m -142.88 -175.52 4.53 Favored 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.431 -1.418 . . . . 0.0 113.343 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -137.51 139.58 40.61 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 119.489 -2.007 . . . . 0.0 110.87 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.624 HG21 ' SG ' ' A' ' 106' ' ' CYS . 1.1 mt -106.97 128.11 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.579 0 C-N-CA 125.865 1.666 . . . . 0.0 109.168 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.8 m -119.49 114.49 22.37 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.624 ' SG ' HG21 ' A' ' 104' ' ' ILE 0.341 20.4 p -150.71 137.67 19.17 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -155.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.559 ' HZ2' HD11 ' A' ' 86' ' ' ILE 0.765 0.0 OUTLIER -20.49 98.5 0.05 OUTLIER Pre-proline 0 CA--C 1.621 3.697 3 N-CA-C 140.664 10.987 . . . . 0.0 140.664 159.535 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.315 0.2 OUTLIER -49.62 -27.82 15.59 Favored 'Trans proline' 0 CA--C 1.589 3.27 1 O-C-N 113.337 -4.086 . . . . 0.0 118.14 173.084 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.82 -42.81 85.24 Favored 'General case' 0 CA--C 1.578 2.045 0 O-C-N 120.069 -1.644 . . . . 0.0 114.459 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.542 ' HB2' ' CG ' ' A' ' 107' ' ' LYS . 52.7 m-85 -78.11 3.87 13.91 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-O 117.367 -1.302 . . . . 0.0 113.469 171.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.28 -103.43 0.14 Allowed 'General case' 0 CA--C 1.583 2.223 0 CA-C-N 121.943 2.156 . . . . 0.0 115.293 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.09 12.08 14.41 Favored 'General case' 0 CA--C 1.586 2.342 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -50.14 156.41 2.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 120.113 2.805 . . . . 0.0 120.113 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.283 7.8 t 73.38 -47.69 0.67 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.39 -52.83 4.16 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.03 148.52 17.89 Favored Glycine 0 CA--C 1.547 2.055 0 C-N-CA 124.35 0.976 . . . . 0.0 112.675 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 t -84.21 143.19 41.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.996 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.76 -39.58 57.33 Favored 'Trans proline' 0 CA--C 1.583 2.929 0 N-CA-C 120.265 3.141 . . . . 0.0 120.265 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -66.2 -62.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 CA-C-N 125.714 3.077 . . . . 0.0 116.229 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -168.57 62.64 0.06 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.13 113.29 23.96 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.087 -1.633 . . . . 0.0 107.925 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.98 165.88 24.74 Favored 'Trans proline' 0 CA--C 1.583 2.946 0 C-N-CA 122.557 2.171 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.2 116.33 3.96 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.61 2.207 . . . . 0.0 112.679 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t30 67.33 53.21 0.77 Allowed 'General case' 0 CA--C 1.59 2.502 0 C-N-CA 125.423 1.489 . . . . 0.0 114.559 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.91 130.39 56.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.508 -1.37 . . . . 0.0 109.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 3.0 m -63.32 152.86 36.73 Favored 'General case' 0 CA--C 1.594 2.66 0 CA-C-N 120.552 1.524 . . . . 0.0 114.999 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.06 172.01 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 119.495 -2.003 . . . . 0.0 111.95 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.8 t -150.98 127.32 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.201 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 78.6 m-85 -142.1 127.21 18.48 Favored 'General case' 0 N--CA 1.517 2.914 0 O-C-N 119.236 -2.165 . . . . 0.0 111.198 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' HE2' ' CD2' ' A' ' 101' ' ' LEU . 16.0 tm-20 -98.36 101.18 12.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.407 -2.058 . . . . 0.0 106.732 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.07 140.42 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.556 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.615 ' HG2' ' H ' ' A' ' 133' ' ' LEU 1.827 30.5 tt0 -138.43 -171.71 3.11 Favored 'General case' 0 N--CA 1.524 3.232 0 CA-C-O 122.608 1.194 . . . . 0.0 109.203 164.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.615 ' H ' ' HG2' ' A' ' 132' ' ' GLU . 24.4 tp -140.94 127.07 19.54 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -162.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.82 -34.97 39.03 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 175.74 159.79 0.26 Allowed 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 127.32 2.248 . . . . 0.0 106.966 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.13 -92.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.135 -1.603 . . . . 0.0 109.593 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -81.13 55.92 2.66 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.149 0 CA-C-O 117.753 -1.582 . . . . 0.0 114.941 175.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.153 1 N-CA-C 123.933 4.333 . . . . 0.0 123.933 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.3 164.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.087 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.798 0.5 OUTLIER -163.62 -168.38 1.64 Allowed 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 120.52 1.509 . . . . 0.0 114.652 164.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.571 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 23.3 pttm -148.66 150.13 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.77 87.49 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 117.362 -1.304 . . . . 0.0 112.763 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.504 2.4 mm -43.95 121.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 117.195 2.295 . . . . 0.0 117.195 -177.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -106.9 -59.24 1.83 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.893 0.877 . . . . 0.0 110.166 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -142.2 106.94 4.86 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' HE2' ' CG2' ' A' ' 36' ' ' ILE . 2.8 mp0 -51.33 -56.85 10.87 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 122.297 2.317 . . . . 0.0 116.342 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.63 -158.73 25.15 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 126.364 1.935 . . . . 0.0 114.63 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -78.24 2.79 17.2 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.4 45.12 95.68 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -114.44 -66.62 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.79 173.06 12.72 Favored 'General case' 0 CA--C 1.581 2.14 0 CA-C-O 122.996 1.379 . . . . 0.0 114.377 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -118.95 147.67 42.98 Favored Pre-proline 0 CA--C 1.581 2.15 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.157 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -68.09 141.72 53.74 Favored 'Trans proline' 0 CA--C 1.582 2.904 0 N-CA-C 118.318 2.392 . . . . 0.0 118.318 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -104.05 167.68 9.61 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 121.534 1.97 . . . . 0.0 112.79 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.256 2.0 tp -62.95 134.65 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.292 0 O-C-N 118.954 -2.341 . . . . 0.0 108.946 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.78 15.13 81.51 Favored Glycine 0 CA--C 1.562 3.012 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -82.95 139.64 33.24 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.374 2.087 . . . . 0.0 110.68 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -83.03 113.35 20.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.386 2.0 t -117.99 136.75 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 C-N-CA 125.438 1.495 . . . . 0.0 112.911 -164.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -120.35 103.79 9.5 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.901 1.334 . . . . 0.0 107.815 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 m -107.55 164.92 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 123.481 1.61 . . . . 0.0 111.961 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.469 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.295 3.7 t60 -130.24 138.06 50.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 164.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -132.5 148.48 52.39 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.789 2.515 . . . . 0.0 117.789 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -116.59 147.62 41.68 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 162.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.9 145.59 13.47 Favored Glycine 0 CA--C 1.545 1.954 0 O-C-N 119.136 -2.227 . . . . 0.0 117.308 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.45 157.75 45.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.515 1.926 . . . . 0.0 114.466 -173.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.99 167.49 11.2 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 169.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.289 1.0 OUTLIER -61.95 -25.59 67.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -68.32 -3.73 11.98 Favored 'General case' 0 CA--C 1.595 2.696 0 CA-C-N 120.069 1.304 . . . . 0.0 112.763 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 44.19 12.41 Favored Glycine 0 N--CA 1.498 2.775 0 CA-C-N 120.334 1.424 . . . . 0.0 114.295 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.0 m -120.13 119.54 33.59 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.84 92.1 3.03 Favored 'General case' 0 CA--C 1.585 2.313 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.969 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -69.74 -30.87 68.58 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 118.891 -2.381 . . . . 0.0 114.962 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -147.0 156.61 43.17 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 125.237 2.446 . . . . 0.0 114.432 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -150.36 93.03 1.93 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.272 63.8 p -47.99 -58.73 4.05 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.635 2.458 . . . . 0.0 117.635 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 85.7 mt -51.9 -44.01 63.61 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.21 -43.87 96.91 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -136.34 35.93 2.74 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -176.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -158.95 -75.11 0.08 Allowed 'General case' 0 CA--C 1.564 1.508 0 O-C-N 120.212 -1.555 . . . . 0.0 109.834 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.13 -161.78 0.06 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 127.19 2.196 . . . . 0.0 108.913 -173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.14 -170.5 2.76 Favored 'General case' 0 CA--C 1.591 2.526 0 O-C-N 118.935 -2.353 . . . . 0.0 107.769 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.47 1.4 t80 -123.77 148.79 46.33 Favored 'General case' 0 CA--C 1.58 2.11 0 O-C-N 118.038 -2.914 . . . . 0.0 111.14 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.3 p -167.07 140.89 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 118.454 -2.654 . . . . 0.0 111.973 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -149.98 -165.44 2.27 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 121.227 0.537 . . . . 0.0 111.184 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.61 63.43 1.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.207 -1.558 . . . . 0.0 112.152 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 10.77 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.81 61.7 2.51 Favored Glycine 0 N--CA 1.511 3.664 0 O-C-N 119.767 -1.833 . . . . 0.0 112.025 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.541 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.394 0.0 OUTLIER -106.48 -85.22 0.5 Allowed 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 123.964 1.84 . . . . 0.0 111.357 -171.795 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.541 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -100.93 -43.47 2.24 Favored Glycine 0 N--CA 1.51 3.61 0 CA-C-O 124.647 2.248 . . . . 0.0 110.473 165.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 1.05 1.3 pp20? 111.49 135.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 131.605 3.962 . . . . 0.0 118.684 165.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.337 12.3 m -79.69 -99.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 109.232 -3.622 . . . . 0.0 104.428 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.454 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.3 pt -133.9 155.72 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 124.451 2.072 . . . . 0.0 105.982 165.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 13.0 tmtt? -67.35 -29.0 68.43 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.752 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.13 82.02 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 117.456 -1.259 . . . . 0.0 112.113 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.454 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.9 m0 -73.15 -43.0 62.2 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 120.882 1.674 . . . . 0.0 113.094 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.33 -36.52 71.25 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 120.034 1.288 . . . . 0.0 114.157 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.283 1.7 mp -67.68 -58.0 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 119.402 1.001 . . . . 0.0 111.452 174.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.16 -39.28 94.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.449 ' HA ' ' SD ' ' A' ' 96' ' ' MET . 65.2 t -63.57 -49.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.301 1.409 . . . . 0.0 111.052 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.66 -32.55 29.97 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.1 p -100.71 19.11 17.68 Favored 'General case' 0 CA--C 1.591 2.534 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 93' ' ' VAL 0.337 1.4 ptt? -115.82 -172.96 2.26 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 122.758 2.526 . . . . 0.0 116.373 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -134.88 152.32 51.65 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 66.6 t -48.17 126.83 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.83 -44.29 1.52 Allowed Glycine 0 N--CA 1.491 2.325 0 CA-C-O 115.904 -2.609 . . . . 0.0 113.455 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -145.53 -173.38 4.11 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.827 2.813 . . . . 0.0 113.264 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.444 ' HG ' ' SD ' ' A' ' 96' ' ' MET 0.704 0.2 OUTLIER -158.71 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.267 1.508 . . . . 0.0 113.97 176.242 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -160.08 -145.87 0.13 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' N ' ' SG ' ' A' ' 102' ' ' CYS 0.326 0.0 OUTLIER -122.94 113.58 19.28 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 124.952 2.31 . . . . 0.0 111.975 170.087 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.316 1.4 mt -78.45 146.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 112.131 -2.304 . . . . 0.0 113.112 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 128' ' ' VAL 2.023 0.1 OUTLIER -161.05 -178.43 6.77 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 120.902 3.668 . . . . 0.0 120.902 146.969 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 p -159.77 162.95 34.96 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -159.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -79.67 144.19 60.2 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-N 112.258 -2.246 . . . . 0.0 108.69 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.84 -21.35 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 N-CA-C 120.293 3.151 . . . . 0.0 120.293 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -60.23 -36.76 78.46 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.43 -3.26 58.23 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 171.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -128.7 -103.75 0.31 Allowed 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 120.483 1.492 . . . . 0.0 114.028 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.364 47.3 m-85 -106.42 -5.33 19.03 Favored 'General case' 0 N--CA 1.523 3.201 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.95 -154.83 49.28 Favored Glycine 0 N--CA 1.488 2.109 0 CA-C-N 122.462 2.392 . . . . 0.0 118.394 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -67.12 -24.57 65.93 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.63 -31.71 15.76 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.88 167.56 43.64 Favored Glycine 0 CA--C 1.552 2.382 0 CA-C-N 121.409 1.913 . . . . 0.0 114.797 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.9 t -86.82 114.82 60.02 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 116.843 -1.551 . . . . 0.0 107.384 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.284 85.0 Cg_exo -40.73 -49.27 4.31 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 122.202 3.885 . . . . 0.0 122.202 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.83 8.88 4.0 Favored 'Trans proline' 0 CA--C 1.577 2.646 0 CA-C-N 125.173 2.883 . . . . 0.0 118.086 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -159.09 -17.53 0.07 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.17 136.63 28.42 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 121.381 1.901 . . . . 0.0 112.702 -172.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.47 170.53 13.04 Favored 'Trans proline' 0 CA--C 1.584 2.987 0 CA-C-N 122.914 2.077 . . . . 0.0 115.211 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.62 135.98 37.74 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 122.758 2.305 . . . . 0.0 114.836 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.3 t30 59.68 56.82 3.44 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 124.901 1.28 . . . . 0.0 113.334 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.56 114.8 27.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.249 -1.532 . . . . 0.0 112.194 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.2 m -68.8 144.31 54.35 Favored 'General case' 0 CA--C 1.591 2.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.716 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.3 mt -113.95 172.62 6.88 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 105' ' ' THR . 20.1 t -153.44 124.44 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.783 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.388 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 1.0 OUTLIER -141.85 130.53 22.77 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-N 124.599 3.363 . . . . 0.0 110.442 175.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -94.48 104.09 16.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.28 140.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -123.99 121.48 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.4 tp -89.25 112.4 23.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 111.955 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -81.74 -41.83 20.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -168.42 154.22 6.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.227 1.489 . . . . 0.0 109.537 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.275 5.8 p90 -151.45 -90.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.52 69.26 6.98 Favored 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.431 1.586 . . . . 0.0 112.194 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.829 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -178.816 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 N-CA-C 120.849 3.099 . . . . 0.0 120.849 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.36 143.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.7 tp -104.32 136.33 44.11 Favored 'General case' 0 CA--C 1.59 2.494 0 C-N-CA 127.003 2.121 . . . . 0.0 106.089 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -121.73 130.57 53.53 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 124.014 3.097 . . . . 0.0 113.406 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.516 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 4.5 t -85.75 147.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 116.613 -1.661 . . . . 0.0 110.203 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.446 0.5 OUTLIER -126.02 125.18 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-N 120.522 1.51 . . . . 0.0 110.007 170.248 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -58.75 2.05 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.611 -0.681 . . . . 0.0 111.874 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -121.94 99.26 6.35 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -56.51 174.61 0.14 Allowed 'General case' 0 CA--C 1.595 2.697 0 O-C-N 119.904 -1.748 . . . . 0.0 115.648 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.81 -165.66 37.68 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 119.215 2.446 . . . . 0.0 119.215 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -91.3 -1.81 57.55 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.69 -90.4 0.08 OUTLIER Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.653 1.569 . . . . 0.0 116.683 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 t -159.88 -25.92 0.07 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -78.75 142.95 36.6 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 p -135.67 114.05 11.09 Favored Pre-proline 0 CA--C 1.577 2.005 0 CA-C-N 109.831 -3.35 . . . . 0.0 107.528 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -67.5 -29.76 36.8 Favored 'Trans proline' 0 CA--C 1.582 2.887 0 N-CA-C 117.27 1.988 . . . . 0.0 117.27 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.524 32.2 mtt 81.29 -150.78 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.318 1.1 tp -50.5 134.17 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 O-C-N 120.585 -1.322 . . . . 0.0 113.625 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 -7.13 76.5 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 116.927 -2.041 . . . . 0.0 117.548 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' HD2' ' C ' ' A' ' 50' ' ' ASP . 28.6 p30 -74.61 128.43 35.54 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 122.827 3.314 . . . . 0.0 112.817 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ptm85 -76.4 125.68 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.931 0.787 . . . . 0.0 109.078 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.2 m -120.44 138.45 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.905 0.882 . . . . 0.0 112.751 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -117.18 108.06 15.21 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.12 160.6 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.301 6.1 m-70 -126.64 113.03 16.18 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 166.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -108.13 146.04 33.25 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.3 m -112.72 139.31 48.45 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 162.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.64 147.66 19.08 Favored Glycine 0 CA--C 1.565 3.188 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.77 171.52 20.24 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 127.93 2.492 . . . . 0.0 113.068 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -93.36 148.75 21.78 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.513 165.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.376 0.2 OUTLIER -61.74 -17.32 55.39 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.01 -28.23 66.19 Favored 'General case' 0 CA--C 1.594 2.636 0 CA-C-N 120.334 1.424 . . . . 0.0 111.823 166.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.18 52.07 0.61 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -135.34 113.19 11.0 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -68.52 120.39 14.49 Favored 'General case' 0 CA--C 1.584 2.274 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.411 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -97.46 -31.69 12.22 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 121.442 1.928 . . . . 0.0 113.498 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -154.16 165.65 35.59 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 123.24 1.495 . . . . 0.0 113.508 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -148.52 -10.38 0.36 Allowed 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.381 97.7 p 61.44 -36.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 122.846 2.566 . . . . 0.0 117.887 -176.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.81 -42.87 97.58 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 128.186 2.594 . . . . 0.0 113.746 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.71 -38.08 74.64 Favored 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.12 -21.72 63.99 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.332 33.4 ttmt 86.05 -23.57 0.15 Allowed 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 126.161 1.784 . . . . 0.0 114.7 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.266 8.3 t70 -92.87 -135.3 0.16 Allowed 'General case' 0 CA--C 1.572 1.81 0 C-N-CA 124.406 1.083 . . . . 0.0 110.477 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 168.87 21.38 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 124.743 1.217 . . . . 0.0 113.731 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.261 4.0 t80 -97.23 144.14 27.33 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.2 p -159.93 147.8 16.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.614 -2.554 . . . . 0.0 109.405 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -159.47 -176.58 5.86 Favored 'General case' 0 CA--C 1.589 2.447 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.278 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.54 132.66 52.55 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 118.922 -2.361 . . . . 0.0 106.307 171.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 107.84 0.63 Allowed 'General case' 0 CA--C 1.577 1.983 0 O-C-N 120.848 -1.158 . . . . 0.0 113.88 -175.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.84 6.81 Favored Glycine 0 N--CA 1.504 3.18 0 O-C-N 120.433 -1.417 . . . . 0.0 113.669 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.266 0.0 OUTLIER -107.71 -75.66 0.63 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.57 1.652 . . . . 0.0 110.812 -175.01 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.496 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -105.31 -51.95 0.85 Allowed Glycine 0 N--CA 1.502 3.097 0 CA-C-O 124.786 2.325 . . . . 0.0 108.808 167.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.723 19.8 tt0 114.75 140.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 128.376 3.941 . . . . 0.0 114.159 166.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.366 12.0 m -79.96 -100.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.106 1 CA-C-N 105.211 -5.45 . . . . 0.0 103.028 177.508 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 89' ' ' TRP . 41.3 pt -135.09 157.5 40.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 124.995 2.331 . . . . 0.0 105.895 165.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 12.7 tmtt? -69.39 -30.39 68.35 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 114.226 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.41 83.27 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 116.22 -1.848 . . . . 0.0 110.567 165.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.43 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.2 m0 -71.28 -44.85 64.42 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 122.074 2.216 . . . . 0.0 113.204 174.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.92 -33.37 68.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.252 1.6 mp -68.67 -58.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 120.187 1.358 . . . . 0.0 110.749 172.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.84 88.84 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.291 11.9 t -62.64 -38.06 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.235 1.379 . . . . 0.0 112.892 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.67 -34.41 64.99 Favored 'General case' 0 CA--C 1.581 2.171 0 CA-C-N 121.002 1.728 . . . . 0.0 113.804 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.7 p -84.45 -0.19 51.93 Favored 'General case' 0 CA--C 1.59 2.5 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 mtt -85.88 105.1 16.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 121.96 2.164 . . . . 0.0 114.242 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.75 141.4 49.75 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 114.779 -2.534 . . . . 0.0 106.756 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.267 1.7 t -9.64 96.13 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.54 4.032 0 CA-C-N 122.841 2.564 . . . . 0.0 112.484 -161.029 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 18.78 -50.28 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 1 N-CA-C 129.289 6.475 . . . . 0.0 129.289 -151.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 69.24 174.35 0.29 Allowed 'General case' 0 CA--C 1.605 3.085 0 CA-C-O 123.089 1.424 . . . . 0.0 108.156 -164.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.311 12.6 tp -126.45 104.42 8.15 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 123.863 1.792 . . . . 0.0 109.109 169.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 35' ' ' VAL . 13.7 p -160.41 -159.29 0.68 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.767 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.623 ' HB2' ' H ' ' A' ' 131' ' ' VAL 2.31 0.0 OUTLIER -160.91 -139.15 0.05 Allowed 'General case' 0 CA--C 1.563 1.455 1 N-CA-C 122.603 4.297 . . . . 0.0 122.603 157.863 . . . . . . . . 5 4 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.0 mt -121.53 146.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 109.548 -3.478 . . . . 0.0 114.676 -165.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.6 m -135.48 91.32 2.71 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 13.7 p -107.41 147.75 29.99 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 -171.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -90.52 137.98 27.05 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.084 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.308 13.9 Cg_endo -54.09 -10.14 1.8 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 120.346 3.172 . . . . 0.0 120.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.35 -38.8 88.26 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 120.494 1.497 . . . . 0.0 113.695 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -86.27 -0.52 56.0 Favored 'General case' 0 CA--C 1.576 1.952 0 C-N-CA 126.059 1.743 . . . . 0.0 114.213 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.28 -111.64 0.19 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -93.5 0.21 56.61 Favored 'General case' 0 N--CA 1.517 2.879 0 CA-C-N 120.742 1.61 . . . . 0.0 114.952 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.69 146.16 3.6 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.928 2.731 . . . . 0.0 119.928 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.346 53.1 p 76.0 -47.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -175.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.72 -55.03 3.03 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.28 149.63 25.75 Favored Glycine 0 CA--C 1.546 1.99 0 CA-C-N 119.548 1.067 . . . . 0.0 111.471 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 t -75.44 129.19 82.68 Favored Pre-proline 0 CA--C 1.579 2.059 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.954 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.281 6.8 Cg_endo -40.43 -44.57 4.31 Favored 'Trans proline' 0 CA--C 1.579 2.763 1 N-CA-C 122.554 4.021 . . . . 0.0 122.554 -175.54 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.64 -37.07 1.87 Allowed 'Trans proline' 0 CA--C 1.572 2.396 0 CA-C-N 125.296 2.927 . . . . 0.0 118.61 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -151.48 -17.99 0.2 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 119.06 2.985 . . . . 0.0 119.06 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.5 mt -79.96 139.66 53.61 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 122.476 2.398 . . . . 0.0 114.028 -173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -93.16 179.06 1.15 Allowed 'Trans proline' 0 CA--C 1.59 3.31 0 CA-C-N 125.332 2.94 . . . . 0.0 115.04 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -60.04 -2.9 1.92 Allowed 'Trans proline' 0 CA--C 1.576 2.607 0 N-CA-C 121.077 3.453 . . . . 0.0 121.077 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.04 92.82 1.38 Allowed 'General case' 0 CA--C 1.589 2.479 0 CA-C-N 120.991 1.723 . . . . 0.0 111.096 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.34 131.62 23.49 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 122.674 2.488 . . . . 0.0 110.216 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.0 m -74.92 128.81 36.46 Favored 'General case' 0 CA--C 1.593 2.629 0 O-C-N 120.836 -1.165 . . . . 0.0 111.63 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.5 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 71.3 mt -107.44 165.23 11.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.93 118.17 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.62 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.345 0.2 OUTLIER -140.33 107.98 5.62 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 121.035 1.743 . . . . 0.0 109.875 172.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.558 ' HA ' ' CA ' ' A' ' 103' ' ' ARG . 39.9 mt-10 -100.51 128.67 46.5 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.241 -1.537 . . . . 0.0 108.342 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.623 ' H ' ' HB2' ' A' ' 103' ' ' ARG 0.363 1.1 p -132.4 149.94 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 124.818 2.246 . . . . 0.0 116.161 -170.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.61 120.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 111.41 -2.632 . . . . 0.0 107.007 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.293 10.5 tp -107.96 109.32 20.78 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 121.713 2.051 . . . . 0.0 108.529 174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -69.5 -55.55 9.9 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 119.726 -1.859 . . . . 0.0 114.014 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -158.6 155.25 27.94 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.737 1.732 . . . . 0.0 107.205 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER -131.46 -108.86 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.244 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -102.24 83.87 2.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.623 0 N-CA-C 122.519 3.768 . . . . 0.0 122.519 -176.64 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.129 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.281 50.9 t -133.74 119.96 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.787 0.803 . . . . 0.0 111.119 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.61 139.17 37.56 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -139.86 84.7 1.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 119.476 -2.015 . . . . 0.0 106.66 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -85.89 101.24 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 115.972 -1.966 . . . . 0.0 111.7 -168.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.485 ' HA ' ' CB ' ' A' ' 102' ' ' CYS 0.642 0.5 OUTLIER -65.51 133.4 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -172.47 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.48 -56.22 2.59 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.44 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -150.93 121.23 7.29 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -72.27 0.13 Allowed 'General case' 0 CA--C 1.581 2.147 0 O-C-N 119.038 -2.289 . . . . 0.0 114.409 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.98 -176.03 37.6 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 125.555 1.55 . . . . 0.0 114.488 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 t -149.91 -3.18 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.632 2.826 . . . . 0.0 118.632 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.19 -75.36 0.51 Allowed Glycine 0 N--CA 1.492 2.385 0 CA-C-N 122.095 2.225 . . . . 0.0 117.19 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.8 p -126.2 -80.73 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.341 0.57 . . . . 0.0 110.393 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -159.46 -146.92 0.15 Allowed 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.227 1.011 . . . . 0.0 110.679 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 p -94.57 168.97 10.36 Favored Pre-proline 0 CA--C 1.582 2.204 0 C-N-CA 125.443 1.497 . . . . 0.0 111.464 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -99.96 -167.1 0.08 OUTLIER 'Trans proline' 0 CA--C 1.569 2.256 0 CA-C-N 122.909 2.075 . . . . 0.0 116.196 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -137.65 146.73 44.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.06 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.529 0.2 OUTLIER -9.95 -123.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.18 38.43 0.01 OUTLIER Glycine 0 N--CA 1.504 3.206 1 N-CA-C 124.042 4.377 . . . . 0.0 124.042 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.67 148.87 38.34 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 119.979 1.889 . . . . 0.0 112.141 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.82 134.47 41.73 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 0.9 OUTLIER -142.26 147.82 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 124.72 2.2 . . . . 0.0 112.123 -163.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CE2' ' HG ' ' A' ' 133' ' ' LEU 0.532 4.9 p90 -79.9 -160.29 0.27 Allowed 'General case' 0 CA--C 1.589 2.462 0 C-N-CA 127.545 2.338 . . . . 0.0 114.335 168.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.295 0.8 OUTLIER 157.6 147.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 127.094 2.158 . . . . 0.0 111.292 159.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.312 0.2 OUTLIER -127.64 111.49 13.78 Favored 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 118.592 -1.243 . . . . 0.0 107.886 164.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 37.1 p90 -101.12 174.65 5.9 Favored 'General case' 0 CA--C 1.589 2.46 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -152.91 113.89 4.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 164.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.81 136.85 8.96 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 124.652 2.251 . . . . 0.0 116.157 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 110.615 -2.792 . . . . 0.0 112.897 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.4 tp -79.07 170.3 16.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 125.367 2.508 . . . . 0.0 108.318 168.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.255 3.1 tm? -58.82 -19.63 43.01 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 110.885 -2.87 . . . . 0.0 114.036 168.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -75.38 4.17 7.78 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 121.071 1.76 . . . . 0.0 113.038 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.27 89.45 Favored Glycine 0 N--CA 1.51 3.618 0 CA-C-N 121.41 1.914 . . . . 0.0 116.188 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -117.76 140.12 50.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -86.05 95.0 9.38 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.908 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -69.97 -35.21 74.26 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.206 -2.184 . . . . 0.0 113.929 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.65 170.17 23.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.755 1.616 . . . . 0.0 112.711 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 95.0 p -160.06 -17.57 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.29 1.3 t 69.97 -53.07 0.63 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.502 -1.999 . . . . 0.0 113.085 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.9 mt -49.99 -49.97 48.67 Favored 'General case' 0 CA--C 1.581 2.154 0 C-N-CA 127.09 2.156 . . . . 0.0 114.255 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.12 -38.45 82.25 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.553 1.168 . . . . 0.0 114.134 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -73.22 2.36 7.51 Favored 'General case' 0 CA--C 1.585 2.32 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 59.9 mttp 85.21 -18.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 175.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -120.26 175.31 6.02 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 123.442 1.592 . . . . 0.0 113.147 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -88.17 162.22 16.82 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.744 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.276 4.2 t80 -99.15 158.39 15.71 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 123.344 1.545 . . . . 0.0 107.851 173.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.4 p -170.01 144.5 2.72 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.716 -1.865 . . . . 0.0 109.214 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -153.29 -162.23 1.43 Allowed 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.725 1.25 . . . . 0.0 110.694 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.93 118.0 14.36 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -45.13 117.15 1.27 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -174.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.82 29.77 73.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 118.41 2.124 . . . . 0.0 118.41 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -99.93 3.95 44.71 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 -172.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.2 58.88 2.02 Favored Glycine 0 N--CA 1.508 3.465 0 N-CA-C 106.301 -2.719 . . . . 0.0 106.301 -172.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -147.07 -48.95 0.18 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 111.994 -2.103 . . . . 0.0 113.121 -166.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.26 8.5 m -124.46 -148.76 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 123.571 1.653 . . . . 0.0 108.888 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.37 159.02 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 124.278 1.99 . . . . 0.0 109.983 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -67.84 -31.53 71.42 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.798 -1.546 . . . . 0.0 113.402 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.68 69.92 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 117.105 -1.426 . . . . 0.0 111.764 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -74.12 -42.86 59.38 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-N 120.948 1.704 . . . . 0.0 112.514 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.74 -35.75 68.94 Favored 'General case' 0 CA--C 1.577 2.001 0 CA-C-N 119.92 1.236 . . . . 0.0 114.311 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.278 1.5 mp -65.99 -57.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 CA-C-N 120.002 1.274 . . . . 0.0 111.206 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.79 96.82 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.437 ' HA ' ' SD ' ' A' ' 96' ' ' MET 0.25 76.3 t -62.08 -46.68 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.728 1.149 . . . . 0.0 112.371 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.17 -34.24 60.0 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.7 p -94.86 -2.61 50.41 Favored 'General case' 0 CA--C 1.585 2.291 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.52 ' SD ' ' HG ' ' A' ' 101' ' ' LEU 0.262 0.8 OUTLIER -102.04 153.15 20.17 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 123.258 2.753 . . . . 0.0 115.444 -177.363 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -99.36 150.82 21.75 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 63.3 t -48.15 124.43 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.594 0 C-N-CA 124.835 1.254 . . . . 0.0 112.557 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -29.12 11.62 Favored Glycine 0 N--CA 1.499 2.844 0 CA-C-O 115.051 -3.083 . . . . 0.0 115.76 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.364 2.2 tp10 -155.82 -176.3 5.88 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 123.008 3.404 . . . . 0.0 116.609 173.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.52 ' HG ' ' SD ' ' A' ' 96' ' ' MET 0.735 0.1 OUTLIER -159.44 -145.39 0.13 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 179.25 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.5 OUTLIER -160.26 -152.41 0.29 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -170.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.5 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 12.1 ptm180 -109.29 130.5 55.49 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 123.864 1.792 . . . . 0.0 111.14 171.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.4 mt -93.81 134.65 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 112.871 -1.968 . . . . 0.0 107.329 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 m -130.16 100.43 5.41 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 9.5 p -115.45 144.97 43.04 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -172.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.15 148.84 72.05 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 116.924 -1.512 . . . . 0.0 111.474 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.267 71.7 Cg_endo -57.98 -19.06 38.46 Favored 'Trans proline' 0 C--N 1.379 2.138 0 CA-C-N 125.587 3.031 . . . . 0.0 119.095 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.38 -38.31 80.17 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 121.465 1.939 . . . . 0.0 114.407 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -79.16 -7.82 58.51 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 124.679 1.192 . . . . 0.0 114.1 169.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -121.52 -103.8 0.39 Allowed 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.735 1.607 . . . . 0.0 112.929 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.478 6.5 m-85 -106.2 -8.22 17.47 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.79 -148.21 49.12 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 t -88.74 61.9 6.2 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 122.407 1.099 . . . . 0.0 111.534 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.79 -52.8 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.406 1.483 . . . . 0.0 112.646 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.99 160.94 25.55 Favored Glycine 0 CA--C 1.544 1.873 0 C-N-CA 124.054 0.835 . . . . 0.0 114.038 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -89.24 139.29 28.58 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.021 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.64 -39.96 37.94 Favored 'Trans proline' 0 CA--C 1.586 3.122 0 N-CA-C 120.597 3.268 . . . . 0.0 120.597 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.33 -29.85 0.45 Allowed 'Trans proline' 0 CA--C 1.574 2.494 0 CA-C-N 125.425 2.973 . . . . 0.0 119.667 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -148.38 -29.34 0.3 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 119.422 3.119 . . . . 0.0 119.422 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mt -79.98 122.1 82.82 Favored Pre-proline 0 CA--C 1.585 2.326 0 CA-C-N 120.467 1.485 . . . . 0.0 113.854 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.69 177.85 2.58 Favored 'Trans proline' 0 CA--C 1.584 2.993 0 C-N-CA 123.119 2.546 . . . . 0.0 117.458 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -50.28 -19.84 4.97 Favored 'Trans proline' 0 CA--C 1.567 2.151 1 N-CA-C 122.927 4.164 . . . . 0.0 122.927 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -160.13 94.87 1.12 Allowed 'General case' 0 CA--C 1.583 2.233 0 CA-C-N 120.671 1.578 . . . . 0.0 106.885 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -147.23 141.9 26.66 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 123.001 2.637 . . . . 0.0 112.436 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -71.44 158.01 37.04 Favored 'General case' 0 CA--C 1.591 2.54 0 O-C-N 121.221 -0.924 . . . . 0.0 112.743 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mt -129.18 161.35 30.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 119.555 -1.966 . . . . 0.0 112.762 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.5 m -144.04 135.97 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 110.798 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 2.4 m-85 -136.15 127.43 28.27 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.71 1.243 . . . . 0.0 109.225 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.88 102.26 14.37 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.69 152.06 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.294 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -133.97 133.2 41.07 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 53' ' ' PHE . 4.6 tt -94.8 143.74 26.21 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -106.33 -60.67 1.62 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -177.29 134.17 0.18 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 125.784 2.707 . . . . 0.0 106.682 -173.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.88 -111.66 0.34 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.6 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.401 42.0 tptt -119.65 -119.1 0.31 Allowed 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 171.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.009 0 CA-C-N 125.721 3.873 . . . . 0.0 120.977 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.374 1 N-CA-C 125.542 4.977 . . . . 0.0 125.542 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.305 67.8 t -141.52 144.98 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 123.002 3.401 . . . . 0.0 117.122 -169.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.2 135.99 48.61 Favored 'General case' 0 CA--C 1.585 2.318 0 C-N-CA 126.724 2.009 . . . . 0.0 109.703 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -128.86 112.55 14.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 123.694 2.952 . . . . 0.0 111.835 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.1 101.01 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.014 -1.053 . . . . 0.0 113.261 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' SG ' ' A' ' 102' ' ' CYS 0.304 2.6 mm -52.07 128.05 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -118.08 -42.57 2.8 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.707 1.203 . . . . 0.0 112.546 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -129.06 112.85 14.44 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.53 -173.01 4.14 Favored 'General case' 0 CA--C 1.598 2.802 0 CA-C-N 121.171 1.805 . . . . 0.0 115.833 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.8 158.67 36.64 Favored Glycine 0 N--CA 1.492 2.382 1 N-CA-C 123.559 4.183 . . . . 0.0 123.559 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -129.15 -72.81 0.59 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.57 114.76 3.98 Favored Glycine 0 CA--C 1.55 2.245 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -58.68 -14.41 8.36 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.7 148.29 42.83 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.0 m -148.52 96.4 3.89 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-N 110.652 -2.977 . . . . 0.0 107.096 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.441 0.5 OUTLIER -104.88 1.2 0.24 Allowed 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 119.818 2.969 . . . . 0.0 119.818 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.533 39.5 mtm 76.79 -140.19 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 164.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 1.1 tp -48.09 136.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 CA-C-O 122.157 0.979 . . . . 0.0 113.347 -174.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.91 -6.62 83.22 Favored Glycine 0 CA--C 1.551 2.344 0 CA-C-O 116.781 -2.122 . . . . 0.0 118.143 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -73.88 128.62 35.99 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 122.62 3.21 . . . . 0.0 113.762 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -78.37 112.48 15.43 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.4 138.96 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.65 104.14 11.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.49 166.29 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 CA-C-O 123.145 1.45 . . . . 0.0 112.556 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.92 113.7 17.54 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.742 170.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -117.87 151.81 36.64 Favored 'General case' 0 CA--C 1.582 2.191 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 97.4 m -127.43 143.26 51.23 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.93 143.08 11.47 Favored Glycine 0 CA--C 1.555 2.589 0 O-C-N 119.984 -1.698 . . . . 0.0 116.87 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.77 151.66 48.73 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 127.479 2.312 . . . . 0.0 112.499 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.39 175.75 9.15 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 123.465 1.603 . . . . 0.0 108.543 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 tp -60.35 -31.65 70.53 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.46 8.07 1.55 Allowed 'General case' 0 CA--C 1.596 2.713 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.59 36.05 82.36 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 119.697 -1.877 . . . . 0.0 114.808 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 m -111.1 119.57 39.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -76.49 112.29 12.85 Favored 'General case' 0 CA--C 1.588 2.442 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.779 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -85.09 -35.19 21.97 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 122.686 2.494 . . . . 0.0 113.689 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.51 158.08 43.85 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 123.469 1.604 . . . . 0.0 113.099 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 t -156.37 100.71 1.99 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.949 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 t -59.72 -40.33 87.62 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.82 -46.1 78.17 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.262 1.425 . . . . 0.0 114.411 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.32 -39.62 68.08 Favored 'General case' 0 CA--C 1.579 2.094 0 C-N-CA 124.82 1.248 . . . . 0.0 113.776 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 -13.15 47.37 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 51.4 mtmt 91.95 -35.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 126.808 2.043 . . . . 0.0 115.334 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -88.53 170.69 10.66 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 123.804 1.764 . . . . 0.0 111.997 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.74 168.66 9.53 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.577 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.278 5.9 t80 -104.83 145.26 30.63 Favored 'General case' 0 CA--C 1.574 1.892 0 O-C-N 120.44 -1.413 . . . . 0.0 109.273 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.1 p -155.66 128.18 7.83 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.814 -1.803 . . . . 0.0 110.095 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -143.16 -175.38 4.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 123.591 0.756 . . . . 0.0 110.194 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.263 13.4 t0 -128.06 124.81 37.96 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 118.796 -2.44 . . . . 0.0 105.551 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.9 104.92 0.09 Allowed 'General case' 0 CA--C 1.579 2.064 0 C-N-CA 124.69 1.196 . . . . 0.0 114.064 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.74 37.72 95.12 Favored Glycine 0 N--CA 1.512 3.721 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 -173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -132.82 -70.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 124.668 1.187 . . . . 0.0 110.636 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.42 74.18 0.21 Allowed Glycine 0 N--CA 1.495 2.586 1 N-CA-C 100.782 -4.927 . . . . 0.0 100.782 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.326 47.8 tp10 -71.91 150.61 44.02 Favored 'General case' 0 CA--C 1.554 1.116 1 CA-C-O 130.25 4.833 . . . . 0.0 116.693 -165.363 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.349 31.4 m -98.46 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 1 CA-C-N 101.55 -7.114 . . . . 0.0 107.087 -174.02 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.3 pt -110.97 159.05 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 124.418 2.056 . . . . 0.0 109.153 171.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -32.41 72.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.745 -1.57 . . . . 0.0 113.257 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.66 -35.48 74.51 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 116.826 -1.559 . . . . 0.0 111.677 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -77.43 -41.6 39.22 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.323 1.874 . . . . 0.0 112.378 173.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.66 -34.1 69.02 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 120.017 1.28 . . . . 0.0 113.885 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.2 mp -66.66 -57.08 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 120.098 1.317 . . . . 0.0 110.968 172.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.51 90.17 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.454 ' HA ' ' SD ' ' A' ' 96' ' ' MET . 99.6 t -63.03 -38.72 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-N 118.967 0.803 . . . . 0.0 112.906 173.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.71 -36.8 70.09 Favored 'General case' 0 CA--C 1.58 2.12 0 CA-C-N 120.282 1.401 . . . . 0.0 113.445 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -82.32 11.37 5.53 Favored 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' A' ' 93' ' ' VAL . 43.3 mtt -94.01 134.92 35.91 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 121.636 2.016 . . . . 0.0 116.103 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.3 163.26 15.43 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 164.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 64.5 t -57.73 131.66 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.943 0 O-C-N 117.899 -3.0 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.53 -21.19 30.48 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 124.172 3.169 . . . . 0.0 114.275 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.64 163.87 27.39 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 120.4 2.1 . . . . 0.0 113.695 176.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 102' ' ' CYS 1.751 0.1 OUTLIER 162.43 155.76 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.797 2.039 . . . . 0.0 113.921 168.009 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 101' ' ' LEU 0.345 81.9 m -143.44 178.97 7.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.998 1.319 . . . . 0.0 112.872 -167.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.301 0.0 OUTLIER -93.64 119.53 32.77 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 124.483 2.087 . . . . 0.0 107.93 171.171 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.56 118.56 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 CA-C-N 111.489 -2.596 . . . . 0.0 108.922 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -112.15 103.26 11.42 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.3 p -119.21 141.14 49.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -171.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.01 141.97 87.21 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.295 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -60.46 -19.97 61.51 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 N-CA-C 119.35 2.788 . . . . 0.0 119.35 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.7 -33.48 75.18 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 122.62 2.463 . . . . 0.0 113.603 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.5 -7.84 54.35 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.76 -101.87 0.42 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 120.076 1.307 . . . . 0.0 111.847 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.257 0.3 OUTLIER -124.56 14.64 8.8 Favored 'General case' 0 CA--C 1.592 2.574 0 CA-C-N 120.431 1.469 . . . . 0.0 113.872 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.05 -31.17 39.85 Favored Glycine 0 N--CA 1.497 2.765 1 N-CA-C 123.105 4.002 . . . . 0.0 123.105 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.9 m -66.66 -11.81 55.52 Favored 'General case' 0 CA--C 1.585 2.319 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.61 -60.15 0.19 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 124.945 1.298 . . . . 0.0 113.284 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.73 152.6 7.22 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.533 1.54 . . . . 0.0 110.792 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 t -81.8 126.54 75.18 Favored Pre-proline 0 CA--C 1.579 2.067 0 CA-C-O 116.647 -1.644 . . . . 0.0 108.993 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -40.38 -43.69 4.07 Favored 'Trans proline' 0 CA--C 1.581 2.871 0 N-CA-C 121.733 3.705 . . . . 0.0 121.733 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.6 -9.79 6.6 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 CA-C-N 125.165 2.88 . . . . 0.0 119.042 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -160.57 -43.68 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.9 125.18 82.57 Favored Pre-proline 0 CA--C 1.58 2.105 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -88.54 171.13 5.3 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 C-N-CA 122.662 2.241 . . . . 0.0 112.301 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.85 -42.15 33.15 Favored 'Trans proline' 0 CA--C 1.574 2.519 0 N-CA-C 117.917 2.237 . . . . 0.0 117.917 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -90.76 61.34 4.74 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.462 -1.399 . . . . 0.0 112.621 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.23 113.62 5.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.044 -1.66 . . . . 0.0 111.972 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -65.06 155.79 33.59 Favored 'General case' 0 CA--C 1.591 2.553 0 C-N-CA 124.107 0.963 . . . . 0.0 112.793 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 mt -114.74 162.75 16.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 124.525 2.107 . . . . 0.0 112.297 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 114.8 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 CA-C-N 112.703 -2.044 . . . . 0.0 108.83 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 1.3 m-85 -131.38 123.9 29.2 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 122.711 2.505 . . . . 0.0 111.756 175.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 90.8 mt-10 -91.97 110.28 21.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . 0.28 1.3 p -138.31 145.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 122.343 1.068 . . . . 0.0 112.248 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -136.23 133.58 37.2 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.813 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.401 ' HB2' ' CE ' ' A' ' 96' ' ' MET . 9.6 tp -93.8 130.33 39.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.69 -51.67 6.3 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.536 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -164.2 154.74 15.08 Favored 'General case' 0 CA--C 1.575 1.923 0 C-N-CA 125.455 1.502 . . . . 0.0 108.522 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.266 0.0 OUTLIER -130.33 -115.15 0.24 Allowed 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 110.239 177.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -122.26 119.29 30.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 -178.396 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -162.75 137.07 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.88 145.99 29.31 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 125.885 1.674 . . . . 0.0 109.041 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.49 ' NZ ' ' HE2' ' A' ' 132' ' ' GLU . 1.6 tmtp? -130.89 125.61 33.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 122.621 2.464 . . . . 0.0 111.797 -177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.2 t -102.04 93.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.367 0.3 OUTLIER -79.24 134.53 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.849 -1.157 . . . . 0.0 111.54 178.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.89 -68.2 0.94 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.581 0.705 . . . . 0.0 111.101 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -99.01 95.32 7.06 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.9 167.33 11.77 Favored 'General case' 0 CA--C 1.59 2.512 0 O-C-N 120.044 -1.66 . . . . 0.0 113.749 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.57 170.92 41.83 Favored Glycine 0 CA--C 1.55 2.24 0 O-C-N 119.53 -1.981 . . . . 0.0 117.959 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 p -78.36 -70.72 0.47 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.27 54.04 0.1 Allowed Glycine 0 N--CA 1.482 1.766 0 C-N-CA 124.674 1.131 . . . . 0.0 113.727 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -140.38 17.05 2.4 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 55.74 -179.04 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 121.588 3.921 . . . . 0.0 121.588 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -116.85 120.59 33.88 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.396 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -66.46 -20.57 54.29 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 117.985 2.263 . . . . 0.0 117.985 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.515 8.7 mtt 80.2 -165.99 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.423 0.4 OUTLIER -39.65 125.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -169.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.79 88.41 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -76.75 142.82 40.29 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 122.857 3.329 . . . . 0.0 113.556 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -73.84 137.84 44.04 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.31 -1.494 . . . . 0.0 109.778 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.32 2.1 t -135.27 144.51 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 119.752 1.16 . . . . 0.0 112.688 -167.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -125.87 100.99 6.63 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.84 167.1 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 127.174 2.19 . . . . 0.0 112.138 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.15 127.57 36.21 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.564 160.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -119.43 155.69 31.54 Favored 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.6 m -125.31 138.56 54.07 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 159.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.53 145.73 14.47 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 123.347 2.794 . . . . 0.0 117.93 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.09 153.04 52.06 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 112.625 -1.787 . . . . 0.0 114.615 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.09 170.67 14.56 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 123.042 1.401 . . . . 0.0 108.642 170.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER -60.43 -26.35 66.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 178.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.68 9.63 3.29 Favored 'General case' 0 CA--C 1.593 2.631 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.1 38.38 73.27 Favored Glycine 0 N--CA 1.509 3.538 0 CA-C-N 121.341 1.882 . . . . 0.0 114.819 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 m -109.34 114.47 28.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -79.71 90.89 5.22 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -69.75 -30.88 68.57 Favored 'General case' 0 CA--C 1.559 1.306 0 O-C-N 119.696 -1.877 . . . . 0.0 114.424 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -154.47 148.11 25.3 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 121.603 2.001 . . . . 0.0 111.345 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 m -145.91 94.76 2.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.526 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 t -57.48 -39.22 75.95 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.15 -44.08 83.11 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -73.86 -42.18 61.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -61.33 -19.51 61.89 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.39 74.4 mmtt 96.63 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.177 2.191 . . . . 0.0 113.192 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.64 152.54 31.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.04 1.4 . . . . 0.0 113.665 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.05 171.45 10.72 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.493 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.252 9.2 t80 -105.23 157.72 17.09 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.092 0.949 . . . . 0.0 109.235 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.7 p -157.89 145.71 18.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 119.295 -2.128 . . . . 0.0 110.313 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -155.15 -173.36 4.53 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.875 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -123.05 123.07 40.03 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -49.15 112.0 0.56 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -172.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.97 47.79 82.26 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -107.21 14.16 26.48 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.88 -42.67 2.37 Favored Glycine 0 N--CA 1.51 3.614 0 O-C-N 120.782 -1.199 . . . . 0.0 111.41 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.279 8.3 tp10 -28.8 -48.96 0.07 Allowed 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 129.386 3.075 . . . . 0.0 118.805 169.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.255 9.3 m -117.61 -147.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 CA-C-O 124.066 1.888 . . . . 0.0 109.785 -175.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.4 pt -110.93 160.77 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 124.104 1.907 . . . . 0.0 110.238 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -32.67 73.25 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.018 -1.446 . . . . 0.0 113.205 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.06 70.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.016 -1.469 . . . . 0.0 112.443 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.27 -42.52 54.84 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.967 1.712 . . . . 0.0 112.423 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.84 -37.73 71.67 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -68.1 -56.74 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.056 0 CA-C-N 119.885 1.22 . . . . 0.0 111.191 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.65 94.54 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.4 t -67.59 -46.23 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.571 1.078 . . . . 0.0 111.736 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.25 62.78 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p -92.22 4.29 53.57 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.429 ' SD ' ' OE2' ' A' ' 132' ' ' GLU . 4.6 ptt? -116.48 119.51 35.85 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 122.304 2.32 . . . . 0.0 112.185 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -78.56 148.69 33.25 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.152 -1.593 . . . . 0.0 108.72 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.6 t -9.47 79.43 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 C-N-CA 125.299 1.44 . . . . 0.0 109.001 -158.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -20.46 -29.45 0.0 OUTLIER Glycine 1 N--CA 1.523 4.437 1 N-CA-C 127.783 5.873 . . . . 0.0 127.783 -144.585 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.663 0.3 OUTLIER 52.97 -125.57 2.4 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 115.581 -2.152 . . . . 0.0 111.549 -161.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.617 ' HA ' ' CB ' ' A' ' 132' ' ' GLU 0.461 0.9 OUTLIER -136.15 132.96 36.69 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.446 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' H ' ' HB2' ' A' ' 132' ' ' GLU 2.674 5.7 m -160.27 -151.98 0.27 Allowed 'General case' 0 CA--C 1.589 2.477 0 CA-C-N 120.224 1.375 . . . . 0.0 114.489 177.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -143.36 158.85 43.3 Favored 'General case' 0 CA--C 1.575 1.942 0 O-C-N 120.108 -1.62 . . . . 0.0 113.662 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.39 143.87 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 C-N-CA 126.128 1.771 . . . . 0.0 110.543 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.3 m -140.09 104.5 4.85 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.1 p -118.87 147.12 44.31 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -172.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -80.71 148.13 64.58 Favored Pre-proline 0 CA--C 1.581 2.166 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.647 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -36.43 -33.06 0.12 Allowed 'Trans proline' 0 CA--C 1.567 2.144 0 N-CA-C 122.079 3.838 . . . . 0.0 122.079 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.1 -44.66 91.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -78.86 -5.96 54.89 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 116.187 -1.863 . . . . 0.0 114.328 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.43 -153.25 0.5 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 122.324 2.329 . . . . 0.0 114.288 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.283 0.1 OUTLIER -82.11 11.42 5.26 Favored 'General case' 0 CA--C 1.575 1.921 0 O-C-N 119.22 -2.175 . . . . 0.0 113.582 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.36 -38.57 45.23 Favored Glycine 0 CA--C 1.553 2.441 0 CA-C-N 124.027 3.103 . . . . 0.0 115.354 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 p -70.78 -51.58 26.06 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 118.316 1.058 . . . . 0.0 113.761 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.98 -34.48 14.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.91 141.96 12.81 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.039 1.29 . . . . 0.0 113.646 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.0 t -95.42 146.17 30.84 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.834 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -41.52 -43.23 5.99 Favored 'Trans proline' 0 CA--C 1.584 3.023 0 C-N-CA 123.65 2.9 . . . . 0.0 119.107 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.72 57.25 6.28 Favored 'Trans proline' 0 CA--C 1.585 3.036 0 CA-C-N 125.325 2.937 . . . . 0.0 115.425 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 61.93 33.39 17.48 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.325 3.454 . . . . 0.0 120.325 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.9 mt -82.91 117.56 68.96 Favored Pre-proline 0 CA--C 1.59 2.485 0 O-C-N 120.127 -1.608 . . . . 0.0 108.768 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -90.31 178.02 2.23 Favored 'Trans proline' 0 CA--C 1.585 3.061 0 CA-C-N 123.483 2.279 . . . . 0.0 116.179 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.41 151.19 54.69 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.072 2.515 . . . . 0.0 117.621 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.252 38.4 t-20 59.62 44.0 15.05 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -177.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.4 105.5 15.46 Favored 'General case' 0 CA--C 1.562 1.436 0 O-C-N 120.534 -1.354 . . . . 0.0 110.35 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.8 m -66.01 150.18 49.08 Favored 'General case' 0 CA--C 1.592 2.562 0 O-C-N 120.843 -1.161 . . . . 0.0 111.651 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.5 tp -132.64 157.48 44.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.552 -1.968 . . . . 0.0 111.663 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 22.3 m -147.05 144.03 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 O-C-N 121.043 -1.036 . . . . 0.0 112.043 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -146.97 134.68 21.11 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.977 -1.077 . . . . 0.0 109.98 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -88.21 112.97 23.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.39 152.94 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.243 -0.91 . . . . 0.0 111.136 -168.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.617 ' CB ' ' HA ' ' A' ' 101' ' ' LEU 0.777 0.2 OUTLIER -154.56 -164.25 1.78 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 116.781 2.141 . . . . 0.0 116.781 164.011 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tt -145.0 133.28 21.67 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.819 1.295 . . . . 0.0 113.376 -173.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.13 -47.71 7.64 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.94 151.07 23.09 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.283 1.433 . . . . 0.0 108.895 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.294 0.0 OUTLIER -143.21 -101.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.421 13.1 tmtt? -111.01 -132.66 0.33 Allowed 'General case' 0 CA--C 1.588 2.418 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.697 0 CA-C-N 124.631 3.378 . . . . 0.0 113.923 177.791 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.373 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.254 60.4 t -135.5 135.45 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 CA-C-O 122.648 1.213 . . . . 0.0 113.842 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -91.41 114.19 26.65 Favored 'General case' 0 CA--C 1.584 2.27 0 CA-C-O 116.614 -1.66 . . . . 0.0 107.956 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -112.39 90.37 3.32 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 124.101 3.137 . . . . 0.0 108.205 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.87 130.33 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.436 -173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 ' SG ' ' A' ' 102' ' ' CYS 0.303 1.0 OUTLIER -82.2 130.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 122.671 1.224 . . . . 0.0 113.133 179.287 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -110.81 -56.33 2.37 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.002 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.36 96.19 3.06 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.24 166.96 1.96 Allowed 'General case' 0 CA--C 1.59 2.495 0 CA-C-N 122.551 2.432 . . . . 0.0 116.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.35 -170.65 37.25 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 120.654 3.021 . . . . 0.0 120.654 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 t -81.02 15.33 1.89 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.46 34.04 68.05 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.5 p -122.6 26.83 8.11 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.8 1.24 . . . . 0.0 113.882 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.451 7.4 pt-20 40.41 -154.92 0.01 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.91 115.65 5.61 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 124.476 1.11 . . . . 0.0 111.191 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -41.26 -28.85 0.53 Allowed 'Trans proline' 0 CA--C 1.583 2.956 1 N-CA-C 122.626 4.049 . . . . 0.0 122.626 165.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.541 44.5 mtm 84.79 -141.56 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.29 1.1 tp -52.01 135.87 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 O-C-N 120.224 -1.548 . . . . 0.0 112.847 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.15 4.94 86.2 Favored Glycine 0 CA--C 1.553 2.442 0 CA-C-O 116.859 -2.078 . . . . 0.0 117.884 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.48 136.44 36.31 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 122.681 3.241 . . . . 0.0 112.577 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.51 98.2 11.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.68 141.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -167.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.18 107.78 14.87 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -114.11 165.95 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 123.272 1.511 . . . . 0.0 113.685 -175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.254 0.1 OUTLIER -132.11 113.36 13.23 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.075 167.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -105.91 161.21 14.65 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 124.019 1.866 . . . . 0.0 113.881 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.7 m -134.22 133.35 40.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 159.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.05 164.79 26.1 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 122.072 2.215 . . . . 0.0 118.048 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.34 155.98 41.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -173.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -85.1 172.19 11.44 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 123.469 1.604 . . . . 0.0 108.877 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.13 -33.82 74.0 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.301 0.2 OUTLIER -69.5 2.94 2.66 Favored 'General case' 0 CA--C 1.592 2.565 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 173.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.88 44.68 23.83 Favored Glycine 0 N--CA 1.503 3.106 0 CA-C-N 119.564 1.074 . . . . 0.0 114.174 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.9 m -120.77 119.81 33.83 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -78.98 97.24 5.98 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.152 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.01 -34.82 71.71 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.263 -2.148 . . . . 0.0 114.944 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.95 175.75 9.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -154.19 -77.1 0.11 Allowed 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.427 1.6 t 111.4 -40.05 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 128.775 2.83 . . . . 0.0 109.205 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.14 -34.81 15.06 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 169.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.95 -35.71 62.04 Favored 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -94.82 -85.01 0.32 Allowed 'General case' 0 CA--C 1.575 1.907 0 C-N-CA 124.716 1.206 . . . . 0.0 110.13 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? 175.32 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 127.29 2.236 . . . . 0.0 107.959 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -22.45 -37.92 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 1 N-CA-C 127.229 6.011 . . . . 0.0 127.229 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.441 53.2 pttt 71.53 -175.11 0.18 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.328 2.8 t80 -118.68 146.93 44.32 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.104 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.7 p -160.63 130.67 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 119.309 -2.119 . . . . 0.0 108.709 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -141.79 -173.71 3.87 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 123.216 0.607 . . . . 0.0 109.788 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.74 128.42 47.72 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 118.843 -2.411 . . . . 0.0 106.306 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.07 107.33 0.46 Allowed 'General case' 0 CA--C 1.578 2.038 0 O-C-N 121.314 -0.866 . . . . 0.0 112.536 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.61 56.32 5.56 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.024 -1.047 . . . . 0.0 114.802 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -102.17 -64.43 1.06 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 124.498 2.094 . . . . 0.0 112.963 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.63 -55.93 0.13 Allowed Glycine 0 N--CA 1.503 3.104 0 C-N-CA 128.86 3.124 . . . . 0.0 107.096 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.824 23.8 tt0 119.05 143.25 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 128.145 3.831 . . . . 0.0 116.807 162.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.347 14.1 m -79.87 -106.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.001 1 CA-C-N 105.319 -5.4 . . . . 0.0 104.962 -178.626 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -125.43 152.91 32.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 124.737 2.208 . . . . 0.0 105.538 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.27 -31.67 72.96 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 113.28 -1.782 . . . . 0.0 113.697 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.07 82.92 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.047 1.339 . . . . 0.0 111.391 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.442 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.9 m0 -70.46 -42.5 71.39 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 120.638 1.563 . . . . 0.0 112.549 172.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.0 -36.44 74.93 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 120.005 1.275 . . . . 0.0 114.185 172.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.259 1.3 mp -66.3 -56.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.274 1.397 . . . . 0.0 111.685 173.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.55 -45.31 91.12 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.285 75.8 t -65.04 -41.5 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 120.412 1.46 . . . . 0.0 112.531 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.58 64.63 Favored 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 120.336 1.426 . . . . 0.0 114.465 171.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 p -95.49 -6.97 39.39 Favored 'General case' 0 CA--C 1.588 2.411 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 38.6 mtp -96.69 123.11 40.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 121.597 1.999 . . . . 0.0 112.52 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -77.99 179.88 6.5 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.99 125.94 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.733 0 O-C-N 120.522 -1.361 . . . . 0.0 111.03 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.92 81.36 Favored Glycine 0 N--CA 1.515 3.934 0 CA-C-N 122.724 2.511 . . . . 0.0 116.901 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.63 132.1 41.46 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.474 2.137 . . . . 0.0 115.364 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.74 114.77 28.39 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.063 0.945 . . . . 0.0 111.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.443 ' SG ' HD12 ' A' ' 36' ' ' ILE . 17.2 m -136.53 159.56 41.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -109.73 127.24 54.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 123.845 1.783 . . . . 0.0 109.286 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.2 mt -92.58 118.59 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.395 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 104.53 11.93 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 7.7 p -118.49 148.56 42.49 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -89.02 142.19 30.04 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.495 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -42.54 -26.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 124.812 3.674 . . . . 0.0 121.413 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -31.94 72.96 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 121.314 1.87 . . . . 0.0 114.555 172.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -91.33 -9.75 43.83 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 125.472 1.509 . . . . 0.0 113.098 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.44 -112.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.196 1.816 . . . . 0.0 112.655 -176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.329 1.3 m-85 -113.79 21.03 15.35 Favored 'General case' 0 CA--C 1.588 2.411 0 CA-C-N 121.219 1.827 . . . . 0.0 113.751 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.2 -15.92 4.15 Favored Glycine 0 N--CA 1.501 2.99 1 N-CA-C 124.332 4.493 . . . . 0.0 124.332 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -71.69 -65.59 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.656 2.228 . . . . 0.0 112.063 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.29 10.4 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.38 160.28 36.38 Favored Glycine 0 CA--C 1.547 2.055 0 CA-C-N 122.144 2.247 . . . . 0.0 112.882 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -81.45 123.68 80.89 Favored Pre-proline 0 CA--C 1.577 2.008 0 O-C-N 120.258 -1.731 . . . . 0.0 107.736 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -33.69 -45.09 0.34 Allowed 'Trans proline' 0 CA--C 1.582 2.891 0 N-CA-C 121.99 3.804 . . . . 0.0 121.99 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -86.88 -16.97 3.32 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 CA-C-N 125.097 2.856 . . . . 0.0 118.948 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -159.09 -38.29 0.06 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.82 129.59 70.25 Favored Pre-proline 0 CA--C 1.581 2.143 0 O-C-N 120.195 -1.566 . . . . 0.0 113.897 -172.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.82 163.17 5.07 Favored 'Trans proline' 0 CA--C 1.586 3.121 0 CA-C-N 123.572 2.312 . . . . 0.0 113.202 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 8.95 0.45 Allowed 'Trans proline' 0 CA--C 1.576 2.619 0 N-CA-C 120.505 3.233 . . . . 0.0 120.505 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -139.68 62.79 1.51 Allowed 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.302 -1.499 . . . . 0.0 110.11 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.3 137.06 17.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.964 -1.71 . . . . 0.0 111.149 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.2 m -72.96 150.16 42.74 Favored 'General case' 0 CA--C 1.588 2.428 0 O-C-N 120.485 -1.385 . . . . 0.0 111.202 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.342 0.2 OUTLIER -134.78 167.33 21.06 Favored 'General case' 0 CA--C 1.574 1.895 0 O-C-N 118.685 -2.509 . . . . 0.0 109.524 176.11 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.6 p -141.22 146.35 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.846 -1.159 . . . . 0.0 112.02 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.288 0.6 OUTLIER -145.77 124.94 12.9 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.88 0.848 . . . . 0.0 110.501 169.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.41 115.25 24.7 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 t -124.26 134.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.026 0.917 . . . . 0.0 112.382 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -107.43 124.45 49.88 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.2 tp -103.31 119.38 38.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.85 -49.12 8.68 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -170.61 170.58 6.71 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.469 1.908 . . . . 0.0 108.122 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.255 5.7 p90 -154.94 -81.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 119.951 -1.718 . . . . 0.0 112.395 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.412 77.2 tttt -119.98 -136.38 0.33 Allowed 'General case' 0 CA--C 1.594 2.644 0 C-N-CA 124.512 1.125 . . . . 0.0 108.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.351 0 O-C-N 117.465 -3.272 . . . . 0.0 112.561 -179.136 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 1 N-CA-C 123.739 4.255 . . . . 0.0 123.739 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -142.75 125.29 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 124.278 0.634 . . . . 0.0 111.859 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -100.6 143.69 30.47 Favored 'General case' 0 CA--C 1.587 2.39 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.314 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -120.61 113.64 20.54 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-N 124.054 3.116 . . . . 0.0 111.434 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.51 92.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.505 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.311 0.4 OUTLIER -76.95 135.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 120.887 -1.133 . . . . 0.0 110.26 178.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -121.09 -56.95 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.458 0.703 . . . . 0.0 111.898 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -118.6 99.73 6.99 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.96 142.71 52.83 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 119.178 -2.201 . . . . 0.0 112.614 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.49 163.54 42.73 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 119.99 -1.693 . . . . 0.0 116.638 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.3 p -121.34 -79.41 0.61 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.142 -176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 2.73 -85.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.204 0 N-CA-C 122.116 3.606 . . . . 0.0 122.116 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.8 p -117.21 26.64 9.63 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.381 6.5 mt-10 55.24 -153.68 0.32 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 176.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -110.58 122.39 38.51 Favored Pre-proline 0 CA--C 1.572 1.801 0 O-C-N 120.559 -1.338 . . . . 0.0 108.497 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.397 0.2 OUTLIER -115.65 -87.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 N-CA-C 119.159 2.715 . . . . 0.0 119.159 -176.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -157.74 171.1 20.91 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 120.847 3.647 . . . . 0.0 120.847 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.36 132.41 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.763 0 CA-C-O 122.874 1.321 . . . . 0.0 109.932 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.85 3.39 68.34 Favored Glycine 0 CA--C 1.558 2.778 0 CA-C-O 116.836 -2.091 . . . . 0.0 118.186 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.79 141.24 56.59 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-N 122.624 3.212 . . . . 0.0 112.82 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -84.47 96.18 9.03 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.086 1.766 . . . . 0.0 108.353 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.31 135.09 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.99 100.46 8.89 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.76 164.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 127.356 2.263 . . . . 0.0 113.719 -172.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.79 124.4 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.583 160.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -115.03 156.87 24.33 Favored 'General case' 0 CA--C 1.593 2.608 0 CA-C-O 122.52 1.153 . . . . 0.0 111.058 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -130.36 138.51 50.44 Favored 'General case' 0 N--CA 1.515 2.792 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 160.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.08 140.71 8.57 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-N 123.329 2.786 . . . . 0.0 117.902 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.19 159.54 42.02 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 127.275 2.23 . . . . 0.0 115.057 -176.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -76.73 177.34 7.65 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.603 1.192 . . . . 0.0 109.594 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.345 0.0 OUTLIER -62.84 -27.06 69.07 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 176.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.9 13.97 0.94 Allowed 'General case' 0 CA--C 1.606 3.106 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.1 33.58 61.13 Favored Glycine 0 N--CA 1.511 3.663 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -91.86 109.42 20.75 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -68.0 107.13 2.58 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -81.64 -34.98 30.51 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 121.083 1.765 . . . . 0.0 112.099 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -155.84 155.48 33.03 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 124.163 1.935 . . . . 0.0 111.337 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -159.95 99.63 1.38 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.146 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -50.84 -34.28 27.21 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.71 -46.69 86.77 Favored 'General case' 0 CA--C 1.58 2.105 0 C-N-CA 125.346 1.458 . . . . 0.0 114.094 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.1 -41.48 77.4 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.418 1.087 . . . . 0.0 113.653 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -70.6 4.92 2.1 Favored 'General case' 0 CA--C 1.59 2.511 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 65.48 8.56 5.13 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 119.318 3.081 . . . . 0.0 119.318 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.12 -157.14 0.61 Allowed 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 125.436 1.494 . . . . 0.0 113.964 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -139.22 162.12 35.75 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 125.425 1.49 . . . . 0.0 109.393 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.354 2.1 t80 -108.47 149.43 28.81 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 120.944 1.702 . . . . 0.0 110.403 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.9 p -160.81 141.76 11.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 119.71 -1.869 . . . . 0.0 109.519 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -155.01 177.45 11.31 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.233 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -116.63 125.77 52.27 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.21 105.83 0.1 Allowed 'General case' 0 CA--C 1.575 1.924 0 C-N-CA 124.198 0.999 . . . . 0.0 113.668 -173.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.6 44.48 93.9 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.42 23.8 tptp -124.47 -79.8 0.61 Allowed 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 118.147 0.974 . . . . 0.0 110.262 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.24 70.57 0.24 Allowed Glycine 0 N--CA 1.505 3.27 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.407 49.8 tt0 -68.14 152.99 44.64 Favored 'General case' 0 CA--C 1.56 1.33 1 CA-C-O 130.466 4.936 . . . . 0.0 118.245 -160.471 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.378 24.5 m -80.27 -126.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.645 2 CA-C-N 100.987 -7.37 . . . . 0.0 106.767 -178.3 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.445 HG13 ' H ' ' A' ' 89' ' ' TRP . 34.5 pt -106.54 154.06 7.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.805 2.24 . . . . 0.0 106.402 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 10.6 tmtt? -69.1 -25.48 64.44 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 112.859 -1.973 . . . . 0.0 114.475 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.69 89.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 116.528 -1.701 . . . . 0.0 111.454 165.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.445 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -71.37 -44.01 65.82 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 121.385 1.902 . . . . 0.0 112.711 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -54.44 -41.18 69.1 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 121.23 1.832 . . . . 0.0 113.868 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -66.87 -61.38 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 CA-C-N 119.714 1.143 . . . . 0.0 112.071 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.5 -33.43 74.13 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.27 20.1 t -72.4 -39.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.82 1.646 . . . . 0.0 110.443 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.22 -31.27 63.35 Favored 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 120.152 1.342 . . . . 0.0 114.179 167.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.6 p -78.39 -19.67 52.82 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.44 ' SD ' HD11 ' A' ' 133' ' ' LEU 0.346 0.0 OUTLIER -90.37 163.84 14.55 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 124.701 3.409 . . . . 0.0 116.263 -179.126 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 137.88 51.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.944 -1.723 . . . . 0.0 112.257 -173.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.2 t -9.94 -171.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 127.922 2.489 . . . . 0.0 116.28 -173.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 25.67 -17.5 0.0 OUTLIER Glycine 0 N--CA 1.509 3.565 2 O-C-N 107.411 -9.555 . . . . 0.0 127.918 155.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.53 48.4 mt-10 -109.81 -149.61 0.44 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 123.996 3.898 . . . . 0.0 116.042 -178.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.528 ' HA ' ' CB ' ' A' ' 132' ' ' GLU . 15.3 tp -135.99 139.04 42.86 Favored 'General case' 0 CA--C 1.592 2.577 0 N-CA-C 119.917 3.303 . . . . 0.0 119.917 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.6 p -146.15 -168.11 2.91 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 122.605 1.193 . . . . 0.0 111.316 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 3.2 mtt180 -140.92 158.96 43.21 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 123.067 1.413 . . . . 0.0 112.555 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.51 135.27 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.414 1.485 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 m -127.59 102.8 7.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 15.7 p -122.0 149.99 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -83.11 141.06 42.89 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.456 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -61.61 -12.04 22.96 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 N-CA-C 119.282 2.762 . . . . 0.0 119.282 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.41 -39.95 92.62 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 121.0 1.727 . . . . 0.0 113.078 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -77.45 -6.98 55.42 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.906 1.282 . . . . 0.0 113.251 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.54 -121.47 0.17 Allowed 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.348 0.2 OUTLIER -85.58 7.44 23.14 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 122.057 2.208 . . . . 0.0 115.7 -178.036 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.8 -32.4 17.97 Favored Glycine 0 N--CA 1.501 2.998 0 CA-C-N 123.448 2.84 . . . . 0.0 119.455 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.1 p -77.92 84.57 4.2 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 118.464 1.132 . . . . 0.0 109.97 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.365 . . 86.43 -14.91 0.48 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.65 162.06 32.44 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 123.53 2.877 . . . . 0.0 113.438 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.421 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 3.5 t -89.51 148.34 40.07 Favored Pre-proline 0 CA--C 1.577 2.014 0 O-C-N 121.047 -1.266 . . . . 0.0 111.102 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.86 -43.55 6.83 Favored 'Trans proline' 0 CA--C 1.587 3.167 0 C-N-CA 123.456 2.771 . . . . 0.0 118.784 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.58 58.6 7.04 Favored 'Trans proline' 0 CA--C 1.586 3.081 0 CA-C-N 125.346 2.945 . . . . 0.0 115.292 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 61.18 31.12 19.59 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.328 3.455 . . . . 0.0 120.328 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.421 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -84.43 134.59 42.44 Favored Pre-proline 0 CA--C 1.596 2.736 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.36 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -90.5 157.56 4.4 Favored 'Trans proline' 0 CA--C 1.591 3.355 0 CA-C-N 125.981 3.172 . . . . 0.0 114.275 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.87 -42.39 64.06 Favored 'Trans proline' 0 CA--C 1.575 2.541 0 N-CA-C 119.732 2.935 . . . . 0.0 119.732 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.09 64.42 3.3 Favored 'General case' 0 CA--C 1.582 2.174 0 O-C-N 120.799 -1.188 . . . . 0.0 113.248 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.92 133.72 21.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.128 -1.608 . . . . 0.0 111.764 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.8 m -69.95 150.11 47.05 Favored 'General case' 0 CA--C 1.59 2.499 0 O-C-N 121.023 -1.048 . . . . 0.0 112.272 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.432 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 9.8 tp -126.43 159.15 34.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 119.846 -1.784 . . . . 0.0 111.726 -173.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.98 136.1 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 O-C-N 121.003 -1.06 . . . . 0.0 110.256 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.274 0.6 OUTLIER -135.28 125.04 25.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.59 113.41 21.8 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 173.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.91 145.56 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.755 -0.591 . . . . 0.0 111.915 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.528 ' CB ' ' HA ' ' A' ' 101' ' ' LEU 0.944 10.5 tt0 -151.54 -151.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 161.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.44 HD11 ' SD ' ' A' ' 96' ' ' MET . 0.4 OUTLIER -144.27 164.07 31.82 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -166.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -120.7 -50.51 2.19 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.349 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.98 152.0 10.84 Favored 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.872 1.669 . . . . 0.0 109.865 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -139.39 -93.66 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.235 -1.541 . . . . 0.0 109.803 178.493 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.436 77.3 tttt -127.91 -107.45 0.3 Allowed 'General case' 0 CA--C 1.588 2.411 0 CA-C-O 115.621 -2.133 . . . . 0.0 107.278 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 1 CA-C-N 126.37 4.168 . . . . 0.0 121.032 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 121.786 3.474 . . . . 0.0 121.786 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.341 11.4 p -136.85 121.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tp -69.61 121.62 17.48 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 127.187 2.195 . . . . 0.0 112.316 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.11 102.31 11.03 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 122.393 2.36 . . . . 0.0 107.297 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.85 92.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.036 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.385 0.6 OUTLIER -65.2 130.68 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.03 -60.8 1.67 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.582 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.48 99.94 7.93 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -53.42 -74.81 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.56 -154.8 25.77 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 117.661 1.824 . . . . 0.0 117.661 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.0 p -87.72 -74.42 0.45 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.47 20.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 121.918 3.527 . . . . 0.0 121.918 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -134.7 67.64 1.5 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.501 12.7 pt-20 -33.59 -101.98 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.989 1 N-CA-C 123.774 4.731 . . . . 0.0 123.774 -170.48 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -112.16 100.01 48.0 Favored Pre-proline 0 CA--C 1.581 2.168 0 N-CA-C 118.233 2.679 . . . . 0.0 118.233 -169.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -100.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.579 2.739 0 C-N-CA 123.813 3.009 . . . . 0.0 119.905 169.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -163.11 161.04 25.0 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.253 0.4 OUTLIER -59.6 138.25 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-O 122.552 1.167 . . . . 0.0 110.897 175.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.15 89.06 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -85.61 157.06 20.46 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-N 121.836 2.818 . . . . 0.0 114.482 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -74.03 136.97 43.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.212 -1.555 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.371 1.1 t -137.81 132.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.388 0.675 . . . . 0.0 109.53 -165.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.44 117.39 26.75 Favored 'General case' 0 CA--C 1.562 1.416 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.42 166.36 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -168.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -130.73 120.84 24.41 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.135 169.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -124.71 137.45 54.35 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 29.4 m -106.98 153.47 22.52 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 160.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.71 142.75 8.98 Favored Glycine 0 CA--C 1.547 2.047 0 O-C-N 119.106 -2.246 . . . . 0.0 116.151 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -135.15 150.13 50.11 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.977 1.711 . . . . 0.0 113.088 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.17 174.3 7.38 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.511 -0.743 . . . . 0.0 111.435 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.5 tp -61.34 -26.55 67.89 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.6 -5.93 13.39 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 167.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.83 58.04 Favored Glycine 0 N--CA 1.502 3.041 0 CA-C-N 120.622 1.555 . . . . 0.0 114.181 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -106.04 120.47 41.86 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -75.95 91.51 3.05 Favored 'General case' 0 CA--C 1.583 2.213 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.872 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -66.69 -32.06 73.13 Favored 'General case' 0 CA--C 1.566 1.56 0 O-C-N 119.282 -2.136 . . . . 0.0 115.516 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -149.19 158.91 44.57 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 120.248 1.386 . . . . 0.0 111.707 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' THR 0.356 43.3 t -135.36 -34.45 0.85 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 120.003 3.334 . . . . 0.0 120.003 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.321 60.0 p 58.31 -53.47 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 123.389 2.813 . . . . 0.0 116.717 -177.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.84 -34.32 27.43 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 128.343 2.657 . . . . 0.0 113.609 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -46.1 -42.72 14.02 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 125.241 1.416 . . . . 0.0 113.547 167.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.687 96.2 mtt180 95.02 38.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 120.023 3.342 . . . . 0.0 120.023 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.51 -56.15 4.37 Favored 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.78 166.82 23.6 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 126.409 1.884 . . . . 0.0 108.122 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -98.93 -162.06 0.92 Allowed 'General case' 0 CA--C 1.579 2.067 0 O-C-N 120.974 -1.079 . . . . 0.0 110.218 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.33 2.5 t80 -128.96 154.18 46.82 Favored 'General case' 0 CA--C 1.588 2.426 0 O-C-N 119.381 -2.074 . . . . 0.0 110.974 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.9 p -167.4 142.17 3.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 118.92 -2.362 . . . . 0.0 109.598 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -153.49 -179.55 7.87 Favored 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.824 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.23 124.36 52.35 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.0 106.17 0.08 Allowed 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 59.28 49.16 81.47 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 -10.98 27.52 Favored 'General case' 0 CA--C 1.579 2.091 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.1 -37.0 3.02 Favored Glycine 0 CA--C 1.564 3.118 0 C-N-CA 124.495 1.045 . . . . 0.0 110.547 -168.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -38.6 -46.72 1.23 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 120.552 3.538 . . . . 0.0 120.552 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.261 7.6 m -117.8 -154.44 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-O 124.101 1.905 . . . . 0.0 109.0 -172.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.434 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.9 pt -101.05 162.34 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 125.09 2.376 . . . . 0.0 110.113 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -69.1 -35.01 75.98 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 112.678 -2.056 . . . . 0.0 114.154 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.64 -33.9 66.78 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 116.704 -1.617 . . . . 0.0 111.161 167.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.434 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -76.21 -47.04 25.49 Favored 'General case' 0 C--N 1.371 1.515 0 CA-C-N 121.492 1.951 . . . . 0.0 112.982 173.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.96 -32.57 69.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 121.194 1.815 . . . . 0.0 115.54 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.255 1.6 mp -65.98 -59.28 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.28 0.945 . . . . 0.0 110.046 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.33 -53.49 57.68 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.613 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.283 56.7 t -54.28 -40.6 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 120.454 1.479 . . . . 0.0 114.26 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.64 70.06 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 119.881 1.219 . . . . 0.0 113.372 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 p -90.55 18.82 5.85 Favored 'General case' 0 CA--C 1.601 2.909 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.4 mtp -119.79 150.41 40.46 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 119.226 -2.171 . . . . 0.0 116.711 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 146.87 29.91 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.838 2.903 . . . . 0.0 118.838 -171.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -45.89 137.13 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 CA-C-N 112.897 -1.956 . . . . 0.0 113.13 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.53 -43.6 1.96 Allowed Glycine 0 N--CA 1.491 2.34 0 CA-C-O 115.608 -2.774 . . . . 0.0 116.713 172.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -149.21 -175.99 5.19 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 121.966 2.883 . . . . 0.0 114.506 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.593 HD22 ' SG ' ' A' ' 102' ' ' CYS 0.997 0.3 OUTLIER -155.49 -142.15 0.11 Allowed 'General case' 0 CA--C 1.604 3.05 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 172.64 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.593 ' SG ' HD22 ' A' ' 101' ' ' LEU 0.321 0.6 OUTLIER -151.41 -160.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 126.477 1.911 . . . . 0.0 113.746 -163.403 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.422 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 ptt85 -118.63 121.08 39.32 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.318 2.009 . . . . 0.0 110.124 165.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 mt -78.76 132.03 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 112.535 -2.12 . . . . 0.0 106.028 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 m -143.22 113.03 7.03 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . 2.679 2.7 m -160.28 -158.79 0.65 Allowed 'General case' 0 CA--C 1.59 2.493 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -97.6 122.68 54.59 Favored Pre-proline 0 CA--C 1.571 1.766 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -168.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 17.6 Cg_exo -42.59 -19.94 0.13 Allowed 'Trans proline' 0 CA--C 1.563 1.948 1 N-CA-C 122.534 4.013 . . . . 0.0 122.534 176.863 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.289 1.7 pm0 -63.03 -34.07 76.79 Favored 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 122.97 2.623 . . . . 0.0 113.098 169.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -74.29 -12.24 60.49 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 124.578 1.151 . . . . 0.0 113.799 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.51 -124.22 0.2 Allowed 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.289 0.6 OUTLIER -80.45 -4.63 54.5 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.133 2.242 . . . . 0.0 115.242 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -47.59 -17.99 0.56 Allowed Glycine 0 N--CA 1.497 2.755 1 N-CA-C 125.363 4.905 . . . . 0.0 125.363 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 t -65.69 -57.22 8.57 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 121.066 2.433 . . . . 0.0 111.379 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.46 -0.74 9.73 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 163.63 39.32 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-N 122.72 2.509 . . . . 0.0 111.82 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.416 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.7 t -85.51 112.21 42.67 Favored Pre-proline 0 CA--C 1.582 2.179 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.288 94.6 Cg_exo -31.52 -49.96 0.27 Allowed 'Trans proline' 0 CA--C 1.58 2.794 1 N-CA-C 123.702 4.462 . . . . 0.0 123.702 -174.042 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.63 -15.42 6.09 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 CA-C-N 125.211 2.897 . . . . 0.0 119.311 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -149.35 -6.89 0.35 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.416 ' HB ' ' H ' ' A' ' 117' ' ' SER . 25.9 mt -125.1 130.5 24.16 Favored Pre-proline 0 N--CA 1.507 2.401 0 CA-C-N 122.397 2.362 . . . . 0.0 113.767 -170.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -89.55 161.38 5.37 Favored 'Trans proline' 0 CA--C 1.591 3.356 0 CA-C-N 123.702 2.358 . . . . 0.0 112.116 173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.03 -33.74 95.23 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 N-CA-C 119.888 2.996 . . . . 0.0 119.888 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -97.24 70.25 2.33 Favored 'General case' 0 CA--C 1.583 2.225 0 O-C-N 120.648 -1.283 . . . . 0.0 110.449 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.94 117.4 4.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 119.786 -1.821 . . . . 0.0 110.701 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 m -48.32 142.45 5.56 Favored 'General case' 0 CA--C 1.59 2.506 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.35 149.22 48.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 122.09 2.223 . . . . 0.0 111.194 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.6 m -144.86 146.95 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -142.53 132.32 24.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.714 -0.616 . . . . 0.0 109.83 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.2 tm-20 -95.7 98.28 10.35 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG13 ' CG ' ' A' ' 132' ' ' GLU . 3.9 t -122.81 162.46 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 -167.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.401 ' CG ' HG13 ' A' ' 131' ' ' VAL 2.899 27.9 mt-10 174.58 167.7 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 120.961 3.689 . . . . 0.0 120.961 162.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.98 130.56 38.51 Favored 'General case' 0 N--CA 1.49 1.554 1 N-CA-C 123.208 4.522 . . . . 0.0 123.208 -153.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.92 -51.05 9.58 Favored 'General case' 0 CA--C 1.581 2.15 0 O-C-N 121.254 -0.904 . . . . 0.0 112.022 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? 176.59 163.28 0.42 Allowed 'General case' 0 CA--C 1.582 2.202 0 C-N-CA 127.676 2.391 . . . . 0.0 106.699 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.57 -82.18 0.22 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.856 -1.778 . . . . 0.0 109.71 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -79.79 -32.48 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.338 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 120.519 2.968 . . . . 0.0 120.519 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.83 146.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.272 0 N-CA-C 118.861 2.911 . . . . 0.0 118.861 -173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -113.89 138.61 50.08 Favored 'General case' 0 CA--C 1.596 2.724 0 C-N-CA 127.369 2.268 . . . . 0.0 107.239 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -125.77 125.62 43.24 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 123.638 2.926 . . . . 0.0 109.458 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.86 119.54 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.561 -0.712 . . . . 0.0 109.568 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -90.16 137.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-N 120.067 1.303 . . . . 0.0 111.629 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -123.47 -60.18 1.49 Allowed 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.552 1.141 . . . . 0.0 110.84 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -121.5 109.33 14.7 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -49.77 -38.27 33.38 Favored 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 119.541 3.163 . . . . 0.0 119.541 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.01 176.34 18.69 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 126.27 1.89 . . . . 0.0 115.886 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -151.56 -17.16 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.36 37.34 0.82 Allowed Glycine 0 N--CA 1.499 2.837 1 N-CA-C 123.37 4.108 . . . . 0.0 123.37 -175.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.3 p 65.69 -6.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.82 177.17 9.32 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 p -134.07 172.96 6.4 Favored Pre-proline 0 CA--C 1.59 2.496 0 C-N-CA 126.465 1.906 . . . . 0.0 109.402 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -100.61 -169.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.568 2.188 0 CA-C-N 123.788 2.388 . . . . 0.0 116.814 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -139.56 162.28 35.46 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 111.998 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.58 ' CD1' ' HD2' ' A' ' 90' ' ' ASP 0.262 1.5 tp -61.65 136.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 O-C-N 119.34 -2.1 . . . . 0.0 110.346 177.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.07 11.5 74.8 Favored Glycine 0 CA--C 1.561 2.912 0 N-CA-C 118.157 2.023 . . . . 0.0 118.157 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 158.94 16.83 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 120.866 2.333 . . . . 0.0 111.82 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -82.75 135.56 34.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.227 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -135.05 136.64 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 119.399 1.0 . . . . 0.0 110.603 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -117.54 109.35 16.61 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 120.575 -1.328 . . . . 0.0 107.688 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.47 173.1 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 CA-C-O 124.812 2.244 . . . . 0.0 113.221 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.62 126.88 39.46 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.96 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 143.5 47.91 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 121.624 3.935 . . . . 0.0 121.624 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.8 m -113.11 143.25 44.67 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 164.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.75 157.81 27.49 Favored Glycine 0 CA--C 1.56 2.874 0 CA-C-N 122.103 2.229 . . . . 0.0 116.037 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.44 151.94 36.09 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.283 1.433 . . . . 0.0 114.8 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.66 174.47 9.92 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.072 1.415 . . . . 0.0 109.316 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -30.17 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.89 5.66 1.47 Allowed 'General case' 0 CA--C 1.597 2.775 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 36.25 65.28 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 119.769 -1.832 . . . . 0.0 115.241 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.7 m -107.71 117.32 33.8 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -79.09 89.52 4.82 Favored 'General case' 0 CA--C 1.592 2.573 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.37 -34.59 78.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 118.81 -2.431 . . . . 0.0 115.595 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -143.02 168.33 19.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -141.55 -40.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.768 1 N-CA-C 128.206 6.372 . . . . 0.0 128.206 -170.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.251 3.9 m -141.83 -101.7 0.14 Allowed 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.312 25.5 mt -90.13 -28.1 19.18 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.318 12.3 t70 110.22 -14.45 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 127.433 2.293 . . . . 0.0 115.128 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.457 4.3 mmp_? 87.16 39.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -153.66 -66.21 0.15 Allowed 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.857 1.263 . . . . 0.0 107.625 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -130.84 -169.26 2.13 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 125.491 1.516 . . . . 0.0 108.611 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -74.07 157.26 36.4 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 119.818 -1.801 . . . . 0.0 112.303 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -74.3 116.5 15.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 123.343 2.792 . . . . 0.0 105.477 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -144.3 144.43 31.47 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.652 -1.28 . . . . 0.0 109.861 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -148.76 -169.87 3.47 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.35 1.071 . . . . 0.0 112.862 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -125.41 113.97 18.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 tp -40.14 113.13 0.33 Allowed 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.79 28.97 61.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 119.526 2.57 . . . . 0.0 119.526 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -96.15 13.02 28.72 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 122.173 2.987 . . . . 0.0 117.447 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.71 -44.96 2.54 Favored Glycine 0 N--CA 1.51 3.618 0 O-C-N 120.91 -1.119 . . . . 0.0 111.052 -172.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.271 37.7 tt0 -23.45 -49.42 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 129.709 3.204 . . . . 0.0 119.641 169.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.302 17.1 m -107.97 -129.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 123.205 1.478 . . . . 0.0 108.098 -177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 89' ' ' TRP . 44.8 pt -130.63 163.78 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 124.069 1.89 . . . . 0.0 108.869 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.256 8.0 tmtm? -69.31 -33.04 72.55 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.181 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.12 77.19 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.324 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' H ' HG13 ' A' ' 86' ' ' ILE . 37.2 m0 -72.06 -41.66 67.14 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.527 1.967 . . . . 0.0 112.957 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.58 ' HD2' ' CD1' ' A' ' 48' ' ' ILE . 17.9 t0 -57.9 -42.36 84.52 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 172.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 4.9 mt -64.78 -56.9 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.745 0 CA-C-N 118.841 0.746 . . . . 0.0 112.192 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.75 84.58 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.286 89.7 t -63.61 -34.9 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.343 1.428 . . . . 0.0 112.702 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.24 71.15 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 120.885 1.675 . . . . 0.0 113.051 169.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -79.77 5.23 14.06 Favored 'General case' 0 CA--C 1.592 2.59 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 18.2 mtt -91.58 139.18 30.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.305 -2.122 . . . . 0.0 115.012 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -93.22 159.69 15.17 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.13 130.35 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.95 0 O-C-N 119.122 -2.236 . . . . 0.0 111.055 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.92 -17.77 43.93 Favored Glycine 0 N--CA 1.514 3.898 0 CA-C-N 123.696 2.953 . . . . 0.0 116.857 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 34.4 tt0 -54.93 125.55 20.74 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 tp -103.96 121.69 43.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.125 0.97 . . . . 0.0 108.798 173.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.483 ' SG ' ' HG2' ' A' ' 100' ' ' GLU . 81.0 m -146.67 179.63 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.548 1.166 . . . . 0.0 110.96 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.44 ' NE ' ' HE2' ' A' ' 130' ' ' GLU . 6.5 mtt180 -136.0 127.6 28.87 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 123.815 1.769 . . . . 0.0 109.643 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.5 134.97 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.658 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 m -130.03 99.8 5.21 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.549 ' SG ' ' CD2' ' A' ' 127' ' ' LEU . 19.9 p -124.25 145.9 49.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -76.15 146.77 78.99 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 112.824 -1.989 . . . . 0.0 112.157 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -47.66 -23.47 3.78 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 N-CA-C 120.34 3.169 . . . . 0.0 120.34 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -63.83 -37.72 88.45 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.556 1.526 . . . . 0.0 115.017 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.14 -1.55 57.98 Favored 'General case' 0 CA--C 1.575 1.929 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.856 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.7 -122.34 0.17 Allowed 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 121.643 2.02 . . . . 0.0 116.264 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.284 3.4 m-85 -83.03 0.57 44.25 Favored 'General case' 0 N--CA 1.517 2.877 0 CA-C-N 121.881 2.128 . . . . 0.0 115.078 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.69 18.97 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 122.571 3.788 . . . . 0.0 122.571 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -67.87 -56.74 7.96 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 119.653 1.726 . . . . 0.0 112.766 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -133.74 -4.11 2.89 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 118.641 2.83 . . . . 0.0 118.641 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.24 155.76 32.02 Favored Glycine 0 CA--C 1.545 1.961 0 CA-C-N 123.693 2.951 . . . . 0.0 111.789 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 t -86.53 128.76 55.64 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 116.879 -1.534 . . . . 0.0 108.814 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -32.99 -45.98 0.29 Allowed 'Trans proline' 0 CA--C 1.58 2.824 1 N-CA-C 124.351 4.712 . . . . 0.0 124.351 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.55 -28.83 9.67 Favored 'Trans proline' 0 CA--C 1.573 2.439 0 CA-C-N 125.783 3.101 . . . . 0.0 119.662 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -163.17 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mt -79.9 146.42 63.94 Favored Pre-proline 0 CA--C 1.595 2.683 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -170.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -102.84 174.51 0.19 Allowed 'Trans proline' 0 CA--C 1.593 3.426 0 CA-C-N 125.119 2.864 . . . . 0.0 114.756 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.34 25.44 0.47 Allowed 'Trans proline' 0 CA--C 1.579 2.765 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -147.89 60.02 1.12 Allowed 'General case' 0 CA--C 1.582 2.209 0 O-C-N 120.103 -1.623 . . . . 0.0 111.706 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.93 120.93 6.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.756 -1.84 . . . . 0.0 109.814 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 96.3 m -68.53 159.22 32.25 Favored 'General case' 0 CA--C 1.584 2.257 0 O-C-N 121.141 -0.974 . . . . 0.0 112.814 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD2' ' SG ' ' A' ' 106' ' ' CYS 0.289 0.0 OUTLIER -141.86 177.53 8.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.23 -2.169 . . . . 0.0 111.372 -177.052 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.3 148.99 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 125.392 1.477 . . . . 0.0 110.942 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.52 124.99 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.726 . . . . 0.0 109.555 172.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HE2' ' NE ' ' A' ' 103' ' ' ARG . 54.2 mt-10 -87.63 118.37 27.07 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.17 141.93 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 121.242 1.837 . . . . 0.0 112.368 -172.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -116.05 110.17 18.53 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.793 0.837 . . . . 0.0 110.378 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 134' ' ' PHE . 2.6 tm? -89.47 141.83 28.21 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 123.701 1.715 . . . . 0.0 111.002 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.404 ' H ' HD23 ' A' ' 133' ' ' LEU . 22.0 m-30 -120.57 -45.44 2.41 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -175.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -158.61 149.88 20.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.082 1.353 . . . . 0.0 109.045 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER -156.54 -90.71 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 O-C-N 121.227 -0.921 . . . . 0.0 111.717 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -79.87 47.15 0.84 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.126 0 N-CA-C 122.979 3.952 . . . . 0.0 122.979 173.567 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.07 168.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.658 1.729 . . . . 0.0 112.133 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.81 0.9 OUTLIER -165.15 -168.23 1.36 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 123.67 0.788 . . . . 0.0 112.514 157.585 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.91 130.69 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.285 1.402 . . . . 0.0 113.846 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.15 118.27 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.02 143.24 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.04 0.924 . . . . 0.0 112.78 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -127.43 -66.43 0.88 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.005 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -111.46 90.36 3.31 Favored 'General case' 0 CA--C 1.586 2.338 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -21.7 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.493 1 N-CA-C 123.207 4.521 . . . . 0.0 123.207 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.11 -142.81 8.62 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -142.27 -53.69 0.42 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.2 -51.82 0.14 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 120.973 3.149 . . . . 0.0 120.973 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.401 9.6 t -85.42 46.68 1.32 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.759 2.504 . . . . 0.0 117.759 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.455 24.0 mt-10 70.08 -172.6 0.17 Allowed 'General case' 0 CA--C 1.583 2.224 1 N-CA-C 123.891 4.774 . . . . 0.0 123.891 168.317 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.8 p -92.49 151.94 41.71 Favored Pre-proline 0 CA--C 1.577 2.003 0 C-N-CA 126.91 2.084 . . . . 0.0 115.523 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.26 147.8 88.16 Favored 'Trans proline' 0 CA--C 1.577 2.653 0 C-N-CA 122.599 2.199 . . . . 0.0 117.19 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.01 153.66 20.59 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.993 -1.692 . . . . 0.0 109.858 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.4 OUTLIER -58.58 131.71 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 120.148 -1.595 . . . . 0.0 112.423 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.38 7.14 85.25 Favored Glycine 0 CA--C 1.558 2.769 0 N-CA-C 118.705 2.242 . . . . 0.0 118.705 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -88.22 154.61 20.29 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 121.61 2.705 . . . . 0.0 114.344 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -80.25 139.45 36.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.518 -1.364 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.332 1.4 t -132.51 140.85 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.149 0.98 . . . . 0.0 111.23 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.77 110.97 14.34 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.6 167.22 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 123.443 1.592 . . . . 0.0 114.804 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.88 111.33 12.47 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -113.53 148.67 35.65 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.7 m -120.06 139.73 52.09 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 163.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.48 143.22 10.76 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 119.748 -1.845 . . . . 0.0 115.801 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.01 154.45 50.5 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.308 -1.946 . . . . 0.0 113.765 -175.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.2 tp -79.23 179.52 7.34 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 123.139 1.447 . . . . 0.0 108.639 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.366 0.0 OUTLIER -64.28 -25.61 68.13 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 178.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.97 14.32 2.29 Favored 'General case' 0 CA--C 1.603 3.004 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.33 31.65 70.38 Favored Glycine 0 N--CA 1.514 3.834 0 O-C-N 119.849 -1.782 . . . . 0.0 116.161 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -86.19 111.32 20.28 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -75.35 89.02 2.59 Favored 'General case' 0 CA--C 1.583 2.23 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -72.16 -30.69 65.24 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 119.376 -2.077 . . . . 0.0 114.408 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -151.31 149.6 29.54 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.547 2.118 . . . . 0.0 113.879 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.4 p -160.1 96.8 1.23 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 112.229 -2.26 . . . . 0.0 106.995 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 t -59.16 -36.96 76.22 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -51.92 -36.78 50.23 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.72 -66.27 0.5 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -161.14 70.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -151.61 -79.39 0.11 Allowed 'General case' 0 CA--C 1.564 1.515 0 O-C-N 120.28 -1.512 . . . . 0.0 108.285 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -167.74 -138.28 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.025 1.73 . . . . 0.0 107.982 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -112.64 -165.92 1.03 Allowed 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.636 1.574 . . . . 0.0 108.46 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.333 2.8 t80 -127.65 146.65 50.48 Favored 'General case' 0 CA--C 1.572 1.822 0 O-C-N 119.098 -2.251 . . . . 0.0 110.147 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.7 p -160.84 140.5 10.79 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 119.526 -1.984 . . . . 0.0 109.151 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -149.65 -176.9 5.59 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.169 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.53 124.95 42.43 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 119.051 -2.281 . . . . 0.0 105.074 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.53 109.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.46 97.95 Favored Glycine 0 N--CA 1.513 3.781 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -132.21 -73.31 0.52 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 123.73 0.812 . . . . 0.0 112.149 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.13 71.65 0.22 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 104.255 -3.538 . . . . 0.0 104.255 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.43 0.0 OUTLIER -65.05 135.33 55.46 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 108.301 -3.949 . . . . 0.0 118.969 -159.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.359 19.2 m -79.91 -108.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 1 CA-C-N 103.299 -6.319 . . . . 0.0 107.0 -177.303 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 89' ' ' TRP . 25.7 pt -132.06 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 123.645 1.688 . . . . 0.0 107.381 168.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -32.12 73.42 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.386 176.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.91 80.62 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.591 -1.195 . . . . 0.0 112.157 168.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.448 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.3 m0 -73.46 -43.49 60.12 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 120.377 1.444 . . . . 0.0 112.39 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -57.93 -35.66 71.39 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.603 1.547 . . . . 0.0 114.774 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.324 29.0 mt -72.68 -58.12 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-N 118.952 0.796 . . . . 0.0 112.087 175.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.7 81.15 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.48 -44.3 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 120.904 1.684 . . . . 0.0 110.692 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.5 -39.73 35.07 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 121.392 1.905 . . . . 0.0 115.136 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.8 p -91.39 6.9 43.61 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 ttt -86.68 -179.6 6.61 Favored 'General case' 0 CA--C 1.58 2.122 0 O-C-N 119.705 -1.872 . . . . 0.0 113.108 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.51 164.63 21.51 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 118.903 -2.373 . . . . 0.0 113.427 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.1 t -53.79 31.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 N-CA-C 120.13 3.381 . . . . 0.0 120.13 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.75 -18.0 0.09 OUTLIER Glycine 0 N--CA 1.501 2.974 0 O-C-N 116.73 -3.731 . . . . 0.0 113.974 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' OE1' ' SG ' ' A' ' 102' ' ' CYS . 39.0 tt0 -43.89 143.76 1.02 Allowed 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 119.709 3.226 . . . . 0.0 119.709 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.71 123.59 50.66 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.659 1.183 . . . . 0.0 109.83 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.43 ' SG ' ' OE1' ' A' ' 100' ' ' GLU . 3.9 m -144.76 165.73 27.25 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.783 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -120.41 120.7 36.7 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 123.929 1.823 . . . . 0.0 110.26 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.497 HG21 ' SG ' ' A' ' 106' ' ' CYS . 3.9 mt -77.39 141.0 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.043 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.855 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.5 m -129.47 109.62 11.2 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.497 ' SG ' HG21 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -115.95 148.13 40.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -174.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -99.95 146.15 31.4 Favored Pre-proline 0 CA--C 1.579 2.08 0 C-N-CA 124.866 1.266 . . . . 0.0 110.381 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.13 -25.55 4.4 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 N-CA-C 119.738 2.938 . . . . 0.0 119.738 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.58 -38.26 86.89 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -92.54 4.49 53.46 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.848 1.259 . . . . 0.0 114.369 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.67 -104.75 0.3 Allowed 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 119.908 1.231 . . . . 0.0 113.762 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.388 47.2 m-85 -106.5 -3.12 21.23 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.17 -154.72 44.04 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 119.099 2.399 . . . . 0.0 119.099 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.7 m -67.9 -15.51 63.65 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.54 -30.46 11.39 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 118.934 2.938 . . . . 0.0 118.934 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 168.33 44.34 Favored Glycine 0 CA--C 1.552 2.355 0 CA-C-N 121.401 1.91 . . . . 0.0 115.074 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.15 120.4 59.84 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 116.666 -1.635 . . . . 0.0 107.674 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 77.1 Cg_exo -37.91 -41.02 1.12 Allowed 'Trans proline' 0 CA--C 1.58 2.814 1 N-CA-C 123.425 4.356 . . . . 0.0 123.425 -175.959 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.0 -30.84 66.66 Favored 'Trans proline' 0 CA--C 1.574 2.506 0 CA-C-N 125.455 2.984 . . . . 0.0 119.856 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -159.78 -27.78 0.07 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.8 mt -79.91 124.37 83.23 Favored Pre-proline 0 CA--C 1.584 2.271 0 C-N-CA 125.299 1.44 . . . . 0.0 111.983 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -95.58 178.3 0.7 Allowed 'Trans proline' 0 CA--C 1.584 3.007 0 C-N-CA 122.765 2.31 . . . . 0.0 116.07 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -53.13 125.29 17.87 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.655 2.903 . . . . 0.0 117.906 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.8 t30 56.16 62.41 2.37 Favored 'General case' 0 CA--C 1.586 2.36 0 C-N-CA 125.017 1.327 . . . . 0.0 113.935 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.04 123.21 40.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.303 -1.498 . . . . 0.0 112.417 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.5 m -67.29 159.25 29.63 Favored 'General case' 0 CA--C 1.593 2.616 0 O-C-N 121.358 -0.839 . . . . 0.0 113.163 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.7 mt -134.34 164.32 27.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.461 -2.024 . . . . 0.0 115.151 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.8 m -148.52 140.05 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 C-N-CA 124.639 1.176 . . . . 0.0 109.944 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.53 126.06 15.86 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.466 -1.396 . . . . 0.0 109.418 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -88.12 118.33 27.63 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.15 139.36 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.102 0.954 . . . . 0.0 111.794 -172.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -116.23 124.56 50.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 tp -104.49 110.12 22.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.221 0.534 . . . . 0.0 109.735 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.7 -43.82 25.02 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -171.73 159.62 5.38 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 123.279 1.514 . . . . 0.0 109.558 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.276 8.1 p90 -152.38 -93.76 0.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -106.51 89.33 3.0 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.739 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.376 -176.753 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.508 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -177.3 156.31 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 1.099 1.2 mp -155.61 -156.11 0.62 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 158.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HG2' ' SG ' ' A' ' 102' ' ' CYS 0.29 1.1 tmmt? -128.86 121.78 28.95 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.252 1.387 . . . . 0.0 113.359 -165.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 t -97.42 96.69 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.602 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.501 0.4 OUTLIER -55.25 132.2 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -173.547 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.89 -71.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.828 -0.545 . . . . 0.0 110.867 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.723 ' NE ' ' HE2' ' A' ' 100' ' ' GLU . 69.0 mtp85 -112.95 96.25 5.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.12 162.54 2.53 Favored 'General case' 0 CA--C 1.591 2.525 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.94 -174.99 50.12 Favored Glycine 0 CA--C 1.55 2.256 0 O-C-N 119.658 -1.901 . . . . 0.0 117.586 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -63.61 -43.22 97.52 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.97 54.19 0.46 Allowed Glycine 0 N--CA 1.48 1.568 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.2 p -136.7 -65.8 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.38 0.672 . . . . 0.0 110.95 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -127.04 163.45 23.72 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.9 p -122.83 142.46 37.91 Favored Pre-proline 0 CA--C 1.58 2.114 0 CA-C-N 110.134 -3.212 . . . . 0.0 109.399 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -60.6 119.82 7.22 Favored 'Trans proline' 0 CA--C 1.581 2.834 0 C-N-CA 123.143 2.562 . . . . 0.0 118.177 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.53 167.48 12.94 Favored 'General case' 0 CA--C 1.571 1.785 0 O-C-N 119.238 -2.164 . . . . 0.0 110.753 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.307 0.3 OUTLIER -59.47 132.09 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 O-C-N 120.132 -1.605 . . . . 0.0 112.187 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.48 2.62 88.91 Favored Glycine 0 CA--C 1.56 2.903 0 N-CA-C 118.558 2.183 . . . . 0.0 118.558 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.71 143.64 44.07 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.391 2.596 . . . . 0.0 113.442 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 107.3 18.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.402 1.5 t -103.43 123.67 57.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 126.762 2.025 . . . . 0.0 111.908 -166.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -111.32 109.93 20.17 Favored 'General case' 0 CA--C 1.573 1.834 0 O-C-N 120.936 -1.102 . . . . 0.0 108.026 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.63 164.48 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.321 11.4 m-70 -121.6 117.53 26.97 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 2.6 p90 -114.05 152.14 31.45 Favored 'General case' 0 CA--C 1.578 2.055 0 CA-C-O 123.369 1.556 . . . . 0.0 114.717 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -130.9 149.58 52.46 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.59 139.64 7.01 Favored Glycine 0 CA--C 1.551 2.331 0 O-C-N 118.735 -2.478 . . . . 0.0 116.681 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -134.93 151.39 50.82 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.292 1.837 . . . . 0.0 115.206 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -95.34 176.17 6.3 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 121.543 -0.723 . . . . 0.0 112.288 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.271 1.8 pt? -62.96 -24.97 68.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.58 -2.9 15.66 Favored 'General case' 0 CA--C 1.595 2.694 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.87 167.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.83 36.84 61.28 Favored Glycine 0 N--CA 1.504 3.186 0 CA-C-N 121.355 1.889 . . . . 0.0 114.043 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -106.14 121.65 44.58 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.487 ' NZ ' ' HG ' ' A' ' 68' ' ' SER . 29.3 ttpp -75.54 89.33 2.71 Favored 'General case' 0 CA--C 1.579 2.086 0 O-C-N 121.9 -0.5 . . . . 0.0 110.482 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -63.63 -31.83 73.11 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 119.568 -1.957 . . . . 0.0 113.767 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -153.35 156.38 38.23 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 124.474 2.083 . . . . 0.0 113.095 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.487 ' HG ' ' NZ ' ' A' ' 65' ' ' LYS . 77.1 p -157.96 96.4 1.47 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.673 -2.058 . . . . 0.0 107.611 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -55.77 -34.34 65.15 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.92 -30.56 66.01 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 3.2 p-10 -42.51 -51.73 4.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.436 ' NE ' ' HD2' ' A' ' 71' ' ' ASP . 17.5 mtm-85 -95.35 27.75 3.19 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.763 1.625 . . . . 0.0 113.644 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.283 31.6 ttpt 71.99 -13.25 0.61 Allowed 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.9 174.91 8.61 Favored 'General case' 0 CA--C 1.575 1.942 0 CA-C-O 123.745 1.736 . . . . 0.0 114.283 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -121.72 171.86 8.56 Favored 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.18 148.06 43.52 Favored 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 122.5 1.143 . . . . 0.0 108.761 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.8 t -169.37 142.97 2.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.15 -2.219 . . . . 0.0 107.398 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -149.83 174.17 12.94 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.533 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -108.25 125.67 51.93 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.39 112.04 1.14 Allowed 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.055 -1.028 . . . . 0.0 112.236 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.16 57.04 11.27 Favored Glycine 0 N--CA 1.505 3.291 0 O-C-N 120.512 -1.368 . . . . 0.0 114.761 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.251 1.9 pptp? -106.17 -73.77 0.67 Allowed 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 123.898 1.808 . . . . 0.0 111.461 -175.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -110.33 -52.75 0.59 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 127.203 2.335 . . . . 0.0 108.346 169.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.757 22.9 tt0 116.71 140.65 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 128.209 3.862 . . . . 0.0 115.003 165.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.332 8.6 m -79.92 -108.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 1 CA-C-N 105.296 -5.411 . . . . 0.0 105.04 179.691 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.25 21.0 pt -120.32 154.32 23.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 124.419 2.057 . . . . 0.0 106.541 163.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.272 13.5 tmtt? -66.61 -29.62 69.71 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.337 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.42 77.92 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 117.122 -1.418 . . . . 0.0 111.911 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -73.19 -46.07 52.69 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 121.043 1.747 . . . . 0.0 112.704 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.82 -37.27 73.52 Favored 'General case' 0 CA--C 1.575 1.94 0 CA-C-N 122.018 2.19 . . . . 0.0 114.335 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.288 1.8 mp -69.27 -64.94 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.994 0 CA-C-N 119.731 1.15 . . . . 0.0 111.215 175.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.81 92.52 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' SD ' ' A' ' 96' ' ' MET 0.341 9.6 t -70.13 -33.08 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 120.903 1.683 . . . . 0.0 111.424 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.71 -38.06 66.6 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 121.584 1.993 . . . . 0.0 112.634 165.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 9.75 5.98 Favored 'General case' 0 CA--C 1.598 2.818 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 93' ' ' VAL . 30.3 mtp -87.53 -178.59 6.16 Favored 'General case' 0 N--CA 1.511 2.59 0 CA-C-N 123.315 2.78 . . . . 0.0 116.516 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -135.95 146.8 47.68 Favored 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -175.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -51.66 123.2 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.1 -45.83 1.28 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-O 116.308 -2.384 . . . . 0.0 114.066 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.723 ' HE2' ' NE ' ' A' ' 38' ' ' ARG . 29.7 mt-10 -148.17 -173.86 4.42 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 121.399 2.6 . . . . 0.0 112.975 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.757 0.2 OUTLIER -157.6 -135.68 0.04 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 177.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -160.18 -150.08 0.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -165.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.599 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 47.5 ptt85 -120.92 130.68 53.97 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 124.441 2.067 . . . . 0.0 111.979 169.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 mt -79.6 141.13 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.02 0 CA-C-N 112.912 -1.949 . . . . 0.0 107.935 174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.9 m -129.79 109.84 11.26 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.582 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 2.1 p -132.49 151.79 51.78 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -171.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -87.8 142.19 32.28 Favored Pre-proline 0 CA--C 1.578 2.019 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.778 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 41.7 Cg_exo -54.67 -12.51 4.55 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 N-CA-C 120.304 3.155 . . . . 0.0 120.304 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.46 -40.8 97.78 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 120.925 1.693 . . . . 0.0 113.604 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.22 -3.34 54.88 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 124.652 1.181 . . . . 0.0 113.332 171.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.3 -114.27 0.24 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.11 8.12 45.19 Favored 'General case' 0 N--CA 1.514 2.731 0 CA-C-N 121.024 1.738 . . . . 0.0 114.866 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.82 141.22 43.04 Favored Glycine 0 N--CA 1.497 2.705 0 CA-C-N 123.231 2.741 . . . . 0.0 116.195 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.297 15.4 m 78.39 -54.57 0.48 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.309 1.044 . . . . 0.0 113.423 -174.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.3 -49.44 7.25 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.58 153.16 28.62 Favored Glycine 0 CA--C 1.547 2.035 0 CA-C-N 119.663 1.12 . . . . 0.0 114.379 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 t -82.45 107.21 8.27 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 116.275 -1.822 . . . . 0.0 107.913 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.499 1.0 OUTLIER -4.14 -99.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.588 3.184 1 C-N-CA 125.768 4.312 . . . . 0.0 122.332 -174.6 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -88.78 37.42 0.41 Allowed 'Trans proline' 0 CA--C 1.58 2.824 0 CA-C-N 127.743 3.801 . . . . 0.0 115.95 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -145.29 -30.5 0.42 Allowed 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.7 mt -130.57 137.37 30.66 Favored Pre-proline 0 N--CA 1.504 2.261 0 CA-C-N 121.471 1.941 . . . . 0.0 113.331 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.47 -175.59 2.0 Allowed 'Trans proline' 0 CA--C 1.591 3.339 0 CA-C-N 122.916 2.077 . . . . 0.0 112.829 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.59 9.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.58 2.777 0 N-CA-C 122.011 3.812 . . . . 0.0 122.011 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.85 93.4 1.26 Allowed 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 121.442 1.928 . . . . 0.0 110.752 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.38 98.15 4.01 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 122.924 2.602 . . . . 0.0 108.989 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.9 m -60.25 131.77 51.83 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.988 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' CD1' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -140.94 177.56 7.96 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 124.66 2.171 . . . . 0.0 114.612 -168.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -148.19 144.95 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 126.704 2.002 . . . . 0.0 108.189 -175.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 0.5 OUTLIER -133.76 124.12 26.07 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 3.8 tm-20 -88.58 97.81 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.23 140.95 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -126.15 119.28 27.11 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 tp -95.94 121.99 38.27 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.6 -46.6 9.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -165.13 157.23 15.46 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 123.855 1.788 . . . . 0.0 108.642 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -152.26 -95.49 0.05 Allowed 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 94.09 3.78 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 3.37 0 CA-C-O 117.63 -1.65 . . . . 0.0 114.561 -173.54 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -179.91 159.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 120.961 2.381 . . . . 0.0 113.755 -171.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.826 2.5 tp -148.23 -169.99 3.48 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.046 160.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 177.1 -175.23 0.13 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 -158.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 36' ' ' ILE 0.955 0.4 OUTLIER 104.28 -166.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.066 1 N-CA-C 126.537 5.754 . . . . 0.0 126.537 161.019 . . . . . . . . 5 4 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' H ' HG12 ' A' ' 35' ' ' VAL 0.392 25.0 mm -25.6 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.324 1 N-CA-C 126.134 5.605 . . . . 0.0 126.134 -167.468 . . . . . . . . 4 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 -60.45 0.97 Allowed 'General case' 0 CA--C 1.583 2.237 0 CA-C-N 110.642 -2.981 . . . . 0.0 106.649 167.165 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -120.07 109.11 15.08 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -64.79 164.98 11.29 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.39 152.91 24.71 Favored Glycine 0 CA--C 1.548 2.125 0 O-C-N 120.402 -1.437 . . . . 0.0 112.401 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.8 p -121.09 -91.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.93 25.39 0.63 Allowed Glycine 0 N--CA 1.506 3.356 1 N-CA-C 124.184 4.434 . . . . 0.0 124.184 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 53.1 p 83.31 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.644 1.978 . . . . 0.0 109.185 -172.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.343 0.0 OUTLIER -0.8 -120.04 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.907 1 N-CA-C 123.04 4.459 . . . . 0.0 123.04 -177.383 . . . . . . . . 4 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 15.5 p -107.46 137.49 19.67 Favored Pre-proline 0 CA--C 1.58 2.11 0 C-N-CA 124.735 1.214 . . . . 0.0 112.722 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.257 11.8 Cg_endo -109.48 -18.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.888 0 N-CA-C 115.84 1.438 . . . . 0.0 115.84 167.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.51 31.5 mtt 78.96 -155.22 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 169.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.323 1.0 OUTLIER -43.84 129.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -174.083 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.26 -10.34 71.53 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-O 116.073 -2.515 . . . . 0.0 117.305 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 123.457 3.629 . . . . 0.0 113.886 -177.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.2 tpt85 -86.49 96.09 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 0.0 109.648 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -91.27 133.02 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.583 0.753 . . . . 0.0 111.828 -172.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.71 102.13 10.45 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 102.307 -3.22 . . . . 0.0 102.307 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.97 -178.21 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-O 124.315 2.007 . . . . 0.0 113.789 -171.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.47 119.43 9.35 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.655 171.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -109.69 152.02 26.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.752 1.615 . . . . 0.0 114.128 -178.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.5 m -127.43 131.67 50.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 159.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.9 144.1 15.61 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-O 124.422 2.123 . . . . 0.0 116.124 -177.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -133.6 156.99 46.85 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 111.515 -2.342 . . . . 0.0 112.844 -175.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.05 163.24 13.03 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 121.308 -0.87 . . . . 0.0 109.157 168.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.268 9.1 tt -65.51 -20.92 66.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.124 -1.61 . . . . 0.0 114.937 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.74 -4.63 6.78 Favored 'General case' 0 CA--C 1.608 3.194 0 CA-C-N 119.926 1.239 . . . . 0.0 112.705 165.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.01 40.71 29.39 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.278 -1.514 . . . . 0.0 116.345 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 83.9 m -117.47 122.52 43.96 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.17 100.32 2.05 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -67.7 -38.69 84.01 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.621 -1.924 . . . . 0.0 112.105 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.44 173.28 11.22 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 125.667 2.651 . . . . 0.0 114.614 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.7 t -157.3 -91.53 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.983 1 N-CA-C 97.477 -5.009 . . . . 0.0 97.477 170.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.76 ' C ' ' H ' ' A' ' 71' ' ' ASP . 73.2 m 76.39 102.15 0.07 Allowed 'General case' 0 C--O 1.239 0.534 1 CA-C-O 97.027 -10.987 . . . . 0.0 103.933 171.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.3 mt -49.04 0.98 0.01 OUTLIER 'General case' 0 CA--C 1.598 2.807 3 O-C-N 75.771 -29.33 . . . . 0.0 121.981 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.76 ' H ' ' C ' ' A' ' 69' ' ' SER 0.408 8.2 p-10 57.26 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 121.495 3.887 . . . . 0.0 121.495 176.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.446 ' NE ' ' HG ' ' A' ' 77' ' ' SER . 3.1 ptp180 -76.93 28.88 0.13 Allowed 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 -177.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.336 53.9 tttm 80.77 -52.59 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 126.414 1.886 . . . . 0.0 112.422 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.22 -160.32 0.79 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 122.307 1.051 . . . . 0.0 108.468 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -65.11 156.74 30.63 Favored 'General case' 0 CA--C 1.578 2.026 0 O-C-N 120.502 -1.374 . . . . 0.0 113.939 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.278 17.9 t80 -65.71 151.5 46.42 Favored 'General case' 0 CA--C 1.571 1.76 0 CA-C-N 122.43 2.377 . . . . 0.0 108.885 179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.446 ' HG ' ' NE ' ' A' ' 72' ' ' ARG . 54.5 p -160.55 143.1 12.99 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 119.946 -1.721 . . . . 0.0 112.456 -175.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -157.2 -179.85 8.59 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.001 176.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -119.88 125.73 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 172.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.83 108.1 0.8 Allowed 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.05 56.55 6.32 Favored Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.288 -0.883 . . . . 0.0 113.547 -173.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -97.74 -65.4 0.97 Allowed 'General case' 0 N--CA 1.512 2.656 0 CA-C-O 124.933 2.302 . . . . 0.0 113.148 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.39 -49.68 0.15 Allowed Glycine 0 CA--C 1.56 2.895 0 N-CA-C 103.719 -3.752 . . . . 0.0 103.719 172.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.903 1.8 tm-20 119.99 139.43 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 127.226 3.393 . . . . 0.0 115.881 163.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.36 9.2 m -79.94 -105.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 1 CA-C-N 106.782 -4.736 . . . . 0.0 105.247 -178.351 . . . . . . . . 3 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.1 pt -122.5 154.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 124.289 1.995 . . . . 0.0 105.963 165.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.282 2.6 mptt -68.29 -30.67 69.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.15 81.78 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 115.791 -2.052 . . . . 0.0 110.617 167.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -73.11 -45.25 58.12 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 122.698 2.499 . . . . 0.0 112.948 174.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.36 -38.31 71.25 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.289 1.859 . . . . 0.0 114.407 175.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.34 28.4 mt -69.25 -60.97 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 CA-C-N 118.997 0.817 . . . . 0.0 112.249 175.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.8 -31.25 70.98 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 117.723 2.49 . . . . 0.0 117.723 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.408 HG12 ' SD ' ' A' ' 96' ' ' MET 0.303 13.5 t -79.08 -28.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 CA-C-N 119.821 1.191 . . . . 0.0 110.933 176.01 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.45 85.58 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.879 1.672 . . . . 0.0 112.481 166.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.0 p -73.01 0.34 11.63 Favored 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 173.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.408 ' SD ' HG12 ' A' ' 93' ' ' VAL . 9.1 mtt -82.21 126.69 32.37 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 122.888 2.585 . . . . 0.0 115.889 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.86 130.49 36.81 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 173.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.0 t -9.49 80.17 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.541 4.076 0 CA-C-N 120.433 1.469 . . . . 0.0 108.92 -157.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.83 63.38 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 CA-C-N 109.748 -3.387 . . . . 0.0 119.429 -145.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.489 8.0 tp10 -29.63 -86.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 -170.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.267 27.7 tp -130.9 113.28 13.84 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.869 0.867 . . . . 0.0 110.192 169.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.6 m -135.38 170.98 15.1 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.37 1.081 . . . . 0.0 109.653 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 161.59 21.85 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 123.593 1.663 . . . . 0.0 113.989 178.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.2 mt -127.66 133.98 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.028 175.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.8 m -135.24 100.12 4.45 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 177.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.4 p -125.52 148.24 48.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 118.733 2.864 . . . . 0.0 118.733 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -63.8 143.22 98.1 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.807 -1.568 . . . . 0.0 110.612 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.08 -11.8 23.48 Favored 'Trans proline' 0 CA--C 1.578 2.696 0 CA-C-N 125.268 2.917 . . . . 0.0 116.977 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.0 -39.63 95.33 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.187 1.812 . . . . 0.0 112.391 171.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -75.71 3.92 8.83 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 169.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.68 -105.45 0.17 Allowed 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.368 1.44 . . . . 0.0 114.078 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -114.02 13.51 18.21 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 120.014 1.279 . . . . 0.0 114.116 -177.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -57.23 -25.66 54.72 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 121.479 3.352 . . . . 0.0 121.479 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.6 p -67.49 -57.34 6.7 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 119.463 1.632 . . . . 0.0 113.318 175.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.24 -15.15 7.31 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 151.74 20.38 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 122.684 2.493 . . . . 0.0 112.175 -176.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 t -75.88 119.34 76.73 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-O 116.158 -1.877 . . . . 0.0 108.172 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.295 96.6 Cg_exo -35.59 -47.62 0.92 Allowed 'Trans proline' 0 CA--C 1.579 2.736 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -175.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -89.95 -10.7 3.42 Favored 'Trans proline' 0 CA--C 1.578 2.679 0 CA-C-N 124.789 2.746 . . . . 0.0 118.251 177.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -144.99 -49.91 0.25 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 119.13 3.011 . . . . 0.0 119.13 -174.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 80.2 mt -80.82 139.28 50.18 Favored Pre-proline 0 CA--C 1.594 2.653 0 CA-C-O 116.353 -1.784 . . . . 0.0 114.975 -171.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -97.58 172.42 0.69 Allowed 'Trans proline' 0 CA--C 1.592 3.405 0 CA-C-N 125.754 3.091 . . . . 0.0 114.525 176.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -64.27 2.54 1.11 Allowed 'Trans proline' 0 CA--C 1.576 2.58 0 N-CA-C 120.272 3.143 . . . . 0.0 120.272 175.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -146.37 57.62 1.19 Allowed 'General case' 0 CA--C 1.58 2.105 0 O-C-N 119.754 -1.841 . . . . 0.0 114.237 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.32 114.46 15.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 119.745 -1.847 . . . . 0.0 106.989 173.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.7 m -59.88 130.89 48.99 Favored 'General case' 0 CA--C 1.586 2.359 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.201 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.91 156.41 18.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 122.137 2.244 . . . . 0.0 115.165 -173.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.0 t -143.68 120.23 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-N 112.294 -2.23 . . . . 0.0 107.727 -173.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 4.1 m-85 -140.7 129.92 23.61 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 119.756 -1.84 . . . . 0.0 110.367 174.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.484 ' N ' ' HE2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -94.75 111.99 23.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 172.145 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.46 131.95 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.39 108.54 17.74 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.645 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 tt -98.45 116.34 30.46 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.574 1.178 . . . . 0.0 109.886 -175.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.94 -51.58 7.03 Favored 'General case' 0 CA--C 1.574 1.878 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.73 -177.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 152.87 30.87 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.918 1.287 . . . . 0.0 109.962 175.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -131.65 -75.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.839 -1.163 . . . . 0.0 112.594 176.706 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.291 57.6 tttm -79.79 -57.1 3.82 Favored 'General case' 0 CA--C 1.584 2.281 0 CA-C-O 115.776 -2.059 . . . . 0.0 115.128 -177.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.017 0 CA-C-N 125.083 3.583 . . . . 0.0 119.602 -179.255 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 1 N-CA-C 125.188 4.835 . . . . 0.0 125.188 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.75 166.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -172.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.759 1.1 tp -159.53 -153.11 0.34 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.437 163.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -157.34 137.29 12.48 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.042 2.201 . . . . 0.0 116.394 -169.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.4 133.37 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.45 -0.781 . . . . 0.0 109.737 174.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.301 1.0 OUTLIER -75.84 133.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 O-C-N 120.522 -1.361 . . . . 0.0 113.602 -177.627 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -114.65 -51.58 2.74 Favored 'General case' 0 CA--C 1.575 1.925 0 C-N-CA 124.606 1.162 . . . . 0.0 112.015 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.09 96.15 2.95 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.522 ' HE2' ' NZ ' ' A' ' 97' ' ' LYS . 3.0 mm-40 -55.62 171.06 0.22 Allowed 'General case' 0 CA--C 1.591 2.539 0 CA-C-N 122.106 2.23 . . . . 0.0 116.444 177.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.26 -172.19 22.65 Favored Glycine 0 CA--C 1.547 2.09 0 O-C-N 120.018 -1.676 . . . . 0.0 116.905 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -166.77 -69.45 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.043 0.937 . . . . 0.0 110.006 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.7 -103.5 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 120.738 3.055 . . . . 0.0 120.738 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.4 p -113.38 49.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.247 1.499 . . . . 0.0 111.693 178.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.443 4.7 pt-20 41.14 -116.85 0.31 Allowed 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 119.598 3.185 . . . . 0.0 119.598 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -150.77 137.08 11.07 Favored Pre-proline 0 CA--C 1.577 2.009 0 C-N-CA 124.925 1.29 . . . . 0.0 113.579 -175.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.251 6.2 Cg_endo -117.19 -26.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.583 2.942 0 C-N-CA 121.782 1.655 . . . . 0.0 115.984 171.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.566 32.3 mtt 82.31 -146.47 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.402 0.3 OUTLIER -47.0 128.94 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -172.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.11 90.62 Favored Glycine 0 CA--C 1.56 2.857 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -174.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -79.6 144.69 33.6 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 122.635 3.217 . . . . 0.0 114.914 -178.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -75.64 131.33 39.87 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.252 0.933 . . . . 0.0 109.088 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.362 2.1 t -131.39 132.03 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 124.141 0.976 . . . . 0.0 112.217 -166.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -117.7 107.13 13.81 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -116.31 159.23 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.972 1.368 . . . . 0.0 114.296 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -116.32 123.57 47.98 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 116.806 -1.568 . . . . 0.0 109.223 166.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.323 0.1 OUTLIER -119.11 135.38 54.68 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.449 1.477 . . . . 0.0 114.303 176.592 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.4 m -104.18 149.17 25.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 159.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.12 144.21 11.14 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 118.622 -2.548 . . . . 0.0 115.656 178.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -136.26 149.11 48.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 112.452 -1.874 . . . . 0.0 114.866 -173.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.17 165.53 17.33 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 123.249 1.499 . . . . 0.0 107.721 167.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -60.5 -27.32 67.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 178.277 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -2.17 11.38 Favored 'General case' 0 CA--C 1.595 2.682 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 171.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.21 45.39 7.05 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.448 -1.407 . . . . 0.0 113.594 -176.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -117.65 113.89 22.58 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -176.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -79.9 93.03 5.59 Favored 'General case' 0 CA--C 1.585 2.311 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.794 -178.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -71.24 -30.04 65.85 Favored 'General case' 0 CA--C 1.566 1.579 0 O-C-N 119.085 -2.259 . . . . 0.0 115.403 175.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -146.86 156.34 43.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.825 1.648 . . . . 0.0 113.717 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 t -157.9 87.87 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.2 t -53.98 -42.31 68.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 174.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.403 ' H ' HD11 ' A' ' 70' ' ' LEU . 4.7 mp -64.3 -39.3 93.64 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 127.523 2.329 . . . . 0.0 113.481 178.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.22 -48.45 81.7 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.45 1.5 . . . . 0.0 113.824 173.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -78.59 -23.44 46.01 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 176.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.348 0.1 OUTLIER 115.27 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 128.572 2.749 . . . . 0.0 111.236 -179.275 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -134.43 149.57 50.77 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -175.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.289 19.4 tptm -166.53 -83.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.112 3.745 . . . . 0.0 121.112 173.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.401 0.4 OUTLIER -89.02 146.7 24.69 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 -161.839 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -165.48 129.0 2.23 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 120.701 -1.249 . . . . 0.0 107.957 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -142.06 -165.04 1.92 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 122.36 1.076 . . . . 0.0 110.323 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.283 9.5 t0 -135.03 125.75 27.14 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 172.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.0 112.06 0.52 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.8 92.76 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -174.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.306 5.6 mmtt -138.38 -80.16 0.34 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -168.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.94 76.61 0.46 Allowed Glycine 0 N--CA 1.503 3.131 1 N-CA-C 99.686 -5.365 . . . . 0.0 99.686 170.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.383 32.7 tp10 -78.63 157.04 28.77 Favored 'General case' 0 CA--C 1.555 1.172 1 CA-C-O 130.104 4.764 . . . . 0.0 119.5 -159.513 . . . . . . . . 3 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.335 33.6 m -107.73 -140.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 1 CA-C-N 101.964 -6.926 . . . . 0.0 107.183 -173.288 . . . . . . . . 3 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 pt -101.08 154.52 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 122.98 1.371 . . . . 0.0 109.452 170.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.517 0.0 OUTLIER -69.94 -21.27 63.28 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 175.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.73 85.78 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 117.692 -1.146 . . . . 0.0 111.366 165.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -73.91 -40.25 63.28 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-N 120.399 1.454 . . . . 0.0 113.073 173.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -57.62 -37.08 72.68 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 119.924 1.238 . . . . 0.0 113.833 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.27 1.5 mp -64.05 -56.83 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 119.431 1.014 . . . . 0.0 110.836 173.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.52 94.48 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 177.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.27 -43.94 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 119.031 0.832 . . . . 0.0 112.519 174.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.07 66.91 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-N 119.695 1.134 . . . . 0.0 113.931 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.0 p -92.29 24.61 3.3 Favored 'General case' 0 CA--C 1.588 2.439 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -122.95 140.07 53.4 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.622 2.01 . . . . 0.0 114.874 178.588 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' NZ ' ' HE2' ' A' ' 39' ' ' GLU . 15.7 pttm -90.4 168.08 12.14 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.403 1.081 . . . . 0.0 111.483 174.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.0 135.83 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.546 0 O-C-N 119.46 -2.025 . . . . 0.0 112.46 -176.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.38 8.8 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-N 124.152 3.16 . . . . 0.0 117.107 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.49 102.74 1.18 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 118.476 1.138 . . . . 0.0 111.999 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.24 131.83 44.25 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.496 1.119 . . . . 0.0 109.062 177.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.0 m -136.8 -169.71 2.53 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.553 1.168 . . . . 0.0 113.422 -176.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.309 3.8 mtt180 -135.91 113.52 10.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 124.942 2.306 . . . . 0.0 108.732 172.548 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -76.97 136.15 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.744 -177.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -117.76 101.7 8.53 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 174.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 5.2 p -115.12 149.33 37.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -171.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -104.96 129.06 25.49 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.675 177.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.53 -16.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.966 0 N-CA-C 122.042 3.824 . . . . 0.0 122.042 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.33 -41.09 92.81 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 121.785 2.084 . . . . 0.0 113.244 169.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -87.08 -0.09 56.1 Favored 'General case' 0 CA--C 1.582 2.189 0 C-N-CA 125.766 1.626 . . . . 0.0 113.656 170.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 -113.35 0.22 Allowed 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -175.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -92.46 13.39 19.77 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 120.672 1.578 . . . . 0.0 113.62 -178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.84 148.48 31.61 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 122.141 2.246 . . . . 0.0 118.084 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.276 8.3 t 73.4 -42.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.299 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.49 -56.45 2.34 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.81 143.53 14.83 Favored Glycine 0 CA--C 1.546 1.992 0 CA-C-N 119.626 1.103 . . . . 0.0 112.028 -175.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.41 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.3 t -78.75 144.76 65.18 Favored Pre-proline 0 CA--C 1.584 2.254 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.62 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -33.06 134.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.071 0 C-N-CA 124.307 3.338 . . . . 0.0 120.603 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.333 0.1 OUTLIER 21.84 46.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.475 2 N-CA-C 125.107 5.003 . . . . 0.0 125.107 -175.563 . . . . . . . . 4 3 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -164.45 -55.94 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.41 ' HB ' ' H ' ' A' ' 117' ' ' SER . 56.9 mt -84.69 136.17 39.63 Favored Pre-proline 0 CA--C 1.592 2.574 0 CA-C-O 116.279 -1.819 . . . . 0.0 112.674 -174.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -99.48 173.9 0.4 Allowed 'Trans proline' 0 CA--C 1.592 3.408 0 CA-C-N 125.943 3.158 . . . . 0.0 115.184 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.42 -18.68 39.97 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 N-CA-C 121.209 3.503 . . . . 0.0 121.209 176.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -140.2 83.12 1.9 Allowed 'General case' 0 CA--C 1.588 2.431 0 CA-C-N 120.448 1.476 . . . . 0.0 111.822 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.85 -153.58 0.56 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 119.453 -2.029 . . . . 0.0 111.081 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.255 65.9 m -139.3 150.87 45.93 Favored 'General case' 0 CA--C 1.591 2.53 0 O-C-N 119.098 -2.251 . . . . 0.0 109.099 173.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 50.9 mt -127.21 162.63 25.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.232 -2.168 . . . . 0.0 112.895 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 79.5 t -146.45 115.46 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.672 -2.058 . . . . 0.0 107.225 -174.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 0.8 OUTLIER -128.91 123.19 31.95 Favored 'General case' 0 N--CA 1.517 2.911 0 CA-C-N 123.13 2.695 . . . . 0.0 111.014 174.25 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.4 tm-20 -92.07 90.9 7.57 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 123.654 1.692 . . . . 0.0 107.467 175.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.47 157.59 41.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -173.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.607 ' HB3' ' SD ' ' A' ' 96' ' ' MET 1.657 16.6 mt-10 -179.06 -174.13 0.32 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.328 168.707 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.546 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 16.2 tp -106.82 145.68 31.83 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 121.111 3.745 . . . . 0.0 121.111 -165.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -92.02 -54.32 3.89 Favored 'General case' 0 CA--C 1.58 2.125 0 CA-C-N 111.887 -2.415 . . . . 0.0 108.572 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -170.58 159.08 6.57 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 126.144 1.778 . . . . 0.0 108.308 171.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.291 0.0 OUTLIER -129.38 -103.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.411 -1.43 . . . . 0.0 110.223 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.447 63.7 tttt -105.76 -96.94 0.34 Allowed 'General case' 0 CA--C 1.581 2.146 0 CA-C-O 116.02 -1.943 . . . . 0.0 110.269 177.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.562 0 CA-C-N 125.167 3.622 . . . . 0.0 116.647 -178.798 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 1 N-CA-C 126.636 5.414 . . . . 0.0 126.636 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.464 HG23 ' H ' ' A' ' 23' ' ' ASP 0.318 9.7 p -123.12 -142.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -165.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -143.92 -175.89 4.77 Favored 'General case' 0 CA--C 1.592 2.572 0 C-N-CA 126.058 1.743 . . . . 0.0 109.158 175.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.423 0.5 OUTLIER 89.49 167.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 126.222 1.809 . . . . 0.0 108.905 -175.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.8 p -119.27 120.78 30.71 Favored Pre-proline 0 CA--C 1.571 1.764 0 O-C-N 116.731 -3.731 . . . . 0.0 108.794 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -63.81 42.11 0.11 Allowed 'Trans proline' 0 CA--C 1.589 3.242 0 N-CA-C 119.971 3.027 . . . . 0.0 119.971 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.63 -62.21 0.05 Allowed 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 127.257 2.223 . . . . 0.0 108.459 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -82.76 -28.07 30.62 Favored 'General case' 0 CA--C 1.582 2.197 0 O-C-N 120.726 -1.234 . . . . 0.0 113.863 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.519 0.0 OUTLIER 85.08 -22.68 0.19 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 -177.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.27 -35.21 15.42 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 118.422 2.749 . . . . 0.0 118.422 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.3 -59.51 5.75 Favored Glycine 0 N--CA 1.479 1.551 1 N-CA-C 127.171 5.629 . . . . 0.0 127.171 -156.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.275 8.2 p -156.68 -141.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.607 -174.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 1.157 8.1 mp 130.35 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 129.159 2.984 . . . . 0.0 111.895 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -154.83 130.33 9.83 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 122.629 2.468 . . . . 0.0 117.403 -162.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.67 119.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 123.414 0.686 . . . . 0.0 111.143 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.283 0.7 OUTLIER -87.19 135.93 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 122.201 1.0 . . . . 0.0 112.077 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -118.64 -60.65 1.75 Allowed 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.611 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -119.69 94.64 4.47 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.08 164.4 5.15 Favored 'General case' 0 CA--C 1.594 2.643 0 O-C-N 119.385 -2.072 . . . . 0.0 113.912 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.74 170.69 45.98 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 122.357 3.703 . . . . 0.0 122.357 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -99.24 -63.88 1.09 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.547 -1.826 . . . . 0.0 107.123 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.23 102.83 1.74 Allowed Glycine 0 CA--C 1.549 2.175 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 p -51.54 -22.57 3.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HE2' ' NZ ' ' A' ' 137' ' ' LYS . 10.0 mt-10 -63.29 153.62 34.24 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 p -115.79 163.52 20.72 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 111.635 -2.529 . . . . 0.0 112.303 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.68 146.16 29.98 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 CA-C-N 123.385 2.245 . . . . 0.0 114.351 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -90.32 164.36 14.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.122 -1.611 . . . . 0.0 110.854 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.3 OUTLIER -61.4 130.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 119.297 -2.127 . . . . 0.0 111.691 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.0 15.22 79.86 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.419 2.128 . . . . 0.0 118.419 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.88 154.02 19.15 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.421 2.11 . . . . 0.0 110.998 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -84.58 124.58 31.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.753 . . . . 0.0 110.208 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.23 132.06 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.008 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.26 93.5 4.72 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 125.168 2.413 . . . . 0.0 104.88 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.04 169.37 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 110.558 -3.019 . . . . 0.0 109.12 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.474 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.335 2.9 t60 -148.49 137.45 21.68 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 159.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -122.71 152.62 40.39 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.107 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.9 m -117.51 150.79 38.37 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 159.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.6 144.97 12.1 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 118.424 -2.672 . . . . 0.0 115.655 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -130.14 153.23 48.73 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 112.648 -1.776 . . . . 0.0 113.746 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.48 168.91 16.04 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 122.975 1.369 . . . . 0.0 107.388 166.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.8 -27.84 66.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -72.42 1.15 8.46 Favored 'General case' 0 CA--C 1.594 2.635 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.5 43.2 12.75 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 120.202 -1.561 . . . . 0.0 113.308 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -114.88 116.24 28.23 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -75.9 87.42 2.87 Favored 'General case' 0 CA--C 1.586 2.338 0 O-C-N 121.966 -0.459 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.91 -28.16 62.31 Favored 'General case' 0 CA--C 1.558 1.26 0 O-C-N 119.46 -2.025 . . . . 0.0 115.432 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -156.07 148.41 23.57 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 t -160.06 113.58 2.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.269 81.1 p -63.13 -38.58 91.75 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.474 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.275 65.7 mt -53.2 -42.34 66.17 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 122.318 2.326 . . . . 0.0 115.76 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' HD2' ' N ' ' A' ' 71' ' ' ASP . 14.3 m-20 -49.92 -36.73 28.67 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 173.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 -85.79 42.51 0.97 Allowed 'General case' 0 CA--C 1.585 2.313 0 C-N-CA 124.745 1.218 . . . . 0.0 114.251 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.324 34.3 ttmt 83.26 -36.72 0.08 Allowed 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.2 -175.07 4.55 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-O 124.034 1.873 . . . . 0.0 115.469 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.89 178.09 4.48 Favored 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 125.254 1.422 . . . . 0.0 113.033 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.99 164.73 11.87 Favored 'General case' 0 CA--C 1.583 2.246 0 O-C-N 120.431 -1.418 . . . . 0.0 108.9 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.5 p -167.44 133.71 2.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 118.939 -2.35 . . . . 0.0 111.111 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -146.27 -176.3 5.11 Favored 'General case' 0 CA--C 1.573 1.827 0 CA-C-O 122.177 0.989 . . . . 0.0 112.214 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -119.26 114.31 22.19 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -40.89 113.85 0.42 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.4 95.17 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -111.5 21.17 16.46 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.27 -42.12 2.74 Favored Glycine 0 N--CA 1.51 3.586 0 O-C-N 121.147 -0.971 . . . . 0.0 112.484 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -32.81 -37.35 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 120.494 3.516 . . . . 0.0 120.494 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.254 20.6 m -123.95 -142.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 123.116 1.436 . . . . 0.0 109.662 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.7 pt -113.86 157.14 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 124.298 1.999 . . . . 0.0 108.284 170.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -64.85 -34.09 77.54 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 113.838 -1.528 . . . . 0.0 113.346 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.07 67.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.199 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -73.17 -43.44 61.45 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 120.226 1.376 . . . . 0.0 112.214 172.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.83 -38.58 70.23 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 121.237 1.835 . . . . 0.0 114.928 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.319 2.2 mp -69.97 -62.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 CA-C-N 119.741 1.155 . . . . 0.0 111.44 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.72 -30.59 70.86 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.284 12.6 t -77.74 -34.45 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 120.036 1.289 . . . . 0.0 110.644 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.39 -38.43 66.16 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 121.224 1.829 . . . . 0.0 112.701 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.8 p -80.88 8.41 8.34 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.504 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 9.3 tpt -100.25 127.76 46.46 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 122.071 2.214 . . . . 0.0 114.814 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -82.08 166.53 19.65 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.41 128.22 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.914 0 O-C-N 120.395 -1.44 . . . . 0.0 109.938 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.49 -0.46 64.43 Favored Glycine 1 N--CA 1.517 4.054 0 CA-C-N 123.201 2.728 . . . . 0.0 117.751 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -73.48 154.5 39.89 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.55 123.39 26.43 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.335 1.054 . . . . 0.0 112.246 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 8.7 p -151.64 174.65 13.22 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -124.86 119.85 30.01 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 124.201 1.953 . . . . 0.0 111.566 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -74.24 138.65 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-N 112.495 -2.138 . . . . 0.0 110.76 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.433 ' CG2' ' HD2' ' A' ' 23' ' ' ASP . 96.8 m -123.12 110.48 15.36 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 102.629 -3.101 . . . . 0.0 102.629 172.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.556 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 2.9 p -115.85 146.38 42.05 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -106.94 135.75 19.53 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.672 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -43.13 -24.59 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.853 1 N-CA-C 122.77 4.104 . . . . 0.0 122.77 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.39 -39.12 92.18 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 121.588 1.995 . . . . 0.0 114.293 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.44 -3.73 58.77 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 125.58 1.552 . . . . 0.0 112.79 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.27 -117.96 0.2 Allowed 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.287 6.6 m-85 -92.45 16.72 11.24 Favored 'General case' 0 N--CA 1.513 2.692 0 CA-C-N 121.005 1.73 . . . . 0.0 114.334 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.65 -63.23 4.61 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 123.008 2.64 . . . . 0.0 117.373 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -79.46 42.62 0.52 Allowed 'General case' 0 CA--C 1.584 2.264 0 CA-C-N 118.92 1.36 . . . . 0.0 114.236 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -171.77 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.99 136.88 6.45 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.22 0.914 . . . . 0.0 110.89 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.402 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.7 t -78.45 118.91 75.12 Favored Pre-proline 0 CA--C 1.581 2.157 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.241 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.272 42.4 Cg_exo -27.37 -51.15 0.11 Allowed 'Trans proline' 0 CA--C 1.579 2.761 1 N-CA-C 124.682 4.839 . . . . 0.0 124.682 -175.684 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.57 -30.14 12.44 Favored 'Trans proline' 0 CA--C 1.572 2.42 0 CA-C-N 125.607 3.038 . . . . 0.0 119.548 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -163.93 -8.95 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' HB ' ' H ' ' A' ' 117' ' ' SER . 19.6 mt -79.93 123.7 83.54 Favored Pre-proline 0 CA--C 1.583 2.248 0 O-C-N 119.631 -1.918 . . . . 0.0 113.299 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.76 171.09 7.23 Favored 'Trans proline' 0 CA--C 1.585 3.067 0 C-N-CA 122.547 2.165 . . . . 0.0 113.441 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.65 12.87 0.23 Allowed 'Trans proline' 0 CA--C 1.58 2.804 0 N-CA-C 120.536 3.245 . . . . 0.0 120.536 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -153.95 67.7 0.75 Allowed 'General case' 0 CA--C 1.582 2.211 0 O-C-N 119.974 -1.704 . . . . 0.0 111.644 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.16 133.89 33.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 119.797 -1.815 . . . . 0.0 110.529 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.291 23.3 m -66.05 152.05 45.51 Favored 'General case' 0 CA--C 1.594 2.639 0 O-C-N 120.703 -1.248 . . . . 0.0 112.447 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 11.8 tp -132.44 158.27 42.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 119.541 -1.974 . . . . 0.0 111.892 -170.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 53.9 t -143.69 124.59 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.862 -169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.303 15.3 m-85 -136.46 124.44 22.8 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 122.286 2.312 . . . . 0.0 112.16 173.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -93.49 113.14 25.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.481 -2.012 . . . . 0.0 107.999 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.7 t -112.34 136.25 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.886 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -119.51 114.97 23.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.28 119.95 38.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.578 1.18 . . . . 0.0 109.498 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -79.73 -56.92 3.93 Favored 'General case' 0 CA--C 1.582 2.184 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.307 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -169.89 161.65 9.04 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 126.031 1.733 . . . . 0.0 109.72 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -138.05 -84.89 0.29 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.784 -1.822 . . . . 0.0 110.862 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.468 ' NZ ' ' HE2' ' A' ' 44' ' ' GLU . 40.0 ttpt -79.83 74.36 6.56 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 125.511 2.577 . . . . 0.0 108.308 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.567 3.299 0 CA-C-N 110.909 -2.86 . . . . 0.0 111.855 -173.778 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.853 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.62 153.17 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.038 0.935 . . . . 0.0 112.731 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -153.9 148.42 26.2 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.316 10.5 tp -120.86 70.09 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 124.546 2.117 . . . . 0.0 108.803 173.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -156.17 64.58 3.77 Favored Pre-proline 0 CA--C 1.585 2.312 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.441 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.251 21.5 Cg_exo -61.49 -29.16 84.45 Favored 'Trans proline' 0 CA--C 1.573 2.463 0 CA-C-N 124.933 2.797 . . . . 0.0 117.442 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.87 52.18 0.81 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.948 1.299 . . . . 0.0 109.066 174.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.312 65.2 mm-40 64.62 39.09 6.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.6 -77.76 0.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 111.514 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.275 49.8 mt-10 -90.13 3.47 53.29 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 174.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.97 12.49 36.48 Favored Glycine 0 N--CA 1.484 1.839 1 N-CA-C 123.815 4.286 . . . . 0.0 123.815 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.324 38.2 t -139.51 133.2 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 1 CA-C-N 124.419 4.109 . . . . 0.0 116.517 -174.038 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.33 134.12 54.05 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 125.912 1.685 . . . . 0.0 109.253 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -129.24 133.09 47.36 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 124.12 3.145 . . . . 0.0 111.453 176.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.9 t -105.1 153.18 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.71 142.38 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.915 0 CA-C-O 122.771 1.272 . . . . 0.0 108.97 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -114.32 -57.89 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.692 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -122.29 112.24 17.89 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.51 -62.9 1.45 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.455 -1.403 . . . . 0.0 114.241 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.1 -155.83 26.43 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 119.364 2.505 . . . . 0.0 119.364 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -91.12 -54.57 3.89 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 114.337 -0.931 . . . . 0.0 113.319 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -39.0 62.15 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.261 73.0 p 74.62 3.25 4.23 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -106.92 167.24 10.02 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 120.772 -1.205 . . . . 0.0 113.001 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.2 p -132.94 108.33 12.75 Favored Pre-proline 0 CA--C 1.577 1.982 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.59 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.353 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.6 ptm -170.83 175.47 4.48 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 120.868 1.667 . . . . 0.0 114.344 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -55.8 132.8 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 CA-C-O 122.334 1.064 . . . . 0.0 111.44 176.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.33 0.3 70.58 Favored Glycine 0 CA--C 1.563 3.079 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.08 137.88 49.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 121.437 2.618 . . . . 0.0 113.585 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -86.65 104.8 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -105.39 131.08 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.074 0.95 . . . . 0.0 110.667 -173.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.255 29.1 p90 -105.23 115.54 30.43 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 105.653 -1.981 . . . . 0.0 105.653 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.28 170.08 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 CA-C-O 125.04 2.352 . . . . 0.0 114.103 -170.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -124.43 119.32 28.84 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 111.58 -2.555 . . . . 0.0 106.358 168.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.333 3.3 p90 -114.72 150.85 34.65 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 123.977 1.846 . . . . 0.0 113.626 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -127.63 151.71 48.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.53 138.38 6.03 Favored Glycine 0 CA--C 1.546 2.001 0 O-C-N 118.742 -2.474 . . . . 0.0 115.944 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.19 150.71 49.4 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 127.323 2.249 . . . . 0.0 112.25 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.5 tp -84.22 -172.75 4.34 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-O 123.984 1.849 . . . . 0.0 109.641 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -58.35 -37.39 75.09 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.19 21.61 0.89 Allowed 'General case' 0 CA--C 1.597 2.756 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.97 33.48 50.61 Favored Glycine 1 N--CA 1.517 4.054 0 O-C-N 120.179 -1.576 . . . . 0.0 115.798 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.7 m -86.72 109.24 19.08 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -69.04 92.36 0.52 Allowed 'General case' 0 CA--C 1.588 2.437 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -73.08 -36.08 66.75 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 119.296 -2.127 . . . . 0.0 114.598 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' HD2' ' CZ ' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -161.65 174.95 12.57 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 123.834 1.778 . . . . 0.0 114.442 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 t -152.42 -147.15 0.22 Allowed 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 51.6 p -148.73 -66.56 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.056 -1.653 . . . . 0.0 108.701 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.317 22.3 mt -61.38 -42.35 98.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -49.99 -42.34 48.84 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.698 ' NE ' ' HD2' ' A' ' 74' ' ' ASP 0.339 32.5 ptt180 -75.57 -75.38 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.545 1.138 . . . . 0.0 113.535 176.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -163.62 -36.7 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.925 1.29 . . . . 0.0 112.172 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.698 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 3.0 p30 -89.28 -157.15 0.43 Allowed 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -145.62 170.71 15.91 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 125.943 1.697 . . . . 0.0 108.498 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.285 3.7 t80 -114.05 154.68 27.28 Favored 'General case' 0 CA--C 1.573 1.856 0 CA-C-O 123.772 1.749 . . . . 0.0 109.125 173.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.2 p -170.9 124.08 0.63 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.802 -1.186 . . . . 0.0 108.171 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -143.22 164.44 30.18 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 121.813 -0.555 . . . . 0.0 111.913 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.97 128.2 49.89 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 119.168 -2.208 . . . . 0.0 106.125 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.57 110.94 1.08 Allowed 'General case' 0 CA--C 1.57 1.733 0 O-C-N 121.27 -0.894 . . . . 0.0 112.77 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 54.76 30.65 Favored Glycine 0 N--CA 1.509 3.542 0 O-C-N 120.65 -1.281 . . . . 0.0 114.606 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -99.15 -71.95 0.68 Allowed 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 124.366 2.031 . . . . 0.0 112.182 -174.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -111.23 -49.98 0.64 Allowed Glycine 0 CA--C 1.561 2.914 0 N-CA-C 104.024 -3.63 . . . . 0.0 104.024 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.778 23.8 tt0 118.89 137.78 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 127.909 3.719 . . . . 0.0 114.634 164.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.348 11.9 m -79.97 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 1 CA-C-N 105.773 -5.194 . . . . 0.0 104.454 178.25 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -132.79 157.39 43.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 124.017 1.865 . . . . 0.0 106.8 166.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -65.01 -33.11 75.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.519 -1.219 . . . . 0.0 113.123 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.26 80.49 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 117.25 -1.357 . . . . 0.0 111.938 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.453 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.0 m0 -73.94 -43.31 58.71 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.685 1.584 . . . . 0.0 112.215 172.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.41 -34.58 72.64 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 121.548 1.976 . . . . 0.0 114.267 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.303 1.5 mp -69.99 -63.25 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.004 0 CA-C-N 120.317 1.417 . . . . 0.0 111.294 174.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.16 -33.14 75.1 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.345 3.5 t -78.35 -25.92 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 CA-C-N 119.764 1.166 . . . . 0.0 111.584 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.23 90.05 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-N 121.238 1.835 . . . . 0.0 111.856 165.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.6 p -82.58 17.57 1.75 Allowed 'General case' 0 CA--C 1.596 2.718 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.505 ' SD ' HD21 ' A' ' 101' ' ' LEU . 2.2 ttt -104.68 143.31 33.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 119.26 -2.15 . . . . 0.0 116.068 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -104.13 152.95 21.5 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 119.039 2.977 . . . . 0.0 119.039 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.88 124.92 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.408 0 CA-C-O 118.478 -0.773 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.9 -55.4 0.53 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 120.683 1.583 . . . . 0.0 112.809 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.305 5.5 tt0 -158.41 -163.59 1.31 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.505 HD21 ' SD ' ' A' ' 96' ' ' MET 0.782 0.5 OUTLIER -162.66 -139.92 0.05 OUTLIER 'General case' 0 CA--C 1.594 2.667 0 C-N-CA 125.091 1.357 . . . . 0.0 111.622 178.414 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.528 ' SG ' ' HG2' ' A' ' 103' ' ' ARG 0.72 51.3 t -160.03 -115.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 127.162 2.185 . . . . 0.0 107.916 175.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.528 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 54.8 ptt85 -135.32 135.15 40.55 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -173.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -89.84 132.07 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 CA-C-N 112.66 -2.063 . . . . 0.0 108.241 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.2 m -121.0 105.99 11.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 15.6 p -124.08 149.6 45.97 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -170.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -81.45 135.98 49.51 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.521 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.265 50.5 Cg_exo -57.7 -17.2 28.0 Favored 'Trans proline' 0 CA--C 1.559 1.756 0 N-CA-C 118.882 2.608 . . . . 0.0 118.882 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.62 -33.94 76.02 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 121.692 2.042 . . . . 0.0 113.907 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.57 -2.87 51.62 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 125.734 1.614 . . . . 0.0 113.462 169.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.51 -113.97 0.22 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 121.499 1.954 . . . . 0.0 113.013 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.308 2.7 m-85 -79.04 -37.55 38.74 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 121.188 1.813 . . . . 0.0 113.12 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.22 -116.15 3.29 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 121.222 3.249 . . . . 0.0 121.222 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -77.85 -31.99 51.83 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.36 -33.76 63.18 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.12 155.99 9.75 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 t -98.9 111.09 59.82 Favored Pre-proline 0 CA--C 1.58 2.117 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.285 47.6 Cg_exo -31.26 -52.0 0.27 Allowed 'Trans proline' 0 CA--C 1.581 2.843 1 N-CA-C 124.19 4.65 . . . . 0.0 124.19 -175.36 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.71 -18.54 32.46 Favored 'Trans proline' 0 CA--C 1.577 2.629 0 N-CA-C 120.494 3.229 . . . . 0.0 120.494 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -160.2 -18.81 0.06 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . 0.289 10.7 mt -79.93 -59.01 0.58 Allowed Pre-proline 0 CA--C 1.605 3.088 1 N-CA-C 124.437 4.977 . . . . 0.0 124.437 -172.262 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . 0.89 0.1 OUTLIER 34.09 -115.29 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.486 2 C-N-CA 126.843 5.029 . . . . 0.0 123.57 -172.325 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.12 99.66 1.32 Allowed 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 125.886 3.138 . . . . 0.0 118.601 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 t30 52.46 70.69 0.54 Allowed 'General case' 0 CA--C 1.593 2.629 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.55 114.52 28.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.618 -1.926 . . . . 0.0 108.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.4 m -54.0 151.52 6.71 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.465 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 72.5 mt -126.77 164.53 21.14 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 124.566 2.127 . . . . 0.0 113.791 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -144.31 113.55 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.601 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 5.7 m-85 -127.07 125.57 41.54 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 122.227 2.285 . . . . 0.0 110.839 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 8.4 tm-20 -93.68 96.03 9.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.362 -1.461 . . . . 0.0 108.296 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.3 138.98 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -132.18 118.44 19.56 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.9 tt -90.83 114.08 26.4 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.814 -1.179 . . . . 0.0 113.877 -175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.31 9.8 m-30 -76.59 -51.42 11.65 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.571 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -163.74 146.85 9.9 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 121.702 2.046 . . . . 0.0 108.353 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.267 0.1 OUTLIER -100.88 -80.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 170.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -80.0 -37.03 35.07 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 177.333 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.056 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -172.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.538 0 C-N-CA 126.218 1.807 . . . . 0.0 106.181 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.87 112.7 0.47 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 118.464 -2.648 . . . . 0.0 112.589 171.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.503 0.0 OUTLIER 155.96 -86.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 C-N-CA 125.79 1.636 . . . . 0.0 111.355 175.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.1 t 172.9 80.76 0.04 OUTLIER Pre-proline 0 CA--C 1.587 2.397 0 C-N-CA 130.351 3.46 . . . . 0.0 104.102 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -73.56 1.48 6.84 Favored 'Trans proline' 0 CA--C 1.568 2.204 1 N-CA-C 127.223 5.817 . . . . 0.0 127.223 -167.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' NZ ' ' HE2' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -152.02 -81.17 0.1 Allowed 'General case' 0 N--CA 1.496 1.852 1 CA-C-N 126.942 4.428 . . . . 0.0 112.62 -177.261 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 2.0 mp0 -77.45 -61.12 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 173.41 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.514 ' HE2' ' NZ ' ' A' ' 27' ' ' LYS . 16.1 tt0 -87.56 7.61 28.86 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.24 6.48 2.11 Favored Glycine 0 N--CA 1.496 2.64 1 N-CA-C 123.676 4.231 . . . . 0.0 123.676 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -174.93 -173.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.194 0 CA-C-O 123.687 1.708 . . . . 0.0 110.681 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.91 2.2 mm? 178.94 165.9 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.71 2.004 . . . . 0.0 113.674 160.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 125.83 53.7 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 11.2 p -114.37 109.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 O-C-N 121.43 -0.793 . . . . 0.0 112.653 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.389 8.2 mm -48.31 133.87 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 N-CA-C 119.712 3.227 . . . . 0.0 119.712 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -115.73 -59.8 1.95 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.201 -1.818 . . . . 0.0 108.867 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -143.49 103.74 4.14 Favored 'General case' 0 CA--C 1.585 2.322 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -53.26 -61.35 2.36 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 119.878 3.288 . . . . 0.0 119.878 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.74 177.42 16.23 Favored Glycine 0 CA--C 1.55 2.281 0 C-N-CA 125.22 1.391 . . . . 0.0 114.635 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 t -162.07 -12.62 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.01 -68.92 1.44 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 122.279 3.672 . . . . 0.0 122.279 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -158.83 66.83 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.768 0.794 . . . . 0.0 112.388 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.391 10.4 mt-10 60.42 -160.33 0.3 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 120.327 3.455 . . . . 0.0 120.327 174.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -97.04 170.86 6.7 Favored Pre-proline 0 CA--C 1.585 2.324 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -99.46 -166.15 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.512 0 CA-C-N 123.073 2.133 . . . . 0.0 117.149 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -130.15 169.71 14.99 Favored 'General case' 0 CA--C 1.573 1.837 0 O-C-N 121.282 -0.887 . . . . 0.0 112.999 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.95 139.18 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.166 0 O-C-N 119.211 -2.181 . . . . 0.0 109.352 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 7.01 86.89 Favored Glycine 0 CA--C 1.567 3.293 0 CA-C-O 117.497 -1.724 . . . . 0.0 117.335 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' HD2' ' HB2' ' A' ' 137' ' ' LYS . 4.8 t0 -74.43 146.85 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 121.531 2.665 . . . . 0.0 113.501 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -85.68 119.96 26.59 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.37 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 123.192 0.597 . . . . 0.0 111.332 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -114.5 111.99 22.27 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.9 m -116.16 162.3 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 124.087 1.899 . . . . 0.0 114.669 -173.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.9 108.03 16.19 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.543 168.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 2.2 p90 -110.51 147.62 33.75 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 123.31 1.528 . . . . 0.0 114.747 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.8 m -131.19 144.5 51.4 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 165.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.88 144.85 12.68 Favored Glycine 0 CA--C 1.551 2.295 0 O-C-N 119.769 -1.832 . . . . 0.0 116.528 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.31 149.8 52.29 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.007 1.723 . . . . 0.0 114.398 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.97 169.55 18.13 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.369 1.081 . . . . 0.0 108.521 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.346 0.0 OUTLIER -61.59 -25.45 67.34 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.81 3.46 11.84 Favored 'General case' 0 CA--C 1.594 2.651 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.54 11.59 Favored Glycine 0 N--CA 1.507 3.387 0 CA-C-N 121.101 1.773 . . . . 0.0 114.343 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.9 m -115.52 115.53 26.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -78.2 96.74 5.29 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -70.09 -32.03 69.89 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.682 -1.886 . . . . 0.0 113.87 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 2.2 t70 -155.22 159.92 40.46 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 124.189 1.947 . . . . 0.0 115.669 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.7 t -158.82 98.75 1.51 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.6 p -54.36 -49.85 68.85 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.428 0.2 OUTLIER -66.49 -44.17 83.35 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -177.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.38 -40.2 61.78 Favored 'General case' 0 CA--C 1.583 2.215 0 C-N-CA 124.423 1.089 . . . . 0.0 113.852 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' NE ' ' HD2' ' A' ' 67' ' ' ASP . 62.1 mtp85 -68.86 -14.81 63.26 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 173.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.384 0.6 OUTLIER 118.52 -41.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 129.005 2.922 . . . . 0.0 114.11 177.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.92 155.53 20.88 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -88.6 135.33 33.55 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 117.258 -1.353 . . . . 0.0 109.276 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -83.11 151.23 25.84 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 122.872 2.578 . . . . 0.0 108.922 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.0 t -168.03 145.92 4.36 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 123.9 1.81 . . . . 0.0 108.429 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -152.46 179.28 8.71 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.007 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -116.26 121.99 43.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.72 109.59 0.24 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.83 37.77 60.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.383 13.9 tppt? -91.03 -8.85 47.92 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-N 120.993 2.397 . . . . 0.0 117.211 -174.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.29 65.75 1.41 Allowed Glycine 0 N--CA 1.504 3.183 0 N-CA-C 103.969 -3.652 . . . . 0.0 103.969 -169.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -156.91 -57.35 0.09 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.958 -1.121 . . . . 0.0 113.208 -164.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.281 13.9 m -98.99 -139.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 122.998 1.38 . . . . 0.0 109.462 -175.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.9 pt -120.67 163.69 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 123.66 1.695 . . . . 0.0 110.317 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.263 2.2 mptt -67.8 -34.68 77.23 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.426 -1.261 . . . . 0.0 113.237 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.12 -32.42 69.82 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 117.313 -1.327 . . . . 0.0 112.607 167.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 29.5 m0 -76.89 -42.66 38.89 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 120.955 1.707 . . . . 0.0 112.613 172.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -59.7 -37.1 77.92 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 120.313 1.415 . . . . 0.0 114.586 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.282 1.4 mp -66.76 -58.35 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-N 119.749 1.159 . . . . 0.0 110.801 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.36 87.94 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.4 HG21 ' SD ' ' A' ' 96' ' ' MET 0.289 92.9 t -67.22 -37.7 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.349 0.977 . . . . 0.0 112.221 172.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.75 -39.05 61.82 Favored 'General case' 0 CA--C 1.588 2.416 0 CA-C-N 121.302 1.864 . . . . 0.0 112.444 168.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.7 p -94.96 42.28 1.09 Allowed 'General case' 0 CA--C 1.597 2.769 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.533 ' SD ' ' HB2' ' A' ' 133' ' ' LEU . 12.4 ttm -112.12 142.59 44.39 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 119.102 -2.249 . . . . 0.0 115.248 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -109.48 139.49 44.41 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 120.13 1.332 . . . . 0.0 113.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.7 131.55 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.399 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.393 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.46 -56.02 0.5 Allowed Glycine 0 N--CA 1.492 2.408 0 CA-C-O 117.107 -1.941 . . . . 0.0 111.329 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -150.45 -162.12 1.49 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-N 118.946 1.373 . . . . 0.0 113.737 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.799 0.6 OUTLIER -154.4 -126.94 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 CA-C-O 124.855 2.264 . . . . 0.0 114.026 176.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.5 OUTLIER -158.52 -147.78 0.18 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 124.357 2.027 . . . . 0.0 110.936 -164.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.502 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -131.76 138.56 48.64 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 124.644 2.164 . . . . 0.0 109.353 170.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.65 134.82 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 112.612 -2.085 . . . . 0.0 108.764 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.9 m -121.27 109.46 14.96 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.535 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 4.7 p -127.03 144.27 51.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -86.07 146.02 41.99 Favored Pre-proline 0 CA--C 1.574 1.902 0 CA-C-N 112.773 -2.012 . . . . 0.0 110.996 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -46.93 -26.21 4.61 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 N-CA-C 119.713 2.928 . . . . 0.0 119.713 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.57 -43.51 89.45 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.774 1.624 . . . . 0.0 114.437 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.86 -1.53 56.62 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.84 -118.35 0.23 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 120.719 1.599 . . . . 0.0 113.931 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.475 16.7 m-85 -83.8 -13.09 54.63 Favored 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 121.86 2.118 . . . . 0.0 115.595 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.82 -153.86 49.64 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.213 3.245 . . . . 0.0 121.213 171.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.8 t -85.26 62.38 7.46 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.995 1.379 . . . . 0.0 110.85 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.19 -54.69 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 126.301 1.84 . . . . 0.0 111.638 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.01 163.88 24.87 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 122.447 1.026 . . . . 0.0 113.796 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.41 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 19.7 t -72.98 143.57 84.22 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 116.827 -1.558 . . . . 0.0 110.862 176.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -49.68 126.82 17.19 Favored 'Trans proline' 0 CA--C 1.581 2.865 0 C-N-CA 122.923 2.415 . . . . 0.0 113.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.322 0.2 OUTLIER 28.58 47.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.575 2.536 0 N-CA-C 121.946 3.787 . . . . 0.0 121.946 -172.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -154.79 -47.66 0.09 Allowed 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.41 ' HB ' ' H ' ' A' ' 117' ' ' SER . 18.1 mt -104.51 150.14 38.18 Favored Pre-proline 0 N--CA 1.512 2.636 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.002 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.66 173.3 8.12 Favored 'Trans proline' 0 CA--C 1.588 3.189 0 CA-C-N 126.412 3.326 . . . . 0.0 116.015 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.18 -21.48 22.49 Favored 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 121.751 3.712 . . . . 0.0 121.751 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -158.71 92.8 1.14 Allowed 'General case' 0 CA--C 1.584 2.283 0 CA-C-N 120.852 1.66 . . . . 0.0 107.651 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.59 133.43 22.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 122.985 2.629 . . . . 0.0 112.916 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 84.7 m -66.56 150.61 48.73 Favored 'General case' 0 CA--C 1.586 2.328 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.535 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.25 0.3 OUTLIER -145.11 175.84 9.95 Favored 'General case' 0 CA--C 1.573 1.843 0 O-C-N 119.643 -1.91 . . . . 0.0 111.196 -177.703 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 m -145.42 146.52 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 125.805 1.642 . . . . 0.0 109.729 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.251 1.7 m-85 -135.96 125.28 24.8 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.481 -0.762 . . . . 0.0 109.745 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 55.6 mt-10 -83.42 114.0 21.15 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.37 136.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -132.41 120.67 22.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.533 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.7 OUTLIER -86.34 123.84 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.367 -1.458 . . . . 0.0 114.616 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.25 -49.48 49.5 Favored 'General case' 0 CA--C 1.587 2.383 0 O-C-N 121.701 -0.624 . . . . 0.0 112.526 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -171.29 155.73 4.38 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.74 1.616 . . . . 0.0 110.385 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.527 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.286 0.2 OUTLIER -126.6 -106.26 0.32 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.567 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.527 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 85.9 tttt -83.46 72.47 10.25 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.508 1.123 . . . . 0.0 110.904 173.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 178.45 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.436 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 34' ' ' LYS 0.409 0.4 OUTLIER 58.37 166.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.96 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 -176.693 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.438 23.6 t0 -162.14 -171.31 2.79 Favored 'General case' 0 CA--C 1.592 2.564 0 C-N-CA 125.937 1.695 . . . . 0.0 108.166 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.287 1.8 pp -75.14 62.22 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -156.53 70.15 4.83 Favored Pre-proline 0 CA--C 1.58 2.131 0 O-C-N 119.487 -2.008 . . . . 0.0 111.769 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.52 -27.69 82.34 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 N-CA-C 119.087 2.687 . . . . 0.0 119.087 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.17 44.18 0.55 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.443 1.097 . . . . 0.0 110.796 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.259 40.6 mm-40 68.76 58.57 0.39 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.308 -1.495 . . . . 0.0 109.688 -171.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -119.39 -70.75 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.339 21.6 mm-40 -89.99 -8.02 52.61 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 120.102 3.371 . . . . 0.0 120.102 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.81 -66.79 0.56 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.11 133.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 118.291 1.045 . . . . 0.0 113.691 -173.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -109.96 141.95 42.01 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 127.119 2.168 . . . . 0.0 107.893 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 22' ' ' VAL . 3.1 mtmp? -159.58 170.75 20.96 Favored 'General case' 0 N--CA 1.51 2.547 2 CA-C-N 126.276 4.125 . . . . 0.0 122.123 -170.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.615 ' O ' ' SG ' ' A' ' 102' ' ' CYS 1.237 3.7 m 106.0 -173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.672 1 N-CA-C 127.785 6.217 . . . . 0.0 127.785 158.351 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.643 34.3 mm -16.41 128.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.342 2 N-CA-C 131.351 7.538 . . . . 0.0 131.351 -153.931 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.654 ' H ' ' HB2' ' A' ' 102' ' ' CYS . 65.0 tttt -142.63 -49.17 0.35 Allowed 'General case' 0 CA--C 1.584 2.257 0 C-N-CA 127.33 2.252 . . . . 0.0 109.537 171.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' NE ' ' HE2' ' A' ' 132' ' ' GLU . 73.8 mtt180 -114.77 101.93 9.52 Favored 'General case' 0 CA--C 1.578 2.033 0 C-N-CA 124.922 1.289 . . . . 0.0 108.693 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.28 174.84 0.63 Allowed 'General case' 0 CA--C 1.597 2.762 0 O-C-N 119.469 -2.019 . . . . 0.0 115.579 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.43 8.26 Favored Glycine 0 N--CA 1.486 2.017 0 O-C-N 119.856 -1.777 . . . . 0.0 116.461 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.5 p -107.37 -76.66 0.61 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.6 70.51 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.267 10.2 t -157.6 61.56 0.48 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.362 1.077 . . . . 0.0 113.179 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.264 30.3 mt-10 59.75 168.69 0.07 Allowed 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 120.855 3.65 . . . . 0.0 120.855 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 p -90.07 165.4 24.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.275 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.43 159.61 17.14 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 CA-C-N 121.919 1.721 . . . . 0.0 114.732 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -98.33 165.54 11.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.345 0.3 OUTLIER -63.73 130.24 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 119.219 -2.176 . . . . 0.0 110.574 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.17 17.61 79.88 Favored Glycine 0 CA--C 1.569 3.431 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.02 147.29 43.06 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.575 1.688 . . . . 0.0 112.256 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -81.83 114.64 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.46 146.14 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.661 0.784 . . . . 0.0 111.307 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.25 46.3 p90 -129.85 98.68 4.86 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 124.86 2.267 . . . . 0.0 111.712 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -90.81 170.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 111.562 -2.563 . . . . 0.0 112.259 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.479 ' CE1' ' HG ' ' A' ' 70' ' ' LEU . 5.1 t60 -134.55 135.82 42.58 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 164.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 6.7 p90 -128.8 142.3 51.03 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.1 m -110.96 144.91 39.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 159.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.34 140.44 7.99 Favored Glycine 0 CA--C 1.548 2.112 0 O-C-N 118.92 -2.363 . . . . 0.0 116.776 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 155.97 47.25 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.675 2.39 . . . . 0.0 112.569 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.49 -174.5 4.84 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 120.475 -1.391 . . . . 0.0 111.044 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 1.9 pt? -64.83 -26.12 68.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.68 1.98 13.18 Favored 'General case' 0 CA--C 1.601 2.93 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.417 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.22 31.82 81.86 Favored Glycine 0 N--CA 1.501 2.996 0 O-C-N 120.477 -1.389 . . . . 0.0 114.821 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -90.25 114.6 26.66 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.4 95.02 1.0 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -70.45 -31.3 68.4 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 119.519 -1.988 . . . . 0.0 114.212 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.526 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 11.2 t0 -154.23 161.18 41.99 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.839 2.257 . . . . 0.0 114.179 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.0 p -151.05 96.92 2.39 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -28.09 27.93 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 120.723 3.601 . . . . 0.0 120.723 -172.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.263 36.5 mt -70.48 -51.72 27.05 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.947 1.703 . . . . 0.0 112.062 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.18 -30.24 70.29 Favored 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' NE ' ' HD2' ' A' ' 67' ' ' ASP . 60.6 ttt-85 -54.01 -19.92 5.52 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 174.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.35 39.0 ttmt 127.36 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 129.387 3.075 . . . . 0.0 111.952 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.3 2.7 p-10 -104.61 -142.8 0.37 Allowed 'General case' 0 CA--C 1.575 1.934 0 CA-C-O 123.076 1.417 . . . . 0.0 111.953 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -124.78 -136.5 0.28 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.404 3.1 t80 -140.25 142.58 35.76 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 118.337 -2.727 . . . . 0.0 109.095 167.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.4 p -155.4 148.75 24.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 118.479 -2.638 . . . . 0.0 109.05 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -157.37 -173.19 4.3 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.223 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -122.21 113.53 19.59 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -39.63 113.57 0.35 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.76 47.44 88.65 Favored Glycine 0 N--CA 1.503 3.149 0 N-CA-C 118.208 2.043 . . . . 0.0 118.208 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -109.39 6.65 24.51 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.78 58.32 2.15 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -149.97 -49.27 0.13 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.295 10.3 m -117.85 -138.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-O 123.04 1.4 . . . . 0.0 108.374 -175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 89' ' ' TRP . 26.7 pt -122.48 163.25 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 123.767 1.746 . . . . 0.0 110.173 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.59 71.54 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.479 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.37 75.04 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.558 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.422 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.4 m0 -75.4 -41.43 56.18 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 120.725 1.602 . . . . 0.0 112.833 172.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.61 -37.99 80.07 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 119.744 1.157 . . . . 0.0 113.863 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.257 1.2 mp -64.61 -54.68 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.709 1.595 . . . . 0.0 111.208 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.71 72.1 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.2 t -60.91 -46.62 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.07 0.85 . . . . 0.0 112.327 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.8 -34.89 55.67 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 p -87.56 6.73 32.92 Favored 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.52 ' SD ' ' HG ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.35 138.05 52.68 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 123.524 2.874 . . . . 0.0 116.806 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -80.93 149.19 29.5 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 113.51 -3.138 . . . . 0.0 111.05 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.279 1.8 t -9.61 87.91 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 123.144 2.702 . . . . 0.0 110.513 -166.003 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -3.19 -37.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 1 N-CA-C 129.839 6.696 . . . . 0.0 129.839 -140.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 61.24 -127.69 0.85 Allowed 'General case' 0 CA--C 1.605 3.075 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.52 ' HG ' ' SD ' ' A' ' 96' ' ' MET 1.672 0.6 OUTLIER 124.57 154.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 161.383 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.654 ' HB2' ' H ' ' A' ' 37' ' ' LYS . 18.8 t -160.19 -104.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.239 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -122.29 158.36 29.7 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 124.875 2.274 . . . . 0.0 116.036 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mt -131.82 114.61 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.007 0 CA-C-N 111.524 -2.58 . . . . 0.0 105.559 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -107.15 99.19 8.76 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 7.8 p -112.39 146.82 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -90.57 141.02 26.81 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.921 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.26 -22.41 8.33 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 N-CA-C 119.882 2.993 . . . . 0.0 119.882 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.99 -42.04 98.7 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.086 1.766 . . . . 0.0 114.434 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.56 0.17 39.39 Favored 'General case' 0 CA--C 1.577 2.0 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.256 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.97 -114.5 0.15 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.38 24.7 m-85 -82.29 -14.11 55.91 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 120.945 1.702 . . . . 0.0 115.176 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.1 -152.0 52.01 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.5 p -67.66 -22.25 65.31 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.12 -33.01 13.51 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.4 169.5 45.68 Favored Glycine 0 CA--C 1.551 2.327 0 CA-C-N 121.05 1.75 . . . . 0.0 114.71 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.8 t -90.42 120.14 69.06 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 116.684 -1.627 . . . . 0.0 108.799 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -37.23 -46.07 1.52 Allowed 'Trans proline' 0 CA--C 1.582 2.887 1 N-CA-C 123.32 4.316 . . . . 0.0 123.32 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.14 -20.11 19.39 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 CA-C-N 125.595 3.034 . . . . 0.0 119.534 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -159.53 -27.17 0.07 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.9 mt -79.98 126.6 79.43 Favored Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 120.183 -1.573 . . . . 0.0 111.938 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -82.68 170.7 12.62 Favored 'Trans proline' 0 CA--C 1.581 2.841 0 C-N-CA 122.365 2.043 . . . . 0.0 115.842 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.41 130.67 22.9 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 C-N-CA 122.85 2.367 . . . . 0.0 114.931 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.9 t30 58.85 60.85 2.34 Favored 'General case' 0 CA--C 1.586 2.364 0 C-N-CA 125.031 1.332 . . . . 0.0 113.413 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.23 123.73 32.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.33 -1.481 . . . . 0.0 112.451 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -59.35 156.2 13.22 Favored 'General case' 0 CA--C 1.587 2.373 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.529 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 87.8 mt -126.62 165.05 19.92 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 124.69 2.186 . . . . 0.0 114.297 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.99 106.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.77 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 2.5 m-85 -120.92 125.82 48.4 Favored 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 122.194 2.27 . . . . 0.0 109.134 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -95.43 98.72 10.76 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.52 140.57 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.346 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.551 ' HE2' ' NE ' ' A' ' 38' ' ' ARG . 50.4 mt-10 -130.3 110.15 11.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.31 25.8 tp -85.19 121.38 27.85 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 122.822 1.296 . . . . 0.0 112.779 -177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.3 15.3 m-30 -84.04 -64.36 1.18 Allowed 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.278 -1.514 . . . . 0.0 111.782 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.17 162.17 40.96 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.912 2.142 . . . . 0.0 110.46 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -143.5 -114.8 0.1 Allowed 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -103.4 173.1 6.45 Favored 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.623 1.569 . . . . 0.0 108.196 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 O-C-N 119.583 -1.948 . . . . 0.0 117.73 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.02 1 N-CA-C 128.819 6.288 . . . . 0.0 128.819 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.397 0.3 OUTLIER 62.43 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 121.267 3.803 . . . . 0.0 121.267 171.049 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.592 ' HD2' ' CG2' ' A' ' 105' ' ' THR . 5.8 m-20 -152.05 138.09 18.2 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.465 0.1 OUTLIER -129.0 93.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 124.051 1.882 . . . . 0.0 108.873 170.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -140.91 72.87 28.07 Favored Pre-proline 0 CA--C 1.58 2.106 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.275 11.3 Cg_exo -74.95 -33.09 4.93 Favored 'Trans proline' 0 CA--C 1.571 2.374 0 CA-C-N 123.909 2.432 . . . . 0.0 117.754 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' NZ ' ' HD2' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -163.48 61.85 0.17 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.747 1.612 . . . . 0.0 111.703 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.264 63.8 mm-40 72.46 25.29 2.76 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.095 -1.628 . . . . 0.0 114.124 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.535 ' HD2' ' NZ ' ' A' ' 27' ' ' LYS . 29.6 m-20 -80.85 -95.61 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 O-C-N 120.406 -1.434 . . . . 0.0 110.98 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.26 11.4 mm-40 -90.26 -15.03 32.09 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.47 10.18 2.84 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.0 t -170.25 150.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 120.029 1.914 . . . . 0.0 112.859 -167.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.69 10.2 tp -151.84 -146.67 0.2 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.962 162.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -179.02 166.42 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.16 -1.587 . . . . 0.0 113.769 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.83 123.23 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.129 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.297 0.3 OUTLIER -89.79 139.28 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 120.25 1.386 . . . . 0.0 111.8 178.826 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.34 -69.18 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.982 -0.449 . . . . 0.0 111.219 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -103.96 68.66 0.92 Allowed 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -38.1 -71.25 0.08 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.04 -178.4 39.44 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.5 p -83.7 -66.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.681 -0.759 . . . . 0.0 112.001 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.96 55.27 0.01 OUTLIER Glycine 0 CA--C 1.54 1.614 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 15.3 t -153.16 63.25 0.77 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.234 1.492 . . . . 0.0 112.527 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.361 46.8 mt-10 69.76 170.38 0.3 Allowed 'General case' 0 CA--C 1.576 1.972 1 N-CA-C 121.943 4.053 . . . . 0.0 121.943 175.126 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.7 p -114.33 160.0 34.49 Favored Pre-proline 0 CA--C 1.587 2.398 0 CA-C-N 111.042 -2.799 . . . . 0.0 110.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.83 129.18 30.91 Favored 'Trans proline' 0 CA--C 1.579 2.752 0 C-N-CA 122.853 2.369 . . . . 0.0 117.023 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -87.12 161.58 18.03 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 122.009 2.186 . . . . 0.0 111.363 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.343 0.4 OUTLIER -62.31 132.15 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 119.029 -2.294 . . . . 0.0 110.896 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.76 0.97 90.0 Favored Glycine 0 CA--C 1.569 3.428 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.56 152.65 20.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 121.504 2.652 . . . . 0.0 112.868 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -83.56 135.7 34.53 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.285 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -132.36 135.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.185 0.594 . . . . 0.0 109.831 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.265 33.4 p90 -115.96 105.31 12.51 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 124.038 1.875 . . . . 0.0 109.707 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.2 m -110.05 173.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 127.138 2.175 . . . . 0.0 114.55 -172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.257 0.1 OUTLIER -135.25 111.33 9.56 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 166.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.257 20.8 p90 -96.63 176.0 6.18 Favored 'General case' 0 CA--C 1.586 2.327 0 CA-C-O 126.291 2.948 . . . . 0.0 113.918 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.262 63.3 m -150.61 140.23 21.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.1 156.6 27.08 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 119.787 -1.82 . . . . 0.0 116.216 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -139.44 147.31 41.21 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 112.346 -1.927 . . . . 0.0 111.704 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 tp -80.64 169.11 18.07 Favored 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 122.762 1.268 . . . . 0.0 107.928 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.319 0.0 OUTLIER -59.24 -26.68 65.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.68 4.09 6.82 Favored 'General case' 0 CA--C 1.595 2.698 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.59 41.89 34.42 Favored Glycine 0 N--CA 1.506 3.339 0 O-C-N 119.804 -1.81 . . . . 0.0 114.434 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.6 m -116.67 117.31 29.46 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -77.36 97.82 5.03 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.054 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -74.0 -37.07 64.53 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.853 -2.404 . . . . 0.0 115.727 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.54 174.37 14.14 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.337 1.426 . . . . 0.0 113.93 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.4 p -159.98 -10.25 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 119.098 2.999 . . . . 0.0 119.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.3 1.6 t 71.7 -49.77 0.69 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.95 -2.344 . . . . 0.0 111.411 -168.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.6 mt -48.23 -39.33 20.9 Favored 'General case' 0 CA--C 1.581 2.14 0 C-N-CA 127.637 2.375 . . . . 0.0 113.972 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.26 -44.97 88.61 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 125.279 1.432 . . . . 0.0 113.025 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -76.69 -22.27 54.19 Favored 'General case' 0 CA--C 1.585 2.326 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.392 57.3 mtpt 106.18 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 127.648 2.379 . . . . 0.0 113.625 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.65 159.86 27.82 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.836 -1.165 . . . . 0.0 113.021 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -80.51 167.28 20.32 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -98.04 155.96 16.87 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-O 123.052 1.406 . . . . 0.0 107.708 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -168.28 118.92 0.79 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 119.622 -1.924 . . . . 0.0 108.724 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -127.92 -174.53 3.22 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.235 1.017 . . . . 0.0 111.127 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.259 9.5 t0 -126.71 121.52 32.29 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 tp -50.67 111.77 0.59 Allowed 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.58 23.42 70.46 Favored Glycine 0 CA--C 1.573 3.71 0 CA-C-O 118.218 -1.323 . . . . 0.0 116.045 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -124.65 -70.7 0.74 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 120.277 2.039 . . . . 0.0 112.952 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.81 73.35 0.3 Allowed Glycine 0 N--CA 1.508 3.443 0 N-CA-C 103.85 -3.7 . . . . 0.0 103.85 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.487 5.7 pt-20 -73.54 134.48 43.8 Favored 'General case' 0 CA--C 1.561 1.366 2 CA-C-O 129.302 4.382 . . . . 0.0 119.196 -158.503 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.353 20.8 m -80.04 -117.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 1 CA-C-N 102.564 -6.653 . . . . 0.0 108.439 -175.445 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.2 pt -121.72 156.11 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 124.285 1.993 . . . . 0.0 107.775 167.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 8.0 tmtt? -66.94 -28.72 68.52 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.927 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.17 83.37 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 117.353 -1.308 . . . . 0.0 111.485 166.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -70.18 -41.59 73.54 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.866 1.666 . . . . 0.0 111.99 172.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.83 -41.26 67.18 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.766 1.621 . . . . 0.0 114.465 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -68.26 -61.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 119.582 1.083 . . . . 0.0 112.586 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.26 -28.45 66.33 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.271 45.5 t -79.16 -43.72 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 117.209 -1.377 . . . . 0.0 109.503 175.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.49 -33.45 31.43 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.161 1.8 . . . . 0.0 115.492 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -86.4 -12.09 50.16 Favored 'General case' 0 CA--C 1.583 2.221 0 CA-C-O 115.597 -2.144 . . . . 0.0 116.645 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -89.62 146.89 24.24 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 125.244 3.656 . . . . 0.0 115.043 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -86.94 159.97 18.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.86 125.95 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.566 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.277 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.12 -49.54 0.89 Allowed Glycine 0 N--CA 1.494 2.512 0 CA-C-O 113.939 -3.701 . . . . 0.0 108.651 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.974 4.5 pt-20 154.01 -93.73 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.417 1 N-CA-C 131.351 7.538 . . . . 0.0 131.351 164.39 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.7 tp -79.09 122.2 25.94 Favored 'General case' 0 N--CA 1.484 1.225 1 N-CA-C 123.96 4.8 . . . . 0.0 123.96 -160.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.2 m -147.41 146.33 29.56 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.053 169.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -109.35 120.93 44.02 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.244 1.973 . . . . 0.0 110.905 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -75.97 146.92 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.297 -2.229 . . . . 0.0 113.521 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.592 ' CG2' ' HD2' ' A' ' 23' ' ' ASP . 31.0 m -136.61 117.17 13.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.8 p -133.47 154.55 50.71 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -96.62 146.61 31.61 Favored Pre-proline 0 CA--C 1.581 2.152 0 CA-C-N 113.797 -1.547 . . . . 0.0 114.022 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -43.25 -29.15 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 N-CA-C 121.62 3.661 . . . . 0.0 121.62 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -65.36 -39.09 91.88 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.22 1.827 . . . . 0.0 115.356 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -86.64 -7.71 58.1 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.958 1.303 . . . . 0.0 113.718 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -115.44 -133.77 0.34 Allowed 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 120.827 1.649 . . . . 0.0 112.398 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.2 4.1 49.74 Favored 'General case' 0 CA--C 1.591 2.556 0 CA-C-N 122.424 2.375 . . . . 0.0 113.411 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.69 -62.14 5.09 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 122.293 3.677 . . . . 0.0 122.293 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -70.48 -39.16 74.37 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -130.04 -7.19 4.4 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.27 158.29 27.66 Favored Glycine 0 CA--C 1.55 2.241 0 CA-C-N 124.421 3.282 . . . . 0.0 113.78 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.1 t -82.75 137.0 44.28 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 116.777 -1.582 . . . . 0.0 109.759 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.266 43.8 Cg_exo -32.82 -45.18 0.25 Allowed 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.464 4.755 . . . . 0.0 124.464 -176.357 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 -52.99 0.08 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 0 CA-C-N 125.934 3.155 . . . . 0.0 118.929 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -152.5 3.57 0.35 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 51.0 mt -79.89 137.43 53.95 Favored Pre-proline 0 CA--C 1.599 2.838 0 O-C-N 119.15 -2.219 . . . . 0.0 113.705 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -92.63 -176.1 0.64 Allowed 'Trans proline' 0 CA--C 1.595 3.545 0 CA-C-N 125.319 2.935 . . . . 0.0 115.533 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -64.18 171.97 6.96 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 N-CA-C 118.722 2.547 . . . . 0.0 118.722 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.262 28.3 t-20 59.23 54.08 5.02 Favored 'General case' 0 CA--C 1.585 2.297 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.06 105.94 13.8 Favored 'General case' 0 CA--C 1.57 1.73 0 O-C-N 120.417 -1.427 . . . . 0.0 113.491 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 85.2 m -82.44 135.37 35.16 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.8 mt -129.93 167.45 18.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 122.694 2.497 . . . . 0.0 115.585 -171.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.29 125.79 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 CA-C-N 111.147 -2.751 . . . . 0.0 107.01 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.275 60.7 m-85 -133.0 162.11 32.58 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 119.89 -1.756 . . . . 0.0 110.977 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.68 104.23 6.25 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.81 131.85 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 122.0 0.905 . . . . 0.0 111.269 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -114.14 111.07 20.99 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.996 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 117.34 29.97 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.57 -65.62 0.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.367 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -156.85 162.36 39.69 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 121.451 1.932 . . . . 0.0 109.491 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -141.38 -98.54 0.14 Allowed 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -80.34 -43.8 20.55 Favored 'General case' 0 CA--C 1.594 2.669 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.949 173.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.649 0 CA-C-N 124.868 3.485 . . . . 0.0 121.038 178.697 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.01 0 N-CA-C 122.897 3.919 . . . . 0.0 122.897 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.424 ' CG2' ' H ' ' A' ' 23' ' ' ASP . 9.8 p -145.51 174.67 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-O 123.074 1.416 . . . . 0.0 113.345 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' H ' ' CG2' ' A' ' 22' ' ' VAL . 7.2 p-10 -143.73 115.56 8.25 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.296 1.038 . . . . 0.0 110.013 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.349 2.4 pp -135.11 -66.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 1.057 0.3 OUTLIER 115.71 -117.21 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 116.479 -3.888 . . . . 0.0 108.182 -173.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -92.62 38.21 0.24 Allowed 'Trans proline' 0 CA--C 1.581 2.828 0 CA-C-N 125.612 3.04 . . . . 0.0 115.83 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.431 1.4 mmmp? 78.73 -22.13 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 118.764 -2.46 . . . . 0.0 115.56 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -73.9 -4.24 33.8 Favored 'General case' 0 CA--C 1.591 2.536 0 C-N-CA 123.642 0.777 . . . . 0.0 112.903 168.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.411 28.8 t0 70.93 54.33 0.25 Allowed 'General case' 0 CA--C 1.58 2.116 0 C-N-CA 126.199 1.8 . . . . 0.0 114.886 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -32.69 52.5 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.8 -19.08 0.11 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 120.101 2.8 . . . . 0.0 120.101 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.02 140.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.588 5.9 tp -155.73 -142.92 0.11 Allowed 'General case' 0 CA--C 1.57 1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.148 168.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -153.45 162.8 40.92 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.193 1.473 . . . . 0.0 114.958 -170.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.1 t -107.49 104.8 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.495 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.496 HD12 ' SG ' ' A' ' 102' ' ' CYS 0.376 2.1 mm -76.81 120.44 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-N 120.588 1.54 . . . . 0.0 112.512 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -95.1 -53.61 3.74 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.474 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -148.91 103.82 3.39 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -76.77 165.9 24.1 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 123.781 2.991 . . . . 0.0 114.344 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.75 -158.68 33.95 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.308 5.0 t -153.26 -77.69 0.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.887 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 13.88 -85.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 122.423 3.729 . . . . 0.0 122.423 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.3 t -143.81 60.34 1.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 121.739 0.781 . . . . 0.0 111.193 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.399 6.4 pt-20 28.01 -114.84 0.03 OUTLIER 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -139.17 121.39 10.24 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.732 1.213 . . . . 0.0 112.681 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -70.09 -114.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.524 0 C-N-CA 122.912 2.408 . . . . 0.0 114.861 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.7 ptm -170.24 179.94 3.3 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 tp -50.48 144.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.258 0 O-C-N 120.771 -1.206 . . . . 0.0 111.268 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.64 -10.59 64.23 Favored Glycine 0 CA--C 1.555 2.562 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -85.85 149.01 25.54 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 121.764 2.782 . . . . 0.0 113.354 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.9 tpt85 -79.94 130.55 35.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.033 -1.042 . . . . 0.0 109.488 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 2.4 t -127.84 146.04 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.272 1.029 . . . . 0.0 110.718 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.253 51.7 p90 -134.32 115.28 13.9 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 122.871 1.32 . . . . 0.0 108.493 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.17 -179.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 CA-C-O 124.087 1.899 . . . . 0.0 113.553 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.57 113.91 9.56 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.479 172.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -115.85 150.13 37.51 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -122.54 147.15 46.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 162.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.06 143.06 9.82 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 119.102 -2.249 . . . . 0.0 117.198 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -134.3 154.78 51.12 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.634 1.974 . . . . 0.0 114.915 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.24 162.59 23.48 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.297 1.6 tm? -61.81 -29.03 69.89 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.05 -2.06 4.99 Favored 'General case' 0 CA--C 1.598 2.808 0 O-C-N 120.323 -1.486 . . . . 0.0 114.934 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.97 50.18 4.48 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 120.17 -1.581 . . . . 0.0 113.98 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.4 m -128.43 115.89 18.89 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.28 112.61 14.17 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.108 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -87.59 -36.99 17.21 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 122.277 2.308 . . . . 0.0 114.303 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -151.44 155.85 39.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.5 1.619 . . . . 0.0 111.148 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.5 p -159.92 104.72 1.54 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.192 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -36.86 80.15 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.61 -34.55 67.34 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 -58.66 3.38 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -158.42 69.77 0.51 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.794 1.179 . . . . 0.0 113.108 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.05 -82.08 0.08 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 120.115 -1.616 . . . . 0.0 108.42 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.71 -157.68 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 127.356 2.262 . . . . 0.0 108.409 -174.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -88.84 -176.94 5.38 Favored 'General case' 0 CA--C 1.578 2.047 0 O-C-N 120.068 -1.645 . . . . 0.0 109.556 169.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.274 9.9 t80 -119.65 160.0 23.34 Favored 'General case' 0 CA--C 1.576 1.971 0 O-C-N 119.627 -1.921 . . . . 0.0 110.344 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 p -165.39 134.42 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 119.792 -1.818 . . . . 0.0 109.198 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -148.07 -178.56 6.35 Favored 'General case' 0 CA--C 1.58 2.103 0 O-C-N 121.374 -0.829 . . . . 0.0 110.977 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 -117.11 127.34 54.04 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.67 103.56 0.05 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -172.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.69 47.96 87.46 Favored Glycine 1 N--CA 1.516 4.017 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.308 0.0 OUTLIER -133.76 -78.81 0.47 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -168.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.29 71.41 0.33 Allowed Glycine 0 N--CA 1.509 3.542 1 N-CA-C 103.066 -4.014 . . . . 0.0 103.066 169.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.474 0.0 OUTLIER -66.37 141.86 57.82 Favored 'General case' 0 CA--C 1.554 1.106 2 CA-C-O 129.274 4.369 . . . . 0.0 119.564 -157.593 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.396 17.4 m -79.93 -110.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 1 CA-C-N 102.751 -6.568 . . . . 0.0 105.617 -176.959 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 89' ' ' TRP . 24.8 pt -125.28 156.76 34.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 124.031 1.872 . . . . 0.0 106.121 167.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.45 -28.94 68.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.115 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.17 -36.02 76.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 117.024 -1.465 . . . . 0.0 112.867 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.418 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.5 m0 -72.91 -45.23 59.32 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 120.785 1.63 . . . . 0.0 112.755 173.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . 0.288 2.7 p30 -56.7 -35.41 68.47 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 121.527 1.967 . . . . 0.0 115.497 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.272 1.6 mp -67.16 -57.77 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-N 119.45 1.023 . . . . 0.0 111.241 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.13 83.09 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 t -68.51 -41.14 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 120.43 1.468 . . . . 0.0 111.585 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.57 62.61 Favored 'General case' 0 CA--C 1.587 2.384 0 CA-C-N 120.16 1.345 . . . . 0.0 113.83 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.4 p -96.44 -3.15 44.0 Favored 'General case' 0 CA--C 1.593 2.606 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.2 ttp -103.02 132.64 49.14 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 121.944 2.157 . . . . 0.0 111.026 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -94.17 153.55 18.03 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.4 t -10.56 -31.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 1 N-CA-C 126.862 5.875 . . . . 0.0 126.862 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.17 17.73 0.22 Allowed Glycine 0 N--CA 1.493 2.449 0 CA-C-O 116.357 -2.357 . . . . 0.0 115.038 -169.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.35 0.9 OUTLIER -129.14 -174.24 3.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -176.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.13 127.51 53.25 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.496 ' SG ' HD12 ' A' ' 36' ' ' ILE . 1.6 m -139.68 165.9 26.04 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.708 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.251 6.0 mtt85 -127.84 116.89 20.86 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.581 1.658 . . . . 0.0 111.143 178.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.62 138.25 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.8 m -132.99 109.64 9.7 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 25.1 p -137.26 149.08 46.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.093 2.998 . . . . 0.0 119.093 -173.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -81.0 142.13 51.47 Favored Pre-proline 0 CA--C 1.577 2.01 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.743 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.55 -25.44 7.72 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 N-CA-C 120.727 3.318 . . . . 0.0 120.727 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.07 -38.68 89.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.364 1.893 . . . . 0.0 114.558 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -79.28 -7.65 58.45 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 124.953 1.301 . . . . 0.0 114.249 169.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.25 -115.84 0.24 Allowed 'General case' 0 CA--C 1.58 2.109 0 CA-C-N 120.7 1.591 . . . . 0.0 114.781 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.285 1.6 m-85 -103.33 29.51 5.56 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 122.178 2.263 . . . . 0.0 113.432 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -52.36 158.18 3.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 120.449 2.939 . . . . 0.0 120.449 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.284 9.9 t 71.1 -64.56 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.89 -15.6 16.81 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.17 177.8 49.85 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-N 122.619 2.463 . . . . 0.0 112.392 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.416 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.4 t -75.31 127.43 86.34 Favored Pre-proline 0 CA--C 1.579 2.093 0 CA-C-O 116.394 -1.765 . . . . 0.0 108.846 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 69.6 Cg_exo -38.3 -43.81 1.9 Allowed 'Trans proline' 0 CA--C 1.582 2.922 1 N-CA-C 123.0 4.192 . . . . 0.0 123.0 -176.961 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.6 -37.06 0.22 Allowed 'Trans proline' 0 CA--C 1.573 2.469 0 CA-C-N 125.491 2.997 . . . . 0.0 119.399 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -150.99 -7.34 0.26 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.416 ' HB ' ' H ' ' A' ' 117' ' ' SER . 1.5 mt -79.9 145.94 62.84 Favored Pre-proline 0 CA--C 1.595 2.678 0 CA-C-N 122.944 2.611 . . . . 0.0 112.797 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.4 160.65 48.81 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 CA-C-N 126.453 3.341 . . . . 0.0 115.497 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -62.2 129.32 26.64 Favored 'Trans proline' 0 CA--C 1.57 2.286 0 C-N-CA 122.721 2.281 . . . . 0.0 116.736 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.58 65.66 1.21 Allowed 'General case' 0 CA--C 1.592 2.579 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.5 140.18 51.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 119.642 -1.911 . . . . 0.0 111.748 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.6 m -59.99 146.46 42.51 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.429 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 6.2 tp -116.8 152.55 34.16 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.931 1.696 . . . . 0.0 112.336 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.26 130.39 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.302 -170.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.256 24.2 m-85 -138.35 161.28 37.33 Favored 'General case' 0 N--CA 1.521 3.085 0 O-C-N 119.444 -2.035 . . . . 0.0 110.435 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 5.9 tm-20 -126.19 104.68 8.36 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.52 135.31 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-O 122.387 1.089 . . . . 0.0 111.107 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -115.35 115.77 27.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.658 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.25 112.17 24.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -77.92 -40.09 40.79 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.23 172.11 1.95 Allowed 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.304 0.0 OUTLIER -146.13 -96.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.374 -2.079 . . . . 0.0 107.919 177.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.47 72.2 tttt -111.42 -99.42 0.41 Allowed 'General case' 0 CA--C 1.586 2.347 0 CA-C-O 116.545 -1.693 . . . . 0.0 110.019 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.22 0 CA-C-N 124.991 3.541 . . . . 0.0 113.973 -178.568 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.963 1 N-CA-C 128.154 6.022 . . . . 0.0 128.154 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.438 0.3 OUTLIER 60.89 -60.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 118.592 2.812 . . . . 0.0 118.592 178.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.267 4.1 p-10 -151.49 112.43 4.27 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 174.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 tp -87.13 95.22 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 123.157 1.456 . . . . 0.0 108.905 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -141.99 89.61 8.77 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.254 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.269 31.3 Cg_exo -59.1 -27.87 86.22 Favored 'Trans proline' 0 CA--C 1.576 2.586 0 CA-C-N 122.879 2.064 . . . . 0.0 115.446 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HG2' ' H ' ' A' ' 28' ' ' GLN 0.254 0.0 OUTLIER -150.99 -97.71 0.06 Allowed 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 170.723 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.496 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 1.7 mp0 -105.91 -0.51 25.05 Favored 'General case' 0 CA--C 1.588 2.419 0 C-N-CA 126.334 1.854 . . . . 0.0 111.497 174.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.266 16.8 t70 -54.62 -77.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -172.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.341 35.1 mt-10 -90.14 -23.87 21.23 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.54 13.04 1.15 Allowed Glycine 0 N--CA 1.506 3.352 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.4 t -169.04 144.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.587 7.8 tp -157.69 -141.92 0.09 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.988 -1.482 . . . . 0.0 111.415 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 29.6 mtpt -155.87 155.75 33.45 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 122.825 2.557 . . . . 0.0 115.876 -171.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.56 108.11 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.408 1.0 OUTLIER -78.83 124.75 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-N 120.274 1.397 . . . . 0.0 113.538 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -110.64 -56.48 2.35 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.059 0.933 . . . . 0.0 110.599 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.262 46.1 ttt180 -113.63 97.98 6.77 Favored 'General case' 0 CA--C 1.597 2.787 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -37.75 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.863 1 N-CA-C 123.349 4.574 . . . . 0.0 123.349 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.18 163.73 28.03 Favored Glycine 0 CA--C 1.55 2.234 0 C-N-CA 125.072 1.32 . . . . 0.0 114.696 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.343 12.4 t -146.41 -72.07 0.24 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.85 69.54 2.64 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 120.756 3.062 . . . . 0.0 120.756 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.27 71.1 p 69.7 61.84 0.27 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.383 4.7 pt-20 30.6 -113.39 0.03 OUTLIER 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -147.52 122.19 5.11 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 115.918 -1.991 . . . . 0.0 110.898 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.42 0.2 OUTLIER -114.26 -40.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.275 1 N-CA-C 125.749 5.25 . . . . 0.0 125.749 177.579 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.526 3.367 2 N-CA-C 127.542 6.127 . . . . 0.0 127.542 -174.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 tp -65.71 141.0 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.03 82.43 Favored Glycine 0 CA--C 1.567 3.322 0 O-C-N 120.286 -1.509 . . . . 0.0 116.527 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HD2' ' HB2' ' A' ' 137' ' ' LYS . 4.0 t0 -72.66 141.38 48.27 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.932 2.366 . . . . 0.0 110.625 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 -85.97 101.03 12.54 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.25 137.2 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.35 0.66 . . . . 0.0 112.416 -169.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.05 104.56 12.26 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -108.98 160.29 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 125.754 2.692 . . . . 0.0 114.697 -172.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -125.05 115.69 20.92 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.705 -2.952 . . . . 0.0 105.106 167.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.331 5.7 p90 -113.95 143.93 43.9 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.728 1.251 . . . . 0.0 114.28 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -118.07 147.32 43.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 164.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.79 136.6 4.67 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 118.894 -2.379 . . . . 0.0 115.278 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.29 160.36 40.64 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 111.852 -2.174 . . . . 0.0 114.921 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.448 HD11 ' H ' ' A' ' 62' ' ' ASP . 1.0 OUTLIER -80.65 178.82 8.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -65.13 -22.62 66.96 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' H ' HD11 ' A' ' 60' ' ' LEU . 36.8 t70 -73.57 -6.46 46.75 Favored 'General case' 0 CA--C 1.601 2.924 0 CA-C-N 119.106 0.867 . . . . 0.0 112.704 165.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.79 47.46 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 125.59 1.567 . . . . 0.0 113.636 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -88.67 108.93 19.72 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -74.49 91.85 2.31 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -73.1 -25.94 61.05 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 119.81 -1.806 . . . . 0.0 113.592 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -151.72 154.17 35.79 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 124.693 2.187 . . . . 0.0 115.308 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.449 ' HG ' ' NE ' ' A' ' 72' ' ' ARG . 79.8 p -153.77 102.3 2.52 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 112.029 -2.35 . . . . 0.0 104.767 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.292 31.6 p -58.87 -67.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.379 32.6 mt -61.39 -45.14 95.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.05 -40.89 24.36 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' NE ' ' HG ' ' A' ' 68' ' ' SER . 60.0 mtt180 -93.91 26.83 3.0 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.339 40.3 tttp 82.44 -30.4 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.49 -170.29 2.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.19 176.66 9.36 Favored 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 126.044 1.738 . . . . 0.0 109.857 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.394 0.5 OUTLIER -132.68 146.02 51.52 Favored 'General case' 0 CA--C 1.575 1.939 0 O-C-N 119.404 -2.06 . . . . 0.0 111.853 173.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.1 p -165.42 150.29 8.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.297 -2.127 . . . . 0.0 109.647 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -159.66 -171.8 3.43 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.665 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -123.18 113.66 19.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -37.99 105.98 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.43 53.52 24.61 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 118.178 2.031 . . . . 0.0 118.178 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -7.2 23.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.59 63.06 2.17 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 -167.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -154.29 -55.45 0.1 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 112.036 -2.082 . . . . 0.0 110.307 -163.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.301 16.6 m -97.82 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 pt -125.64 163.2 27.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 124.459 2.076 . . . . 0.0 109.261 172.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.254 0.9 OUTLIER -68.07 -34.58 76.7 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.178 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.39 70.71 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.601 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -73.26 -46.27 50.95 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 121.136 1.789 . . . . 0.0 112.28 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.95 -35.83 69.57 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 121.361 1.891 . . . . 0.0 115.571 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.29 1.7 mp -65.22 -61.55 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.207 0 CA-C-N 119.855 1.207 . . . . 0.0 111.627 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.91 80.91 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.301 6.4 t -74.27 -32.87 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.189 0 O-C-N 121.237 -0.914 . . . . 0.0 111.084 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.99 -24.72 68.04 Favored 'General case' 0 CA--C 1.577 2.008 0 CA-C-N 120.709 1.595 . . . . 0.0 113.833 166.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.0 p -97.22 8.0 45.44 Favored 'General case' 0 CA--C 1.596 2.724 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.787 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 8.6 tpt -93.71 140.32 29.78 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 119.515 -1.991 . . . . 0.0 113.346 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.24 145.61 26.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.778 . . . . 0.0 114.203 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.05 125.23 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.32 -12.91 53.49 Favored Glycine 0 N--CA 1.496 2.675 0 CA-C-O 114.972 -3.127 . . . . 0.0 117.888 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.483 67.7 mt-10 -113.16 -159.5 0.69 Allowed 'General case' 0 CA--C 1.583 2.234 0 CA-C-N 122.805 3.303 . . . . 0.0 117.434 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.0 tp -140.26 138.75 35.26 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 119.082 2.994 . . . . 0.0 119.082 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 0.8 OUTLIER -160.02 157.82 29.41 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.909 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -104.88 128.71 53.21 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.204 1.478 . . . . 0.0 113.177 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.609 HG21 ' SG ' ' A' ' 106' ' ' CYS . 11.0 mt -71.88 131.72 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.231 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.625 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.1 m -113.98 108.78 17.48 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.609 ' SG ' HG21 ' A' ' 104' ' ' ILE 0.315 11.4 p -160.16 162.92 34.01 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 120.09 3.366 . . . . 0.0 120.09 -163.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HD3' ' SG ' ' A' ' 106' ' ' CYS 2.574 0.0 OUTLIER 134.61 -147.52 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.165 1 N-CA-C 147.669 13.581 . . . . 0.0 147.669 157.447 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.888 21.9 Cg_exo 35.09 -63.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.577 2.631 1 C-N-CA 126.206 4.604 . . . . 0.0 120.952 -162.214 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.31 -33.37 75.69 Favored 'General case' 0 CA--C 1.579 2.07 0 O-C-N 118.818 -2.426 . . . . 0.0 114.805 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -80.76 0.99 32.26 Favored 'General case' 0 CA--C 1.598 2.82 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.69 -104.86 0.09 Allowed 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.87 -7.53 54.01 Favored 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -45.56 -21.39 0.49 Allowed Glycine 0 N--CA 1.503 3.112 1 N-CA-C 123.868 4.307 . . . . 0.0 123.868 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.9 p -71.92 -56.12 6.26 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.603 1.702 . . . . 0.0 112.79 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.19 -0.24 3.72 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.56 153.82 27.29 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-N 123.56 2.891 . . . . 0.0 115.133 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.5 t -82.97 130.77 56.26 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.635 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -34.29 -47.57 0.55 Allowed 'Trans proline' 0 CA--C 1.581 2.841 1 N-CA-C 122.666 4.064 . . . . 0.0 122.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.23 -54.71 0.36 Allowed 'Trans proline' 0 CA--C 1.571 2.351 0 CA-C-N 125.682 3.065 . . . . 0.0 116.725 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -173.0 78.3 0.04 OUTLIER 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 119.344 0.975 . . . . 0.0 113.542 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.9 mt -141.09 125.65 10.59 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 119.673 -1.892 . . . . 0.0 109.377 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -90.31 162.69 4.59 Favored 'Trans proline' 0 CA--C 1.589 3.264 0 CA-C-N 123.442 2.265 . . . . 0.0 112.223 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.28 -34.6 66.88 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.103 2.309 . . . . 0.0 118.103 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -89.68 56.71 3.63 Favored 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 125.981 1.712 . . . . 0.0 113.215 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.54 106.94 4.37 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.014 -1.678 . . . . 0.0 113.664 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 m -60.35 154.09 21.15 Favored 'General case' 0 CA--C 1.587 2.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.2 mt -124.27 172.34 9.17 Favored 'General case' 0 CA--C 1.566 1.567 0 O-C-N 120.288 -1.507 . . . . 0.0 111.834 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.46 123.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -123.78 120.82 33.78 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 119.937 1.244 . . . . 0.0 108.228 176.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.15 107.79 19.35 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.961 -1.087 . . . . 0.0 108.716 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -112.45 135.86 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.17 0.986 . . . . 0.0 110.892 -171.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -114.43 112.71 23.44 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.9 115.1 28.86 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.891 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -78.94 -50.21 11.54 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -169.94 159.67 7.92 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 123.833 1.777 . . . . 0.0 110.384 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.91 -87.97 0.08 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 102.76 -3.052 . . . . 0.0 102.76 -177.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HB2' ' HD2' ' A' ' 50' ' ' ASP . 53.6 tptt -121.89 95.45 4.67 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 170.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.635 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 177.477 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.923 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.94 148.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.9 0.85 . . . . 0.0 111.832 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -164.75 152.1 11.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.262 2.8 tp -126.71 61.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.989 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.238 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.63 ' HG ' ' NZ ' ' A' ' 107' ' ' LYS . 1.1 t -159.42 99.46 1.56 Allowed Pre-proline 0 CA--C 1.572 1.814 0 O-C-N 120.703 -1.248 . . . . 0.0 114.12 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -64.06 6.7 0.27 Allowed 'Trans proline' 0 CA--C 1.584 2.994 0 N-CA-C 119.915 3.006 . . . . 0.0 119.915 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.447 30.4 mmmt 94.57 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.746 2.418 . . . . 0.0 110.447 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.287 32.0 mm-40 76.59 40.98 0.2 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.24 -168.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -137.76 -93.0 0.21 Allowed 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 -173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.398 3.1 mp0 -84.5 -15.49 45.75 Favored 'General case' 0 N--CA 1.487 1.378 1 N-CA-C 122.404 4.224 . . . . 0.0 122.404 -171.146 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.4 -62.69 0.59 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.68 146.47 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 N-CA-C 119.028 2.973 . . . . 0.0 119.028 -170.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.42 136.9 52.86 Favored 'General case' 0 CA--C 1.598 2.793 0 C-N-CA 126.548 1.939 . . . . 0.0 107.539 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -124.19 118.65 27.34 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 118.291 -2.756 . . . . 0.0 108.211 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.13 136.03 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.579 -0.701 . . . . 0.0 109.613 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.426 HD12 ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -100.22 151.43 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 122.124 0.964 . . . . 0.0 113.044 -177.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -131.18 -63.62 0.84 Allowed 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 124.22 1.008 . . . . 0.0 110.851 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -112.79 89.86 3.19 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -35.09 -56.21 0.59 Allowed 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -151.75 17.38 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 124.63 1.109 . . . . 0.0 115.495 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 t -79.66 -34.17 40.65 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.35 45.74 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 120.429 2.932 . . . . 0.0 120.429 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.25 67.2 p 68.84 -5.88 0.95 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 118.894 2.924 . . . . 0.0 118.894 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -75.86 131.94 40.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.0 p -107.93 163.61 16.57 Favored Pre-proline 0 N--CA 1.503 2.185 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.47 166.43 25.93 Favored 'Trans proline' 0 CA--C 1.577 2.639 0 CA-C-N 122.39 1.889 . . . . 0.0 114.436 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -102.39 163.34 12.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.52 -1.363 . . . . 0.0 111.546 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.355 0.3 OUTLIER -63.16 128.51 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.179 -2.2 . . . . 0.0 110.432 178.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 4.03 84.58 Favored Glycine 0 CA--C 1.572 3.594 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HD2' ' HA ' ' A' ' 137' ' ' LYS . 9.7 t0 -65.23 166.34 9.99 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 121.189 2.494 . . . . 0.0 114.35 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -108.21 101.12 10.37 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 119.926 1.239 . . . . 0.0 108.933 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.93 139.0 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 123.61 0.764 . . . . 0.0 111.05 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.28 41.6 p90 -117.32 101.12 8.16 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 124.865 2.269 . . . . 0.0 109.267 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -102.19 170.93 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 111.076 -2.783 . . . . 0.0 112.731 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.96 100.7 3.22 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 166.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -97.69 160.22 14.45 Favored 'General case' 0 CA--C 1.593 2.635 0 CA-C-O 122.724 1.249 . . . . 0.0 113.299 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -128.0 147.96 50.52 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.15 142.43 9.1 Favored Glycine 0 CA--C 1.55 2.222 0 O-C-N 119.098 -2.251 . . . . 0.0 116.464 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -130.27 149.11 52.11 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.49 1.916 . . . . 0.0 115.205 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.29 171.4 12.75 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.922 1.344 . . . . 0.0 108.746 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 3.3 tt -62.56 -29.46 70.6 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.05 7.01 1.81 Allowed 'General case' 0 CA--C 1.597 2.786 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.37 66.0 Favored Glycine 0 N--CA 1.509 3.557 0 O-C-N 119.841 -1.787 . . . . 0.0 114.744 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -112.62 118.53 35.31 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -77.88 93.11 4.33 Favored 'General case' 0 CA--C 1.583 2.225 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -64.66 -30.31 71.33 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 119.151 -2.218 . . . . 0.0 114.559 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.14 152.85 31.73 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 124.513 2.102 . . . . 0.0 112.492 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.6 p -159.35 86.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 t -52.91 -40.66 63.73 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.12 -38.81 54.13 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.691 1.996 . . . . 0.0 115.694 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.68 -34.26 18.49 Favored 'General case' 0 CA--C 1.578 2.025 0 C-N-CA 125.879 1.672 . . . . 0.0 114.88 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -29.78 70.88 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.312 2.708 . . . . 0.0 118.312 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.352 58.5 tptt 131.5 -56.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 127.677 2.391 . . . . 0.0 111.695 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -98.35 174.06 6.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 123.602 1.667 . . . . 0.0 113.199 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.06 175.62 6.25 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 125.298 1.439 . . . . 0.0 114.389 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.345 2.3 t80 -108.49 153.27 23.57 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-O 122.989 1.376 . . . . 0.0 108.356 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.9 p -163.53 111.79 1.22 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 118.154 -2.841 . . . . 0.0 104.514 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -125.54 177.06 6.42 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.116 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.308 33.6 t70 -86.32 -139.34 0.09 Allowed 'General case' 0 CA--C 1.584 2.251 0 O-C-N 119.117 -2.24 . . . . 0.0 105.803 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 tp -141.5 109.96 5.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 118.579 -2.576 . . . . 0.0 104.265 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 48.44 16.12 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.414 14.5 tppt? -106.82 6.58 29.6 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-N 119.902 1.851 . . . . 0.0 114.441 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.1 -51.99 1.65 Allowed Glycine 0 N--CA 1.508 3.478 0 O-C-N 120.151 -1.593 . . . . 0.0 109.953 -172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.283 52.9 tt0 -20.2 -53.82 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 120.654 3.575 . . . . 0.0 120.654 168.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.294 16.5 m -101.87 -135.61 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 123.228 1.49 . . . . 0.0 110.12 -174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.7 pt -126.55 162.51 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.774 1.75 . . . . 0.0 109.797 173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -67.16 -33.61 75.79 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.172 -1.376 . . . . 0.0 113.109 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.2 73.09 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.29 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -74.77 -42.18 58.66 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-N 120.854 1.661 . . . . 0.0 112.205 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.84 -38.5 85.7 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.21 1.368 . . . . 0.0 113.863 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.4 mp -68.6 -60.64 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-N 119.09 0.859 . . . . 0.0 111.615 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.05 72.94 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.311 15.5 t -74.16 -32.79 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 CA-C-N 120.344 1.429 . . . . 0.0 110.652 175.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.25 73.92 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 121.02 1.736 . . . . 0.0 112.749 166.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.8 p -83.85 8.24 15.51 Favored 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.544 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 tpt -91.95 130.3 37.73 Favored 'General case' 0 CA--C 1.579 2.072 0 O-C-N 119.483 -2.011 . . . . 0.0 112.209 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.33 135.35 41.89 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 116.423 -1.751 . . . . 0.0 109.461 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.288 3.6 t -9.65 82.84 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-O 124.729 2.204 . . . . 0.0 108.308 -161.044 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -54.99 46.88 0.01 OUTLIER Glycine 0 N--CA 1.502 3.037 2 CA-C-N 107.532 -4.394 . . . . 0.0 123.702 -140.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 0.4 OUTLIER -29.02 -87.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -169.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.61 121.51 17.67 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.754 0.822 . . . . 0.0 112.646 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.544 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 2.4 m -149.2 167.36 26.2 Favored 'General case' 0 CA--C 1.575 1.92 0 C-N-CA 123.949 0.899 . . . . 0.0 111.779 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -131.83 133.6 44.86 Favored 'General case' 0 CA--C 1.557 1.226 0 O-C-N 119.134 -2.229 . . . . 0.0 112.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.3 mt -90.71 129.27 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 CA-C-N 112.689 -2.05 . . . . 0.0 108.862 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 106.4 14.35 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.581 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 5.0 p -129.36 147.48 51.19 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -169.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.63 ' NZ ' ' HG ' ' A' ' 25' ' ' SER . 45.7 mttp -91.69 146.25 32.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.037 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.26 82.4 Cg_endo -61.87 -14.55 37.43 Favored 'Trans proline' 0 CA--C 1.568 2.213 0 N-CA-C 118.023 2.278 . . . . 0.0 118.023 -176.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.82 -38.46 78.7 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 120.778 1.626 . . . . 0.0 114.427 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.58 2.54 52.85 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 125.632 1.573 . . . . 0.0 113.495 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.61 -113.8 0.17 Allowed 'General case' 0 CA--C 1.58 2.132 0 CA-C-N 120.774 1.624 . . . . 0.0 115.269 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.271 4.9 m-85 -88.08 0.33 56.12 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 120.953 1.706 . . . . 0.0 115.378 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.4 -19.39 1.87 Allowed Glycine 0 N--CA 1.499 2.86 1 N-CA-C 124.219 4.447 . . . . 0.0 124.219 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -71.36 -57.41 4.48 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 120.271 2.036 . . . . 0.0 111.869 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.52 0.34 2.49 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.5 157.07 33.3 Favored Glycine 0 CA--C 1.546 1.996 0 CA-C-N 123.999 3.091 . . . . 0.0 112.483 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.7 t -86.53 125.56 66.99 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-O 116.918 -1.515 . . . . 0.0 108.423 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.274 28.1 Cg_exo -26.24 -49.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.877 1 N-CA-C 124.882 4.916 . . . . 0.0 124.882 -176.334 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -46.16 1.3 Allowed 'Trans proline' 0 CA--C 1.572 2.391 0 CA-C-N 125.861 3.129 . . . . 0.0 118.977 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -152.58 -11.78 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.2 mt -79.91 144.13 59.03 Favored Pre-proline 0 CA--C 1.595 2.692 0 CA-C-N 121.858 2.117 . . . . 0.0 115.564 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -102.48 176.16 0.19 Allowed 'Trans proline' 0 CA--C 1.594 3.497 0 CA-C-N 125.278 2.921 . . . . 0.0 113.661 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.5 -37.87 5.1 Favored 'Trans proline' 0 CA--C 1.573 2.464 0 C-N-CA 122.239 1.959 . . . . 0.0 116.619 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -80.89 50.87 1.44 Allowed 'General case' 0 CA--C 1.582 2.177 0 O-C-N 120.06 -1.65 . . . . 0.0 115.202 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.28 127.91 17.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.218 -1.551 . . . . 0.0 112.831 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.1 m -80.26 161.73 24.98 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.973 -1.079 . . . . 0.0 112.817 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.581 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.3 0.5 OUTLIER -145.12 174.0 11.44 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 119.711 -1.868 . . . . 0.0 112.274 -176.569 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.57 125.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 125.039 1.336 . . . . 0.0 108.005 -171.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.285 4.7 m-85 -124.13 122.85 38.94 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 120.302 1.41 . . . . 0.0 110.58 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.17 121.73 32.47 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.77 128.0 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 121.369 0.604 . . . . 0.0 111.806 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.56 100.56 9.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.285 16.2 tp -103.99 126.81 51.4 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.687 1.232 . . . . 0.0 111.703 -174.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -86.04 -60.32 2.04 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 120.897 -1.127 . . . . 0.0 112.836 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -157.5 -178.06 7.06 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 119.939 1.245 . . . . 0.0 110.088 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.26 -60.65 0.08 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 50' ' ' ASP 0.28 58.3 tttm -79.82 -44.51 20.43 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.614 2.82 . . . . 0.0 118.614 -172.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.823 0 CA-C-N 124.774 3.443 . . . . 0.0 121.188 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 120.476 2.95 . . . . 0.0 120.476 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -63.86 132.32 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 118.566 1.183 . . . . 0.0 110.704 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -119.64 131.62 55.5 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.426 3.1 tp -156.51 125.89 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-O 125.196 2.427 . . . . 0.0 115.317 171.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.6 t -139.12 124.32 11.81 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-N 111.832 -2.44 . . . . 0.0 106.959 161.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -70.1 45.59 0.5 Allowed 'Trans proline' 0 CA--C 1.593 3.441 0 CA-C-N 126.319 3.292 . . . . 0.0 117.522 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -172.7 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 127.705 2.402 . . . . 0.0 107.195 -176.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.565 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 1.1 mp0 -72.43 -31.67 65.68 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 124.705 1.202 . . . . 0.0 113.89 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.454 22.1 t70 77.62 -54.54 0.53 Allowed 'General case' 0 CA--C 1.575 1.94 0 C-N-CA 126.311 1.844 . . . . 0.0 111.88 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -90.35 41.95 1.08 Allowed 'General case' 0 CA--C 1.579 2.06 0 O-C-N 120.193 -1.567 . . . . 0.0 114.096 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.91 -46.23 53.5 Favored Glycine 1 N--CA 1.518 4.141 0 CA-C-N 122.468 2.394 . . . . 0.0 112.15 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.394 17.1 t -123.89 119.28 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.2 tp -89.93 122.42 32.94 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 125.251 1.42 . . . . 0.0 108.68 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -114.77 97.81 6.48 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 122.816 2.553 . . . . 0.0 108.568 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 109.318 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -86.17 145.48 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-O 121.591 0.71 . . . . 0.0 111.836 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -123.58 -53.67 1.78 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 123.568 0.747 . . . . 0.0 111.491 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -124.1 107.18 10.99 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -72.54 0.05 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.75 -156.82 28.83 Favored Glycine 0 CA--C 1.547 2.092 0 C-N-CA 125.1 1.334 . . . . 0.0 111.713 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -88.74 -7.48 56.18 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.6 -85.73 0.06 OUTLIER Glycine 0 CA--C 1.538 1.482 0 O-C-N 121.164 -0.96 . . . . 0.0 111.943 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -165.45 5.27 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -87.23 154.02 21.04 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 123.775 2.989 . . . . 0.0 115.1 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 p -128.23 164.29 38.48 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 112.974 -1.921 . . . . 0.0 113.284 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.48 -176.42 2.28 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-N 122.515 1.934 . . . . 0.0 115.775 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.5 ptp -133.92 167.34 20.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.461 -1.399 . . . . 0.0 112.426 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.279 1.5 tp -60.58 136.68 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 O-C-N 119.251 -2.155 . . . . 0.0 110.967 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.33 61.46 Favored Glycine 0 CA--C 1.559 2.787 0 N-CA-C 118.412 2.125 . . . . 0.0 118.412 -173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.85 149.13 26.58 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.63 2.215 . . . . 0.0 112.019 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -78.37 133.89 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.368 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.5 m -136.84 138.75 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 118.804 0.729 . . . . 0.0 111.57 -173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -116.73 102.43 9.42 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.551 -1.343 . . . . 0.0 108.543 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.2 m -102.32 167.81 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.62 117.91 17.59 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -112.18 150.85 30.26 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 m -119.05 151.6 37.94 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 157.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.07 142.32 8.86 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 118.229 -2.795 . . . . 0.0 115.459 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -130.25 155.07 46.89 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.027 -1.587 . . . . 0.0 115.01 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.1 tp -78.48 177.01 8.86 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 123.086 1.422 . . . . 0.0 107.378 166.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -63.81 -25.8 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.75 13.74 2.0 Allowed 'General case' 0 CA--C 1.604 3.023 0 CA-C-N 119.077 0.853 . . . . 0.0 113.268 168.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.66 29.7 75.48 Favored Glycine 0 N--CA 1.509 3.541 0 O-C-N 120.034 -1.666 . . . . 0.0 116.432 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -86.74 113.9 22.97 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -74.39 85.28 1.98 Allowed 'General case' 0 CA--C 1.586 2.331 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.64 -30.78 69.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 119.66 -1.9 . . . . 0.0 115.403 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -149.57 141.24 23.53 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.575 1.179 . . . . 0.0 111.496 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.9 p -160.02 93.26 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.4 p -61.01 -35.83 77.89 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -52.92 -39.13 62.57 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.65 -41.8 44.38 Favored 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 125.034 1.334 . . . . 0.0 114.223 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -68.54 -20.12 64.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 33.9 mtmm 101.8 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 127.407 2.283 . . . . 0.0 112.118 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.1 153.31 41.77 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 123.0 1.381 . . . . 0.0 114.356 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -93.29 178.77 5.62 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.506 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.302 4.5 t80 -114.35 153.25 30.14 Favored 'General case' 0 CA--C 1.587 2.372 0 O-C-N 120.95 -1.094 . . . . 0.0 110.082 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.8 p -161.63 145.94 12.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 118.491 -2.631 . . . . 0.0 111.342 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -155.22 -171.26 3.74 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -124.05 114.5 19.81 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.64 110.07 0.18 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.29 29.87 67.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -106.13 0.91 25.8 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.23 61.29 1.33 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -148.27 -51.29 0.17 Allowed 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 111.191 -2.505 . . . . 0.0 111.991 -166.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.261 13.5 m -125.9 -140.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.969 1.366 . . . . 0.0 109.756 -173.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.559 HD11 ' HZ2' ' A' ' 107' ' ' LYS . 12.6 pt -115.21 162.51 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-O 123.826 1.774 . . . . 0.0 109.88 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -65.88 -34.1 77.37 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.655 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.1 -39.72 75.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -70.23 -40.78 74.29 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.641 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.26 -33.78 74.09 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 119.593 1.088 . . . . 0.0 113.921 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -67.37 -59.17 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 119.925 1.238 . . . . 0.0 110.622 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.0 87.67 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.332 5.2 t -60.4 -41.22 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.712 173.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.21 -39.29 56.23 Favored 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 121.506 1.957 . . . . 0.0 113.251 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -97.69 51.0 1.05 Allowed 'General case' 0 CA--C 1.593 2.624 0 C-N-CA 123.846 0.858 . . . . 0.0 112.618 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.1 ttt -138.37 152.3 48.31 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 119.479 -2.013 . . . . 0.0 113.881 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -118.53 146.08 44.83 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.558 2.799 . . . . 0.0 118.558 -172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -18.45 -29.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.756 1 N-CA-C 127.354 6.057 . . . . 0.0 127.354 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.37 -2.14 0.14 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-O 115.566 -2.797 . . . . 0.0 116.601 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 78.1 mm-40 -112.6 -145.43 0.4 Allowed 'General case' 0 N--CA 1.516 2.856 0 N-CA-C 121.012 3.708 . . . . 0.0 121.012 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 16.1 tp -133.94 140.6 46.88 Favored 'General case' 0 CA--C 1.601 2.932 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.47 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 58.8 m -142.88 -175.52 4.53 Favored 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.431 -1.418 . . . . 0.0 113.343 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -137.51 139.58 40.61 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 119.489 -2.007 . . . . 0.0 110.87 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.624 HG21 ' SG ' ' A' ' 106' ' ' CYS . 1.1 mt -106.97 128.11 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.579 0 C-N-CA 125.865 1.666 . . . . 0.0 109.168 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.8 m -119.49 114.49 22.37 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.624 ' SG ' HG21 ' A' ' 104' ' ' ILE 0.341 20.4 p -150.71 137.67 19.17 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -155.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.559 ' HZ2' HD11 ' A' ' 86' ' ' ILE 0.765 0.0 OUTLIER -20.49 98.5 0.05 OUTLIER Pre-proline 0 CA--C 1.621 3.697 3 N-CA-C 140.664 10.987 . . . . 0.0 140.664 159.535 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.315 0.2 OUTLIER -49.62 -27.82 15.59 Favored 'Trans proline' 0 CA--C 1.589 3.27 1 O-C-N 113.337 -4.086 . . . . 0.0 118.14 173.084 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.82 -42.81 85.24 Favored 'General case' 0 CA--C 1.578 2.045 0 O-C-N 120.069 -1.644 . . . . 0.0 114.459 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.542 ' HB2' ' CG ' ' A' ' 107' ' ' LYS . 52.7 m-85 -78.11 3.87 13.91 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-O 117.367 -1.302 . . . . 0.0 113.469 171.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -141.28 -103.43 0.14 Allowed 'General case' 0 CA--C 1.583 2.223 0 CA-C-N 121.943 2.156 . . . . 0.0 115.293 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.09 12.08 14.41 Favored 'General case' 0 CA--C 1.586 2.342 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -50.14 156.41 2.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 120.113 2.805 . . . . 0.0 120.113 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.283 7.8 t 73.38 -47.69 0.67 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.39 -52.83 4.16 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.03 148.52 17.89 Favored Glycine 0 CA--C 1.547 2.055 0 C-N-CA 124.35 0.976 . . . . 0.0 112.675 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.2 t -84.21 143.19 41.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.996 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.76 -39.58 57.33 Favored 'Trans proline' 0 CA--C 1.583 2.929 0 N-CA-C 120.265 3.141 . . . . 0.0 120.265 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -66.2 -62.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 CA-C-N 125.714 3.077 . . . . 0.0 116.229 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -168.57 62.64 0.06 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.13 113.29 23.96 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.087 -1.633 . . . . 0.0 107.925 177.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.98 165.88 24.74 Favored 'Trans proline' 0 CA--C 1.583 2.946 0 C-N-CA 122.557 2.171 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.2 116.33 3.96 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.61 2.207 . . . . 0.0 112.679 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t30 67.33 53.21 0.77 Allowed 'General case' 0 CA--C 1.59 2.502 0 C-N-CA 125.423 1.489 . . . . 0.0 114.559 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.91 130.39 56.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.508 -1.37 . . . . 0.0 109.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 3.0 m -63.32 152.86 36.73 Favored 'General case' 0 CA--C 1.594 2.66 0 CA-C-N 120.552 1.524 . . . . 0.0 114.999 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.06 172.01 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 119.495 -2.003 . . . . 0.0 111.95 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.8 t -150.98 127.32 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.201 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 78.6 m-85 -142.1 127.21 18.48 Favored 'General case' 0 N--CA 1.517 2.914 0 O-C-N 119.236 -2.165 . . . . 0.0 111.198 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' HE2' ' CD2' ' A' ' 101' ' ' LEU . 16.0 tm-20 -98.36 101.18 12.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.407 -2.058 . . . . 0.0 106.732 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.07 140.42 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.556 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.615 ' HG2' ' H ' ' A' ' 133' ' ' LEU 1.827 30.5 tt0 -138.43 -171.71 3.11 Favored 'General case' 0 N--CA 1.524 3.232 0 CA-C-O 122.608 1.194 . . . . 0.0 109.203 164.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.615 ' H ' ' HG2' ' A' ' 132' ' ' GLU . 24.4 tp -140.94 127.07 19.54 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -162.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.82 -34.97 39.03 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 175.74 159.79 0.26 Allowed 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 127.32 2.248 . . . . 0.0 106.966 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.13 -92.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.135 -1.603 . . . . 0.0 109.593 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -81.13 55.92 2.66 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.149 0 CA-C-O 117.753 -1.582 . . . . 0.0 114.941 175.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.394 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -102.15 165.96 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 125.62 1.568 . . . . 0.0 114.439 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -155.69 140.28 16.93 Favored 'General case' 0 CA--C 1.58 2.098 0 O-C-N 120.753 -1.217 . . . . 0.0 110.072 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.632 0.7 OUTLIER 101.62 -13.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 174.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.896 49.2 m 58.21 58.76 6.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 118.153 -2.842 . . . . 0.0 118.29 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.81 74.07 4.54 Favored 'Trans proline' 0 CA--C 1.582 2.912 0 C-N-CA 123.282 2.655 . . . . 0.0 117.16 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -118.13 -89.02 0.6 Allowed 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.0 38.19 1.25 Allowed 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.16 63.01 1.86 Allowed 'General case' 0 CA--C 1.589 2.447 0 O-C-N 120.32 -1.488 . . . . 0.0 110.996 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.444 32.4 mt-10 -66.98 -43.35 83.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 -174.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.48 -13.5 4.27 Favored Glycine 0 N--CA 1.503 3.153 1 N-CA-C 123.933 4.333 . . . . 0.0 123.933 171.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.3 164.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.087 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.798 0.5 OUTLIER -163.62 -168.38 1.64 Allowed 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 120.52 1.509 . . . . 0.0 114.652 164.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.571 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 23.3 pttm -148.66 150.13 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.77 87.49 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 117.362 -1.304 . . . . 0.0 112.763 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.504 2.4 mm -43.95 121.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 117.195 2.295 . . . . 0.0 117.195 -177.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -106.9 -59.24 1.83 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.893 0.877 . . . . 0.0 110.166 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -142.2 106.94 4.86 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' HE2' ' CG2' ' A' ' 36' ' ' ILE . 2.8 mp0 -51.33 -56.85 10.87 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 122.297 2.317 . . . . 0.0 116.342 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.63 -158.73 25.15 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 126.364 1.935 . . . . 0.0 114.63 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -78.24 2.79 17.2 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.4 45.12 95.68 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -114.44 -66.62 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.79 173.06 12.72 Favored 'General case' 0 CA--C 1.581 2.14 0 CA-C-O 122.996 1.379 . . . . 0.0 114.377 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -118.95 147.67 42.98 Favored Pre-proline 0 CA--C 1.581 2.15 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.157 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -68.09 141.72 53.74 Favored 'Trans proline' 0 CA--C 1.582 2.904 0 N-CA-C 118.318 2.392 . . . . 0.0 118.318 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -104.05 167.68 9.61 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 121.534 1.97 . . . . 0.0 112.79 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.256 2.0 tp -62.95 134.65 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.292 0 O-C-N 118.954 -2.341 . . . . 0.0 108.946 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.78 15.13 81.51 Favored Glycine 0 CA--C 1.562 3.012 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -82.95 139.64 33.24 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.374 2.087 . . . . 0.0 110.68 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -83.03 113.35 20.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.386 2.0 t -117.99 136.75 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 C-N-CA 125.438 1.495 . . . . 0.0 112.911 -164.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -120.35 103.79 9.5 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.901 1.334 . . . . 0.0 107.815 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 m -107.55 164.92 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 123.481 1.61 . . . . 0.0 111.961 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.469 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.295 3.7 t60 -130.24 138.06 50.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 164.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -132.5 148.48 52.39 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.789 2.515 . . . . 0.0 117.789 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -116.59 147.62 41.68 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 162.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.9 145.59 13.47 Favored Glycine 0 CA--C 1.545 1.954 0 O-C-N 119.136 -2.227 . . . . 0.0 117.308 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.45 157.75 45.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.515 1.926 . . . . 0.0 114.466 -173.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.99 167.49 11.2 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 169.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.289 1.0 OUTLIER -61.95 -25.59 67.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -68.32 -3.73 11.98 Favored 'General case' 0 CA--C 1.595 2.696 0 CA-C-N 120.069 1.304 . . . . 0.0 112.763 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 44.19 12.41 Favored Glycine 0 N--CA 1.498 2.775 0 CA-C-N 120.334 1.424 . . . . 0.0 114.295 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.0 m -120.13 119.54 33.59 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.84 92.1 3.03 Favored 'General case' 0 CA--C 1.585 2.313 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.969 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -69.74 -30.87 68.58 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 118.891 -2.381 . . . . 0.0 114.962 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -147.0 156.61 43.17 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 125.237 2.446 . . . . 0.0 114.432 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -150.36 93.03 1.93 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.272 63.8 p -47.99 -58.73 4.05 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.635 2.458 . . . . 0.0 117.635 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 85.7 mt -51.9 -44.01 63.61 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.21 -43.87 96.91 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -136.34 35.93 2.74 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -176.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -158.95 -75.11 0.08 Allowed 'General case' 0 CA--C 1.564 1.508 0 O-C-N 120.212 -1.555 . . . . 0.0 109.834 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.13 -161.78 0.06 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 127.19 2.196 . . . . 0.0 108.913 -173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.14 -170.5 2.76 Favored 'General case' 0 CA--C 1.591 2.526 0 O-C-N 118.935 -2.353 . . . . 0.0 107.769 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.47 1.4 t80 -123.77 148.79 46.33 Favored 'General case' 0 CA--C 1.58 2.11 0 O-C-N 118.038 -2.914 . . . . 0.0 111.14 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.3 p -167.07 140.89 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 118.454 -2.654 . . . . 0.0 111.973 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -149.98 -165.44 2.27 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 121.227 0.537 . . . . 0.0 111.184 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.61 63.43 1.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.207 -1.558 . . . . 0.0 112.152 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 10.77 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.81 61.7 2.51 Favored Glycine 0 N--CA 1.511 3.664 0 O-C-N 119.767 -1.833 . . . . 0.0 112.025 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.541 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.394 0.0 OUTLIER -106.48 -85.22 0.5 Allowed 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 123.964 1.84 . . . . 0.0 111.357 -171.795 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.541 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -100.93 -43.47 2.24 Favored Glycine 0 N--CA 1.51 3.61 0 CA-C-O 124.647 2.248 . . . . 0.0 110.473 165.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 1.05 1.3 pp20? 111.49 135.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 131.605 3.962 . . . . 0.0 118.684 165.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.337 12.3 m -79.69 -99.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 109.232 -3.622 . . . . 0.0 104.428 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.454 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.3 pt -133.9 155.72 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 124.451 2.072 . . . . 0.0 105.982 165.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 13.0 tmtt? -67.35 -29.0 68.43 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.752 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.13 82.02 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 117.456 -1.259 . . . . 0.0 112.113 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.454 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.9 m0 -73.15 -43.0 62.2 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 120.882 1.674 . . . . 0.0 113.094 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.33 -36.52 71.25 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 120.034 1.288 . . . . 0.0 114.157 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.283 1.7 mp -67.68 -58.0 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 119.402 1.001 . . . . 0.0 111.452 174.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.16 -39.28 94.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.449 ' HA ' ' SD ' ' A' ' 96' ' ' MET . 65.2 t -63.57 -49.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.301 1.409 . . . . 0.0 111.052 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.66 -32.55 29.97 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.1 p -100.71 19.11 17.68 Favored 'General case' 0 CA--C 1.591 2.534 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 93' ' ' VAL 0.337 1.4 ptt? -115.82 -172.96 2.26 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 122.758 2.526 . . . . 0.0 116.373 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -134.88 152.32 51.65 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 66.6 t -48.17 126.83 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.83 -44.29 1.52 Allowed Glycine 0 N--CA 1.491 2.325 0 CA-C-O 115.904 -2.609 . . . . 0.0 113.455 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -145.53 -173.38 4.11 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.827 2.813 . . . . 0.0 113.264 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.444 ' HG ' ' SD ' ' A' ' 96' ' ' MET 0.704 0.2 OUTLIER -158.71 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.267 1.508 . . . . 0.0 113.97 176.242 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -160.08 -145.87 0.13 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' N ' ' SG ' ' A' ' 102' ' ' CYS 0.326 0.0 OUTLIER -122.94 113.58 19.28 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 124.952 2.31 . . . . 0.0 111.975 170.087 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . 0.316 1.4 mt -78.45 146.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 112.131 -2.304 . . . . 0.0 113.112 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 128' ' ' VAL 2.023 0.1 OUTLIER -161.05 -178.43 6.77 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 120.902 3.668 . . . . 0.0 120.902 146.969 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 p -159.77 162.95 34.96 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -159.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -79.67 144.19 60.2 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-N 112.258 -2.246 . . . . 0.0 108.69 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.84 -21.35 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 N-CA-C 120.293 3.151 . . . . 0.0 120.293 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -60.23 -36.76 78.46 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.43 -3.26 58.23 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 171.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -128.7 -103.75 0.31 Allowed 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 120.483 1.492 . . . . 0.0 114.028 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.364 47.3 m-85 -106.42 -5.33 19.03 Favored 'General case' 0 N--CA 1.523 3.201 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.95 -154.83 49.28 Favored Glycine 0 N--CA 1.488 2.109 0 CA-C-N 122.462 2.392 . . . . 0.0 118.394 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -67.12 -24.57 65.93 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.63 -31.71 15.76 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.88 167.56 43.64 Favored Glycine 0 CA--C 1.552 2.382 0 CA-C-N 121.409 1.913 . . . . 0.0 114.797 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.9 t -86.82 114.82 60.02 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 116.843 -1.551 . . . . 0.0 107.384 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.284 85.0 Cg_exo -40.73 -49.27 4.31 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 122.202 3.885 . . . . 0.0 122.202 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.83 8.88 4.0 Favored 'Trans proline' 0 CA--C 1.577 2.646 0 CA-C-N 125.173 2.883 . . . . 0.0 118.086 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -159.09 -17.53 0.07 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.17 136.63 28.42 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 121.381 1.901 . . . . 0.0 112.702 -172.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.47 170.53 13.04 Favored 'Trans proline' 0 CA--C 1.584 2.987 0 CA-C-N 122.914 2.077 . . . . 0.0 115.211 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.62 135.98 37.74 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 122.758 2.305 . . . . 0.0 114.836 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.3 t30 59.68 56.82 3.44 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 124.901 1.28 . . . . 0.0 113.334 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.56 114.8 27.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.249 -1.532 . . . . 0.0 112.194 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.2 m -68.8 144.31 54.35 Favored 'General case' 0 CA--C 1.591 2.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.716 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.3 mt -113.95 172.62 6.88 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 105' ' ' THR . 20.1 t -153.44 124.44 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.783 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.388 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 1.0 OUTLIER -141.85 130.53 22.77 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-N 124.599 3.363 . . . . 0.0 110.442 175.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -94.48 104.09 16.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.28 140.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -123.99 121.48 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.4 tp -89.25 112.4 23.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 111.955 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -81.74 -41.83 20.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -168.42 154.22 6.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.227 1.489 . . . . 0.0 109.537 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.275 5.8 p90 -151.45 -90.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.52 69.26 6.98 Favored 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.431 1.586 . . . . 0.0 112.194 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.829 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -178.816 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.06 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 11.5 p -63.55 151.75 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.095 1.448 . . . . 0.0 111.871 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -124.5 133.73 53.25 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.292 9.8 tp -138.36 40.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.809 0 CA-C-N 113.222 -1.808 . . . . 0.0 110.085 166.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.49 ' HG ' ' CE ' ' A' ' 107' ' ' LYS . 0.2 OUTLIER -154.64 -49.3 0.01 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 174.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -66.21 55.84 0.4 Allowed 'Trans proline' 0 CA--C 1.579 2.754 0 CA-C-N 125.235 2.905 . . . . 0.0 118.893 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' CD ' ' H ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -157.75 -85.38 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' H ' ' CD ' ' A' ' 27' ' ' LYS . 2.1 mp0 -101.24 24.73 9.08 Favored 'General case' 0 CA--C 1.59 2.497 0 C-N-CA 124.594 1.157 . . . . 0.0 113.95 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.0 t70 56.19 54.46 7.77 Favored 'General case' 0 CA--C 1.586 2.355 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.324 2.8 mp0 -76.37 -24.89 54.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 118.643 2.831 . . . . 0.0 118.643 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.9 -34.93 2.1 Favored Glycine 0 N--CA 1.473 1.163 0 N-CA-C 120.849 3.099 . . . . 0.0 120.849 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.36 143.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.7 tp -104.32 136.33 44.11 Favored 'General case' 0 CA--C 1.59 2.494 0 C-N-CA 127.003 2.121 . . . . 0.0 106.089 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -121.73 130.57 53.53 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 124.014 3.097 . . . . 0.0 113.406 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.516 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 4.5 t -85.75 147.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 116.613 -1.661 . . . . 0.0 110.203 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.446 0.5 OUTLIER -126.02 125.18 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-N 120.522 1.51 . . . . 0.0 110.007 170.248 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -58.75 2.05 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.611 -0.681 . . . . 0.0 111.874 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -121.94 99.26 6.35 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -56.51 174.61 0.14 Allowed 'General case' 0 CA--C 1.595 2.697 0 O-C-N 119.904 -1.748 . . . . 0.0 115.648 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.81 -165.66 37.68 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 119.215 2.446 . . . . 0.0 119.215 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -91.3 -1.81 57.55 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.69 -90.4 0.08 OUTLIER Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.653 1.569 . . . . 0.0 116.683 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 t -159.88 -25.92 0.07 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -78.75 142.95 36.6 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 p -135.67 114.05 11.09 Favored Pre-proline 0 CA--C 1.577 2.005 0 CA-C-N 109.831 -3.35 . . . . 0.0 107.528 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -67.5 -29.76 36.8 Favored 'Trans proline' 0 CA--C 1.582 2.887 0 N-CA-C 117.27 1.988 . . . . 0.0 117.27 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.524 32.2 mtt 81.29 -150.78 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.318 1.1 tp -50.5 134.17 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 O-C-N 120.585 -1.322 . . . . 0.0 113.625 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 -7.13 76.5 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 116.927 -2.041 . . . . 0.0 117.548 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' HD2' ' C ' ' A' ' 50' ' ' ASP . 28.6 p30 -74.61 128.43 35.54 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 122.827 3.314 . . . . 0.0 112.817 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ptm85 -76.4 125.68 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.931 0.787 . . . . 0.0 109.078 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.2 m -120.44 138.45 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.905 0.882 . . . . 0.0 112.751 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -117.18 108.06 15.21 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.12 160.6 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.301 6.1 m-70 -126.64 113.03 16.18 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 166.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -108.13 146.04 33.25 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.3 m -112.72 139.31 48.45 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 162.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.64 147.66 19.08 Favored Glycine 0 CA--C 1.565 3.188 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.77 171.52 20.24 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 127.93 2.492 . . . . 0.0 113.068 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -93.36 148.75 21.78 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.513 165.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.376 0.2 OUTLIER -61.74 -17.32 55.39 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.01 -28.23 66.19 Favored 'General case' 0 CA--C 1.594 2.636 0 CA-C-N 120.334 1.424 . . . . 0.0 111.823 166.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.18 52.07 0.61 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -135.34 113.19 11.0 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -68.52 120.39 14.49 Favored 'General case' 0 CA--C 1.584 2.274 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.411 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -97.46 -31.69 12.22 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 121.442 1.928 . . . . 0.0 113.498 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -154.16 165.65 35.59 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 123.24 1.495 . . . . 0.0 113.508 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -148.52 -10.38 0.36 Allowed 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.381 97.7 p 61.44 -36.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 122.846 2.566 . . . . 0.0 117.887 -176.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.81 -42.87 97.58 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 128.186 2.594 . . . . 0.0 113.746 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.71 -38.08 74.64 Favored 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.12 -21.72 63.99 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.332 33.4 ttmt 86.05 -23.57 0.15 Allowed 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 126.161 1.784 . . . . 0.0 114.7 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.266 8.3 t70 -92.87 -135.3 0.16 Allowed 'General case' 0 CA--C 1.572 1.81 0 C-N-CA 124.406 1.083 . . . . 0.0 110.477 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 168.87 21.38 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 124.743 1.217 . . . . 0.0 113.731 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.261 4.0 t80 -97.23 144.14 27.33 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.2 p -159.93 147.8 16.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.614 -2.554 . . . . 0.0 109.405 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -159.47 -176.58 5.86 Favored 'General case' 0 CA--C 1.589 2.447 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.278 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.54 132.66 52.55 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 118.922 -2.361 . . . . 0.0 106.307 171.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 107.84 0.63 Allowed 'General case' 0 CA--C 1.577 1.983 0 O-C-N 120.848 -1.158 . . . . 0.0 113.88 -175.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.84 6.81 Favored Glycine 0 N--CA 1.504 3.18 0 O-C-N 120.433 -1.417 . . . . 0.0 113.669 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.266 0.0 OUTLIER -107.71 -75.66 0.63 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.57 1.652 . . . . 0.0 110.812 -175.01 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.496 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -105.31 -51.95 0.85 Allowed Glycine 0 N--CA 1.502 3.097 0 CA-C-O 124.786 2.325 . . . . 0.0 108.808 167.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.723 19.8 tt0 114.75 140.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 128.376 3.941 . . . . 0.0 114.159 166.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.366 12.0 m -79.96 -100.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.106 1 CA-C-N 105.211 -5.45 . . . . 0.0 103.028 177.508 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 89' ' ' TRP . 41.3 pt -135.09 157.5 40.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 124.995 2.331 . . . . 0.0 105.895 165.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 12.7 tmtt? -69.39 -30.39 68.35 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 114.226 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.41 83.27 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 116.22 -1.848 . . . . 0.0 110.567 165.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.43 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.2 m0 -71.28 -44.85 64.42 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 122.074 2.216 . . . . 0.0 113.204 174.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.92 -33.37 68.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.252 1.6 mp -68.67 -58.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 120.187 1.358 . . . . 0.0 110.749 172.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.84 88.84 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.291 11.9 t -62.64 -38.06 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.235 1.379 . . . . 0.0 112.892 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.67 -34.41 64.99 Favored 'General case' 0 CA--C 1.581 2.171 0 CA-C-N 121.002 1.728 . . . . 0.0 113.804 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.7 p -84.45 -0.19 51.93 Favored 'General case' 0 CA--C 1.59 2.5 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 mtt -85.88 105.1 16.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 121.96 2.164 . . . . 0.0 114.242 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.75 141.4 49.75 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 114.779 -2.534 . . . . 0.0 106.756 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.267 1.7 t -9.64 96.13 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.54 4.032 0 CA-C-N 122.841 2.564 . . . . 0.0 112.484 -161.029 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 18.78 -50.28 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 1 N-CA-C 129.289 6.475 . . . . 0.0 129.289 -151.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 69.24 174.35 0.29 Allowed 'General case' 0 CA--C 1.605 3.085 0 CA-C-O 123.089 1.424 . . . . 0.0 108.156 -164.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.311 12.6 tp -126.45 104.42 8.15 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 123.863 1.792 . . . . 0.0 109.109 169.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 35' ' ' VAL . 13.7 p -160.41 -159.29 0.68 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.767 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.623 ' HB2' ' H ' ' A' ' 131' ' ' VAL 2.31 0.0 OUTLIER -160.91 -139.15 0.05 Allowed 'General case' 0 CA--C 1.563 1.455 1 N-CA-C 122.603 4.297 . . . . 0.0 122.603 157.863 . . . . . . . . 5 4 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.0 mt -121.53 146.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 109.548 -3.478 . . . . 0.0 114.676 -165.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.6 m -135.48 91.32 2.71 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 13.7 p -107.41 147.75 29.99 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 -171.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.49 ' CE ' ' HG ' ' A' ' 25' ' ' SER . 58.5 mttm -90.52 137.98 27.05 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.084 176.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.308 13.9 Cg_endo -54.09 -10.14 1.8 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 120.346 3.172 . . . . 0.0 120.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.35 -38.8 88.26 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 120.494 1.497 . . . . 0.0 113.695 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -86.27 -0.52 56.0 Favored 'General case' 0 CA--C 1.576 1.952 0 C-N-CA 126.059 1.743 . . . . 0.0 114.213 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.28 -111.64 0.19 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -93.5 0.21 56.61 Favored 'General case' 0 N--CA 1.517 2.879 0 CA-C-N 120.742 1.61 . . . . 0.0 114.952 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.69 146.16 3.6 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.928 2.731 . . . . 0.0 119.928 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.346 53.1 p 76.0 -47.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -175.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.72 -55.03 3.03 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.28 149.63 25.75 Favored Glycine 0 CA--C 1.546 1.99 0 CA-C-N 119.548 1.067 . . . . 0.0 111.471 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 t -75.44 129.19 82.68 Favored Pre-proline 0 CA--C 1.579 2.059 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.954 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.281 6.8 Cg_endo -40.43 -44.57 4.31 Favored 'Trans proline' 0 CA--C 1.579 2.763 1 N-CA-C 122.554 4.021 . . . . 0.0 122.554 -175.54 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.64 -37.07 1.87 Allowed 'Trans proline' 0 CA--C 1.572 2.396 0 CA-C-N 125.296 2.927 . . . . 0.0 118.61 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -151.48 -17.99 0.2 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 119.06 2.985 . . . . 0.0 119.06 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.5 mt -79.96 139.66 53.61 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 122.476 2.398 . . . . 0.0 114.028 -173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -93.16 179.06 1.15 Allowed 'Trans proline' 0 CA--C 1.59 3.31 0 CA-C-N 125.332 2.94 . . . . 0.0 115.04 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -60.04 -2.9 1.92 Allowed 'Trans proline' 0 CA--C 1.576 2.607 0 N-CA-C 121.077 3.453 . . . . 0.0 121.077 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.04 92.82 1.38 Allowed 'General case' 0 CA--C 1.589 2.479 0 CA-C-N 120.991 1.723 . . . . 0.0 111.096 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.34 131.62 23.49 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 122.674 2.488 . . . . 0.0 110.216 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.0 m -74.92 128.81 36.46 Favored 'General case' 0 CA--C 1.593 2.629 0 O-C-N 120.836 -1.165 . . . . 0.0 111.63 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.5 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 71.3 mt -107.44 165.23 11.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.93 118.17 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.62 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.345 0.2 OUTLIER -140.33 107.98 5.62 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 121.035 1.743 . . . . 0.0 109.875 172.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.558 ' HA ' ' CA ' ' A' ' 103' ' ' ARG . 39.9 mt-10 -100.51 128.67 46.5 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.241 -1.537 . . . . 0.0 108.342 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.623 ' H ' ' HB2' ' A' ' 103' ' ' ARG 0.363 1.1 p -132.4 149.94 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 124.818 2.246 . . . . 0.0 116.161 -170.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.61 120.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 111.41 -2.632 . . . . 0.0 107.007 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . 0.293 10.5 tp -107.96 109.32 20.78 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 121.713 2.051 . . . . 0.0 108.529 174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -69.5 -55.55 9.9 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 119.726 -1.859 . . . . 0.0 114.014 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -158.6 155.25 27.94 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.737 1.732 . . . . 0.0 107.205 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER -131.46 -108.86 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.244 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -102.24 83.87 2.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.623 0 N-CA-C 122.519 3.768 . . . . 0.0 122.519 -176.64 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 1 N-CA-C 127.807 5.883 . . . . 0.0 127.807 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.69 123.35 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 1 N-CA-C 99.902 -4.11 . . . . 0.0 99.902 162.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -164.64 155.69 15.01 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 120.083 3.364 . . . . 0.0 120.083 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.274 5.3 tp -161.66 142.2 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.274 0 CA-C-O 125.339 2.495 . . . . 0.0 110.65 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -142.76 127.85 10.08 Favored Pre-proline 0 CA--C 1.58 2.101 0 CA-C-N 112.659 -2.064 . . . . 0.0 107.686 166.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -58.74 21.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.902 1 N-CA-C 123.736 4.476 . . . . 0.0 123.736 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.54 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -145.97 -79.02 0.17 Allowed 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.99 -1.694 . . . . 0.0 108.264 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.54 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 2.0 mp0 -99.78 81.59 2.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.303 37.1 p30 -18.95 -24.69 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.247 1 N-CA-C 126.23 5.641 . . . . 0.0 126.23 -174.392 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -90.18 26.27 1.94 Allowed 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -35.39 59.04 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 118.525 -2.609 . . . . 0.0 118.221 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.281 50.9 t -133.74 119.96 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.787 0.803 . . . . 0.0 111.119 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.61 139.17 37.56 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -139.86 84.7 1.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 119.476 -2.015 . . . . 0.0 106.66 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -85.89 101.24 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 115.972 -1.966 . . . . 0.0 111.7 -168.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.485 ' HA ' ' CB ' ' A' ' 102' ' ' CYS 0.642 0.5 OUTLIER -65.51 133.4 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -172.47 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.48 -56.22 2.59 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.44 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -150.93 121.23 7.29 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -72.27 0.13 Allowed 'General case' 0 CA--C 1.581 2.147 0 O-C-N 119.038 -2.289 . . . . 0.0 114.409 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.98 -176.03 37.6 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 125.555 1.55 . . . . 0.0 114.488 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 t -149.91 -3.18 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.632 2.826 . . . . 0.0 118.632 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.19 -75.36 0.51 Allowed Glycine 0 N--CA 1.492 2.385 0 CA-C-N 122.095 2.225 . . . . 0.0 117.19 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.8 p -126.2 -80.73 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.341 0.57 . . . . 0.0 110.393 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -159.46 -146.92 0.15 Allowed 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.227 1.011 . . . . 0.0 110.679 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 p -94.57 168.97 10.36 Favored Pre-proline 0 CA--C 1.582 2.204 0 C-N-CA 125.443 1.497 . . . . 0.0 111.464 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -99.96 -167.1 0.08 OUTLIER 'Trans proline' 0 CA--C 1.569 2.256 0 CA-C-N 122.909 2.075 . . . . 0.0 116.196 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -137.65 146.73 44.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.06 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.529 0.2 OUTLIER -9.95 -123.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -49.18 38.43 0.01 OUTLIER Glycine 0 N--CA 1.504 3.206 1 N-CA-C 124.042 4.377 . . . . 0.0 124.042 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.67 148.87 38.34 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 119.979 1.889 . . . . 0.0 112.141 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.82 134.47 41.73 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 0.9 OUTLIER -142.26 147.82 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 124.72 2.2 . . . . 0.0 112.123 -163.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CE2' ' HG ' ' A' ' 133' ' ' LEU 0.532 4.9 p90 -79.9 -160.29 0.27 Allowed 'General case' 0 CA--C 1.589 2.462 0 C-N-CA 127.545 2.338 . . . . 0.0 114.335 168.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . 0.295 0.8 OUTLIER 157.6 147.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 127.094 2.158 . . . . 0.0 111.292 159.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.312 0.2 OUTLIER -127.64 111.49 13.78 Favored 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 118.592 -1.243 . . . . 0.0 107.886 164.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 37.1 p90 -101.12 174.65 5.9 Favored 'General case' 0 CA--C 1.589 2.46 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -152.91 113.89 4.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 164.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.81 136.85 8.96 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 124.652 2.251 . . . . 0.0 116.157 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 110.615 -2.792 . . . . 0.0 112.897 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.4 tp -79.07 170.3 16.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 125.367 2.508 . . . . 0.0 108.318 168.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.255 3.1 tm? -58.82 -19.63 43.01 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 110.885 -2.87 . . . . 0.0 114.036 168.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -75.38 4.17 7.78 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 121.071 1.76 . . . . 0.0 113.038 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.27 89.45 Favored Glycine 0 N--CA 1.51 3.618 0 CA-C-N 121.41 1.914 . . . . 0.0 116.188 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -117.76 140.12 50.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -86.05 95.0 9.38 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.908 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -69.97 -35.21 74.26 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.206 -2.184 . . . . 0.0 113.929 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.65 170.17 23.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.755 1.616 . . . . 0.0 112.711 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 95.0 p -160.06 -17.57 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.29 1.3 t 69.97 -53.07 0.63 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.502 -1.999 . . . . 0.0 113.085 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.9 mt -49.99 -49.97 48.67 Favored 'General case' 0 CA--C 1.581 2.154 0 C-N-CA 127.09 2.156 . . . . 0.0 114.255 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.12 -38.45 82.25 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.553 1.168 . . . . 0.0 114.134 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -73.22 2.36 7.51 Favored 'General case' 0 CA--C 1.585 2.32 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 59.9 mttp 85.21 -18.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 175.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -120.26 175.31 6.02 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 123.442 1.592 . . . . 0.0 113.147 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -88.17 162.22 16.82 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.744 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.276 4.2 t80 -99.15 158.39 15.71 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 123.344 1.545 . . . . 0.0 107.851 173.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.4 p -170.01 144.5 2.72 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.716 -1.865 . . . . 0.0 109.214 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -153.29 -162.23 1.43 Allowed 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.725 1.25 . . . . 0.0 110.694 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.93 118.0 14.36 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -45.13 117.15 1.27 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -174.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.82 29.77 73.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 118.41 2.124 . . . . 0.0 118.41 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -99.93 3.95 44.71 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 -172.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.2 58.88 2.02 Favored Glycine 0 N--CA 1.508 3.465 0 N-CA-C 106.301 -2.719 . . . . 0.0 106.301 -172.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -147.07 -48.95 0.18 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 111.994 -2.103 . . . . 0.0 113.121 -166.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.26 8.5 m -124.46 -148.76 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 123.571 1.653 . . . . 0.0 108.888 -174.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.37 159.02 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 124.278 1.99 . . . . 0.0 109.983 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -67.84 -31.53 71.42 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.798 -1.546 . . . . 0.0 113.402 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.68 69.92 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 117.105 -1.426 . . . . 0.0 111.764 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -74.12 -42.86 59.38 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-N 120.948 1.704 . . . . 0.0 112.514 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.74 -35.75 68.94 Favored 'General case' 0 CA--C 1.577 2.001 0 CA-C-N 119.92 1.236 . . . . 0.0 114.311 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.278 1.5 mp -65.99 -57.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 CA-C-N 120.002 1.274 . . . . 0.0 111.206 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.79 96.82 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.437 ' HA ' ' SD ' ' A' ' 96' ' ' MET 0.25 76.3 t -62.08 -46.68 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.728 1.149 . . . . 0.0 112.371 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.17 -34.24 60.0 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.7 p -94.86 -2.61 50.41 Favored 'General case' 0 CA--C 1.585 2.291 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.52 ' SD ' ' HG ' ' A' ' 101' ' ' LEU 0.262 0.8 OUTLIER -102.04 153.15 20.17 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 123.258 2.753 . . . . 0.0 115.444 -177.363 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -99.36 150.82 21.75 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 63.3 t -48.15 124.43 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.594 0 C-N-CA 124.835 1.254 . . . . 0.0 112.557 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -29.12 11.62 Favored Glycine 0 N--CA 1.499 2.844 0 CA-C-O 115.051 -3.083 . . . . 0.0 115.76 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.364 2.2 tp10 -155.82 -176.3 5.88 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 123.008 3.404 . . . . 0.0 116.609 173.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.52 ' HG ' ' SD ' ' A' ' 96' ' ' MET 0.735 0.1 OUTLIER -159.44 -145.39 0.13 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 179.25 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.5 OUTLIER -160.26 -152.41 0.29 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -170.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.5 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 12.1 ptm180 -109.29 130.5 55.49 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 123.864 1.792 . . . . 0.0 111.14 171.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.4 mt -93.81 134.65 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 112.871 -1.968 . . . . 0.0 107.329 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 m -130.16 100.43 5.41 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 9.5 p -115.45 144.97 43.04 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -172.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.15 148.84 72.05 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 116.924 -1.512 . . . . 0.0 111.474 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.267 71.7 Cg_endo -57.98 -19.06 38.46 Favored 'Trans proline' 0 C--N 1.379 2.138 0 CA-C-N 125.587 3.031 . . . . 0.0 119.095 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.38 -38.31 80.17 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 121.465 1.939 . . . . 0.0 114.407 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.539 ' HH ' ' NZ ' ' A' ' 27' ' ' LYS . 46.2 m-85 -79.16 -7.82 58.51 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 124.679 1.192 . . . . 0.0 114.1 169.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -121.52 -103.8 0.39 Allowed 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.735 1.607 . . . . 0.0 112.929 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.478 6.5 m-85 -106.2 -8.22 17.47 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.79 -148.21 49.12 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 t -88.74 61.9 6.2 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 122.407 1.099 . . . . 0.0 111.534 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.79 -52.8 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.406 1.483 . . . . 0.0 112.646 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.99 160.94 25.55 Favored Glycine 0 CA--C 1.544 1.873 0 C-N-CA 124.054 0.835 . . . . 0.0 114.038 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -89.24 139.29 28.58 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.021 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.64 -39.96 37.94 Favored 'Trans proline' 0 CA--C 1.586 3.122 0 N-CA-C 120.597 3.268 . . . . 0.0 120.597 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.33 -29.85 0.45 Allowed 'Trans proline' 0 CA--C 1.574 2.494 0 CA-C-N 125.425 2.973 . . . . 0.0 119.667 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -148.38 -29.34 0.3 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 119.422 3.119 . . . . 0.0 119.422 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mt -79.98 122.1 82.82 Favored Pre-proline 0 CA--C 1.585 2.326 0 CA-C-N 120.467 1.485 . . . . 0.0 113.854 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.69 177.85 2.58 Favored 'Trans proline' 0 CA--C 1.584 2.993 0 C-N-CA 123.119 2.546 . . . . 0.0 117.458 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -50.28 -19.84 4.97 Favored 'Trans proline' 0 CA--C 1.567 2.151 1 N-CA-C 122.927 4.164 . . . . 0.0 122.927 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -160.13 94.87 1.12 Allowed 'General case' 0 CA--C 1.583 2.233 0 CA-C-N 120.671 1.578 . . . . 0.0 106.885 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -147.23 141.9 26.66 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 123.001 2.637 . . . . 0.0 112.436 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -71.44 158.01 37.04 Favored 'General case' 0 CA--C 1.591 2.54 0 O-C-N 121.221 -0.924 . . . . 0.0 112.743 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mt -129.18 161.35 30.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 119.555 -1.966 . . . . 0.0 112.762 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.5 m -144.04 135.97 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 110.798 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 2.4 m-85 -136.15 127.43 28.27 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.71 1.243 . . . . 0.0 109.225 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.88 102.26 14.37 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.69 152.06 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.294 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -133.97 133.2 41.07 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 53' ' ' PHE . 4.6 tt -94.8 143.74 26.21 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -106.33 -60.67 1.62 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -177.29 134.17 0.18 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 125.784 2.707 . . . . 0.0 106.682 -173.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.88 -111.66 0.34 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.6 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.401 42.0 tptt -119.65 -119.1 0.31 Allowed 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 171.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.009 0 CA-C-N 125.721 3.873 . . . . 0.0 120.977 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 10.8 p -67.08 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.549 1.175 . . . . 0.0 112.716 -176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -138.5 125.4 21.14 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -172.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 34.9 pt -126.44 56.4 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 123.834 1.778 . . . . 0.0 110.164 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.9 p -148.66 -38.75 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 114.537 -2.649 . . . . 0.0 116.283 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.92 89.11 0.15 Allowed 'Trans proline' 0 CA--C 1.58 2.797 0 CA-C-N 126.497 3.356 . . . . 0.0 111.581 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.427 8.4 mptt 73.22 -14.16 0.64 Allowed 'General case' 0 CA--C 1.581 2.171 0 O-C-N 119.421 -2.05 . . . . 0.0 115.231 -173.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.93 -22.83 58.37 Favored 'General case' 0 CA--C 1.587 2.384 0 C-N-CA 124.66 1.184 . . . . 0.0 112.708 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.309 24.2 t70 65.6 5.77 3.46 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 119.364 3.098 . . . . 0.0 119.364 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.03 17.38 6.95 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.05 -6.0 3.32 Favored Glycine 0 N--CA 1.477 1.374 1 N-CA-C 125.542 4.977 . . . . 0.0 125.542 173.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.305 67.8 t -141.52 144.98 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 123.002 3.401 . . . . 0.0 117.122 -169.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.2 135.99 48.61 Favored 'General case' 0 CA--C 1.585 2.318 0 C-N-CA 126.724 2.009 . . . . 0.0 109.703 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -128.86 112.55 14.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 123.694 2.952 . . . . 0.0 111.835 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.1 101.01 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.014 -1.053 . . . . 0.0 113.261 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' SG ' ' A' ' 102' ' ' CYS 0.304 2.6 mm -52.07 128.05 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -118.08 -42.57 2.8 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.707 1.203 . . . . 0.0 112.546 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -129.06 112.85 14.44 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.53 -173.01 4.14 Favored 'General case' 0 CA--C 1.598 2.802 0 CA-C-N 121.171 1.805 . . . . 0.0 115.833 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.8 158.67 36.64 Favored Glycine 0 N--CA 1.492 2.382 1 N-CA-C 123.559 4.183 . . . . 0.0 123.559 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -129.15 -72.81 0.59 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.57 114.76 3.98 Favored Glycine 0 CA--C 1.55 2.245 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -58.68 -14.41 8.36 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.7 148.29 42.83 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.0 m -148.52 96.4 3.89 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-N 110.652 -2.977 . . . . 0.0 107.096 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.441 0.5 OUTLIER -104.88 1.2 0.24 Allowed 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 119.818 2.969 . . . . 0.0 119.818 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.533 39.5 mtm 76.79 -140.19 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 164.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 1.1 tp -48.09 136.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 CA-C-O 122.157 0.979 . . . . 0.0 113.347 -174.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.91 -6.62 83.22 Favored Glycine 0 CA--C 1.551 2.344 0 CA-C-O 116.781 -2.122 . . . . 0.0 118.143 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -73.88 128.62 35.99 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 122.62 3.21 . . . . 0.0 113.762 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -78.37 112.48 15.43 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.4 138.96 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.65 104.14 11.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.49 166.29 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 CA-C-O 123.145 1.45 . . . . 0.0 112.556 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.92 113.7 17.54 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.742 170.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -117.87 151.81 36.64 Favored 'General case' 0 CA--C 1.582 2.191 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 97.4 m -127.43 143.26 51.23 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.93 143.08 11.47 Favored Glycine 0 CA--C 1.555 2.589 0 O-C-N 119.984 -1.698 . . . . 0.0 116.87 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.77 151.66 48.73 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 127.479 2.312 . . . . 0.0 112.499 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.39 175.75 9.15 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 123.465 1.603 . . . . 0.0 108.543 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 tp -60.35 -31.65 70.53 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.46 8.07 1.55 Allowed 'General case' 0 CA--C 1.596 2.713 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.59 36.05 82.36 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 119.697 -1.877 . . . . 0.0 114.808 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 m -111.1 119.57 39.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -76.49 112.29 12.85 Favored 'General case' 0 CA--C 1.588 2.442 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.779 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -85.09 -35.19 21.97 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 122.686 2.494 . . . . 0.0 113.689 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.51 158.08 43.85 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 123.469 1.604 . . . . 0.0 113.099 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 t -156.37 100.71 1.99 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.949 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 t -59.72 -40.33 87.62 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.82 -46.1 78.17 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.262 1.425 . . . . 0.0 114.411 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.32 -39.62 68.08 Favored 'General case' 0 CA--C 1.579 2.094 0 C-N-CA 124.82 1.248 . . . . 0.0 113.776 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 -13.15 47.37 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 51.4 mtmt 91.95 -35.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 126.808 2.043 . . . . 0.0 115.334 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -88.53 170.69 10.66 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 123.804 1.764 . . . . 0.0 111.997 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.74 168.66 9.53 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.577 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.278 5.9 t80 -104.83 145.26 30.63 Favored 'General case' 0 CA--C 1.574 1.892 0 O-C-N 120.44 -1.413 . . . . 0.0 109.273 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.1 p -155.66 128.18 7.83 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.814 -1.803 . . . . 0.0 110.095 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -143.16 -175.38 4.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 123.591 0.756 . . . . 0.0 110.194 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.263 13.4 t0 -128.06 124.81 37.96 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 118.796 -2.44 . . . . 0.0 105.551 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.9 104.92 0.09 Allowed 'General case' 0 CA--C 1.579 2.064 0 C-N-CA 124.69 1.196 . . . . 0.0 114.064 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.74 37.72 95.12 Favored Glycine 0 N--CA 1.512 3.721 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 -173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -132.82 -70.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 124.668 1.187 . . . . 0.0 110.636 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.42 74.18 0.21 Allowed Glycine 0 N--CA 1.495 2.586 1 N-CA-C 100.782 -4.927 . . . . 0.0 100.782 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.326 47.8 tp10 -71.91 150.61 44.02 Favored 'General case' 0 CA--C 1.554 1.116 1 CA-C-O 130.25 4.833 . . . . 0.0 116.693 -165.363 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.349 31.4 m -98.46 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 1 CA-C-N 101.55 -7.114 . . . . 0.0 107.087 -174.02 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.3 pt -110.97 159.05 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 124.418 2.056 . . . . 0.0 109.153 171.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -32.41 72.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.745 -1.57 . . . . 0.0 113.257 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.66 -35.48 74.51 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 116.826 -1.559 . . . . 0.0 111.677 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -77.43 -41.6 39.22 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.323 1.874 . . . . 0.0 112.378 173.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.66 -34.1 69.02 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 120.017 1.28 . . . . 0.0 113.885 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.2 mp -66.66 -57.08 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 120.098 1.317 . . . . 0.0 110.968 172.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.51 90.17 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.454 ' HA ' ' SD ' ' A' ' 96' ' ' MET . 99.6 t -63.03 -38.72 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-N 118.967 0.803 . . . . 0.0 112.906 173.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.71 -36.8 70.09 Favored 'General case' 0 CA--C 1.58 2.12 0 CA-C-N 120.282 1.401 . . . . 0.0 113.445 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -82.32 11.37 5.53 Favored 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' A' ' 93' ' ' VAL . 43.3 mtt -94.01 134.92 35.91 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 121.636 2.016 . . . . 0.0 116.103 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.3 163.26 15.43 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 164.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 64.5 t -57.73 131.66 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.943 0 O-C-N 117.899 -3.0 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.53 -21.19 30.48 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 124.172 3.169 . . . . 0.0 114.275 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.64 163.87 27.39 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 120.4 2.1 . . . . 0.0 113.695 176.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 102' ' ' CYS 1.751 0.1 OUTLIER 162.43 155.76 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.797 2.039 . . . . 0.0 113.921 168.009 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 101' ' ' LEU 0.345 81.9 m -143.44 178.97 7.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.998 1.319 . . . . 0.0 112.872 -167.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.301 0.0 OUTLIER -93.64 119.53 32.77 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 124.483 2.087 . . . . 0.0 107.93 171.171 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.56 118.56 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 CA-C-N 111.489 -2.596 . . . . 0.0 108.922 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -112.15 103.26 11.42 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.3 p -119.21 141.14 49.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -171.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.01 141.97 87.21 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.295 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -60.46 -19.97 61.51 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 N-CA-C 119.35 2.788 . . . . 0.0 119.35 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.7 -33.48 75.18 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 122.62 2.463 . . . . 0.0 113.603 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.5 -7.84 54.35 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.76 -101.87 0.42 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 120.076 1.307 . . . . 0.0 111.847 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.257 0.3 OUTLIER -124.56 14.64 8.8 Favored 'General case' 0 CA--C 1.592 2.574 0 CA-C-N 120.431 1.469 . . . . 0.0 113.872 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.05 -31.17 39.85 Favored Glycine 0 N--CA 1.497 2.765 1 N-CA-C 123.105 4.002 . . . . 0.0 123.105 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.9 m -66.66 -11.81 55.52 Favored 'General case' 0 CA--C 1.585 2.319 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.61 -60.15 0.19 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 124.945 1.298 . . . . 0.0 113.284 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.73 152.6 7.22 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.533 1.54 . . . . 0.0 110.792 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 t -81.8 126.54 75.18 Favored Pre-proline 0 CA--C 1.579 2.067 0 CA-C-O 116.647 -1.644 . . . . 0.0 108.993 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -40.38 -43.69 4.07 Favored 'Trans proline' 0 CA--C 1.581 2.871 0 N-CA-C 121.733 3.705 . . . . 0.0 121.733 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.6 -9.79 6.6 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 CA-C-N 125.165 2.88 . . . . 0.0 119.042 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -160.57 -43.68 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.9 125.18 82.57 Favored Pre-proline 0 CA--C 1.58 2.105 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -88.54 171.13 5.3 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 C-N-CA 122.662 2.241 . . . . 0.0 112.301 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.85 -42.15 33.15 Favored 'Trans proline' 0 CA--C 1.574 2.519 0 N-CA-C 117.917 2.237 . . . . 0.0 117.917 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -90.76 61.34 4.74 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.462 -1.399 . . . . 0.0 112.621 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.23 113.62 5.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.044 -1.66 . . . . 0.0 111.972 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -65.06 155.79 33.59 Favored 'General case' 0 CA--C 1.591 2.553 0 C-N-CA 124.107 0.963 . . . . 0.0 112.793 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 mt -114.74 162.75 16.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 124.525 2.107 . . . . 0.0 112.297 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 114.8 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 CA-C-N 112.703 -2.044 . . . . 0.0 108.83 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 1.3 m-85 -131.38 123.9 29.2 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 122.711 2.505 . . . . 0.0 111.756 175.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 90.8 mt-10 -91.97 110.28 21.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . 0.28 1.3 p -138.31 145.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 122.343 1.068 . . . . 0.0 112.248 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -136.23 133.58 37.2 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.813 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.401 ' HB2' ' CE ' ' A' ' 96' ' ' MET . 9.6 tp -93.8 130.33 39.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.69 -51.67 6.3 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.536 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -164.2 154.74 15.08 Favored 'General case' 0 CA--C 1.575 1.923 0 C-N-CA 125.455 1.502 . . . . 0.0 108.522 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.266 0.0 OUTLIER -130.33 -115.15 0.24 Allowed 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 110.239 177.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -122.26 119.29 30.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 -178.396 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 34' ' ' LYS 0.395 70.0 t 71.13 -36.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-O 115.395 -2.241 . . . . 0.0 113.693 -176.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.643 3.4 t0 63.62 162.17 0.11 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 123.73 2.968 . . . . 0.0 117.534 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 0.0 OUTLIER -153.52 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.234 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 1.439 28.7 m 100.49 64.79 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.167 0 O-C-N 119.052 -2.28 . . . . 0.0 115.178 -166.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.21 125.79 14.06 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 124.306 3.337 . . . . 0.0 110.916 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.553 6.9 mptt 88.44 -36.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.39 -6.9 55.04 Favored 'General case' 0 CA--C 1.596 2.713 0 O-C-N 121.325 -0.859 . . . . 0.0 112.051 165.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 78.66 111.37 0.07 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 114.769 -2.539 . . . . 0.0 107.117 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -9.38 72.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 125.254 2.454 . . . . 0.0 117.616 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.12 63.4 Favored Glycine 0 N--CA 1.481 1.651 0 CA-C-N 112.043 -2.344 . . . . 0.0 117.071 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -162.75 137.07 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.88 145.99 29.31 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 125.885 1.674 . . . . 0.0 109.041 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.49 ' NZ ' ' HE2' ' A' ' 132' ' ' GLU . 1.6 tmtp? -130.89 125.61 33.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 122.621 2.464 . . . . 0.0 111.797 -177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.2 t -102.04 93.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.367 0.3 OUTLIER -79.24 134.53 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.849 -1.157 . . . . 0.0 111.54 178.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.89 -68.2 0.94 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.581 0.705 . . . . 0.0 111.101 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -99.01 95.32 7.06 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.9 167.33 11.77 Favored 'General case' 0 CA--C 1.59 2.512 0 O-C-N 120.044 -1.66 . . . . 0.0 113.749 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.57 170.92 41.83 Favored Glycine 0 CA--C 1.55 2.24 0 O-C-N 119.53 -1.981 . . . . 0.0 117.959 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 p -78.36 -70.72 0.47 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.27 54.04 0.1 Allowed Glycine 0 N--CA 1.482 1.766 0 C-N-CA 124.674 1.131 . . . . 0.0 113.727 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -140.38 17.05 2.4 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 55.74 -179.04 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 121.588 3.921 . . . . 0.0 121.588 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -116.85 120.59 33.88 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.396 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -66.46 -20.57 54.29 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 117.985 2.263 . . . . 0.0 117.985 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.515 8.7 mtt 80.2 -165.99 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.423 0.4 OUTLIER -39.65 125.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -169.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.79 88.41 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -76.75 142.82 40.29 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 122.857 3.329 . . . . 0.0 113.556 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -73.84 137.84 44.04 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.31 -1.494 . . . . 0.0 109.778 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.32 2.1 t -135.27 144.51 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 119.752 1.16 . . . . 0.0 112.688 -167.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -125.87 100.99 6.63 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.84 167.1 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 127.174 2.19 . . . . 0.0 112.138 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.15 127.57 36.21 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.564 160.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -119.43 155.69 31.54 Favored 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.6 m -125.31 138.56 54.07 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 159.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.53 145.73 14.47 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 123.347 2.794 . . . . 0.0 117.93 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.09 153.04 52.06 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 112.625 -1.787 . . . . 0.0 114.615 -175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.09 170.67 14.56 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 123.042 1.401 . . . . 0.0 108.642 170.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER -60.43 -26.35 66.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 178.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.68 9.63 3.29 Favored 'General case' 0 CA--C 1.593 2.631 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.1 38.38 73.27 Favored Glycine 0 N--CA 1.509 3.538 0 CA-C-N 121.341 1.882 . . . . 0.0 114.819 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 m -109.34 114.47 28.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -79.71 90.89 5.22 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -69.75 -30.88 68.57 Favored 'General case' 0 CA--C 1.559 1.306 0 O-C-N 119.696 -1.877 . . . . 0.0 114.424 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -154.47 148.11 25.3 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 121.603 2.001 . . . . 0.0 111.345 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 m -145.91 94.76 2.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.526 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 t -57.48 -39.22 75.95 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.15 -44.08 83.11 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -73.86 -42.18 61.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -61.33 -19.51 61.89 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.39 74.4 mmtt 96.63 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.177 2.191 . . . . 0.0 113.192 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.64 152.54 31.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.04 1.4 . . . . 0.0 113.665 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.05 171.45 10.72 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.493 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.252 9.2 t80 -105.23 157.72 17.09 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.092 0.949 . . . . 0.0 109.235 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.7 p -157.89 145.71 18.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 119.295 -2.128 . . . . 0.0 110.313 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -155.15 -173.36 4.53 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.875 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -123.05 123.07 40.03 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -49.15 112.0 0.56 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -172.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.97 47.79 82.26 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -107.21 14.16 26.48 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.88 -42.67 2.37 Favored Glycine 0 N--CA 1.51 3.614 0 O-C-N 120.782 -1.199 . . . . 0.0 111.41 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.279 8.3 tp10 -28.8 -48.96 0.07 Allowed 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 129.386 3.075 . . . . 0.0 118.805 169.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.255 9.3 m -117.61 -147.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 CA-C-O 124.066 1.888 . . . . 0.0 109.785 -175.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.4 pt -110.93 160.77 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 124.104 1.907 . . . . 0.0 110.238 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -32.67 73.25 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.018 -1.446 . . . . 0.0 113.205 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.06 70.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.016 -1.469 . . . . 0.0 112.443 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.27 -42.52 54.84 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.967 1.712 . . . . 0.0 112.423 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.84 -37.73 71.67 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -68.1 -56.74 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.056 0 CA-C-N 119.885 1.22 . . . . 0.0 111.191 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.65 94.54 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.4 t -67.59 -46.23 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.571 1.078 . . . . 0.0 111.736 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.25 62.78 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p -92.22 4.29 53.57 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.429 ' SD ' ' OE2' ' A' ' 132' ' ' GLU . 4.6 ptt? -116.48 119.51 35.85 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 122.304 2.32 . . . . 0.0 112.185 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -78.56 148.69 33.25 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.152 -1.593 . . . . 0.0 108.72 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.6 t -9.47 79.43 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 C-N-CA 125.299 1.44 . . . . 0.0 109.001 -158.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -20.46 -29.45 0.0 OUTLIER Glycine 1 N--CA 1.523 4.437 1 N-CA-C 127.783 5.873 . . . . 0.0 127.783 -144.585 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.663 0.3 OUTLIER 52.97 -125.57 2.4 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 115.581 -2.152 . . . . 0.0 111.549 -161.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.617 ' HA ' ' CB ' ' A' ' 132' ' ' GLU 0.461 0.9 OUTLIER -136.15 132.96 36.69 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.446 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' H ' ' HB2' ' A' ' 132' ' ' GLU 2.674 5.7 m -160.27 -151.98 0.27 Allowed 'General case' 0 CA--C 1.589 2.477 0 CA-C-N 120.224 1.375 . . . . 0.0 114.489 177.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -143.36 158.85 43.3 Favored 'General case' 0 CA--C 1.575 1.942 0 O-C-N 120.108 -1.62 . . . . 0.0 113.662 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.39 143.87 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 C-N-CA 126.128 1.771 . . . . 0.0 110.543 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.3 m -140.09 104.5 4.85 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.1 p -118.87 147.12 44.31 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -172.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -80.71 148.13 64.58 Favored Pre-proline 0 CA--C 1.581 2.166 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.647 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -36.43 -33.06 0.12 Allowed 'Trans proline' 0 CA--C 1.567 2.144 0 N-CA-C 122.079 3.838 . . . . 0.0 122.079 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.1 -44.66 91.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -78.86 -5.96 54.89 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 116.187 -1.863 . . . . 0.0 114.328 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.43 -153.25 0.5 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 122.324 2.329 . . . . 0.0 114.288 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.283 0.1 OUTLIER -82.11 11.42 5.26 Favored 'General case' 0 CA--C 1.575 1.921 0 O-C-N 119.22 -2.175 . . . . 0.0 113.582 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.36 -38.57 45.23 Favored Glycine 0 CA--C 1.553 2.441 0 CA-C-N 124.027 3.103 . . . . 0.0 115.354 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 p -70.78 -51.58 26.06 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 118.316 1.058 . . . . 0.0 113.761 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.98 -34.48 14.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.91 141.96 12.81 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.039 1.29 . . . . 0.0 113.646 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.0 t -95.42 146.17 30.84 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.834 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -41.52 -43.23 5.99 Favored 'Trans proline' 0 CA--C 1.584 3.023 0 C-N-CA 123.65 2.9 . . . . 0.0 119.107 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.72 57.25 6.28 Favored 'Trans proline' 0 CA--C 1.585 3.036 0 CA-C-N 125.325 2.937 . . . . 0.0 115.425 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 61.93 33.39 17.48 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.325 3.454 . . . . 0.0 120.325 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.9 mt -82.91 117.56 68.96 Favored Pre-proline 0 CA--C 1.59 2.485 0 O-C-N 120.127 -1.608 . . . . 0.0 108.768 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -90.31 178.02 2.23 Favored 'Trans proline' 0 CA--C 1.585 3.061 0 CA-C-N 123.483 2.279 . . . . 0.0 116.179 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.41 151.19 54.69 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.072 2.515 . . . . 0.0 117.621 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.252 38.4 t-20 59.62 44.0 15.05 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -177.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.4 105.5 15.46 Favored 'General case' 0 CA--C 1.562 1.436 0 O-C-N 120.534 -1.354 . . . . 0.0 110.35 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.8 m -66.01 150.18 49.08 Favored 'General case' 0 CA--C 1.592 2.562 0 O-C-N 120.843 -1.161 . . . . 0.0 111.651 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.5 tp -132.64 157.48 44.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.552 -1.968 . . . . 0.0 111.663 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 22.3 m -147.05 144.03 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 O-C-N 121.043 -1.036 . . . . 0.0 112.043 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -146.97 134.68 21.11 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.977 -1.077 . . . . 0.0 109.98 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -88.21 112.97 23.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.39 152.94 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.243 -0.91 . . . . 0.0 111.136 -168.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.617 ' CB ' ' HA ' ' A' ' 101' ' ' LEU 0.777 0.2 OUTLIER -154.56 -164.25 1.78 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 116.781 2.141 . . . . 0.0 116.781 164.011 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.6 tt -145.0 133.28 21.67 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.819 1.295 . . . . 0.0 113.376 -173.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.13 -47.71 7.64 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.94 151.07 23.09 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.283 1.433 . . . . 0.0 108.895 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.294 0.0 OUTLIER -143.21 -101.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.421 13.1 tmtt? -111.01 -132.66 0.33 Allowed 'General case' 0 CA--C 1.588 2.418 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.697 0 CA-C-N 124.631 3.378 . . . . 0.0 113.923 177.791 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.308 0 CA-C-O 118.653 -1.082 . . . . 0.0 114.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.479 0.4 OUTLIER 65.38 -63.3 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -175.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.54 107.32 5.94 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.632 0.773 . . . . 0.0 110.02 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 5.8 tp -157.53 138.92 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.116 0 CA-C-O 125.508 2.575 . . . . 0.0 113.131 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.508 ' HG ' ' N ' ' A' ' 29' ' ' ASP . 32.1 p -144.59 136.49 13.0 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.711 166.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -46.09 88.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 124.177 3.251 . . . . 0.0 117.132 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.496 8.4 mptt 79.46 -28.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.29 -27.07 64.12 Favored 'General case' 0 CA--C 1.593 2.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.508 ' N ' ' HG ' ' A' ' 25' ' ' SER 0.457 1.5 m-20 74.55 -60.83 0.51 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 127.902 2.481 . . . . 0.0 115.393 175.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.317 12.8 pt-20 -90.33 40.83 1.02 Allowed 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.89 -42.75 24.49 Favored Glycine 0 N--CA 1.507 3.373 0 O-C-N 119.286 -2.133 . . . . 0.0 115.438 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.254 60.4 t -135.5 135.45 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 CA-C-O 122.648 1.213 . . . . 0.0 113.842 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -91.41 114.19 26.65 Favored 'General case' 0 CA--C 1.584 2.27 0 CA-C-O 116.614 -1.66 . . . . 0.0 107.956 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -112.39 90.37 3.32 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 124.101 3.137 . . . . 0.0 108.205 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.87 130.33 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.436 -173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 ' SG ' ' A' ' 102' ' ' CYS 0.303 1.0 OUTLIER -82.2 130.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 122.671 1.224 . . . . 0.0 113.133 179.287 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -110.81 -56.33 2.37 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.002 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.36 96.19 3.06 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.24 166.96 1.96 Allowed 'General case' 0 CA--C 1.59 2.495 0 CA-C-N 122.551 2.432 . . . . 0.0 116.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.35 -170.65 37.25 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 120.654 3.021 . . . . 0.0 120.654 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 t -81.02 15.33 1.89 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.46 34.04 68.05 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.5 p -122.6 26.83 8.11 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.8 1.24 . . . . 0.0 113.882 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.451 7.4 pt-20 40.41 -154.92 0.01 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.91 115.65 5.61 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 124.476 1.11 . . . . 0.0 111.191 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -41.26 -28.85 0.53 Allowed 'Trans proline' 0 CA--C 1.583 2.956 1 N-CA-C 122.626 4.049 . . . . 0.0 122.626 165.137 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.541 44.5 mtm 84.79 -141.56 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.29 1.1 tp -52.01 135.87 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 O-C-N 120.224 -1.548 . . . . 0.0 112.847 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.15 4.94 86.2 Favored Glycine 0 CA--C 1.553 2.442 0 CA-C-O 116.859 -2.078 . . . . 0.0 117.884 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.48 136.44 36.31 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 122.681 3.241 . . . . 0.0 112.577 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.51 98.2 11.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.68 141.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -167.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.18 107.78 14.87 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -114.11 165.95 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 123.272 1.511 . . . . 0.0 113.685 -175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.254 0.1 OUTLIER -132.11 113.36 13.23 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.075 167.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -105.91 161.21 14.65 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 124.019 1.866 . . . . 0.0 113.881 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.7 m -134.22 133.35 40.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 159.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.05 164.79 26.1 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 122.072 2.215 . . . . 0.0 118.048 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.34 155.98 41.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -173.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -85.1 172.19 11.44 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 123.469 1.604 . . . . 0.0 108.877 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.13 -33.82 74.0 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.301 0.2 OUTLIER -69.5 2.94 2.66 Favored 'General case' 0 CA--C 1.592 2.565 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 173.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.88 44.68 23.83 Favored Glycine 0 N--CA 1.503 3.106 0 CA-C-N 119.564 1.074 . . . . 0.0 114.174 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.9 m -120.77 119.81 33.83 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -78.98 97.24 5.98 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.152 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.01 -34.82 71.71 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.263 -2.148 . . . . 0.0 114.944 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.95 175.75 9.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -154.19 -77.1 0.11 Allowed 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.427 1.6 t 111.4 -40.05 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 128.775 2.83 . . . . 0.0 109.205 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.14 -34.81 15.06 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 169.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.95 -35.71 62.04 Favored 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -94.82 -85.01 0.32 Allowed 'General case' 0 CA--C 1.575 1.907 0 C-N-CA 124.716 1.206 . . . . 0.0 110.13 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? 175.32 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 127.29 2.236 . . . . 0.0 107.959 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -22.45 -37.92 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 1 N-CA-C 127.229 6.011 . . . . 0.0 127.229 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.441 53.2 pttt 71.53 -175.11 0.18 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.328 2.8 t80 -118.68 146.93 44.32 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.104 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.7 p -160.63 130.67 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 119.309 -2.119 . . . . 0.0 108.709 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -141.79 -173.71 3.87 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 123.216 0.607 . . . . 0.0 109.788 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.74 128.42 47.72 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 118.843 -2.411 . . . . 0.0 106.306 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.07 107.33 0.46 Allowed 'General case' 0 CA--C 1.578 2.038 0 O-C-N 121.314 -0.866 . . . . 0.0 112.536 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.61 56.32 5.56 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.024 -1.047 . . . . 0.0 114.802 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -102.17 -64.43 1.06 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 124.498 2.094 . . . . 0.0 112.963 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.63 -55.93 0.13 Allowed Glycine 0 N--CA 1.503 3.104 0 C-N-CA 128.86 3.124 . . . . 0.0 107.096 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.824 23.8 tt0 119.05 143.25 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 128.145 3.831 . . . . 0.0 116.807 162.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.347 14.1 m -79.87 -106.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.001 1 CA-C-N 105.319 -5.4 . . . . 0.0 104.962 -178.626 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -125.43 152.91 32.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 124.737 2.208 . . . . 0.0 105.538 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.27 -31.67 72.96 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 113.28 -1.782 . . . . 0.0 113.697 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.07 82.92 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.047 1.339 . . . . 0.0 111.391 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.442 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.9 m0 -70.46 -42.5 71.39 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 120.638 1.563 . . . . 0.0 112.549 172.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.0 -36.44 74.93 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 120.005 1.275 . . . . 0.0 114.185 172.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.259 1.3 mp -66.3 -56.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.274 1.397 . . . . 0.0 111.685 173.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.55 -45.31 91.12 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.285 75.8 t -65.04 -41.5 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 120.412 1.46 . . . . 0.0 112.531 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.58 64.63 Favored 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 120.336 1.426 . . . . 0.0 114.465 171.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 p -95.49 -6.97 39.39 Favored 'General case' 0 CA--C 1.588 2.411 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 38.6 mtp -96.69 123.11 40.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 121.597 1.999 . . . . 0.0 112.52 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -77.99 179.88 6.5 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.99 125.94 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.733 0 O-C-N 120.522 -1.361 . . . . 0.0 111.03 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.92 81.36 Favored Glycine 0 N--CA 1.515 3.934 0 CA-C-N 122.724 2.511 . . . . 0.0 116.901 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.63 132.1 41.46 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.474 2.137 . . . . 0.0 115.364 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.74 114.77 28.39 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.063 0.945 . . . . 0.0 111.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.443 ' SG ' HD12 ' A' ' 36' ' ' ILE . 17.2 m -136.53 159.56 41.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -109.73 127.24 54.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 123.845 1.783 . . . . 0.0 109.286 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.2 mt -92.58 118.59 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.395 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 104.53 11.93 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 7.7 p -118.49 148.56 42.49 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -89.02 142.19 30.04 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.495 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -42.54 -26.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 124.812 3.674 . . . . 0.0 121.413 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -31.94 72.96 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 121.314 1.87 . . . . 0.0 114.555 172.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -91.33 -9.75 43.83 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 125.472 1.509 . . . . 0.0 113.098 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.44 -112.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.196 1.816 . . . . 0.0 112.655 -176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.329 1.3 m-85 -113.79 21.03 15.35 Favored 'General case' 0 CA--C 1.588 2.411 0 CA-C-N 121.219 1.827 . . . . 0.0 113.751 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.2 -15.92 4.15 Favored Glycine 0 N--CA 1.501 2.99 1 N-CA-C 124.332 4.493 . . . . 0.0 124.332 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -71.69 -65.59 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.656 2.228 . . . . 0.0 112.063 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.29 10.4 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.38 160.28 36.38 Favored Glycine 0 CA--C 1.547 2.055 0 CA-C-N 122.144 2.247 . . . . 0.0 112.882 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -81.45 123.68 80.89 Favored Pre-proline 0 CA--C 1.577 2.008 0 O-C-N 120.258 -1.731 . . . . 0.0 107.736 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -33.69 -45.09 0.34 Allowed 'Trans proline' 0 CA--C 1.582 2.891 0 N-CA-C 121.99 3.804 . . . . 0.0 121.99 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -86.88 -16.97 3.32 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 CA-C-N 125.097 2.856 . . . . 0.0 118.948 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -159.09 -38.29 0.06 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.82 129.59 70.25 Favored Pre-proline 0 CA--C 1.581 2.143 0 O-C-N 120.195 -1.566 . . . . 0.0 113.897 -172.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.82 163.17 5.07 Favored 'Trans proline' 0 CA--C 1.586 3.121 0 CA-C-N 123.572 2.312 . . . . 0.0 113.202 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 8.95 0.45 Allowed 'Trans proline' 0 CA--C 1.576 2.619 0 N-CA-C 120.505 3.233 . . . . 0.0 120.505 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -139.68 62.79 1.51 Allowed 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.302 -1.499 . . . . 0.0 110.11 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.3 137.06 17.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.964 -1.71 . . . . 0.0 111.149 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.2 m -72.96 150.16 42.74 Favored 'General case' 0 CA--C 1.588 2.428 0 O-C-N 120.485 -1.385 . . . . 0.0 111.202 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.342 0.2 OUTLIER -134.78 167.33 21.06 Favored 'General case' 0 CA--C 1.574 1.895 0 O-C-N 118.685 -2.509 . . . . 0.0 109.524 176.11 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.6 p -141.22 146.35 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.846 -1.159 . . . . 0.0 112.02 -175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.288 0.6 OUTLIER -145.77 124.94 12.9 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.88 0.848 . . . . 0.0 110.501 169.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.41 115.25 24.7 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 t -124.26 134.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.026 0.917 . . . . 0.0 112.382 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -107.43 124.45 49.88 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.2 tp -103.31 119.38 38.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.85 -49.12 8.68 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -170.61 170.58 6.71 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.469 1.908 . . . . 0.0 108.122 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.255 5.7 p90 -154.94 -81.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 119.951 -1.718 . . . . 0.0 112.395 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.412 77.2 tttt -119.98 -136.38 0.33 Allowed 'General case' 0 CA--C 1.594 2.644 0 C-N-CA 124.512 1.125 . . . . 0.0 108.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.351 0 O-C-N 117.465 -3.272 . . . . 0.0 112.561 -179.136 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.016 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.444 ' C ' ' H ' ' A' ' 34' ' ' LYS 0.308 33.1 t 63.37 166.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.31 0 C-N-CA 125.822 1.649 . . . . 0.0 111.746 -177.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.432 28.2 t0 -156.45 169.3 24.94 Favored 'General case' 0 CA--C 1.577 1.992 0 O-C-N 118.036 -2.915 . . . . 0.0 107.111 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.4 -172.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 124.39 2.043 . . . . 0.0 106.531 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.607 0.5 OUTLIER -160.13 136.05 6.14 Favored Pre-proline 0 CA--C 1.584 2.254 0 O-C-N 118.785 -2.447 . . . . 0.0 115.058 167.233 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -38.92 -4.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.51 2.445 2 N-CA-C 127.996 6.114 . . . . 0.0 127.996 -173.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 75.81 1.18 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 121.546 1.976 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.306 34.0 mm-40 72.82 29.75 1.85 Allowed 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.714 -172.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.394 1.7 p30 53.15 24.71 3.76 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 119.886 3.291 . . . . 0.0 119.886 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -90.3 -35.57 15.19 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 120.117 3.376 . . . . 0.0 120.117 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.17 -53.88 4.69 Favored Glycine 0 N--CA 1.493 2.45 1 N-CA-C 123.739 4.255 . . . . 0.0 123.739 -158.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -142.75 125.29 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 124.278 0.634 . . . . 0.0 111.859 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -100.6 143.69 30.47 Favored 'General case' 0 CA--C 1.587 2.39 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.314 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 22' ' ' VAL . 1.9 tmmt? -120.61 113.64 20.54 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-N 124.054 3.116 . . . . 0.0 111.434 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.51 92.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.505 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.311 0.4 OUTLIER -76.95 135.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 120.887 -1.133 . . . . 0.0 110.26 178.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -121.09 -56.95 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.458 0.703 . . . . 0.0 111.898 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -118.6 99.73 6.99 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.96 142.71 52.83 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 119.178 -2.201 . . . . 0.0 112.614 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.49 163.54 42.73 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 119.99 -1.693 . . . . 0.0 116.638 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.3 p -121.34 -79.41 0.61 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.142 -176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 2.73 -85.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.204 0 N-CA-C 122.116 3.606 . . . . 0.0 122.116 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.8 p -117.21 26.64 9.63 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.381 6.5 mt-10 55.24 -153.68 0.32 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 176.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -110.58 122.39 38.51 Favored Pre-proline 0 CA--C 1.572 1.801 0 O-C-N 120.559 -1.338 . . . . 0.0 108.497 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.397 0.2 OUTLIER -115.65 -87.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 N-CA-C 119.159 2.715 . . . . 0.0 119.159 -176.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -157.74 171.1 20.91 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 120.847 3.647 . . . . 0.0 120.847 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.36 132.41 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.763 0 CA-C-O 122.874 1.321 . . . . 0.0 109.932 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.85 3.39 68.34 Favored Glycine 0 CA--C 1.558 2.778 0 CA-C-O 116.836 -2.091 . . . . 0.0 118.186 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.79 141.24 56.59 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-N 122.624 3.212 . . . . 0.0 112.82 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -84.47 96.18 9.03 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.086 1.766 . . . . 0.0 108.353 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.31 135.09 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.99 100.46 8.89 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.76 164.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 127.356 2.263 . . . . 0.0 113.719 -172.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.79 124.4 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.583 160.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -115.03 156.87 24.33 Favored 'General case' 0 CA--C 1.593 2.608 0 CA-C-O 122.52 1.153 . . . . 0.0 111.058 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -130.36 138.51 50.44 Favored 'General case' 0 N--CA 1.515 2.792 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 160.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.08 140.71 8.57 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-N 123.329 2.786 . . . . 0.0 117.902 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.19 159.54 42.02 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 127.275 2.23 . . . . 0.0 115.057 -176.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -76.73 177.34 7.65 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.603 1.192 . . . . 0.0 109.594 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.345 0.0 OUTLIER -62.84 -27.06 69.07 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 176.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.9 13.97 0.94 Allowed 'General case' 0 CA--C 1.606 3.106 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.1 33.58 61.13 Favored Glycine 0 N--CA 1.511 3.663 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -91.86 109.42 20.75 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -68.0 107.13 2.58 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -81.64 -34.98 30.51 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 121.083 1.765 . . . . 0.0 112.099 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -155.84 155.48 33.03 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 124.163 1.935 . . . . 0.0 111.337 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -159.95 99.63 1.38 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.146 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -50.84 -34.28 27.21 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.71 -46.69 86.77 Favored 'General case' 0 CA--C 1.58 2.105 0 C-N-CA 125.346 1.458 . . . . 0.0 114.094 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.1 -41.48 77.4 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.418 1.087 . . . . 0.0 113.653 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -70.6 4.92 2.1 Favored 'General case' 0 CA--C 1.59 2.511 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 65.48 8.56 5.13 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 119.318 3.081 . . . . 0.0 119.318 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.12 -157.14 0.61 Allowed 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 125.436 1.494 . . . . 0.0 113.964 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -139.22 162.12 35.75 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 125.425 1.49 . . . . 0.0 109.393 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.354 2.1 t80 -108.47 149.43 28.81 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 120.944 1.702 . . . . 0.0 110.403 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.9 p -160.81 141.76 11.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 119.71 -1.869 . . . . 0.0 109.519 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -155.01 177.45 11.31 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.233 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -116.63 125.77 52.27 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.21 105.83 0.1 Allowed 'General case' 0 CA--C 1.575 1.924 0 C-N-CA 124.198 0.999 . . . . 0.0 113.668 -173.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.6 44.48 93.9 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.42 23.8 tptp -124.47 -79.8 0.61 Allowed 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 118.147 0.974 . . . . 0.0 110.262 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.24 70.57 0.24 Allowed Glycine 0 N--CA 1.505 3.27 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.407 49.8 tt0 -68.14 152.99 44.64 Favored 'General case' 0 CA--C 1.56 1.33 1 CA-C-O 130.466 4.936 . . . . 0.0 118.245 -160.471 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.378 24.5 m -80.27 -126.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.645 2 CA-C-N 100.987 -7.37 . . . . 0.0 106.767 -178.3 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.445 HG13 ' H ' ' A' ' 89' ' ' TRP . 34.5 pt -106.54 154.06 7.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.805 2.24 . . . . 0.0 106.402 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 10.6 tmtt? -69.1 -25.48 64.44 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 112.859 -1.973 . . . . 0.0 114.475 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.69 89.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 116.528 -1.701 . . . . 0.0 111.454 165.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.445 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -71.37 -44.01 65.82 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 121.385 1.902 . . . . 0.0 112.711 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -54.44 -41.18 69.1 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 121.23 1.832 . . . . 0.0 113.868 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -66.87 -61.38 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 CA-C-N 119.714 1.143 . . . . 0.0 112.071 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.5 -33.43 74.13 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.27 20.1 t -72.4 -39.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.82 1.646 . . . . 0.0 110.443 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.22 -31.27 63.35 Favored 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 120.152 1.342 . . . . 0.0 114.179 167.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.6 p -78.39 -19.67 52.82 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.44 ' SD ' HD11 ' A' ' 133' ' ' LEU 0.346 0.0 OUTLIER -90.37 163.84 14.55 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 124.701 3.409 . . . . 0.0 116.263 -179.126 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 137.88 51.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.944 -1.723 . . . . 0.0 112.257 -173.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.2 t -9.94 -171.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 127.922 2.489 . . . . 0.0 116.28 -173.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 25.67 -17.5 0.0 OUTLIER Glycine 0 N--CA 1.509 3.565 2 O-C-N 107.411 -9.555 . . . . 0.0 127.918 155.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.53 48.4 mt-10 -109.81 -149.61 0.44 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 123.996 3.898 . . . . 0.0 116.042 -178.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.528 ' HA ' ' CB ' ' A' ' 132' ' ' GLU . 15.3 tp -135.99 139.04 42.86 Favored 'General case' 0 CA--C 1.592 2.577 0 N-CA-C 119.917 3.303 . . . . 0.0 119.917 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.6 p -146.15 -168.11 2.91 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 122.605 1.193 . . . . 0.0 111.316 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 3.2 mtt180 -140.92 158.96 43.21 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 123.067 1.413 . . . . 0.0 112.555 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.51 135.27 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.414 1.485 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 m -127.59 102.8 7.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 15.7 p -122.0 149.99 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -83.11 141.06 42.89 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.456 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -61.61 -12.04 22.96 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 N-CA-C 119.282 2.762 . . . . 0.0 119.282 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.41 -39.95 92.62 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 121.0 1.727 . . . . 0.0 113.078 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -77.45 -6.98 55.42 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.906 1.282 . . . . 0.0 113.251 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.54 -121.47 0.17 Allowed 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.348 0.2 OUTLIER -85.58 7.44 23.14 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 122.057 2.208 . . . . 0.0 115.7 -178.036 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.8 -32.4 17.97 Favored Glycine 0 N--CA 1.501 2.998 0 CA-C-N 123.448 2.84 . . . . 0.0 119.455 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.1 p -77.92 84.57 4.2 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 118.464 1.132 . . . . 0.0 109.97 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.365 . . 86.43 -14.91 0.48 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.65 162.06 32.44 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 123.53 2.877 . . . . 0.0 113.438 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.421 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 3.5 t -89.51 148.34 40.07 Favored Pre-proline 0 CA--C 1.577 2.014 0 O-C-N 121.047 -1.266 . . . . 0.0 111.102 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.86 -43.55 6.83 Favored 'Trans proline' 0 CA--C 1.587 3.167 0 C-N-CA 123.456 2.771 . . . . 0.0 118.784 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.58 58.6 7.04 Favored 'Trans proline' 0 CA--C 1.586 3.081 0 CA-C-N 125.346 2.945 . . . . 0.0 115.292 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 61.18 31.12 19.59 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.328 3.455 . . . . 0.0 120.328 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.421 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -84.43 134.59 42.44 Favored Pre-proline 0 CA--C 1.596 2.736 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.36 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -90.5 157.56 4.4 Favored 'Trans proline' 0 CA--C 1.591 3.355 0 CA-C-N 125.981 3.172 . . . . 0.0 114.275 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.87 -42.39 64.06 Favored 'Trans proline' 0 CA--C 1.575 2.541 0 N-CA-C 119.732 2.935 . . . . 0.0 119.732 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.09 64.42 3.3 Favored 'General case' 0 CA--C 1.582 2.174 0 O-C-N 120.799 -1.188 . . . . 0.0 113.248 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.92 133.72 21.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.128 -1.608 . . . . 0.0 111.764 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.8 m -69.95 150.11 47.05 Favored 'General case' 0 CA--C 1.59 2.499 0 O-C-N 121.023 -1.048 . . . . 0.0 112.272 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.432 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 9.8 tp -126.43 159.15 34.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 119.846 -1.784 . . . . 0.0 111.726 -173.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.98 136.1 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 O-C-N 121.003 -1.06 . . . . 0.0 110.256 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.274 0.6 OUTLIER -135.28 125.04 25.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.59 113.41 21.8 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 173.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.91 145.56 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.755 -0.591 . . . . 0.0 111.915 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.528 ' CB ' ' HA ' ' A' ' 101' ' ' LEU 0.944 10.5 tt0 -151.54 -151.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 161.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.44 HD11 ' SD ' ' A' ' 96' ' ' MET . 0.4 OUTLIER -144.27 164.07 31.82 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -166.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -120.7 -50.51 2.19 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.349 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.98 152.0 10.84 Favored 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.872 1.669 . . . . 0.0 109.865 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -139.39 -93.66 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.235 -1.541 . . . . 0.0 109.803 178.493 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.436 77.3 tttt -127.91 -107.45 0.3 Allowed 'General case' 0 CA--C 1.588 2.411 0 CA-C-O 115.621 -2.133 . . . . 0.0 107.278 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 1 CA-C-N 126.37 4.168 . . . . 0.0 121.032 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.082 0 CA-C-O 119.827 -0.429 . . . . 0.0 114.094 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.523 2.7 p 55.83 -141.04 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.054 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.19 112.14 7.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.602 -1.311 . . . . 0.0 114.527 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.74 108.24 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 CA-C-O 123.551 1.643 . . . . 0.0 113.392 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.408 1.7 p -152.2 88.26 4.12 Favored Pre-proline 0 CA--C 1.59 2.484 0 O-C-N 118.146 -2.846 . . . . 0.0 105.916 161.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -83.68 56.49 5.26 Favored 'Trans proline' 0 CA--C 1.579 2.73 0 C-N-CA 123.419 2.746 . . . . 0.0 118.307 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.45 -52.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.228 -1.545 . . . . 0.0 109.407 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.05 -35.08 61.9 Favored 'General case' 0 CA--C 1.583 2.239 0 O-C-N 121.332 -0.855 . . . . 0.0 110.716 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.262 19.6 t70 120.38 132.81 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.211 0 C-N-CA 129.61 3.164 . . . . 0.0 105.67 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -9.33 73.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 128.83 2.852 . . . . 0.0 117.932 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.36 -21.87 57.72 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 121.786 3.474 . . . . 0.0 121.786 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.341 11.4 p -136.85 121.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tp -69.61 121.62 17.48 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 127.187 2.195 . . . . 0.0 112.316 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.11 102.31 11.03 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 122.393 2.36 . . . . 0.0 107.297 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.85 92.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.036 -177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.385 0.6 OUTLIER -65.2 130.68 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.03 -60.8 1.67 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.582 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.48 99.94 7.93 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -53.42 -74.81 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.56 -154.8 25.77 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 117.661 1.824 . . . . 0.0 117.661 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.0 p -87.72 -74.42 0.45 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.47 20.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 121.918 3.527 . . . . 0.0 121.918 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -134.7 67.64 1.5 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.501 12.7 pt-20 -33.59 -101.98 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.989 1 N-CA-C 123.774 4.731 . . . . 0.0 123.774 -170.48 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -112.16 100.01 48.0 Favored Pre-proline 0 CA--C 1.581 2.168 0 N-CA-C 118.233 2.679 . . . . 0.0 118.233 -169.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -100.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.579 2.739 0 C-N-CA 123.813 3.009 . . . . 0.0 119.905 169.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -163.11 161.04 25.0 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.253 0.4 OUTLIER -59.6 138.25 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-O 122.552 1.167 . . . . 0.0 110.897 175.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.15 89.06 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -85.61 157.06 20.46 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-N 121.836 2.818 . . . . 0.0 114.482 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -74.03 136.97 43.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.212 -1.555 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.371 1.1 t -137.81 132.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.388 0.675 . . . . 0.0 109.53 -165.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.44 117.39 26.75 Favored 'General case' 0 CA--C 1.562 1.416 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.42 166.36 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -168.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -130.73 120.84 24.41 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.135 169.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -124.71 137.45 54.35 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 29.4 m -106.98 153.47 22.52 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 160.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.71 142.75 8.98 Favored Glycine 0 CA--C 1.547 2.047 0 O-C-N 119.106 -2.246 . . . . 0.0 116.151 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -135.15 150.13 50.11 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.977 1.711 . . . . 0.0 113.088 -177.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.17 174.3 7.38 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.511 -0.743 . . . . 0.0 111.435 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.5 tp -61.34 -26.55 67.89 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.6 -5.93 13.39 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 167.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.83 58.04 Favored Glycine 0 N--CA 1.502 3.041 0 CA-C-N 120.622 1.555 . . . . 0.0 114.181 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -106.04 120.47 41.86 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -75.95 91.51 3.05 Favored 'General case' 0 CA--C 1.583 2.213 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.872 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -66.69 -32.06 73.13 Favored 'General case' 0 CA--C 1.566 1.56 0 O-C-N 119.282 -2.136 . . . . 0.0 115.516 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -149.19 158.91 44.57 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 120.248 1.386 . . . . 0.0 111.707 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' THR 0.356 43.3 t -135.36 -34.45 0.85 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 120.003 3.334 . . . . 0.0 120.003 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.321 60.0 p 58.31 -53.47 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 123.389 2.813 . . . . 0.0 116.717 -177.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.84 -34.32 27.43 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 128.343 2.657 . . . . 0.0 113.609 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -46.1 -42.72 14.02 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 125.241 1.416 . . . . 0.0 113.547 167.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.687 96.2 mtt180 95.02 38.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 120.023 3.342 . . . . 0.0 120.023 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.51 -56.15 4.37 Favored 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.78 166.82 23.6 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 126.409 1.884 . . . . 0.0 108.122 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -98.93 -162.06 0.92 Allowed 'General case' 0 CA--C 1.579 2.067 0 O-C-N 120.974 -1.079 . . . . 0.0 110.218 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.33 2.5 t80 -128.96 154.18 46.82 Favored 'General case' 0 CA--C 1.588 2.426 0 O-C-N 119.381 -2.074 . . . . 0.0 110.974 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.9 p -167.4 142.17 3.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 118.92 -2.362 . . . . 0.0 109.598 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -153.49 -179.55 7.87 Favored 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.824 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.23 124.36 52.35 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.0 106.17 0.08 Allowed 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 59.28 49.16 81.47 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 -10.98 27.52 Favored 'General case' 0 CA--C 1.579 2.091 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.1 -37.0 3.02 Favored Glycine 0 CA--C 1.564 3.118 0 C-N-CA 124.495 1.045 . . . . 0.0 110.547 -168.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -38.6 -46.72 1.23 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 120.552 3.538 . . . . 0.0 120.552 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.261 7.6 m -117.8 -154.44 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-O 124.101 1.905 . . . . 0.0 109.0 -172.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.434 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.9 pt -101.05 162.34 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 125.09 2.376 . . . . 0.0 110.113 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -69.1 -35.01 75.98 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 112.678 -2.056 . . . . 0.0 114.154 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.64 -33.9 66.78 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 116.704 -1.617 . . . . 0.0 111.161 167.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.434 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -76.21 -47.04 25.49 Favored 'General case' 0 C--N 1.371 1.515 0 CA-C-N 121.492 1.951 . . . . 0.0 112.982 173.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.96 -32.57 69.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 121.194 1.815 . . . . 0.0 115.54 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.255 1.6 mp -65.98 -59.28 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.28 0.945 . . . . 0.0 110.046 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.33 -53.49 57.68 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.613 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.283 56.7 t -54.28 -40.6 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 120.454 1.479 . . . . 0.0 114.26 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.64 70.06 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 119.881 1.219 . . . . 0.0 113.372 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 p -90.55 18.82 5.85 Favored 'General case' 0 CA--C 1.601 2.909 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.4 mtp -119.79 150.41 40.46 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 119.226 -2.171 . . . . 0.0 116.711 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 146.87 29.91 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.838 2.903 . . . . 0.0 118.838 -171.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -45.89 137.13 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 CA-C-N 112.897 -1.956 . . . . 0.0 113.13 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.53 -43.6 1.96 Allowed Glycine 0 N--CA 1.491 2.34 0 CA-C-O 115.608 -2.774 . . . . 0.0 116.713 172.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -149.21 -175.99 5.19 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 121.966 2.883 . . . . 0.0 114.506 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.593 HD22 ' SG ' ' A' ' 102' ' ' CYS 0.997 0.3 OUTLIER -155.49 -142.15 0.11 Allowed 'General case' 0 CA--C 1.604 3.05 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 172.64 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.593 ' SG ' HD22 ' A' ' 101' ' ' LEU 0.321 0.6 OUTLIER -151.41 -160.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 126.477 1.911 . . . . 0.0 113.746 -163.403 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.422 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 ptt85 -118.63 121.08 39.32 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.318 2.009 . . . . 0.0 110.124 165.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 mt -78.76 132.03 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 112.535 -2.12 . . . . 0.0 106.028 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 m -143.22 113.03 7.03 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . 2.679 2.7 m -160.28 -158.79 0.65 Allowed 'General case' 0 CA--C 1.59 2.493 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -97.6 122.68 54.59 Favored Pre-proline 0 CA--C 1.571 1.766 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -168.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 17.6 Cg_exo -42.59 -19.94 0.13 Allowed 'Trans proline' 0 CA--C 1.563 1.948 1 N-CA-C 122.534 4.013 . . . . 0.0 122.534 176.863 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.289 1.7 pm0 -63.03 -34.07 76.79 Favored 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 122.97 2.623 . . . . 0.0 113.098 169.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -74.29 -12.24 60.49 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 124.578 1.151 . . . . 0.0 113.799 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.51 -124.22 0.2 Allowed 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.289 0.6 OUTLIER -80.45 -4.63 54.5 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.133 2.242 . . . . 0.0 115.242 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -47.59 -17.99 0.56 Allowed Glycine 0 N--CA 1.497 2.755 1 N-CA-C 125.363 4.905 . . . . 0.0 125.363 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 t -65.69 -57.22 8.57 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 121.066 2.433 . . . . 0.0 111.379 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.46 -0.74 9.73 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 163.63 39.32 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-N 122.72 2.509 . . . . 0.0 111.82 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.416 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.7 t -85.51 112.21 42.67 Favored Pre-proline 0 CA--C 1.582 2.179 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.288 94.6 Cg_exo -31.52 -49.96 0.27 Allowed 'Trans proline' 0 CA--C 1.58 2.794 1 N-CA-C 123.702 4.462 . . . . 0.0 123.702 -174.042 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.63 -15.42 6.09 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 CA-C-N 125.211 2.897 . . . . 0.0 119.311 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -149.35 -6.89 0.35 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.416 ' HB ' ' H ' ' A' ' 117' ' ' SER . 25.9 mt -125.1 130.5 24.16 Favored Pre-proline 0 N--CA 1.507 2.401 0 CA-C-N 122.397 2.362 . . . . 0.0 113.767 -170.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -89.55 161.38 5.37 Favored 'Trans proline' 0 CA--C 1.591 3.356 0 CA-C-N 123.702 2.358 . . . . 0.0 112.116 173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.03 -33.74 95.23 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 N-CA-C 119.888 2.996 . . . . 0.0 119.888 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -97.24 70.25 2.33 Favored 'General case' 0 CA--C 1.583 2.225 0 O-C-N 120.648 -1.283 . . . . 0.0 110.449 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.94 117.4 4.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 119.786 -1.821 . . . . 0.0 110.701 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 m -48.32 142.45 5.56 Favored 'General case' 0 CA--C 1.59 2.506 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.35 149.22 48.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 122.09 2.223 . . . . 0.0 111.194 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.6 m -144.86 146.95 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -142.53 132.32 24.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.714 -0.616 . . . . 0.0 109.83 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.2 tm-20 -95.7 98.28 10.35 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.401 HG13 ' CG ' ' A' ' 132' ' ' GLU . 3.9 t -122.81 162.46 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 -167.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.401 ' CG ' HG13 ' A' ' 131' ' ' VAL 2.899 27.9 mt-10 174.58 167.7 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 120.961 3.689 . . . . 0.0 120.961 162.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.98 130.56 38.51 Favored 'General case' 0 N--CA 1.49 1.554 1 N-CA-C 123.208 4.522 . . . . 0.0 123.208 -153.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.92 -51.05 9.58 Favored 'General case' 0 CA--C 1.581 2.15 0 O-C-N 121.254 -0.904 . . . . 0.0 112.022 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? 176.59 163.28 0.42 Allowed 'General case' 0 CA--C 1.582 2.202 0 C-N-CA 127.676 2.391 . . . . 0.0 106.699 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.57 -82.18 0.22 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.856 -1.778 . . . . 0.0 109.71 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt -79.79 -32.48 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.338 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 121.389 3.315 . . . . 0.0 121.389 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -81.71 130.73 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -171.36 152.05 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.332 0.2 OUTLIER -118.71 58.64 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.779 0 CA-C-O 124.157 1.932 . . . . 0.0 105.959 162.236 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.05 84.27 1.86 Allowed Pre-proline 0 CA--C 1.583 2.215 0 C-N-CA 127.65 2.38 . . . . 0.0 107.449 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.26 32.6 Cg_exo -57.78 -28.35 81.74 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.92 53.83 0.77 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.227 1.411 . . . . 0.0 107.854 175.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.278 2.8 mp0 56.4 38.67 29.91 Favored 'General case' 0 CA--C 1.59 2.504 0 O-C-N 120.324 -1.485 . . . . 0.0 113.839 -171.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -109.66 -55.06 2.48 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.399 1.1 mp0 -74.89 -24.19 58.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 120.771 3.619 . . . . 0.0 120.771 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.08 -46.03 0.71 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 120.519 2.968 . . . . 0.0 120.519 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.83 146.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.272 0 N-CA-C 118.861 2.911 . . . . 0.0 118.861 -173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -113.89 138.61 50.08 Favored 'General case' 0 CA--C 1.596 2.724 0 C-N-CA 127.369 2.268 . . . . 0.0 107.239 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -125.77 125.62 43.24 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 123.638 2.926 . . . . 0.0 109.458 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.86 119.54 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.561 -0.712 . . . . 0.0 109.568 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -90.16 137.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-N 120.067 1.303 . . . . 0.0 111.629 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -123.47 -60.18 1.49 Allowed 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.552 1.141 . . . . 0.0 110.84 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -121.5 109.33 14.7 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -49.77 -38.27 33.38 Favored 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 119.541 3.163 . . . . 0.0 119.541 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.01 176.34 18.69 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 126.27 1.89 . . . . 0.0 115.886 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -151.56 -17.16 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.36 37.34 0.82 Allowed Glycine 0 N--CA 1.499 2.837 1 N-CA-C 123.37 4.108 . . . . 0.0 123.37 -175.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.3 p 65.69 -6.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.82 177.17 9.32 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 p -134.07 172.96 6.4 Favored Pre-proline 0 CA--C 1.59 2.496 0 C-N-CA 126.465 1.906 . . . . 0.0 109.402 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -100.61 -169.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.568 2.188 0 CA-C-N 123.788 2.388 . . . . 0.0 116.814 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -139.56 162.28 35.46 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 111.998 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.58 ' CD1' ' HD2' ' A' ' 90' ' ' ASP 0.262 1.5 tp -61.65 136.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 O-C-N 119.34 -2.1 . . . . 0.0 110.346 177.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.07 11.5 74.8 Favored Glycine 0 CA--C 1.561 2.912 0 N-CA-C 118.157 2.023 . . . . 0.0 118.157 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 158.94 16.83 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 120.866 2.333 . . . . 0.0 111.82 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -82.75 135.56 34.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.227 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -135.05 136.64 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 119.399 1.0 . . . . 0.0 110.603 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -117.54 109.35 16.61 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 120.575 -1.328 . . . . 0.0 107.688 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.47 173.1 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 CA-C-O 124.812 2.244 . . . . 0.0 113.221 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.62 126.88 39.46 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.96 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 143.5 47.91 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 121.624 3.935 . . . . 0.0 121.624 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.8 m -113.11 143.25 44.67 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 164.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.75 157.81 27.49 Favored Glycine 0 CA--C 1.56 2.874 0 CA-C-N 122.103 2.229 . . . . 0.0 116.037 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.44 151.94 36.09 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.283 1.433 . . . . 0.0 114.8 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.66 174.47 9.92 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.072 1.415 . . . . 0.0 109.316 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -30.17 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.89 5.66 1.47 Allowed 'General case' 0 CA--C 1.597 2.775 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 36.25 65.28 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 119.769 -1.832 . . . . 0.0 115.241 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.7 m -107.71 117.32 33.8 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -79.09 89.52 4.82 Favored 'General case' 0 CA--C 1.592 2.573 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.37 -34.59 78.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 118.81 -2.431 . . . . 0.0 115.595 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -143.02 168.33 19.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -141.55 -40.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.768 1 N-CA-C 128.206 6.372 . . . . 0.0 128.206 -170.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.251 3.9 m -141.83 -101.7 0.14 Allowed 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . 0.312 25.5 mt -90.13 -28.1 19.18 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.318 12.3 t70 110.22 -14.45 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 127.433 2.293 . . . . 0.0 115.128 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.457 4.3 mmp_? 87.16 39.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -153.66 -66.21 0.15 Allowed 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.857 1.263 . . . . 0.0 107.625 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -130.84 -169.26 2.13 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 125.491 1.516 . . . . 0.0 108.611 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -74.07 157.26 36.4 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 119.818 -1.801 . . . . 0.0 112.303 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -74.3 116.5 15.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 123.343 2.792 . . . . 0.0 105.477 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -144.3 144.43 31.47 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.652 -1.28 . . . . 0.0 109.861 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -148.76 -169.87 3.47 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.35 1.071 . . . . 0.0 112.862 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -125.41 113.97 18.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 tp -40.14 113.13 0.33 Allowed 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.79 28.97 61.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 119.526 2.57 . . . . 0.0 119.526 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -96.15 13.02 28.72 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 122.173 2.987 . . . . 0.0 117.447 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.71 -44.96 2.54 Favored Glycine 0 N--CA 1.51 3.618 0 O-C-N 120.91 -1.119 . . . . 0.0 111.052 -172.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.271 37.7 tt0 -23.45 -49.42 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 129.709 3.204 . . . . 0.0 119.641 169.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.302 17.1 m -107.97 -129.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 123.205 1.478 . . . . 0.0 108.098 -177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 89' ' ' TRP . 44.8 pt -130.63 163.78 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 124.069 1.89 . . . . 0.0 108.869 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.256 8.0 tmtm? -69.31 -33.04 72.55 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.181 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.12 77.19 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.324 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' H ' HG13 ' A' ' 86' ' ' ILE . 37.2 m0 -72.06 -41.66 67.14 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.527 1.967 . . . . 0.0 112.957 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.58 ' HD2' ' CD1' ' A' ' 48' ' ' ILE . 17.9 t0 -57.9 -42.36 84.52 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 172.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 4.9 mt -64.78 -56.9 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.745 0 CA-C-N 118.841 0.746 . . . . 0.0 112.192 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.75 84.58 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.286 89.7 t -63.61 -34.9 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.343 1.428 . . . . 0.0 112.702 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.24 71.15 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 120.885 1.675 . . . . 0.0 113.051 169.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -79.77 5.23 14.06 Favored 'General case' 0 CA--C 1.592 2.59 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 18.2 mtt -91.58 139.18 30.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.305 -2.122 . . . . 0.0 115.012 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -93.22 159.69 15.17 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.13 130.35 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.95 0 O-C-N 119.122 -2.236 . . . . 0.0 111.055 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.92 -17.77 43.93 Favored Glycine 0 N--CA 1.514 3.898 0 CA-C-N 123.696 2.953 . . . . 0.0 116.857 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 34.4 tt0 -54.93 125.55 20.74 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 tp -103.96 121.69 43.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.125 0.97 . . . . 0.0 108.798 173.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.483 ' SG ' ' HG2' ' A' ' 100' ' ' GLU . 81.0 m -146.67 179.63 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.548 1.166 . . . . 0.0 110.96 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.44 ' NE ' ' HE2' ' A' ' 130' ' ' GLU . 6.5 mtt180 -136.0 127.6 28.87 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 123.815 1.769 . . . . 0.0 109.643 175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.5 134.97 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.658 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 m -130.03 99.8 5.21 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.549 ' SG ' ' CD2' ' A' ' 127' ' ' LEU . 19.9 p -124.25 145.9 49.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -76.15 146.77 78.99 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 112.824 -1.989 . . . . 0.0 112.157 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -47.66 -23.47 3.78 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 N-CA-C 120.34 3.169 . . . . 0.0 120.34 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -63.83 -37.72 88.45 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.556 1.526 . . . . 0.0 115.017 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.14 -1.55 57.98 Favored 'General case' 0 CA--C 1.575 1.929 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.856 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.7 -122.34 0.17 Allowed 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 121.643 2.02 . . . . 0.0 116.264 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.284 3.4 m-85 -83.03 0.57 44.25 Favored 'General case' 0 N--CA 1.517 2.877 0 CA-C-N 121.881 2.128 . . . . 0.0 115.078 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.69 18.97 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 122.571 3.788 . . . . 0.0 122.571 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -67.87 -56.74 7.96 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 119.653 1.726 . . . . 0.0 112.766 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -133.74 -4.11 2.89 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 118.641 2.83 . . . . 0.0 118.641 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.24 155.76 32.02 Favored Glycine 0 CA--C 1.545 1.961 0 CA-C-N 123.693 2.951 . . . . 0.0 111.789 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 t -86.53 128.76 55.64 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 116.879 -1.534 . . . . 0.0 108.814 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -32.99 -45.98 0.29 Allowed 'Trans proline' 0 CA--C 1.58 2.824 1 N-CA-C 124.351 4.712 . . . . 0.0 124.351 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.55 -28.83 9.67 Favored 'Trans proline' 0 CA--C 1.573 2.439 0 CA-C-N 125.783 3.101 . . . . 0.0 119.662 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -163.17 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mt -79.9 146.42 63.94 Favored Pre-proline 0 CA--C 1.595 2.683 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -170.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -102.84 174.51 0.19 Allowed 'Trans proline' 0 CA--C 1.593 3.426 0 CA-C-N 125.119 2.864 . . . . 0.0 114.756 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.34 25.44 0.47 Allowed 'Trans proline' 0 CA--C 1.579 2.765 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -147.89 60.02 1.12 Allowed 'General case' 0 CA--C 1.582 2.209 0 O-C-N 120.103 -1.623 . . . . 0.0 111.706 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.93 120.93 6.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.756 -1.84 . . . . 0.0 109.814 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 96.3 m -68.53 159.22 32.25 Favored 'General case' 0 CA--C 1.584 2.257 0 O-C-N 121.141 -0.974 . . . . 0.0 112.814 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD2' ' SG ' ' A' ' 106' ' ' CYS 0.289 0.0 OUTLIER -141.86 177.53 8.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.23 -2.169 . . . . 0.0 111.372 -177.052 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.3 148.99 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 125.392 1.477 . . . . 0.0 110.942 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.52 124.99 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.726 . . . . 0.0 109.555 172.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HE2' ' NE ' ' A' ' 103' ' ' ARG . 54.2 mt-10 -87.63 118.37 27.07 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.17 141.93 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 121.242 1.837 . . . . 0.0 112.368 -172.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -116.05 110.17 18.53 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.793 0.837 . . . . 0.0 110.378 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 134' ' ' PHE . 2.6 tm? -89.47 141.83 28.21 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 123.701 1.715 . . . . 0.0 111.002 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.404 ' H ' HD23 ' A' ' 133' ' ' LEU . 22.0 m-30 -120.57 -45.44 2.41 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -175.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -158.61 149.88 20.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.082 1.353 . . . . 0.0 109.045 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER -156.54 -90.71 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 O-C-N 121.227 -0.921 . . . . 0.0 111.717 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -79.87 47.15 0.84 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.126 0 N-CA-C 122.979 3.952 . . . . 0.0 122.979 173.567 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.862 0 N-CA-C 120.349 2.9 . . . . 0.0 120.349 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.93 178.07 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 123.59 1.662 . . . . 0.0 112.574 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -157.31 102.26 1.92 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 125.954 1.702 . . . . 0.0 106.418 171.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.389 10.1 tp -104.69 71.34 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 125.135 2.398 . . . . 0.0 115.038 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.9 p -137.61 -43.36 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 115.033 -2.413 . . . . 0.0 114.697 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.94 10.17 0.24 Allowed 'Trans proline' 0 CA--C 1.576 2.602 0 CA-C-N 126.398 3.321 . . . . 0.0 120.265 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.76 -67.3 0.35 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.542 1.137 . . . . 0.0 111.934 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.31 -11.74 58.42 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.332 10.8 t70 63.38 33.23 14.0 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.346 13.6 tp10 -66.46 -33.6 76.06 Favored 'General case' 0 CA--C 1.574 1.903 0 O-C-N 120.083 -1.635 . . . . 0.0 113.821 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 -25.43 4.61 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.07 168.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.658 1.729 . . . . 0.0 112.133 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.81 0.9 OUTLIER -165.15 -168.23 1.36 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 123.67 0.788 . . . . 0.0 112.514 157.585 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.91 130.69 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.285 1.402 . . . . 0.0 113.846 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.15 118.27 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.02 143.24 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.04 0.924 . . . . 0.0 112.78 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -127.43 -66.43 0.88 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.005 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -111.46 90.36 3.31 Favored 'General case' 0 CA--C 1.586 2.338 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -21.7 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.493 1 N-CA-C 123.207 4.521 . . . . 0.0 123.207 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.11 -142.81 8.62 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -142.27 -53.69 0.42 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.2 -51.82 0.14 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 120.973 3.149 . . . . 0.0 120.973 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.401 9.6 t -85.42 46.68 1.32 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.759 2.504 . . . . 0.0 117.759 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.455 24.0 mt-10 70.08 -172.6 0.17 Allowed 'General case' 0 CA--C 1.583 2.224 1 N-CA-C 123.891 4.774 . . . . 0.0 123.891 168.317 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.8 p -92.49 151.94 41.71 Favored Pre-proline 0 CA--C 1.577 2.003 0 C-N-CA 126.91 2.084 . . . . 0.0 115.523 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.26 147.8 88.16 Favored 'Trans proline' 0 CA--C 1.577 2.653 0 C-N-CA 122.599 2.199 . . . . 0.0 117.19 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.01 153.66 20.59 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.993 -1.692 . . . . 0.0 109.858 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.4 OUTLIER -58.58 131.71 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 120.148 -1.595 . . . . 0.0 112.423 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.38 7.14 85.25 Favored Glycine 0 CA--C 1.558 2.769 0 N-CA-C 118.705 2.242 . . . . 0.0 118.705 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -88.22 154.61 20.29 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 121.61 2.705 . . . . 0.0 114.344 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -80.25 139.45 36.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.518 -1.364 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.332 1.4 t -132.51 140.85 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.149 0.98 . . . . 0.0 111.23 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.77 110.97 14.34 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.0 m -120.6 167.22 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 123.443 1.592 . . . . 0.0 114.804 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.88 111.33 12.47 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -113.53 148.67 35.65 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.7 m -120.06 139.73 52.09 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 163.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.48 143.22 10.76 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 119.748 -1.845 . . . . 0.0 115.801 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.01 154.45 50.5 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.308 -1.946 . . . . 0.0 113.765 -175.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.2 tp -79.23 179.52 7.34 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 123.139 1.447 . . . . 0.0 108.639 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.366 0.0 OUTLIER -64.28 -25.61 68.13 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 178.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.97 14.32 2.29 Favored 'General case' 0 CA--C 1.603 3.004 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.33 31.65 70.38 Favored Glycine 0 N--CA 1.514 3.834 0 O-C-N 119.849 -1.782 . . . . 0.0 116.161 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -86.19 111.32 20.28 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -75.35 89.02 2.59 Favored 'General case' 0 CA--C 1.583 2.23 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -72.16 -30.69 65.24 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 119.376 -2.077 . . . . 0.0 114.408 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -151.31 149.6 29.54 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.547 2.118 . . . . 0.0 113.879 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.4 p -160.1 96.8 1.23 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 112.229 -2.26 . . . . 0.0 106.995 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 t -59.16 -36.96 76.22 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -51.92 -36.78 50.23 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.72 -66.27 0.5 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -161.14 70.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -151.61 -79.39 0.11 Allowed 'General case' 0 CA--C 1.564 1.515 0 O-C-N 120.28 -1.512 . . . . 0.0 108.285 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -167.74 -138.28 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.025 1.73 . . . . 0.0 107.982 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -112.64 -165.92 1.03 Allowed 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.636 1.574 . . . . 0.0 108.46 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.333 2.8 t80 -127.65 146.65 50.48 Favored 'General case' 0 CA--C 1.572 1.822 0 O-C-N 119.098 -2.251 . . . . 0.0 110.147 170.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.7 p -160.84 140.5 10.79 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 119.526 -1.984 . . . . 0.0 109.151 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -149.65 -176.9 5.59 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.169 -176.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.53 124.95 42.43 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 119.051 -2.281 . . . . 0.0 105.074 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.53 109.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.46 97.95 Favored Glycine 0 N--CA 1.513 3.781 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -132.21 -73.31 0.52 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 123.73 0.812 . . . . 0.0 112.149 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.13 71.65 0.22 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 104.255 -3.538 . . . . 0.0 104.255 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.43 0.0 OUTLIER -65.05 135.33 55.46 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 108.301 -3.949 . . . . 0.0 118.969 -159.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.359 19.2 m -79.91 -108.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 1 CA-C-N 103.299 -6.319 . . . . 0.0 107.0 -177.303 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 89' ' ' TRP . 25.7 pt -132.06 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 123.645 1.688 . . . . 0.0 107.381 168.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -32.12 73.42 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.386 176.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.91 80.62 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.591 -1.195 . . . . 0.0 112.157 168.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.448 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.3 m0 -73.46 -43.49 60.12 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 120.377 1.444 . . . . 0.0 112.39 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -57.93 -35.66 71.39 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.603 1.547 . . . . 0.0 114.774 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.324 29.0 mt -72.68 -58.12 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-N 118.952 0.796 . . . . 0.0 112.087 175.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.7 81.15 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.48 -44.3 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 120.904 1.684 . . . . 0.0 110.692 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.5 -39.73 35.07 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 121.392 1.905 . . . . 0.0 115.136 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.8 p -91.39 6.9 43.61 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 ttt -86.68 -179.6 6.61 Favored 'General case' 0 CA--C 1.58 2.122 0 O-C-N 119.705 -1.872 . . . . 0.0 113.108 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.51 164.63 21.51 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 118.903 -2.373 . . . . 0.0 113.427 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.1 t -53.79 31.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 N-CA-C 120.13 3.381 . . . . 0.0 120.13 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.75 -18.0 0.09 OUTLIER Glycine 0 N--CA 1.501 2.974 0 O-C-N 116.73 -3.731 . . . . 0.0 113.974 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' OE1' ' SG ' ' A' ' 102' ' ' CYS . 39.0 tt0 -43.89 143.76 1.02 Allowed 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 119.709 3.226 . . . . 0.0 119.709 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.71 123.59 50.66 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.659 1.183 . . . . 0.0 109.83 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.43 ' SG ' ' OE1' ' A' ' 100' ' ' GLU . 3.9 m -144.76 165.73 27.25 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.783 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -120.41 120.7 36.7 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 123.929 1.823 . . . . 0.0 110.26 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.497 HG21 ' SG ' ' A' ' 106' ' ' CYS . 3.9 mt -77.39 141.0 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.043 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.855 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.5 m -129.47 109.62 11.2 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.497 ' SG ' HG21 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -115.95 148.13 40.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -174.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -99.95 146.15 31.4 Favored Pre-proline 0 CA--C 1.579 2.08 0 C-N-CA 124.866 1.266 . . . . 0.0 110.381 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.13 -25.55 4.4 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 N-CA-C 119.738 2.938 . . . . 0.0 119.738 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.58 -38.26 86.89 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -92.54 4.49 53.46 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.848 1.259 . . . . 0.0 114.369 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.67 -104.75 0.3 Allowed 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 119.908 1.231 . . . . 0.0 113.762 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.388 47.2 m-85 -106.5 -3.12 21.23 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.17 -154.72 44.04 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 119.099 2.399 . . . . 0.0 119.099 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.7 m -67.9 -15.51 63.65 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.54 -30.46 11.39 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 118.934 2.938 . . . . 0.0 118.934 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 168.33 44.34 Favored Glycine 0 CA--C 1.552 2.355 0 CA-C-N 121.401 1.91 . . . . 0.0 115.074 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.15 120.4 59.84 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 116.666 -1.635 . . . . 0.0 107.674 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 77.1 Cg_exo -37.91 -41.02 1.12 Allowed 'Trans proline' 0 CA--C 1.58 2.814 1 N-CA-C 123.425 4.356 . . . . 0.0 123.425 -175.959 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.0 -30.84 66.66 Favored 'Trans proline' 0 CA--C 1.574 2.506 0 CA-C-N 125.455 2.984 . . . . 0.0 119.856 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -159.78 -27.78 0.07 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.8 mt -79.91 124.37 83.23 Favored Pre-proline 0 CA--C 1.584 2.271 0 C-N-CA 125.299 1.44 . . . . 0.0 111.983 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -95.58 178.3 0.7 Allowed 'Trans proline' 0 CA--C 1.584 3.007 0 C-N-CA 122.765 2.31 . . . . 0.0 116.07 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -53.13 125.29 17.87 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.655 2.903 . . . . 0.0 117.906 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.8 t30 56.16 62.41 2.37 Favored 'General case' 0 CA--C 1.586 2.36 0 C-N-CA 125.017 1.327 . . . . 0.0 113.935 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.04 123.21 40.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.303 -1.498 . . . . 0.0 112.417 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.5 m -67.29 159.25 29.63 Favored 'General case' 0 CA--C 1.593 2.616 0 O-C-N 121.358 -0.839 . . . . 0.0 113.163 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.7 mt -134.34 164.32 27.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.461 -2.024 . . . . 0.0 115.151 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.8 m -148.52 140.05 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 C-N-CA 124.639 1.176 . . . . 0.0 109.944 174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.53 126.06 15.86 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.466 -1.396 . . . . 0.0 109.418 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -88.12 118.33 27.63 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.15 139.36 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.102 0.954 . . . . 0.0 111.794 -172.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -116.23 124.56 50.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 tp -104.49 110.12 22.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.221 0.534 . . . . 0.0 109.735 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.7 -43.82 25.02 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -171.73 159.62 5.38 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 123.279 1.514 . . . . 0.0 109.558 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.276 8.1 p90 -152.38 -93.76 0.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -106.51 89.33 3.0 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.739 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.376 -176.753 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 N-CA-C 107.29 -2.324 . . . . 0.0 107.29 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -174.77 150.48 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 124.966 1.306 . . . . 0.0 108.757 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.61 126.67 4.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.415 -1.428 . . . . 0.0 108.3 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.376 24.7 mm -111.67 48.44 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-O 122.747 1.26 . . . . 0.0 112.035 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.29 -55.98 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 116.197 -1.858 . . . . 0.0 113.691 173.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.64 -14.42 35.64 Favored 'Trans proline' 0 CA--C 1.576 2.593 0 CA-C-N 125.337 2.942 . . . . 0.0 119.121 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -129.6 -55.03 1.16 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.622 1.569 . . . . 0.0 110.754 178.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -16.6 59.8 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.465 1.9 p30 65.24 25.05 12.27 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 120.106 3.373 . . . . 0.0 120.106 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.436 3.6 mp0 -90.02 -36.41 14.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.45 -32.9 0.64 Allowed Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -177.3 156.31 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 1.099 1.2 mp -155.61 -156.11 0.62 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 158.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.54 ' HG2' ' SG ' ' A' ' 102' ' ' CYS 0.29 1.1 tmmt? -128.86 121.78 28.95 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.252 1.387 . . . . 0.0 113.359 -165.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 t -97.42 96.69 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.602 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.501 0.4 OUTLIER -55.25 132.2 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -173.547 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.89 -71.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.828 -0.545 . . . . 0.0 110.867 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.723 ' NE ' ' HE2' ' A' ' 100' ' ' GLU . 69.0 mtp85 -112.95 96.25 5.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.12 162.54 2.53 Favored 'General case' 0 CA--C 1.591 2.525 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.94 -174.99 50.12 Favored Glycine 0 CA--C 1.55 2.256 0 O-C-N 119.658 -1.901 . . . . 0.0 117.586 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -63.61 -43.22 97.52 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.97 54.19 0.46 Allowed Glycine 0 N--CA 1.48 1.568 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.2 p -136.7 -65.8 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.38 0.672 . . . . 0.0 110.95 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -127.04 163.45 23.72 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.9 p -122.83 142.46 37.91 Favored Pre-proline 0 CA--C 1.58 2.114 0 CA-C-N 110.134 -3.212 . . . . 0.0 109.399 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -60.6 119.82 7.22 Favored 'Trans proline' 0 CA--C 1.581 2.834 0 C-N-CA 123.143 2.562 . . . . 0.0 118.177 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.53 167.48 12.94 Favored 'General case' 0 CA--C 1.571 1.785 0 O-C-N 119.238 -2.164 . . . . 0.0 110.753 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.307 0.3 OUTLIER -59.47 132.09 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 O-C-N 120.132 -1.605 . . . . 0.0 112.187 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.48 2.62 88.91 Favored Glycine 0 CA--C 1.56 2.903 0 N-CA-C 118.558 2.183 . . . . 0.0 118.558 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.71 143.64 44.07 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.391 2.596 . . . . 0.0 113.442 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 107.3 18.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.402 1.5 t -103.43 123.67 57.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 126.762 2.025 . . . . 0.0 111.908 -166.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -111.32 109.93 20.17 Favored 'General case' 0 CA--C 1.573 1.834 0 O-C-N 120.936 -1.102 . . . . 0.0 108.026 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.63 164.48 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.321 11.4 m-70 -121.6 117.53 26.97 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 2.6 p90 -114.05 152.14 31.45 Favored 'General case' 0 CA--C 1.578 2.055 0 CA-C-O 123.369 1.556 . . . . 0.0 114.717 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -130.9 149.58 52.46 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.59 139.64 7.01 Favored Glycine 0 CA--C 1.551 2.331 0 O-C-N 118.735 -2.478 . . . . 0.0 116.681 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -134.93 151.39 50.82 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.292 1.837 . . . . 0.0 115.206 -175.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -95.34 176.17 6.3 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 121.543 -0.723 . . . . 0.0 112.288 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.271 1.8 pt? -62.96 -24.97 68.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.58 -2.9 15.66 Favored 'General case' 0 CA--C 1.595 2.694 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.87 167.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.83 36.84 61.28 Favored Glycine 0 N--CA 1.504 3.186 0 CA-C-N 121.355 1.889 . . . . 0.0 114.043 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -106.14 121.65 44.58 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.487 ' NZ ' ' HG ' ' A' ' 68' ' ' SER . 29.3 ttpp -75.54 89.33 2.71 Favored 'General case' 0 CA--C 1.579 2.086 0 O-C-N 121.9 -0.5 . . . . 0.0 110.482 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -63.63 -31.83 73.11 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 119.568 -1.957 . . . . 0.0 113.767 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -153.35 156.38 38.23 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 124.474 2.083 . . . . 0.0 113.095 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.487 ' HG ' ' NZ ' ' A' ' 65' ' ' LYS . 77.1 p -157.96 96.4 1.47 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.673 -2.058 . . . . 0.0 107.611 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -55.77 -34.34 65.15 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.92 -30.56 66.01 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HD2' ' NE ' ' A' ' 72' ' ' ARG . 3.2 p-10 -42.51 -51.73 4.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.436 ' NE ' ' HD2' ' A' ' 71' ' ' ASP . 17.5 mtm-85 -95.35 27.75 3.19 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.763 1.625 . . . . 0.0 113.644 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.283 31.6 ttpt 71.99 -13.25 0.61 Allowed 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.9 174.91 8.61 Favored 'General case' 0 CA--C 1.575 1.942 0 CA-C-O 123.745 1.736 . . . . 0.0 114.283 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -121.72 171.86 8.56 Favored 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.18 148.06 43.52 Favored 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 122.5 1.143 . . . . 0.0 108.761 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.8 t -169.37 142.97 2.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.15 -2.219 . . . . 0.0 107.398 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -149.83 174.17 12.94 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.533 -177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -108.25 125.67 51.93 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.39 112.04 1.14 Allowed 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.055 -1.028 . . . . 0.0 112.236 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.16 57.04 11.27 Favored Glycine 0 N--CA 1.505 3.291 0 O-C-N 120.512 -1.368 . . . . 0.0 114.761 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.251 1.9 pptp? -106.17 -73.77 0.67 Allowed 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 123.898 1.808 . . . . 0.0 111.461 -175.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -110.33 -52.75 0.59 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 127.203 2.335 . . . . 0.0 108.346 169.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.757 22.9 tt0 116.71 140.65 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 128.209 3.862 . . . . 0.0 115.003 165.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.332 8.6 m -79.92 -108.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 1 CA-C-N 105.296 -5.411 . . . . 0.0 105.04 179.691 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.25 21.0 pt -120.32 154.32 23.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 124.419 2.057 . . . . 0.0 106.541 163.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.272 13.5 tmtt? -66.61 -29.62 69.71 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.337 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.42 77.92 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 117.122 -1.418 . . . . 0.0 111.911 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -73.19 -46.07 52.69 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 121.043 1.747 . . . . 0.0 112.704 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.82 -37.27 73.52 Favored 'General case' 0 CA--C 1.575 1.94 0 CA-C-N 122.018 2.19 . . . . 0.0 114.335 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.288 1.8 mp -69.27 -64.94 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.994 0 CA-C-N 119.731 1.15 . . . . 0.0 111.215 175.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.81 92.52 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' SD ' ' A' ' 96' ' ' MET 0.341 9.6 t -70.13 -33.08 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 120.903 1.683 . . . . 0.0 111.424 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.71 -38.06 66.6 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 121.584 1.993 . . . . 0.0 112.634 165.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 9.75 5.98 Favored 'General case' 0 CA--C 1.598 2.818 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 93' ' ' VAL . 30.3 mtp -87.53 -178.59 6.16 Favored 'General case' 0 N--CA 1.511 2.59 0 CA-C-N 123.315 2.78 . . . . 0.0 116.516 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -135.95 146.8 47.68 Favored 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -175.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -51.66 123.2 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.1 -45.83 1.28 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-O 116.308 -2.384 . . . . 0.0 114.066 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.723 ' HE2' ' NE ' ' A' ' 38' ' ' ARG . 29.7 mt-10 -148.17 -173.86 4.42 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 121.399 2.6 . . . . 0.0 112.975 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.757 0.2 OUTLIER -157.6 -135.68 0.04 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 177.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -160.18 -150.08 0.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -165.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.599 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 47.5 ptt85 -120.92 130.68 53.97 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 124.441 2.067 . . . . 0.0 111.979 169.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 mt -79.6 141.13 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.02 0 CA-C-N 112.912 -1.949 . . . . 0.0 107.935 174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.9 m -129.79 109.84 11.26 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.582 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 2.1 p -132.49 151.79 51.78 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -171.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -87.8 142.19 32.28 Favored Pre-proline 0 CA--C 1.578 2.019 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.778 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 41.7 Cg_exo -54.67 -12.51 4.55 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 N-CA-C 120.304 3.155 . . . . 0.0 120.304 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.46 -40.8 97.78 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 120.925 1.693 . . . . 0.0 113.604 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.22 -3.34 54.88 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 124.652 1.181 . . . . 0.0 113.332 171.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.3 -114.27 0.24 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.11 8.12 45.19 Favored 'General case' 0 N--CA 1.514 2.731 0 CA-C-N 121.024 1.738 . . . . 0.0 114.866 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.82 141.22 43.04 Favored Glycine 0 N--CA 1.497 2.705 0 CA-C-N 123.231 2.741 . . . . 0.0 116.195 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.297 15.4 m 78.39 -54.57 0.48 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.309 1.044 . . . . 0.0 113.423 -174.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.3 -49.44 7.25 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.58 153.16 28.62 Favored Glycine 0 CA--C 1.547 2.035 0 CA-C-N 119.663 1.12 . . . . 0.0 114.379 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 t -82.45 107.21 8.27 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 116.275 -1.822 . . . . 0.0 107.913 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.499 1.0 OUTLIER -4.14 -99.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.588 3.184 1 C-N-CA 125.768 4.312 . . . . 0.0 122.332 -174.6 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -88.78 37.42 0.41 Allowed 'Trans proline' 0 CA--C 1.58 2.824 0 CA-C-N 127.743 3.801 . . . . 0.0 115.95 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -145.29 -30.5 0.42 Allowed 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.7 mt -130.57 137.37 30.66 Favored Pre-proline 0 N--CA 1.504 2.261 0 CA-C-N 121.471 1.941 . . . . 0.0 113.331 -172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.47 -175.59 2.0 Allowed 'Trans proline' 0 CA--C 1.591 3.339 0 CA-C-N 122.916 2.077 . . . . 0.0 112.829 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.59 9.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.58 2.777 0 N-CA-C 122.011 3.812 . . . . 0.0 122.011 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.85 93.4 1.26 Allowed 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 121.442 1.928 . . . . 0.0 110.752 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.38 98.15 4.01 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 122.924 2.602 . . . . 0.0 108.989 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.9 m -60.25 131.77 51.83 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.988 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' CD1' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -140.94 177.56 7.96 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 124.66 2.171 . . . . 0.0 114.612 -168.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 m -148.19 144.95 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 126.704 2.002 . . . . 0.0 108.189 -175.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 0.5 OUTLIER -133.76 124.12 26.07 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 3.8 tm-20 -88.58 97.81 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.23 140.95 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -126.15 119.28 27.11 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 tp -95.94 121.99 38.27 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.6 -46.6 9.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -165.13 157.23 15.46 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 123.855 1.788 . . . . 0.0 108.642 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -152.26 -95.49 0.05 Allowed 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 94.09 3.78 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 3.37 0 CA-C-O 117.63 -1.65 . . . . 0.0 114.561 -173.54 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 121.643 3.417 . . . . 0.0 121.643 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.19 154.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 CA-C-O 122.483 1.135 . . . . 0.0 110.752 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -153.14 141.33 20.48 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 121.588 0.709 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.347 19.4 pt -125.48 78.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 124.842 2.258 . . . . 0.0 110.274 174.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -137.15 -37.7 0.02 OUTLIER Pre-proline 0 CA--C 1.577 1.993 0 CA-C-O 114.431 -2.699 . . . . 0.0 116.496 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.21 93.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.91 0 CA-C-N 126.69 3.425 . . . . 0.0 112.691 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.394 74.3 mmtt 70.39 -12.03 0.55 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -174.48 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -77.92 -23.38 48.66 Favored 'General case' 0 CA--C 1.581 2.168 0 C-N-CA 124.99 1.316 . . . . 0.0 113.589 174.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.469 1.4 p30 64.75 7.05 3.6 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 121.282 3.808 . . . . 0.0 121.282 176.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.55 -9.2 58.54 Favored 'General case' 0 CA--C 1.584 2.267 0 CA-C-N 120.503 1.501 . . . . 0.0 114.894 176.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 -1.14 62.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -179.91 159.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 120.961 2.381 . . . . 0.0 113.755 -171.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.826 2.5 tp -148.23 -169.99 3.48 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.046 160.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 177.1 -175.23 0.13 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 -158.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 36' ' ' ILE 0.955 0.4 OUTLIER 104.28 -166.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.066 1 N-CA-C 126.537 5.754 . . . . 0.0 126.537 161.019 . . . . . . . . 5 4 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' H ' HG12 ' A' ' 35' ' ' VAL 0.392 25.0 mm -25.6 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.324 1 N-CA-C 126.134 5.605 . . . . 0.0 126.134 -167.468 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 -60.45 0.97 Allowed 'General case' 0 CA--C 1.583 2.237 0 CA-C-N 110.642 -2.981 . . . . 0.0 106.649 167.165 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -120.07 109.11 15.08 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -64.79 164.98 11.29 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.39 152.91 24.71 Favored Glycine 0 CA--C 1.548 2.125 0 O-C-N 120.402 -1.437 . . . . 0.0 112.401 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.8 p -121.09 -91.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.93 25.39 0.63 Allowed Glycine 0 N--CA 1.506 3.356 1 N-CA-C 124.184 4.434 . . . . 0.0 124.184 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 53.1 p 83.31 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.644 1.978 . . . . 0.0 109.185 -172.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.343 0.0 OUTLIER -0.8 -120.04 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.907 1 N-CA-C 123.04 4.459 . . . . 0.0 123.04 -177.383 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 15.5 p -107.46 137.49 19.67 Favored Pre-proline 0 CA--C 1.58 2.11 0 C-N-CA 124.735 1.214 . . . . 0.0 112.722 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.257 11.8 Cg_endo -109.48 -18.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.888 0 N-CA-C 115.84 1.438 . . . . 0.0 115.84 167.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.51 31.5 mtt 78.96 -155.22 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 169.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.323 1.0 OUTLIER -43.84 129.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -174.083 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.26 -10.34 71.53 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-O 116.073 -2.515 . . . . 0.0 117.305 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 123.457 3.629 . . . . 0.0 113.886 -177.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.2 tpt85 -86.49 96.09 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 0.0 109.648 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -91.27 133.02 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.583 0.753 . . . . 0.0 111.828 -172.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.71 102.13 10.45 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 102.307 -3.22 . . . . 0.0 102.307 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.97 -178.21 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-O 124.315 2.007 . . . . 0.0 113.789 -171.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.47 119.43 9.35 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.655 171.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -109.69 152.02 26.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.752 1.615 . . . . 0.0 114.128 -178.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.5 m -127.43 131.67 50.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 159.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.9 144.1 15.61 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-O 124.422 2.123 . . . . 0.0 116.124 -177.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -133.6 156.99 46.85 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 111.515 -2.342 . . . . 0.0 112.844 -175.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.05 163.24 13.03 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 121.308 -0.87 . . . . 0.0 109.157 168.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.268 9.1 tt -65.51 -20.92 66.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.124 -1.61 . . . . 0.0 114.937 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.74 -4.63 6.78 Favored 'General case' 0 CA--C 1.608 3.194 0 CA-C-N 119.926 1.239 . . . . 0.0 112.705 165.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.01 40.71 29.39 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.278 -1.514 . . . . 0.0 116.345 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 83.9 m -117.47 122.52 43.96 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.17 100.32 2.05 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -67.7 -38.69 84.01 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.621 -1.924 . . . . 0.0 112.105 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.44 173.28 11.22 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 125.667 2.651 . . . . 0.0 114.614 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.7 t -157.3 -91.53 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.983 1 N-CA-C 97.477 -5.009 . . . . 0.0 97.477 170.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.76 ' C ' ' H ' ' A' ' 71' ' ' ASP . 73.2 m 76.39 102.15 0.07 Allowed 'General case' 0 C--O 1.239 0.534 1 CA-C-O 97.027 -10.987 . . . . 0.0 103.933 171.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.3 mt -49.04 0.98 0.01 OUTLIER 'General case' 0 CA--C 1.598 2.807 3 O-C-N 75.771 -29.33 . . . . 0.0 121.981 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.76 ' H ' ' C ' ' A' ' 69' ' ' SER 0.408 8.2 p-10 57.26 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 121.495 3.887 . . . . 0.0 121.495 176.856 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.446 ' NE ' ' HG ' ' A' ' 77' ' ' SER . 3.1 ptp180 -76.93 28.88 0.13 Allowed 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 -177.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.336 53.9 tttm 80.77 -52.59 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 126.414 1.886 . . . . 0.0 112.422 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.22 -160.32 0.79 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 122.307 1.051 . . . . 0.0 108.468 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -65.11 156.74 30.63 Favored 'General case' 0 CA--C 1.578 2.026 0 O-C-N 120.502 -1.374 . . . . 0.0 113.939 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.278 17.9 t80 -65.71 151.5 46.42 Favored 'General case' 0 CA--C 1.571 1.76 0 CA-C-N 122.43 2.377 . . . . 0.0 108.885 179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.446 ' HG ' ' NE ' ' A' ' 72' ' ' ARG . 54.5 p -160.55 143.1 12.99 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 119.946 -1.721 . . . . 0.0 112.456 -175.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -157.2 -179.85 8.59 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.001 176.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -119.88 125.73 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 172.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.83 108.1 0.8 Allowed 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.05 56.55 6.32 Favored Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.288 -0.883 . . . . 0.0 113.547 -173.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -97.74 -65.4 0.97 Allowed 'General case' 0 N--CA 1.512 2.656 0 CA-C-O 124.933 2.302 . . . . 0.0 113.148 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.39 -49.68 0.15 Allowed Glycine 0 CA--C 1.56 2.895 0 N-CA-C 103.719 -3.752 . . . . 0.0 103.719 172.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.903 1.8 tm-20 119.99 139.43 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 127.226 3.393 . . . . 0.0 115.881 163.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.36 9.2 m -79.94 -105.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 1 CA-C-N 106.782 -4.736 . . . . 0.0 105.247 -178.351 . . . . . . . . 3 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.1 pt -122.5 154.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 124.289 1.995 . . . . 0.0 105.963 165.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.282 2.6 mptt -68.29 -30.67 69.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.15 81.78 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 115.791 -2.052 . . . . 0.0 110.617 167.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -73.11 -45.25 58.12 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 122.698 2.499 . . . . 0.0 112.948 174.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.36 -38.31 71.25 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.289 1.859 . . . . 0.0 114.407 175.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.34 28.4 mt -69.25 -60.97 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 CA-C-N 118.997 0.817 . . . . 0.0 112.249 175.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.8 -31.25 70.98 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 117.723 2.49 . . . . 0.0 117.723 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.408 HG12 ' SD ' ' A' ' 96' ' ' MET 0.303 13.5 t -79.08 -28.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 CA-C-N 119.821 1.191 . . . . 0.0 110.933 176.01 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.45 85.58 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.879 1.672 . . . . 0.0 112.481 166.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.0 p -73.01 0.34 11.63 Favored 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 173.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.408 ' SD ' HG12 ' A' ' 93' ' ' VAL . 9.1 mtt -82.21 126.69 32.37 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 122.888 2.585 . . . . 0.0 115.889 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.86 130.49 36.81 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 173.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.0 t -9.49 80.17 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.541 4.076 0 CA-C-N 120.433 1.469 . . . . 0.0 108.92 -157.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.83 63.38 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 CA-C-N 109.748 -3.387 . . . . 0.0 119.429 -145.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.489 8.0 tp10 -29.63 -86.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 -170.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.267 27.7 tp -130.9 113.28 13.84 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.869 0.867 . . . . 0.0 110.192 169.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.6 m -135.38 170.98 15.1 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.37 1.081 . . . . 0.0 109.653 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 161.59 21.85 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 123.593 1.663 . . . . 0.0 113.989 178.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.2 mt -127.66 133.98 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.028 175.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.8 m -135.24 100.12 4.45 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 177.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.4 p -125.52 148.24 48.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 118.733 2.864 . . . . 0.0 118.733 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -63.8 143.22 98.1 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.807 -1.568 . . . . 0.0 110.612 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.08 -11.8 23.48 Favored 'Trans proline' 0 CA--C 1.578 2.696 0 CA-C-N 125.268 2.917 . . . . 0.0 116.977 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.0 -39.63 95.33 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.187 1.812 . . . . 0.0 112.391 171.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -75.71 3.92 8.83 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 169.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.68 -105.45 0.17 Allowed 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.368 1.44 . . . . 0.0 114.078 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -114.02 13.51 18.21 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 120.014 1.279 . . . . 0.0 114.116 -177.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -57.23 -25.66 54.72 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 121.479 3.352 . . . . 0.0 121.479 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.6 p -67.49 -57.34 6.7 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 119.463 1.632 . . . . 0.0 113.318 175.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.24 -15.15 7.31 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 151.74 20.38 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 122.684 2.493 . . . . 0.0 112.175 -176.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.1 t -75.88 119.34 76.73 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-O 116.158 -1.877 . . . . 0.0 108.172 176.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.295 96.6 Cg_exo -35.59 -47.62 0.92 Allowed 'Trans proline' 0 CA--C 1.579 2.736 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -175.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -89.95 -10.7 3.42 Favored 'Trans proline' 0 CA--C 1.578 2.679 0 CA-C-N 124.789 2.746 . . . . 0.0 118.251 177.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -144.99 -49.91 0.25 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 119.13 3.011 . . . . 0.0 119.13 -174.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 80.2 mt -80.82 139.28 50.18 Favored Pre-proline 0 CA--C 1.594 2.653 0 CA-C-O 116.353 -1.784 . . . . 0.0 114.975 -171.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -97.58 172.42 0.69 Allowed 'Trans proline' 0 CA--C 1.592 3.405 0 CA-C-N 125.754 3.091 . . . . 0.0 114.525 176.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -64.27 2.54 1.11 Allowed 'Trans proline' 0 CA--C 1.576 2.58 0 N-CA-C 120.272 3.143 . . . . 0.0 120.272 175.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -146.37 57.62 1.19 Allowed 'General case' 0 CA--C 1.58 2.105 0 O-C-N 119.754 -1.841 . . . . 0.0 114.237 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.32 114.46 15.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 119.745 -1.847 . . . . 0.0 106.989 173.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.7 m -59.88 130.89 48.99 Favored 'General case' 0 CA--C 1.586 2.359 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.201 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.91 156.41 18.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 122.137 2.244 . . . . 0.0 115.165 -173.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.0 t -143.68 120.23 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-N 112.294 -2.23 . . . . 0.0 107.727 -173.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 4.1 m-85 -140.7 129.92 23.61 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 119.756 -1.84 . . . . 0.0 110.367 174.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.484 ' N ' ' HE2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -94.75 111.99 23.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 172.145 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.46 131.95 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.39 108.54 17.74 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.645 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 tt -98.45 116.34 30.46 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.574 1.178 . . . . 0.0 109.886 -175.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.94 -51.58 7.03 Favored 'General case' 0 CA--C 1.574 1.878 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.73 -177.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 152.87 30.87 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.918 1.287 . . . . 0.0 109.962 175.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -131.65 -75.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.839 -1.163 . . . . 0.0 112.594 176.706 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.291 57.6 tttm -79.79 -57.1 3.82 Favored 'General case' 0 CA--C 1.584 2.281 0 CA-C-O 115.776 -2.059 . . . . 0.0 115.128 -177.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.017 0 CA-C-N 125.083 3.583 . . . . 0.0 119.602 -179.255 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.887 1 N-CA-C 127.638 5.815 . . . . 0.0 127.638 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.473 3.5 t 63.44 -64.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 177.225 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -155.57 157.06 36.19 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 121.749 2.068 . . . . 0.0 115.638 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.581 1.1 pt 137.01 -61.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 C-N-CA 127.247 2.219 . . . . 0.0 116.92 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 1.057 70.0 m 82.74 68.56 0.11 Allowed Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 116.984 -3.572 . . . . 0.0 114.727 -170.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -31.9 -24.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.51 2 N-CA-C 127.59 5.958 . . . . 0.0 127.59 -174.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.296 0.0 OUTLIER -69.18 -61.58 1.73 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 122.033 2.197 . . . . 0.0 111.507 176.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -95.95 -8.35 34.06 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.467 2.0 p30 61.85 7.73 2.14 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 118.432 2.752 . . . . 0.0 118.432 -175.057 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -90.45 -38.59 13.16 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.57 -51.03 6.77 Favored Glycine 0 N--CA 1.483 1.822 1 N-CA-C 125.188 4.835 . . . . 0.0 125.188 -157.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.75 166.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -172.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.759 1.1 tp -159.53 -153.11 0.34 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.437 163.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -157.34 137.29 12.48 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.042 2.201 . . . . 0.0 116.394 -169.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.4 133.37 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.45 -0.781 . . . . 0.0 109.737 174.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.301 1.0 OUTLIER -75.84 133.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 O-C-N 120.522 -1.361 . . . . 0.0 113.602 -177.627 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -114.65 -51.58 2.74 Favored 'General case' 0 CA--C 1.575 1.925 0 C-N-CA 124.606 1.162 . . . . 0.0 112.015 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.09 96.15 2.95 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.522 ' HE2' ' NZ ' ' A' ' 97' ' ' LYS . 3.0 mm-40 -55.62 171.06 0.22 Allowed 'General case' 0 CA--C 1.591 2.539 0 CA-C-N 122.106 2.23 . . . . 0.0 116.444 177.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.26 -172.19 22.65 Favored Glycine 0 CA--C 1.547 2.09 0 O-C-N 120.018 -1.676 . . . . 0.0 116.905 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -166.77 -69.45 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.043 0.937 . . . . 0.0 110.006 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.7 -103.5 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 120.738 3.055 . . . . 0.0 120.738 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.4 p -113.38 49.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.247 1.499 . . . . 0.0 111.693 178.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.443 4.7 pt-20 41.14 -116.85 0.31 Allowed 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 119.598 3.185 . . . . 0.0 119.598 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -150.77 137.08 11.07 Favored Pre-proline 0 CA--C 1.577 2.009 0 C-N-CA 124.925 1.29 . . . . 0.0 113.579 -175.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.251 6.2 Cg_endo -117.19 -26.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.583 2.942 0 C-N-CA 121.782 1.655 . . . . 0.0 115.984 171.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.566 32.3 mtt 82.31 -146.47 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.402 0.3 OUTLIER -47.0 128.94 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -172.647 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.11 90.62 Favored Glycine 0 CA--C 1.56 2.857 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -174.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -79.6 144.69 33.6 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 122.635 3.217 . . . . 0.0 114.914 -178.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -75.64 131.33 39.87 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.252 0.933 . . . . 0.0 109.088 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.362 2.1 t -131.39 132.03 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 124.141 0.976 . . . . 0.0 112.217 -166.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -117.7 107.13 13.81 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 m -116.31 159.23 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.972 1.368 . . . . 0.0 114.296 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -116.32 123.57 47.98 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 116.806 -1.568 . . . . 0.0 109.223 166.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.323 0.1 OUTLIER -119.11 135.38 54.68 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.449 1.477 . . . . 0.0 114.303 176.592 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.4 m -104.18 149.17 25.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 159.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.12 144.21 11.14 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 118.622 -2.548 . . . . 0.0 115.656 178.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -136.26 149.11 48.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 112.452 -1.874 . . . . 0.0 114.866 -173.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.17 165.53 17.33 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 123.249 1.499 . . . . 0.0 107.721 167.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.277 0.0 OUTLIER -60.5 -27.32 67.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 178.277 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -2.17 11.38 Favored 'General case' 0 CA--C 1.595 2.682 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 171.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.21 45.39 7.05 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.448 -1.407 . . . . 0.0 113.594 -176.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -117.65 113.89 22.58 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -176.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -79.9 93.03 5.59 Favored 'General case' 0 CA--C 1.585 2.311 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.794 -178.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -71.24 -30.04 65.85 Favored 'General case' 0 CA--C 1.566 1.579 0 O-C-N 119.085 -2.259 . . . . 0.0 115.403 175.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -146.86 156.34 43.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.825 1.648 . . . . 0.0 113.717 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 t -157.9 87.87 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.2 t -53.98 -42.31 68.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 174.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.403 ' H ' HD11 ' A' ' 70' ' ' LEU . 4.7 mp -64.3 -39.3 93.64 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 127.523 2.329 . . . . 0.0 113.481 178.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.22 -48.45 81.7 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.45 1.5 . . . . 0.0 113.824 173.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -78.59 -23.44 46.01 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 176.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.348 0.1 OUTLIER 115.27 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 128.572 2.749 . . . . 0.0 111.236 -179.275 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -134.43 149.57 50.77 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -175.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.289 19.4 tptm -166.53 -83.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.112 3.745 . . . . 0.0 121.112 173.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.401 0.4 OUTLIER -89.02 146.7 24.69 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 -161.839 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -165.48 129.0 2.23 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 120.701 -1.249 . . . . 0.0 107.957 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -142.06 -165.04 1.92 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 122.36 1.076 . . . . 0.0 110.323 179.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.283 9.5 t0 -135.03 125.75 27.14 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 172.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.0 112.06 0.52 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.8 92.76 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -174.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.306 5.6 mmtt -138.38 -80.16 0.34 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -168.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.94 76.61 0.46 Allowed Glycine 0 N--CA 1.503 3.131 1 N-CA-C 99.686 -5.365 . . . . 0.0 99.686 170.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.383 32.7 tp10 -78.63 157.04 28.77 Favored 'General case' 0 CA--C 1.555 1.172 1 CA-C-O 130.104 4.764 . . . . 0.0 119.5 -159.513 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.335 33.6 m -107.73 -140.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 1 CA-C-N 101.964 -6.926 . . . . 0.0 107.183 -173.288 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 pt -101.08 154.52 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 122.98 1.371 . . . . 0.0 109.452 170.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.517 0.0 OUTLIER -69.94 -21.27 63.28 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 175.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.73 85.78 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 117.692 -1.146 . . . . 0.0 111.366 165.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -73.91 -40.25 63.28 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-N 120.399 1.454 . . . . 0.0 113.073 173.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -57.62 -37.08 72.68 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 119.924 1.238 . . . . 0.0 113.833 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.27 1.5 mp -64.05 -56.83 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 119.431 1.014 . . . . 0.0 110.836 173.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.52 94.48 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 177.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.27 -43.94 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 119.031 0.832 . . . . 0.0 112.519 174.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.07 66.91 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-N 119.695 1.134 . . . . 0.0 113.931 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.0 p -92.29 24.61 3.3 Favored 'General case' 0 CA--C 1.588 2.439 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -122.95 140.07 53.4 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.622 2.01 . . . . 0.0 114.874 178.588 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' NZ ' ' HE2' ' A' ' 39' ' ' GLU . 15.7 pttm -90.4 168.08 12.14 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.403 1.081 . . . . 0.0 111.483 174.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.0 135.83 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.546 0 O-C-N 119.46 -2.025 . . . . 0.0 112.46 -176.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.38 8.8 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-N 124.152 3.16 . . . . 0.0 117.107 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.49 102.74 1.18 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 118.476 1.138 . . . . 0.0 111.999 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.24 131.83 44.25 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.496 1.119 . . . . 0.0 109.062 177.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.0 m -136.8 -169.71 2.53 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.553 1.168 . . . . 0.0 113.422 -176.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.309 3.8 mtt180 -135.91 113.52 10.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 124.942 2.306 . . . . 0.0 108.732 172.548 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -76.97 136.15 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.744 -177.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -117.76 101.7 8.53 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 174.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 5.2 p -115.12 149.33 37.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -171.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -104.96 129.06 25.49 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.675 177.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.53 -16.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.966 0 N-CA-C 122.042 3.824 . . . . 0.0 122.042 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.33 -41.09 92.81 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 121.785 2.084 . . . . 0.0 113.244 169.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -87.08 -0.09 56.1 Favored 'General case' 0 CA--C 1.582 2.189 0 C-N-CA 125.766 1.626 . . . . 0.0 113.656 170.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 -113.35 0.22 Allowed 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -175.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -92.46 13.39 19.77 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 120.672 1.578 . . . . 0.0 113.62 -178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.84 148.48 31.61 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 122.141 2.246 . . . . 0.0 118.084 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.276 8.3 t 73.4 -42.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.299 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.49 -56.45 2.34 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.81 143.53 14.83 Favored Glycine 0 CA--C 1.546 1.992 0 CA-C-N 119.626 1.103 . . . . 0.0 112.028 -175.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.41 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.3 t -78.75 144.76 65.18 Favored Pre-proline 0 CA--C 1.584 2.254 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.62 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -33.06 134.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.071 0 C-N-CA 124.307 3.338 . . . . 0.0 120.603 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.333 0.1 OUTLIER 21.84 46.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.475 2 N-CA-C 125.107 5.003 . . . . 0.0 125.107 -175.563 . . . . . . . . 4 3 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -164.45 -55.94 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.41 ' HB ' ' H ' ' A' ' 117' ' ' SER . 56.9 mt -84.69 136.17 39.63 Favored Pre-proline 0 CA--C 1.592 2.574 0 CA-C-O 116.279 -1.819 . . . . 0.0 112.674 -174.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -99.48 173.9 0.4 Allowed 'Trans proline' 0 CA--C 1.592 3.408 0 CA-C-N 125.943 3.158 . . . . 0.0 115.184 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.42 -18.68 39.97 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 N-CA-C 121.209 3.503 . . . . 0.0 121.209 176.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -140.2 83.12 1.9 Allowed 'General case' 0 CA--C 1.588 2.431 0 CA-C-N 120.448 1.476 . . . . 0.0 111.822 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.85 -153.58 0.56 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 119.453 -2.029 . . . . 0.0 111.081 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.255 65.9 m -139.3 150.87 45.93 Favored 'General case' 0 CA--C 1.591 2.53 0 O-C-N 119.098 -2.251 . . . . 0.0 109.099 173.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 50.9 mt -127.21 162.63 25.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.232 -2.168 . . . . 0.0 112.895 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 79.5 t -146.45 115.46 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.672 -2.058 . . . . 0.0 107.225 -174.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 0.8 OUTLIER -128.91 123.19 31.95 Favored 'General case' 0 N--CA 1.517 2.911 0 CA-C-N 123.13 2.695 . . . . 0.0 111.014 174.25 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.4 tm-20 -92.07 90.9 7.57 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 123.654 1.692 . . . . 0.0 107.467 175.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.47 157.59 41.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -173.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.607 ' HB3' ' SD ' ' A' ' 96' ' ' MET 1.657 16.6 mt-10 -179.06 -174.13 0.32 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.328 168.707 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.546 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 16.2 tp -106.82 145.68 31.83 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 121.111 3.745 . . . . 0.0 121.111 -165.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -92.02 -54.32 3.89 Favored 'General case' 0 CA--C 1.58 2.125 0 CA-C-N 111.887 -2.415 . . . . 0.0 108.572 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -170.58 159.08 6.57 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 126.144 1.778 . . . . 0.0 108.308 171.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.291 0.0 OUTLIER -129.38 -103.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.411 -1.43 . . . . 0.0 110.223 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.447 63.7 tttt -105.76 -96.94 0.34 Allowed 'General case' 0 CA--C 1.581 2.146 0 CA-C-O 116.02 -1.943 . . . . 0.0 110.269 177.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.562 0 CA-C-N 125.167 3.622 . . . . 0.0 116.647 -178.798 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 1 N-CA-C 127.171 5.629 . . . . 0.0 127.171 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 33' ' ' LEU 0.275 8.2 p -156.68 -141.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.607 -174.088 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.605 ' H ' HG22 ' A' ' 32' ' ' VAL 1.157 8.1 mp 130.35 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 129.159 2.984 . . . . 0.0 111.895 171.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -154.83 130.33 9.83 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 122.629 2.468 . . . . 0.0 117.403 -162.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.67 119.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 123.414 0.686 . . . . 0.0 111.143 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.283 0.7 OUTLIER -87.19 135.93 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 122.201 1.0 . . . . 0.0 112.077 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -118.64 -60.65 1.75 Allowed 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.611 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -119.69 94.64 4.47 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.08 164.4 5.15 Favored 'General case' 0 CA--C 1.594 2.643 0 O-C-N 119.385 -2.072 . . . . 0.0 113.912 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.74 170.69 45.98 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 122.357 3.703 . . . . 0.0 122.357 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -99.24 -63.88 1.09 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.547 -1.826 . . . . 0.0 107.123 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.23 102.83 1.74 Allowed Glycine 0 CA--C 1.549 2.175 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 p -51.54 -22.57 3.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.29 153.62 34.24 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 p -115.79 163.52 20.72 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 111.635 -2.529 . . . . 0.0 112.303 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.68 146.16 29.98 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 CA-C-N 123.385 2.245 . . . . 0.0 114.351 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -90.32 164.36 14.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.122 -1.611 . . . . 0.0 110.854 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.3 OUTLIER -61.4 130.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 119.297 -2.127 . . . . 0.0 111.691 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.0 15.22 79.86 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.419 2.128 . . . . 0.0 118.419 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.88 154.02 19.15 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.421 2.11 . . . . 0.0 110.998 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -84.58 124.58 31.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.753 . . . . 0.0 110.208 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.23 132.06 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.008 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.26 93.5 4.72 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 125.168 2.413 . . . . 0.0 104.88 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.04 169.37 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 110.558 -3.019 . . . . 0.0 109.12 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.449 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.335 2.9 t60 -148.49 137.45 21.68 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 159.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -122.71 152.62 40.39 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.107 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.9 m -117.51 150.79 38.37 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 159.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.6 144.97 12.1 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 118.424 -2.672 . . . . 0.0 115.655 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.433 ' HE3' HG12 ' A' ' 128' ' ' VAL . 1.9 m-90 -130.14 153.23 48.73 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 112.648 -1.776 . . . . 0.0 113.746 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.48 168.91 16.04 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 122.975 1.369 . . . . 0.0 107.388 166.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.8 -27.84 66.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -72.42 1.15 8.46 Favored 'General case' 0 CA--C 1.594 2.635 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.5 43.2 12.75 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 120.202 -1.561 . . . . 0.0 113.308 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -114.88 116.24 28.23 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -75.9 87.42 2.87 Favored 'General case' 0 CA--C 1.586 2.338 0 O-C-N 121.966 -0.459 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.91 -28.16 62.31 Favored 'General case' 0 CA--C 1.558 1.26 0 O-C-N 119.46 -2.025 . . . . 0.0 115.432 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -156.07 148.41 23.57 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 t -160.06 113.58 2.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.269 81.1 p -63.13 -38.58 91.75 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.275 65.7 mt -53.2 -42.34 66.17 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 122.318 2.326 . . . . 0.0 115.76 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -49.92 -36.73 28.67 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 -85.79 42.51 0.97 Allowed 'General case' 0 CA--C 1.585 2.313 0 C-N-CA 124.745 1.218 . . . . 0.0 114.251 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.324 34.3 ttmt 83.26 -36.72 0.08 Allowed 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.2 -175.07 4.55 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-O 124.034 1.873 . . . . 0.0 115.469 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.89 178.09 4.48 Favored 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 125.254 1.422 . . . . 0.0 113.033 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.99 164.73 11.87 Favored 'General case' 0 CA--C 1.583 2.246 0 O-C-N 120.431 -1.418 . . . . 0.0 108.9 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.5 p -167.44 133.71 2.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 118.939 -2.35 . . . . 0.0 111.111 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CG ' HG11 ' A' ' 85' ' ' VAL . 23.5 p90 -146.27 -176.3 5.11 Favored 'General case' 0 CA--C 1.573 1.827 0 CA-C-O 122.177 0.989 . . . . 0.0 112.214 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -119.26 114.31 22.19 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -40.89 113.85 0.42 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.4 95.17 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -111.5 21.17 16.46 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.27 -42.12 2.74 Favored Glycine 0 N--CA 1.51 3.586 0 O-C-N 121.147 -0.971 . . . . 0.0 112.484 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -32.81 -37.35 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 120.494 3.516 . . . . 0.0 120.494 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.254 20.6 m -123.95 -142.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 123.116 1.436 . . . . 0.0 109.662 -173.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 89' ' ' TRP . 13.7 pt -113.86 157.14 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 124.298 1.999 . . . . 0.0 108.284 170.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -64.85 -34.09 77.54 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 113.838 -1.528 . . . . 0.0 113.346 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.07 67.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.199 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.488 ' H ' HG13 ' A' ' 86' ' ' ILE . 33.0 m0 -73.17 -43.44 61.45 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 120.226 1.376 . . . . 0.0 112.214 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.83 -38.58 70.23 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 121.237 1.835 . . . . 0.0 114.928 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.319 2.2 mp -69.97 -62.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 CA-C-N 119.741 1.155 . . . . 0.0 111.44 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -66.72 -30.59 70.86 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.284 12.6 t -77.74 -34.45 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 120.036 1.289 . . . . 0.0 110.644 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.39 -38.43 66.16 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 121.224 1.829 . . . . 0.0 112.701 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.8 p -80.88 8.41 8.34 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.504 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 9.3 tpt -100.25 127.76 46.46 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 122.071 2.214 . . . . 0.0 114.814 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -82.08 166.53 19.65 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.41 128.22 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.914 0 O-C-N 120.395 -1.44 . . . . 0.0 109.938 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.49 -0.46 64.43 Favored Glycine 1 N--CA 1.517 4.054 0 CA-C-N 123.201 2.728 . . . . 0.0 117.751 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -73.48 154.5 39.89 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.55 123.39 26.43 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.335 1.054 . . . . 0.0 112.246 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 8.7 p -151.64 174.65 13.22 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -124.86 119.85 30.01 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 124.201 1.953 . . . . 0.0 111.566 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.2 mt -74.24 138.65 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-N 112.495 -2.138 . . . . 0.0 110.76 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -123.12 110.48 15.36 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 102.629 -3.101 . . . . 0.0 102.629 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 2.9 p -115.85 146.38 42.05 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -106.94 135.75 19.53 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.672 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -43.13 -24.59 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.853 1 N-CA-C 122.77 4.104 . . . . 0.0 122.77 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.39 -39.12 92.18 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 121.588 1.995 . . . . 0.0 114.293 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.44 -3.73 58.77 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 125.58 1.552 . . . . 0.0 112.79 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.27 -117.96 0.2 Allowed 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.433 ' CE2' HD21 ' A' ' 127' ' ' LEU 0.287 6.6 m-85 -92.45 16.72 11.24 Favored 'General case' 0 N--CA 1.513 2.692 0 CA-C-N 121.005 1.73 . . . . 0.0 114.334 -178.084 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.65 -63.23 4.61 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 123.008 2.64 . . . . 0.0 117.373 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -79.46 42.62 0.52 Allowed 'General case' 0 CA--C 1.584 2.264 0 CA-C-N 118.92 1.36 . . . . 0.0 114.236 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -171.77 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.99 136.88 6.45 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.22 0.914 . . . . 0.0 110.89 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.448 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.7 t -78.45 118.91 75.12 Favored Pre-proline 0 CA--C 1.581 2.157 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.241 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.272 42.4 Cg_exo -27.37 -51.15 0.11 Allowed 'Trans proline' 0 CA--C 1.579 2.761 1 N-CA-C 124.682 4.839 . . . . 0.0 124.682 -175.684 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.57 -30.14 12.44 Favored 'Trans proline' 0 CA--C 1.572 2.42 0 CA-C-N 125.607 3.038 . . . . 0.0 119.548 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -163.93 -8.95 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 117' ' ' SER . 19.6 mt -79.93 123.7 83.54 Favored Pre-proline 0 CA--C 1.583 2.248 0 O-C-N 119.631 -1.918 . . . . 0.0 113.299 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.76 171.09 7.23 Favored 'Trans proline' 0 CA--C 1.585 3.067 0 C-N-CA 122.547 2.165 . . . . 0.0 113.441 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.65 12.87 0.23 Allowed 'Trans proline' 0 CA--C 1.58 2.804 0 N-CA-C 120.536 3.245 . . . . 0.0 120.536 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -153.95 67.7 0.75 Allowed 'General case' 0 CA--C 1.582 2.211 0 O-C-N 119.974 -1.704 . . . . 0.0 111.644 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.16 133.89 33.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 119.797 -1.815 . . . . 0.0 110.529 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.291 23.3 m -66.05 152.05 45.51 Favored 'General case' 0 CA--C 1.594 2.639 0 O-C-N 120.703 -1.248 . . . . 0.0 112.447 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.602 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 11.8 tp -132.44 158.27 42.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 119.541 -1.974 . . . . 0.0 111.892 -170.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.433 HG12 ' HE3' ' A' ' 59' ' ' TRP . 53.9 t -143.69 124.59 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.862 -169.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.303 15.3 m-85 -136.46 124.44 22.8 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 122.286 2.312 . . . . 0.0 112.16 173.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -93.49 113.14 25.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.481 -2.012 . . . . 0.0 107.999 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.7 t -112.34 136.25 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.886 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -119.51 114.97 23.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.28 119.95 38.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.578 1.18 . . . . 0.0 109.498 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -79.73 -56.92 3.93 Favored 'General case' 0 CA--C 1.582 2.184 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.307 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -169.89 161.65 9.04 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 126.031 1.733 . . . . 0.0 109.72 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.434 ' HD1' ' H ' ' A' ' 137' ' ' LYS . 1.4 p90 -138.05 -84.89 0.29 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.784 -1.822 . . . . 0.0 110.862 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.434 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 40.0 ttpt -79.83 74.36 6.56 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 125.511 2.577 . . . . 0.0 108.308 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.567 3.299 0 CA-C-N 110.909 -2.86 . . . . 0.0 111.855 -173.778 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 1 N-CA-C 123.815 4.286 . . . . 0.0 123.815 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.324 38.2 t -139.51 133.2 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 1 CA-C-N 124.419 4.109 . . . . 0.0 116.517 -174.038 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.33 134.12 54.05 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 125.912 1.685 . . . . 0.0 109.253 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -129.24 133.09 47.36 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 124.12 3.145 . . . . 0.0 111.453 176.262 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 77.9 t -105.1 153.18 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.71 142.38 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.915 0 CA-C-O 122.771 1.272 . . . . 0.0 108.97 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 102' ' ' CYS . 55.6 tptt -114.32 -57.89 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.692 172.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -122.29 112.24 17.89 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.51 -62.9 1.45 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.455 -1.403 . . . . 0.0 114.241 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.1 -155.83 26.43 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 119.364 2.505 . . . . 0.0 119.364 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -91.12 -54.57 3.89 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 114.337 -0.931 . . . . 0.0 113.319 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -39.0 62.15 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.261 73.0 p 74.62 3.25 4.23 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -106.92 167.24 10.02 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 120.772 -1.205 . . . . 0.0 113.001 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.2 p -132.94 108.33 12.75 Favored Pre-proline 0 CA--C 1.577 1.982 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.59 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.353 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.6 ptm -170.83 175.47 4.48 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 120.868 1.667 . . . . 0.0 114.344 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -55.8 132.8 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 CA-C-O 122.334 1.064 . . . . 0.0 111.44 176.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.33 0.3 70.58 Favored Glycine 0 CA--C 1.563 3.079 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.08 137.88 49.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 121.437 2.618 . . . . 0.0 113.585 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -86.65 104.8 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 136' ' ' PHE . 1.5 m -105.39 131.08 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.074 0.95 . . . . 0.0 110.667 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.255 29.1 p90 -105.23 115.54 30.43 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 105.653 -1.981 . . . . 0.0 105.653 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.28 170.08 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 CA-C-O 125.04 2.352 . . . . 0.0 114.103 -170.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 70' ' ' LEU . 2.3 t60 -124.43 119.32 28.84 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 111.58 -2.555 . . . . 0.0 106.358 168.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.333 3.3 p90 -114.72 150.85 34.65 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 123.977 1.846 . . . . 0.0 113.626 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -127.63 151.71 48.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.53 138.38 6.03 Favored Glycine 0 CA--C 1.546 2.001 0 O-C-N 118.742 -2.474 . . . . 0.0 115.944 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.19 150.71 49.4 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 127.323 2.249 . . . . 0.0 112.25 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.5 tp -84.22 -172.75 4.34 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-O 123.984 1.849 . . . . 0.0 109.641 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -58.35 -37.39 75.09 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.19 21.61 0.89 Allowed 'General case' 0 CA--C 1.597 2.756 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.97 33.48 50.61 Favored Glycine 1 N--CA 1.517 4.054 0 O-C-N 120.179 -1.576 . . . . 0.0 115.798 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.7 m -86.72 109.24 19.08 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -69.04 92.36 0.52 Allowed 'General case' 0 CA--C 1.588 2.437 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -73.08 -36.08 66.75 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 119.296 -2.127 . . . . 0.0 114.598 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.65 174.95 12.57 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 123.834 1.778 . . . . 0.0 114.442 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 t -152.42 -147.15 0.22 Allowed 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 51.6 p -148.73 -66.56 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.056 -1.653 . . . . 0.0 108.701 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 55' ' ' HIS 0.317 22.3 mt -61.38 -42.35 98.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -49.99 -42.34 48.84 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.339 32.5 ptt180 -75.57 -75.38 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.545 1.138 . . . . 0.0 113.535 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -163.62 -36.7 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.925 1.29 . . . . 0.0 112.172 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -89.28 -157.15 0.43 Allowed 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -145.62 170.71 15.91 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 125.943 1.697 . . . . 0.0 108.498 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.285 3.7 t80 -114.05 154.68 27.28 Favored 'General case' 0 CA--C 1.573 1.856 0 CA-C-O 123.772 1.749 . . . . 0.0 109.125 173.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.2 p -170.9 124.08 0.63 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.802 -1.186 . . . . 0.0 108.171 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.2 p90 -143.22 164.44 30.18 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 121.813 -0.555 . . . . 0.0 111.913 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.97 128.2 49.89 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 119.168 -2.208 . . . . 0.0 106.125 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.57 110.94 1.08 Allowed 'General case' 0 CA--C 1.57 1.733 0 O-C-N 121.27 -0.894 . . . . 0.0 112.77 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 54.76 30.65 Favored Glycine 0 N--CA 1.509 3.542 0 O-C-N 120.65 -1.281 . . . . 0.0 114.606 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.637 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -99.15 -71.95 0.68 Allowed 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 124.366 2.031 . . . . 0.0 112.182 -174.456 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.637 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -111.23 -49.98 0.64 Allowed Glycine 0 CA--C 1.561 2.914 0 N-CA-C 104.024 -3.63 . . . . 0.0 104.024 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.778 23.8 tt0 118.89 137.78 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 127.909 3.719 . . . . 0.0 114.634 164.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.478 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.348 11.9 m -79.97 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 1 CA-C-N 105.773 -5.194 . . . . 0.0 104.454 178.25 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.554 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -132.79 157.39 43.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 124.017 1.865 . . . . 0.0 106.8 166.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -65.01 -33.11 75.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.519 -1.219 . . . . 0.0 113.123 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.26 80.49 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 117.25 -1.357 . . . . 0.0 111.938 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.554 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.0 m0 -73.94 -43.31 58.71 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.685 1.584 . . . . 0.0 112.215 172.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.41 -34.58 72.64 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 121.548 1.976 . . . . 0.0 114.267 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.303 1.5 mp -69.99 -63.25 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.004 0 CA-C-N 120.317 1.417 . . . . 0.0 111.294 174.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.16 -33.14 75.1 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.345 3.5 t -78.35 -25.92 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 CA-C-N 119.764 1.166 . . . . 0.0 111.584 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.23 90.05 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-N 121.238 1.835 . . . . 0.0 111.856 165.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.6 p -82.58 17.57 1.75 Allowed 'General case' 0 CA--C 1.596 2.718 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.536 ' SD ' HD22 ' A' ' 101' ' ' LEU . 2.2 ttt -104.68 143.31 33.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 119.26 -2.15 . . . . 0.0 116.068 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -104.13 152.95 21.5 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 119.039 2.977 . . . . 0.0 119.039 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.88 124.92 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.408 0 CA-C-O 118.478 -0.773 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.9 -55.4 0.53 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 120.683 1.583 . . . . 0.0 112.809 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.305 5.5 tt0 -158.41 -163.59 1.31 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 102' ' ' CYS 0.782 0.5 OUTLIER -162.66 -139.92 0.05 OUTLIER 'General case' 0 CA--C 1.594 2.667 0 C-N-CA 125.091 1.357 . . . . 0.0 111.622 178.414 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.614 ' H ' HD23 ' A' ' 101' ' ' LEU 0.72 51.3 t -160.03 -115.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 127.162 2.185 . . . . 0.0 107.916 175.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 54.8 ptt85 -135.32 135.15 40.55 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -173.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -89.84 132.07 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 CA-C-N 112.66 -2.063 . . . . 0.0 108.241 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.2 m -121.0 105.99 11.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 15.6 p -124.08 149.6 45.97 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -170.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -81.45 135.98 49.51 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.521 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.265 50.5 Cg_exo -57.7 -17.2 28.0 Favored 'Trans proline' 0 CA--C 1.559 1.756 0 N-CA-C 118.882 2.608 . . . . 0.0 118.882 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.62 -33.94 76.02 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 121.692 2.042 . . . . 0.0 113.907 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.57 -2.87 51.62 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 125.734 1.614 . . . . 0.0 113.462 169.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.51 -113.97 0.22 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 121.499 1.954 . . . . 0.0 113.013 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 127' ' ' LEU 0.308 2.7 m-85 -79.04 -37.55 38.74 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 121.188 1.813 . . . . 0.0 113.12 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.22 -116.15 3.29 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 121.222 3.249 . . . . 0.0 121.222 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -77.85 -31.99 51.83 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.36 -33.76 63.18 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.12 155.99 9.75 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 t -98.9 111.09 59.82 Favored Pre-proline 0 CA--C 1.58 2.117 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.285 47.6 Cg_exo -31.26 -52.0 0.27 Allowed 'Trans proline' 0 CA--C 1.581 2.843 1 N-CA-C 124.19 4.65 . . . . 0.0 124.19 -175.36 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.71 -18.54 32.46 Favored 'Trans proline' 0 CA--C 1.577 2.629 0 N-CA-C 120.494 3.229 . . . . 0.0 120.494 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -160.2 -18.81 0.06 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . 0.289 10.7 mt -79.93 -59.01 0.58 Allowed Pre-proline 0 CA--C 1.605 3.088 1 N-CA-C 124.437 4.977 . . . . 0.0 124.437 -172.262 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . 0.89 0.1 OUTLIER 34.09 -115.29 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.486 2 C-N-CA 126.843 5.029 . . . . 0.0 123.57 -172.325 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.12 99.66 1.32 Allowed 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 125.886 3.138 . . . . 0.0 118.601 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 t30 52.46 70.69 0.54 Allowed 'General case' 0 CA--C 1.593 2.629 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.55 114.52 28.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.618 -1.926 . . . . 0.0 108.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.4 m -54.0 151.52 6.71 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 72.5 mt -126.77 164.53 21.14 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 124.566 2.127 . . . . 0.0 113.791 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -144.31 113.55 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.601 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 5.7 m-85 -127.07 125.57 41.54 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 122.227 2.285 . . . . 0.0 110.839 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -93.68 96.03 9.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.362 -1.461 . . . . 0.0 108.296 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.3 138.98 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -132.18 118.44 19.56 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 96' ' ' MET . 6.9 tt -90.83 114.08 26.4 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.814 -1.179 . . . . 0.0 113.877 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.31 9.8 m-30 -76.59 -51.42 11.65 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.571 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -163.74 146.85 9.9 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 121.702 2.046 . . . . 0.0 108.353 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.526 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.267 0.1 OUTLIER -100.88 -80.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 170.188 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.526 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 14.1 mmtm -80.0 -37.03 35.07 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 177.333 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 1 N-CA-C 123.676 4.231 . . . . 0.0 123.676 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 106' ' ' CYS . 10.8 p -174.93 -173.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.194 0 CA-C-O 123.687 1.708 . . . . 0.0 110.681 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.91 2.2 mm? 178.94 165.9 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.71 2.004 . . . . 0.0 113.674 160.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 125.83 53.7 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 11.2 p -114.37 109.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 O-C-N 121.43 -0.793 . . . . 0.0 112.653 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.389 8.2 mm -48.31 133.87 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 N-CA-C 119.712 3.227 . . . . 0.0 119.712 -175.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -115.73 -59.8 1.95 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.201 -1.818 . . . . 0.0 108.867 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -143.49 103.74 4.14 Favored 'General case' 0 CA--C 1.585 2.322 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -53.26 -61.35 2.36 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 119.878 3.288 . . . . 0.0 119.878 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.74 177.42 16.23 Favored Glycine 0 CA--C 1.55 2.281 0 C-N-CA 125.22 1.391 . . . . 0.0 114.635 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 t -162.07 -12.62 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.01 -68.92 1.44 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 122.279 3.672 . . . . 0.0 122.279 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -158.83 66.83 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.768 0.794 . . . . 0.0 112.388 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.391 10.4 mt-10 60.42 -160.33 0.3 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 120.327 3.455 . . . . 0.0 120.327 174.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -97.04 170.86 6.7 Favored Pre-proline 0 CA--C 1.585 2.324 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -99.46 -166.15 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.512 0 CA-C-N 123.073 2.133 . . . . 0.0 117.149 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -130.15 169.71 14.99 Favored 'General case' 0 CA--C 1.573 1.837 0 O-C-N 121.282 -0.887 . . . . 0.0 112.999 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.95 139.18 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.166 0 O-C-N 119.211 -2.181 . . . . 0.0 109.352 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 7.01 86.89 Favored Glycine 0 CA--C 1.567 3.293 0 CA-C-O 117.497 -1.724 . . . . 0.0 117.335 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.43 146.85 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 121.531 2.665 . . . . 0.0 113.501 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -85.68 119.96 26.59 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.37 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 123.192 0.597 . . . . 0.0 111.332 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -114.5 111.99 22.27 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 76' ' ' PHE . 22.9 m -116.16 162.3 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 124.087 1.899 . . . . 0.0 114.669 -173.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.445 ' ND1' HD23 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -114.9 108.03 16.19 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.543 168.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 2.2 p90 -110.51 147.62 33.75 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 123.31 1.528 . . . . 0.0 114.747 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.8 m -131.19 144.5 51.4 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 165.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.88 144.85 12.68 Favored Glycine 0 CA--C 1.551 2.295 0 O-C-N 119.769 -1.832 . . . . 0.0 116.528 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.467 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -132.31 149.8 52.29 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.007 1.723 . . . . 0.0 114.398 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.97 169.55 18.13 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.369 1.081 . . . . 0.0 108.521 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.346 0.0 OUTLIER -61.59 -25.45 67.34 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.81 3.46 11.84 Favored 'General case' 0 CA--C 1.594 2.651 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.54 11.59 Favored Glycine 0 N--CA 1.507 3.387 0 CA-C-N 121.101 1.773 . . . . 0.0 114.343 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.9 m -115.52 115.53 26.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -78.2 96.74 5.29 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -70.09 -32.03 69.89 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.682 -1.886 . . . . 0.0 113.87 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.22 159.92 40.46 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 124.189 1.947 . . . . 0.0 115.669 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.7 t -158.82 98.75 1.51 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.6 p -54.36 -49.85 68.85 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.445 HD23 ' ND1' ' A' ' 55' ' ' HIS 0.428 0.2 OUTLIER -66.49 -44.17 83.35 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -177.839 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.38 -40.2 61.78 Favored 'General case' 0 CA--C 1.583 2.215 0 C-N-CA 124.423 1.089 . . . . 0.0 113.852 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.1 mtp85 -68.86 -14.81 63.26 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.384 0.6 OUTLIER 118.52 -41.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 129.005 2.922 . . . . 0.0 114.11 177.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.92 155.53 20.88 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -88.6 135.33 33.55 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 117.258 -1.353 . . . . 0.0 109.276 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HB3' HG23 ' A' ' 54' ' ' VAL . 6.9 t80 -83.11 151.23 25.84 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 122.872 2.578 . . . . 0.0 108.922 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.0 t -168.03 145.92 4.36 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 123.9 1.81 . . . . 0.0 108.429 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.5 p90 -152.46 179.28 8.71 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.007 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -116.26 121.99 43.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.72 109.59 0.24 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.83 37.77 60.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.383 13.9 tppt? -91.03 -8.85 47.92 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-N 120.993 2.397 . . . . 0.0 117.211 -174.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.29 65.75 1.41 Allowed Glycine 0 N--CA 1.504 3.183 0 N-CA-C 103.969 -3.652 . . . . 0.0 103.969 -169.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -156.91 -57.35 0.09 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.958 -1.121 . . . . 0.0 113.208 -164.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.524 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.281 13.9 m -98.99 -139.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 122.998 1.38 . . . . 0.0 109.462 -175.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 89' ' ' TRP . 15.9 pt -120.67 163.69 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 123.66 1.695 . . . . 0.0 110.317 173.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.263 2.2 mptt -67.8 -34.68 77.23 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.426 -1.261 . . . . 0.0 113.237 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.12 -32.42 69.82 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 117.313 -1.327 . . . . 0.0 112.607 167.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.4 ' H ' HG13 ' A' ' 86' ' ' ILE . 29.5 m0 -76.89 -42.66 38.89 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 120.955 1.707 . . . . 0.0 112.613 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -59.7 -37.1 77.92 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 120.313 1.415 . . . . 0.0 114.586 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.282 1.4 mp -66.76 -58.35 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-N 119.749 1.159 . . . . 0.0 110.801 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.36 87.94 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.413 HG22 ' SD ' ' A' ' 96' ' ' MET 0.289 92.9 t -67.22 -37.7 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.349 0.977 . . . . 0.0 112.221 172.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.75 -39.05 61.82 Favored 'General case' 0 CA--C 1.588 2.416 0 CA-C-N 121.302 1.864 . . . . 0.0 112.444 168.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.7 p -94.96 42.28 1.09 Allowed 'General case' 0 CA--C 1.597 2.769 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 133' ' ' LEU . 12.4 ttm -112.12 142.59 44.39 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 119.102 -2.249 . . . . 0.0 115.248 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -109.48 139.49 44.41 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 120.13 1.332 . . . . 0.0 113.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.7 131.55 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.399 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.393 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.46 -56.02 0.5 Allowed Glycine 0 N--CA 1.492 2.408 0 CA-C-O 117.107 -1.941 . . . . 0.0 111.329 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -150.45 -162.12 1.49 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-N 118.946 1.373 . . . . 0.0 113.737 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.469 HD13 ' HG3' ' A' ' 96' ' ' MET 0.799 0.6 OUTLIER -154.4 -126.94 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 CA-C-O 124.855 2.264 . . . . 0.0 114.026 176.159 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.5 OUTLIER -158.52 -147.78 0.18 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 124.357 2.027 . . . . 0.0 110.936 -164.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.502 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -131.76 138.56 48.64 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 124.644 2.164 . . . . 0.0 109.353 170.715 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.65 134.82 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 112.612 -2.085 . . . . 0.0 108.764 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.9 m -121.27 109.46 14.96 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.535 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 4.7 p -127.03 144.27 51.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -86.07 146.02 41.99 Favored Pre-proline 0 CA--C 1.574 1.902 0 CA-C-N 112.773 -2.012 . . . . 0.0 110.996 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -46.93 -26.21 4.61 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 N-CA-C 119.713 2.928 . . . . 0.0 119.713 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.57 -43.51 89.45 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.774 1.624 . . . . 0.0 114.437 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.86 -1.53 56.62 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.84 -118.35 0.23 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 120.719 1.599 . . . . 0.0 113.931 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.475 16.7 m-85 -83.8 -13.09 54.63 Favored 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 121.86 2.118 . . . . 0.0 115.595 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.82 -153.86 49.64 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.213 3.245 . . . . 0.0 121.213 171.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.8 t -85.26 62.38 7.46 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.995 1.379 . . . . 0.0 110.85 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.19 -54.69 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 126.301 1.84 . . . . 0.0 111.638 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.01 163.88 24.87 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 122.447 1.026 . . . . 0.0 113.796 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.518 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 19.7 t -72.98 143.57 84.22 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 116.827 -1.558 . . . . 0.0 110.862 176.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -49.68 126.82 17.19 Favored 'Trans proline' 0 CA--C 1.581 2.865 0 C-N-CA 122.923 2.415 . . . . 0.0 113.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.322 0.2 OUTLIER 28.58 47.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.575 2.536 0 N-CA-C 121.946 3.787 . . . . 0.0 121.946 -172.156 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -154.79 -47.66 0.09 Allowed 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' HB ' ' H ' ' A' ' 117' ' ' SER . 18.1 mt -104.51 150.14 38.18 Favored Pre-proline 0 N--CA 1.512 2.636 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.002 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.66 173.3 8.12 Favored 'Trans proline' 0 CA--C 1.588 3.189 0 CA-C-N 126.412 3.326 . . . . 0.0 116.015 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.18 -21.48 22.49 Favored 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 121.751 3.712 . . . . 0.0 121.751 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -158.71 92.8 1.14 Allowed 'General case' 0 CA--C 1.584 2.283 0 CA-C-N 120.852 1.66 . . . . 0.0 107.651 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.59 133.43 22.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 122.985 2.629 . . . . 0.0 112.916 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 84.7 m -66.56 150.61 48.73 Favored 'General case' 0 CA--C 1.586 2.328 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.535 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.25 0.3 OUTLIER -145.11 175.84 9.95 Favored 'General case' 0 CA--C 1.573 1.843 0 O-C-N 119.643 -1.91 . . . . 0.0 111.196 -177.703 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.467 HG23 ' HE3' ' A' ' 59' ' ' TRP . 1.9 m -145.42 146.52 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 125.805 1.642 . . . . 0.0 109.729 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.251 1.7 m-85 -135.96 125.28 24.8 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.481 -0.762 . . . . 0.0 109.745 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 55.6 mt-10 -83.42 114.0 21.15 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.37 136.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -132.41 120.67 22.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.542 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.7 OUTLIER -86.34 123.84 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.367 -1.458 . . . . 0.0 114.616 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.25 -49.48 49.5 Favored 'General case' 0 CA--C 1.587 2.383 0 O-C-N 121.701 -0.624 . . . . 0.0 112.526 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -171.29 155.73 4.38 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.74 1.616 . . . . 0.0 110.385 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.511 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.286 0.2 OUTLIER -126.6 -106.26 0.32 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.567 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.511 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 85.9 tttt -83.46 72.47 10.25 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.508 1.123 . . . . 0.0 110.904 173.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 178.45 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.11 133.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 118.291 1.045 . . . . 0.0 113.691 -173.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -109.96 141.95 42.01 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 127.119 2.168 . . . . 0.0 107.893 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB3' HG13 ' A' ' 35' ' ' VAL . 3.1 mtmp? -159.58 170.75 20.96 Favored 'General case' 0 N--CA 1.51 2.547 2 CA-C-N 126.276 4.125 . . . . 0.0 122.123 -170.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.615 ' O ' ' SG ' ' A' ' 102' ' ' CYS 1.237 3.7 m 106.0 -173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.672 1 N-CA-C 127.785 6.217 . . . . 0.0 127.785 158.351 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.701 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.643 34.3 mm -16.41 128.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.342 2 N-CA-C 131.351 7.538 . . . . 0.0 131.351 -153.931 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -142.63 -49.17 0.35 Allowed 'General case' 0 CA--C 1.584 2.257 0 C-N-CA 127.33 2.252 . . . . 0.0 109.537 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -114.77 101.93 9.52 Favored 'General case' 0 CA--C 1.578 2.033 0 C-N-CA 124.922 1.289 . . . . 0.0 108.693 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.28 174.84 0.63 Allowed 'General case' 0 CA--C 1.597 2.762 0 O-C-N 119.469 -2.019 . . . . 0.0 115.579 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.43 8.26 Favored Glycine 0 N--CA 1.486 2.017 0 O-C-N 119.856 -1.777 . . . . 0.0 116.461 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.5 p -107.37 -76.66 0.61 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.6 70.51 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.267 10.2 t -157.6 61.56 0.48 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.362 1.077 . . . . 0.0 113.179 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.264 30.3 mt-10 59.75 168.69 0.07 Allowed 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 120.855 3.65 . . . . 0.0 120.855 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 p -90.07 165.4 24.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.275 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.43 159.61 17.14 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 CA-C-N 121.919 1.721 . . . . 0.0 114.732 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -98.33 165.54 11.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.345 0.3 OUTLIER -63.73 130.24 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 119.219 -2.176 . . . . 0.0 110.574 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.17 17.61 79.88 Favored Glycine 0 CA--C 1.569 3.431 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.02 147.29 43.06 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.575 1.688 . . . . 0.0 112.256 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -81.83 114.64 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.46 146.14 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.661 0.784 . . . . 0.0 111.307 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.25 46.3 p90 -129.85 98.68 4.86 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 124.86 2.267 . . . . 0.0 111.712 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.1 m -90.81 170.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 111.562 -2.563 . . . . 0.0 112.259 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.446 ' CE1' ' HG ' ' A' ' 70' ' ' LEU . 5.1 t60 -134.55 135.82 42.58 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 164.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 6.7 p90 -128.8 142.3 51.03 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.1 m -110.96 144.91 39.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 159.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.34 140.44 7.99 Favored Glycine 0 CA--C 1.548 2.112 0 O-C-N 118.92 -2.363 . . . . 0.0 116.776 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 155.97 47.25 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.675 2.39 . . . . 0.0 112.569 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.49 -174.5 4.84 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 120.475 -1.391 . . . . 0.0 111.044 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 1.9 pt? -64.83 -26.12 68.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.68 1.98 13.18 Favored 'General case' 0 CA--C 1.601 2.93 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.417 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.22 31.82 81.86 Favored Glycine 0 N--CA 1.501 2.996 0 O-C-N 120.477 -1.389 . . . . 0.0 114.821 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -90.25 114.6 26.66 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.4 95.02 1.0 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -70.45 -31.3 68.4 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 119.519 -1.988 . . . . 0.0 114.212 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -154.23 161.18 41.99 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.839 2.257 . . . . 0.0 114.179 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.0 p -151.05 96.92 2.39 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -28.09 27.93 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 120.723 3.601 . . . . 0.0 120.723 -172.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.263 36.5 mt -70.48 -51.72 27.05 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.947 1.703 . . . . 0.0 112.062 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.18 -30.24 70.29 Favored 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -54.01 -19.92 5.52 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.35 39.0 ttmt 127.36 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 129.387 3.075 . . . . 0.0 111.952 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.3 2.7 p-10 -104.61 -142.8 0.37 Allowed 'General case' 0 CA--C 1.575 1.934 0 CA-C-O 123.076 1.417 . . . . 0.0 111.953 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -124.78 -136.5 0.28 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.528 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.404 3.1 t80 -140.25 142.58 35.76 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 118.337 -2.727 . . . . 0.0 109.095 167.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.4 p -155.4 148.75 24.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 118.479 -2.638 . . . . 0.0 109.05 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.508 ' CG ' HG11 ' A' ' 85' ' ' VAL . 30.3 p90 -157.37 -173.19 4.3 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.223 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -122.21 113.53 19.59 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -39.63 113.57 0.35 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.76 47.44 88.65 Favored Glycine 0 N--CA 1.503 3.149 0 N-CA-C 118.208 2.043 . . . . 0.0 118.208 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -109.39 6.65 24.51 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.78 58.32 2.15 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -149.97 -49.27 0.13 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.295 10.3 m -117.85 -138.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-O 123.04 1.4 . . . . 0.0 108.374 -175.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 89' ' ' TRP . 26.7 pt -122.48 163.25 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 123.767 1.746 . . . . 0.0 110.173 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.59 71.54 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.479 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.37 75.04 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.558 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.505 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.4 m0 -75.4 -41.43 56.18 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 120.725 1.602 . . . . 0.0 112.833 172.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.61 -37.99 80.07 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 119.744 1.157 . . . . 0.0 113.863 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.257 1.2 mp -64.61 -54.68 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.709 1.595 . . . . 0.0 111.208 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.71 72.1 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.2 t -60.91 -46.62 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.07 0.85 . . . . 0.0 112.327 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.8 -34.89 55.67 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 p -87.56 6.73 32.92 Favored 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.533 ' SD ' ' HG ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.35 138.05 52.68 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 123.524 2.874 . . . . 0.0 116.806 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -80.93 149.19 29.5 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 113.51 -3.138 . . . . 0.0 111.05 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.279 1.8 t -9.61 87.91 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 123.144 2.702 . . . . 0.0 110.513 -166.003 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 133' ' ' LEU . . . -3.19 -37.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 1 N-CA-C 129.839 6.696 . . . . 0.0 129.839 -140.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 61.24 -127.69 0.85 Allowed 'General case' 0 CA--C 1.605 3.075 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.739 HD13 ' H ' ' A' ' 102' ' ' CYS 1.672 0.6 OUTLIER 124.57 154.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 161.383 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.739 ' H ' HD13 ' A' ' 101' ' ' LEU . 18.8 t -160.19 -104.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.239 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -122.29 158.36 29.7 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 124.875 2.274 . . . . 0.0 116.036 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mt -131.82 114.61 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.007 0 CA-C-N 111.524 -2.58 . . . . 0.0 105.559 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -107.15 99.19 8.76 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 7.8 p -112.39 146.82 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -90.57 141.02 26.81 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.921 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.26 -22.41 8.33 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 N-CA-C 119.882 2.993 . . . . 0.0 119.882 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.99 -42.04 98.7 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.086 1.766 . . . . 0.0 114.434 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.56 0.17 39.39 Favored 'General case' 0 CA--C 1.577 2.0 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.256 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.97 -114.5 0.15 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.467 ' CD2' HD11 ' A' ' 127' ' ' LEU 0.38 24.7 m-85 -82.29 -14.11 55.91 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 120.945 1.702 . . . . 0.0 115.176 -178.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.1 -152.0 52.01 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.5 p -67.66 -22.25 65.31 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.12 -33.01 13.51 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.4 169.5 45.68 Favored Glycine 0 CA--C 1.551 2.327 0 CA-C-N 121.05 1.75 . . . . 0.0 114.71 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.473 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 6.8 t -90.42 120.14 69.06 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 116.684 -1.627 . . . . 0.0 108.799 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -37.23 -46.07 1.52 Allowed 'Trans proline' 0 CA--C 1.582 2.887 1 N-CA-C 123.32 4.316 . . . . 0.0 123.32 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.14 -20.11 19.39 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 CA-C-N 125.595 3.034 . . . . 0.0 119.534 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -159.53 -27.17 0.07 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 117' ' ' SER . 89.9 mt -79.98 126.6 79.43 Favored Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 120.183 -1.573 . . . . 0.0 111.938 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -82.68 170.7 12.62 Favored 'Trans proline' 0 CA--C 1.581 2.841 0 C-N-CA 122.365 2.043 . . . . 0.0 115.842 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.41 130.67 22.9 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 C-N-CA 122.85 2.367 . . . . 0.0 114.931 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.9 t30 58.85 60.85 2.34 Favored 'General case' 0 CA--C 1.586 2.364 0 C-N-CA 125.031 1.332 . . . . 0.0 113.413 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.23 123.73 32.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.33 -1.481 . . . . 0.0 112.451 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -59.35 156.2 13.22 Favored 'General case' 0 CA--C 1.587 2.373 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 87.8 mt -126.62 165.05 19.92 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 124.69 2.186 . . . . 0.0 114.297 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.99 106.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.77 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 2.5 m-85 -120.92 125.82 48.4 Favored 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 122.194 2.27 . . . . 0.0 109.134 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -95.43 98.72 10.76 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.52 140.57 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.346 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 50.4 mt-10 -130.3 110.15 11.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.484 ' O ' ' HA3' ' A' ' 99' ' ' GLY 0.31 25.8 tp -85.19 121.38 27.85 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 122.822 1.296 . . . . 0.0 112.779 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.3 15.3 m-30 -84.04 -64.36 1.18 Allowed 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.278 -1.514 . . . . 0.0 111.782 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.17 162.17 40.96 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.912 2.142 . . . . 0.0 110.46 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -143.5 -114.8 0.1 Allowed 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -103.4 173.1 6.45 Favored 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.623 1.569 . . . . 0.0 108.196 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 O-C-N 119.583 -1.948 . . . . 0.0 117.73 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.0 t -170.25 150.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 120.029 1.914 . . . . 0.0 112.859 -167.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.69 10.2 tp -151.84 -146.67 0.2 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.962 162.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -179.02 166.42 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.16 -1.587 . . . . 0.0 113.769 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.83 123.23 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.129 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.297 0.3 OUTLIER -89.79 139.28 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 120.25 1.386 . . . . 0.0 111.8 178.826 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.34 -69.18 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.982 -0.449 . . . . 0.0 111.219 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HB2' ' H ' ' A' ' 101' ' ' LEU . 89.8 mtt-85 -103.96 68.66 0.92 Allowed 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -38.1 -71.25 0.08 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.04 -178.4 39.44 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.5 p -83.7 -66.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.681 -0.759 . . . . 0.0 112.001 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.96 55.27 0.01 OUTLIER Glycine 0 CA--C 1.54 1.614 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 15.3 t -153.16 63.25 0.77 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.234 1.492 . . . . 0.0 112.527 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.361 46.8 mt-10 69.76 170.38 0.3 Allowed 'General case' 0 CA--C 1.576 1.972 1 N-CA-C 121.943 4.053 . . . . 0.0 121.943 175.126 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.7 p -114.33 160.0 34.49 Favored Pre-proline 0 CA--C 1.587 2.398 0 CA-C-N 111.042 -2.799 . . . . 0.0 110.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.83 129.18 30.91 Favored 'Trans proline' 0 CA--C 1.579 2.752 0 C-N-CA 122.853 2.369 . . . . 0.0 117.023 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -87.12 161.58 18.03 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 122.009 2.186 . . . . 0.0 111.363 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.343 0.4 OUTLIER -62.31 132.15 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 119.029 -2.294 . . . . 0.0 110.896 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.76 0.97 90.0 Favored Glycine 0 CA--C 1.569 3.428 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.56 152.65 20.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 121.504 2.652 . . . . 0.0 112.868 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -83.56 135.7 34.53 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.285 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -132.36 135.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.185 0.594 . . . . 0.0 109.831 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.265 33.4 p90 -115.96 105.31 12.51 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 124.038 1.875 . . . . 0.0 109.707 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.2 m -110.05 173.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 127.138 2.175 . . . . 0.0 114.55 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.257 0.1 OUTLIER -135.25 111.33 9.56 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 166.229 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.257 20.8 p90 -96.63 176.0 6.18 Favored 'General case' 0 CA--C 1.586 2.327 0 CA-C-O 126.291 2.948 . . . . 0.0 113.918 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.262 63.3 m -150.61 140.23 21.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.1 156.6 27.08 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 119.787 -1.82 . . . . 0.0 116.216 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -139.44 147.31 41.21 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 112.346 -1.927 . . . . 0.0 111.704 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 tp -80.64 169.11 18.07 Favored 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 122.762 1.268 . . . . 0.0 107.928 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.319 0.0 OUTLIER -59.24 -26.68 65.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.68 4.09 6.82 Favored 'General case' 0 CA--C 1.595 2.698 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.59 41.89 34.42 Favored Glycine 0 N--CA 1.506 3.339 0 O-C-N 119.804 -1.81 . . . . 0.0 114.434 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.6 m -116.67 117.31 29.46 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -77.36 97.82 5.03 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.054 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -74.0 -37.07 64.53 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.853 -2.404 . . . . 0.0 115.727 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.54 174.37 14.14 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.337 1.426 . . . . 0.0 113.93 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.4 p -159.98 -10.25 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 119.098 2.999 . . . . 0.0 119.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.3 1.6 t 71.7 -49.77 0.69 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.95 -2.344 . . . . 0.0 111.411 -168.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.6 mt -48.23 -39.33 20.9 Favored 'General case' 0 CA--C 1.581 2.14 0 C-N-CA 127.637 2.375 . . . . 0.0 113.972 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.26 -44.97 88.61 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 125.279 1.432 . . . . 0.0 113.025 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -76.69 -22.27 54.19 Favored 'General case' 0 CA--C 1.585 2.326 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.392 57.3 mtpt 106.18 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 127.648 2.379 . . . . 0.0 113.625 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.65 159.86 27.82 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.836 -1.165 . . . . 0.0 113.021 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -80.51 167.28 20.32 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 54' ' ' VAL . 12.0 t80 -98.04 155.96 16.87 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-O 123.052 1.406 . . . . 0.0 107.708 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -168.28 118.92 0.79 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 119.622 -1.924 . . . . 0.0 108.724 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.453 ' CG ' HG11 ' A' ' 85' ' ' VAL . 21.7 p90 -127.92 -174.53 3.22 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.235 1.017 . . . . 0.0 111.127 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.259 9.5 t0 -126.71 121.52 32.29 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 94' ' ' ALA . 11.6 tp -50.67 111.77 0.59 Allowed 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.58 23.42 70.46 Favored Glycine 0 CA--C 1.573 3.71 0 CA-C-O 118.218 -1.323 . . . . 0.0 116.045 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -124.65 -70.7 0.74 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 120.277 2.039 . . . . 0.0 112.952 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.81 73.35 0.3 Allowed Glycine 0 N--CA 1.508 3.443 0 N-CA-C 103.85 -3.7 . . . . 0.0 103.85 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.487 5.7 pt-20 -73.54 134.48 43.8 Favored 'General case' 0 CA--C 1.561 1.366 2 CA-C-O 129.302 4.382 . . . . 0.0 119.196 -158.503 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.453 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.353 20.8 m -80.04 -117.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 1 CA-C-N 102.564 -6.653 . . . . 0.0 108.439 -175.445 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.495 HG13 ' H ' ' A' ' 89' ' ' TRP . 18.2 pt -121.72 156.11 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 124.285 1.993 . . . . 0.0 107.775 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 8.0 tmtt? -66.94 -28.72 68.52 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.927 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.17 83.37 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 117.353 -1.308 . . . . 0.0 111.485 166.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.495 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.0 m0 -70.18 -41.59 73.54 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.866 1.666 . . . . 0.0 111.99 172.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.83 -41.26 67.18 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.766 1.621 . . . . 0.0 114.465 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -68.26 -61.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 119.582 1.083 . . . . 0.0 112.586 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.517 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -69.26 -28.45 66.33 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.271 45.5 t -79.16 -43.72 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 117.209 -1.377 . . . . 0.0 109.503 175.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -51.49 -33.45 31.43 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.161 1.8 . . . . 0.0 115.492 170.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -86.4 -12.09 50.16 Favored 'General case' 0 CA--C 1.583 2.221 0 CA-C-O 115.597 -2.144 . . . . 0.0 116.645 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -89.62 146.89 24.24 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 125.244 3.656 . . . . 0.0 115.043 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -86.94 159.97 18.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.86 125.95 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.566 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.277 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.12 -49.54 0.89 Allowed Glycine 0 N--CA 1.494 2.512 0 CA-C-O 113.939 -3.701 . . . . 0.0 108.651 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.974 4.5 pt-20 154.01 -93.73 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.417 1 N-CA-C 131.351 7.538 . . . . 0.0 131.351 164.39 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.433 ' H ' ' HB2' ' A' ' 38' ' ' ARG . 33.7 tp -79.09 122.2 25.94 Favored 'General case' 0 N--CA 1.484 1.225 1 N-CA-C 123.96 4.8 . . . . 0.0 123.96 -160.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.2 m -147.41 146.33 29.56 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.053 169.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -109.35 120.93 44.02 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.244 1.973 . . . . 0.0 110.905 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.2 mt -75.97 146.92 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.297 -2.229 . . . . 0.0 113.521 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -136.61 117.17 13.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.8 p -133.47 154.55 50.71 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -96.62 146.61 31.61 Favored Pre-proline 0 CA--C 1.581 2.152 0 CA-C-N 113.797 -1.547 . . . . 0.0 114.022 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 12.4 Cg_exo -43.25 -29.15 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 N-CA-C 121.62 3.661 . . . . 0.0 121.62 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -65.36 -39.09 91.88 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.22 1.827 . . . . 0.0 115.356 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -86.64 -7.71 58.1 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.958 1.303 . . . . 0.0 113.718 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.479 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -115.44 -133.77 0.34 Allowed 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 120.827 1.649 . . . . 0.0 112.398 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.2 4.1 49.74 Favored 'General case' 0 CA--C 1.591 2.556 0 CA-C-N 122.424 2.375 . . . . 0.0 113.411 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 108' ' ' PRO . . . -49.69 -62.14 5.09 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 122.293 3.677 . . . . 0.0 122.293 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -70.48 -39.16 74.37 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -130.04 -7.19 4.4 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.27 158.29 27.66 Favored Glycine 0 CA--C 1.55 2.241 0 CA-C-N 124.421 3.282 . . . . 0.0 113.78 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.466 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 6.1 t -82.75 137.0 44.28 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 116.777 -1.582 . . . . 0.0 109.759 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.266 43.8 Cg_exo -32.82 -45.18 0.25 Allowed 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.464 4.755 . . . . 0.0 124.464 -176.357 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 -52.99 0.08 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 0 CA-C-N 125.934 3.155 . . . . 0.0 118.929 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -152.5 3.57 0.35 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.466 ' HB ' ' H ' ' A' ' 117' ' ' SER . 51.0 mt -79.89 137.43 53.95 Favored Pre-proline 0 CA--C 1.599 2.838 0 O-C-N 119.15 -2.219 . . . . 0.0 113.705 -174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -92.63 -176.1 0.64 Allowed 'Trans proline' 0 CA--C 1.595 3.545 0 CA-C-N 125.319 2.935 . . . . 0.0 115.533 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -64.18 171.97 6.96 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 N-CA-C 118.722 2.547 . . . . 0.0 118.722 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.262 28.3 t-20 59.23 54.08 5.02 Favored 'General case' 0 CA--C 1.585 2.297 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.06 105.94 13.8 Favored 'General case' 0 CA--C 1.57 1.73 0 O-C-N 120.417 -1.427 . . . . 0.0 113.491 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 85.2 m -82.44 135.37 35.16 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.479 HD12 ' HB1' ' A' ' 111' ' ' ALA . 85.8 mt -129.93 167.45 18.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 122.694 2.497 . . . . 0.0 115.585 -171.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.29 125.79 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 CA-C-N 111.147 -2.751 . . . . 0.0 107.01 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.275 60.7 m-85 -133.0 162.11 32.58 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 119.89 -1.756 . . . . 0.0 110.977 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.68 104.23 6.25 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.81 131.85 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 122.0 0.905 . . . . 0.0 111.269 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -114.14 111.07 20.99 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.996 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 117.34 29.97 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.57 -65.62 0.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.367 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -156.85 162.36 39.69 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 121.451 1.932 . . . . 0.0 109.491 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -141.38 -98.54 0.14 Allowed 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -80.34 -43.8 20.55 Favored 'General case' 0 CA--C 1.594 2.669 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.949 173.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.649 0 CA-C-N 124.868 3.485 . . . . 0.0 121.038 178.697 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.265 0 N-CA-C 120.101 2.8 . . . . 0.0 120.101 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.02 140.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.588 5.9 tp -155.73 -142.92 0.11 Allowed 'General case' 0 CA--C 1.57 1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.148 168.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -153.45 162.8 40.92 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.193 1.473 . . . . 0.0 114.958 -170.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.1 t -107.49 104.8 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.495 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.376 2.1 mm -76.81 120.44 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-N 120.588 1.54 . . . . 0.0 112.512 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -95.1 -53.61 3.74 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.474 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -148.91 103.82 3.39 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -76.77 165.9 24.1 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 123.781 2.991 . . . . 0.0 114.344 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.75 -158.68 33.95 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.308 5.0 t -153.26 -77.69 0.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.887 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 13.88 -85.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 122.423 3.729 . . . . 0.0 122.423 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.3 t -143.81 60.34 1.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 121.739 0.781 . . . . 0.0 111.193 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.399 6.4 pt-20 28.01 -114.84 0.03 OUTLIER 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -139.17 121.39 10.24 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.732 1.213 . . . . 0.0 112.681 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -70.09 -114.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.524 0 C-N-CA 122.912 2.408 . . . . 0.0 114.861 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.7 ptm -170.24 179.94 3.3 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 tp -50.48 144.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.258 0 O-C-N 120.771 -1.206 . . . . 0.0 111.268 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.64 -10.59 64.23 Favored Glycine 0 CA--C 1.555 2.562 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -85.85 149.01 25.54 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 121.764 2.782 . . . . 0.0 113.354 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.9 tpt85 -79.94 130.55 35.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.033 -1.042 . . . . 0.0 109.488 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 2.4 t -127.84 146.04 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.272 1.029 . . . . 0.0 110.718 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.253 51.7 p90 -134.32 115.28 13.9 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 122.871 1.32 . . . . 0.0 108.493 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.17 -179.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 CA-C-O 124.087 1.899 . . . . 0.0 113.553 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.57 113.91 9.56 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.479 172.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -115.85 150.13 37.51 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -122.54 147.15 46.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 162.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.06 143.06 9.82 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 119.102 -2.249 . . . . 0.0 117.198 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -134.3 154.78 51.12 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.634 1.974 . . . . 0.0 114.915 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.24 162.59 23.48 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.297 1.6 tm? -61.81 -29.03 69.89 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.05 -2.06 4.99 Favored 'General case' 0 CA--C 1.598 2.808 0 O-C-N 120.323 -1.486 . . . . 0.0 114.934 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.97 50.18 4.48 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 120.17 -1.581 . . . . 0.0 113.98 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.4 m -128.43 115.89 18.89 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.28 112.61 14.17 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.108 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -87.59 -36.99 17.21 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 122.277 2.308 . . . . 0.0 114.303 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -151.44 155.85 39.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.5 1.619 . . . . 0.0 111.148 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.5 p -159.92 104.72 1.54 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.192 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -36.86 80.15 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.61 -34.55 67.34 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 -58.66 3.38 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -158.42 69.77 0.51 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.794 1.179 . . . . 0.0 113.108 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.05 -82.08 0.08 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 120.115 -1.616 . . . . 0.0 108.42 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.71 -157.68 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 127.356 2.262 . . . . 0.0 108.409 -174.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -88.84 -176.94 5.38 Favored 'General case' 0 CA--C 1.578 2.047 0 O-C-N 120.068 -1.645 . . . . 0.0 109.556 169.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.274 9.9 t80 -119.65 160.0 23.34 Favored 'General case' 0 CA--C 1.576 1.971 0 O-C-N 119.627 -1.921 . . . . 0.0 110.344 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 p -165.39 134.42 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 119.792 -1.818 . . . . 0.0 109.198 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.493 ' CG ' HG11 ' A' ' 85' ' ' VAL . 15.8 p90 -148.07 -178.56 6.35 Favored 'General case' 0 CA--C 1.58 2.103 0 O-C-N 121.374 -0.829 . . . . 0.0 110.977 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 -117.11 127.34 54.04 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.67 103.56 0.05 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -172.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.69 47.96 87.46 Favored Glycine 1 N--CA 1.516 4.017 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.308 0.0 OUTLIER -133.76 -78.81 0.47 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -168.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.29 71.41 0.33 Allowed Glycine 0 N--CA 1.509 3.542 1 N-CA-C 103.066 -4.014 . . . . 0.0 103.066 169.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.474 0.0 OUTLIER -66.37 141.86 57.82 Favored 'General case' 0 CA--C 1.554 1.106 2 CA-C-O 129.274 4.369 . . . . 0.0 119.564 -157.593 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.493 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.396 17.4 m -79.93 -110.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 1 CA-C-N 102.751 -6.568 . . . . 0.0 105.617 -176.959 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.469 HG13 ' H ' ' A' ' 89' ' ' TRP . 24.8 pt -125.28 156.76 34.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 124.031 1.872 . . . . 0.0 106.121 167.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.45 -28.94 68.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.115 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.17 -36.02 76.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 117.024 -1.465 . . . . 0.0 112.867 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.469 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.5 m0 -72.91 -45.23 59.32 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 120.785 1.63 . . . . 0.0 112.755 173.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . 0.288 2.7 p30 -56.7 -35.41 68.47 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 121.527 1.967 . . . . 0.0 115.497 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.272 1.6 mp -67.16 -57.77 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-N 119.45 1.023 . . . . 0.0 111.241 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.13 83.09 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 t -68.51 -41.14 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 120.43 1.468 . . . . 0.0 111.585 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.57 62.61 Favored 'General case' 0 CA--C 1.587 2.384 0 CA-C-N 120.16 1.345 . . . . 0.0 113.83 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.4 p -96.44 -3.15 44.0 Favored 'General case' 0 CA--C 1.593 2.606 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.2 ttp -103.02 132.64 49.14 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 121.944 2.157 . . . . 0.0 111.026 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -94.17 153.55 18.03 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.4 t -10.56 -31.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 1 N-CA-C 126.862 5.875 . . . . 0.0 126.862 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.17 17.73 0.22 Allowed Glycine 0 N--CA 1.493 2.449 0 CA-C-O 116.357 -2.357 . . . . 0.0 115.038 -169.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.35 0.9 OUTLIER -129.14 -174.24 3.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -176.212 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.13 127.51 53.25 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.438 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.6 m -139.68 165.9 26.04 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.708 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.251 6.0 mtt85 -127.84 116.89 20.86 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.581 1.658 . . . . 0.0 111.143 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.62 138.25 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.8 m -132.99 109.64 9.7 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 25.1 p -137.26 149.08 46.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.093 2.998 . . . . 0.0 119.093 -173.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -81.0 142.13 51.47 Favored Pre-proline 0 CA--C 1.577 2.01 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.743 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.55 -25.44 7.72 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 N-CA-C 120.727 3.318 . . . . 0.0 120.727 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.07 -38.68 89.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.364 1.893 . . . . 0.0 114.558 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -79.28 -7.65 58.45 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 124.953 1.301 . . . . 0.0 114.249 169.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.25 -115.84 0.24 Allowed 'General case' 0 CA--C 1.58 2.109 0 CA-C-N 120.7 1.591 . . . . 0.0 114.781 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.285 1.6 m-85 -103.33 29.51 5.56 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 122.178 2.263 . . . . 0.0 113.432 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -52.36 158.18 3.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 120.449 2.939 . . . . 0.0 120.449 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.284 9.9 t 71.1 -64.56 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.89 -15.6 16.81 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.17 177.8 49.85 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-N 122.619 2.463 . . . . 0.0 112.392 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.508 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.4 t -75.31 127.43 86.34 Favored Pre-proline 0 CA--C 1.579 2.093 0 CA-C-O 116.394 -1.765 . . . . 0.0 108.846 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 69.6 Cg_exo -38.3 -43.81 1.9 Allowed 'Trans proline' 0 CA--C 1.582 2.922 1 N-CA-C 123.0 4.192 . . . . 0.0 123.0 -176.961 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.6 -37.06 0.22 Allowed 'Trans proline' 0 CA--C 1.573 2.469 0 CA-C-N 125.491 2.997 . . . . 0.0 119.399 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -150.99 -7.34 0.26 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.508 ' HB ' ' H ' ' A' ' 117' ' ' SER . 1.5 mt -79.9 145.94 62.84 Favored Pre-proline 0 CA--C 1.595 2.678 0 CA-C-N 122.944 2.611 . . . . 0.0 112.797 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.4 160.65 48.81 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 CA-C-N 126.453 3.341 . . . . 0.0 115.497 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -62.2 129.32 26.64 Favored 'Trans proline' 0 CA--C 1.57 2.286 0 C-N-CA 122.721 2.281 . . . . 0.0 116.736 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.58 65.66 1.21 Allowed 'General case' 0 CA--C 1.592 2.579 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.5 140.18 51.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 119.642 -1.911 . . . . 0.0 111.748 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.6 m -59.99 146.46 42.51 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.408 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 6.2 tp -116.8 152.55 34.16 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.931 1.696 . . . . 0.0 112.336 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.26 130.39 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.302 -170.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.256 24.2 m-85 -138.35 161.28 37.33 Favored 'General case' 0 N--CA 1.521 3.085 0 O-C-N 119.444 -2.035 . . . . 0.0 110.435 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -126.19 104.68 8.36 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.52 135.31 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-O 122.387 1.089 . . . . 0.0 111.107 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -115.35 115.77 27.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.658 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.25 112.17 24.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -77.92 -40.09 40.79 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.23 172.11 1.95 Allowed 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.304 0.0 OUTLIER -146.13 -96.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.374 -2.079 . . . . 0.0 107.919 177.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.47 72.2 tttt -111.42 -99.42 0.41 Allowed 'General case' 0 CA--C 1.586 2.347 0 CA-C-O 116.545 -1.693 . . . . 0.0 110.019 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.22 0 CA-C-N 124.991 3.541 . . . . 0.0 113.973 -178.568 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.352 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 106' ' ' CYS . 23.4 t -169.04 144.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.587 7.8 tp -157.69 -141.92 0.09 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.988 -1.482 . . . . 0.0 111.415 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 29.6 mtpt -155.87 155.75 33.45 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 122.825 2.557 . . . . 0.0 115.876 -171.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.56 108.11 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 102' ' ' CYS 0.408 1.0 OUTLIER -78.83 124.75 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-N 120.274 1.397 . . . . 0.0 113.538 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -110.64 -56.48 2.35 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.059 0.933 . . . . 0.0 110.599 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.262 46.1 ttt180 -113.63 97.98 6.77 Favored 'General case' 0 CA--C 1.597 2.787 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 36' ' ' ILE . 31.0 mt-10 -37.75 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.863 1 N-CA-C 123.349 4.574 . . . . 0.0 123.349 -177.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.18 163.73 28.03 Favored Glycine 0 CA--C 1.55 2.234 0 C-N-CA 125.072 1.32 . . . . 0.0 114.696 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.343 12.4 t -146.41 -72.07 0.24 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.85 69.54 2.64 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 120.756 3.062 . . . . 0.0 120.756 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.27 71.1 p 69.7 61.84 0.27 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.383 4.7 pt-20 30.6 -113.39 0.03 OUTLIER 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -147.52 122.19 5.11 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 115.918 -1.991 . . . . 0.0 110.898 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.42 0.2 OUTLIER -114.26 -40.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.275 1 N-CA-C 125.749 5.25 . . . . 0.0 125.749 177.579 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 1.9 ptt? -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.526 3.367 2 N-CA-C 127.542 6.127 . . . . 0.0 127.542 -174.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 tp -65.71 141.0 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.03 82.43 Favored Glycine 0 CA--C 1.567 3.322 0 O-C-N 120.286 -1.509 . . . . 0.0 116.527 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' MET . 4.0 t0 -72.66 141.38 48.27 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.932 2.366 . . . . 0.0 110.625 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 -85.97 101.03 12.54 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.25 137.2 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.35 0.66 . . . . 0.0 112.416 -169.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.05 104.56 12.26 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 76' ' ' PHE . 12.2 m -108.98 160.29 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 125.754 2.692 . . . . 0.0 114.697 -172.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.482 ' CD2' HD12 ' A' ' 70' ' ' LEU . 1.6 t60 -125.05 115.69 20.92 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.705 -2.952 . . . . 0.0 105.106 167.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.331 5.7 p90 -113.95 143.93 43.9 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.728 1.251 . . . . 0.0 114.28 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -118.07 147.32 43.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 164.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.79 136.6 4.67 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 118.894 -2.379 . . . . 0.0 115.278 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.29 160.36 40.64 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 111.852 -2.174 . . . . 0.0 114.921 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.504 HD12 ' H ' ' A' ' 62' ' ' ASP . 1.0 OUTLIER -80.65 178.82 8.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -65.13 -22.62 66.96 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 60' ' ' LEU . 36.8 t70 -73.57 -6.46 46.75 Favored 'General case' 0 CA--C 1.601 2.924 0 CA-C-N 119.106 0.867 . . . . 0.0 112.704 165.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.79 47.46 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 125.59 1.567 . . . . 0.0 113.636 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -88.67 108.93 19.72 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -74.49 91.85 2.31 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -73.1 -25.94 61.05 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 119.81 -1.806 . . . . 0.0 113.592 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -151.72 154.17 35.79 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 124.693 2.187 . . . . 0.0 115.308 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.8 p -153.77 102.3 2.52 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 112.029 -2.35 . . . . 0.0 104.767 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.292 31.6 p -58.87 -67.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.482 HD12 ' CD2' ' A' ' 55' ' ' HIS 0.379 32.6 mt -61.39 -45.14 95.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.05 -40.89 24.36 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -93.91 26.83 3.0 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.339 40.3 tttp 82.44 -30.4 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.49 -170.29 2.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.19 176.66 9.36 Favored 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 126.044 1.738 . . . . 0.0 109.857 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.473 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.394 0.5 OUTLIER -132.68 146.02 51.52 Favored 'General case' 0 CA--C 1.575 1.939 0 O-C-N 119.404 -2.06 . . . . 0.0 111.853 173.737 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.1 p -165.42 150.29 8.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.297 -2.127 . . . . 0.0 109.647 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.548 ' CG ' HG11 ' A' ' 85' ' ' VAL . 27.2 p90 -159.66 -171.8 3.43 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.665 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -123.18 113.66 19.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -37.99 105.98 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.43 53.52 24.61 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 118.178 2.031 . . . . 0.0 118.178 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -7.2 23.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.59 63.06 2.17 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 -167.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -154.29 -55.45 0.1 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 112.036 -2.082 . . . . 0.0 110.307 -163.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.548 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.301 16.6 m -97.82 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.431 HD12 ' HE3' ' A' ' 107' ' ' LYS . 3.7 pt -125.64 163.2 27.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 124.459 2.076 . . . . 0.0 109.261 172.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.254 0.9 OUTLIER -68.07 -34.58 76.7 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.178 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.39 70.71 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.601 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -73.26 -46.27 50.95 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 121.136 1.789 . . . . 0.0 112.28 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.95 -35.83 69.57 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 121.361 1.891 . . . . 0.0 115.571 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.29 1.7 mp -65.22 -61.55 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.207 0 CA-C-N 119.855 1.207 . . . . 0.0 111.627 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -67.05 -35.91 80.91 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.301 6.4 t -74.27 -32.87 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.189 0 O-C-N 121.237 -0.914 . . . . 0.0 111.084 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.99 -24.72 68.04 Favored 'General case' 0 CA--C 1.577 2.008 0 CA-C-N 120.709 1.595 . . . . 0.0 113.833 166.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.0 p -97.22 8.0 45.44 Favored 'General case' 0 CA--C 1.596 2.724 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.787 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 8.6 tpt -93.71 140.32 29.78 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 119.515 -1.991 . . . . 0.0 113.346 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.24 145.61 26.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.778 . . . . 0.0 114.203 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.05 125.23 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.32 -12.91 53.49 Favored Glycine 0 N--CA 1.496 2.675 0 CA-C-O 114.972 -3.127 . . . . 0.0 117.888 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.483 67.7 mt-10 -113.16 -159.5 0.69 Allowed 'General case' 0 CA--C 1.583 2.234 0 CA-C-N 122.805 3.303 . . . . 0.0 117.434 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.0 tp -140.26 138.75 35.26 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 119.082 2.994 . . . . 0.0 119.082 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 0.8 OUTLIER -160.02 157.82 29.41 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.909 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -104.88 128.71 53.21 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.204 1.478 . . . . 0.0 113.177 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.757 HG22 ' SG ' ' A' ' 106' ' ' CYS . 11.0 mt -71.88 131.72 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.231 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.625 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.1 m -113.98 108.78 17.48 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.757 ' SG ' HG22 ' A' ' 104' ' ' ILE 0.315 11.4 p -160.16 162.92 34.01 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 120.09 3.366 . . . . 0.0 120.09 -163.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.617 ' HD2' ' HB2' ' A' ' 106' ' ' CYS 2.574 0.0 OUTLIER 134.61 -147.52 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.165 1 N-CA-C 147.669 13.581 . . . . 0.0 147.669 157.447 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.888 21.9 Cg_exo 35.09 -63.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.577 2.631 1 C-N-CA 126.206 4.604 . . . . 0.0 120.952 -162.214 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.31 -33.37 75.69 Favored 'General case' 0 CA--C 1.579 2.07 0 O-C-N 118.818 -2.426 . . . . 0.0 114.805 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -80.76 0.99 32.26 Favored 'General case' 0 CA--C 1.598 2.82 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.447 ' HB2' ' HG3' ' A' ' 107' ' ' LYS . . . -147.69 -104.86 0.09 Allowed 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 127' ' ' LEU . 3.1 m-85 -89.87 -7.53 54.01 Favored 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -176.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -45.56 -21.39 0.49 Allowed Glycine 0 N--CA 1.503 3.112 1 N-CA-C 123.868 4.307 . . . . 0.0 123.868 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.9 p -71.92 -56.12 6.26 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.603 1.702 . . . . 0.0 112.79 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.19 -0.24 3.72 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.56 153.82 27.29 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-N 123.56 2.891 . . . . 0.0 115.133 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.465 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 7.5 t -82.97 130.77 56.26 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.635 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -34.29 -47.57 0.55 Allowed 'Trans proline' 0 CA--C 1.581 2.841 1 N-CA-C 122.666 4.064 . . . . 0.0 122.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.23 -54.71 0.36 Allowed 'Trans proline' 0 CA--C 1.571 2.351 0 CA-C-N 125.682 3.065 . . . . 0.0 116.725 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -173.0 78.3 0.04 OUTLIER 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 119.344 0.975 . . . . 0.0 113.542 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -141.09 125.65 10.59 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 119.673 -1.892 . . . . 0.0 109.377 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -90.31 162.69 4.59 Favored 'Trans proline' 0 CA--C 1.589 3.264 0 CA-C-N 123.442 2.265 . . . . 0.0 112.223 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.28 -34.6 66.88 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.103 2.309 . . . . 0.0 118.103 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -89.68 56.71 3.63 Favored 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 125.981 1.712 . . . . 0.0 113.215 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.54 106.94 4.37 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.014 -1.678 . . . . 0.0 113.664 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 m -60.35 154.09 21.15 Favored 'General case' 0 CA--C 1.587 2.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 112' ' ' TYR . 29.2 mt -124.27 172.34 9.17 Favored 'General case' 0 CA--C 1.566 1.567 0 O-C-N 120.288 -1.507 . . . . 0.0 111.834 -174.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.46 123.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -123.78 120.82 33.78 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 119.937 1.244 . . . . 0.0 108.228 176.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.15 107.79 19.35 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.961 -1.087 . . . . 0.0 108.716 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -112.45 135.86 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.17 0.986 . . . . 0.0 110.892 -171.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -114.43 112.71 23.44 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.9 115.1 28.86 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.891 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -78.94 -50.21 11.54 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -169.94 159.67 7.92 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 123.833 1.777 . . . . 0.0 110.384 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.91 -87.97 0.08 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 102.76 -3.052 . . . . 0.0 102.76 -177.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -121.89 95.45 4.67 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 170.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.635 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 177.477 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.68 146.47 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 N-CA-C 119.028 2.973 . . . . 0.0 119.028 -170.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.42 136.9 52.86 Favored 'General case' 0 CA--C 1.598 2.793 0 C-N-CA 126.548 1.939 . . . . 0.0 107.539 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -124.19 118.65 27.34 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 118.291 -2.756 . . . . 0.0 108.211 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.13 136.03 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.579 -0.701 . . . . 0.0 109.613 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.22 151.43 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 122.124 0.964 . . . . 0.0 113.044 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -131.18 -63.62 0.84 Allowed 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 124.22 1.008 . . . . 0.0 110.851 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -112.79 89.86 3.19 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -35.09 -56.21 0.59 Allowed 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -151.75 17.38 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 124.63 1.109 . . . . 0.0 115.495 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 t -79.66 -34.17 40.65 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.35 45.74 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 120.429 2.932 . . . . 0.0 120.429 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.25 67.2 p 68.84 -5.88 0.95 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 118.894 2.924 . . . . 0.0 118.894 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -75.86 131.94 40.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.0 p -107.93 163.61 16.57 Favored Pre-proline 0 N--CA 1.503 2.185 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.47 166.43 25.93 Favored 'Trans proline' 0 CA--C 1.577 2.639 0 CA-C-N 122.39 1.889 . . . . 0.0 114.436 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -102.39 163.34 12.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.52 -1.363 . . . . 0.0 111.546 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.355 0.3 OUTLIER -63.16 128.51 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.179 -2.2 . . . . 0.0 110.432 178.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 4.03 84.58 Favored Glycine 0 CA--C 1.572 3.594 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.23 166.34 9.99 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 121.189 2.494 . . . . 0.0 114.35 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -108.21 101.12 10.37 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 119.926 1.239 . . . . 0.0 108.933 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.93 139.0 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 123.61 0.764 . . . . 0.0 111.05 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.28 41.6 p90 -117.32 101.12 8.16 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 124.865 2.269 . . . . 0.0 109.267 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 76' ' ' PHE . 2.1 p -102.19 170.93 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 111.076 -2.783 . . . . 0.0 112.731 -170.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.96 100.7 3.22 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 166.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -97.69 160.22 14.45 Favored 'General case' 0 CA--C 1.593 2.635 0 CA-C-O 122.724 1.249 . . . . 0.0 113.299 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -128.0 147.96 50.52 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.15 142.43 9.1 Favored Glycine 0 CA--C 1.55 2.222 0 O-C-N 119.098 -2.251 . . . . 0.0 116.464 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.569 ' CE3' HG12 ' A' ' 128' ' ' VAL . 2.0 m-90 -130.27 149.11 52.11 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.49 1.916 . . . . 0.0 115.205 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.29 171.4 12.75 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.922 1.344 . . . . 0.0 108.746 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 3.3 tt -62.56 -29.46 70.6 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.05 7.01 1.81 Allowed 'General case' 0 CA--C 1.597 2.786 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.37 66.0 Favored Glycine 0 N--CA 1.509 3.557 0 O-C-N 119.841 -1.787 . . . . 0.0 114.744 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -112.62 118.53 35.31 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -77.88 93.11 4.33 Favored 'General case' 0 CA--C 1.583 2.225 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -64.66 -30.31 71.33 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 119.151 -2.218 . . . . 0.0 114.559 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.14 152.85 31.73 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 124.513 2.102 . . . . 0.0 112.492 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.6 p -159.35 86.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 t -52.91 -40.66 63.73 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.12 -38.81 54.13 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.691 1.996 . . . . 0.0 115.694 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.68 -34.26 18.49 Favored 'General case' 0 CA--C 1.578 2.025 0 C-N-CA 125.879 1.672 . . . . 0.0 114.88 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -29.78 70.88 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.312 2.708 . . . . 0.0 118.312 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.352 58.5 tptt 131.5 -56.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 127.677 2.391 . . . . 0.0 111.695 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -98.35 174.06 6.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 123.602 1.667 . . . . 0.0 113.199 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.06 175.62 6.25 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 125.298 1.439 . . . . 0.0 114.389 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HB3' HG13 ' A' ' 54' ' ' VAL 0.345 2.3 t80 -108.49 153.27 23.57 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-O 122.989 1.376 . . . . 0.0 108.356 173.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.9 p -163.53 111.79 1.22 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 118.154 -2.841 . . . . 0.0 104.514 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.539 ' CD1' HG11 ' A' ' 85' ' ' VAL . 2.4 p90 -125.54 177.06 6.42 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.116 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.308 33.6 t70 -86.32 -139.34 0.09 Allowed 'General case' 0 CA--C 1.584 2.251 0 O-C-N 119.117 -2.24 . . . . 0.0 105.803 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 tp -141.5 109.96 5.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 118.579 -2.576 . . . . 0.0 104.265 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 48.44 16.12 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.414 14.5 tppt? -106.82 6.58 29.6 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-N 119.902 1.851 . . . . 0.0 114.441 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.1 -51.99 1.65 Allowed Glycine 0 N--CA 1.508 3.478 0 O-C-N 120.151 -1.593 . . . . 0.0 109.953 -172.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.283 52.9 tt0 -20.2 -53.82 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 120.654 3.575 . . . . 0.0 120.654 168.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 78' ' ' PHE 0.294 16.5 m -101.87 -135.61 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 123.228 1.49 . . . . 0.0 110.12 -174.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 89' ' ' TRP . 13.7 pt -126.55 162.51 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.774 1.75 . . . . 0.0 109.797 173.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -67.16 -33.61 75.79 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.172 -1.376 . . . . 0.0 113.109 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.2 73.09 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.29 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' H ' HG13 ' A' ' 86' ' ' ILE . 35.1 m0 -74.77 -42.18 58.66 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-N 120.854 1.661 . . . . 0.0 112.205 172.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.84 -38.5 85.7 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.21 1.368 . . . . 0.0 113.863 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.4 mp -68.6 -60.64 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-N 119.09 0.859 . . . . 0.0 111.615 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.05 72.94 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.311 15.5 t -74.16 -32.79 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 CA-C-N 120.344 1.429 . . . . 0.0 110.652 175.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.25 73.92 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 121.02 1.736 . . . . 0.0 112.749 166.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.8 p -83.85 8.24 15.51 Favored 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.531 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 tpt -91.95 130.3 37.73 Favored 'General case' 0 CA--C 1.579 2.072 0 O-C-N 119.483 -2.011 . . . . 0.0 112.209 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.33 135.35 41.89 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 116.423 -1.751 . . . . 0.0 109.461 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.288 3.6 t -9.65 82.84 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-O 124.729 2.204 . . . . 0.0 108.308 -161.044 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 133' ' ' LEU . . . -54.99 46.88 0.01 OUTLIER Glycine 0 N--CA 1.502 3.037 2 CA-C-N 107.532 -4.394 . . . . 0.0 123.702 -140.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 0.4 OUTLIER -29.02 -87.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -169.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.61 121.51 17.67 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.754 0.822 . . . . 0.0 112.646 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.531 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 2.4 m -149.2 167.36 26.2 Favored 'General case' 0 CA--C 1.575 1.92 0 C-N-CA 123.949 0.899 . . . . 0.0 111.779 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -131.83 133.6 44.86 Favored 'General case' 0 CA--C 1.557 1.226 0 O-C-N 119.134 -2.229 . . . . 0.0 112.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.3 mt -90.71 129.27 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 CA-C-N 112.689 -2.05 . . . . 0.0 108.862 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 106.4 14.35 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.581 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 5.0 p -129.36 147.48 51.19 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -169.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -91.69 146.25 32.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.037 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.26 82.4 Cg_endo -61.87 -14.55 37.43 Favored 'Trans proline' 0 CA--C 1.568 2.213 0 N-CA-C 118.023 2.278 . . . . 0.0 118.023 -176.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.82 -38.46 78.7 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 120.778 1.626 . . . . 0.0 114.427 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.58 2.54 52.85 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 125.632 1.573 . . . . 0.0 113.495 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.61 -113.8 0.17 Allowed 'General case' 0 CA--C 1.58 2.132 0 CA-C-N 120.774 1.624 . . . . 0.0 115.269 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.271 4.9 m-85 -88.08 0.33 56.12 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 120.953 1.706 . . . . 0.0 115.378 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.4 -19.39 1.87 Allowed Glycine 0 N--CA 1.499 2.86 1 N-CA-C 124.219 4.447 . . . . 0.0 124.219 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -71.36 -57.41 4.48 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 120.271 2.036 . . . . 0.0 111.869 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.52 0.34 2.49 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.5 157.07 33.3 Favored Glycine 0 CA--C 1.546 1.996 0 CA-C-N 123.999 3.091 . . . . 0.0 112.483 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.423 ' HB3' HD12 ' A' ' 121' ' ' ILE . 2.7 t -86.53 125.56 66.99 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-O 116.918 -1.515 . . . . 0.0 108.423 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.274 28.1 Cg_exo -26.24 -49.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.877 1 N-CA-C 124.882 4.916 . . . . 0.0 124.882 -176.334 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -46.16 1.3 Allowed 'Trans proline' 0 CA--C 1.572 2.391 0 CA-C-N 125.861 3.129 . . . . 0.0 118.977 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -152.58 -11.78 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 117' ' ' SER . 14.2 mt -79.91 144.13 59.03 Favored Pre-proline 0 CA--C 1.595 2.692 0 CA-C-N 121.858 2.117 . . . . 0.0 115.564 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -102.48 176.16 0.19 Allowed 'Trans proline' 0 CA--C 1.594 3.497 0 CA-C-N 125.278 2.921 . . . . 0.0 113.661 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.5 -37.87 5.1 Favored 'Trans proline' 0 CA--C 1.573 2.464 0 C-N-CA 122.239 1.959 . . . . 0.0 116.619 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -80.89 50.87 1.44 Allowed 'General case' 0 CA--C 1.582 2.177 0 O-C-N 120.06 -1.65 . . . . 0.0 115.202 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.28 127.91 17.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.218 -1.551 . . . . 0.0 112.831 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.1 m -80.26 161.73 24.98 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.973 -1.079 . . . . 0.0 112.817 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.581 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.3 0.5 OUTLIER -145.12 174.0 11.44 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 119.711 -1.868 . . . . 0.0 112.274 -176.569 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.569 HG12 ' CE3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -148.57 125.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 125.039 1.336 . . . . 0.0 108.005 -171.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.285 4.7 m-85 -124.13 122.85 38.94 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 120.302 1.41 . . . . 0.0 110.58 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.17 121.73 32.47 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.77 128.0 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 121.369 0.604 . . . . 0.0 111.806 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.56 100.56 9.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.453 ' HB3' ' HA3' ' A' ' 99' ' ' GLY 0.285 16.2 tp -103.99 126.81 51.4 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.687 1.232 . . . . 0.0 111.703 -174.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -86.04 -60.32 2.04 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 120.897 -1.127 . . . . 0.0 112.836 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -157.5 -178.06 7.06 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 119.939 1.245 . . . . 0.0 110.088 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.26 -60.65 0.08 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.28 58.3 tttm -79.82 -44.51 20.43 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.614 2.82 . . . . 0.0 118.614 -172.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.823 0 CA-C-N 124.774 3.443 . . . . 0.0 121.188 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.141 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 107' ' ' LYS 0.394 17.1 t -123.89 119.28 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 173.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.2 tp -89.93 122.42 32.94 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 125.251 1.42 . . . . 0.0 108.68 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -114.77 97.81 6.48 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 122.816 2.553 . . . . 0.0 108.568 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 109.318 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -86.17 145.48 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-O 121.591 0.71 . . . . 0.0 111.836 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -123.58 -53.67 1.78 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 123.568 0.747 . . . . 0.0 111.491 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -124.1 107.18 10.99 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -72.54 0.05 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.75 -156.82 28.83 Favored Glycine 0 CA--C 1.547 2.092 0 C-N-CA 125.1 1.334 . . . . 0.0 111.713 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -88.74 -7.48 56.18 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.6 -85.73 0.06 OUTLIER Glycine 0 CA--C 1.538 1.482 0 O-C-N 121.164 -0.96 . . . . 0.0 111.943 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -165.45 5.27 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -87.23 154.02 21.04 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 123.775 2.989 . . . . 0.0 115.1 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 p -128.23 164.29 38.48 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 112.974 -1.921 . . . . 0.0 113.284 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.48 -176.42 2.28 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-N 122.515 1.934 . . . . 0.0 115.775 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.5 ptp -133.92 167.34 20.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.461 -1.399 . . . . 0.0 112.426 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.279 1.5 tp -60.58 136.68 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 O-C-N 119.251 -2.155 . . . . 0.0 110.967 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.33 61.46 Favored Glycine 0 CA--C 1.559 2.787 0 N-CA-C 118.412 2.125 . . . . 0.0 118.412 -173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.85 149.13 26.58 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.63 2.215 . . . . 0.0 112.019 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -78.37 133.89 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.368 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.45 ' HB ' HD11 ' A' ' 133' ' ' LEU . 9.5 m -136.84 138.75 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 118.804 0.729 . . . . 0.0 111.57 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -116.73 102.43 9.42 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.551 -1.343 . . . . 0.0 108.543 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.2 m -102.32 167.81 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.62 117.91 17.59 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -112.18 150.85 30.26 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 m -119.05 151.6 37.94 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 157.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.07 142.32 8.86 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 118.229 -2.795 . . . . 0.0 115.459 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.411 ' CE3' HG12 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -130.25 155.07 46.89 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.027 -1.587 . . . . 0.0 115.01 -175.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.1 tp -78.48 177.01 8.86 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 123.086 1.422 . . . . 0.0 107.378 166.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -63.81 -25.8 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.75 13.74 2.0 Allowed 'General case' 0 CA--C 1.604 3.023 0 CA-C-N 119.077 0.853 . . . . 0.0 113.268 168.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.66 29.7 75.48 Favored Glycine 0 N--CA 1.509 3.541 0 O-C-N 120.034 -1.666 . . . . 0.0 116.432 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -86.74 113.9 22.97 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -74.39 85.28 1.98 Allowed 'General case' 0 CA--C 1.586 2.331 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.64 -30.78 69.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 119.66 -1.9 . . . . 0.0 115.403 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -149.57 141.24 23.53 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.575 1.179 . . . . 0.0 111.496 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.9 p -160.02 93.26 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.4 p -61.01 -35.83 77.89 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -52.92 -39.13 62.57 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.65 -41.8 44.38 Favored 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 125.034 1.334 . . . . 0.0 114.223 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -68.54 -20.12 64.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 33.9 mtmm 101.8 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 127.407 2.283 . . . . 0.0 112.118 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.1 153.31 41.77 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 123.0 1.381 . . . . 0.0 114.356 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -93.29 178.77 5.62 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.506 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.474 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.302 4.5 t80 -114.35 153.25 30.14 Favored 'General case' 0 CA--C 1.587 2.372 0 O-C-N 120.95 -1.094 . . . . 0.0 110.082 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.8 p -161.63 145.94 12.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 118.491 -2.631 . . . . 0.0 111.342 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 85' ' ' VAL . 25.6 p90 -155.22 -171.26 3.74 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -124.05 114.5 19.81 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.64 110.07 0.18 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.29 29.87 67.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -106.13 0.91 25.8 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.23 61.29 1.33 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -148.27 -51.29 0.17 Allowed 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 111.191 -2.505 . . . . 0.0 111.991 -166.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.261 13.5 m -125.9 -140.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.969 1.366 . . . . 0.0 109.756 -173.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.523 HD12 ' HZ3' ' A' ' 107' ' ' LYS . 12.6 pt -115.21 162.51 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-O 123.826 1.774 . . . . 0.0 109.88 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -65.88 -34.1 77.37 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.655 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . . . -57.1 -39.72 75.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 168.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.444 ' H ' HG13 ' A' ' 86' ' ' ILE . 32.8 m0 -70.23 -40.78 74.29 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.641 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.26 -33.78 74.09 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 119.593 1.088 . . . . 0.0 113.921 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -67.37 -59.17 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 119.925 1.238 . . . . 0.0 110.622 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.405 ' CB ' HD13 ' A' ' 104' ' ' ILE . . . -60.03 -47.0 87.67 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.332 5.2 t -60.4 -41.22 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.712 173.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.21 -39.29 56.23 Favored 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 121.506 1.957 . . . . 0.0 113.251 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -97.69 51.0 1.05 Allowed 'General case' 0 CA--C 1.593 2.624 0 C-N-CA 123.846 0.858 . . . . 0.0 112.618 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.1 ttt -138.37 152.3 48.31 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 119.479 -2.013 . . . . 0.0 113.881 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -118.53 146.08 44.83 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.558 2.799 . . . . 0.0 118.558 -172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -18.45 -29.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.756 1 N-CA-C 127.354 6.057 . . . . 0.0 127.354 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.37 -2.14 0.14 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-O 115.566 -2.797 . . . . 0.0 116.601 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 78.1 mm-40 -112.6 -145.43 0.4 Allowed 'General case' 0 N--CA 1.516 2.856 0 N-CA-C 121.012 3.708 . . . . 0.0 121.012 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 16.1 tp -133.94 140.6 46.88 Favored 'General case' 0 CA--C 1.601 2.932 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.47 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 58.8 m -142.88 -175.52 4.53 Favored 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.431 -1.418 . . . . 0.0 113.343 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -137.51 139.58 40.61 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 119.489 -2.007 . . . . 0.0 110.87 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.654 HG22 ' SG ' ' A' ' 106' ' ' CYS . 1.1 mt -106.97 128.11 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.579 0 C-N-CA 125.865 1.666 . . . . 0.0 109.168 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.8 m -119.49 114.49 22.37 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.654 ' SG ' HG22 ' A' ' 104' ' ' ILE 0.341 20.4 p -150.71 137.67 19.17 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -155.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.684 ' HG2' ' HB2' ' A' ' 110' ' ' TYR 0.765 0.0 OUTLIER -20.49 98.5 0.05 OUTLIER Pre-proline 0 CA--C 1.621 3.697 3 N-CA-C 140.664 10.987 . . . . 0.0 140.664 159.535 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.315 0.2 OUTLIER -49.62 -27.82 15.59 Favored 'Trans proline' 0 CA--C 1.589 3.27 1 O-C-N 113.337 -4.086 . . . . 0.0 118.14 173.084 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.82 -42.81 85.24 Favored 'General case' 0 CA--C 1.578 2.045 0 O-C-N 120.069 -1.644 . . . . 0.0 114.459 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.684 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 52.7 m-85 -78.11 3.87 13.91 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-O 117.367 -1.302 . . . . 0.0 113.469 171.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.452 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . . . -141.28 -103.43 0.14 Allowed 'General case' 0 CA--C 1.583 2.223 0 CA-C-N 121.943 2.156 . . . . 0.0 115.293 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.09 12.08 14.41 Favored 'General case' 0 CA--C 1.586 2.342 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -50.14 156.41 2.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 120.113 2.805 . . . . 0.0 120.113 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.283 7.8 t 73.38 -47.69 0.67 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.39 -52.83 4.16 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.03 148.52 17.89 Favored Glycine 0 CA--C 1.547 2.055 0 C-N-CA 124.35 0.976 . . . . 0.0 112.675 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.475 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.2 t -84.21 143.19 41.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.996 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.76 -39.58 57.33 Favored 'Trans proline' 0 CA--C 1.583 2.929 0 N-CA-C 120.265 3.141 . . . . 0.0 120.265 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -66.2 -62.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 CA-C-N 125.714 3.077 . . . . 0.0 116.229 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -168.57 62.64 0.06 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.475 ' HB ' ' H ' ' A' ' 117' ' ' SER . 69.3 mt -126.13 113.29 23.96 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.087 -1.633 . . . . 0.0 107.925 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.98 165.88 24.74 Favored 'Trans proline' 0 CA--C 1.583 2.946 0 C-N-CA 122.557 2.171 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.2 116.33 3.96 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.61 2.207 . . . . 0.0 112.679 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t30 67.33 53.21 0.77 Allowed 'General case' 0 CA--C 1.59 2.502 0 C-N-CA 125.423 1.489 . . . . 0.0 114.559 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.91 130.39 56.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.508 -1.37 . . . . 0.0 109.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 3.0 m -63.32 152.86 36.73 Favored 'General case' 0 CA--C 1.594 2.66 0 CA-C-N 120.552 1.524 . . . . 0.0 114.999 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.06 172.01 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 119.495 -2.003 . . . . 0.0 111.95 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.411 HG12 ' CE3' ' A' ' 59' ' ' TRP . 55.8 t -150.98 127.32 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.201 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 78.6 m-85 -142.1 127.21 18.48 Favored 'General case' 0 N--CA 1.517 2.914 0 O-C-N 119.236 -2.165 . . . . 0.0 111.198 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -98.36 101.18 12.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.407 -2.058 . . . . 0.0 106.732 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.07 140.42 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.556 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 101' ' ' LEU 1.827 30.5 tt0 -138.43 -171.71 3.11 Favored 'General case' 0 N--CA 1.524 3.232 0 CA-C-O 122.608 1.194 . . . . 0.0 109.203 164.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.532 ' H ' ' HG2' ' A' ' 132' ' ' GLU . 24.4 tp -140.94 127.07 19.54 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -162.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.82 -34.97 39.03 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 175.74 159.79 0.26 Allowed 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 127.32 2.248 . . . . 0.0 106.966 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.13 -92.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.135 -1.603 . . . . 0.0 109.593 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -81.13 55.92 2.66 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.149 0 CA-C-O 117.753 -1.582 . . . . 0.0 114.941 175.76 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.153 1 N-CA-C 123.933 4.333 . . . . 0.0 123.933 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.3 164.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.087 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.798 0.5 OUTLIER -163.62 -168.38 1.64 Allowed 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 120.52 1.509 . . . . 0.0 114.652 164.69 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 23.3 pttm -148.66 150.13 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 2.7 t -113.77 87.49 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 117.362 -1.304 . . . . 0.0 112.763 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.504 2.4 mm -43.95 121.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 117.195 2.295 . . . . 0.0 117.195 -177.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -106.9 -59.24 1.83 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.893 0.877 . . . . 0.0 110.166 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -142.2 106.94 4.86 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -51.33 -56.85 10.87 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 122.297 2.317 . . . . 0.0 116.342 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.63 -158.73 25.15 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 126.364 1.935 . . . . 0.0 114.63 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -78.24 2.79 17.2 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.4 45.12 95.68 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -114.44 -66.62 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.79 173.06 12.72 Favored 'General case' 0 CA--C 1.581 2.14 0 CA-C-O 122.996 1.379 . . . . 0.0 114.377 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -118.95 147.67 42.98 Favored Pre-proline 0 CA--C 1.581 2.15 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.157 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -68.09 141.72 53.74 Favored 'Trans proline' 0 CA--C 1.582 2.904 0 N-CA-C 118.318 2.392 . . . . 0.0 118.318 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -104.05 167.68 9.61 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 121.534 1.97 . . . . 0.0 112.79 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.256 2.0 tp -62.95 134.65 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.292 0 O-C-N 118.954 -2.341 . . . . 0.0 108.946 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.78 15.13 81.51 Favored Glycine 0 CA--C 1.562 3.012 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -82.95 139.64 33.24 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.374 2.087 . . . . 0.0 110.68 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 136' ' ' PHE . 1.6 tmm_? -83.03 113.35 20.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.386 2.0 t -117.99 136.75 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 C-N-CA 125.438 1.495 . . . . 0.0 112.911 -164.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -120.35 103.79 9.5 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.901 1.334 . . . . 0.0 107.815 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.461 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.6 m -107.55 164.92 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 123.481 1.61 . . . . 0.0 111.961 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.419 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.295 3.7 t60 -130.24 138.06 50.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 164.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -132.5 148.48 52.39 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.789 2.515 . . . . 0.0 117.789 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -116.59 147.62 41.68 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 162.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.9 145.59 13.47 Favored Glycine 0 CA--C 1.545 1.954 0 O-C-N 119.136 -2.227 . . . . 0.0 117.308 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.45 157.75 45.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.515 1.926 . . . . 0.0 114.466 -173.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.99 167.49 11.2 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 169.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.289 1.0 OUTLIER -61.95 -25.59 67.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -68.32 -3.73 11.98 Favored 'General case' 0 CA--C 1.595 2.696 0 CA-C-N 120.069 1.304 . . . . 0.0 112.763 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 44.19 12.41 Favored Glycine 0 N--CA 1.498 2.775 0 CA-C-N 120.334 1.424 . . . . 0.0 114.295 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.0 m -120.13 119.54 33.59 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.84 92.1 3.03 Favored 'General case' 0 CA--C 1.585 2.313 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.969 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -69.74 -30.87 68.58 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 118.891 -2.381 . . . . 0.0 114.962 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -147.0 156.61 43.17 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 125.237 2.446 . . . . 0.0 114.432 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -150.36 93.03 1.93 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.272 63.8 p -47.99 -58.73 4.05 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.635 2.458 . . . . 0.0 117.635 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.419 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 85.7 mt -51.9 -44.01 63.61 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.21 -43.87 96.91 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -136.34 35.93 2.74 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -176.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -158.95 -75.11 0.08 Allowed 'General case' 0 CA--C 1.564 1.508 0 O-C-N 120.212 -1.555 . . . . 0.0 109.834 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.13 -161.78 0.06 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 127.19 2.196 . . . . 0.0 108.913 -173.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.14 -170.5 2.76 Favored 'General case' 0 CA--C 1.591 2.526 0 O-C-N 118.935 -2.353 . . . . 0.0 107.769 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.47 1.4 t80 -123.77 148.79 46.33 Favored 'General case' 0 CA--C 1.58 2.11 0 O-C-N 118.038 -2.914 . . . . 0.0 111.14 173.425 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.3 p -167.07 140.89 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 118.454 -2.654 . . . . 0.0 111.973 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CG ' HG11 ' A' ' 85' ' ' VAL . 35.5 p90 -149.98 -165.44 2.27 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 121.227 0.537 . . . . 0.0 111.184 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.61 63.43 1.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.207 -1.558 . . . . 0.0 112.152 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 10.77 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.81 61.7 2.51 Favored Glycine 0 N--CA 1.511 3.664 0 O-C-N 119.767 -1.833 . . . . 0.0 112.025 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.662 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.394 0.0 OUTLIER -106.48 -85.22 0.5 Allowed 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 123.964 1.84 . . . . 0.0 111.357 -171.795 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.662 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -100.93 -43.47 2.24 Favored Glycine 0 N--CA 1.51 3.61 0 CA-C-O 124.647 2.248 . . . . 0.0 110.473 165.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 1.05 1.3 pp20? 111.49 135.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 131.605 3.962 . . . . 0.0 118.684 165.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 86' ' ' ILE 0.337 12.3 m -79.69 -99.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 109.232 -3.622 . . . . 0.0 104.428 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.535 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.3 pt -133.9 155.72 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 124.451 2.072 . . . . 0.0 105.982 165.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 13.0 tmtt? -67.35 -29.0 68.43 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.752 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.13 82.02 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 117.456 -1.259 . . . . 0.0 112.113 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.535 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.9 m0 -73.15 -43.0 62.2 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 120.882 1.674 . . . . 0.0 113.094 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.33 -36.52 71.25 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 120.034 1.288 . . . . 0.0 114.157 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.283 1.7 mp -67.68 -58.0 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 119.402 1.001 . . . . 0.0 111.452 174.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.485 ' CB ' HD13 ' A' ' 104' ' ' ILE . . . -63.16 -39.28 94.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.447 ' HA ' ' SD ' ' A' ' 96' ' ' MET . 65.2 t -63.57 -49.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.301 1.409 . . . . 0.0 111.052 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.66 -32.55 29.97 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.1 p -100.71 19.11 17.68 Favored 'General case' 0 CA--C 1.591 2.534 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 93' ' ' VAL 0.337 1.4 ptt? -115.82 -172.96 2.26 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 122.758 2.526 . . . . 0.0 116.373 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -134.88 152.32 51.65 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 66.6 t -48.17 126.83 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.83 -44.29 1.52 Allowed Glycine 0 N--CA 1.491 2.325 0 CA-C-O 115.904 -2.609 . . . . 0.0 113.455 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -145.53 -173.38 4.11 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.827 2.813 . . . . 0.0 113.264 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 102' ' ' CYS 0.704 0.2 OUTLIER -158.71 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.267 1.508 . . . . 0.0 113.97 176.242 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -160.08 -145.87 0.13 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' N ' ' SG ' ' A' ' 102' ' ' CYS 0.326 0.0 OUTLIER -122.94 113.58 19.28 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 124.952 2.31 . . . . 0.0 111.975 170.087 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.485 HD13 ' CB ' ' A' ' 92' ' ' ALA 0.316 1.4 mt -78.45 146.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 112.131 -2.304 . . . . 0.0 113.112 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 106' ' ' CYS 2.023 0.1 OUTLIER -161.05 -178.43 6.77 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 120.902 3.668 . . . . 0.0 120.902 146.969 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 111' ' ' ALA . 1.9 p -159.77 162.95 34.96 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -159.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -79.67 144.19 60.2 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-N 112.258 -2.246 . . . . 0.0 108.69 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.84 -21.35 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 N-CA-C 120.293 3.151 . . . . 0.0 120.293 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -60.23 -36.76 78.46 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.43 -3.26 58.23 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 171.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -128.7 -103.75 0.31 Allowed 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 120.483 1.492 . . . . 0.0 114.028 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.364 47.3 m-85 -106.42 -5.33 19.03 Favored 'General case' 0 N--CA 1.523 3.201 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.95 -154.83 49.28 Favored Glycine 0 N--CA 1.488 2.109 0 CA-C-N 122.462 2.392 . . . . 0.0 118.394 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -67.12 -24.57 65.93 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.63 -31.71 15.76 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.88 167.56 43.64 Favored Glycine 0 CA--C 1.552 2.382 0 CA-C-N 121.409 1.913 . . . . 0.0 114.797 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.428 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 5.9 t -86.82 114.82 60.02 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 116.843 -1.551 . . . . 0.0 107.384 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.284 85.0 Cg_exo -40.73 -49.27 4.31 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 122.202 3.885 . . . . 0.0 122.202 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.83 8.88 4.0 Favored 'Trans proline' 0 CA--C 1.577 2.646 0 CA-C-N 125.173 2.883 . . . . 0.0 118.086 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -159.09 -17.53 0.07 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.428 ' HB ' ' H ' ' A' ' 117' ' ' SER . 41.7 mt -125.17 136.63 28.42 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 121.381 1.901 . . . . 0.0 112.702 -172.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.47 170.53 13.04 Favored 'Trans proline' 0 CA--C 1.584 2.987 0 CA-C-N 122.914 2.077 . . . . 0.0 115.211 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.62 135.98 37.74 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 122.758 2.305 . . . . 0.0 114.836 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.3 t30 59.68 56.82 3.44 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 124.901 1.28 . . . . 0.0 113.334 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.56 114.8 27.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.249 -1.532 . . . . 0.0 112.194 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.2 m -68.8 144.31 54.35 Favored 'General case' 0 CA--C 1.591 2.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.716 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.466 HD12 ' HB1' ' A' ' 111' ' ' ALA . 21.3 mt -113.95 172.62 6.88 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -172.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -153.44 124.44 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.783 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.388 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 1.0 OUTLIER -141.85 130.53 22.77 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-N 124.599 3.363 . . . . 0.0 110.442 175.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -94.48 104.09 16.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.28 140.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -123.99 121.48 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.4 tp -89.25 112.4 23.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 111.955 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -81.74 -41.83 20.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -168.42 154.22 6.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.227 1.489 . . . . 0.0 109.537 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' ARG 0.275 5.8 p90 -151.45 -90.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 178.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.52 69.26 6.98 Favored 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.431 1.586 . . . . 0.0 112.194 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.829 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -178.816 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 N-CA-C 120.849 3.099 . . . . 0.0 120.849 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.36 143.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.7 tp -104.32 136.33 44.11 Favored 'General case' 0 CA--C 1.59 2.494 0 C-N-CA 127.003 2.121 . . . . 0.0 106.089 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -121.73 130.57 53.53 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 124.014 3.097 . . . . 0.0 113.406 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 4.5 t -85.75 147.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 116.613 -1.661 . . . . 0.0 110.203 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 102' ' ' CYS 0.446 0.5 OUTLIER -126.02 125.18 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-N 120.522 1.51 . . . . 0.0 110.007 170.248 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -58.75 2.05 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.611 -0.681 . . . . 0.0 111.874 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -121.94 99.26 6.35 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -56.51 174.61 0.14 Allowed 'General case' 0 CA--C 1.595 2.697 0 O-C-N 119.904 -1.748 . . . . 0.0 115.648 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.81 -165.66 37.68 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 119.215 2.446 . . . . 0.0 119.215 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -91.3 -1.81 57.55 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.69 -90.4 0.08 OUTLIER Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.653 1.569 . . . . 0.0 116.683 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 t -159.88 -25.92 0.07 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -78.75 142.95 36.6 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 p -135.67 114.05 11.09 Favored Pre-proline 0 CA--C 1.577 2.005 0 CA-C-N 109.831 -3.35 . . . . 0.0 107.528 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -67.5 -29.76 36.8 Favored 'Trans proline' 0 CA--C 1.582 2.887 0 N-CA-C 117.27 1.988 . . . . 0.0 117.27 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.524 32.2 mtt 81.29 -150.78 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.318 1.1 tp -50.5 134.17 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 O-C-N 120.585 -1.322 . . . . 0.0 113.625 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 -7.13 76.5 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 116.927 -2.041 . . . . 0.0 117.548 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -74.61 128.43 35.54 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 122.827 3.314 . . . . 0.0 112.817 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ptm85 -76.4 125.68 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.931 0.787 . . . . 0.0 109.078 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 136' ' ' PHE . 23.2 m -120.44 138.45 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.905 0.882 . . . . 0.0 112.751 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -117.18 108.06 15.21 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.7 m -119.12 160.6 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.301 6.1 m-70 -126.64 113.03 16.18 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 166.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -108.13 146.04 33.25 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.3 m -112.72 139.31 48.45 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 162.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.64 147.66 19.08 Favored Glycine 0 CA--C 1.565 3.188 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.77 171.52 20.24 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 127.93 2.492 . . . . 0.0 113.068 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -93.36 148.75 21.78 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.513 165.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.376 0.2 OUTLIER -61.74 -17.32 55.39 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.01 -28.23 66.19 Favored 'General case' 0 CA--C 1.594 2.636 0 CA-C-N 120.334 1.424 . . . . 0.0 111.823 166.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.18 52.07 0.61 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -135.34 113.19 11.0 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -68.52 120.39 14.49 Favored 'General case' 0 CA--C 1.584 2.274 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.411 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -97.46 -31.69 12.22 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 121.442 1.928 . . . . 0.0 113.498 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -154.16 165.65 35.59 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 123.24 1.495 . . . . 0.0 113.508 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -148.52 -10.38 0.36 Allowed 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.381 97.7 p 61.44 -36.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 122.846 2.566 . . . . 0.0 117.887 -176.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.81 -42.87 97.58 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 128.186 2.594 . . . . 0.0 113.746 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.71 -38.08 74.64 Favored 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.12 -21.72 63.99 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.332 33.4 ttmt 86.05 -23.57 0.15 Allowed 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 126.161 1.784 . . . . 0.0 114.7 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.266 8.3 t70 -92.87 -135.3 0.16 Allowed 'General case' 0 CA--C 1.572 1.81 0 C-N-CA 124.406 1.083 . . . . 0.0 110.477 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 168.87 21.38 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 124.743 1.217 . . . . 0.0 113.731 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.261 4.0 t80 -97.23 144.14 27.33 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.2 p -159.93 147.8 16.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.614 -2.554 . . . . 0.0 109.405 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.2 p90 -159.47 -176.58 5.86 Favored 'General case' 0 CA--C 1.589 2.447 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.278 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.54 132.66 52.55 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 118.922 -2.361 . . . . 0.0 106.307 171.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 107.84 0.63 Allowed 'General case' 0 CA--C 1.577 1.983 0 O-C-N 120.848 -1.158 . . . . 0.0 113.88 -175.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.84 6.81 Favored Glycine 0 N--CA 1.504 3.18 0 O-C-N 120.433 -1.417 . . . . 0.0 113.669 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.621 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.266 0.0 OUTLIER -107.71 -75.66 0.63 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.57 1.652 . . . . 0.0 110.812 -175.01 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.621 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -105.31 -51.95 0.85 Allowed Glycine 0 N--CA 1.502 3.097 0 CA-C-O 124.786 2.325 . . . . 0.0 108.808 167.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.723 19.8 tt0 114.75 140.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 128.376 3.941 . . . . 0.0 114.159 166.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.366 12.0 m -79.96 -100.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.106 1 CA-C-N 105.211 -5.45 . . . . 0.0 103.028 177.508 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.502 HG13 ' H ' ' A' ' 89' ' ' TRP . 41.3 pt -135.09 157.5 40.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 124.995 2.331 . . . . 0.0 105.895 165.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 12.7 tmtt? -69.39 -30.39 68.35 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 114.226 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.41 83.27 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 116.22 -1.848 . . . . 0.0 110.567 165.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.502 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.2 m0 -71.28 -44.85 64.42 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 122.074 2.216 . . . . 0.0 113.204 174.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.92 -33.37 68.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.252 1.6 mp -68.67 -58.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 120.187 1.358 . . . . 0.0 110.749 172.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.84 88.84 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.291 11.9 t -62.64 -38.06 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.235 1.379 . . . . 0.0 112.892 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.67 -34.41 64.99 Favored 'General case' 0 CA--C 1.581 2.171 0 CA-C-N 121.002 1.728 . . . . 0.0 113.804 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.7 p -84.45 -0.19 51.93 Favored 'General case' 0 CA--C 1.59 2.5 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 mtt -85.88 105.1 16.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 121.96 2.164 . . . . 0.0 114.242 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.75 141.4 49.75 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 114.779 -2.534 . . . . 0.0 106.756 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.267 1.7 t -9.64 96.13 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.54 4.032 0 CA-C-N 122.841 2.564 . . . . 0.0 112.484 -161.029 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 133' ' ' LEU . . . 18.78 -50.28 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 1 N-CA-C 129.289 6.475 . . . . 0.0 129.289 -151.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 69.24 174.35 0.29 Allowed 'General case' 0 CA--C 1.605 3.085 0 CA-C-O 123.089 1.424 . . . . 0.0 108.156 -164.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.707 HD13 ' HG3' ' A' ' 132' ' ' GLU 0.311 12.6 tp -126.45 104.42 8.15 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 123.863 1.792 . . . . 0.0 109.109 169.426 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.7 p -160.41 -159.29 0.68 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.767 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.776 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 2.31 0.0 OUTLIER -160.91 -139.15 0.05 Allowed 'General case' 0 CA--C 1.563 1.455 1 N-CA-C 122.603 4.297 . . . . 0.0 122.603 157.863 . . . . . . . . 5 4 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 103' ' ' ARG . 8.0 mt -121.53 146.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 109.548 -3.478 . . . . 0.0 114.676 -165.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.6 m -135.48 91.32 2.71 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 13.7 p -107.41 147.75 29.99 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 -171.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -90.52 137.98 27.05 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.084 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.308 13.9 Cg_endo -54.09 -10.14 1.8 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 120.346 3.172 . . . . 0.0 120.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.35 -38.8 88.26 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 120.494 1.497 . . . . 0.0 113.695 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -86.27 -0.52 56.0 Favored 'General case' 0 CA--C 1.576 1.952 0 C-N-CA 126.059 1.743 . . . . 0.0 114.213 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.28 -111.64 0.19 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CD2' HD11 ' A' ' 127' ' ' LEU . 2.6 m-85 -93.5 0.21 56.61 Favored 'General case' 0 N--CA 1.517 2.879 0 CA-C-N 120.742 1.61 . . . . 0.0 114.952 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.69 146.16 3.6 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.928 2.731 . . . . 0.0 119.928 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.346 53.1 p 76.0 -47.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -175.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.72 -55.03 3.03 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.28 149.63 25.75 Favored Glycine 0 CA--C 1.546 1.99 0 CA-C-N 119.548 1.067 . . . . 0.0 111.471 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.45 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 7.4 t -75.44 129.19 82.68 Favored Pre-proline 0 CA--C 1.579 2.059 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.954 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.281 6.8 Cg_endo -40.43 -44.57 4.31 Favored 'Trans proline' 0 CA--C 1.579 2.763 1 N-CA-C 122.554 4.021 . . . . 0.0 122.554 -175.54 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.64 -37.07 1.87 Allowed 'Trans proline' 0 CA--C 1.572 2.396 0 CA-C-N 125.296 2.927 . . . . 0.0 118.61 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -151.48 -17.99 0.2 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 119.06 2.985 . . . . 0.0 119.06 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 117' ' ' SER . 85.5 mt -79.96 139.66 53.61 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 122.476 2.398 . . . . 0.0 114.028 -173.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -93.16 179.06 1.15 Allowed 'Trans proline' 0 CA--C 1.59 3.31 0 CA-C-N 125.332 2.94 . . . . 0.0 115.04 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -60.04 -2.9 1.92 Allowed 'Trans proline' 0 CA--C 1.576 2.607 0 N-CA-C 121.077 3.453 . . . . 0.0 121.077 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.04 92.82 1.38 Allowed 'General case' 0 CA--C 1.589 2.479 0 CA-C-N 120.991 1.723 . . . . 0.0 111.096 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.34 131.62 23.49 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 122.674 2.488 . . . . 0.0 110.216 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.0 m -74.92 128.81 36.46 Favored 'General case' 0 CA--C 1.593 2.629 0 O-C-N 120.836 -1.165 . . . . 0.0 111.63 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.474 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 71.3 mt -107.44 165.23 11.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.93 118.17 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.62 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.345 0.2 OUTLIER -140.33 107.98 5.62 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 121.035 1.743 . . . . 0.0 109.875 172.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.776 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 39.9 mt-10 -100.51 128.67 46.5 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.241 -1.537 . . . . 0.0 108.342 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.738 ' H ' ' HB2' ' A' ' 103' ' ' ARG 0.363 1.1 p -132.4 149.94 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 124.818 2.246 . . . . 0.0 116.161 -170.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.707 ' HG3' HD13 ' A' ' 101' ' ' LEU . 1.6 mp0 -102.61 120.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 111.41 -2.632 . . . . 0.0 107.007 178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 99' ' ' GLY 0.293 10.5 tp -107.96 109.32 20.78 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 121.713 2.051 . . . . 0.0 108.529 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -69.5 -55.55 9.9 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 119.726 -1.859 . . . . 0.0 114.014 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -158.6 155.25 27.94 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.737 1.732 . . . . 0.0 107.205 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.447 ' HB3' HG12 ' A' ' 52' ' ' VAL 0.255 0.0 OUTLIER -131.46 -108.86 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.244 177.114 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -102.24 83.87 2.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.623 0 N-CA-C 122.519 3.768 . . . . 0.0 122.519 -176.64 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.129 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.281 50.9 t -133.74 119.96 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.787 0.803 . . . . 0.0 111.119 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.61 139.17 37.56 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -139.86 84.7 1.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 119.476 -2.015 . . . . 0.0 106.66 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -85.89 101.24 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 115.972 -1.966 . . . . 0.0 111.7 -168.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.653 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.642 0.5 OUTLIER -65.51 133.4 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -172.47 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.48 -56.22 2.59 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.44 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -150.93 121.23 7.29 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -72.27 0.13 Allowed 'General case' 0 CA--C 1.581 2.147 0 O-C-N 119.038 -2.289 . . . . 0.0 114.409 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.98 -176.03 37.6 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 125.555 1.55 . . . . 0.0 114.488 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 t -149.91 -3.18 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.632 2.826 . . . . 0.0 118.632 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.19 -75.36 0.51 Allowed Glycine 0 N--CA 1.492 2.385 0 CA-C-N 122.095 2.225 . . . . 0.0 117.19 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.8 p -126.2 -80.73 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.341 0.57 . . . . 0.0 110.393 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -159.46 -146.92 0.15 Allowed 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.227 1.011 . . . . 0.0 110.679 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 p -94.57 168.97 10.36 Favored Pre-proline 0 CA--C 1.582 2.204 0 C-N-CA 125.443 1.497 . . . . 0.0 111.464 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -99.96 -167.1 0.08 OUTLIER 'Trans proline' 0 CA--C 1.569 2.256 0 CA-C-N 122.909 2.075 . . . . 0.0 116.196 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -137.65 146.73 44.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.06 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.609 HG23 ' H ' ' A' ' 49' ' ' GLY 0.529 0.2 OUTLIER -9.95 -123.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.807 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.609 ' H ' HG23 ' A' ' 48' ' ' ILE . . . -49.18 38.43 0.01 OUTLIER Glycine 0 N--CA 1.504 3.206 1 N-CA-C 124.042 4.377 . . . . 0.0 124.042 177.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.67 148.87 38.34 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 119.979 1.889 . . . . 0.0 112.141 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.82 134.47 41.73 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 0.9 OUTLIER -142.26 147.82 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 124.72 2.2 . . . . 0.0 112.123 -163.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.553 ' CE2' ' HG ' ' A' ' 133' ' ' LEU 0.532 4.9 p90 -79.9 -160.29 0.27 Allowed 'General case' 0 CA--C 1.589 2.462 0 C-N-CA 127.545 2.338 . . . . 0.0 114.335 168.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.908 HG23 ' HB3' ' A' ' 76' ' ' PHE 0.295 0.8 OUTLIER 157.6 147.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 127.094 2.158 . . . . 0.0 111.292 159.506 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.312 0.2 OUTLIER -127.64 111.49 13.78 Favored 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 118.592 -1.243 . . . . 0.0 107.886 164.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 37.1 p90 -101.12 174.65 5.9 Favored 'General case' 0 CA--C 1.589 2.46 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -152.91 113.89 4.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 164.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.81 136.85 8.96 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 124.652 2.251 . . . . 0.0 116.157 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.461 ' HE3' HG23 ' A' ' 128' ' ' VAL . 1.1 m-90 -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 110.615 -2.792 . . . . 0.0 112.897 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.4 tp -79.07 170.3 16.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 125.367 2.508 . . . . 0.0 108.318 168.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.255 3.1 tm? -58.82 -19.63 43.01 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 110.885 -2.87 . . . . 0.0 114.036 168.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -75.38 4.17 7.78 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 121.071 1.76 . . . . 0.0 113.038 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.27 89.45 Favored Glycine 0 N--CA 1.51 3.618 0 CA-C-N 121.41 1.914 . . . . 0.0 116.188 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -117.76 140.12 50.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -86.05 95.0 9.38 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.908 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -69.97 -35.21 74.26 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.206 -2.184 . . . . 0.0 113.929 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.65 170.17 23.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.755 1.616 . . . . 0.0 112.711 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 95.0 p -160.06 -17.57 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.29 1.3 t 69.97 -53.07 0.63 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.502 -1.999 . . . . 0.0 113.085 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.9 mt -49.99 -49.97 48.67 Favored 'General case' 0 CA--C 1.581 2.154 0 C-N-CA 127.09 2.156 . . . . 0.0 114.255 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.12 -38.45 82.25 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.553 1.168 . . . . 0.0 114.134 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -73.22 2.36 7.51 Favored 'General case' 0 CA--C 1.585 2.32 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 59.9 mttp 85.21 -18.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 175.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -120.26 175.31 6.02 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 123.442 1.592 . . . . 0.0 113.147 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -88.17 162.22 16.82 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.744 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.908 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.276 4.2 t80 -99.15 158.39 15.71 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 123.344 1.545 . . . . 0.0 107.851 173.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.4 p -170.01 144.5 2.72 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.716 -1.865 . . . . 0.0 109.214 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CG ' HG11 ' A' ' 85' ' ' VAL . 32.2 p90 -153.29 -162.23 1.43 Allowed 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.725 1.25 . . . . 0.0 110.694 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.93 118.0 14.36 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -45.13 117.15 1.27 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -174.084 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.82 29.77 73.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 118.41 2.124 . . . . 0.0 118.41 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -99.93 3.95 44.71 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 -172.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.2 58.88 2.02 Favored Glycine 0 N--CA 1.508 3.465 0 N-CA-C 106.301 -2.719 . . . . 0.0 106.301 -172.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -147.07 -48.95 0.18 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 111.994 -2.103 . . . . 0.0 113.121 -166.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.26 8.5 m -124.46 -148.76 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 123.571 1.653 . . . . 0.0 108.888 -174.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.37 159.02 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 124.278 1.99 . . . . 0.0 109.983 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -67.84 -31.53 71.42 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.798 -1.546 . . . . 0.0 113.402 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.68 69.92 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 117.105 -1.426 . . . . 0.0 111.764 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -74.12 -42.86 59.38 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-N 120.948 1.704 . . . . 0.0 112.514 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.74 -35.75 68.94 Favored 'General case' 0 CA--C 1.577 2.001 0 CA-C-N 119.92 1.236 . . . . 0.0 114.311 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.278 1.5 mp -65.99 -57.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 CA-C-N 120.002 1.274 . . . . 0.0 111.206 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.79 96.82 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.427 ' HA ' ' SD ' ' A' ' 96' ' ' MET 0.25 76.3 t -62.08 -46.68 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.728 1.149 . . . . 0.0 112.371 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.17 -34.24 60.0 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.7 p -94.86 -2.61 50.41 Favored 'General case' 0 CA--C 1.585 2.291 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.463 ' SD ' ' HG ' ' A' ' 101' ' ' LEU 0.262 0.8 OUTLIER -102.04 153.15 20.17 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 123.258 2.753 . . . . 0.0 115.444 -177.363 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -99.36 150.82 21.75 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 133' ' ' LEU . 63.3 t -48.15 124.43 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.594 0 C-N-CA 124.835 1.254 . . . . 0.0 112.557 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -29.12 11.62 Favored Glycine 0 N--CA 1.499 2.844 0 CA-C-O 115.051 -3.083 . . . . 0.0 115.76 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.364 2.2 tp10 -155.82 -176.3 5.88 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 123.008 3.404 . . . . 0.0 116.609 173.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.479 HD13 ' H ' ' A' ' 102' ' ' CYS 0.735 0.1 OUTLIER -159.44 -145.39 0.13 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 179.25 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -160.26 -152.41 0.29 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -170.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.5 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 12.1 ptm180 -109.29 130.5 55.49 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 123.864 1.792 . . . . 0.0 111.14 171.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.4 mt -93.81 134.65 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 112.871 -1.968 . . . . 0.0 107.329 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 m -130.16 100.43 5.41 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 9.5 p -115.45 144.97 43.04 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -172.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.15 148.84 72.05 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 116.924 -1.512 . . . . 0.0 111.474 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.267 71.7 Cg_endo -57.98 -19.06 38.46 Favored 'Trans proline' 0 C--N 1.379 2.138 0 CA-C-N 125.587 3.031 . . . . 0.0 119.095 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.38 -38.31 80.17 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 121.465 1.939 . . . . 0.0 114.407 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -79.16 -7.82 58.51 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 124.679 1.192 . . . . 0.0 114.1 169.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -121.52 -103.8 0.39 Allowed 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.735 1.607 . . . . 0.0 112.929 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.478 6.5 m-85 -106.2 -8.22 17.47 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.79 -148.21 49.12 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 t -88.74 61.9 6.2 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 122.407 1.099 . . . . 0.0 111.534 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.79 -52.8 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.406 1.483 . . . . 0.0 112.646 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.99 160.94 25.55 Favored Glycine 0 CA--C 1.544 1.873 0 C-N-CA 124.054 0.835 . . . . 0.0 114.038 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -89.24 139.29 28.58 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.021 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.64 -39.96 37.94 Favored 'Trans proline' 0 CA--C 1.586 3.122 0 N-CA-C 120.597 3.268 . . . . 0.0 120.597 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.33 -29.85 0.45 Allowed 'Trans proline' 0 CA--C 1.574 2.494 0 CA-C-N 125.425 2.973 . . . . 0.0 119.667 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -148.38 -29.34 0.3 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 119.422 3.119 . . . . 0.0 119.422 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mt -79.98 122.1 82.82 Favored Pre-proline 0 CA--C 1.585 2.326 0 CA-C-N 120.467 1.485 . . . . 0.0 113.854 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.69 177.85 2.58 Favored 'Trans proline' 0 CA--C 1.584 2.993 0 C-N-CA 123.119 2.546 . . . . 0.0 117.458 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -50.28 -19.84 4.97 Favored 'Trans proline' 0 CA--C 1.567 2.151 1 N-CA-C 122.927 4.164 . . . . 0.0 122.927 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -160.13 94.87 1.12 Allowed 'General case' 0 CA--C 1.583 2.233 0 CA-C-N 120.671 1.578 . . . . 0.0 106.885 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -147.23 141.9 26.66 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 123.001 2.637 . . . . 0.0 112.436 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -71.44 158.01 37.04 Favored 'General case' 0 CA--C 1.591 2.54 0 O-C-N 121.221 -0.924 . . . . 0.0 112.743 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.533 HD12 ' HB1' ' A' ' 111' ' ' ALA . 9.2 mt -129.18 161.35 30.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 119.555 -1.966 . . . . 0.0 112.762 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.461 HG23 ' HE3' ' A' ' 59' ' ' TRP . 12.5 m -144.04 135.97 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 110.798 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 2.4 m-85 -136.15 127.43 28.27 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.71 1.243 . . . . 0.0 109.225 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.88 102.26 14.37 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.69 152.06 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.294 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -133.97 133.2 41.07 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 53' ' ' PHE . 4.6 tt -94.8 143.74 26.21 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -106.33 -60.67 1.62 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -177.29 134.17 0.18 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 125.784 2.707 . . . . 0.0 106.682 -173.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.429 ' CE2' HD11 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -118.88 -111.66 0.34 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.6 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.401 42.0 tptt -119.65 -119.1 0.31 Allowed 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 171.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.009 0 CA-C-N 125.721 3.873 . . . . 0.0 120.977 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.374 1 N-CA-C 125.542 4.977 . . . . 0.0 125.542 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.305 67.8 t -141.52 144.98 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 123.002 3.401 . . . . 0.0 117.122 -169.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.2 135.99 48.61 Favored 'General case' 0 CA--C 1.585 2.318 0 C-N-CA 126.724 2.009 . . . . 0.0 109.703 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -128.86 112.55 14.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 123.694 2.952 . . . . 0.0 111.835 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.1 101.01 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.014 -1.053 . . . . 0.0 113.261 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.513 ' HA ' ' SG ' ' A' ' 102' ' ' CYS 0.304 2.6 mm -52.07 128.05 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -118.08 -42.57 2.8 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.707 1.203 . . . . 0.0 112.546 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -129.06 112.85 14.44 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.53 -173.01 4.14 Favored 'General case' 0 CA--C 1.598 2.802 0 CA-C-N 121.171 1.805 . . . . 0.0 115.833 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.8 158.67 36.64 Favored Glycine 0 N--CA 1.492 2.382 1 N-CA-C 123.559 4.183 . . . . 0.0 123.559 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -129.15 -72.81 0.59 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.57 114.76 3.98 Favored Glycine 0 CA--C 1.55 2.245 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -58.68 -14.41 8.36 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.7 148.29 42.83 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.0 m -148.52 96.4 3.89 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-N 110.652 -2.977 . . . . 0.0 107.096 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.441 0.5 OUTLIER -104.88 1.2 0.24 Allowed 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 119.818 2.969 . . . . 0.0 119.818 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.533 39.5 mtm 76.79 -140.19 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 164.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 1.1 tp -48.09 136.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 CA-C-O 122.157 0.979 . . . . 0.0 113.347 -174.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.91 -6.62 83.22 Favored Glycine 0 CA--C 1.551 2.344 0 CA-C-O 116.781 -2.122 . . . . 0.0 118.143 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -73.88 128.62 35.99 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 122.62 3.21 . . . . 0.0 113.762 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -78.37 112.48 15.43 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.4 138.96 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.65 104.14 11.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.49 166.29 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 CA-C-O 123.145 1.45 . . . . 0.0 112.556 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.92 113.7 17.54 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.742 170.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -117.87 151.81 36.64 Favored 'General case' 0 CA--C 1.582 2.191 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 97.4 m -127.43 143.26 51.23 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.93 143.08 11.47 Favored Glycine 0 CA--C 1.555 2.589 0 O-C-N 119.984 -1.698 . . . . 0.0 116.87 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.77 151.66 48.73 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 127.479 2.312 . . . . 0.0 112.499 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.39 175.75 9.15 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 123.465 1.603 . . . . 0.0 108.543 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 tp -60.35 -31.65 70.53 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.46 8.07 1.55 Allowed 'General case' 0 CA--C 1.596 2.713 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.59 36.05 82.36 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 119.697 -1.877 . . . . 0.0 114.808 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 m -111.1 119.57 39.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -76.49 112.29 12.85 Favored 'General case' 0 CA--C 1.588 2.442 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.779 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -85.09 -35.19 21.97 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 122.686 2.494 . . . . 0.0 113.689 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.51 158.08 43.85 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 123.469 1.604 . . . . 0.0 113.099 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 t -156.37 100.71 1.99 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.949 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 t -59.72 -40.33 87.62 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.82 -46.1 78.17 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.262 1.425 . . . . 0.0 114.411 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.32 -39.62 68.08 Favored 'General case' 0 CA--C 1.579 2.094 0 C-N-CA 124.82 1.248 . . . . 0.0 113.776 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 -13.15 47.37 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 51.4 mtmt 91.95 -35.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 126.808 2.043 . . . . 0.0 115.334 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -88.53 170.69 10.66 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 123.804 1.764 . . . . 0.0 111.997 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.74 168.66 9.53 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.577 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.278 5.9 t80 -104.83 145.26 30.63 Favored 'General case' 0 CA--C 1.574 1.892 0 O-C-N 120.44 -1.413 . . . . 0.0 109.273 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.1 p -155.66 128.18 7.83 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.814 -1.803 . . . . 0.0 110.095 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.8 p90 -143.16 -175.38 4.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 123.591 0.756 . . . . 0.0 110.194 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' LYS 0.263 13.4 t0 -128.06 124.81 37.96 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 118.796 -2.44 . . . . 0.0 105.551 174.062 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.9 104.92 0.09 Allowed 'General case' 0 CA--C 1.579 2.064 0 C-N-CA 124.69 1.196 . . . . 0.0 114.064 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.74 37.72 95.12 Favored Glycine 0 N--CA 1.512 3.721 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 -173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 5.0 mtpt -132.82 -70.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 124.668 1.187 . . . . 0.0 110.636 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.42 74.18 0.21 Allowed Glycine 0 N--CA 1.495 2.586 1 N-CA-C 100.782 -4.927 . . . . 0.0 100.782 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.326 47.8 tp10 -71.91 150.61 44.02 Favored 'General case' 0 CA--C 1.554 1.116 1 CA-C-O 130.25 4.833 . . . . 0.0 116.693 -165.363 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.349 31.4 m -98.46 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 1 CA-C-N 101.55 -7.114 . . . . 0.0 107.087 -174.02 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 89' ' ' TRP . 19.3 pt -110.97 159.05 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 124.418 2.056 . . . . 0.0 109.153 171.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -32.41 72.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.745 -1.57 . . . . 0.0 113.257 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.66 -35.48 74.51 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 116.826 -1.559 . . . . 0.0 111.677 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.45 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.0 m0 -77.43 -41.6 39.22 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.323 1.874 . . . . 0.0 112.378 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.66 -34.1 69.02 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 120.017 1.28 . . . . 0.0 113.885 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.2 mp -66.66 -57.08 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 120.098 1.317 . . . . 0.0 110.968 172.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.51 90.17 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.538 HG22 ' CE ' ' A' ' 96' ' ' MET . 99.6 t -63.03 -38.72 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-N 118.967 0.803 . . . . 0.0 112.906 173.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.71 -36.8 70.09 Favored 'General case' 0 CA--C 1.58 2.12 0 CA-C-N 120.282 1.401 . . . . 0.0 113.445 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -82.32 11.37 5.53 Favored 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.538 ' CE ' HG22 ' A' ' 93' ' ' VAL . 43.3 mtt -94.01 134.92 35.91 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 121.636 2.016 . . . . 0.0 116.103 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.3 163.26 15.43 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 164.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 64.5 t -57.73 131.66 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.943 0 O-C-N 117.899 -3.0 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.53 -21.19 30.48 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 124.172 3.169 . . . . 0.0 114.275 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.64 163.87 27.39 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 120.4 2.1 . . . . 0.0 113.695 176.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.671 HD13 ' H ' ' A' ' 102' ' ' CYS 1.751 0.1 OUTLIER 162.43 155.76 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.797 2.039 . . . . 0.0 113.921 168.009 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.671 ' H ' HD13 ' A' ' 101' ' ' LEU 0.345 81.9 m -143.44 178.97 7.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.998 1.319 . . . . 0.0 112.872 -167.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.479 ' HB3' ' HG2' ' A' ' 130' ' ' GLU 0.301 0.0 OUTLIER -93.64 119.53 32.77 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 124.483 2.087 . . . . 0.0 107.93 171.171 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.56 118.56 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 CA-C-N 111.489 -2.596 . . . . 0.0 108.922 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -112.15 103.26 11.42 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.3 p -119.21 141.14 49.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -171.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.01 141.97 87.21 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.295 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -60.46 -19.97 61.51 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 N-CA-C 119.35 2.788 . . . . 0.0 119.35 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.7 -33.48 75.18 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 122.62 2.463 . . . . 0.0 113.603 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.5 -7.84 54.35 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.76 -101.87 0.42 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 120.076 1.307 . . . . 0.0 111.847 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.257 0.3 OUTLIER -124.56 14.64 8.8 Favored 'General case' 0 CA--C 1.592 2.574 0 CA-C-N 120.431 1.469 . . . . 0.0 113.872 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.05 -31.17 39.85 Favored Glycine 0 N--CA 1.497 2.765 1 N-CA-C 123.105 4.002 . . . . 0.0 123.105 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.9 m -66.66 -11.81 55.52 Favored 'General case' 0 CA--C 1.585 2.319 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.61 -60.15 0.19 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 124.945 1.298 . . . . 0.0 113.284 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.73 152.6 7.22 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.533 1.54 . . . . 0.0 110.792 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 t -81.8 126.54 75.18 Favored Pre-proline 0 CA--C 1.579 2.067 0 CA-C-O 116.647 -1.644 . . . . 0.0 108.993 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -40.38 -43.69 4.07 Favored 'Trans proline' 0 CA--C 1.581 2.871 0 N-CA-C 121.733 3.705 . . . . 0.0 121.733 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.6 -9.79 6.6 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 CA-C-N 125.165 2.88 . . . . 0.0 119.042 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -160.57 -43.68 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.9 125.18 82.57 Favored Pre-proline 0 CA--C 1.58 2.105 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -88.54 171.13 5.3 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 C-N-CA 122.662 2.241 . . . . 0.0 112.301 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.85 -42.15 33.15 Favored 'Trans proline' 0 CA--C 1.574 2.519 0 N-CA-C 117.917 2.237 . . . . 0.0 117.917 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -90.76 61.34 4.74 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.462 -1.399 . . . . 0.0 112.621 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.23 113.62 5.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.044 -1.66 . . . . 0.0 111.972 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -65.06 155.79 33.59 Favored 'General case' 0 CA--C 1.591 2.553 0 C-N-CA 124.107 0.963 . . . . 0.0 112.793 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 mt -114.74 162.75 16.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 124.525 2.107 . . . . 0.0 112.297 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 114.8 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 CA-C-N 112.703 -2.044 . . . . 0.0 108.83 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 1.3 m-85 -131.38 123.9 29.2 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 122.711 2.505 . . . . 0.0 111.756 175.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.479 ' HG2' ' HB3' ' A' ' 103' ' ' ARG . 90.8 mt-10 -91.97 110.28 21.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . 0.28 1.3 p -138.31 145.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 122.343 1.068 . . . . 0.0 112.248 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 41.0 tt0 -136.23 133.58 37.2 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.813 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 tp -93.8 130.33 39.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.69 -51.67 6.3 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.536 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -164.2 154.74 15.08 Favored 'General case' 0 CA--C 1.575 1.923 0 C-N-CA 125.455 1.502 . . . . 0.0 108.522 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.266 0.0 OUTLIER -130.33 -115.15 0.24 Allowed 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 110.239 177.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -122.26 119.29 30.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 -178.396 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -162.75 137.07 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.88 145.99 29.31 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 125.885 1.674 . . . . 0.0 109.041 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -130.89 125.61 33.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 122.621 2.464 . . . . 0.0 111.797 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.2 t -102.04 93.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.367 0.3 OUTLIER -79.24 134.53 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.849 -1.157 . . . . 0.0 111.54 178.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.89 -68.2 0.94 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.581 0.705 . . . . 0.0 111.101 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -99.01 95.32 7.06 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.9 167.33 11.77 Favored 'General case' 0 CA--C 1.59 2.512 0 O-C-N 120.044 -1.66 . . . . 0.0 113.749 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.57 170.92 41.83 Favored Glycine 0 CA--C 1.55 2.24 0 O-C-N 119.53 -1.981 . . . . 0.0 117.959 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 p -78.36 -70.72 0.47 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.27 54.04 0.1 Allowed Glycine 0 N--CA 1.482 1.766 0 C-N-CA 124.674 1.131 . . . . 0.0 113.727 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -140.38 17.05 2.4 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 55.74 -179.04 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 121.588 3.921 . . . . 0.0 121.588 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -116.85 120.59 33.88 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.396 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HG2' ' HB3' ' A' ' 137' ' ' LYS . 70.9 Cg_exo -66.46 -20.57 54.29 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 117.985 2.263 . . . . 0.0 117.985 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.515 8.7 mtt 80.2 -165.99 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.423 0.4 OUTLIER -39.65 125.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -169.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.79 88.41 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -76.75 142.82 40.29 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 122.857 3.329 . . . . 0.0 113.556 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' PHE . 18.4 ptp180 -73.84 137.84 44.04 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.31 -1.494 . . . . 0.0 109.778 177.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.32 2.1 t -135.27 144.51 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 119.752 1.16 . . . . 0.0 112.688 -167.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -125.87 100.99 6.63 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.84 167.1 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 127.174 2.19 . . . . 0.0 112.138 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.15 127.57 36.21 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.564 160.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -119.43 155.69 31.54 Favored 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.6 m -125.31 138.56 54.07 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 159.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.53 145.73 14.47 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 123.347 2.794 . . . . 0.0 117.93 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -134.09 153.04 52.06 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 112.625 -1.787 . . . . 0.0 114.615 -175.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.09 170.67 14.56 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 123.042 1.401 . . . . 0.0 108.642 170.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER -60.43 -26.35 66.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 178.627 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.68 9.63 3.29 Favored 'General case' 0 CA--C 1.593 2.631 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.1 38.38 73.27 Favored Glycine 0 N--CA 1.509 3.538 0 CA-C-N 121.341 1.882 . . . . 0.0 114.819 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 m -109.34 114.47 28.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -79.71 90.89 5.22 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -69.75 -30.88 68.57 Favored 'General case' 0 CA--C 1.559 1.306 0 O-C-N 119.696 -1.877 . . . . 0.0 114.424 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -154.47 148.11 25.3 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 121.603 2.001 . . . . 0.0 111.345 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 m -145.91 94.76 2.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.526 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 t -57.48 -39.22 75.95 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.15 -44.08 83.11 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -73.86 -42.18 61.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -61.33 -19.51 61.89 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.39 74.4 mmtt 96.63 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.177 2.191 . . . . 0.0 113.192 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.64 152.54 31.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.04 1.4 . . . . 0.0 113.665 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.05 171.45 10.72 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.493 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.252 9.2 t80 -105.23 157.72 17.09 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.092 0.949 . . . . 0.0 109.235 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.7 p -157.89 145.71 18.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 119.295 -2.128 . . . . 0.0 110.313 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 85' ' ' VAL . 23.8 p90 -155.15 -173.36 4.53 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.875 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -123.05 123.07 40.03 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -49.15 112.0 0.56 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -172.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.97 47.79 82.26 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -107.21 14.16 26.48 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.88 -42.67 2.37 Favored Glycine 0 N--CA 1.51 3.614 0 O-C-N 120.782 -1.199 . . . . 0.0 111.41 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.279 8.3 tp10 -28.8 -48.96 0.07 Allowed 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 129.386 3.075 . . . . 0.0 118.805 169.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.255 9.3 m -117.61 -147.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 CA-C-O 124.066 1.888 . . . . 0.0 109.785 -175.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.4 pt -110.93 160.77 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 124.104 1.907 . . . . 0.0 110.238 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -32.67 73.25 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.018 -1.446 . . . . 0.0 113.205 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.06 70.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.016 -1.469 . . . . 0.0 112.443 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.27 -42.52 54.84 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.967 1.712 . . . . 0.0 112.423 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.84 -37.73 71.67 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -68.1 -56.74 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.056 0 CA-C-N 119.885 1.22 . . . . 0.0 111.191 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.65 94.54 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.4 t -67.59 -46.23 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.571 1.078 . . . . 0.0 111.736 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.25 62.78 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p -92.22 4.29 53.57 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.429 ' SD ' ' OE2' ' A' ' 132' ' ' GLU . 4.6 ptt? -116.48 119.51 35.85 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 122.304 2.32 . . . . 0.0 112.185 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -78.56 148.69 33.25 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.152 -1.593 . . . . 0.0 108.72 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.6 t -9.47 79.43 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 C-N-CA 125.299 1.44 . . . . 0.0 109.001 -158.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.55 ' H ' HD22 ' A' ' 133' ' ' LEU . . . -20.46 -29.45 0.0 OUTLIER Glycine 1 N--CA 1.523 4.437 1 N-CA-C 127.783 5.873 . . . . 0.0 127.783 -144.585 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.663 0.3 OUTLIER 52.97 -125.57 2.4 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 115.581 -2.152 . . . . 0.0 111.549 -161.897 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 132' ' ' GLU 0.461 0.9 OUTLIER -136.15 132.96 36.69 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.446 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 132' ' ' GLU 2.674 5.7 m -160.27 -151.98 0.27 Allowed 'General case' 0 CA--C 1.589 2.477 0 CA-C-N 120.224 1.375 . . . . 0.0 114.489 177.022 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -143.36 158.85 43.3 Favored 'General case' 0 CA--C 1.575 1.942 0 O-C-N 120.108 -1.62 . . . . 0.0 113.662 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.39 143.87 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 C-N-CA 126.128 1.771 . . . . 0.0 110.543 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.3 m -140.09 104.5 4.85 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.1 p -118.87 147.12 44.31 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -172.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -80.71 148.13 64.58 Favored Pre-proline 0 CA--C 1.581 2.166 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.647 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -36.43 -33.06 0.12 Allowed 'Trans proline' 0 CA--C 1.567 2.144 0 N-CA-C 122.079 3.838 . . . . 0.0 122.079 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.1 -44.66 91.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -78.86 -5.96 54.89 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 116.187 -1.863 . . . . 0.0 114.328 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.43 -153.25 0.5 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 122.324 2.329 . . . . 0.0 114.288 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.283 0.1 OUTLIER -82.11 11.42 5.26 Favored 'General case' 0 CA--C 1.575 1.921 0 O-C-N 119.22 -2.175 . . . . 0.0 113.582 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.36 -38.57 45.23 Favored Glycine 0 CA--C 1.553 2.441 0 CA-C-N 124.027 3.103 . . . . 0.0 115.354 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 p -70.78 -51.58 26.06 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 118.316 1.058 . . . . 0.0 113.761 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.98 -34.48 14.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.91 141.96 12.81 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.039 1.29 . . . . 0.0 113.646 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.478 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 2.0 t -95.42 146.17 30.84 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.834 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -41.52 -43.23 5.99 Favored 'Trans proline' 0 CA--C 1.584 3.023 0 C-N-CA 123.65 2.9 . . . . 0.0 119.107 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.72 57.25 6.28 Favored 'Trans proline' 0 CA--C 1.585 3.036 0 CA-C-N 125.325 2.937 . . . . 0.0 115.425 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 61.93 33.39 17.48 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.325 3.454 . . . . 0.0 120.325 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.478 ' HB ' ' H ' ' A' ' 117' ' ' SER . 11.9 mt -82.91 117.56 68.96 Favored Pre-proline 0 CA--C 1.59 2.485 0 O-C-N 120.127 -1.608 . . . . 0.0 108.768 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -90.31 178.02 2.23 Favored 'Trans proline' 0 CA--C 1.585 3.061 0 CA-C-N 123.483 2.279 . . . . 0.0 116.179 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.41 151.19 54.69 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.072 2.515 . . . . 0.0 117.621 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.252 38.4 t-20 59.62 44.0 15.05 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -177.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.4 105.5 15.46 Favored 'General case' 0 CA--C 1.562 1.436 0 O-C-N 120.534 -1.354 . . . . 0.0 110.35 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.8 m -66.01 150.18 49.08 Favored 'General case' 0 CA--C 1.592 2.562 0 O-C-N 120.843 -1.161 . . . . 0.0 111.651 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.5 tp -132.64 157.48 44.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.552 -1.968 . . . . 0.0 111.663 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.494 HG23 ' HE3' ' A' ' 59' ' ' TRP . 22.3 m -147.05 144.03 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 O-C-N 121.043 -1.036 . . . . 0.0 112.043 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -146.97 134.68 21.11 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.977 -1.077 . . . . 0.0 109.98 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -88.21 112.97 23.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.39 152.94 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.243 -0.91 . . . . 0.0 111.136 -168.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.644 ' CB ' ' HA ' ' A' ' 101' ' ' LEU 0.777 0.2 OUTLIER -154.56 -164.25 1.78 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 116.781 2.141 . . . . 0.0 116.781 164.011 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 99' ' ' GLY . 5.6 tt -145.0 133.28 21.67 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.819 1.295 . . . . 0.0 113.376 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.13 -47.71 7.64 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.94 151.07 23.09 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.283 1.433 . . . . 0.0 108.895 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.447 ' CD2' HD11 ' A' ' 133' ' ' LEU 0.294 0.0 OUTLIER -143.21 -101.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.629 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 46' ' ' PRO 0.421 13.1 tmtt? -111.01 -132.66 0.33 Allowed 'General case' 0 CA--C 1.588 2.418 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.229 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.697 0 CA-C-N 124.631 3.378 . . . . 0.0 113.923 177.791 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.373 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.254 60.4 t -135.5 135.45 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 CA-C-O 122.648 1.213 . . . . 0.0 113.842 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -91.41 114.19 26.65 Favored 'General case' 0 CA--C 1.584 2.27 0 CA-C-O 116.614 -1.66 . . . . 0.0 107.956 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -112.39 90.37 3.32 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 124.101 3.137 . . . . 0.0 108.205 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.87 130.33 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.436 -173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.303 1.0 OUTLIER -82.2 130.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 122.671 1.224 . . . . 0.0 113.133 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -110.81 -56.33 2.37 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.002 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.36 96.19 3.06 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.24 166.96 1.96 Allowed 'General case' 0 CA--C 1.59 2.495 0 CA-C-N 122.551 2.432 . . . . 0.0 116.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.35 -170.65 37.25 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 120.654 3.021 . . . . 0.0 120.654 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 t -81.02 15.33 1.89 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.46 34.04 68.05 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.5 p -122.6 26.83 8.11 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.8 1.24 . . . . 0.0 113.882 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.451 7.4 pt-20 40.41 -154.92 0.01 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.91 115.65 5.61 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 124.476 1.11 . . . . 0.0 111.191 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -41.26 -28.85 0.53 Allowed 'Trans proline' 0 CA--C 1.583 2.956 1 N-CA-C 122.626 4.049 . . . . 0.0 122.626 165.137 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.541 44.5 mtm 84.79 -141.56 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.29 1.1 tp -52.01 135.87 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 O-C-N 120.224 -1.548 . . . . 0.0 112.847 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.15 4.94 86.2 Favored Glycine 0 CA--C 1.553 2.442 0 CA-C-O 116.859 -2.078 . . . . 0.0 117.884 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.48 136.44 36.31 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 122.681 3.241 . . . . 0.0 112.577 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.51 98.2 11.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 136' ' ' PHE . 29.9 m -93.68 141.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -167.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.18 107.78 14.87 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 76' ' ' PHE . 3.1 m -114.11 165.95 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 123.272 1.511 . . . . 0.0 113.685 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.254 0.1 OUTLIER -132.11 113.36 13.23 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.075 167.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -105.91 161.21 14.65 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 124.019 1.866 . . . . 0.0 113.881 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.7 m -134.22 133.35 40.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 159.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.05 164.79 26.1 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 122.072 2.215 . . . . 0.0 118.048 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.596 ' HE3' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -148.34 155.98 41.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -173.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -85.1 172.19 11.44 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 123.469 1.604 . . . . 0.0 108.877 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.13 -33.82 74.0 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.301 0.2 OUTLIER -69.5 2.94 2.66 Favored 'General case' 0 CA--C 1.592 2.565 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 173.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.88 44.68 23.83 Favored Glycine 0 N--CA 1.503 3.106 0 CA-C-N 119.564 1.074 . . . . 0.0 114.174 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.9 m -120.77 119.81 33.83 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -78.98 97.24 5.98 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.152 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.01 -34.82 71.71 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.263 -2.148 . . . . 0.0 114.944 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.95 175.75 9.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -154.19 -77.1 0.11 Allowed 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.427 1.6 t 111.4 -40.05 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 128.775 2.83 . . . . 0.0 109.205 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.14 -34.81 15.06 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 169.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.95 -35.71 62.04 Favored 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -94.82 -85.01 0.32 Allowed 'General case' 0 CA--C 1.575 1.907 0 C-N-CA 124.716 1.206 . . . . 0.0 110.13 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? 175.32 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 127.29 2.236 . . . . 0.0 107.959 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -22.45 -37.92 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 1 N-CA-C 127.229 6.011 . . . . 0.0 127.229 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.441 53.2 pttt 71.53 -175.11 0.18 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.467 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.328 2.8 t80 -118.68 146.93 44.32 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.104 174.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.7 p -160.63 130.67 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 119.309 -2.119 . . . . 0.0 108.709 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.508 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.8 p90 -141.79 -173.71 3.87 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 123.216 0.607 . . . . 0.0 109.788 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.74 128.42 47.72 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 118.843 -2.411 . . . . 0.0 106.306 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.07 107.33 0.46 Allowed 'General case' 0 CA--C 1.578 2.038 0 O-C-N 121.314 -0.866 . . . . 0.0 112.536 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.61 56.32 5.56 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.024 -1.047 . . . . 0.0 114.802 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -102.17 -64.43 1.06 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 124.498 2.094 . . . . 0.0 112.963 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.63 -55.93 0.13 Allowed Glycine 0 N--CA 1.503 3.104 0 C-N-CA 128.86 3.124 . . . . 0.0 107.096 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.824 23.8 tt0 119.05 143.25 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 128.145 3.831 . . . . 0.0 116.807 162.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.347 14.1 m -79.87 -106.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.001 1 CA-C-N 105.319 -5.4 . . . . 0.0 104.962 -178.626 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -125.43 152.91 32.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 124.737 2.208 . . . . 0.0 105.538 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.27 -31.67 72.96 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 113.28 -1.782 . . . . 0.0 113.697 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.07 82.92 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.047 1.339 . . . . 0.0 111.391 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.544 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.9 m0 -70.46 -42.5 71.39 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 120.638 1.563 . . . . 0.0 112.549 172.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.0 -36.44 74.93 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 120.005 1.275 . . . . 0.0 114.185 172.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.259 1.3 mp -66.3 -56.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.274 1.397 . . . . 0.0 111.685 173.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.55 -45.31 91.12 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.285 75.8 t -65.04 -41.5 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 120.412 1.46 . . . . 0.0 112.531 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.58 64.63 Favored 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 120.336 1.426 . . . . 0.0 114.465 171.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 p -95.49 -6.97 39.39 Favored 'General case' 0 CA--C 1.588 2.411 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 38.6 mtp -96.69 123.11 40.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 121.597 1.999 . . . . 0.0 112.52 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -77.99 179.88 6.5 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.99 125.94 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.733 0 O-C-N 120.522 -1.361 . . . . 0.0 111.03 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.92 81.36 Favored Glycine 0 N--CA 1.515 3.934 0 CA-C-N 122.724 2.511 . . . . 0.0 116.901 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.63 132.1 41.46 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.474 2.137 . . . . 0.0 115.364 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.74 114.77 28.39 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.063 0.945 . . . . 0.0 111.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.2 m -136.53 159.56 41.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -109.73 127.24 54.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 123.845 1.783 . . . . 0.0 109.286 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.2 mt -92.58 118.59 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.395 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 104.53 11.93 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 7.7 p -118.49 148.56 42.49 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -89.02 142.19 30.04 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.495 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -42.54 -26.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 124.812 3.674 . . . . 0.0 121.413 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -31.94 72.96 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 121.314 1.87 . . . . 0.0 114.555 172.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -91.33 -9.75 43.83 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 125.472 1.509 . . . . 0.0 113.098 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.44 -112.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.196 1.816 . . . . 0.0 112.655 -176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.329 1.3 m-85 -113.79 21.03 15.35 Favored 'General case' 0 CA--C 1.588 2.411 0 CA-C-N 121.219 1.827 . . . . 0.0 113.751 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.2 -15.92 4.15 Favored Glycine 0 N--CA 1.501 2.99 1 N-CA-C 124.332 4.493 . . . . 0.0 124.332 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -71.69 -65.59 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.656 2.228 . . . . 0.0 112.063 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.29 10.4 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.38 160.28 36.38 Favored Glycine 0 CA--C 1.547 2.055 0 CA-C-N 122.144 2.247 . . . . 0.0 112.882 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -81.45 123.68 80.89 Favored Pre-proline 0 CA--C 1.577 2.008 0 O-C-N 120.258 -1.731 . . . . 0.0 107.736 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -33.69 -45.09 0.34 Allowed 'Trans proline' 0 CA--C 1.582 2.891 0 N-CA-C 121.99 3.804 . . . . 0.0 121.99 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -86.88 -16.97 3.32 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 CA-C-N 125.097 2.856 . . . . 0.0 118.948 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -159.09 -38.29 0.06 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.82 129.59 70.25 Favored Pre-proline 0 CA--C 1.581 2.143 0 O-C-N 120.195 -1.566 . . . . 0.0 113.897 -172.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.82 163.17 5.07 Favored 'Trans proline' 0 CA--C 1.586 3.121 0 CA-C-N 123.572 2.312 . . . . 0.0 113.202 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 8.95 0.45 Allowed 'Trans proline' 0 CA--C 1.576 2.619 0 N-CA-C 120.505 3.233 . . . . 0.0 120.505 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -139.68 62.79 1.51 Allowed 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.302 -1.499 . . . . 0.0 110.11 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.3 137.06 17.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.964 -1.71 . . . . 0.0 111.149 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.2 m -72.96 150.16 42.74 Favored 'General case' 0 CA--C 1.588 2.428 0 O-C-N 120.485 -1.385 . . . . 0.0 111.202 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.342 0.2 OUTLIER -134.78 167.33 21.06 Favored 'General case' 0 CA--C 1.574 1.895 0 O-C-N 118.685 -2.509 . . . . 0.0 109.524 176.11 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.596 HG13 ' HE3' ' A' ' 59' ' ' TRP . 1.6 p -141.22 146.35 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.846 -1.159 . . . . 0.0 112.02 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.288 0.6 OUTLIER -145.77 124.94 12.9 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.88 0.848 . . . . 0.0 110.501 169.162 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.41 115.25 24.7 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 t -124.26 134.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.026 0.917 . . . . 0.0 112.382 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -107.43 124.45 49.88 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 136' ' ' PHE . 57.2 tp -103.31 119.38 38.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.85 -49.12 8.68 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -170.61 170.58 6.71 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.469 1.908 . . . . 0.0 108.122 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.416 ' CD2' HD21 ' A' ' 133' ' ' LEU 0.255 5.7 p90 -154.94 -81.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 119.951 -1.718 . . . . 0.0 112.395 -175.307 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.412 77.2 tttt -119.98 -136.38 0.33 Allowed 'General case' 0 CA--C 1.594 2.644 0 C-N-CA 124.512 1.125 . . . . 0.0 108.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.351 0 O-C-N 117.465 -3.272 . . . . 0.0 112.561 -179.136 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 1 N-CA-C 123.739 4.255 . . . . 0.0 123.739 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -142.75 125.29 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 124.278 0.634 . . . . 0.0 111.859 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -100.6 143.69 30.47 Favored 'General case' 0 CA--C 1.587 2.39 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.314 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -120.61 113.64 20.54 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-N 124.054 3.116 . . . . 0.0 111.434 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.51 92.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.505 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.311 0.4 OUTLIER -76.95 135.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 120.887 -1.133 . . . . 0.0 110.26 178.072 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -121.09 -56.95 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.458 0.703 . . . . 0.0 111.898 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -118.6 99.73 6.99 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.96 142.71 52.83 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 119.178 -2.201 . . . . 0.0 112.614 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.49 163.54 42.73 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 119.99 -1.693 . . . . 0.0 116.638 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.3 p -121.34 -79.41 0.61 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.142 -176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 2.73 -85.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.204 0 N-CA-C 122.116 3.606 . . . . 0.0 122.116 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.404 ' H ' HG21 ' A' ' 98' ' ' VAL . 69.8 p -117.21 26.64 9.63 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.381 6.5 mt-10 55.24 -153.68 0.32 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 176.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -110.58 122.39 38.51 Favored Pre-proline 0 CA--C 1.572 1.801 0 O-C-N 120.559 -1.338 . . . . 0.0 108.497 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.397 0.2 OUTLIER -115.65 -87.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 N-CA-C 119.159 2.715 . . . . 0.0 119.159 -176.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -157.74 171.1 20.91 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 120.847 3.647 . . . . 0.0 120.847 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.36 132.41 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.763 0 CA-C-O 122.874 1.321 . . . . 0.0 109.932 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.85 3.39 68.34 Favored Glycine 0 CA--C 1.558 2.778 0 CA-C-O 116.836 -2.091 . . . . 0.0 118.186 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.79 141.24 56.59 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-N 122.624 3.212 . . . . 0.0 112.82 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -84.47 96.18 9.03 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.086 1.766 . . . . 0.0 108.353 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.31 135.09 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.99 100.46 8.89 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.76 164.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 127.356 2.263 . . . . 0.0 113.719 -172.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.79 124.4 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.583 160.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -115.03 156.87 24.33 Favored 'General case' 0 CA--C 1.593 2.608 0 CA-C-O 122.52 1.153 . . . . 0.0 111.058 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -130.36 138.51 50.44 Favored 'General case' 0 N--CA 1.515 2.792 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 160.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.08 140.71 8.57 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-N 123.329 2.786 . . . . 0.0 117.902 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.19 159.54 42.02 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 127.275 2.23 . . . . 0.0 115.057 -176.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -76.73 177.34 7.65 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.603 1.192 . . . . 0.0 109.594 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.345 0.0 OUTLIER -62.84 -27.06 69.07 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 176.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.9 13.97 0.94 Allowed 'General case' 0 CA--C 1.606 3.106 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.1 33.58 61.13 Favored Glycine 0 N--CA 1.511 3.663 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -91.86 109.42 20.75 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -68.0 107.13 2.58 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -81.64 -34.98 30.51 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 121.083 1.765 . . . . 0.0 112.099 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -155.84 155.48 33.03 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 124.163 1.935 . . . . 0.0 111.337 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -159.95 99.63 1.38 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.146 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -50.84 -34.28 27.21 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.71 -46.69 86.77 Favored 'General case' 0 CA--C 1.58 2.105 0 C-N-CA 125.346 1.458 . . . . 0.0 114.094 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.1 -41.48 77.4 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.418 1.087 . . . . 0.0 113.653 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -70.6 4.92 2.1 Favored 'General case' 0 CA--C 1.59 2.511 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 65.48 8.56 5.13 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 119.318 3.081 . . . . 0.0 119.318 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.12 -157.14 0.61 Allowed 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 125.436 1.494 . . . . 0.0 113.964 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -139.22 162.12 35.75 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 125.425 1.49 . . . . 0.0 109.393 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.354 2.1 t80 -108.47 149.43 28.81 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 120.944 1.702 . . . . 0.0 110.403 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.9 p -160.81 141.76 11.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 119.71 -1.869 . . . . 0.0 109.519 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 85' ' ' VAL . 9.1 p90 -155.01 177.45 11.31 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.233 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -116.63 125.77 52.27 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.21 105.83 0.1 Allowed 'General case' 0 CA--C 1.575 1.924 0 C-N-CA 124.198 0.999 . . . . 0.0 113.668 -173.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.6 44.48 93.9 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.42 23.8 tptp -124.47 -79.8 0.61 Allowed 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 118.147 0.974 . . . . 0.0 110.262 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.24 70.57 0.24 Allowed Glycine 0 N--CA 1.505 3.27 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.407 49.8 tt0 -68.14 152.99 44.64 Favored 'General case' 0 CA--C 1.56 1.33 1 CA-C-O 130.466 4.936 . . . . 0.0 118.245 -160.471 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.378 24.5 m -80.27 -126.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.645 2 CA-C-N 100.987 -7.37 . . . . 0.0 106.767 -178.3 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 89' ' ' TRP . 34.5 pt -106.54 154.06 7.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.805 2.24 . . . . 0.0 106.402 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 10.6 tmtt? -69.1 -25.48 64.44 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 112.859 -1.973 . . . . 0.0 114.475 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.69 89.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 116.528 -1.701 . . . . 0.0 111.454 165.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.522 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -71.37 -44.01 65.82 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 121.385 1.902 . . . . 0.0 112.711 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -54.44 -41.18 69.1 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 121.23 1.832 . . . . 0.0 113.868 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -66.87 -61.38 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 CA-C-N 119.714 1.143 . . . . 0.0 112.071 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.617 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -68.5 -33.43 74.13 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.27 20.1 t -72.4 -39.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.82 1.646 . . . . 0.0 110.443 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.22 -31.27 63.35 Favored 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 120.152 1.342 . . . . 0.0 114.179 167.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.6 p -78.39 -19.67 52.82 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 133' ' ' LEU 0.346 0.0 OUTLIER -90.37 163.84 14.55 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 124.701 3.409 . . . . 0.0 116.263 -179.126 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 137.88 51.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.944 -1.723 . . . . 0.0 112.257 -173.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.404 HG21 ' H ' ' A' ' 43' ' ' THR . 77.2 t -9.94 -171.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 127.922 2.489 . . . . 0.0 116.28 -173.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 25.67 -17.5 0.0 OUTLIER Glycine 0 N--CA 1.509 3.565 2 O-C-N 107.411 -9.555 . . . . 0.0 127.918 155.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.548 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.53 48.4 mt-10 -109.81 -149.61 0.44 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 123.996 3.898 . . . . 0.0 116.042 -178.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 15.3 tp -135.99 139.04 42.86 Favored 'General case' 0 CA--C 1.592 2.577 0 N-CA-C 119.917 3.303 . . . . 0.0 119.917 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.6 p -146.15 -168.11 2.91 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 122.605 1.193 . . . . 0.0 111.316 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 3.2 mtt180 -140.92 158.96 43.21 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 123.067 1.413 . . . . 0.0 112.555 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.8 mt -117.51 135.27 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.414 1.485 . . . . 0.0 109.262 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 m -127.59 102.8 7.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 15.7 p -122.0 149.99 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -83.11 141.06 42.89 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.456 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -61.61 -12.04 22.96 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 N-CA-C 119.282 2.762 . . . . 0.0 119.282 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.41 -39.95 92.62 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 121.0 1.727 . . . . 0.0 113.078 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -77.45 -6.98 55.42 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.906 1.282 . . . . 0.0 113.251 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.54 -121.47 0.17 Allowed 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CE2' HD21 ' A' ' 127' ' ' LEU 0.348 0.2 OUTLIER -85.58 7.44 23.14 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 122.057 2.208 . . . . 0.0 115.7 -178.036 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.8 -32.4 17.97 Favored Glycine 0 N--CA 1.501 2.998 0 CA-C-N 123.448 2.84 . . . . 0.0 119.455 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.1 p -77.92 84.57 4.2 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 118.464 1.132 . . . . 0.0 109.97 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.365 . . 86.43 -14.91 0.48 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.65 162.06 32.44 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 123.53 2.877 . . . . 0.0 113.438 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 3.5 t -89.51 148.34 40.07 Favored Pre-proline 0 CA--C 1.577 2.014 0 O-C-N 121.047 -1.266 . . . . 0.0 111.102 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.86 -43.55 6.83 Favored 'Trans proline' 0 CA--C 1.587 3.167 0 C-N-CA 123.456 2.771 . . . . 0.0 118.784 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.58 58.6 7.04 Favored 'Trans proline' 0 CA--C 1.586 3.081 0 CA-C-N 125.346 2.945 . . . . 0.0 115.292 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 61.18 31.12 19.59 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.328 3.455 . . . . 0.0 120.328 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.499 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -84.43 134.59 42.44 Favored Pre-proline 0 CA--C 1.596 2.736 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.36 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -90.5 157.56 4.4 Favored 'Trans proline' 0 CA--C 1.591 3.355 0 CA-C-N 125.981 3.172 . . . . 0.0 114.275 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.87 -42.39 64.06 Favored 'Trans proline' 0 CA--C 1.575 2.541 0 N-CA-C 119.732 2.935 . . . . 0.0 119.732 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.09 64.42 3.3 Favored 'General case' 0 CA--C 1.582 2.174 0 O-C-N 120.799 -1.188 . . . . 0.0 113.248 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.92 133.72 21.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.128 -1.608 . . . . 0.0 111.764 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.8 m -69.95 150.11 47.05 Favored 'General case' 0 CA--C 1.59 2.499 0 O-C-N 121.023 -1.048 . . . . 0.0 112.272 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 112' ' ' TYR . 9.8 tp -126.43 159.15 34.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 119.846 -1.784 . . . . 0.0 111.726 -173.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.98 136.1 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 O-C-N 121.003 -1.06 . . . . 0.0 110.256 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.274 0.6 OUTLIER -135.28 125.04 25.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.59 113.41 21.8 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 173.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.91 145.56 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.755 -0.591 . . . . 0.0 111.915 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 101' ' ' LEU 0.944 10.5 tt0 -151.54 -151.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 161.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -144.27 164.07 31.82 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -166.552 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.456 ' H ' HD23 ' A' ' 133' ' ' LEU . 47.8 m-85 -120.7 -50.51 2.19 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.349 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.98 152.0 10.84 Favored 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.872 1.669 . . . . 0.0 109.865 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -139.39 -93.66 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.235 -1.541 . . . . 0.0 109.803 178.493 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.436 77.3 tttt -127.91 -107.45 0.3 Allowed 'General case' 0 CA--C 1.588 2.411 0 CA-C-O 115.621 -2.133 . . . . 0.0 107.278 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 1 CA-C-N 126.37 4.168 . . . . 0.0 121.032 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 121.786 3.474 . . . . 0.0 121.786 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.341 11.4 p -136.85 121.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tp -69.61 121.62 17.48 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 127.187 2.195 . . . . 0.0 112.316 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.11 102.31 11.03 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 122.393 2.36 . . . . 0.0 107.297 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 3.4 t -92.85 92.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.036 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.385 0.6 OUTLIER -65.2 130.68 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.03 -60.8 1.67 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.582 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.48 99.94 7.93 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -53.42 -74.81 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.56 -154.8 25.77 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 117.661 1.824 . . . . 0.0 117.661 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.0 p -87.72 -74.42 0.45 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.47 20.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 121.918 3.527 . . . . 0.0 121.918 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -134.7 67.64 1.5 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.501 12.7 pt-20 -33.59 -101.98 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.989 1 N-CA-C 123.774 4.731 . . . . 0.0 123.774 -170.48 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -112.16 100.01 48.0 Favored Pre-proline 0 CA--C 1.581 2.168 0 N-CA-C 118.233 2.679 . . . . 0.0 118.233 -169.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -100.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.579 2.739 0 C-N-CA 123.813 3.009 . . . . 0.0 119.905 169.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -163.11 161.04 25.0 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.253 0.4 OUTLIER -59.6 138.25 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-O 122.552 1.167 . . . . 0.0 110.897 175.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.15 89.06 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -85.61 157.06 20.46 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-N 121.836 2.818 . . . . 0.0 114.482 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -74.03 136.97 43.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.212 -1.555 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.371 1.1 t -137.81 132.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.388 0.675 . . . . 0.0 109.53 -165.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.44 117.39 26.75 Favored 'General case' 0 CA--C 1.562 1.416 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' A' ' 76' ' ' PHE . 19.4 m -128.42 166.36 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -130.73 120.84 24.41 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.135 169.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -124.71 137.45 54.35 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 29.4 m -106.98 153.47 22.52 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 160.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.71 142.75 8.98 Favored Glycine 0 CA--C 1.547 2.047 0 O-C-N 119.106 -2.246 . . . . 0.0 116.151 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.459 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -135.15 150.13 50.11 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.977 1.711 . . . . 0.0 113.088 -177.117 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.17 174.3 7.38 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.511 -0.743 . . . . 0.0 111.435 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.5 tp -61.34 -26.55 67.89 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.6 -5.93 13.39 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 167.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.83 58.04 Favored Glycine 0 N--CA 1.502 3.041 0 CA-C-N 120.622 1.555 . . . . 0.0 114.181 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -106.04 120.47 41.86 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -75.95 91.51 3.05 Favored 'General case' 0 CA--C 1.583 2.213 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.872 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -66.69 -32.06 73.13 Favored 'General case' 0 CA--C 1.566 1.56 0 O-C-N 119.282 -2.136 . . . . 0.0 115.516 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -149.19 158.91 44.57 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 120.248 1.386 . . . . 0.0 111.707 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 57' ' ' THR 0.356 43.3 t -135.36 -34.45 0.85 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 120.003 3.334 . . . . 0.0 120.003 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.321 60.0 p 58.31 -53.47 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 123.389 2.813 . . . . 0.0 116.717 -177.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.84 -34.32 27.43 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 128.343 2.657 . . . . 0.0 113.609 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -46.1 -42.72 14.02 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 125.241 1.416 . . . . 0.0 113.547 167.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.687 96.2 mtt180 95.02 38.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 120.023 3.342 . . . . 0.0 120.023 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.51 -56.15 4.37 Favored 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.78 166.82 23.6 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 126.409 1.884 . . . . 0.0 108.122 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -98.93 -162.06 0.92 Allowed 'General case' 0 CA--C 1.579 2.067 0 O-C-N 120.974 -1.079 . . . . 0.0 110.218 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.601 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.33 2.5 t80 -128.96 154.18 46.82 Favored 'General case' 0 CA--C 1.588 2.426 0 O-C-N 119.381 -2.074 . . . . 0.0 110.974 173.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.9 p -167.4 142.17 3.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 118.92 -2.362 . . . . 0.0 109.598 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CG ' HG11 ' A' ' 85' ' ' VAL . 6.6 p90 -153.49 -179.55 7.87 Favored 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.824 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.23 124.36 52.35 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.0 106.17 0.08 Allowed 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 59.28 49.16 81.47 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 -10.98 27.52 Favored 'General case' 0 CA--C 1.579 2.091 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.1 -37.0 3.02 Favored Glycine 0 CA--C 1.564 3.118 0 C-N-CA 124.495 1.045 . . . . 0.0 110.547 -168.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -38.6 -46.72 1.23 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 120.552 3.538 . . . . 0.0 120.552 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.505 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.261 7.6 m -117.8 -154.44 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-O 124.101 1.905 . . . . 0.0 109.0 -172.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.475 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.9 pt -101.05 162.34 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 125.09 2.376 . . . . 0.0 110.113 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -69.1 -35.01 75.98 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 112.678 -2.056 . . . . 0.0 114.154 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.64 -33.9 66.78 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 116.704 -1.617 . . . . 0.0 111.161 167.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.475 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -76.21 -47.04 25.49 Favored 'General case' 0 C--N 1.371 1.515 0 CA-C-N 121.492 1.951 . . . . 0.0 112.982 173.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.96 -32.57 69.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 121.194 1.815 . . . . 0.0 115.54 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.255 1.6 mp -65.98 -59.28 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.28 0.945 . . . . 0.0 110.046 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.33 -53.49 57.68 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.613 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.283 56.7 t -54.28 -40.6 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 120.454 1.479 . . . . 0.0 114.26 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.64 70.06 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 119.881 1.219 . . . . 0.0 113.372 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 p -90.55 18.82 5.85 Favored 'General case' 0 CA--C 1.601 2.909 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.543 ' CE ' HD22 ' A' ' 101' ' ' LEU . 56.4 mtp -119.79 150.41 40.46 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 119.226 -2.171 . . . . 0.0 116.711 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 146.87 29.91 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.838 2.903 . . . . 0.0 118.838 -171.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -45.89 137.13 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 CA-C-N 112.897 -1.956 . . . . 0.0 113.13 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.53 -43.6 1.96 Allowed Glycine 0 N--CA 1.491 2.34 0 CA-C-O 115.608 -2.774 . . . . 0.0 116.713 172.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.6 mt-10 -149.21 -175.99 5.19 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 121.966 2.883 . . . . 0.0 114.506 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.543 HD22 ' CE ' ' A' ' 96' ' ' MET 0.997 0.3 OUTLIER -155.49 -142.15 0.11 Allowed 'General case' 0 CA--C 1.604 3.05 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 172.64 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.533 ' SG ' HD23 ' A' ' 101' ' ' LEU 0.321 0.6 OUTLIER -151.41 -160.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 126.477 1.911 . . . . 0.0 113.746 -163.403 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.422 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 ptt85 -118.63 121.08 39.32 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.318 2.009 . . . . 0.0 110.124 165.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 mt -78.76 132.03 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 112.535 -2.12 . . . . 0.0 106.028 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.417 ' HA ' HG12 ' A' ' 128' ' ' VAL . 11.3 m -143.22 113.03 7.03 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . 2.679 2.7 m -160.28 -158.79 0.65 Allowed 'General case' 0 CA--C 1.59 2.493 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -97.6 122.68 54.59 Favored Pre-proline 0 CA--C 1.571 1.766 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -168.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 17.6 Cg_exo -42.59 -19.94 0.13 Allowed 'Trans proline' 0 CA--C 1.563 1.948 1 N-CA-C 122.534 4.013 . . . . 0.0 122.534 176.863 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.289 1.7 pm0 -63.03 -34.07 76.79 Favored 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 122.97 2.623 . . . . 0.0 113.098 169.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -74.29 -12.24 60.49 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 124.578 1.151 . . . . 0.0 113.799 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.51 -124.22 0.2 Allowed 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.289 0.6 OUTLIER -80.45 -4.63 54.5 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.133 2.242 . . . . 0.0 115.242 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -47.59 -17.99 0.56 Allowed Glycine 0 N--CA 1.497 2.755 1 N-CA-C 125.363 4.905 . . . . 0.0 125.363 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 t -65.69 -57.22 8.57 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 121.066 2.433 . . . . 0.0 111.379 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.46 -0.74 9.73 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 163.63 39.32 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-N 122.72 2.509 . . . . 0.0 111.82 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.528 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.7 t -85.51 112.21 42.67 Favored Pre-proline 0 CA--C 1.582 2.179 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.288 94.6 Cg_exo -31.52 -49.96 0.27 Allowed 'Trans proline' 0 CA--C 1.58 2.794 1 N-CA-C 123.702 4.462 . . . . 0.0 123.702 -174.042 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.63 -15.42 6.09 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 CA-C-N 125.211 2.897 . . . . 0.0 119.311 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -149.35 -6.89 0.35 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.528 ' HB ' ' H ' ' A' ' 117' ' ' SER . 25.9 mt -125.1 130.5 24.16 Favored Pre-proline 0 N--CA 1.507 2.401 0 CA-C-N 122.397 2.362 . . . . 0.0 113.767 -170.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -89.55 161.38 5.37 Favored 'Trans proline' 0 CA--C 1.591 3.356 0 CA-C-N 123.702 2.358 . . . . 0.0 112.116 173.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.03 -33.74 95.23 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 N-CA-C 119.888 2.996 . . . . 0.0 119.888 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -97.24 70.25 2.33 Favored 'General case' 0 CA--C 1.583 2.225 0 O-C-N 120.648 -1.283 . . . . 0.0 110.449 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.94 117.4 4.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 119.786 -1.821 . . . . 0.0 110.701 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 m -48.32 142.45 5.56 Favored 'General case' 0 CA--C 1.59 2.506 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.35 149.22 48.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 122.09 2.223 . . . . 0.0 111.194 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.459 HG23 ' HE3' ' A' ' 59' ' ' TRP . 30.6 m -144.86 146.95 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -142.53 132.32 24.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.714 -0.616 . . . . 0.0 109.83 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -95.7 98.28 10.35 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.422 HG12 ' HG3' ' A' ' 132' ' ' GLU . 3.9 t -122.81 162.46 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 -167.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.422 ' HG3' HG12 ' A' ' 131' ' ' VAL 2.899 27.9 mt-10 174.58 167.7 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 120.961 3.689 . . . . 0.0 120.961 162.105 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.98 130.56 38.51 Favored 'General case' 0 N--CA 1.49 1.554 1 N-CA-C 123.208 4.522 . . . . 0.0 123.208 -153.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.92 -51.05 9.58 Favored 'General case' 0 CA--C 1.581 2.15 0 O-C-N 121.254 -0.904 . . . . 0.0 112.022 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? 176.59 163.28 0.42 Allowed 'General case' 0 CA--C 1.582 2.202 0 C-N-CA 127.676 2.391 . . . . 0.0 106.699 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.412 ' HD1' ' H ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -141.57 -82.18 0.22 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.856 -1.778 . . . . 0.0 109.71 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.412 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 19.1 mmmt -79.79 -32.48 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.338 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 120.519 2.968 . . . . 0.0 120.519 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.83 146.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.272 0 N-CA-C 118.861 2.911 . . . . 0.0 118.861 -173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -113.89 138.61 50.08 Favored 'General case' 0 CA--C 1.596 2.724 0 C-N-CA 127.369 2.268 . . . . 0.0 107.239 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -125.77 125.62 43.24 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 123.638 2.926 . . . . 0.0 109.458 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.86 119.54 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.561 -0.712 . . . . 0.0 109.568 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.565 HD13 ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -90.16 137.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-N 120.067 1.303 . . . . 0.0 111.629 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -123.47 -60.18 1.49 Allowed 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.552 1.141 . . . . 0.0 110.84 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -121.5 109.33 14.7 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -49.77 -38.27 33.38 Favored 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 119.541 3.163 . . . . 0.0 119.541 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.01 176.34 18.69 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 126.27 1.89 . . . . 0.0 115.886 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -151.56 -17.16 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.36 37.34 0.82 Allowed Glycine 0 N--CA 1.499 2.837 1 N-CA-C 123.37 4.108 . . . . 0.0 123.37 -175.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.3 p 65.69 -6.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.82 177.17 9.32 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 p -134.07 172.96 6.4 Favored Pre-proline 0 CA--C 1.59 2.496 0 C-N-CA 126.465 1.906 . . . . 0.0 109.402 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -100.61 -169.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.568 2.188 0 CA-C-N 123.788 2.388 . . . . 0.0 116.814 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -139.56 162.28 35.46 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 111.998 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 1.5 tp -61.65 136.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 O-C-N 119.34 -2.1 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.07 11.5 74.8 Favored Glycine 0 CA--C 1.561 2.912 0 N-CA-C 118.157 2.023 . . . . 0.0 118.157 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 158.94 16.83 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 120.866 2.333 . . . . 0.0 111.82 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -82.75 135.56 34.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.227 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -135.05 136.64 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 119.399 1.0 . . . . 0.0 110.603 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -117.54 109.35 16.61 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 120.575 -1.328 . . . . 0.0 107.688 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.47 173.1 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 CA-C-O 124.812 2.244 . . . . 0.0 113.221 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.62 126.88 39.46 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.96 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 143.5 47.91 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 121.624 3.935 . . . . 0.0 121.624 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.8 m -113.11 143.25 44.67 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 164.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.75 157.81 27.49 Favored Glycine 0 CA--C 1.56 2.874 0 CA-C-N 122.103 2.229 . . . . 0.0 116.037 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.44 151.94 36.09 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.283 1.433 . . . . 0.0 114.8 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.66 174.47 9.92 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.072 1.415 . . . . 0.0 109.316 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -30.17 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.89 5.66 1.47 Allowed 'General case' 0 CA--C 1.597 2.775 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 36.25 65.28 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 119.769 -1.832 . . . . 0.0 115.241 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.7 m -107.71 117.32 33.8 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -79.09 89.52 4.82 Favored 'General case' 0 CA--C 1.592 2.573 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.37 -34.59 78.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 118.81 -2.431 . . . . 0.0 115.595 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -143.02 168.33 19.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -141.55 -40.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.768 1 N-CA-C 128.206 6.372 . . . . 0.0 128.206 -170.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.251 3.9 m -141.83 -101.7 0.14 Allowed 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 75' ' ' LYS 0.312 25.5 mt -90.13 -28.1 19.18 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.318 12.3 t70 110.22 -14.45 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 127.433 2.293 . . . . 0.0 115.128 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.457 4.3 mmp_? 87.16 39.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -153.66 -66.21 0.15 Allowed 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.857 1.263 . . . . 0.0 107.625 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -130.84 -169.26 2.13 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 125.491 1.516 . . . . 0.0 108.611 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HA ' HD22 ' A' ' 70' ' ' LEU . 40.1 mmtm -74.07 157.26 36.4 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 119.818 -1.801 . . . . 0.0 112.303 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -74.3 116.5 15.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 123.343 2.792 . . . . 0.0 105.477 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -144.3 144.43 31.47 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.652 -1.28 . . . . 0.0 109.861 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CG ' HG11 ' A' ' 85' ' ' VAL . 36.5 p90 -148.76 -169.87 3.47 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.35 1.071 . . . . 0.0 112.862 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -125.41 113.97 18.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 tp -40.14 113.13 0.33 Allowed 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.79 28.97 61.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 119.526 2.57 . . . . 0.0 119.526 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -96.15 13.02 28.72 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 122.173 2.987 . . . . 0.0 117.447 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.71 -44.96 2.54 Favored Glycine 0 N--CA 1.51 3.618 0 O-C-N 120.91 -1.119 . . . . 0.0 111.052 -172.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.271 37.7 tt0 -23.45 -49.42 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 129.709 3.204 . . . . 0.0 119.641 169.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.585 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.302 17.1 m -107.97 -129.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 123.205 1.478 . . . . 0.0 108.098 -177.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.564 HG13 ' H ' ' A' ' 89' ' ' TRP . 44.8 pt -130.63 163.78 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 124.069 1.89 . . . . 0.0 108.869 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.256 8.0 tmtm? -69.31 -33.04 72.55 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.181 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.12 77.19 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.324 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.564 ' H ' HG13 ' A' ' 86' ' ' ILE . 37.2 m0 -72.06 -41.66 67.14 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.527 1.967 . . . . 0.0 112.957 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -57.9 -42.36 84.52 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 4.9 mt -64.78 -56.9 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.745 0 CA-C-N 118.841 0.746 . . . . 0.0 112.192 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.75 84.58 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.286 89.7 t -63.61 -34.9 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.343 1.428 . . . . 0.0 112.702 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.24 71.15 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 120.885 1.675 . . . . 0.0 113.051 169.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -79.77 5.23 14.06 Favored 'General case' 0 CA--C 1.592 2.59 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 18.2 mtt -91.58 139.18 30.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.305 -2.122 . . . . 0.0 115.012 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -93.22 159.69 15.17 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.13 130.35 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.95 0 O-C-N 119.122 -2.236 . . . . 0.0 111.055 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.92 -17.77 43.93 Favored Glycine 0 N--CA 1.514 3.898 0 CA-C-N 123.696 2.953 . . . . 0.0 116.857 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.462 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 34.4 tt0 -54.93 125.55 20.74 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 tp -103.96 121.69 43.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.125 0.97 . . . . 0.0 108.798 173.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.565 ' SG ' HD13 ' A' ' 36' ' ' ILE . 81.0 m -146.67 179.63 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.548 1.166 . . . . 0.0 110.96 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -136.0 127.6 28.87 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 123.815 1.769 . . . . 0.0 109.643 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.5 134.97 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.658 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 m -130.03 99.8 5.21 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.549 ' SG ' ' CD2' ' A' ' 127' ' ' LEU . 19.9 p -124.25 145.9 49.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -76.15 146.77 78.99 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 112.824 -1.989 . . . . 0.0 112.157 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -47.66 -23.47 3.78 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 N-CA-C 120.34 3.169 . . . . 0.0 120.34 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -63.83 -37.72 88.45 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.556 1.526 . . . . 0.0 115.017 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.14 -1.55 57.98 Favored 'General case' 0 CA--C 1.575 1.929 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.856 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.7 -122.34 0.17 Allowed 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 121.643 2.02 . . . . 0.0 116.264 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 127' ' ' LEU 0.284 3.4 m-85 -83.03 0.57 44.25 Favored 'General case' 0 N--CA 1.517 2.877 0 CA-C-N 121.881 2.128 . . . . 0.0 115.078 -178.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.69 18.97 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 122.571 3.788 . . . . 0.0 122.571 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -67.87 -56.74 7.96 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 119.653 1.726 . . . . 0.0 112.766 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -133.74 -4.11 2.89 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 118.641 2.83 . . . . 0.0 118.641 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.24 155.76 32.02 Favored Glycine 0 CA--C 1.545 1.961 0 CA-C-N 123.693 2.951 . . . . 0.0 111.789 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 t -86.53 128.76 55.64 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 116.879 -1.534 . . . . 0.0 108.814 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -32.99 -45.98 0.29 Allowed 'Trans proline' 0 CA--C 1.58 2.824 1 N-CA-C 124.351 4.712 . . . . 0.0 124.351 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.55 -28.83 9.67 Favored 'Trans proline' 0 CA--C 1.573 2.439 0 CA-C-N 125.783 3.101 . . . . 0.0 119.662 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -163.17 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mt -79.9 146.42 63.94 Favored Pre-proline 0 CA--C 1.595 2.683 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -170.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -102.84 174.51 0.19 Allowed 'Trans proline' 0 CA--C 1.593 3.426 0 CA-C-N 125.119 2.864 . . . . 0.0 114.756 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.34 25.44 0.47 Allowed 'Trans proline' 0 CA--C 1.579 2.765 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -147.89 60.02 1.12 Allowed 'General case' 0 CA--C 1.582 2.209 0 O-C-N 120.103 -1.623 . . . . 0.0 111.706 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.93 120.93 6.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.756 -1.84 . . . . 0.0 109.814 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 96.3 m -68.53 159.22 32.25 Favored 'General case' 0 CA--C 1.584 2.257 0 O-C-N 121.141 -0.974 . . . . 0.0 112.814 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD2' ' SG ' ' A' ' 106' ' ' CYS 0.289 0.0 OUTLIER -141.86 177.53 8.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.23 -2.169 . . . . 0.0 111.372 -177.052 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.3 148.99 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 125.392 1.477 . . . . 0.0 110.942 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.52 124.99 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.726 . . . . 0.0 109.555 172.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -87.63 118.37 27.07 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.17 141.93 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 121.242 1.837 . . . . 0.0 112.368 -172.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -116.05 110.17 18.53 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.793 0.837 . . . . 0.0 110.378 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.47 141.83 28.21 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 123.701 1.715 . . . . 0.0 111.002 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -120.57 -45.44 2.41 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -158.61 149.88 20.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.082 1.353 . . . . 0.0 109.045 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.425 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.284 0.0 OUTLIER -156.54 -90.71 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 O-C-N 121.227 -0.921 . . . . 0.0 111.717 179.791 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.425 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 43.8 tttm -79.87 47.15 0.84 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.126 0 N-CA-C 122.979 3.952 . . . . 0.0 122.979 173.567 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.07 168.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.658 1.729 . . . . 0.0 112.133 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.81 0.9 OUTLIER -165.15 -168.23 1.36 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 123.67 0.788 . . . . 0.0 112.514 157.585 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.91 130.69 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.285 1.402 . . . . 0.0 113.846 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.15 118.27 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.02 143.24 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.04 0.924 . . . . 0.0 112.78 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -127.43 -66.43 0.88 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.005 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -111.46 90.36 3.31 Favored 'General case' 0 CA--C 1.586 2.338 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -21.7 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.493 1 N-CA-C 123.207 4.521 . . . . 0.0 123.207 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.11 -142.81 8.62 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -142.27 -53.69 0.42 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.2 -51.82 0.14 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 120.973 3.149 . . . . 0.0 120.973 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.428 HG23 HG21 ' A' ' 98' ' ' VAL 0.401 9.6 t -85.42 46.68 1.32 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.759 2.504 . . . . 0.0 117.759 -176.54 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.455 24.0 mt-10 70.08 -172.6 0.17 Allowed 'General case' 0 CA--C 1.583 2.224 1 N-CA-C 123.891 4.774 . . . . 0.0 123.891 168.317 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.8 p -92.49 151.94 41.71 Favored Pre-proline 0 CA--C 1.577 2.003 0 C-N-CA 126.91 2.084 . . . . 0.0 115.523 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.26 147.8 88.16 Favored 'Trans proline' 0 CA--C 1.577 2.653 0 C-N-CA 122.599 2.199 . . . . 0.0 117.19 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.01 153.66 20.59 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.993 -1.692 . . . . 0.0 109.858 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.4 OUTLIER -58.58 131.71 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 120.148 -1.595 . . . . 0.0 112.423 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.38 7.14 85.25 Favored Glycine 0 CA--C 1.558 2.769 0 N-CA-C 118.705 2.242 . . . . 0.0 118.705 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -88.22 154.61 20.29 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 121.61 2.705 . . . . 0.0 114.344 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -80.25 139.45 36.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.518 -1.364 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.332 1.4 t -132.51 140.85 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.149 0.98 . . . . 0.0 111.23 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.77 110.97 14.34 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 76' ' ' PHE . 3.0 m -120.6 167.22 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 123.443 1.592 . . . . 0.0 114.804 -174.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.88 111.33 12.47 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -113.53 148.67 35.65 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.7 m -120.06 139.73 52.09 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 163.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.48 143.22 10.76 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 119.748 -1.845 . . . . 0.0 115.801 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.406 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -133.01 154.45 50.5 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.308 -1.946 . . . . 0.0 113.765 -175.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.2 tp -79.23 179.52 7.34 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 123.139 1.447 . . . . 0.0 108.639 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.366 0.0 OUTLIER -64.28 -25.61 68.13 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 178.081 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.97 14.32 2.29 Favored 'General case' 0 CA--C 1.603 3.004 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.33 31.65 70.38 Favored Glycine 0 N--CA 1.514 3.834 0 O-C-N 119.849 -1.782 . . . . 0.0 116.161 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -86.19 111.32 20.28 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -75.35 89.02 2.59 Favored 'General case' 0 CA--C 1.583 2.23 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -72.16 -30.69 65.24 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 119.376 -2.077 . . . . 0.0 114.408 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -151.31 149.6 29.54 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.547 2.118 . . . . 0.0 113.879 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.4 p -160.1 96.8 1.23 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 112.229 -2.26 . . . . 0.0 106.995 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 t -59.16 -36.96 76.22 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -51.92 -36.78 50.23 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.72 -66.27 0.5 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -161.14 70.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -151.61 -79.39 0.11 Allowed 'General case' 0 CA--C 1.564 1.515 0 O-C-N 120.28 -1.512 . . . . 0.0 108.285 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -167.74 -138.28 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.025 1.73 . . . . 0.0 107.982 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -112.64 -165.92 1.03 Allowed 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.636 1.574 . . . . 0.0 108.46 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.333 2.8 t80 -127.65 146.65 50.48 Favored 'General case' 0 CA--C 1.572 1.822 0 O-C-N 119.098 -2.251 . . . . 0.0 110.147 170.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.7 p -160.84 140.5 10.79 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 119.526 -1.984 . . . . 0.0 109.151 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CG ' HG11 ' A' ' 85' ' ' VAL . 6.3 p90 -149.65 -176.9 5.59 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.169 -176.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.53 124.95 42.43 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 119.051 -2.281 . . . . 0.0 105.074 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.53 109.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.46 97.95 Favored Glycine 0 N--CA 1.513 3.781 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -132.21 -73.31 0.52 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 123.73 0.812 . . . . 0.0 112.149 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.13 71.65 0.22 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 104.255 -3.538 . . . . 0.0 104.255 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.43 0.0 OUTLIER -65.05 135.33 55.46 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 108.301 -3.949 . . . . 0.0 118.969 -159.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.502 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.359 19.2 m -79.91 -108.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 1 CA-C-N 103.299 -6.319 . . . . 0.0 107.0 -177.303 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.552 HG13 ' H ' ' A' ' 89' ' ' TRP . 25.7 pt -132.06 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 123.645 1.688 . . . . 0.0 107.381 168.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -32.12 73.42 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.386 176.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.91 80.62 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.591 -1.195 . . . . 0.0 112.157 168.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.552 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.3 m0 -73.46 -43.49 60.12 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 120.377 1.444 . . . . 0.0 112.39 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -57.93 -35.66 71.39 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.603 1.547 . . . . 0.0 114.774 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.324 29.0 mt -72.68 -58.12 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-N 118.952 0.796 . . . . 0.0 112.087 175.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.7 81.15 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.48 -44.3 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 120.904 1.684 . . . . 0.0 110.692 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.5 -39.73 35.07 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 121.392 1.905 . . . . 0.0 115.136 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.8 p -91.39 6.9 43.61 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 ttt -86.68 -179.6 6.61 Favored 'General case' 0 CA--C 1.58 2.122 0 O-C-N 119.705 -1.872 . . . . 0.0 113.108 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.51 164.63 21.51 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 118.903 -2.373 . . . . 0.0 113.427 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 98' ' ' VAL . 89.1 t -53.79 31.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 N-CA-C 120.13 3.381 . . . . 0.0 120.13 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.75 -18.0 0.09 OUTLIER Glycine 0 N--CA 1.501 2.974 0 O-C-N 116.73 -3.731 . . . . 0.0 113.974 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' OE1' ' SG ' ' A' ' 102' ' ' CYS . 39.0 tt0 -43.89 143.76 1.02 Allowed 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 119.709 3.226 . . . . 0.0 119.709 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.71 123.59 50.66 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.659 1.183 . . . . 0.0 109.83 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.43 ' SG ' ' OE1' ' A' ' 100' ' ' GLU . 3.9 m -144.76 165.73 27.25 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.783 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -120.41 120.7 36.7 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 123.929 1.823 . . . . 0.0 110.26 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.481 HG22 ' SG ' ' A' ' 106' ' ' CYS . 3.9 mt -77.39 141.0 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.043 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.855 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.5 m -129.47 109.62 11.2 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.481 ' SG ' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -115.95 148.13 40.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -174.092 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -99.95 146.15 31.4 Favored Pre-proline 0 CA--C 1.579 2.08 0 C-N-CA 124.866 1.266 . . . . 0.0 110.381 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.13 -25.55 4.4 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 N-CA-C 119.738 2.938 . . . . 0.0 119.738 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.58 -38.26 86.89 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -92.54 4.49 53.46 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.848 1.259 . . . . 0.0 114.369 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -129.67 -104.75 0.3 Allowed 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 119.908 1.231 . . . . 0.0 113.762 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.388 47.2 m-85 -106.5 -3.12 21.23 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.17 -154.72 44.04 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 119.099 2.399 . . . . 0.0 119.099 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.7 m -67.9 -15.51 63.65 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.54 -30.46 11.39 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 118.934 2.938 . . . . 0.0 118.934 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 168.33 44.34 Favored Glycine 0 CA--C 1.552 2.355 0 CA-C-N 121.401 1.91 . . . . 0.0 115.074 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.15 120.4 59.84 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 116.666 -1.635 . . . . 0.0 107.674 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 77.1 Cg_exo -37.91 -41.02 1.12 Allowed 'Trans proline' 0 CA--C 1.58 2.814 1 N-CA-C 123.425 4.356 . . . . 0.0 123.425 -175.959 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.0 -30.84 66.66 Favored 'Trans proline' 0 CA--C 1.574 2.506 0 CA-C-N 125.455 2.984 . . . . 0.0 119.856 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -159.78 -27.78 0.07 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.8 mt -79.91 124.37 83.23 Favored Pre-proline 0 CA--C 1.584 2.271 0 C-N-CA 125.299 1.44 . . . . 0.0 111.983 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -95.58 178.3 0.7 Allowed 'Trans proline' 0 CA--C 1.584 3.007 0 C-N-CA 122.765 2.31 . . . . 0.0 116.07 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -53.13 125.29 17.87 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.655 2.903 . . . . 0.0 117.906 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.8 t30 56.16 62.41 2.37 Favored 'General case' 0 CA--C 1.586 2.36 0 C-N-CA 125.017 1.327 . . . . 0.0 113.935 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.04 123.21 40.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.303 -1.498 . . . . 0.0 112.417 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.5 m -67.29 159.25 29.63 Favored 'General case' 0 CA--C 1.593 2.616 0 O-C-N 121.358 -0.839 . . . . 0.0 113.163 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 111' ' ' ALA . 16.7 mt -134.34 164.32 27.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.461 -2.024 . . . . 0.0 115.151 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 59' ' ' TRP . 3.8 m -148.52 140.05 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 C-N-CA 124.639 1.176 . . . . 0.0 109.944 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.53 126.06 15.86 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.466 -1.396 . . . . 0.0 109.418 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -88.12 118.33 27.63 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.15 139.36 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.102 0.954 . . . . 0.0 111.794 -172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -116.23 124.56 50.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 tp -104.49 110.12 22.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.221 0.534 . . . . 0.0 109.735 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.7 -43.82 25.02 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -171.73 159.62 5.38 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 123.279 1.514 . . . . 0.0 109.558 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.276 8.1 p90 -152.38 -93.76 0.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -106.51 89.33 3.0 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.739 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.376 -176.753 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.508 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -177.3 156.31 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 33' ' ' LEU 1.099 1.2 mp -155.61 -156.11 0.62 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 158.053 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HG2' ' SG ' ' A' ' 102' ' ' CYS 0.29 1.1 tmmt? -128.86 121.78 28.95 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.252 1.387 . . . . 0.0 113.359 -165.274 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 10.4 t -97.42 96.69 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.602 -178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.501 0.4 OUTLIER -55.25 132.2 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -173.547 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.89 -71.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.828 -0.545 . . . . 0.0 110.867 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -112.95 96.25 5.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.12 162.54 2.53 Favored 'General case' 0 CA--C 1.591 2.525 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.94 -174.99 50.12 Favored Glycine 0 CA--C 1.55 2.256 0 O-C-N 119.658 -1.901 . . . . 0.0 117.586 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -63.61 -43.22 97.52 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.97 54.19 0.46 Allowed Glycine 0 N--CA 1.48 1.568 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.2 p -136.7 -65.8 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.38 0.672 . . . . 0.0 110.95 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -127.04 163.45 23.72 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.9 p -122.83 142.46 37.91 Favored Pre-proline 0 CA--C 1.58 2.114 0 CA-C-N 110.134 -3.212 . . . . 0.0 109.399 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -60.6 119.82 7.22 Favored 'Trans proline' 0 CA--C 1.581 2.834 0 C-N-CA 123.143 2.562 . . . . 0.0 118.177 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.53 167.48 12.94 Favored 'General case' 0 CA--C 1.571 1.785 0 O-C-N 119.238 -2.164 . . . . 0.0 110.753 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.307 0.3 OUTLIER -59.47 132.09 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 O-C-N 120.132 -1.605 . . . . 0.0 112.187 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.48 2.62 88.91 Favored Glycine 0 CA--C 1.56 2.903 0 N-CA-C 118.558 2.183 . . . . 0.0 118.558 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.71 143.64 44.07 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.391 2.596 . . . . 0.0 113.442 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 107.3 18.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.402 1.5 t -103.43 123.67 57.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 126.762 2.025 . . . . 0.0 111.908 -166.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -111.32 109.93 20.17 Favored 'General case' 0 CA--C 1.573 1.834 0 O-C-N 120.936 -1.102 . . . . 0.0 108.026 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.63 164.48 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.321 11.4 m-70 -121.6 117.53 26.97 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 2.6 p90 -114.05 152.14 31.45 Favored 'General case' 0 CA--C 1.578 2.055 0 CA-C-O 123.369 1.556 . . . . 0.0 114.717 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -130.9 149.58 52.46 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.59 139.64 7.01 Favored Glycine 0 CA--C 1.551 2.331 0 O-C-N 118.735 -2.478 . . . . 0.0 116.681 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.4 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -134.93 151.39 50.82 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.292 1.837 . . . . 0.0 115.206 -175.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -95.34 176.17 6.3 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 121.543 -0.723 . . . . 0.0 112.288 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.271 1.8 pt? -62.96 -24.97 68.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.58 -2.9 15.66 Favored 'General case' 0 CA--C 1.595 2.694 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.87 167.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.83 36.84 61.28 Favored Glycine 0 N--CA 1.504 3.186 0 CA-C-N 121.355 1.889 . . . . 0.0 114.043 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -106.14 121.65 44.58 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -75.54 89.33 2.71 Favored 'General case' 0 CA--C 1.579 2.086 0 O-C-N 121.9 -0.5 . . . . 0.0 110.482 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -63.63 -31.83 73.11 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 119.568 -1.957 . . . . 0.0 113.767 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -153.35 156.38 38.23 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 124.474 2.083 . . . . 0.0 113.095 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 77.1 p -157.96 96.4 1.47 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.673 -2.058 . . . . 0.0 107.611 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -55.77 -34.34 65.15 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.92 -30.56 66.01 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -42.51 -51.73 4.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtm-85 -95.35 27.75 3.19 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.763 1.625 . . . . 0.0 113.644 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.283 31.6 ttpt 71.99 -13.25 0.61 Allowed 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.9 174.91 8.61 Favored 'General case' 0 CA--C 1.575 1.942 0 CA-C-O 123.745 1.736 . . . . 0.0 114.283 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -121.72 171.86 8.56 Favored 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.18 148.06 43.52 Favored 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 122.5 1.143 . . . . 0.0 108.761 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.8 t -169.37 142.97 2.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.15 -2.219 . . . . 0.0 107.398 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CG ' HG11 ' A' ' 85' ' ' VAL . 14.4 p90 -149.83 174.17 12.94 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.533 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -108.25 125.67 51.93 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.39 112.04 1.14 Allowed 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.055 -1.028 . . . . 0.0 112.236 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.16 57.04 11.27 Favored Glycine 0 N--CA 1.505 3.291 0 O-C-N 120.512 -1.368 . . . . 0.0 114.761 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.592 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.251 1.9 pptp? -106.17 -73.77 0.67 Allowed 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 123.898 1.808 . . . . 0.0 111.461 -175.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.592 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -110.33 -52.75 0.59 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 127.203 2.335 . . . . 0.0 108.346 169.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.757 22.9 tt0 116.71 140.65 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 128.209 3.862 . . . . 0.0 115.003 165.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.332 8.6 m -79.92 -108.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 1 CA-C-N 105.296 -5.411 . . . . 0.0 105.04 179.691 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.496 HG13 ' H ' ' A' ' 89' ' ' TRP 0.25 21.0 pt -120.32 154.32 23.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 124.419 2.057 . . . . 0.0 106.541 163.599 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.272 13.5 tmtt? -66.61 -29.62 69.71 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.337 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.42 77.92 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 117.122 -1.418 . . . . 0.0 111.911 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.496 ' H ' HG13 ' A' ' 86' ' ' ILE . 38.5 m0 -73.19 -46.07 52.69 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 121.043 1.747 . . . . 0.0 112.704 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.82 -37.27 73.52 Favored 'General case' 0 CA--C 1.575 1.94 0 CA-C-N 122.018 2.19 . . . . 0.0 114.335 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.288 1.8 mp -69.27 -64.94 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.994 0 CA-C-N 119.731 1.15 . . . . 0.0 111.215 175.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -63.67 -38.81 92.52 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.442 HG22 ' SD ' ' A' ' 96' ' ' MET 0.341 9.6 t -70.13 -33.08 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 120.903 1.683 . . . . 0.0 111.424 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.71 -38.06 66.6 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 121.584 1.993 . . . . 0.0 112.634 165.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 9.75 5.98 Favored 'General case' 0 CA--C 1.598 2.818 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.442 ' SD ' HG22 ' A' ' 93' ' ' VAL . 30.3 mtp -87.53 -178.59 6.16 Favored 'General case' 0 N--CA 1.511 2.59 0 CA-C-N 123.315 2.78 . . . . 0.0 116.516 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -135.95 146.8 47.68 Favored 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -175.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -51.66 123.2 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.1 -45.83 1.28 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-O 116.308 -2.384 . . . . 0.0 114.066 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 29.7 mt-10 -148.17 -173.86 4.42 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 121.399 2.6 . . . . 0.0 112.975 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.435 HD13 ' H ' ' A' ' 102' ' ' CYS 0.757 0.2 OUTLIER -157.6 -135.68 0.04 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 177.755 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -160.18 -150.08 0.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -165.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.599 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 47.5 ptt85 -120.92 130.68 53.97 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 124.441 2.067 . . . . 0.0 111.979 169.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 92' ' ' ALA . 3.6 mt -79.6 141.13 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.02 0 CA-C-N 112.912 -1.949 . . . . 0.0 107.935 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.9 m -129.79 109.84 11.26 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.582 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 2.1 p -132.49 151.79 51.78 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -171.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -87.8 142.19 32.28 Favored Pre-proline 0 CA--C 1.578 2.019 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.778 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 41.7 Cg_exo -54.67 -12.51 4.55 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 N-CA-C 120.304 3.155 . . . . 0.0 120.304 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.46 -40.8 97.78 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 120.925 1.693 . . . . 0.0 113.604 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.22 -3.34 54.88 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 124.652 1.181 . . . . 0.0 113.332 171.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.3 -114.27 0.24 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.11 8.12 45.19 Favored 'General case' 0 N--CA 1.514 2.731 0 CA-C-N 121.024 1.738 . . . . 0.0 114.866 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.82 141.22 43.04 Favored Glycine 0 N--CA 1.497 2.705 0 CA-C-N 123.231 2.741 . . . . 0.0 116.195 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.297 15.4 m 78.39 -54.57 0.48 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.309 1.044 . . . . 0.0 113.423 -174.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.3 -49.44 7.25 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.58 153.16 28.62 Favored Glycine 0 CA--C 1.547 2.035 0 CA-C-N 119.663 1.12 . . . . 0.0 114.379 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 10.8 t -82.45 107.21 8.27 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 116.275 -1.822 . . . . 0.0 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.499 1.0 OUTLIER -4.14 -99.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.588 3.184 1 C-N-CA 125.768 4.312 . . . . 0.0 122.332 -174.6 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -88.78 37.42 0.41 Allowed 'Trans proline' 0 CA--C 1.58 2.824 0 CA-C-N 127.743 3.801 . . . . 0.0 115.95 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -145.29 -30.5 0.42 Allowed 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.499 ' HB ' ' H ' ' A' ' 117' ' ' SER . 32.7 mt -130.57 137.37 30.66 Favored Pre-proline 0 N--CA 1.504 2.261 0 CA-C-N 121.471 1.941 . . . . 0.0 113.331 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.47 -175.59 2.0 Allowed 'Trans proline' 0 CA--C 1.591 3.339 0 CA-C-N 122.916 2.077 . . . . 0.0 112.829 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.59 9.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.58 2.777 0 N-CA-C 122.011 3.812 . . . . 0.0 122.011 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.85 93.4 1.26 Allowed 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 121.442 1.928 . . . . 0.0 110.752 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.38 98.15 4.01 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 122.924 2.602 . . . . 0.0 108.989 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.9 m -60.25 131.77 51.83 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.988 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' CD1' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -140.94 177.56 7.96 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 124.66 2.171 . . . . 0.0 114.612 -168.095 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG23 ' HE3' ' A' ' 59' ' ' TRP . 1.7 m -148.19 144.95 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 126.704 2.002 . . . . 0.0 108.189 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 0.5 OUTLIER -133.76 124.12 26.07 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -88.58 97.81 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 101' ' ' LEU . 2.5 t -108.23 140.95 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -175.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -126.15 119.28 27.11 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 tp -95.94 121.99 38.27 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.6 -46.6 9.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -165.13 157.23 15.46 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 123.855 1.788 . . . . 0.0 108.642 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -152.26 -95.49 0.05 Allowed 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 94.09 3.78 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 3.37 0 CA-C-O 117.63 -1.65 . . . . 0.0 114.561 -173.54 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -179.91 159.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 120.961 2.381 . . . . 0.0 113.755 -171.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.826 2.5 tp -148.23 -169.99 3.48 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.046 160.747 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 177.1 -175.23 0.13 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 -158.134 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG13 ' H ' ' A' ' 36' ' ' ILE 0.955 0.4 OUTLIER 104.28 -166.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.066 1 N-CA-C 126.537 5.754 . . . . 0.0 126.537 161.019 . . . . . . . . 5 4 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 35' ' ' VAL 0.392 25.0 mm -25.6 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.324 1 N-CA-C 126.134 5.605 . . . . 0.0 126.134 -167.468 . . . . . . . . 4 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 -60.45 0.97 Allowed 'General case' 0 CA--C 1.583 2.237 0 CA-C-N 110.642 -2.981 . . . . 0.0 106.649 167.165 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -120.07 109.11 15.08 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -64.79 164.98 11.29 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.39 152.91 24.71 Favored Glycine 0 CA--C 1.548 2.125 0 O-C-N 120.402 -1.437 . . . . 0.0 112.401 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.8 p -121.09 -91.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.93 25.39 0.63 Allowed Glycine 0 N--CA 1.506 3.356 1 N-CA-C 124.184 4.434 . . . . 0.0 124.184 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 53.1 p 83.31 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.644 1.978 . . . . 0.0 109.185 -172.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.343 0.0 OUTLIER -0.8 -120.04 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.907 1 N-CA-C 123.04 4.459 . . . . 0.0 123.04 -177.383 . . . . . . . . 4 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 15.5 p -107.46 137.49 19.67 Favored Pre-proline 0 CA--C 1.58 2.11 0 C-N-CA 124.735 1.214 . . . . 0.0 112.722 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.257 11.8 Cg_endo -109.48 -18.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.888 0 N-CA-C 115.84 1.438 . . . . 0.0 115.84 167.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.51 31.5 mtt 78.96 -155.22 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 169.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.323 1.0 OUTLIER -43.84 129.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -174.083 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.26 -10.34 71.53 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-O 116.073 -2.515 . . . . 0.0 117.305 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 123.457 3.629 . . . . 0.0 113.886 -177.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.2 tpt85 -86.49 96.09 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 0.0 109.648 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -91.27 133.02 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.583 0.753 . . . . 0.0 111.828 -172.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.71 102.13 10.45 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 102.307 -3.22 . . . . 0.0 102.307 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.97 -178.21 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-O 124.315 2.007 . . . . 0.0 113.789 -171.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.467 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -145.47 119.43 9.35 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.655 171.539 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -109.69 152.02 26.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.752 1.615 . . . . 0.0 114.128 -178.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.5 m -127.43 131.67 50.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 159.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.9 144.1 15.61 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-O 124.422 2.123 . . . . 0.0 116.124 -177.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -133.6 156.99 46.85 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 111.515 -2.342 . . . . 0.0 112.844 -175.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.05 163.24 13.03 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 121.308 -0.87 . . . . 0.0 109.157 168.182 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.268 9.1 tt -65.51 -20.92 66.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.124 -1.61 . . . . 0.0 114.937 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.74 -4.63 6.78 Favored 'General case' 0 CA--C 1.608 3.194 0 CA-C-N 119.926 1.239 . . . . 0.0 112.705 165.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.01 40.71 29.39 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.278 -1.514 . . . . 0.0 116.345 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 83.9 m -117.47 122.52 43.96 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.17 100.32 2.05 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -67.7 -38.69 84.01 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.621 -1.924 . . . . 0.0 112.105 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.44 173.28 11.22 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 125.667 2.651 . . . . 0.0 114.614 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 69' ' ' SER . 18.7 t -157.3 -91.53 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.983 1 N-CA-C 97.477 -5.009 . . . . 0.0 97.477 170.867 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 68' ' ' SER . 73.2 m 76.39 102.15 0.07 Allowed 'General case' 0 C--O 1.239 0.534 1 CA-C-O 97.027 -10.987 . . . . 0.0 103.933 171.843 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.556 HD22 ' HA ' ' A' ' 75' ' ' LYS . 9.3 mt -49.04 0.98 0.01 OUTLIER 'General case' 0 CA--C 1.598 2.807 3 O-C-N 75.771 -29.33 . . . . 0.0 121.981 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' SER 0.408 8.2 p-10 57.26 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 121.495 3.887 . . . . 0.0 121.495 176.856 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -76.93 28.88 0.13 Allowed 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.336 53.9 tttm 80.77 -52.59 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 126.414 1.886 . . . . 0.0 112.422 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.22 -160.32 0.79 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 122.307 1.051 . . . . 0.0 108.468 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HA ' HD22 ' A' ' 70' ' ' LEU . 8.7 mtmp? -65.11 156.74 30.63 Favored 'General case' 0 CA--C 1.578 2.026 0 O-C-N 120.502 -1.374 . . . . 0.0 113.939 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.481 ' H ' HD22 ' A' ' 70' ' ' LEU 0.278 17.9 t80 -65.71 151.5 46.42 Favored 'General case' 0 CA--C 1.571 1.76 0 CA-C-N 122.43 2.377 . . . . 0.0 108.885 179.179 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.5 p -160.55 143.1 12.99 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 119.946 -1.721 . . . . 0.0 112.456 -175.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CG ' HG11 ' A' ' 85' ' ' VAL . 31.4 p90 -157.2 -179.85 8.59 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.001 176.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -119.88 125.73 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 172.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.83 108.1 0.8 Allowed 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.05 56.55 6.32 Favored Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.288 -0.883 . . . . 0.0 113.547 -173.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -97.74 -65.4 0.97 Allowed 'General case' 0 N--CA 1.512 2.656 0 CA-C-O 124.933 2.302 . . . . 0.0 113.148 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.39 -49.68 0.15 Allowed Glycine 0 CA--C 1.56 2.895 0 N-CA-C 103.719 -3.752 . . . . 0.0 103.719 172.202 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.903 1.8 tm-20 119.99 139.43 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 127.226 3.393 . . . . 0.0 115.881 163.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.451 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.36 9.2 m -79.94 -105.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 1 CA-C-N 106.782 -4.736 . . . . 0.0 105.247 -178.351 . . . . . . . . 4 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.47 HG13 ' H ' ' A' ' 89' ' ' TRP . 36.1 pt -122.5 154.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 124.289 1.995 . . . . 0.0 105.963 165.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.282 2.6 mptt -68.29 -30.67 69.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.15 81.78 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 115.791 -2.052 . . . . 0.0 110.617 167.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.47 ' H ' HG13 ' A' ' 86' ' ' ILE . 41.6 m0 -73.11 -45.25 58.12 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 122.698 2.499 . . . . 0.0 112.948 174.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.36 -38.31 71.25 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.289 1.859 . . . . 0.0 114.407 175.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.34 28.4 mt -69.25 -60.97 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 CA-C-N 118.997 0.817 . . . . 0.0 112.249 175.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.8 -31.25 70.98 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 117.723 2.49 . . . . 0.0 117.723 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.404 HG13 ' SD ' ' A' ' 96' ' ' MET 0.303 13.5 t -79.08 -28.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 CA-C-N 119.821 1.191 . . . . 0.0 110.933 176.01 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.45 85.58 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.879 1.672 . . . . 0.0 112.481 166.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.0 p -73.01 0.34 11.63 Favored 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 173.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.404 ' SD ' HG13 ' A' ' 93' ' ' VAL . 9.1 mtt -82.21 126.69 32.37 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 122.888 2.585 . . . . 0.0 115.889 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.86 130.49 36.81 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 173.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.0 t -9.49 80.17 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.541 4.076 0 CA-C-N 120.433 1.469 . . . . 0.0 108.92 -157.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.83 63.38 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 CA-C-N 109.748 -3.387 . . . . 0.0 119.429 -145.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.489 8.0 tp10 -29.63 -86.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 -170.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.267 27.7 tp -130.9 113.28 13.84 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.869 0.867 . . . . 0.0 110.192 169.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.6 m -135.38 170.98 15.1 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.37 1.081 . . . . 0.0 109.653 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 161.59 21.85 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 123.593 1.663 . . . . 0.0 113.989 178.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.2 mt -127.66 133.98 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.028 175.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.8 m -135.24 100.12 4.45 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 177.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.4 p -125.52 148.24 48.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 118.733 2.864 . . . . 0.0 118.733 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -63.8 143.22 98.1 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.807 -1.568 . . . . 0.0 110.612 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.08 -11.8 23.48 Favored 'Trans proline' 0 CA--C 1.578 2.696 0 CA-C-N 125.268 2.917 . . . . 0.0 116.977 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.0 -39.63 95.33 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.187 1.812 . . . . 0.0 112.391 171.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -75.71 3.92 8.83 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 169.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.68 -105.45 0.17 Allowed 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.368 1.44 . . . . 0.0 114.078 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -114.02 13.51 18.21 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 120.014 1.279 . . . . 0.0 114.116 -177.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -57.23 -25.66 54.72 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 121.479 3.352 . . . . 0.0 121.479 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.6 p -67.49 -57.34 6.7 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 119.463 1.632 . . . . 0.0 113.318 175.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.24 -15.15 7.31 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 151.74 20.38 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 122.684 2.493 . . . . 0.0 112.175 -176.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.517 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 10.1 t -75.88 119.34 76.73 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-O 116.158 -1.877 . . . . 0.0 108.172 176.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.295 96.6 Cg_exo -35.59 -47.62 0.92 Allowed 'Trans proline' 0 CA--C 1.579 2.736 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -175.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -89.95 -10.7 3.42 Favored 'Trans proline' 0 CA--C 1.578 2.679 0 CA-C-N 124.789 2.746 . . . . 0.0 118.251 177.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -144.99 -49.91 0.25 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 119.13 3.011 . . . . 0.0 119.13 -174.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.517 ' HB ' ' H ' ' A' ' 117' ' ' SER . 80.2 mt -80.82 139.28 50.18 Favored Pre-proline 0 CA--C 1.594 2.653 0 CA-C-O 116.353 -1.784 . . . . 0.0 114.975 -171.456 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -97.58 172.42 0.69 Allowed 'Trans proline' 0 CA--C 1.592 3.405 0 CA-C-N 125.754 3.091 . . . . 0.0 114.525 176.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -64.27 2.54 1.11 Allowed 'Trans proline' 0 CA--C 1.576 2.58 0 N-CA-C 120.272 3.143 . . . . 0.0 120.272 175.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -146.37 57.62 1.19 Allowed 'General case' 0 CA--C 1.58 2.105 0 O-C-N 119.754 -1.841 . . . . 0.0 114.237 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.32 114.46 15.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 119.745 -1.847 . . . . 0.0 106.989 173.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.7 m -59.88 130.89 48.99 Favored 'General case' 0 CA--C 1.586 2.359 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.201 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.91 156.41 18.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 122.137 2.244 . . . . 0.0 115.165 -173.572 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.0 t -143.68 120.23 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-N 112.294 -2.23 . . . . 0.0 107.727 -173.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 4.1 m-85 -140.7 129.92 23.61 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 119.756 -1.84 . . . . 0.0 110.367 174.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 111.99 23.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 172.145 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.46 131.95 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.39 108.54 17.74 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.645 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 tt -98.45 116.34 30.46 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.574 1.178 . . . . 0.0 109.886 -175.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.94 -51.58 7.03 Favored 'General case' 0 CA--C 1.574 1.878 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.73 -177.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 152.87 30.87 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.918 1.287 . . . . 0.0 109.962 175.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -131.65 -75.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.839 -1.163 . . . . 0.0 112.594 176.706 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.291 57.6 tttm -79.79 -57.1 3.82 Favored 'General case' 0 CA--C 1.584 2.281 0 CA-C-O 115.776 -2.059 . . . . 0.0 115.128 -177.418 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.017 0 CA-C-N 125.083 3.583 . . . . 0.0 119.602 -179.255 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 1 N-CA-C 125.188 4.835 . . . . 0.0 125.188 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.75 166.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -172.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.759 1.1 tp -159.53 -153.11 0.34 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.437 163.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -157.34 137.29 12.48 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.042 2.201 . . . . 0.0 116.394 -169.311 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.4 133.37 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.45 -0.781 . . . . 0.0 109.737 174.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.513 HD13 ' SG ' ' A' ' 102' ' ' CYS 0.301 1.0 OUTLIER -75.84 133.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 O-C-N 120.522 -1.361 . . . . 0.0 113.602 -177.627 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -114.65 -51.58 2.74 Favored 'General case' 0 CA--C 1.575 1.925 0 C-N-CA 124.606 1.162 . . . . 0.0 112.015 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.09 96.15 2.95 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.62 171.06 0.22 Allowed 'General case' 0 CA--C 1.591 2.539 0 CA-C-N 122.106 2.23 . . . . 0.0 116.444 177.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.26 -172.19 22.65 Favored Glycine 0 CA--C 1.547 2.09 0 O-C-N 120.018 -1.676 . . . . 0.0 116.905 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -166.77 -69.45 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.043 0.937 . . . . 0.0 110.006 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.7 -103.5 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 120.738 3.055 . . . . 0.0 120.738 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.437 ' H ' HG21 ' A' ' 98' ' ' VAL . 43.4 p -113.38 49.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.247 1.499 . . . . 0.0 111.693 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.443 4.7 pt-20 41.14 -116.85 0.31 Allowed 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 119.598 3.185 . . . . 0.0 119.598 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -150.77 137.08 11.07 Favored Pre-proline 0 CA--C 1.577 2.009 0 C-N-CA 124.925 1.29 . . . . 0.0 113.579 -175.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.251 6.2 Cg_endo -117.19 -26.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.583 2.942 0 C-N-CA 121.782 1.655 . . . . 0.0 115.984 171.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.566 32.3 mtt 82.31 -146.47 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.402 0.3 OUTLIER -47.0 128.94 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -172.647 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.11 90.62 Favored Glycine 0 CA--C 1.56 2.857 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -174.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -79.6 144.69 33.6 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 122.635 3.217 . . . . 0.0 114.914 -178.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -75.64 131.33 39.87 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.252 0.933 . . . . 0.0 109.088 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.362 2.1 t -131.39 132.03 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 124.141 0.976 . . . . 0.0 112.217 -166.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -117.7 107.13 13.81 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.1 m -116.31 159.23 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.972 1.368 . . . . 0.0 114.296 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 16.9 m170 -116.32 123.57 47.98 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 116.806 -1.568 . . . . 0.0 109.223 166.201 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.323 0.1 OUTLIER -119.11 135.38 54.68 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.449 1.477 . . . . 0.0 114.303 176.592 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.4 m -104.18 149.17 25.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 159.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.12 144.21 11.14 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 118.622 -2.548 . . . . 0.0 115.656 178.404 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.426 ' CE3' HG12 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -136.26 149.11 48.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 112.452 -1.874 . . . . 0.0 114.866 -173.994 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.17 165.53 17.33 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 123.249 1.499 . . . . 0.0 107.721 167.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 126' ' ' THR 0.277 0.0 OUTLIER -60.5 -27.32 67.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 178.277 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -2.17 11.38 Favored 'General case' 0 CA--C 1.595 2.682 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 171.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.21 45.39 7.05 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.448 -1.407 . . . . 0.0 113.594 -176.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -117.65 113.89 22.58 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -176.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -79.9 93.03 5.59 Favored 'General case' 0 CA--C 1.585 2.311 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.794 -178.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -71.24 -30.04 65.85 Favored 'General case' 0 CA--C 1.566 1.579 0 O-C-N 119.085 -2.259 . . . . 0.0 115.403 175.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -146.86 156.34 43.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.825 1.648 . . . . 0.0 113.717 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 t -157.9 87.87 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.105 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 75' ' ' LYS . 47.2 t -53.98 -42.31 68.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 174.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 70' ' ' LEU . 4.7 mp -64.3 -39.3 93.64 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 127.523 2.329 . . . . 0.0 113.481 178.179 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.22 -48.45 81.7 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.45 1.5 . . . . 0.0 113.824 173.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -78.59 -23.44 46.01 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 176.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.348 0.1 OUTLIER 115.27 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 128.572 2.749 . . . . 0.0 111.236 -179.275 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -134.43 149.57 50.77 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -175.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' HB3' ' CB ' ' A' ' 69' ' ' SER 0.289 19.4 tptm -166.53 -83.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.112 3.745 . . . . 0.0 121.112 173.805 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.587 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.401 0.4 OUTLIER -89.02 146.7 24.69 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 -161.839 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -165.48 129.0 2.23 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 120.701 -1.249 . . . . 0.0 107.957 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CG ' HG11 ' A' ' 85' ' ' VAL . 27.2 p90 -142.06 -165.04 1.92 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 122.36 1.076 . . . . 0.0 110.323 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.283 9.5 t0 -135.03 125.75 27.14 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 172.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.0 112.06 0.52 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.177 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.8 92.76 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -174.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.306 5.6 mmtt -138.38 -80.16 0.34 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -168.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.94 76.61 0.46 Allowed Glycine 0 N--CA 1.503 3.131 1 N-CA-C 99.686 -5.365 . . . . 0.0 99.686 170.522 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.383 32.7 tp10 -78.63 157.04 28.77 Favored 'General case' 0 CA--C 1.555 1.172 1 CA-C-O 130.104 4.764 . . . . 0.0 119.5 -159.513 . . . . . . . . 3 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.335 33.6 m -107.73 -140.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 1 CA-C-N 101.964 -6.926 . . . . 0.0 107.183 -173.288 . . . . . . . . 4 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 89' ' ' TRP . 12.2 pt -101.08 154.52 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 122.98 1.371 . . . . 0.0 109.452 170.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.517 0.0 OUTLIER -69.94 -21.27 63.28 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 175.927 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.73 85.78 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 117.692 -1.146 . . . . 0.0 111.366 165.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.453 ' H ' HG13 ' A' ' 86' ' ' ILE . 44.5 m0 -73.91 -40.25 63.28 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-N 120.399 1.454 . . . . 0.0 113.073 173.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -57.62 -37.08 72.68 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 119.924 1.238 . . . . 0.0 113.833 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.27 1.5 mp -64.05 -56.83 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 119.431 1.014 . . . . 0.0 110.836 173.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.52 94.48 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 177.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.489 HG22 ' CE ' ' A' ' 96' ' ' MET . 79.3 t -63.27 -43.94 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 119.031 0.832 . . . . 0.0 112.519 174.129 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.07 66.91 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-N 119.695 1.134 . . . . 0.0 113.931 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.0 p -92.29 24.61 3.3 Favored 'General case' 0 CA--C 1.588 2.439 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.601 ' SD ' ' HB3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -122.95 140.07 53.4 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.622 2.01 . . . . 0.0 114.874 178.588 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -90.4 168.08 12.14 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.403 1.081 . . . . 0.0 111.483 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.437 HG21 ' H ' ' A' ' 43' ' ' THR . 78.3 t -59.0 135.83 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.546 0 O-C-N 119.46 -2.025 . . . . 0.0 112.46 -176.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.38 8.8 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-N 124.152 3.16 . . . . 0.0 117.107 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.49 102.74 1.18 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 118.476 1.138 . . . . 0.0 111.999 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -98.24 131.83 44.25 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.496 1.119 . . . . 0.0 109.062 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.513 ' SG ' HD13 ' A' ' 36' ' ' ILE . 86.0 m -136.8 -169.71 2.53 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.553 1.168 . . . . 0.0 113.422 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.309 3.8 mtt180 -135.91 113.52 10.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 124.942 2.306 . . . . 0.0 108.732 172.548 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -76.97 136.15 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.744 -177.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -117.76 101.7 8.53 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 174.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 5.2 p -115.12 149.33 37.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -171.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -104.96 129.06 25.49 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.675 177.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.53 -16.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.966 0 N-CA-C 122.042 3.824 . . . . 0.0 122.042 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.33 -41.09 92.81 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 121.785 2.084 . . . . 0.0 113.244 169.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -87.08 -0.09 56.1 Favored 'General case' 0 CA--C 1.582 2.189 0 C-N-CA 125.766 1.626 . . . . 0.0 113.656 170.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 -113.35 0.22 Allowed 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -175.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -92.46 13.39 19.77 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 120.672 1.578 . . . . 0.0 113.62 -178.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.84 148.48 31.61 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 122.141 2.246 . . . . 0.0 118.084 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.276 8.3 t 73.4 -42.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.299 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.49 -56.45 2.34 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.81 143.53 14.83 Favored Glycine 0 CA--C 1.546 1.992 0 CA-C-N 119.626 1.103 . . . . 0.0 112.028 -175.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.431 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.3 t -78.75 144.76 65.18 Favored Pre-proline 0 CA--C 1.584 2.254 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.62 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -33.06 134.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.071 0 C-N-CA 124.307 3.338 . . . . 0.0 120.603 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.333 0.1 OUTLIER 21.84 46.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.475 2 N-CA-C 125.107 5.003 . . . . 0.0 125.107 -175.563 . . . . . . . . 4 3 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -164.45 -55.94 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.056 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.431 ' HB ' ' H ' ' A' ' 117' ' ' SER . 56.9 mt -84.69 136.17 39.63 Favored Pre-proline 0 CA--C 1.592 2.574 0 CA-C-O 116.279 -1.819 . . . . 0.0 112.674 -174.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -99.48 173.9 0.4 Allowed 'Trans proline' 0 CA--C 1.592 3.408 0 CA-C-N 125.943 3.158 . . . . 0.0 115.184 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.42 -18.68 39.97 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 N-CA-C 121.209 3.503 . . . . 0.0 121.209 176.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -140.2 83.12 1.9 Allowed 'General case' 0 CA--C 1.588 2.431 0 CA-C-N 120.448 1.476 . . . . 0.0 111.822 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.85 -153.58 0.56 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 119.453 -2.029 . . . . 0.0 111.081 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.417 ' H ' HD12 ' A' ' 61' ' ' LEU 0.255 65.9 m -139.3 150.87 45.93 Favored 'General case' 0 CA--C 1.591 2.53 0 O-C-N 119.098 -2.251 . . . . 0.0 109.099 173.44 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 50.9 mt -127.21 162.63 25.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.232 -2.168 . . . . 0.0 112.895 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.426 HG12 ' CE3' ' A' ' 59' ' ' TRP . 79.5 t -146.45 115.46 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.672 -2.058 . . . . 0.0 107.225 -174.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 0.8 OUTLIER -128.91 123.19 31.95 Favored 'General case' 0 N--CA 1.517 2.911 0 CA-C-N 123.13 2.695 . . . . 0.0 111.014 174.25 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.4 tm-20 -92.07 90.9 7.57 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 123.654 1.692 . . . . 0.0 107.467 175.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 1.5 p -134.47 157.59 41.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -173.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 101' ' ' LEU 1.657 16.6 mt-10 -179.06 -174.13 0.32 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.328 168.707 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.554 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 16.2 tp -106.82 145.68 31.83 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 121.111 3.745 . . . . 0.0 121.111 -165.115 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -92.02 -54.32 3.89 Favored 'General case' 0 CA--C 1.58 2.125 0 CA-C-N 111.887 -2.415 . . . . 0.0 108.572 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -170.58 159.08 6.57 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 126.144 1.778 . . . . 0.0 108.308 171.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.291 0.0 OUTLIER -129.38 -103.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.411 -1.43 . . . . 0.0 110.223 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.447 63.7 tttt -105.76 -96.94 0.34 Allowed 'General case' 0 CA--C 1.581 2.146 0 CA-C-O 116.02 -1.943 . . . . 0.0 110.269 177.12 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.562 0 CA-C-N 125.167 3.622 . . . . 0.0 116.647 -178.798 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 1 N-CA-C 126.636 5.414 . . . . 0.0 126.636 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG22 ' H ' ' A' ' 23' ' ' ASP 0.318 9.7 p -123.12 -142.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -165.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.621 ' H ' HG22 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -143.92 -175.89 4.77 Favored 'General case' 0 CA--C 1.592 2.572 0 C-N-CA 126.058 1.743 . . . . 0.0 109.158 175.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.423 0.5 OUTLIER 89.49 167.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 126.222 1.809 . . . . 0.0 108.905 -175.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.8 p -119.27 120.78 30.71 Favored Pre-proline 0 CA--C 1.571 1.764 0 O-C-N 116.731 -3.731 . . . . 0.0 108.794 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -63.81 42.11 0.11 Allowed 'Trans proline' 0 CA--C 1.589 3.242 0 N-CA-C 119.971 3.027 . . . . 0.0 119.971 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.63 -62.21 0.05 Allowed 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 127.257 2.223 . . . . 0.0 108.459 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -82.76 -28.07 30.62 Favored 'General case' 0 CA--C 1.582 2.197 0 O-C-N 120.726 -1.234 . . . . 0.0 113.863 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.519 0.0 OUTLIER 85.08 -22.68 0.19 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 -177.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.27 -35.21 15.42 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 118.422 2.749 . . . . 0.0 118.422 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.3 -59.51 5.75 Favored Glycine 0 N--CA 1.479 1.551 1 N-CA-C 127.171 5.629 . . . . 0.0 127.171 -156.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 33' ' ' LEU 0.275 8.2 p -156.68 -141.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.607 -174.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.605 ' H ' HG22 ' A' ' 32' ' ' VAL 1.157 8.1 mp 130.35 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 129.159 2.984 . . . . 0.0 111.895 171.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -154.83 130.33 9.83 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 122.629 2.468 . . . . 0.0 117.403 -162.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.67 119.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 123.414 0.686 . . . . 0.0 111.143 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.283 0.7 OUTLIER -87.19 135.93 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 122.201 1.0 . . . . 0.0 112.077 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -118.64 -60.65 1.75 Allowed 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.611 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -119.69 94.64 4.47 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.08 164.4 5.15 Favored 'General case' 0 CA--C 1.594 2.643 0 O-C-N 119.385 -2.072 . . . . 0.0 113.912 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.74 170.69 45.98 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 122.357 3.703 . . . . 0.0 122.357 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -99.24 -63.88 1.09 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.547 -1.826 . . . . 0.0 107.123 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.23 102.83 1.74 Allowed Glycine 0 CA--C 1.549 2.175 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 p -51.54 -22.57 3.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.29 153.62 34.24 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 p -115.79 163.52 20.72 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 111.635 -2.529 . . . . 0.0 112.303 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.68 146.16 29.98 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 CA-C-N 123.385 2.245 . . . . 0.0 114.351 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -90.32 164.36 14.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.122 -1.611 . . . . 0.0 110.854 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.3 OUTLIER -61.4 130.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 119.297 -2.127 . . . . 0.0 111.691 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.0 15.22 79.86 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.419 2.128 . . . . 0.0 118.419 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.88 154.02 19.15 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.421 2.11 . . . . 0.0 110.998 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -84.58 124.58 31.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.753 . . . . 0.0 110.208 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.23 132.06 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.008 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.26 93.5 4.72 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 125.168 2.413 . . . . 0.0 104.88 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.04 169.37 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 110.558 -3.019 . . . . 0.0 109.12 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.449 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.335 2.9 t60 -148.49 137.45 21.68 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 159.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -122.71 152.62 40.39 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.107 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.9 m -117.51 150.79 38.37 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 159.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.6 144.97 12.1 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 118.424 -2.672 . . . . 0.0 115.655 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.433 ' HE3' HG12 ' A' ' 128' ' ' VAL . 1.9 m-90 -130.14 153.23 48.73 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 112.648 -1.776 . . . . 0.0 113.746 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.48 168.91 16.04 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 122.975 1.369 . . . . 0.0 107.388 166.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.8 -27.84 66.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -72.42 1.15 8.46 Favored 'General case' 0 CA--C 1.594 2.635 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.5 43.2 12.75 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 120.202 -1.561 . . . . 0.0 113.308 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -114.88 116.24 28.23 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -75.9 87.42 2.87 Favored 'General case' 0 CA--C 1.586 2.338 0 O-C-N 121.966 -0.459 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.91 -28.16 62.31 Favored 'General case' 0 CA--C 1.558 1.26 0 O-C-N 119.46 -2.025 . . . . 0.0 115.432 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -156.07 148.41 23.57 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 t -160.06 113.58 2.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.269 81.1 p -63.13 -38.58 91.75 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.275 65.7 mt -53.2 -42.34 66.17 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 122.318 2.326 . . . . 0.0 115.76 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -49.92 -36.73 28.67 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 -85.79 42.51 0.97 Allowed 'General case' 0 CA--C 1.585 2.313 0 C-N-CA 124.745 1.218 . . . . 0.0 114.251 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.324 34.3 ttmt 83.26 -36.72 0.08 Allowed 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.2 -175.07 4.55 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-O 124.034 1.873 . . . . 0.0 115.469 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.89 178.09 4.48 Favored 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 125.254 1.422 . . . . 0.0 113.033 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.99 164.73 11.87 Favored 'General case' 0 CA--C 1.583 2.246 0 O-C-N 120.431 -1.418 . . . . 0.0 108.9 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.5 p -167.44 133.71 2.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 118.939 -2.35 . . . . 0.0 111.111 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CG ' HG11 ' A' ' 85' ' ' VAL . 23.5 p90 -146.27 -176.3 5.11 Favored 'General case' 0 CA--C 1.573 1.827 0 CA-C-O 122.177 0.989 . . . . 0.0 112.214 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -119.26 114.31 22.19 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -40.89 113.85 0.42 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.4 95.17 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -111.5 21.17 16.46 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.27 -42.12 2.74 Favored Glycine 0 N--CA 1.51 3.586 0 O-C-N 121.147 -0.971 . . . . 0.0 112.484 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -32.81 -37.35 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 120.494 3.516 . . . . 0.0 120.494 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.254 20.6 m -123.95 -142.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 123.116 1.436 . . . . 0.0 109.662 -173.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 89' ' ' TRP . 13.7 pt -113.86 157.14 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 124.298 1.999 . . . . 0.0 108.284 170.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -64.85 -34.09 77.54 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 113.838 -1.528 . . . . 0.0 113.346 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.07 67.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.199 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.488 ' H ' HG13 ' A' ' 86' ' ' ILE . 33.0 m0 -73.17 -43.44 61.45 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 120.226 1.376 . . . . 0.0 112.214 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.83 -38.58 70.23 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 121.237 1.835 . . . . 0.0 114.928 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.319 2.2 mp -69.97 -62.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 CA-C-N 119.741 1.155 . . . . 0.0 111.44 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -66.72 -30.59 70.86 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.284 12.6 t -77.74 -34.45 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 120.036 1.289 . . . . 0.0 110.644 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.39 -38.43 66.16 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 121.224 1.829 . . . . 0.0 112.701 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.8 p -80.88 8.41 8.34 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.504 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 9.3 tpt -100.25 127.76 46.46 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 122.071 2.214 . . . . 0.0 114.814 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -82.08 166.53 19.65 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.41 128.22 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.914 0 O-C-N 120.395 -1.44 . . . . 0.0 109.938 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.49 -0.46 64.43 Favored Glycine 1 N--CA 1.517 4.054 0 CA-C-N 123.201 2.728 . . . . 0.0 117.751 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -73.48 154.5 39.89 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.55 123.39 26.43 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.335 1.054 . . . . 0.0 112.246 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 8.7 p -151.64 174.65 13.22 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -124.86 119.85 30.01 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 124.201 1.953 . . . . 0.0 111.566 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.2 mt -74.24 138.65 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-N 112.495 -2.138 . . . . 0.0 110.76 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -123.12 110.48 15.36 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 102.629 -3.101 . . . . 0.0 102.629 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 2.9 p -115.85 146.38 42.05 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -106.94 135.75 19.53 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.672 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -43.13 -24.59 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.853 1 N-CA-C 122.77 4.104 . . . . 0.0 122.77 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.39 -39.12 92.18 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 121.588 1.995 . . . . 0.0 114.293 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.44 -3.73 58.77 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 125.58 1.552 . . . . 0.0 112.79 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.27 -117.96 0.2 Allowed 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.433 ' CE2' HD21 ' A' ' 127' ' ' LEU 0.287 6.6 m-85 -92.45 16.72 11.24 Favored 'General case' 0 N--CA 1.513 2.692 0 CA-C-N 121.005 1.73 . . . . 0.0 114.334 -178.084 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.65 -63.23 4.61 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 123.008 2.64 . . . . 0.0 117.373 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -79.46 42.62 0.52 Allowed 'General case' 0 CA--C 1.584 2.264 0 CA-C-N 118.92 1.36 . . . . 0.0 114.236 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -171.77 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.99 136.88 6.45 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.22 0.914 . . . . 0.0 110.89 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.448 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.7 t -78.45 118.91 75.12 Favored Pre-proline 0 CA--C 1.581 2.157 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.241 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.272 42.4 Cg_exo -27.37 -51.15 0.11 Allowed 'Trans proline' 0 CA--C 1.579 2.761 1 N-CA-C 124.682 4.839 . . . . 0.0 124.682 -175.684 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.57 -30.14 12.44 Favored 'Trans proline' 0 CA--C 1.572 2.42 0 CA-C-N 125.607 3.038 . . . . 0.0 119.548 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -163.93 -8.95 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 117' ' ' SER . 19.6 mt -79.93 123.7 83.54 Favored Pre-proline 0 CA--C 1.583 2.248 0 O-C-N 119.631 -1.918 . . . . 0.0 113.299 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.76 171.09 7.23 Favored 'Trans proline' 0 CA--C 1.585 3.067 0 C-N-CA 122.547 2.165 . . . . 0.0 113.441 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.65 12.87 0.23 Allowed 'Trans proline' 0 CA--C 1.58 2.804 0 N-CA-C 120.536 3.245 . . . . 0.0 120.536 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -153.95 67.7 0.75 Allowed 'General case' 0 CA--C 1.582 2.211 0 O-C-N 119.974 -1.704 . . . . 0.0 111.644 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.16 133.89 33.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 119.797 -1.815 . . . . 0.0 110.529 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.291 23.3 m -66.05 152.05 45.51 Favored 'General case' 0 CA--C 1.594 2.639 0 O-C-N 120.703 -1.248 . . . . 0.0 112.447 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.602 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 11.8 tp -132.44 158.27 42.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 119.541 -1.974 . . . . 0.0 111.892 -170.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.433 HG12 ' HE3' ' A' ' 59' ' ' TRP . 53.9 t -143.69 124.59 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.862 -169.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.303 15.3 m-85 -136.46 124.44 22.8 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 122.286 2.312 . . . . 0.0 112.16 173.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -93.49 113.14 25.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.481 -2.012 . . . . 0.0 107.999 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.7 t -112.34 136.25 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.886 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -119.51 114.97 23.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.28 119.95 38.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.578 1.18 . . . . 0.0 109.498 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -79.73 -56.92 3.93 Favored 'General case' 0 CA--C 1.582 2.184 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.307 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -169.89 161.65 9.04 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 126.031 1.733 . . . . 0.0 109.72 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.434 ' HD1' ' H ' ' A' ' 137' ' ' LYS . 1.4 p90 -138.05 -84.89 0.29 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.784 -1.822 . . . . 0.0 110.862 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.434 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 40.0 ttpt -79.83 74.36 6.56 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 125.511 2.577 . . . . 0.0 108.308 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.567 3.299 0 CA-C-N 110.909 -2.86 . . . . 0.0 111.855 -173.778 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.853 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.62 153.17 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.038 0.935 . . . . 0.0 112.731 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -153.9 148.42 26.2 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.316 10.5 tp -120.86 70.09 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 124.546 2.117 . . . . 0.0 108.803 173.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -156.17 64.58 3.77 Favored Pre-proline 0 CA--C 1.585 2.312 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.441 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.251 21.5 Cg_exo -61.49 -29.16 84.45 Favored 'Trans proline' 0 CA--C 1.573 2.463 0 CA-C-N 124.933 2.797 . . . . 0.0 117.442 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.87 52.18 0.81 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.948 1.299 . . . . 0.0 109.066 174.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.312 65.2 mm-40 64.62 39.09 6.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.6 -77.76 0.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 111.514 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.275 49.8 mt-10 -90.13 3.47 53.29 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 174.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.97 12.49 36.48 Favored Glycine 0 N--CA 1.484 1.839 1 N-CA-C 123.815 4.286 . . . . 0.0 123.815 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.324 38.2 t -139.51 133.2 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 1 CA-C-N 124.419 4.109 . . . . 0.0 116.517 -174.038 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.33 134.12 54.05 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 125.912 1.685 . . . . 0.0 109.253 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -129.24 133.09 47.36 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 124.12 3.145 . . . . 0.0 111.453 176.262 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 77.9 t -105.1 153.18 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.71 142.38 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.915 0 CA-C-O 122.771 1.272 . . . . 0.0 108.97 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 102' ' ' CYS . 55.6 tptt -114.32 -57.89 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.692 172.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -122.29 112.24 17.89 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.51 -62.9 1.45 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.455 -1.403 . . . . 0.0 114.241 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.1 -155.83 26.43 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 119.364 2.505 . . . . 0.0 119.364 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -91.12 -54.57 3.89 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 114.337 -0.931 . . . . 0.0 113.319 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -39.0 62.15 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.261 73.0 p 74.62 3.25 4.23 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -106.92 167.24 10.02 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 120.772 -1.205 . . . . 0.0 113.001 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.2 p -132.94 108.33 12.75 Favored Pre-proline 0 CA--C 1.577 1.982 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.59 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.353 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.6 ptm -170.83 175.47 4.48 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 120.868 1.667 . . . . 0.0 114.344 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -55.8 132.8 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 CA-C-O 122.334 1.064 . . . . 0.0 111.44 176.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.33 0.3 70.58 Favored Glycine 0 CA--C 1.563 3.079 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.08 137.88 49.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 121.437 2.618 . . . . 0.0 113.585 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -86.65 104.8 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 136' ' ' PHE . 1.5 m -105.39 131.08 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.074 0.95 . . . . 0.0 110.667 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.255 29.1 p90 -105.23 115.54 30.43 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 105.653 -1.981 . . . . 0.0 105.653 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.28 170.08 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 CA-C-O 125.04 2.352 . . . . 0.0 114.103 -170.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 70' ' ' LEU . 2.3 t60 -124.43 119.32 28.84 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 111.58 -2.555 . . . . 0.0 106.358 168.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.333 3.3 p90 -114.72 150.85 34.65 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 123.977 1.846 . . . . 0.0 113.626 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -127.63 151.71 48.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.53 138.38 6.03 Favored Glycine 0 CA--C 1.546 2.001 0 O-C-N 118.742 -2.474 . . . . 0.0 115.944 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.19 150.71 49.4 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 127.323 2.249 . . . . 0.0 112.25 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.5 tp -84.22 -172.75 4.34 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-O 123.984 1.849 . . . . 0.0 109.641 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -58.35 -37.39 75.09 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.19 21.61 0.89 Allowed 'General case' 0 CA--C 1.597 2.756 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.97 33.48 50.61 Favored Glycine 1 N--CA 1.517 4.054 0 O-C-N 120.179 -1.576 . . . . 0.0 115.798 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.7 m -86.72 109.24 19.08 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -69.04 92.36 0.52 Allowed 'General case' 0 CA--C 1.588 2.437 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -73.08 -36.08 66.75 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 119.296 -2.127 . . . . 0.0 114.598 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.65 174.95 12.57 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 123.834 1.778 . . . . 0.0 114.442 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 t -152.42 -147.15 0.22 Allowed 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 51.6 p -148.73 -66.56 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.056 -1.653 . . . . 0.0 108.701 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 55' ' ' HIS 0.317 22.3 mt -61.38 -42.35 98.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -49.99 -42.34 48.84 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.339 32.5 ptt180 -75.57 -75.38 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.545 1.138 . . . . 0.0 113.535 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -163.62 -36.7 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.925 1.29 . . . . 0.0 112.172 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -89.28 -157.15 0.43 Allowed 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -145.62 170.71 15.91 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 125.943 1.697 . . . . 0.0 108.498 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.285 3.7 t80 -114.05 154.68 27.28 Favored 'General case' 0 CA--C 1.573 1.856 0 CA-C-O 123.772 1.749 . . . . 0.0 109.125 173.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.2 p -170.9 124.08 0.63 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.802 -1.186 . . . . 0.0 108.171 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.2 p90 -143.22 164.44 30.18 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 121.813 -0.555 . . . . 0.0 111.913 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.97 128.2 49.89 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 119.168 -2.208 . . . . 0.0 106.125 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.57 110.94 1.08 Allowed 'General case' 0 CA--C 1.57 1.733 0 O-C-N 121.27 -0.894 . . . . 0.0 112.77 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 54.76 30.65 Favored Glycine 0 N--CA 1.509 3.542 0 O-C-N 120.65 -1.281 . . . . 0.0 114.606 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.637 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -99.15 -71.95 0.68 Allowed 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 124.366 2.031 . . . . 0.0 112.182 -174.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.637 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -111.23 -49.98 0.64 Allowed Glycine 0 CA--C 1.561 2.914 0 N-CA-C 104.024 -3.63 . . . . 0.0 104.024 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.778 23.8 tt0 118.89 137.78 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 127.909 3.719 . . . . 0.0 114.634 164.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.478 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.348 11.9 m -79.97 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 1 CA-C-N 105.773 -5.194 . . . . 0.0 104.454 178.25 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.554 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -132.79 157.39 43.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 124.017 1.865 . . . . 0.0 106.8 166.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -65.01 -33.11 75.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.519 -1.219 . . . . 0.0 113.123 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.26 80.49 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 117.25 -1.357 . . . . 0.0 111.938 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.554 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.0 m0 -73.94 -43.31 58.71 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.685 1.584 . . . . 0.0 112.215 172.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.41 -34.58 72.64 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 121.548 1.976 . . . . 0.0 114.267 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.303 1.5 mp -69.99 -63.25 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.004 0 CA-C-N 120.317 1.417 . . . . 0.0 111.294 174.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.16 -33.14 75.1 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.345 3.5 t -78.35 -25.92 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 CA-C-N 119.764 1.166 . . . . 0.0 111.584 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.23 90.05 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-N 121.238 1.835 . . . . 0.0 111.856 165.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.6 p -82.58 17.57 1.75 Allowed 'General case' 0 CA--C 1.596 2.718 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.536 ' SD ' HD22 ' A' ' 101' ' ' LEU . 2.2 ttt -104.68 143.31 33.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 119.26 -2.15 . . . . 0.0 116.068 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -104.13 152.95 21.5 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 119.039 2.977 . . . . 0.0 119.039 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.88 124.92 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.408 0 CA-C-O 118.478 -0.773 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.9 -55.4 0.53 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 120.683 1.583 . . . . 0.0 112.809 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.305 5.5 tt0 -158.41 -163.59 1.31 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 102' ' ' CYS 0.782 0.5 OUTLIER -162.66 -139.92 0.05 OUTLIER 'General case' 0 CA--C 1.594 2.667 0 C-N-CA 125.091 1.357 . . . . 0.0 111.622 178.414 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.614 ' H ' HD23 ' A' ' 101' ' ' LEU 0.72 51.3 t -160.03 -115.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 127.162 2.185 . . . . 0.0 107.916 175.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 54.8 ptt85 -135.32 135.15 40.55 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -173.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -89.84 132.07 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 CA-C-N 112.66 -2.063 . . . . 0.0 108.241 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.2 m -121.0 105.99 11.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 15.6 p -124.08 149.6 45.97 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -170.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -81.45 135.98 49.51 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.521 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.265 50.5 Cg_exo -57.7 -17.2 28.0 Favored 'Trans proline' 0 CA--C 1.559 1.756 0 N-CA-C 118.882 2.608 . . . . 0.0 118.882 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.62 -33.94 76.02 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 121.692 2.042 . . . . 0.0 113.907 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.57 -2.87 51.62 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 125.734 1.614 . . . . 0.0 113.462 169.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.51 -113.97 0.22 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 121.499 1.954 . . . . 0.0 113.013 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 127' ' ' LEU 0.308 2.7 m-85 -79.04 -37.55 38.74 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 121.188 1.813 . . . . 0.0 113.12 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.22 -116.15 3.29 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 121.222 3.249 . . . . 0.0 121.222 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -77.85 -31.99 51.83 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.36 -33.76 63.18 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.12 155.99 9.75 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 t -98.9 111.09 59.82 Favored Pre-proline 0 CA--C 1.58 2.117 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.285 47.6 Cg_exo -31.26 -52.0 0.27 Allowed 'Trans proline' 0 CA--C 1.581 2.843 1 N-CA-C 124.19 4.65 . . . . 0.0 124.19 -175.36 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.71 -18.54 32.46 Favored 'Trans proline' 0 CA--C 1.577 2.629 0 N-CA-C 120.494 3.229 . . . . 0.0 120.494 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -160.2 -18.81 0.06 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . 0.289 10.7 mt -79.93 -59.01 0.58 Allowed Pre-proline 0 CA--C 1.605 3.088 1 N-CA-C 124.437 4.977 . . . . 0.0 124.437 -172.262 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . 0.89 0.1 OUTLIER 34.09 -115.29 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.486 2 C-N-CA 126.843 5.029 . . . . 0.0 123.57 -172.325 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.12 99.66 1.32 Allowed 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 125.886 3.138 . . . . 0.0 118.601 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 t30 52.46 70.69 0.54 Allowed 'General case' 0 CA--C 1.593 2.629 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.55 114.52 28.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.618 -1.926 . . . . 0.0 108.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.4 m -54.0 151.52 6.71 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 72.5 mt -126.77 164.53 21.14 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 124.566 2.127 . . . . 0.0 113.791 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -144.31 113.55 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.601 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 5.7 m-85 -127.07 125.57 41.54 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 122.227 2.285 . . . . 0.0 110.839 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -93.68 96.03 9.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.362 -1.461 . . . . 0.0 108.296 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.3 138.98 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -132.18 118.44 19.56 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 96' ' ' MET . 6.9 tt -90.83 114.08 26.4 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.814 -1.179 . . . . 0.0 113.877 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.31 9.8 m-30 -76.59 -51.42 11.65 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.571 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -163.74 146.85 9.9 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 121.702 2.046 . . . . 0.0 108.353 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.526 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.267 0.1 OUTLIER -100.88 -80.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 170.188 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.526 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 14.1 mmtm -80.0 -37.03 35.07 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 177.333 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.056 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -172.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.538 0 C-N-CA 126.218 1.807 . . . . 0.0 106.181 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.87 112.7 0.47 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 118.464 -2.648 . . . . 0.0 112.589 171.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.503 0.0 OUTLIER 155.96 -86.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 C-N-CA 125.79 1.636 . . . . 0.0 111.355 175.16 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.1 t 172.9 80.76 0.04 OUTLIER Pre-proline 0 CA--C 1.587 2.397 0 C-N-CA 130.351 3.46 . . . . 0.0 104.102 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -73.56 1.48 6.84 Favored 'Trans proline' 0 CA--C 1.568 2.204 1 N-CA-C 127.223 5.817 . . . . 0.0 127.223 -167.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.02 -81.17 0.1 Allowed 'General case' 0 N--CA 1.496 1.852 1 CA-C-N 126.942 4.428 . . . . 0.0 112.62 -177.261 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.45 -61.12 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 173.41 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -87.56 7.61 28.86 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.24 6.48 2.11 Favored Glycine 0 N--CA 1.496 2.64 1 N-CA-C 123.676 4.231 . . . . 0.0 123.676 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 106' ' ' CYS . 10.8 p -174.93 -173.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.194 0 CA-C-O 123.687 1.708 . . . . 0.0 110.681 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.91 2.2 mm? 178.94 165.9 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.71 2.004 . . . . 0.0 113.674 160.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 125.83 53.7 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 11.2 p -114.37 109.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 O-C-N 121.43 -0.793 . . . . 0.0 112.653 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.389 8.2 mm -48.31 133.87 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 N-CA-C 119.712 3.227 . . . . 0.0 119.712 -175.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -115.73 -59.8 1.95 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.201 -1.818 . . . . 0.0 108.867 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -143.49 103.74 4.14 Favored 'General case' 0 CA--C 1.585 2.322 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -53.26 -61.35 2.36 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 119.878 3.288 . . . . 0.0 119.878 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.74 177.42 16.23 Favored Glycine 0 CA--C 1.55 2.281 0 C-N-CA 125.22 1.391 . . . . 0.0 114.635 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 t -162.07 -12.62 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.01 -68.92 1.44 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 122.279 3.672 . . . . 0.0 122.279 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -158.83 66.83 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.768 0.794 . . . . 0.0 112.388 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.391 10.4 mt-10 60.42 -160.33 0.3 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 120.327 3.455 . . . . 0.0 120.327 174.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -97.04 170.86 6.7 Favored Pre-proline 0 CA--C 1.585 2.324 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -99.46 -166.15 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.512 0 CA-C-N 123.073 2.133 . . . . 0.0 117.149 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -130.15 169.71 14.99 Favored 'General case' 0 CA--C 1.573 1.837 0 O-C-N 121.282 -0.887 . . . . 0.0 112.999 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.95 139.18 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.166 0 O-C-N 119.211 -2.181 . . . . 0.0 109.352 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 7.01 86.89 Favored Glycine 0 CA--C 1.567 3.293 0 CA-C-O 117.497 -1.724 . . . . 0.0 117.335 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.43 146.85 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 121.531 2.665 . . . . 0.0 113.501 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -85.68 119.96 26.59 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.37 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 123.192 0.597 . . . . 0.0 111.332 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -114.5 111.99 22.27 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 76' ' ' PHE . 22.9 m -116.16 162.3 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 124.087 1.899 . . . . 0.0 114.669 -173.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.445 ' ND1' HD23 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -114.9 108.03 16.19 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.543 168.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 2.2 p90 -110.51 147.62 33.75 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 123.31 1.528 . . . . 0.0 114.747 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.8 m -131.19 144.5 51.4 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 165.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.88 144.85 12.68 Favored Glycine 0 CA--C 1.551 2.295 0 O-C-N 119.769 -1.832 . . . . 0.0 116.528 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.467 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -132.31 149.8 52.29 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.007 1.723 . . . . 0.0 114.398 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.97 169.55 18.13 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.369 1.081 . . . . 0.0 108.521 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.346 0.0 OUTLIER -61.59 -25.45 67.34 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.81 3.46 11.84 Favored 'General case' 0 CA--C 1.594 2.651 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.54 11.59 Favored Glycine 0 N--CA 1.507 3.387 0 CA-C-N 121.101 1.773 . . . . 0.0 114.343 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.9 m -115.52 115.53 26.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -78.2 96.74 5.29 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -70.09 -32.03 69.89 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.682 -1.886 . . . . 0.0 113.87 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.22 159.92 40.46 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 124.189 1.947 . . . . 0.0 115.669 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.7 t -158.82 98.75 1.51 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.6 p -54.36 -49.85 68.85 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.445 HD23 ' ND1' ' A' ' 55' ' ' HIS 0.428 0.2 OUTLIER -66.49 -44.17 83.35 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -177.839 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.38 -40.2 61.78 Favored 'General case' 0 CA--C 1.583 2.215 0 C-N-CA 124.423 1.089 . . . . 0.0 113.852 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.1 mtp85 -68.86 -14.81 63.26 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.384 0.6 OUTLIER 118.52 -41.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 129.005 2.922 . . . . 0.0 114.11 177.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.92 155.53 20.88 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -88.6 135.33 33.55 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 117.258 -1.353 . . . . 0.0 109.276 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HB3' HG23 ' A' ' 54' ' ' VAL . 6.9 t80 -83.11 151.23 25.84 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 122.872 2.578 . . . . 0.0 108.922 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.0 t -168.03 145.92 4.36 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 123.9 1.81 . . . . 0.0 108.429 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.5 p90 -152.46 179.28 8.71 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.007 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -116.26 121.99 43.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.72 109.59 0.24 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.83 37.77 60.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.383 13.9 tppt? -91.03 -8.85 47.92 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-N 120.993 2.397 . . . . 0.0 117.211 -174.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.29 65.75 1.41 Allowed Glycine 0 N--CA 1.504 3.183 0 N-CA-C 103.969 -3.652 . . . . 0.0 103.969 -169.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -156.91 -57.35 0.09 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.958 -1.121 . . . . 0.0 113.208 -164.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.524 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.281 13.9 m -98.99 -139.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 122.998 1.38 . . . . 0.0 109.462 -175.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 89' ' ' TRP . 15.9 pt -120.67 163.69 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 123.66 1.695 . . . . 0.0 110.317 173.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.263 2.2 mptt -67.8 -34.68 77.23 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.426 -1.261 . . . . 0.0 113.237 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.12 -32.42 69.82 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 117.313 -1.327 . . . . 0.0 112.607 167.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.4 ' H ' HG13 ' A' ' 86' ' ' ILE . 29.5 m0 -76.89 -42.66 38.89 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 120.955 1.707 . . . . 0.0 112.613 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -59.7 -37.1 77.92 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 120.313 1.415 . . . . 0.0 114.586 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.282 1.4 mp -66.76 -58.35 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-N 119.749 1.159 . . . . 0.0 110.801 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.36 87.94 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.413 HG22 ' SD ' ' A' ' 96' ' ' MET 0.289 92.9 t -67.22 -37.7 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.349 0.977 . . . . 0.0 112.221 172.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.75 -39.05 61.82 Favored 'General case' 0 CA--C 1.588 2.416 0 CA-C-N 121.302 1.864 . . . . 0.0 112.444 168.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.7 p -94.96 42.28 1.09 Allowed 'General case' 0 CA--C 1.597 2.769 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 133' ' ' LEU . 12.4 ttm -112.12 142.59 44.39 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 119.102 -2.249 . . . . 0.0 115.248 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -109.48 139.49 44.41 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 120.13 1.332 . . . . 0.0 113.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.7 131.55 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.399 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.393 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.46 -56.02 0.5 Allowed Glycine 0 N--CA 1.492 2.408 0 CA-C-O 117.107 -1.941 . . . . 0.0 111.329 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -150.45 -162.12 1.49 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-N 118.946 1.373 . . . . 0.0 113.737 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.469 HD13 ' HG3' ' A' ' 96' ' ' MET 0.799 0.6 OUTLIER -154.4 -126.94 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 CA-C-O 124.855 2.264 . . . . 0.0 114.026 176.159 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.5 OUTLIER -158.52 -147.78 0.18 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 124.357 2.027 . . . . 0.0 110.936 -164.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.502 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -131.76 138.56 48.64 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 124.644 2.164 . . . . 0.0 109.353 170.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.65 134.82 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 112.612 -2.085 . . . . 0.0 108.764 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.9 m -121.27 109.46 14.96 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.535 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 4.7 p -127.03 144.27 51.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -86.07 146.02 41.99 Favored Pre-proline 0 CA--C 1.574 1.902 0 CA-C-N 112.773 -2.012 . . . . 0.0 110.996 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -46.93 -26.21 4.61 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 N-CA-C 119.713 2.928 . . . . 0.0 119.713 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.57 -43.51 89.45 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.774 1.624 . . . . 0.0 114.437 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.86 -1.53 56.62 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.84 -118.35 0.23 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 120.719 1.599 . . . . 0.0 113.931 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.475 16.7 m-85 -83.8 -13.09 54.63 Favored 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 121.86 2.118 . . . . 0.0 115.595 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.82 -153.86 49.64 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.213 3.245 . . . . 0.0 121.213 171.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.8 t -85.26 62.38 7.46 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.995 1.379 . . . . 0.0 110.85 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.19 -54.69 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 126.301 1.84 . . . . 0.0 111.638 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.01 163.88 24.87 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 122.447 1.026 . . . . 0.0 113.796 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.518 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 19.7 t -72.98 143.57 84.22 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 116.827 -1.558 . . . . 0.0 110.862 176.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -49.68 126.82 17.19 Favored 'Trans proline' 0 CA--C 1.581 2.865 0 C-N-CA 122.923 2.415 . . . . 0.0 113.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.322 0.2 OUTLIER 28.58 47.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.575 2.536 0 N-CA-C 121.946 3.787 . . . . 0.0 121.946 -172.156 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -154.79 -47.66 0.09 Allowed 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.518 ' HB ' ' H ' ' A' ' 117' ' ' SER . 18.1 mt -104.51 150.14 38.18 Favored Pre-proline 0 N--CA 1.512 2.636 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.002 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.66 173.3 8.12 Favored 'Trans proline' 0 CA--C 1.588 3.189 0 CA-C-N 126.412 3.326 . . . . 0.0 116.015 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.18 -21.48 22.49 Favored 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 121.751 3.712 . . . . 0.0 121.751 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -158.71 92.8 1.14 Allowed 'General case' 0 CA--C 1.584 2.283 0 CA-C-N 120.852 1.66 . . . . 0.0 107.651 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.59 133.43 22.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 122.985 2.629 . . . . 0.0 112.916 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 84.7 m -66.56 150.61 48.73 Favored 'General case' 0 CA--C 1.586 2.328 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.535 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.25 0.3 OUTLIER -145.11 175.84 9.95 Favored 'General case' 0 CA--C 1.573 1.843 0 O-C-N 119.643 -1.91 . . . . 0.0 111.196 -177.703 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.467 HG23 ' HE3' ' A' ' 59' ' ' TRP . 1.9 m -145.42 146.52 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 125.805 1.642 . . . . 0.0 109.729 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.251 1.7 m-85 -135.96 125.28 24.8 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.481 -0.762 . . . . 0.0 109.745 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 55.6 mt-10 -83.42 114.0 21.15 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.37 136.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -132.41 120.67 22.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.542 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.7 OUTLIER -86.34 123.84 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.367 -1.458 . . . . 0.0 114.616 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.25 -49.48 49.5 Favored 'General case' 0 CA--C 1.587 2.383 0 O-C-N 121.701 -0.624 . . . . 0.0 112.526 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -171.29 155.73 4.38 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.74 1.616 . . . . 0.0 110.385 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.511 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.286 0.2 OUTLIER -126.6 -106.26 0.32 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.567 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.511 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 85.9 tttt -83.46 72.47 10.25 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.508 1.123 . . . . 0.0 110.904 173.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 178.45 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.436 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.409 0.4 OUTLIER 58.37 166.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.96 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 -176.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.438 23.6 t0 -162.14 -171.31 2.79 Favored 'General case' 0 CA--C 1.592 2.564 0 C-N-CA 125.937 1.695 . . . . 0.0 108.166 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.287 1.8 pp -75.14 62.22 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -156.53 70.15 4.83 Favored Pre-proline 0 CA--C 1.58 2.131 0 O-C-N 119.487 -2.008 . . . . 0.0 111.769 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.52 -27.69 82.34 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 N-CA-C 119.087 2.687 . . . . 0.0 119.087 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.17 44.18 0.55 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.443 1.097 . . . . 0.0 110.796 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.259 40.6 mm-40 68.76 58.57 0.39 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.308 -1.495 . . . . 0.0 109.688 -171.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -119.39 -70.75 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.339 21.6 mm-40 -89.99 -8.02 52.61 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 120.102 3.371 . . . . 0.0 120.102 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.81 -66.79 0.56 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.11 133.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 118.291 1.045 . . . . 0.0 113.691 -173.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -109.96 141.95 42.01 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 127.119 2.168 . . . . 0.0 107.893 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB3' HG13 ' A' ' 35' ' ' VAL . 3.1 mtmp? -159.58 170.75 20.96 Favored 'General case' 0 N--CA 1.51 2.547 2 CA-C-N 126.276 4.125 . . . . 0.0 122.123 -170.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.615 ' O ' ' SG ' ' A' ' 102' ' ' CYS 1.237 3.7 m 106.0 -173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.672 1 N-CA-C 127.785 6.217 . . . . 0.0 127.785 158.351 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.701 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.643 34.3 mm -16.41 128.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.342 2 N-CA-C 131.351 7.538 . . . . 0.0 131.351 -153.931 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -142.63 -49.17 0.35 Allowed 'General case' 0 CA--C 1.584 2.257 0 C-N-CA 127.33 2.252 . . . . 0.0 109.537 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -114.77 101.93 9.52 Favored 'General case' 0 CA--C 1.578 2.033 0 C-N-CA 124.922 1.289 . . . . 0.0 108.693 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.28 174.84 0.63 Allowed 'General case' 0 CA--C 1.597 2.762 0 O-C-N 119.469 -2.019 . . . . 0.0 115.579 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.43 8.26 Favored Glycine 0 N--CA 1.486 2.017 0 O-C-N 119.856 -1.777 . . . . 0.0 116.461 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.5 p -107.37 -76.66 0.61 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.6 70.51 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.267 10.2 t -157.6 61.56 0.48 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.362 1.077 . . . . 0.0 113.179 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.264 30.3 mt-10 59.75 168.69 0.07 Allowed 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 120.855 3.65 . . . . 0.0 120.855 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 p -90.07 165.4 24.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.275 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.43 159.61 17.14 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 CA-C-N 121.919 1.721 . . . . 0.0 114.732 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -98.33 165.54 11.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.345 0.3 OUTLIER -63.73 130.24 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 119.219 -2.176 . . . . 0.0 110.574 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.17 17.61 79.88 Favored Glycine 0 CA--C 1.569 3.431 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.02 147.29 43.06 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.575 1.688 . . . . 0.0 112.256 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -81.83 114.64 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.46 146.14 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.661 0.784 . . . . 0.0 111.307 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.25 46.3 p90 -129.85 98.68 4.86 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 124.86 2.267 . . . . 0.0 111.712 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.1 m -90.81 170.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 111.562 -2.563 . . . . 0.0 112.259 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.446 ' CE1' ' HG ' ' A' ' 70' ' ' LEU . 5.1 t60 -134.55 135.82 42.58 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 164.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 6.7 p90 -128.8 142.3 51.03 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.1 m -110.96 144.91 39.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 159.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.34 140.44 7.99 Favored Glycine 0 CA--C 1.548 2.112 0 O-C-N 118.92 -2.363 . . . . 0.0 116.776 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 155.97 47.25 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.675 2.39 . . . . 0.0 112.569 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.49 -174.5 4.84 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 120.475 -1.391 . . . . 0.0 111.044 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 1.9 pt? -64.83 -26.12 68.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.68 1.98 13.18 Favored 'General case' 0 CA--C 1.601 2.93 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.417 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.22 31.82 81.86 Favored Glycine 0 N--CA 1.501 2.996 0 O-C-N 120.477 -1.389 . . . . 0.0 114.821 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -90.25 114.6 26.66 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.4 95.02 1.0 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -70.45 -31.3 68.4 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 119.519 -1.988 . . . . 0.0 114.212 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -154.23 161.18 41.99 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.839 2.257 . . . . 0.0 114.179 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.0 p -151.05 96.92 2.39 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -28.09 27.93 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 120.723 3.601 . . . . 0.0 120.723 -172.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.263 36.5 mt -70.48 -51.72 27.05 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.947 1.703 . . . . 0.0 112.062 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.18 -30.24 70.29 Favored 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -54.01 -19.92 5.52 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.35 39.0 ttmt 127.36 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 129.387 3.075 . . . . 0.0 111.952 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.3 2.7 p-10 -104.61 -142.8 0.37 Allowed 'General case' 0 CA--C 1.575 1.934 0 CA-C-O 123.076 1.417 . . . . 0.0 111.953 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -124.78 -136.5 0.28 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.528 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.404 3.1 t80 -140.25 142.58 35.76 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 118.337 -2.727 . . . . 0.0 109.095 167.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.4 p -155.4 148.75 24.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 118.479 -2.638 . . . . 0.0 109.05 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.508 ' CG ' HG11 ' A' ' 85' ' ' VAL . 30.3 p90 -157.37 -173.19 4.3 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.223 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -122.21 113.53 19.59 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -39.63 113.57 0.35 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.76 47.44 88.65 Favored Glycine 0 N--CA 1.503 3.149 0 N-CA-C 118.208 2.043 . . . . 0.0 118.208 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -109.39 6.65 24.51 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.78 58.32 2.15 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -149.97 -49.27 0.13 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.295 10.3 m -117.85 -138.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-O 123.04 1.4 . . . . 0.0 108.374 -175.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 89' ' ' TRP . 26.7 pt -122.48 163.25 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 123.767 1.746 . . . . 0.0 110.173 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.59 71.54 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.479 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.37 75.04 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.558 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.505 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.4 m0 -75.4 -41.43 56.18 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 120.725 1.602 . . . . 0.0 112.833 172.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.61 -37.99 80.07 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 119.744 1.157 . . . . 0.0 113.863 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.257 1.2 mp -64.61 -54.68 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.709 1.595 . . . . 0.0 111.208 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.71 72.1 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.2 t -60.91 -46.62 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.07 0.85 . . . . 0.0 112.327 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.8 -34.89 55.67 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 p -87.56 6.73 32.92 Favored 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.533 ' SD ' ' HG ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.35 138.05 52.68 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 123.524 2.874 . . . . 0.0 116.806 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -80.93 149.19 29.5 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 113.51 -3.138 . . . . 0.0 111.05 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.279 1.8 t -9.61 87.91 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 123.144 2.702 . . . . 0.0 110.513 -166.003 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 133' ' ' LEU . . . -3.19 -37.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 1 N-CA-C 129.839 6.696 . . . . 0.0 129.839 -140.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 61.24 -127.69 0.85 Allowed 'General case' 0 CA--C 1.605 3.075 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.739 HD13 ' H ' ' A' ' 102' ' ' CYS 1.672 0.6 OUTLIER 124.57 154.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 161.383 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.739 ' H ' HD13 ' A' ' 101' ' ' LEU . 18.8 t -160.19 -104.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.239 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -122.29 158.36 29.7 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 124.875 2.274 . . . . 0.0 116.036 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mt -131.82 114.61 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.007 0 CA-C-N 111.524 -2.58 . . . . 0.0 105.559 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -107.15 99.19 8.76 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 7.8 p -112.39 146.82 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -90.57 141.02 26.81 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.921 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.26 -22.41 8.33 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 N-CA-C 119.882 2.993 . . . . 0.0 119.882 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.99 -42.04 98.7 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.086 1.766 . . . . 0.0 114.434 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.56 0.17 39.39 Favored 'General case' 0 CA--C 1.577 2.0 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.256 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.97 -114.5 0.15 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.467 ' CD2' HD11 ' A' ' 127' ' ' LEU 0.38 24.7 m-85 -82.29 -14.11 55.91 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 120.945 1.702 . . . . 0.0 115.176 -178.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.1 -152.0 52.01 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.5 p -67.66 -22.25 65.31 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.12 -33.01 13.51 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.4 169.5 45.68 Favored Glycine 0 CA--C 1.551 2.327 0 CA-C-N 121.05 1.75 . . . . 0.0 114.71 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.473 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 6.8 t -90.42 120.14 69.06 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 116.684 -1.627 . . . . 0.0 108.799 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -37.23 -46.07 1.52 Allowed 'Trans proline' 0 CA--C 1.582 2.887 1 N-CA-C 123.32 4.316 . . . . 0.0 123.32 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.14 -20.11 19.39 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 CA-C-N 125.595 3.034 . . . . 0.0 119.534 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -159.53 -27.17 0.07 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 117' ' ' SER . 89.9 mt -79.98 126.6 79.43 Favored Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 120.183 -1.573 . . . . 0.0 111.938 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -82.68 170.7 12.62 Favored 'Trans proline' 0 CA--C 1.581 2.841 0 C-N-CA 122.365 2.043 . . . . 0.0 115.842 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.41 130.67 22.9 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 C-N-CA 122.85 2.367 . . . . 0.0 114.931 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.9 t30 58.85 60.85 2.34 Favored 'General case' 0 CA--C 1.586 2.364 0 C-N-CA 125.031 1.332 . . . . 0.0 113.413 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.23 123.73 32.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.33 -1.481 . . . . 0.0 112.451 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -59.35 156.2 13.22 Favored 'General case' 0 CA--C 1.587 2.373 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 87.8 mt -126.62 165.05 19.92 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 124.69 2.186 . . . . 0.0 114.297 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.99 106.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.77 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 2.5 m-85 -120.92 125.82 48.4 Favored 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 122.194 2.27 . . . . 0.0 109.134 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -95.43 98.72 10.76 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.52 140.57 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.346 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 50.4 mt-10 -130.3 110.15 11.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.484 ' O ' ' HA3' ' A' ' 99' ' ' GLY 0.31 25.8 tp -85.19 121.38 27.85 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 122.822 1.296 . . . . 0.0 112.779 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.3 15.3 m-30 -84.04 -64.36 1.18 Allowed 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.278 -1.514 . . . . 0.0 111.782 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.17 162.17 40.96 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.912 2.142 . . . . 0.0 110.46 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -143.5 -114.8 0.1 Allowed 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -103.4 173.1 6.45 Favored 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.623 1.569 . . . . 0.0 108.196 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 O-C-N 119.583 -1.948 . . . . 0.0 117.73 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.02 1 N-CA-C 128.819 6.288 . . . . 0.0 128.819 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.397 0.3 OUTLIER 62.43 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 121.267 3.803 . . . . 0.0 121.267 171.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -152.05 138.09 18.2 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.465 0.1 OUTLIER -129.0 93.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 124.051 1.882 . . . . 0.0 108.873 170.071 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -140.91 72.87 28.07 Favored Pre-proline 0 CA--C 1.58 2.106 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.275 11.3 Cg_exo -74.95 -33.09 4.93 Favored 'Trans proline' 0 CA--C 1.571 2.374 0 CA-C-N 123.909 2.432 . . . . 0.0 117.754 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.48 61.85 0.17 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.747 1.612 . . . . 0.0 111.703 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.264 63.8 mm-40 72.46 25.29 2.76 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.095 -1.628 . . . . 0.0 114.124 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -80.85 -95.61 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 O-C-N 120.406 -1.434 . . . . 0.0 110.98 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.26 11.4 mm-40 -90.26 -15.03 32.09 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.47 10.18 2.84 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.0 t -170.25 150.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 120.029 1.914 . . . . 0.0 112.859 -167.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.69 10.2 tp -151.84 -146.67 0.2 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.962 162.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -179.02 166.42 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.16 -1.587 . . . . 0.0 113.769 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.83 123.23 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.129 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.297 0.3 OUTLIER -89.79 139.28 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 120.25 1.386 . . . . 0.0 111.8 178.826 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.34 -69.18 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.982 -0.449 . . . . 0.0 111.219 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HB2' ' H ' ' A' ' 101' ' ' LEU . 89.8 mtt-85 -103.96 68.66 0.92 Allowed 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -38.1 -71.25 0.08 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.04 -178.4 39.44 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.5 p -83.7 -66.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.681 -0.759 . . . . 0.0 112.001 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.96 55.27 0.01 OUTLIER Glycine 0 CA--C 1.54 1.614 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 15.3 t -153.16 63.25 0.77 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.234 1.492 . . . . 0.0 112.527 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.361 46.8 mt-10 69.76 170.38 0.3 Allowed 'General case' 0 CA--C 1.576 1.972 1 N-CA-C 121.943 4.053 . . . . 0.0 121.943 175.126 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.7 p -114.33 160.0 34.49 Favored Pre-proline 0 CA--C 1.587 2.398 0 CA-C-N 111.042 -2.799 . . . . 0.0 110.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.83 129.18 30.91 Favored 'Trans proline' 0 CA--C 1.579 2.752 0 C-N-CA 122.853 2.369 . . . . 0.0 117.023 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -87.12 161.58 18.03 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 122.009 2.186 . . . . 0.0 111.363 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.343 0.4 OUTLIER -62.31 132.15 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 119.029 -2.294 . . . . 0.0 110.896 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.76 0.97 90.0 Favored Glycine 0 CA--C 1.569 3.428 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.56 152.65 20.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 121.504 2.652 . . . . 0.0 112.868 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -83.56 135.7 34.53 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.285 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -132.36 135.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.185 0.594 . . . . 0.0 109.831 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.265 33.4 p90 -115.96 105.31 12.51 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 124.038 1.875 . . . . 0.0 109.707 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.2 m -110.05 173.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 127.138 2.175 . . . . 0.0 114.55 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.257 0.1 OUTLIER -135.25 111.33 9.56 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 166.229 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.257 20.8 p90 -96.63 176.0 6.18 Favored 'General case' 0 CA--C 1.586 2.327 0 CA-C-O 126.291 2.948 . . . . 0.0 113.918 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.262 63.3 m -150.61 140.23 21.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.1 156.6 27.08 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 119.787 -1.82 . . . . 0.0 116.216 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -139.44 147.31 41.21 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 112.346 -1.927 . . . . 0.0 111.704 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 tp -80.64 169.11 18.07 Favored 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 122.762 1.268 . . . . 0.0 107.928 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.319 0.0 OUTLIER -59.24 -26.68 65.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.68 4.09 6.82 Favored 'General case' 0 CA--C 1.595 2.698 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.59 41.89 34.42 Favored Glycine 0 N--CA 1.506 3.339 0 O-C-N 119.804 -1.81 . . . . 0.0 114.434 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.6 m -116.67 117.31 29.46 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -77.36 97.82 5.03 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.054 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -74.0 -37.07 64.53 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.853 -2.404 . . . . 0.0 115.727 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.54 174.37 14.14 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.337 1.426 . . . . 0.0 113.93 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.4 p -159.98 -10.25 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 119.098 2.999 . . . . 0.0 119.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.3 1.6 t 71.7 -49.77 0.69 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.95 -2.344 . . . . 0.0 111.411 -168.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.6 mt -48.23 -39.33 20.9 Favored 'General case' 0 CA--C 1.581 2.14 0 C-N-CA 127.637 2.375 . . . . 0.0 113.972 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.26 -44.97 88.61 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 125.279 1.432 . . . . 0.0 113.025 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -76.69 -22.27 54.19 Favored 'General case' 0 CA--C 1.585 2.326 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.392 57.3 mtpt 106.18 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 127.648 2.379 . . . . 0.0 113.625 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.65 159.86 27.82 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.836 -1.165 . . . . 0.0 113.021 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -80.51 167.28 20.32 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 54' ' ' VAL . 12.0 t80 -98.04 155.96 16.87 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-O 123.052 1.406 . . . . 0.0 107.708 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -168.28 118.92 0.79 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 119.622 -1.924 . . . . 0.0 108.724 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.453 ' CG ' HG11 ' A' ' 85' ' ' VAL . 21.7 p90 -127.92 -174.53 3.22 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.235 1.017 . . . . 0.0 111.127 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.259 9.5 t0 -126.71 121.52 32.29 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 94' ' ' ALA . 11.6 tp -50.67 111.77 0.59 Allowed 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.58 23.42 70.46 Favored Glycine 0 CA--C 1.573 3.71 0 CA-C-O 118.218 -1.323 . . . . 0.0 116.045 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -124.65 -70.7 0.74 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 120.277 2.039 . . . . 0.0 112.952 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.81 73.35 0.3 Allowed Glycine 0 N--CA 1.508 3.443 0 N-CA-C 103.85 -3.7 . . . . 0.0 103.85 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.487 5.7 pt-20 -73.54 134.48 43.8 Favored 'General case' 0 CA--C 1.561 1.366 2 CA-C-O 129.302 4.382 . . . . 0.0 119.196 -158.503 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.453 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.353 20.8 m -80.04 -117.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 1 CA-C-N 102.564 -6.653 . . . . 0.0 108.439 -175.445 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.495 HG13 ' H ' ' A' ' 89' ' ' TRP . 18.2 pt -121.72 156.11 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 124.285 1.993 . . . . 0.0 107.775 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 8.0 tmtt? -66.94 -28.72 68.52 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.927 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.17 83.37 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 117.353 -1.308 . . . . 0.0 111.485 166.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.495 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.0 m0 -70.18 -41.59 73.54 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.866 1.666 . . . . 0.0 111.99 172.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.83 -41.26 67.18 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.766 1.621 . . . . 0.0 114.465 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -68.26 -61.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 119.582 1.083 . . . . 0.0 112.586 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.517 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -69.26 -28.45 66.33 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.271 45.5 t -79.16 -43.72 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 117.209 -1.377 . . . . 0.0 109.503 175.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -51.49 -33.45 31.43 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.161 1.8 . . . . 0.0 115.492 170.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -86.4 -12.09 50.16 Favored 'General case' 0 CA--C 1.583 2.221 0 CA-C-O 115.597 -2.144 . . . . 0.0 116.645 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -89.62 146.89 24.24 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 125.244 3.656 . . . . 0.0 115.043 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -86.94 159.97 18.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.86 125.95 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.566 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.277 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.12 -49.54 0.89 Allowed Glycine 0 N--CA 1.494 2.512 0 CA-C-O 113.939 -3.701 . . . . 0.0 108.651 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.974 4.5 pt-20 154.01 -93.73 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.417 1 N-CA-C 131.351 7.538 . . . . 0.0 131.351 164.39 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.433 ' H ' ' HB2' ' A' ' 38' ' ' ARG . 33.7 tp -79.09 122.2 25.94 Favored 'General case' 0 N--CA 1.484 1.225 1 N-CA-C 123.96 4.8 . . . . 0.0 123.96 -160.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.2 m -147.41 146.33 29.56 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.053 169.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -109.35 120.93 44.02 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.244 1.973 . . . . 0.0 110.905 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.2 mt -75.97 146.92 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.297 -2.229 . . . . 0.0 113.521 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -136.61 117.17 13.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.8 p -133.47 154.55 50.71 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -96.62 146.61 31.61 Favored Pre-proline 0 CA--C 1.581 2.152 0 CA-C-N 113.797 -1.547 . . . . 0.0 114.022 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 12.4 Cg_exo -43.25 -29.15 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 N-CA-C 121.62 3.661 . . . . 0.0 121.62 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -65.36 -39.09 91.88 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.22 1.827 . . . . 0.0 115.356 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -86.64 -7.71 58.1 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.958 1.303 . . . . 0.0 113.718 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.479 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -115.44 -133.77 0.34 Allowed 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 120.827 1.649 . . . . 0.0 112.398 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.2 4.1 49.74 Favored 'General case' 0 CA--C 1.591 2.556 0 CA-C-N 122.424 2.375 . . . . 0.0 113.411 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 108' ' ' PRO . . . -49.69 -62.14 5.09 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 122.293 3.677 . . . . 0.0 122.293 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -70.48 -39.16 74.37 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -130.04 -7.19 4.4 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.27 158.29 27.66 Favored Glycine 0 CA--C 1.55 2.241 0 CA-C-N 124.421 3.282 . . . . 0.0 113.78 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.466 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 6.1 t -82.75 137.0 44.28 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 116.777 -1.582 . . . . 0.0 109.759 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.266 43.8 Cg_exo -32.82 -45.18 0.25 Allowed 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.464 4.755 . . . . 0.0 124.464 -176.357 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 -52.99 0.08 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 0 CA-C-N 125.934 3.155 . . . . 0.0 118.929 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -152.5 3.57 0.35 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.466 ' HB ' ' H ' ' A' ' 117' ' ' SER . 51.0 mt -79.89 137.43 53.95 Favored Pre-proline 0 CA--C 1.599 2.838 0 O-C-N 119.15 -2.219 . . . . 0.0 113.705 -174.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -92.63 -176.1 0.64 Allowed 'Trans proline' 0 CA--C 1.595 3.545 0 CA-C-N 125.319 2.935 . . . . 0.0 115.533 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -64.18 171.97 6.96 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 N-CA-C 118.722 2.547 . . . . 0.0 118.722 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.262 28.3 t-20 59.23 54.08 5.02 Favored 'General case' 0 CA--C 1.585 2.297 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.06 105.94 13.8 Favored 'General case' 0 CA--C 1.57 1.73 0 O-C-N 120.417 -1.427 . . . . 0.0 113.491 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 85.2 m -82.44 135.37 35.16 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.479 HD12 ' HB1' ' A' ' 111' ' ' ALA . 85.8 mt -129.93 167.45 18.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 122.694 2.497 . . . . 0.0 115.585 -171.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.29 125.79 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 CA-C-N 111.147 -2.751 . . . . 0.0 107.01 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.275 60.7 m-85 -133.0 162.11 32.58 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 119.89 -1.756 . . . . 0.0 110.977 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.68 104.23 6.25 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.81 131.85 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 122.0 0.905 . . . . 0.0 111.269 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -114.14 111.07 20.99 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.996 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 117.34 29.97 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.57 -65.62 0.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.367 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -156.85 162.36 39.69 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 121.451 1.932 . . . . 0.0 109.491 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -141.38 -98.54 0.14 Allowed 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -80.34 -43.8 20.55 Favored 'General case' 0 CA--C 1.594 2.669 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.949 173.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.649 0 CA-C-N 124.868 3.485 . . . . 0.0 121.038 178.697 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.01 0 N-CA-C 122.897 3.919 . . . . 0.0 122.897 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.51 174.67 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-O 123.074 1.416 . . . . 0.0 113.345 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.73 115.56 8.25 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.296 1.038 . . . . 0.0 110.013 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.661 HD12 ' H ' ' A' ' 25' ' ' SER 0.349 2.4 pp -135.11 -66.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.661 ' H ' HD12 ' A' ' 24' ' ' ILE 1.057 0.3 OUTLIER 115.71 -117.21 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 116.479 -3.888 . . . . 0.0 108.182 -173.698 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -92.62 38.21 0.24 Allowed 'Trans proline' 0 CA--C 1.581 2.828 0 CA-C-N 125.612 3.04 . . . . 0.0 115.83 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.431 1.4 mmmp? 78.73 -22.13 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 118.764 -2.46 . . . . 0.0 115.56 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -73.9 -4.24 33.8 Favored 'General case' 0 CA--C 1.591 2.536 0 C-N-CA 123.642 0.777 . . . . 0.0 112.903 168.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.411 28.8 t0 70.93 54.33 0.25 Allowed 'General case' 0 CA--C 1.58 2.116 0 C-N-CA 126.199 1.8 . . . . 0.0 114.886 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -32.69 52.5 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.8 -19.08 0.11 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 120.101 2.8 . . . . 0.0 120.101 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.02 140.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.588 5.9 tp -155.73 -142.92 0.11 Allowed 'General case' 0 CA--C 1.57 1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.148 168.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -153.45 162.8 40.92 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.193 1.473 . . . . 0.0 114.958 -170.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.1 t -107.49 104.8 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.495 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.376 2.1 mm -76.81 120.44 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-N 120.588 1.54 . . . . 0.0 112.512 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -95.1 -53.61 3.74 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.474 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -148.91 103.82 3.39 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -76.77 165.9 24.1 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 123.781 2.991 . . . . 0.0 114.344 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.75 -158.68 33.95 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.308 5.0 t -153.26 -77.69 0.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.887 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 13.88 -85.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 122.423 3.729 . . . . 0.0 122.423 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.3 t -143.81 60.34 1.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 121.739 0.781 . . . . 0.0 111.193 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.399 6.4 pt-20 28.01 -114.84 0.03 OUTLIER 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -139.17 121.39 10.24 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.732 1.213 . . . . 0.0 112.681 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -70.09 -114.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.524 0 C-N-CA 122.912 2.408 . . . . 0.0 114.861 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.7 ptm -170.24 179.94 3.3 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 tp -50.48 144.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.258 0 O-C-N 120.771 -1.206 . . . . 0.0 111.268 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.64 -10.59 64.23 Favored Glycine 0 CA--C 1.555 2.562 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -85.85 149.01 25.54 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 121.764 2.782 . . . . 0.0 113.354 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.9 tpt85 -79.94 130.55 35.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.033 -1.042 . . . . 0.0 109.488 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 2.4 t -127.84 146.04 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.272 1.029 . . . . 0.0 110.718 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.253 51.7 p90 -134.32 115.28 13.9 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 122.871 1.32 . . . . 0.0 108.493 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.17 -179.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 CA-C-O 124.087 1.899 . . . . 0.0 113.553 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.57 113.91 9.56 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.479 172.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -115.85 150.13 37.51 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -122.54 147.15 46.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 162.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.06 143.06 9.82 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 119.102 -2.249 . . . . 0.0 117.198 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -134.3 154.78 51.12 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.634 1.974 . . . . 0.0 114.915 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.24 162.59 23.48 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.297 1.6 tm? -61.81 -29.03 69.89 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.05 -2.06 4.99 Favored 'General case' 0 CA--C 1.598 2.808 0 O-C-N 120.323 -1.486 . . . . 0.0 114.934 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.97 50.18 4.48 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 120.17 -1.581 . . . . 0.0 113.98 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.4 m -128.43 115.89 18.89 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.28 112.61 14.17 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.108 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -87.59 -36.99 17.21 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 122.277 2.308 . . . . 0.0 114.303 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -151.44 155.85 39.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.5 1.619 . . . . 0.0 111.148 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.5 p -159.92 104.72 1.54 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.192 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -36.86 80.15 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.61 -34.55 67.34 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 -58.66 3.38 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -158.42 69.77 0.51 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.794 1.179 . . . . 0.0 113.108 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.05 -82.08 0.08 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 120.115 -1.616 . . . . 0.0 108.42 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.71 -157.68 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 127.356 2.262 . . . . 0.0 108.409 -174.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -88.84 -176.94 5.38 Favored 'General case' 0 CA--C 1.578 2.047 0 O-C-N 120.068 -1.645 . . . . 0.0 109.556 169.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.274 9.9 t80 -119.65 160.0 23.34 Favored 'General case' 0 CA--C 1.576 1.971 0 O-C-N 119.627 -1.921 . . . . 0.0 110.344 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 p -165.39 134.42 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 119.792 -1.818 . . . . 0.0 109.198 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.493 ' CG ' HG11 ' A' ' 85' ' ' VAL . 15.8 p90 -148.07 -178.56 6.35 Favored 'General case' 0 CA--C 1.58 2.103 0 O-C-N 121.374 -0.829 . . . . 0.0 110.977 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 -117.11 127.34 54.04 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.67 103.56 0.05 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -172.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.69 47.96 87.46 Favored Glycine 1 N--CA 1.516 4.017 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.308 0.0 OUTLIER -133.76 -78.81 0.47 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -168.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.29 71.41 0.33 Allowed Glycine 0 N--CA 1.509 3.542 1 N-CA-C 103.066 -4.014 . . . . 0.0 103.066 169.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.474 0.0 OUTLIER -66.37 141.86 57.82 Favored 'General case' 0 CA--C 1.554 1.106 2 CA-C-O 129.274 4.369 . . . . 0.0 119.564 -157.593 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.493 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.396 17.4 m -79.93 -110.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 1 CA-C-N 102.751 -6.568 . . . . 0.0 105.617 -176.959 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.469 HG13 ' H ' ' A' ' 89' ' ' TRP . 24.8 pt -125.28 156.76 34.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 124.031 1.872 . . . . 0.0 106.121 167.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.45 -28.94 68.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.115 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.17 -36.02 76.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 117.024 -1.465 . . . . 0.0 112.867 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.469 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.5 m0 -72.91 -45.23 59.32 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 120.785 1.63 . . . . 0.0 112.755 173.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . 0.288 2.7 p30 -56.7 -35.41 68.47 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 121.527 1.967 . . . . 0.0 115.497 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.272 1.6 mp -67.16 -57.77 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-N 119.45 1.023 . . . . 0.0 111.241 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.13 83.09 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 t -68.51 -41.14 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 120.43 1.468 . . . . 0.0 111.585 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.57 62.61 Favored 'General case' 0 CA--C 1.587 2.384 0 CA-C-N 120.16 1.345 . . . . 0.0 113.83 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.4 p -96.44 -3.15 44.0 Favored 'General case' 0 CA--C 1.593 2.606 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.2 ttp -103.02 132.64 49.14 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 121.944 2.157 . . . . 0.0 111.026 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -94.17 153.55 18.03 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.4 t -10.56 -31.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 1 N-CA-C 126.862 5.875 . . . . 0.0 126.862 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.17 17.73 0.22 Allowed Glycine 0 N--CA 1.493 2.449 0 CA-C-O 116.357 -2.357 . . . . 0.0 115.038 -169.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.35 0.9 OUTLIER -129.14 -174.24 3.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -176.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.13 127.51 53.25 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.438 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.6 m -139.68 165.9 26.04 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.708 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.251 6.0 mtt85 -127.84 116.89 20.86 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.581 1.658 . . . . 0.0 111.143 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.62 138.25 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.8 m -132.99 109.64 9.7 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 25.1 p -137.26 149.08 46.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.093 2.998 . . . . 0.0 119.093 -173.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -81.0 142.13 51.47 Favored Pre-proline 0 CA--C 1.577 2.01 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.743 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.55 -25.44 7.72 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 N-CA-C 120.727 3.318 . . . . 0.0 120.727 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.07 -38.68 89.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.364 1.893 . . . . 0.0 114.558 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -79.28 -7.65 58.45 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 124.953 1.301 . . . . 0.0 114.249 169.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.25 -115.84 0.24 Allowed 'General case' 0 CA--C 1.58 2.109 0 CA-C-N 120.7 1.591 . . . . 0.0 114.781 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.285 1.6 m-85 -103.33 29.51 5.56 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 122.178 2.263 . . . . 0.0 113.432 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -52.36 158.18 3.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 120.449 2.939 . . . . 0.0 120.449 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.284 9.9 t 71.1 -64.56 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.89 -15.6 16.81 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.17 177.8 49.85 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-N 122.619 2.463 . . . . 0.0 112.392 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.508 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.4 t -75.31 127.43 86.34 Favored Pre-proline 0 CA--C 1.579 2.093 0 CA-C-O 116.394 -1.765 . . . . 0.0 108.846 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 69.6 Cg_exo -38.3 -43.81 1.9 Allowed 'Trans proline' 0 CA--C 1.582 2.922 1 N-CA-C 123.0 4.192 . . . . 0.0 123.0 -176.961 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.6 -37.06 0.22 Allowed 'Trans proline' 0 CA--C 1.573 2.469 0 CA-C-N 125.491 2.997 . . . . 0.0 119.399 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -150.99 -7.34 0.26 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.508 ' HB ' ' H ' ' A' ' 117' ' ' SER . 1.5 mt -79.9 145.94 62.84 Favored Pre-proline 0 CA--C 1.595 2.678 0 CA-C-N 122.944 2.611 . . . . 0.0 112.797 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.4 160.65 48.81 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 CA-C-N 126.453 3.341 . . . . 0.0 115.497 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -62.2 129.32 26.64 Favored 'Trans proline' 0 CA--C 1.57 2.286 0 C-N-CA 122.721 2.281 . . . . 0.0 116.736 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.58 65.66 1.21 Allowed 'General case' 0 CA--C 1.592 2.579 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.5 140.18 51.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 119.642 -1.911 . . . . 0.0 111.748 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.6 m -59.99 146.46 42.51 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.408 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 6.2 tp -116.8 152.55 34.16 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.931 1.696 . . . . 0.0 112.336 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.26 130.39 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.302 -170.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.256 24.2 m-85 -138.35 161.28 37.33 Favored 'General case' 0 N--CA 1.521 3.085 0 O-C-N 119.444 -2.035 . . . . 0.0 110.435 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -126.19 104.68 8.36 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.52 135.31 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-O 122.387 1.089 . . . . 0.0 111.107 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -115.35 115.77 27.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.658 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.25 112.17 24.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -77.92 -40.09 40.79 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.23 172.11 1.95 Allowed 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.304 0.0 OUTLIER -146.13 -96.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.374 -2.079 . . . . 0.0 107.919 177.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.47 72.2 tttt -111.42 -99.42 0.41 Allowed 'General case' 0 CA--C 1.586 2.347 0 CA-C-O 116.545 -1.693 . . . . 0.0 110.019 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.22 0 CA-C-N 124.991 3.541 . . . . 0.0 113.973 -178.568 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.963 1 N-CA-C 128.154 6.022 . . . . 0.0 128.154 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.438 0.3 OUTLIER 60.89 -60.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 118.592 2.812 . . . . 0.0 118.592 178.232 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.267 4.1 p-10 -151.49 112.43 4.27 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 174.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.489 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 4.8 tp -87.13 95.22 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 123.157 1.456 . . . . 0.0 108.905 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -141.99 89.61 8.77 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.254 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.269 31.3 Cg_exo -59.1 -27.87 86.22 Favored 'Trans proline' 0 CA--C 1.576 2.586 0 CA-C-N 122.879 2.064 . . . . 0.0 115.446 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 28' ' ' GLN 0.254 0.0 OUTLIER -150.99 -97.71 0.06 Allowed 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 170.723 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 1.7 mp0 -105.91 -0.51 25.05 Favored 'General case' 0 CA--C 1.588 2.419 0 C-N-CA 126.334 1.854 . . . . 0.0 111.497 174.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.266 16.8 t70 -54.62 -77.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -172.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.341 35.1 mt-10 -90.14 -23.87 21.23 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.54 13.04 1.15 Allowed Glycine 0 N--CA 1.506 3.352 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 106' ' ' CYS . 23.4 t -169.04 144.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 24' ' ' ILE 0.587 7.8 tp -157.69 -141.92 0.09 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.988 -1.482 . . . . 0.0 111.415 165.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 29.6 mtpt -155.87 155.75 33.45 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 122.825 2.557 . . . . 0.0 115.876 -171.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.56 108.11 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 102' ' ' CYS 0.408 1.0 OUTLIER -78.83 124.75 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-N 120.274 1.397 . . . . 0.0 113.538 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -110.64 -56.48 2.35 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.059 0.933 . . . . 0.0 110.599 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.262 46.1 ttt180 -113.63 97.98 6.77 Favored 'General case' 0 CA--C 1.597 2.787 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 36' ' ' ILE . 31.0 mt-10 -37.75 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.863 1 N-CA-C 123.349 4.574 . . . . 0.0 123.349 -177.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.18 163.73 28.03 Favored Glycine 0 CA--C 1.55 2.234 0 C-N-CA 125.072 1.32 . . . . 0.0 114.696 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.343 12.4 t -146.41 -72.07 0.24 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.85 69.54 2.64 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 120.756 3.062 . . . . 0.0 120.756 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.27 71.1 p 69.7 61.84 0.27 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.383 4.7 pt-20 30.6 -113.39 0.03 OUTLIER 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -147.52 122.19 5.11 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 115.918 -1.991 . . . . 0.0 110.898 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.42 0.2 OUTLIER -114.26 -40.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.275 1 N-CA-C 125.749 5.25 . . . . 0.0 125.749 177.579 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 1.9 ptt? -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.526 3.367 2 N-CA-C 127.542 6.127 . . . . 0.0 127.542 -174.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 tp -65.71 141.0 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.03 82.43 Favored Glycine 0 CA--C 1.567 3.322 0 O-C-N 120.286 -1.509 . . . . 0.0 116.527 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' MET . 4.0 t0 -72.66 141.38 48.27 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.932 2.366 . . . . 0.0 110.625 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 -85.97 101.03 12.54 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.25 137.2 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.35 0.66 . . . . 0.0 112.416 -169.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.05 104.56 12.26 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 76' ' ' PHE . 12.2 m -108.98 160.29 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 125.754 2.692 . . . . 0.0 114.697 -172.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.482 ' CD2' HD12 ' A' ' 70' ' ' LEU . 1.6 t60 -125.05 115.69 20.92 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.705 -2.952 . . . . 0.0 105.106 167.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.331 5.7 p90 -113.95 143.93 43.9 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.728 1.251 . . . . 0.0 114.28 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -118.07 147.32 43.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 164.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.79 136.6 4.67 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 118.894 -2.379 . . . . 0.0 115.278 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.29 160.36 40.64 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 111.852 -2.174 . . . . 0.0 114.921 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD12 ' H ' ' A' ' 62' ' ' ASP . 1.0 OUTLIER -80.65 178.82 8.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -65.13 -22.62 66.96 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 60' ' ' LEU . 36.8 t70 -73.57 -6.46 46.75 Favored 'General case' 0 CA--C 1.601 2.924 0 CA-C-N 119.106 0.867 . . . . 0.0 112.704 165.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.79 47.46 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 125.59 1.567 . . . . 0.0 113.636 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -88.67 108.93 19.72 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -74.49 91.85 2.31 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -73.1 -25.94 61.05 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 119.81 -1.806 . . . . 0.0 113.592 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -151.72 154.17 35.79 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 124.693 2.187 . . . . 0.0 115.308 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.8 p -153.77 102.3 2.52 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 112.029 -2.35 . . . . 0.0 104.767 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.292 31.6 p -58.87 -67.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.482 HD12 ' CD2' ' A' ' 55' ' ' HIS 0.379 32.6 mt -61.39 -45.14 95.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.05 -40.89 24.36 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -93.91 26.83 3.0 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.339 40.3 tttp 82.44 -30.4 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.49 -170.29 2.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.19 176.66 9.36 Favored 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 126.044 1.738 . . . . 0.0 109.857 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.473 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.394 0.5 OUTLIER -132.68 146.02 51.52 Favored 'General case' 0 CA--C 1.575 1.939 0 O-C-N 119.404 -2.06 . . . . 0.0 111.853 173.737 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.1 p -165.42 150.29 8.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.297 -2.127 . . . . 0.0 109.647 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.548 ' CG ' HG11 ' A' ' 85' ' ' VAL . 27.2 p90 -159.66 -171.8 3.43 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.665 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -123.18 113.66 19.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -37.99 105.98 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.43 53.52 24.61 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 118.178 2.031 . . . . 0.0 118.178 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -7.2 23.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.59 63.06 2.17 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 -167.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -154.29 -55.45 0.1 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 112.036 -2.082 . . . . 0.0 110.307 -163.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.548 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.301 16.6 m -97.82 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.431 HD12 ' HE3' ' A' ' 107' ' ' LYS . 3.7 pt -125.64 163.2 27.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 124.459 2.076 . . . . 0.0 109.261 172.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.254 0.9 OUTLIER -68.07 -34.58 76.7 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.178 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.39 70.71 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.601 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -73.26 -46.27 50.95 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 121.136 1.789 . . . . 0.0 112.28 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.95 -35.83 69.57 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 121.361 1.891 . . . . 0.0 115.571 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.29 1.7 mp -65.22 -61.55 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.207 0 CA-C-N 119.855 1.207 . . . . 0.0 111.627 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -67.05 -35.91 80.91 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.301 6.4 t -74.27 -32.87 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.189 0 O-C-N 121.237 -0.914 . . . . 0.0 111.084 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.99 -24.72 68.04 Favored 'General case' 0 CA--C 1.577 2.008 0 CA-C-N 120.709 1.595 . . . . 0.0 113.833 166.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.0 p -97.22 8.0 45.44 Favored 'General case' 0 CA--C 1.596 2.724 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.787 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 8.6 tpt -93.71 140.32 29.78 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 119.515 -1.991 . . . . 0.0 113.346 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.24 145.61 26.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.778 . . . . 0.0 114.203 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.05 125.23 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.32 -12.91 53.49 Favored Glycine 0 N--CA 1.496 2.675 0 CA-C-O 114.972 -3.127 . . . . 0.0 117.888 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.483 67.7 mt-10 -113.16 -159.5 0.69 Allowed 'General case' 0 CA--C 1.583 2.234 0 CA-C-N 122.805 3.303 . . . . 0.0 117.434 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.0 tp -140.26 138.75 35.26 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 119.082 2.994 . . . . 0.0 119.082 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 0.8 OUTLIER -160.02 157.82 29.41 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.909 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -104.88 128.71 53.21 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.204 1.478 . . . . 0.0 113.177 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.757 HG22 ' SG ' ' A' ' 106' ' ' CYS . 11.0 mt -71.88 131.72 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.231 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.625 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.1 m -113.98 108.78 17.48 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.757 ' SG ' HG22 ' A' ' 104' ' ' ILE 0.315 11.4 p -160.16 162.92 34.01 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 120.09 3.366 . . . . 0.0 120.09 -163.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.617 ' HD2' ' HB2' ' A' ' 106' ' ' CYS 2.574 0.0 OUTLIER 134.61 -147.52 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.165 1 N-CA-C 147.669 13.581 . . . . 0.0 147.669 157.447 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.888 21.9 Cg_exo 35.09 -63.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.577 2.631 1 C-N-CA 126.206 4.604 . . . . 0.0 120.952 -162.214 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.31 -33.37 75.69 Favored 'General case' 0 CA--C 1.579 2.07 0 O-C-N 118.818 -2.426 . . . . 0.0 114.805 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -80.76 0.99 32.26 Favored 'General case' 0 CA--C 1.598 2.82 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.447 ' HB2' ' HG3' ' A' ' 107' ' ' LYS . . . -147.69 -104.86 0.09 Allowed 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 127' ' ' LEU . 3.1 m-85 -89.87 -7.53 54.01 Favored 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -176.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -45.56 -21.39 0.49 Allowed Glycine 0 N--CA 1.503 3.112 1 N-CA-C 123.868 4.307 . . . . 0.0 123.868 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.9 p -71.92 -56.12 6.26 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.603 1.702 . . . . 0.0 112.79 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.19 -0.24 3.72 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.56 153.82 27.29 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-N 123.56 2.891 . . . . 0.0 115.133 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.465 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 7.5 t -82.97 130.77 56.26 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.635 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -34.29 -47.57 0.55 Allowed 'Trans proline' 0 CA--C 1.581 2.841 1 N-CA-C 122.666 4.064 . . . . 0.0 122.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.23 -54.71 0.36 Allowed 'Trans proline' 0 CA--C 1.571 2.351 0 CA-C-N 125.682 3.065 . . . . 0.0 116.725 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -173.0 78.3 0.04 OUTLIER 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 119.344 0.975 . . . . 0.0 113.542 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -141.09 125.65 10.59 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 119.673 -1.892 . . . . 0.0 109.377 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -90.31 162.69 4.59 Favored 'Trans proline' 0 CA--C 1.589 3.264 0 CA-C-N 123.442 2.265 . . . . 0.0 112.223 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.28 -34.6 66.88 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.103 2.309 . . . . 0.0 118.103 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -89.68 56.71 3.63 Favored 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 125.981 1.712 . . . . 0.0 113.215 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.54 106.94 4.37 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.014 -1.678 . . . . 0.0 113.664 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 m -60.35 154.09 21.15 Favored 'General case' 0 CA--C 1.587 2.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 112' ' ' TYR . 29.2 mt -124.27 172.34 9.17 Favored 'General case' 0 CA--C 1.566 1.567 0 O-C-N 120.288 -1.507 . . . . 0.0 111.834 -174.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.46 123.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -123.78 120.82 33.78 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 119.937 1.244 . . . . 0.0 108.228 176.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.15 107.79 19.35 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.961 -1.087 . . . . 0.0 108.716 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -112.45 135.86 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.17 0.986 . . . . 0.0 110.892 -171.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -114.43 112.71 23.44 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.9 115.1 28.86 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.891 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -78.94 -50.21 11.54 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -169.94 159.67 7.92 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 123.833 1.777 . . . . 0.0 110.384 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.91 -87.97 0.08 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 102.76 -3.052 . . . . 0.0 102.76 -177.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -121.89 95.45 4.67 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 170.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.635 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 177.477 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.923 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.94 148.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.9 0.85 . . . . 0.0 111.832 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -164.75 152.1 11.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.262 2.8 tp -126.71 61.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.989 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.238 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 t -159.42 99.46 1.56 Allowed Pre-proline 0 CA--C 1.572 1.814 0 O-C-N 120.703 -1.248 . . . . 0.0 114.12 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -64.06 6.7 0.27 Allowed 'Trans proline' 0 CA--C 1.584 2.994 0 N-CA-C 119.915 3.006 . . . . 0.0 119.915 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.447 30.4 mmmt 94.57 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.746 2.418 . . . . 0.0 110.447 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.287 32.0 mm-40 76.59 40.98 0.2 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.24 -168.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -137.76 -93.0 0.21 Allowed 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 -173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.398 3.1 mp0 -84.5 -15.49 45.75 Favored 'General case' 0 N--CA 1.487 1.378 1 N-CA-C 122.404 4.224 . . . . 0.0 122.404 -171.146 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.4 -62.69 0.59 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.68 146.47 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 N-CA-C 119.028 2.973 . . . . 0.0 119.028 -170.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.42 136.9 52.86 Favored 'General case' 0 CA--C 1.598 2.793 0 C-N-CA 126.548 1.939 . . . . 0.0 107.539 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -124.19 118.65 27.34 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 118.291 -2.756 . . . . 0.0 108.211 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.13 136.03 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.579 -0.701 . . . . 0.0 109.613 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.22 151.43 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 122.124 0.964 . . . . 0.0 113.044 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -131.18 -63.62 0.84 Allowed 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 124.22 1.008 . . . . 0.0 110.851 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -112.79 89.86 3.19 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -35.09 -56.21 0.59 Allowed 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -151.75 17.38 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 124.63 1.109 . . . . 0.0 115.495 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 t -79.66 -34.17 40.65 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.35 45.74 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 120.429 2.932 . . . . 0.0 120.429 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.25 67.2 p 68.84 -5.88 0.95 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 118.894 2.924 . . . . 0.0 118.894 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -75.86 131.94 40.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.0 p -107.93 163.61 16.57 Favored Pre-proline 0 N--CA 1.503 2.185 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.47 166.43 25.93 Favored 'Trans proline' 0 CA--C 1.577 2.639 0 CA-C-N 122.39 1.889 . . . . 0.0 114.436 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -102.39 163.34 12.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.52 -1.363 . . . . 0.0 111.546 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.355 0.3 OUTLIER -63.16 128.51 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.179 -2.2 . . . . 0.0 110.432 178.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 4.03 84.58 Favored Glycine 0 CA--C 1.572 3.594 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.23 166.34 9.99 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 121.189 2.494 . . . . 0.0 114.35 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -108.21 101.12 10.37 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 119.926 1.239 . . . . 0.0 108.933 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.93 139.0 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 123.61 0.764 . . . . 0.0 111.05 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.28 41.6 p90 -117.32 101.12 8.16 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 124.865 2.269 . . . . 0.0 109.267 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 76' ' ' PHE . 2.1 p -102.19 170.93 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 111.076 -2.783 . . . . 0.0 112.731 -170.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.96 100.7 3.22 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 166.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -97.69 160.22 14.45 Favored 'General case' 0 CA--C 1.593 2.635 0 CA-C-O 122.724 1.249 . . . . 0.0 113.299 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -128.0 147.96 50.52 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.15 142.43 9.1 Favored Glycine 0 CA--C 1.55 2.222 0 O-C-N 119.098 -2.251 . . . . 0.0 116.464 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.569 ' CE3' HG12 ' A' ' 128' ' ' VAL . 2.0 m-90 -130.27 149.11 52.11 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.49 1.916 . . . . 0.0 115.205 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.29 171.4 12.75 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.922 1.344 . . . . 0.0 108.746 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 3.3 tt -62.56 -29.46 70.6 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.05 7.01 1.81 Allowed 'General case' 0 CA--C 1.597 2.786 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.37 66.0 Favored Glycine 0 N--CA 1.509 3.557 0 O-C-N 119.841 -1.787 . . . . 0.0 114.744 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -112.62 118.53 35.31 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -77.88 93.11 4.33 Favored 'General case' 0 CA--C 1.583 2.225 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -64.66 -30.31 71.33 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 119.151 -2.218 . . . . 0.0 114.559 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.14 152.85 31.73 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 124.513 2.102 . . . . 0.0 112.492 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.6 p -159.35 86.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 t -52.91 -40.66 63.73 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.12 -38.81 54.13 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.691 1.996 . . . . 0.0 115.694 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.68 -34.26 18.49 Favored 'General case' 0 CA--C 1.578 2.025 0 C-N-CA 125.879 1.672 . . . . 0.0 114.88 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -29.78 70.88 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.312 2.708 . . . . 0.0 118.312 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.352 58.5 tptt 131.5 -56.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 127.677 2.391 . . . . 0.0 111.695 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -98.35 174.06 6.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 123.602 1.667 . . . . 0.0 113.199 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.06 175.62 6.25 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 125.298 1.439 . . . . 0.0 114.389 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HB3' HG13 ' A' ' 54' ' ' VAL 0.345 2.3 t80 -108.49 153.27 23.57 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-O 122.989 1.376 . . . . 0.0 108.356 173.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.9 p -163.53 111.79 1.22 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 118.154 -2.841 . . . . 0.0 104.514 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.539 ' CD1' HG11 ' A' ' 85' ' ' VAL . 2.4 p90 -125.54 177.06 6.42 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.116 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.308 33.6 t70 -86.32 -139.34 0.09 Allowed 'General case' 0 CA--C 1.584 2.251 0 O-C-N 119.117 -2.24 . . . . 0.0 105.803 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 tp -141.5 109.96 5.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 118.579 -2.576 . . . . 0.0 104.265 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 48.44 16.12 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.414 14.5 tppt? -106.82 6.58 29.6 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-N 119.902 1.851 . . . . 0.0 114.441 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.1 -51.99 1.65 Allowed Glycine 0 N--CA 1.508 3.478 0 O-C-N 120.151 -1.593 . . . . 0.0 109.953 -172.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.283 52.9 tt0 -20.2 -53.82 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 120.654 3.575 . . . . 0.0 120.654 168.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 78' ' ' PHE 0.294 16.5 m -101.87 -135.61 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 123.228 1.49 . . . . 0.0 110.12 -174.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 89' ' ' TRP . 13.7 pt -126.55 162.51 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.774 1.75 . . . . 0.0 109.797 173.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -67.16 -33.61 75.79 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.172 -1.376 . . . . 0.0 113.109 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.2 73.09 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.29 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' H ' HG13 ' A' ' 86' ' ' ILE . 35.1 m0 -74.77 -42.18 58.66 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-N 120.854 1.661 . . . . 0.0 112.205 172.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.84 -38.5 85.7 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.21 1.368 . . . . 0.0 113.863 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.4 mp -68.6 -60.64 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-N 119.09 0.859 . . . . 0.0 111.615 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.05 72.94 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.311 15.5 t -74.16 -32.79 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 CA-C-N 120.344 1.429 . . . . 0.0 110.652 175.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.25 73.92 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 121.02 1.736 . . . . 0.0 112.749 166.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.8 p -83.85 8.24 15.51 Favored 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.531 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 tpt -91.95 130.3 37.73 Favored 'General case' 0 CA--C 1.579 2.072 0 O-C-N 119.483 -2.011 . . . . 0.0 112.209 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.33 135.35 41.89 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 116.423 -1.751 . . . . 0.0 109.461 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.288 3.6 t -9.65 82.84 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-O 124.729 2.204 . . . . 0.0 108.308 -161.044 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 133' ' ' LEU . . . -54.99 46.88 0.01 OUTLIER Glycine 0 N--CA 1.502 3.037 2 CA-C-N 107.532 -4.394 . . . . 0.0 123.702 -140.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 0.4 OUTLIER -29.02 -87.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -169.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.61 121.51 17.67 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.754 0.822 . . . . 0.0 112.646 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.531 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 2.4 m -149.2 167.36 26.2 Favored 'General case' 0 CA--C 1.575 1.92 0 C-N-CA 123.949 0.899 . . . . 0.0 111.779 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -131.83 133.6 44.86 Favored 'General case' 0 CA--C 1.557 1.226 0 O-C-N 119.134 -2.229 . . . . 0.0 112.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.3 mt -90.71 129.27 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 CA-C-N 112.689 -2.05 . . . . 0.0 108.862 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 106.4 14.35 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.581 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 5.0 p -129.36 147.48 51.19 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -169.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -91.69 146.25 32.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.037 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.26 82.4 Cg_endo -61.87 -14.55 37.43 Favored 'Trans proline' 0 CA--C 1.568 2.213 0 N-CA-C 118.023 2.278 . . . . 0.0 118.023 -176.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.82 -38.46 78.7 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 120.778 1.626 . . . . 0.0 114.427 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.58 2.54 52.85 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 125.632 1.573 . . . . 0.0 113.495 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.61 -113.8 0.17 Allowed 'General case' 0 CA--C 1.58 2.132 0 CA-C-N 120.774 1.624 . . . . 0.0 115.269 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.271 4.9 m-85 -88.08 0.33 56.12 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 120.953 1.706 . . . . 0.0 115.378 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.4 -19.39 1.87 Allowed Glycine 0 N--CA 1.499 2.86 1 N-CA-C 124.219 4.447 . . . . 0.0 124.219 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -71.36 -57.41 4.48 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 120.271 2.036 . . . . 0.0 111.869 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.52 0.34 2.49 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.5 157.07 33.3 Favored Glycine 0 CA--C 1.546 1.996 0 CA-C-N 123.999 3.091 . . . . 0.0 112.483 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.423 ' HB3' HD12 ' A' ' 121' ' ' ILE . 2.7 t -86.53 125.56 66.99 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-O 116.918 -1.515 . . . . 0.0 108.423 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.274 28.1 Cg_exo -26.24 -49.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.877 1 N-CA-C 124.882 4.916 . . . . 0.0 124.882 -176.334 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -46.16 1.3 Allowed 'Trans proline' 0 CA--C 1.572 2.391 0 CA-C-N 125.861 3.129 . . . . 0.0 118.977 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -152.58 -11.78 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 117' ' ' SER . 14.2 mt -79.91 144.13 59.03 Favored Pre-proline 0 CA--C 1.595 2.692 0 CA-C-N 121.858 2.117 . . . . 0.0 115.564 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -102.48 176.16 0.19 Allowed 'Trans proline' 0 CA--C 1.594 3.497 0 CA-C-N 125.278 2.921 . . . . 0.0 113.661 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.5 -37.87 5.1 Favored 'Trans proline' 0 CA--C 1.573 2.464 0 C-N-CA 122.239 1.959 . . . . 0.0 116.619 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -80.89 50.87 1.44 Allowed 'General case' 0 CA--C 1.582 2.177 0 O-C-N 120.06 -1.65 . . . . 0.0 115.202 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.28 127.91 17.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.218 -1.551 . . . . 0.0 112.831 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.1 m -80.26 161.73 24.98 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.973 -1.079 . . . . 0.0 112.817 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.581 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.3 0.5 OUTLIER -145.12 174.0 11.44 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 119.711 -1.868 . . . . 0.0 112.274 -176.569 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.569 HG12 ' CE3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -148.57 125.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 125.039 1.336 . . . . 0.0 108.005 -171.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.285 4.7 m-85 -124.13 122.85 38.94 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 120.302 1.41 . . . . 0.0 110.58 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.17 121.73 32.47 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.77 128.0 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 121.369 0.604 . . . . 0.0 111.806 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.56 100.56 9.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.453 ' HB3' ' HA3' ' A' ' 99' ' ' GLY 0.285 16.2 tp -103.99 126.81 51.4 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.687 1.232 . . . . 0.0 111.703 -174.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -86.04 -60.32 2.04 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 120.897 -1.127 . . . . 0.0 112.836 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -157.5 -178.06 7.06 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 119.939 1.245 . . . . 0.0 110.088 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.26 -60.65 0.08 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.28 58.3 tttm -79.82 -44.51 20.43 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.614 2.82 . . . . 0.0 118.614 -172.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.823 0 CA-C-N 124.774 3.443 . . . . 0.0 121.188 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 120.476 2.95 . . . . 0.0 120.476 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -63.86 132.32 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 118.566 1.183 . . . . 0.0 110.704 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -119.64 131.62 55.5 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.426 3.1 tp -156.51 125.89 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-O 125.196 2.427 . . . . 0.0 115.317 171.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.489 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 33.6 t -139.12 124.32 11.81 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-N 111.832 -2.44 . . . . 0.0 106.959 161.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -70.1 45.59 0.5 Allowed 'Trans proline' 0 CA--C 1.593 3.441 0 CA-C-N 126.319 3.292 . . . . 0.0 117.522 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -172.7 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 127.705 2.402 . . . . 0.0 107.195 -176.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 2.5 mp0 -72.43 -31.67 65.68 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 124.705 1.202 . . . . 0.0 113.89 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.454 22.1 t70 77.62 -54.54 0.53 Allowed 'General case' 0 CA--C 1.575 1.94 0 C-N-CA 126.311 1.844 . . . . 0.0 111.88 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -90.35 41.95 1.08 Allowed 'General case' 0 CA--C 1.579 2.06 0 O-C-N 120.193 -1.567 . . . . 0.0 114.096 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 25' ' ' SER . . . -69.91 -46.23 53.5 Favored Glycine 1 N--CA 1.518 4.141 0 CA-C-N 122.468 2.394 . . . . 0.0 112.15 177.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 107' ' ' LYS 0.394 17.1 t -123.89 119.28 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 173.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.2 tp -89.93 122.42 32.94 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 125.251 1.42 . . . . 0.0 108.68 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -114.77 97.81 6.48 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 122.816 2.553 . . . . 0.0 108.568 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 109.318 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -86.17 145.48 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-O 121.591 0.71 . . . . 0.0 111.836 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -123.58 -53.67 1.78 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 123.568 0.747 . . . . 0.0 111.491 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -124.1 107.18 10.99 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -72.54 0.05 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.75 -156.82 28.83 Favored Glycine 0 CA--C 1.547 2.092 0 C-N-CA 125.1 1.334 . . . . 0.0 111.713 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -88.74 -7.48 56.18 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.6 -85.73 0.06 OUTLIER Glycine 0 CA--C 1.538 1.482 0 O-C-N 121.164 -0.96 . . . . 0.0 111.943 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -165.45 5.27 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -87.23 154.02 21.04 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 123.775 2.989 . . . . 0.0 115.1 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 p -128.23 164.29 38.48 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 112.974 -1.921 . . . . 0.0 113.284 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.48 -176.42 2.28 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-N 122.515 1.934 . . . . 0.0 115.775 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.5 ptp -133.92 167.34 20.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.461 -1.399 . . . . 0.0 112.426 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.279 1.5 tp -60.58 136.68 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 O-C-N 119.251 -2.155 . . . . 0.0 110.967 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.33 61.46 Favored Glycine 0 CA--C 1.559 2.787 0 N-CA-C 118.412 2.125 . . . . 0.0 118.412 -173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.85 149.13 26.58 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.63 2.215 . . . . 0.0 112.019 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -78.37 133.89 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.368 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.45 ' HB ' HD11 ' A' ' 133' ' ' LEU . 9.5 m -136.84 138.75 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 118.804 0.729 . . . . 0.0 111.57 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -116.73 102.43 9.42 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.551 -1.343 . . . . 0.0 108.543 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.2 m -102.32 167.81 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.62 117.91 17.59 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -112.18 150.85 30.26 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 m -119.05 151.6 37.94 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 157.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.07 142.32 8.86 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 118.229 -2.795 . . . . 0.0 115.459 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.411 ' CE3' HG12 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -130.25 155.07 46.89 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.027 -1.587 . . . . 0.0 115.01 -175.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.1 tp -78.48 177.01 8.86 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 123.086 1.422 . . . . 0.0 107.378 166.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -63.81 -25.8 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.75 13.74 2.0 Allowed 'General case' 0 CA--C 1.604 3.023 0 CA-C-N 119.077 0.853 . . . . 0.0 113.268 168.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.66 29.7 75.48 Favored Glycine 0 N--CA 1.509 3.541 0 O-C-N 120.034 -1.666 . . . . 0.0 116.432 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -86.74 113.9 22.97 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -74.39 85.28 1.98 Allowed 'General case' 0 CA--C 1.586 2.331 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.64 -30.78 69.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 119.66 -1.9 . . . . 0.0 115.403 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -149.57 141.24 23.53 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.575 1.179 . . . . 0.0 111.496 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.9 p -160.02 93.26 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.4 p -61.01 -35.83 77.89 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -52.92 -39.13 62.57 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.65 -41.8 44.38 Favored 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 125.034 1.334 . . . . 0.0 114.223 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -68.54 -20.12 64.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 33.9 mtmm 101.8 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 127.407 2.283 . . . . 0.0 112.118 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.1 153.31 41.77 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 123.0 1.381 . . . . 0.0 114.356 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -93.29 178.77 5.62 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.506 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.474 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.302 4.5 t80 -114.35 153.25 30.14 Favored 'General case' 0 CA--C 1.587 2.372 0 O-C-N 120.95 -1.094 . . . . 0.0 110.082 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.8 p -161.63 145.94 12.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 118.491 -2.631 . . . . 0.0 111.342 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 85' ' ' VAL . 25.6 p90 -155.22 -171.26 3.74 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -124.05 114.5 19.81 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.64 110.07 0.18 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.29 29.87 67.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -106.13 0.91 25.8 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.23 61.29 1.33 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -148.27 -51.29 0.17 Allowed 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 111.191 -2.505 . . . . 0.0 111.991 -166.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.261 13.5 m -125.9 -140.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.969 1.366 . . . . 0.0 109.756 -173.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.523 HD12 ' HZ3' ' A' ' 107' ' ' LYS . 12.6 pt -115.21 162.51 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-O 123.826 1.774 . . . . 0.0 109.88 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -65.88 -34.1 77.37 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.655 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . . . -57.1 -39.72 75.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 168.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.444 ' H ' HG13 ' A' ' 86' ' ' ILE . 32.8 m0 -70.23 -40.78 74.29 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.641 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.26 -33.78 74.09 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 119.593 1.088 . . . . 0.0 113.921 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -67.37 -59.17 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 119.925 1.238 . . . . 0.0 110.622 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.405 ' CB ' HD13 ' A' ' 104' ' ' ILE . . . -60.03 -47.0 87.67 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.332 5.2 t -60.4 -41.22 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.712 173.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.21 -39.29 56.23 Favored 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 121.506 1.957 . . . . 0.0 113.251 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -97.69 51.0 1.05 Allowed 'General case' 0 CA--C 1.593 2.624 0 C-N-CA 123.846 0.858 . . . . 0.0 112.618 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.1 ttt -138.37 152.3 48.31 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 119.479 -2.013 . . . . 0.0 113.881 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -118.53 146.08 44.83 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.558 2.799 . . . . 0.0 118.558 -172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -18.45 -29.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.756 1 N-CA-C 127.354 6.057 . . . . 0.0 127.354 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.37 -2.14 0.14 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-O 115.566 -2.797 . . . . 0.0 116.601 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 78.1 mm-40 -112.6 -145.43 0.4 Allowed 'General case' 0 N--CA 1.516 2.856 0 N-CA-C 121.012 3.708 . . . . 0.0 121.012 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 16.1 tp -133.94 140.6 46.88 Favored 'General case' 0 CA--C 1.601 2.932 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.47 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 58.8 m -142.88 -175.52 4.53 Favored 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.431 -1.418 . . . . 0.0 113.343 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -137.51 139.58 40.61 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 119.489 -2.007 . . . . 0.0 110.87 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.654 HG22 ' SG ' ' A' ' 106' ' ' CYS . 1.1 mt -106.97 128.11 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.579 0 C-N-CA 125.865 1.666 . . . . 0.0 109.168 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.8 m -119.49 114.49 22.37 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.654 ' SG ' HG22 ' A' ' 104' ' ' ILE 0.341 20.4 p -150.71 137.67 19.17 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -155.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.684 ' HG2' ' HB2' ' A' ' 110' ' ' TYR 0.765 0.0 OUTLIER -20.49 98.5 0.05 OUTLIER Pre-proline 0 CA--C 1.621 3.697 3 N-CA-C 140.664 10.987 . . . . 0.0 140.664 159.535 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.315 0.2 OUTLIER -49.62 -27.82 15.59 Favored 'Trans proline' 0 CA--C 1.589 3.27 1 O-C-N 113.337 -4.086 . . . . 0.0 118.14 173.084 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.82 -42.81 85.24 Favored 'General case' 0 CA--C 1.578 2.045 0 O-C-N 120.069 -1.644 . . . . 0.0 114.459 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.684 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 52.7 m-85 -78.11 3.87 13.91 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-O 117.367 -1.302 . . . . 0.0 113.469 171.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.452 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . . . -141.28 -103.43 0.14 Allowed 'General case' 0 CA--C 1.583 2.223 0 CA-C-N 121.943 2.156 . . . . 0.0 115.293 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.09 12.08 14.41 Favored 'General case' 0 CA--C 1.586 2.342 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -50.14 156.41 2.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 120.113 2.805 . . . . 0.0 120.113 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.283 7.8 t 73.38 -47.69 0.67 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.39 -52.83 4.16 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.03 148.52 17.89 Favored Glycine 0 CA--C 1.547 2.055 0 C-N-CA 124.35 0.976 . . . . 0.0 112.675 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.475 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.2 t -84.21 143.19 41.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.996 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.76 -39.58 57.33 Favored 'Trans proline' 0 CA--C 1.583 2.929 0 N-CA-C 120.265 3.141 . . . . 0.0 120.265 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -66.2 -62.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 CA-C-N 125.714 3.077 . . . . 0.0 116.229 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -168.57 62.64 0.06 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.475 ' HB ' ' H ' ' A' ' 117' ' ' SER . 69.3 mt -126.13 113.29 23.96 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.087 -1.633 . . . . 0.0 107.925 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.98 165.88 24.74 Favored 'Trans proline' 0 CA--C 1.583 2.946 0 C-N-CA 122.557 2.171 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.2 116.33 3.96 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.61 2.207 . . . . 0.0 112.679 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t30 67.33 53.21 0.77 Allowed 'General case' 0 CA--C 1.59 2.502 0 C-N-CA 125.423 1.489 . . . . 0.0 114.559 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.91 130.39 56.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.508 -1.37 . . . . 0.0 109.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 3.0 m -63.32 152.86 36.73 Favored 'General case' 0 CA--C 1.594 2.66 0 CA-C-N 120.552 1.524 . . . . 0.0 114.999 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.06 172.01 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 119.495 -2.003 . . . . 0.0 111.95 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.411 HG12 ' CE3' ' A' ' 59' ' ' TRP . 55.8 t -150.98 127.32 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.201 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 78.6 m-85 -142.1 127.21 18.48 Favored 'General case' 0 N--CA 1.517 2.914 0 O-C-N 119.236 -2.165 . . . . 0.0 111.198 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -98.36 101.18 12.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.407 -2.058 . . . . 0.0 106.732 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.07 140.42 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.556 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 101' ' ' LEU 1.827 30.5 tt0 -138.43 -171.71 3.11 Favored 'General case' 0 N--CA 1.524 3.232 0 CA-C-O 122.608 1.194 . . . . 0.0 109.203 164.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.532 ' H ' ' HG2' ' A' ' 132' ' ' GLU . 24.4 tp -140.94 127.07 19.54 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -162.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.82 -34.97 39.03 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 175.74 159.79 0.26 Allowed 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 127.32 2.248 . . . . 0.0 106.966 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.13 -92.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.135 -1.603 . . . . 0.0 109.593 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -81.13 55.92 2.66 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.149 0 CA-C-O 117.753 -1.582 . . . . 0.0 114.941 175.76 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.394 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -102.15 165.96 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 125.62 1.568 . . . . 0.0 114.439 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -155.69 140.28 16.93 Favored 'General case' 0 CA--C 1.58 2.098 0 O-C-N 120.753 -1.217 . . . . 0.0 110.072 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.632 0.7 OUTLIER 101.62 -13.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 174.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.896 49.2 m 58.21 58.76 6.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 118.153 -2.842 . . . . 0.0 118.29 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.81 74.07 4.54 Favored 'Trans proline' 0 CA--C 1.582 2.912 0 C-N-CA 123.282 2.655 . . . . 0.0 117.16 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -118.13 -89.02 0.6 Allowed 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.0 38.19 1.25 Allowed 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.16 63.01 1.86 Allowed 'General case' 0 CA--C 1.589 2.447 0 O-C-N 120.32 -1.488 . . . . 0.0 110.996 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.444 32.4 mt-10 -66.98 -43.35 83.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 -174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.48 -13.5 4.27 Favored Glycine 0 N--CA 1.503 3.153 1 N-CA-C 123.933 4.333 . . . . 0.0 123.933 171.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.3 164.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.087 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.798 0.5 OUTLIER -163.62 -168.38 1.64 Allowed 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 120.52 1.509 . . . . 0.0 114.652 164.69 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 23.3 pttm -148.66 150.13 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 2.7 t -113.77 87.49 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 117.362 -1.304 . . . . 0.0 112.763 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.504 2.4 mm -43.95 121.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 117.195 2.295 . . . . 0.0 117.195 -177.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -106.9 -59.24 1.83 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.893 0.877 . . . . 0.0 110.166 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -142.2 106.94 4.86 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -51.33 -56.85 10.87 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 122.297 2.317 . . . . 0.0 116.342 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.63 -158.73 25.15 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 126.364 1.935 . . . . 0.0 114.63 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -78.24 2.79 17.2 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.4 45.12 95.68 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -114.44 -66.62 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.79 173.06 12.72 Favored 'General case' 0 CA--C 1.581 2.14 0 CA-C-O 122.996 1.379 . . . . 0.0 114.377 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -118.95 147.67 42.98 Favored Pre-proline 0 CA--C 1.581 2.15 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.157 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -68.09 141.72 53.74 Favored 'Trans proline' 0 CA--C 1.582 2.904 0 N-CA-C 118.318 2.392 . . . . 0.0 118.318 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -104.05 167.68 9.61 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 121.534 1.97 . . . . 0.0 112.79 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.256 2.0 tp -62.95 134.65 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.292 0 O-C-N 118.954 -2.341 . . . . 0.0 108.946 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.78 15.13 81.51 Favored Glycine 0 CA--C 1.562 3.012 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -82.95 139.64 33.24 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.374 2.087 . . . . 0.0 110.68 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 136' ' ' PHE . 1.6 tmm_? -83.03 113.35 20.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.386 2.0 t -117.99 136.75 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 C-N-CA 125.438 1.495 . . . . 0.0 112.911 -164.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -120.35 103.79 9.5 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.901 1.334 . . . . 0.0 107.815 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.461 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.6 m -107.55 164.92 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 123.481 1.61 . . . . 0.0 111.961 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.419 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.295 3.7 t60 -130.24 138.06 50.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 164.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -132.5 148.48 52.39 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.789 2.515 . . . . 0.0 117.789 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -116.59 147.62 41.68 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 162.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.9 145.59 13.47 Favored Glycine 0 CA--C 1.545 1.954 0 O-C-N 119.136 -2.227 . . . . 0.0 117.308 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.45 157.75 45.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.515 1.926 . . . . 0.0 114.466 -173.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.99 167.49 11.2 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 169.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.289 1.0 OUTLIER -61.95 -25.59 67.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -68.32 -3.73 11.98 Favored 'General case' 0 CA--C 1.595 2.696 0 CA-C-N 120.069 1.304 . . . . 0.0 112.763 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 44.19 12.41 Favored Glycine 0 N--CA 1.498 2.775 0 CA-C-N 120.334 1.424 . . . . 0.0 114.295 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.0 m -120.13 119.54 33.59 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.84 92.1 3.03 Favored 'General case' 0 CA--C 1.585 2.313 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.969 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -69.74 -30.87 68.58 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 118.891 -2.381 . . . . 0.0 114.962 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -147.0 156.61 43.17 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 125.237 2.446 . . . . 0.0 114.432 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -150.36 93.03 1.93 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.272 63.8 p -47.99 -58.73 4.05 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.635 2.458 . . . . 0.0 117.635 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.419 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 85.7 mt -51.9 -44.01 63.61 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.21 -43.87 96.91 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -136.34 35.93 2.74 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -176.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -158.95 -75.11 0.08 Allowed 'General case' 0 CA--C 1.564 1.508 0 O-C-N 120.212 -1.555 . . . . 0.0 109.834 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.13 -161.78 0.06 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 127.19 2.196 . . . . 0.0 108.913 -173.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.14 -170.5 2.76 Favored 'General case' 0 CA--C 1.591 2.526 0 O-C-N 118.935 -2.353 . . . . 0.0 107.769 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.47 1.4 t80 -123.77 148.79 46.33 Favored 'General case' 0 CA--C 1.58 2.11 0 O-C-N 118.038 -2.914 . . . . 0.0 111.14 173.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.3 p -167.07 140.89 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 118.454 -2.654 . . . . 0.0 111.973 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CG ' HG11 ' A' ' 85' ' ' VAL . 35.5 p90 -149.98 -165.44 2.27 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 121.227 0.537 . . . . 0.0 111.184 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.61 63.43 1.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.207 -1.558 . . . . 0.0 112.152 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 10.77 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.81 61.7 2.51 Favored Glycine 0 N--CA 1.511 3.664 0 O-C-N 119.767 -1.833 . . . . 0.0 112.025 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.662 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.394 0.0 OUTLIER -106.48 -85.22 0.5 Allowed 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 123.964 1.84 . . . . 0.0 111.357 -171.795 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.662 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -100.93 -43.47 2.24 Favored Glycine 0 N--CA 1.51 3.61 0 CA-C-O 124.647 2.248 . . . . 0.0 110.473 165.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 1.05 1.3 pp20? 111.49 135.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 131.605 3.962 . . . . 0.0 118.684 165.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 86' ' ' ILE 0.337 12.3 m -79.69 -99.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 109.232 -3.622 . . . . 0.0 104.428 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.535 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.3 pt -133.9 155.72 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 124.451 2.072 . . . . 0.0 105.982 165.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 13.0 tmtt? -67.35 -29.0 68.43 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.752 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.13 82.02 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 117.456 -1.259 . . . . 0.0 112.113 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.535 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.9 m0 -73.15 -43.0 62.2 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 120.882 1.674 . . . . 0.0 113.094 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.33 -36.52 71.25 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 120.034 1.288 . . . . 0.0 114.157 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.283 1.7 mp -67.68 -58.0 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 119.402 1.001 . . . . 0.0 111.452 174.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.485 ' CB ' HD13 ' A' ' 104' ' ' ILE . . . -63.16 -39.28 94.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.447 ' HA ' ' SD ' ' A' ' 96' ' ' MET . 65.2 t -63.57 -49.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.301 1.409 . . . . 0.0 111.052 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.66 -32.55 29.97 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.1 p -100.71 19.11 17.68 Favored 'General case' 0 CA--C 1.591 2.534 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 93' ' ' VAL 0.337 1.4 ptt? -115.82 -172.96 2.26 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 122.758 2.526 . . . . 0.0 116.373 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -134.88 152.32 51.65 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 66.6 t -48.17 126.83 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.83 -44.29 1.52 Allowed Glycine 0 N--CA 1.491 2.325 0 CA-C-O 115.904 -2.609 . . . . 0.0 113.455 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -145.53 -173.38 4.11 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.827 2.813 . . . . 0.0 113.264 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 102' ' ' CYS 0.704 0.2 OUTLIER -158.71 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.267 1.508 . . . . 0.0 113.97 176.242 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -160.08 -145.87 0.13 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' N ' ' SG ' ' A' ' 102' ' ' CYS 0.326 0.0 OUTLIER -122.94 113.58 19.28 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 124.952 2.31 . . . . 0.0 111.975 170.087 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.485 HD13 ' CB ' ' A' ' 92' ' ' ALA 0.316 1.4 mt -78.45 146.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 112.131 -2.304 . . . . 0.0 113.112 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 106' ' ' CYS 2.023 0.1 OUTLIER -161.05 -178.43 6.77 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 120.902 3.668 . . . . 0.0 120.902 146.969 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 111' ' ' ALA . 1.9 p -159.77 162.95 34.96 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -159.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -79.67 144.19 60.2 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-N 112.258 -2.246 . . . . 0.0 108.69 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.84 -21.35 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 N-CA-C 120.293 3.151 . . . . 0.0 120.293 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -60.23 -36.76 78.46 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.43 -3.26 58.23 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 171.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -128.7 -103.75 0.31 Allowed 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 120.483 1.492 . . . . 0.0 114.028 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.364 47.3 m-85 -106.42 -5.33 19.03 Favored 'General case' 0 N--CA 1.523 3.201 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.95 -154.83 49.28 Favored Glycine 0 N--CA 1.488 2.109 0 CA-C-N 122.462 2.392 . . . . 0.0 118.394 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -67.12 -24.57 65.93 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.63 -31.71 15.76 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.88 167.56 43.64 Favored Glycine 0 CA--C 1.552 2.382 0 CA-C-N 121.409 1.913 . . . . 0.0 114.797 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.428 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 5.9 t -86.82 114.82 60.02 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 116.843 -1.551 . . . . 0.0 107.384 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.284 85.0 Cg_exo -40.73 -49.27 4.31 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 122.202 3.885 . . . . 0.0 122.202 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.83 8.88 4.0 Favored 'Trans proline' 0 CA--C 1.577 2.646 0 CA-C-N 125.173 2.883 . . . . 0.0 118.086 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -159.09 -17.53 0.07 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.428 ' HB ' ' H ' ' A' ' 117' ' ' SER . 41.7 mt -125.17 136.63 28.42 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 121.381 1.901 . . . . 0.0 112.702 -172.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.47 170.53 13.04 Favored 'Trans proline' 0 CA--C 1.584 2.987 0 CA-C-N 122.914 2.077 . . . . 0.0 115.211 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.62 135.98 37.74 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 122.758 2.305 . . . . 0.0 114.836 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.3 t30 59.68 56.82 3.44 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 124.901 1.28 . . . . 0.0 113.334 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.56 114.8 27.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.249 -1.532 . . . . 0.0 112.194 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.2 m -68.8 144.31 54.35 Favored 'General case' 0 CA--C 1.591 2.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.716 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD12 ' HB1' ' A' ' 111' ' ' ALA . 21.3 mt -113.95 172.62 6.88 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -172.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -153.44 124.44 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.783 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.388 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 1.0 OUTLIER -141.85 130.53 22.77 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-N 124.599 3.363 . . . . 0.0 110.442 175.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -94.48 104.09 16.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.28 140.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -123.99 121.48 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.4 tp -89.25 112.4 23.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 111.955 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -81.74 -41.83 20.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -168.42 154.22 6.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.227 1.489 . . . . 0.0 109.537 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' ARG 0.275 5.8 p90 -151.45 -90.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 178.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.52 69.26 6.98 Favored 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.431 1.586 . . . . 0.0 112.194 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.829 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -178.816 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.06 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 11.5 p -63.55 151.75 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.095 1.448 . . . . 0.0 111.871 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -124.5 133.73 53.25 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.292 9.8 tp -138.36 40.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.809 0 CA-C-N 113.222 -1.808 . . . . 0.0 110.085 166.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.64 -49.3 0.01 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -66.21 55.84 0.4 Allowed 'Trans proline' 0 CA--C 1.579 2.754 0 CA-C-N 125.235 2.905 . . . . 0.0 118.893 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.75 -85.38 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.24 24.73 9.08 Favored 'General case' 0 CA--C 1.59 2.497 0 C-N-CA 124.594 1.157 . . . . 0.0 113.95 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.0 t70 56.19 54.46 7.77 Favored 'General case' 0 CA--C 1.586 2.355 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.324 2.8 mp0 -76.37 -24.89 54.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 118.643 2.831 . . . . 0.0 118.643 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.9 -34.93 2.1 Favored Glycine 0 N--CA 1.473 1.163 0 N-CA-C 120.849 3.099 . . . . 0.0 120.849 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.36 143.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.7 tp -104.32 136.33 44.11 Favored 'General case' 0 CA--C 1.59 2.494 0 C-N-CA 127.003 2.121 . . . . 0.0 106.089 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -121.73 130.57 53.53 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 124.014 3.097 . . . . 0.0 113.406 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 4.5 t -85.75 147.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 116.613 -1.661 . . . . 0.0 110.203 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 102' ' ' CYS 0.446 0.5 OUTLIER -126.02 125.18 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-N 120.522 1.51 . . . . 0.0 110.007 170.248 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -58.75 2.05 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.611 -0.681 . . . . 0.0 111.874 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -121.94 99.26 6.35 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -56.51 174.61 0.14 Allowed 'General case' 0 CA--C 1.595 2.697 0 O-C-N 119.904 -1.748 . . . . 0.0 115.648 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.81 -165.66 37.68 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 119.215 2.446 . . . . 0.0 119.215 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -91.3 -1.81 57.55 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.69 -90.4 0.08 OUTLIER Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.653 1.569 . . . . 0.0 116.683 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 t -159.88 -25.92 0.07 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -78.75 142.95 36.6 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 p -135.67 114.05 11.09 Favored Pre-proline 0 CA--C 1.577 2.005 0 CA-C-N 109.831 -3.35 . . . . 0.0 107.528 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -67.5 -29.76 36.8 Favored 'Trans proline' 0 CA--C 1.582 2.887 0 N-CA-C 117.27 1.988 . . . . 0.0 117.27 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.524 32.2 mtt 81.29 -150.78 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.318 1.1 tp -50.5 134.17 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 O-C-N 120.585 -1.322 . . . . 0.0 113.625 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 -7.13 76.5 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 116.927 -2.041 . . . . 0.0 117.548 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -74.61 128.43 35.54 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 122.827 3.314 . . . . 0.0 112.817 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ptm85 -76.4 125.68 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.931 0.787 . . . . 0.0 109.078 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 136' ' ' PHE . 23.2 m -120.44 138.45 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.905 0.882 . . . . 0.0 112.751 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -117.18 108.06 15.21 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.7 m -119.12 160.6 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.301 6.1 m-70 -126.64 113.03 16.18 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 166.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -108.13 146.04 33.25 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.3 m -112.72 139.31 48.45 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 162.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.64 147.66 19.08 Favored Glycine 0 CA--C 1.565 3.188 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.77 171.52 20.24 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 127.93 2.492 . . . . 0.0 113.068 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -93.36 148.75 21.78 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.513 165.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.376 0.2 OUTLIER -61.74 -17.32 55.39 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.01 -28.23 66.19 Favored 'General case' 0 CA--C 1.594 2.636 0 CA-C-N 120.334 1.424 . . . . 0.0 111.823 166.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.18 52.07 0.61 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -135.34 113.19 11.0 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -68.52 120.39 14.49 Favored 'General case' 0 CA--C 1.584 2.274 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.411 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -97.46 -31.69 12.22 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 121.442 1.928 . . . . 0.0 113.498 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -154.16 165.65 35.59 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 123.24 1.495 . . . . 0.0 113.508 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -148.52 -10.38 0.36 Allowed 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.381 97.7 p 61.44 -36.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 122.846 2.566 . . . . 0.0 117.887 -176.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.81 -42.87 97.58 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 128.186 2.594 . . . . 0.0 113.746 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.71 -38.08 74.64 Favored 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.12 -21.72 63.99 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.332 33.4 ttmt 86.05 -23.57 0.15 Allowed 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 126.161 1.784 . . . . 0.0 114.7 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.266 8.3 t70 -92.87 -135.3 0.16 Allowed 'General case' 0 CA--C 1.572 1.81 0 C-N-CA 124.406 1.083 . . . . 0.0 110.477 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 168.87 21.38 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 124.743 1.217 . . . . 0.0 113.731 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.261 4.0 t80 -97.23 144.14 27.33 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.2 p -159.93 147.8 16.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.614 -2.554 . . . . 0.0 109.405 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.2 p90 -159.47 -176.58 5.86 Favored 'General case' 0 CA--C 1.589 2.447 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.278 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.54 132.66 52.55 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 118.922 -2.361 . . . . 0.0 106.307 171.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 107.84 0.63 Allowed 'General case' 0 CA--C 1.577 1.983 0 O-C-N 120.848 -1.158 . . . . 0.0 113.88 -175.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.84 6.81 Favored Glycine 0 N--CA 1.504 3.18 0 O-C-N 120.433 -1.417 . . . . 0.0 113.669 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.621 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.266 0.0 OUTLIER -107.71 -75.66 0.63 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.57 1.652 . . . . 0.0 110.812 -175.01 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.621 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -105.31 -51.95 0.85 Allowed Glycine 0 N--CA 1.502 3.097 0 CA-C-O 124.786 2.325 . . . . 0.0 108.808 167.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.723 19.8 tt0 114.75 140.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 128.376 3.941 . . . . 0.0 114.159 166.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.366 12.0 m -79.96 -100.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.106 1 CA-C-N 105.211 -5.45 . . . . 0.0 103.028 177.508 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.502 HG13 ' H ' ' A' ' 89' ' ' TRP . 41.3 pt -135.09 157.5 40.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 124.995 2.331 . . . . 0.0 105.895 165.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 12.7 tmtt? -69.39 -30.39 68.35 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 114.226 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.41 83.27 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 116.22 -1.848 . . . . 0.0 110.567 165.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.502 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.2 m0 -71.28 -44.85 64.42 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 122.074 2.216 . . . . 0.0 113.204 174.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.92 -33.37 68.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.252 1.6 mp -68.67 -58.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 120.187 1.358 . . . . 0.0 110.749 172.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.84 88.84 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.291 11.9 t -62.64 -38.06 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.235 1.379 . . . . 0.0 112.892 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.67 -34.41 64.99 Favored 'General case' 0 CA--C 1.581 2.171 0 CA-C-N 121.002 1.728 . . . . 0.0 113.804 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.7 p -84.45 -0.19 51.93 Favored 'General case' 0 CA--C 1.59 2.5 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 mtt -85.88 105.1 16.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 121.96 2.164 . . . . 0.0 114.242 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.75 141.4 49.75 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 114.779 -2.534 . . . . 0.0 106.756 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.267 1.7 t -9.64 96.13 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.54 4.032 0 CA-C-N 122.841 2.564 . . . . 0.0 112.484 -161.029 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 133' ' ' LEU . . . 18.78 -50.28 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 1 N-CA-C 129.289 6.475 . . . . 0.0 129.289 -151.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 69.24 174.35 0.29 Allowed 'General case' 0 CA--C 1.605 3.085 0 CA-C-O 123.089 1.424 . . . . 0.0 108.156 -164.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.707 HD13 ' HG3' ' A' ' 132' ' ' GLU 0.311 12.6 tp -126.45 104.42 8.15 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 123.863 1.792 . . . . 0.0 109.109 169.426 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.7 p -160.41 -159.29 0.68 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.767 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.776 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 2.31 0.0 OUTLIER -160.91 -139.15 0.05 Allowed 'General case' 0 CA--C 1.563 1.455 1 N-CA-C 122.603 4.297 . . . . 0.0 122.603 157.863 . . . . . . . . 5 4 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 103' ' ' ARG . 8.0 mt -121.53 146.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 109.548 -3.478 . . . . 0.0 114.676 -165.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.6 m -135.48 91.32 2.71 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 13.7 p -107.41 147.75 29.99 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 -171.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -90.52 137.98 27.05 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.084 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.308 13.9 Cg_endo -54.09 -10.14 1.8 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 120.346 3.172 . . . . 0.0 120.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.35 -38.8 88.26 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 120.494 1.497 . . . . 0.0 113.695 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -86.27 -0.52 56.0 Favored 'General case' 0 CA--C 1.576 1.952 0 C-N-CA 126.059 1.743 . . . . 0.0 114.213 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.28 -111.64 0.19 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CD2' HD11 ' A' ' 127' ' ' LEU . 2.6 m-85 -93.5 0.21 56.61 Favored 'General case' 0 N--CA 1.517 2.879 0 CA-C-N 120.742 1.61 . . . . 0.0 114.952 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.69 146.16 3.6 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.928 2.731 . . . . 0.0 119.928 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.346 53.1 p 76.0 -47.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -175.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.72 -55.03 3.03 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.28 149.63 25.75 Favored Glycine 0 CA--C 1.546 1.99 0 CA-C-N 119.548 1.067 . . . . 0.0 111.471 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.45 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 7.4 t -75.44 129.19 82.68 Favored Pre-proline 0 CA--C 1.579 2.059 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.954 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.281 6.8 Cg_endo -40.43 -44.57 4.31 Favored 'Trans proline' 0 CA--C 1.579 2.763 1 N-CA-C 122.554 4.021 . . . . 0.0 122.554 -175.54 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.64 -37.07 1.87 Allowed 'Trans proline' 0 CA--C 1.572 2.396 0 CA-C-N 125.296 2.927 . . . . 0.0 118.61 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -151.48 -17.99 0.2 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 119.06 2.985 . . . . 0.0 119.06 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 117' ' ' SER . 85.5 mt -79.96 139.66 53.61 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 122.476 2.398 . . . . 0.0 114.028 -173.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -93.16 179.06 1.15 Allowed 'Trans proline' 0 CA--C 1.59 3.31 0 CA-C-N 125.332 2.94 . . . . 0.0 115.04 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -60.04 -2.9 1.92 Allowed 'Trans proline' 0 CA--C 1.576 2.607 0 N-CA-C 121.077 3.453 . . . . 0.0 121.077 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.04 92.82 1.38 Allowed 'General case' 0 CA--C 1.589 2.479 0 CA-C-N 120.991 1.723 . . . . 0.0 111.096 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.34 131.62 23.49 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 122.674 2.488 . . . . 0.0 110.216 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.0 m -74.92 128.81 36.46 Favored 'General case' 0 CA--C 1.593 2.629 0 O-C-N 120.836 -1.165 . . . . 0.0 111.63 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.474 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 71.3 mt -107.44 165.23 11.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.93 118.17 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.62 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.345 0.2 OUTLIER -140.33 107.98 5.62 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 121.035 1.743 . . . . 0.0 109.875 172.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.776 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 39.9 mt-10 -100.51 128.67 46.5 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.241 -1.537 . . . . 0.0 108.342 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.738 ' H ' ' HB2' ' A' ' 103' ' ' ARG 0.363 1.1 p -132.4 149.94 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 124.818 2.246 . . . . 0.0 116.161 -170.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.707 ' HG3' HD13 ' A' ' 101' ' ' LEU . 1.6 mp0 -102.61 120.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 111.41 -2.632 . . . . 0.0 107.007 178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 99' ' ' GLY 0.293 10.5 tp -107.96 109.32 20.78 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 121.713 2.051 . . . . 0.0 108.529 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -69.5 -55.55 9.9 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 119.726 -1.859 . . . . 0.0 114.014 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -158.6 155.25 27.94 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.737 1.732 . . . . 0.0 107.205 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.447 ' HB3' HG12 ' A' ' 52' ' ' VAL 0.255 0.0 OUTLIER -131.46 -108.86 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.244 177.114 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -102.24 83.87 2.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.623 0 N-CA-C 122.519 3.768 . . . . 0.0 122.519 -176.64 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 1 N-CA-C 127.807 5.883 . . . . 0.0 127.807 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.69 123.35 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 1 N-CA-C 99.902 -4.11 . . . . 0.0 99.902 162.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -164.64 155.69 15.01 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 120.083 3.364 . . . . 0.0 120.083 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.274 5.3 tp -161.66 142.2 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.274 0 CA-C-O 125.339 2.495 . . . . 0.0 110.65 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -142.76 127.85 10.08 Favored Pre-proline 0 CA--C 1.58 2.101 0 CA-C-N 112.659 -2.064 . . . . 0.0 107.686 166.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -58.74 21.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.902 1 N-CA-C 123.736 4.476 . . . . 0.0 123.736 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -145.97 -79.02 0.17 Allowed 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.99 -1.694 . . . . 0.0 108.264 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 2.0 mp0 -99.78 81.59 2.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.303 37.1 p30 -18.95 -24.69 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.247 1 N-CA-C 126.23 5.641 . . . . 0.0 126.23 -174.392 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -90.18 26.27 1.94 Allowed 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -35.39 59.04 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 118.525 -2.609 . . . . 0.0 118.221 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.281 50.9 t -133.74 119.96 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.787 0.803 . . . . 0.0 111.119 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.61 139.17 37.56 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -139.86 84.7 1.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 119.476 -2.015 . . . . 0.0 106.66 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -85.89 101.24 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 115.972 -1.966 . . . . 0.0 111.7 -168.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.653 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.642 0.5 OUTLIER -65.51 133.4 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -172.47 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.48 -56.22 2.59 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.44 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -150.93 121.23 7.29 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -72.27 0.13 Allowed 'General case' 0 CA--C 1.581 2.147 0 O-C-N 119.038 -2.289 . . . . 0.0 114.409 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.98 -176.03 37.6 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 125.555 1.55 . . . . 0.0 114.488 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 t -149.91 -3.18 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.632 2.826 . . . . 0.0 118.632 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.19 -75.36 0.51 Allowed Glycine 0 N--CA 1.492 2.385 0 CA-C-N 122.095 2.225 . . . . 0.0 117.19 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.8 p -126.2 -80.73 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.341 0.57 . . . . 0.0 110.393 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -159.46 -146.92 0.15 Allowed 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.227 1.011 . . . . 0.0 110.679 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 p -94.57 168.97 10.36 Favored Pre-proline 0 CA--C 1.582 2.204 0 C-N-CA 125.443 1.497 . . . . 0.0 111.464 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -99.96 -167.1 0.08 OUTLIER 'Trans proline' 0 CA--C 1.569 2.256 0 CA-C-N 122.909 2.075 . . . . 0.0 116.196 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -137.65 146.73 44.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.06 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.609 HG23 ' H ' ' A' ' 49' ' ' GLY 0.529 0.2 OUTLIER -9.95 -123.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.807 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.609 ' H ' HG23 ' A' ' 48' ' ' ILE . . . -49.18 38.43 0.01 OUTLIER Glycine 0 N--CA 1.504 3.206 1 N-CA-C 124.042 4.377 . . . . 0.0 124.042 177.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.67 148.87 38.34 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 119.979 1.889 . . . . 0.0 112.141 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.82 134.47 41.73 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 0.9 OUTLIER -142.26 147.82 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 124.72 2.2 . . . . 0.0 112.123 -163.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.553 ' CE2' ' HG ' ' A' ' 133' ' ' LEU 0.532 4.9 p90 -79.9 -160.29 0.27 Allowed 'General case' 0 CA--C 1.589 2.462 0 C-N-CA 127.545 2.338 . . . . 0.0 114.335 168.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.908 HG23 ' HB3' ' A' ' 76' ' ' PHE 0.295 0.8 OUTLIER 157.6 147.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 127.094 2.158 . . . . 0.0 111.292 159.506 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.312 0.2 OUTLIER -127.64 111.49 13.78 Favored 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 118.592 -1.243 . . . . 0.0 107.886 164.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 37.1 p90 -101.12 174.65 5.9 Favored 'General case' 0 CA--C 1.589 2.46 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -152.91 113.89 4.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 164.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.81 136.85 8.96 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 124.652 2.251 . . . . 0.0 116.157 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.461 ' HE3' HG23 ' A' ' 128' ' ' VAL . 1.1 m-90 -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 110.615 -2.792 . . . . 0.0 112.897 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.4 tp -79.07 170.3 16.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 125.367 2.508 . . . . 0.0 108.318 168.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.255 3.1 tm? -58.82 -19.63 43.01 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 110.885 -2.87 . . . . 0.0 114.036 168.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -75.38 4.17 7.78 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 121.071 1.76 . . . . 0.0 113.038 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.27 89.45 Favored Glycine 0 N--CA 1.51 3.618 0 CA-C-N 121.41 1.914 . . . . 0.0 116.188 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -117.76 140.12 50.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -86.05 95.0 9.38 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.908 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -69.97 -35.21 74.26 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.206 -2.184 . . . . 0.0 113.929 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.65 170.17 23.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.755 1.616 . . . . 0.0 112.711 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 95.0 p -160.06 -17.57 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.29 1.3 t 69.97 -53.07 0.63 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.502 -1.999 . . . . 0.0 113.085 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.9 mt -49.99 -49.97 48.67 Favored 'General case' 0 CA--C 1.581 2.154 0 C-N-CA 127.09 2.156 . . . . 0.0 114.255 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.12 -38.45 82.25 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.553 1.168 . . . . 0.0 114.134 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -73.22 2.36 7.51 Favored 'General case' 0 CA--C 1.585 2.32 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 59.9 mttp 85.21 -18.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 175.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -120.26 175.31 6.02 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 123.442 1.592 . . . . 0.0 113.147 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -88.17 162.22 16.82 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.744 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.908 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.276 4.2 t80 -99.15 158.39 15.71 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 123.344 1.545 . . . . 0.0 107.851 173.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.4 p -170.01 144.5 2.72 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.716 -1.865 . . . . 0.0 109.214 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CG ' HG11 ' A' ' 85' ' ' VAL . 32.2 p90 -153.29 -162.23 1.43 Allowed 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.725 1.25 . . . . 0.0 110.694 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.93 118.0 14.36 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -45.13 117.15 1.27 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -174.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.82 29.77 73.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 118.41 2.124 . . . . 0.0 118.41 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -99.93 3.95 44.71 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 -172.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.2 58.88 2.02 Favored Glycine 0 N--CA 1.508 3.465 0 N-CA-C 106.301 -2.719 . . . . 0.0 106.301 -172.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -147.07 -48.95 0.18 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 111.994 -2.103 . . . . 0.0 113.121 -166.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.26 8.5 m -124.46 -148.76 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 123.571 1.653 . . . . 0.0 108.888 -174.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.37 159.02 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 124.278 1.99 . . . . 0.0 109.983 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -67.84 -31.53 71.42 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.798 -1.546 . . . . 0.0 113.402 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.68 69.92 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 117.105 -1.426 . . . . 0.0 111.764 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -74.12 -42.86 59.38 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-N 120.948 1.704 . . . . 0.0 112.514 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.74 -35.75 68.94 Favored 'General case' 0 CA--C 1.577 2.001 0 CA-C-N 119.92 1.236 . . . . 0.0 114.311 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.278 1.5 mp -65.99 -57.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 CA-C-N 120.002 1.274 . . . . 0.0 111.206 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.79 96.82 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.427 ' HA ' ' SD ' ' A' ' 96' ' ' MET 0.25 76.3 t -62.08 -46.68 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.728 1.149 . . . . 0.0 112.371 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.17 -34.24 60.0 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.7 p -94.86 -2.61 50.41 Favored 'General case' 0 CA--C 1.585 2.291 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.463 ' SD ' ' HG ' ' A' ' 101' ' ' LEU 0.262 0.8 OUTLIER -102.04 153.15 20.17 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 123.258 2.753 . . . . 0.0 115.444 -177.363 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -99.36 150.82 21.75 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 133' ' ' LEU . 63.3 t -48.15 124.43 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.594 0 C-N-CA 124.835 1.254 . . . . 0.0 112.557 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -29.12 11.62 Favored Glycine 0 N--CA 1.499 2.844 0 CA-C-O 115.051 -3.083 . . . . 0.0 115.76 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.364 2.2 tp10 -155.82 -176.3 5.88 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 123.008 3.404 . . . . 0.0 116.609 173.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.479 HD13 ' H ' ' A' ' 102' ' ' CYS 0.735 0.1 OUTLIER -159.44 -145.39 0.13 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 179.25 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -160.26 -152.41 0.29 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -170.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.5 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 12.1 ptm180 -109.29 130.5 55.49 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 123.864 1.792 . . . . 0.0 111.14 171.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.4 mt -93.81 134.65 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 112.871 -1.968 . . . . 0.0 107.329 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 m -130.16 100.43 5.41 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 9.5 p -115.45 144.97 43.04 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -172.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.15 148.84 72.05 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 116.924 -1.512 . . . . 0.0 111.474 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.267 71.7 Cg_endo -57.98 -19.06 38.46 Favored 'Trans proline' 0 C--N 1.379 2.138 0 CA-C-N 125.587 3.031 . . . . 0.0 119.095 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.38 -38.31 80.17 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 121.465 1.939 . . . . 0.0 114.407 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -79.16 -7.82 58.51 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 124.679 1.192 . . . . 0.0 114.1 169.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -121.52 -103.8 0.39 Allowed 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.735 1.607 . . . . 0.0 112.929 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.478 6.5 m-85 -106.2 -8.22 17.47 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.79 -148.21 49.12 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 t -88.74 61.9 6.2 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 122.407 1.099 . . . . 0.0 111.534 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.79 -52.8 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.406 1.483 . . . . 0.0 112.646 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.99 160.94 25.55 Favored Glycine 0 CA--C 1.544 1.873 0 C-N-CA 124.054 0.835 . . . . 0.0 114.038 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -89.24 139.29 28.58 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.021 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.64 -39.96 37.94 Favored 'Trans proline' 0 CA--C 1.586 3.122 0 N-CA-C 120.597 3.268 . . . . 0.0 120.597 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.33 -29.85 0.45 Allowed 'Trans proline' 0 CA--C 1.574 2.494 0 CA-C-N 125.425 2.973 . . . . 0.0 119.667 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -148.38 -29.34 0.3 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 119.422 3.119 . . . . 0.0 119.422 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mt -79.98 122.1 82.82 Favored Pre-proline 0 CA--C 1.585 2.326 0 CA-C-N 120.467 1.485 . . . . 0.0 113.854 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.69 177.85 2.58 Favored 'Trans proline' 0 CA--C 1.584 2.993 0 C-N-CA 123.119 2.546 . . . . 0.0 117.458 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -50.28 -19.84 4.97 Favored 'Trans proline' 0 CA--C 1.567 2.151 1 N-CA-C 122.927 4.164 . . . . 0.0 122.927 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -160.13 94.87 1.12 Allowed 'General case' 0 CA--C 1.583 2.233 0 CA-C-N 120.671 1.578 . . . . 0.0 106.885 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -147.23 141.9 26.66 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 123.001 2.637 . . . . 0.0 112.436 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -71.44 158.01 37.04 Favored 'General case' 0 CA--C 1.591 2.54 0 O-C-N 121.221 -0.924 . . . . 0.0 112.743 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.533 HD12 ' HB1' ' A' ' 111' ' ' ALA . 9.2 mt -129.18 161.35 30.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 119.555 -1.966 . . . . 0.0 112.762 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.461 HG23 ' HE3' ' A' ' 59' ' ' TRP . 12.5 m -144.04 135.97 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 110.798 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 2.4 m-85 -136.15 127.43 28.27 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.71 1.243 . . . . 0.0 109.225 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.88 102.26 14.37 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.69 152.06 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.294 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -133.97 133.2 41.07 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 53' ' ' PHE . 4.6 tt -94.8 143.74 26.21 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -106.33 -60.67 1.62 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -177.29 134.17 0.18 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 125.784 2.707 . . . . 0.0 106.682 -173.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.429 ' CE2' HD11 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -118.88 -111.66 0.34 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.6 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.401 42.0 tptt -119.65 -119.1 0.31 Allowed 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 171.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.009 0 CA-C-N 125.721 3.873 . . . . 0.0 120.977 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 10.8 p -67.08 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.549 1.175 . . . . 0.0 112.716 -176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -138.5 125.4 21.14 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -172.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 34.9 pt -126.44 56.4 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 123.834 1.778 . . . . 0.0 110.164 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.9 p -148.66 -38.75 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 114.537 -2.649 . . . . 0.0 116.283 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.92 89.11 0.15 Allowed 'Trans proline' 0 CA--C 1.58 2.797 0 CA-C-N 126.497 3.356 . . . . 0.0 111.581 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.427 8.4 mptt 73.22 -14.16 0.64 Allowed 'General case' 0 CA--C 1.581 2.171 0 O-C-N 119.421 -2.05 . . . . 0.0 115.231 -173.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.93 -22.83 58.37 Favored 'General case' 0 CA--C 1.587 2.384 0 C-N-CA 124.66 1.184 . . . . 0.0 112.708 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.309 24.2 t70 65.6 5.77 3.46 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 119.364 3.098 . . . . 0.0 119.364 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.03 17.38 6.95 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.05 -6.0 3.32 Favored Glycine 0 N--CA 1.477 1.374 1 N-CA-C 125.542 4.977 . . . . 0.0 125.542 173.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.305 67.8 t -141.52 144.98 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 123.002 3.401 . . . . 0.0 117.122 -169.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.2 135.99 48.61 Favored 'General case' 0 CA--C 1.585 2.318 0 C-N-CA 126.724 2.009 . . . . 0.0 109.703 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -128.86 112.55 14.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 123.694 2.952 . . . . 0.0 111.835 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.1 101.01 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.014 -1.053 . . . . 0.0 113.261 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.513 ' HA ' ' SG ' ' A' ' 102' ' ' CYS 0.304 2.6 mm -52.07 128.05 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -118.08 -42.57 2.8 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.707 1.203 . . . . 0.0 112.546 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -129.06 112.85 14.44 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.53 -173.01 4.14 Favored 'General case' 0 CA--C 1.598 2.802 0 CA-C-N 121.171 1.805 . . . . 0.0 115.833 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.8 158.67 36.64 Favored Glycine 0 N--CA 1.492 2.382 1 N-CA-C 123.559 4.183 . . . . 0.0 123.559 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -129.15 -72.81 0.59 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.57 114.76 3.98 Favored Glycine 0 CA--C 1.55 2.245 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -58.68 -14.41 8.36 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.7 148.29 42.83 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.0 m -148.52 96.4 3.89 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-N 110.652 -2.977 . . . . 0.0 107.096 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.441 0.5 OUTLIER -104.88 1.2 0.24 Allowed 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 119.818 2.969 . . . . 0.0 119.818 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.533 39.5 mtm 76.79 -140.19 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 164.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 1.1 tp -48.09 136.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 CA-C-O 122.157 0.979 . . . . 0.0 113.347 -174.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.91 -6.62 83.22 Favored Glycine 0 CA--C 1.551 2.344 0 CA-C-O 116.781 -2.122 . . . . 0.0 118.143 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -73.88 128.62 35.99 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 122.62 3.21 . . . . 0.0 113.762 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -78.37 112.48 15.43 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.4 138.96 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.65 104.14 11.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.49 166.29 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 CA-C-O 123.145 1.45 . . . . 0.0 112.556 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.92 113.7 17.54 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.742 170.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -117.87 151.81 36.64 Favored 'General case' 0 CA--C 1.582 2.191 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 97.4 m -127.43 143.26 51.23 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.93 143.08 11.47 Favored Glycine 0 CA--C 1.555 2.589 0 O-C-N 119.984 -1.698 . . . . 0.0 116.87 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.77 151.66 48.73 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 127.479 2.312 . . . . 0.0 112.499 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.39 175.75 9.15 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 123.465 1.603 . . . . 0.0 108.543 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 tp -60.35 -31.65 70.53 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.46 8.07 1.55 Allowed 'General case' 0 CA--C 1.596 2.713 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.59 36.05 82.36 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 119.697 -1.877 . . . . 0.0 114.808 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 m -111.1 119.57 39.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -76.49 112.29 12.85 Favored 'General case' 0 CA--C 1.588 2.442 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.779 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -85.09 -35.19 21.97 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 122.686 2.494 . . . . 0.0 113.689 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.51 158.08 43.85 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 123.469 1.604 . . . . 0.0 113.099 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 t -156.37 100.71 1.99 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.949 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 t -59.72 -40.33 87.62 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.82 -46.1 78.17 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.262 1.425 . . . . 0.0 114.411 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.32 -39.62 68.08 Favored 'General case' 0 CA--C 1.579 2.094 0 C-N-CA 124.82 1.248 . . . . 0.0 113.776 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 -13.15 47.37 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 51.4 mtmt 91.95 -35.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 126.808 2.043 . . . . 0.0 115.334 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -88.53 170.69 10.66 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 123.804 1.764 . . . . 0.0 111.997 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.74 168.66 9.53 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.577 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.278 5.9 t80 -104.83 145.26 30.63 Favored 'General case' 0 CA--C 1.574 1.892 0 O-C-N 120.44 -1.413 . . . . 0.0 109.273 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.1 p -155.66 128.18 7.83 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.814 -1.803 . . . . 0.0 110.095 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.8 p90 -143.16 -175.38 4.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 123.591 0.756 . . . . 0.0 110.194 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' LYS 0.263 13.4 t0 -128.06 124.81 37.96 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 118.796 -2.44 . . . . 0.0 105.551 174.062 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.9 104.92 0.09 Allowed 'General case' 0 CA--C 1.579 2.064 0 C-N-CA 124.69 1.196 . . . . 0.0 114.064 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.74 37.72 95.12 Favored Glycine 0 N--CA 1.512 3.721 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 -173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 5.0 mtpt -132.82 -70.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 124.668 1.187 . . . . 0.0 110.636 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.42 74.18 0.21 Allowed Glycine 0 N--CA 1.495 2.586 1 N-CA-C 100.782 -4.927 . . . . 0.0 100.782 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.326 47.8 tp10 -71.91 150.61 44.02 Favored 'General case' 0 CA--C 1.554 1.116 1 CA-C-O 130.25 4.833 . . . . 0.0 116.693 -165.363 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.349 31.4 m -98.46 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 1 CA-C-N 101.55 -7.114 . . . . 0.0 107.087 -174.02 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 89' ' ' TRP . 19.3 pt -110.97 159.05 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 124.418 2.056 . . . . 0.0 109.153 171.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -32.41 72.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.745 -1.57 . . . . 0.0 113.257 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.66 -35.48 74.51 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 116.826 -1.559 . . . . 0.0 111.677 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.45 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.0 m0 -77.43 -41.6 39.22 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.323 1.874 . . . . 0.0 112.378 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.66 -34.1 69.02 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 120.017 1.28 . . . . 0.0 113.885 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.2 mp -66.66 -57.08 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 120.098 1.317 . . . . 0.0 110.968 172.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.51 90.17 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.538 HG22 ' CE ' ' A' ' 96' ' ' MET . 99.6 t -63.03 -38.72 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-N 118.967 0.803 . . . . 0.0 112.906 173.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.71 -36.8 70.09 Favored 'General case' 0 CA--C 1.58 2.12 0 CA-C-N 120.282 1.401 . . . . 0.0 113.445 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -82.32 11.37 5.53 Favored 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.538 ' CE ' HG22 ' A' ' 93' ' ' VAL . 43.3 mtt -94.01 134.92 35.91 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 121.636 2.016 . . . . 0.0 116.103 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.3 163.26 15.43 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 164.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 64.5 t -57.73 131.66 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.943 0 O-C-N 117.899 -3.0 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.53 -21.19 30.48 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 124.172 3.169 . . . . 0.0 114.275 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.64 163.87 27.39 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 120.4 2.1 . . . . 0.0 113.695 176.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.671 HD13 ' H ' ' A' ' 102' ' ' CYS 1.751 0.1 OUTLIER 162.43 155.76 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.797 2.039 . . . . 0.0 113.921 168.009 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.671 ' H ' HD13 ' A' ' 101' ' ' LEU 0.345 81.9 m -143.44 178.97 7.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.998 1.319 . . . . 0.0 112.872 -167.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.479 ' HB3' ' HG2' ' A' ' 130' ' ' GLU 0.301 0.0 OUTLIER -93.64 119.53 32.77 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 124.483 2.087 . . . . 0.0 107.93 171.171 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.56 118.56 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 CA-C-N 111.489 -2.596 . . . . 0.0 108.922 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -112.15 103.26 11.42 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.3 p -119.21 141.14 49.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -171.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.01 141.97 87.21 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.295 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -60.46 -19.97 61.51 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 N-CA-C 119.35 2.788 . . . . 0.0 119.35 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.7 -33.48 75.18 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 122.62 2.463 . . . . 0.0 113.603 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.5 -7.84 54.35 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.76 -101.87 0.42 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 120.076 1.307 . . . . 0.0 111.847 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.257 0.3 OUTLIER -124.56 14.64 8.8 Favored 'General case' 0 CA--C 1.592 2.574 0 CA-C-N 120.431 1.469 . . . . 0.0 113.872 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.05 -31.17 39.85 Favored Glycine 0 N--CA 1.497 2.765 1 N-CA-C 123.105 4.002 . . . . 0.0 123.105 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.9 m -66.66 -11.81 55.52 Favored 'General case' 0 CA--C 1.585 2.319 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.61 -60.15 0.19 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 124.945 1.298 . . . . 0.0 113.284 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.73 152.6 7.22 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.533 1.54 . . . . 0.0 110.792 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 t -81.8 126.54 75.18 Favored Pre-proline 0 CA--C 1.579 2.067 0 CA-C-O 116.647 -1.644 . . . . 0.0 108.993 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -40.38 -43.69 4.07 Favored 'Trans proline' 0 CA--C 1.581 2.871 0 N-CA-C 121.733 3.705 . . . . 0.0 121.733 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.6 -9.79 6.6 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 CA-C-N 125.165 2.88 . . . . 0.0 119.042 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -160.57 -43.68 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.9 125.18 82.57 Favored Pre-proline 0 CA--C 1.58 2.105 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -88.54 171.13 5.3 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 C-N-CA 122.662 2.241 . . . . 0.0 112.301 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.85 -42.15 33.15 Favored 'Trans proline' 0 CA--C 1.574 2.519 0 N-CA-C 117.917 2.237 . . . . 0.0 117.917 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -90.76 61.34 4.74 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.462 -1.399 . . . . 0.0 112.621 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.23 113.62 5.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.044 -1.66 . . . . 0.0 111.972 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -65.06 155.79 33.59 Favored 'General case' 0 CA--C 1.591 2.553 0 C-N-CA 124.107 0.963 . . . . 0.0 112.793 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 mt -114.74 162.75 16.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 124.525 2.107 . . . . 0.0 112.297 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 114.8 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 CA-C-N 112.703 -2.044 . . . . 0.0 108.83 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 1.3 m-85 -131.38 123.9 29.2 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 122.711 2.505 . . . . 0.0 111.756 175.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.479 ' HG2' ' HB3' ' A' ' 103' ' ' ARG . 90.8 mt-10 -91.97 110.28 21.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . 0.28 1.3 p -138.31 145.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 122.343 1.068 . . . . 0.0 112.248 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 41.0 tt0 -136.23 133.58 37.2 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.813 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 tp -93.8 130.33 39.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.69 -51.67 6.3 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.536 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -164.2 154.74 15.08 Favored 'General case' 0 CA--C 1.575 1.923 0 C-N-CA 125.455 1.502 . . . . 0.0 108.522 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.266 0.0 OUTLIER -130.33 -115.15 0.24 Allowed 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 110.239 177.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -122.26 119.29 30.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 -178.396 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.395 70.0 t 71.13 -36.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-O 115.395 -2.241 . . . . 0.0 113.693 -176.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.643 3.4 t0 63.62 162.17 0.11 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 123.73 2.968 . . . . 0.0 117.534 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 0.0 OUTLIER -153.52 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.234 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 1.439 28.7 m 100.49 64.79 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.167 0 O-C-N 119.052 -2.28 . . . . 0.0 115.178 -166.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.21 125.79 14.06 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 124.306 3.337 . . . . 0.0 110.916 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.553 6.9 mptt 88.44 -36.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.39 -6.9 55.04 Favored 'General case' 0 CA--C 1.596 2.713 0 O-C-N 121.325 -0.859 . . . . 0.0 112.051 165.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 78.66 111.37 0.07 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 114.769 -2.539 . . . . 0.0 107.117 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -9.38 72.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 125.254 2.454 . . . . 0.0 117.616 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.12 63.4 Favored Glycine 0 N--CA 1.481 1.651 0 CA-C-N 112.043 -2.344 . . . . 0.0 117.071 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -162.75 137.07 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.88 145.99 29.31 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 125.885 1.674 . . . . 0.0 109.041 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -130.89 125.61 33.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 122.621 2.464 . . . . 0.0 111.797 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.2 t -102.04 93.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.367 0.3 OUTLIER -79.24 134.53 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.849 -1.157 . . . . 0.0 111.54 178.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.89 -68.2 0.94 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.581 0.705 . . . . 0.0 111.101 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -99.01 95.32 7.06 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.9 167.33 11.77 Favored 'General case' 0 CA--C 1.59 2.512 0 O-C-N 120.044 -1.66 . . . . 0.0 113.749 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.57 170.92 41.83 Favored Glycine 0 CA--C 1.55 2.24 0 O-C-N 119.53 -1.981 . . . . 0.0 117.959 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 p -78.36 -70.72 0.47 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.27 54.04 0.1 Allowed Glycine 0 N--CA 1.482 1.766 0 C-N-CA 124.674 1.131 . . . . 0.0 113.727 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -140.38 17.05 2.4 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 55.74 -179.04 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 121.588 3.921 . . . . 0.0 121.588 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -116.85 120.59 33.88 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.396 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HG2' ' HB3' ' A' ' 137' ' ' LYS . 70.9 Cg_exo -66.46 -20.57 54.29 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 117.985 2.263 . . . . 0.0 117.985 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.515 8.7 mtt 80.2 -165.99 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.423 0.4 OUTLIER -39.65 125.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -169.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.79 88.41 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -76.75 142.82 40.29 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 122.857 3.329 . . . . 0.0 113.556 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' PHE . 18.4 ptp180 -73.84 137.84 44.04 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.31 -1.494 . . . . 0.0 109.778 177.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.32 2.1 t -135.27 144.51 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 119.752 1.16 . . . . 0.0 112.688 -167.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -125.87 100.99 6.63 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.84 167.1 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 127.174 2.19 . . . . 0.0 112.138 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.15 127.57 36.21 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.564 160.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -119.43 155.69 31.54 Favored 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.6 m -125.31 138.56 54.07 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 159.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.53 145.73 14.47 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 123.347 2.794 . . . . 0.0 117.93 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -134.09 153.04 52.06 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 112.625 -1.787 . . . . 0.0 114.615 -175.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.09 170.67 14.56 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 123.042 1.401 . . . . 0.0 108.642 170.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER -60.43 -26.35 66.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 178.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.68 9.63 3.29 Favored 'General case' 0 CA--C 1.593 2.631 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.1 38.38 73.27 Favored Glycine 0 N--CA 1.509 3.538 0 CA-C-N 121.341 1.882 . . . . 0.0 114.819 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 m -109.34 114.47 28.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -79.71 90.89 5.22 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -69.75 -30.88 68.57 Favored 'General case' 0 CA--C 1.559 1.306 0 O-C-N 119.696 -1.877 . . . . 0.0 114.424 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -154.47 148.11 25.3 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 121.603 2.001 . . . . 0.0 111.345 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 m -145.91 94.76 2.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.526 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 t -57.48 -39.22 75.95 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.15 -44.08 83.11 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -73.86 -42.18 61.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -61.33 -19.51 61.89 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.39 74.4 mmtt 96.63 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.177 2.191 . . . . 0.0 113.192 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.64 152.54 31.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.04 1.4 . . . . 0.0 113.665 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.05 171.45 10.72 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.493 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.252 9.2 t80 -105.23 157.72 17.09 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.092 0.949 . . . . 0.0 109.235 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.7 p -157.89 145.71 18.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 119.295 -2.128 . . . . 0.0 110.313 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 85' ' ' VAL . 23.8 p90 -155.15 -173.36 4.53 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.875 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -123.05 123.07 40.03 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -49.15 112.0 0.56 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -172.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.97 47.79 82.26 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -107.21 14.16 26.48 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.88 -42.67 2.37 Favored Glycine 0 N--CA 1.51 3.614 0 O-C-N 120.782 -1.199 . . . . 0.0 111.41 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.279 8.3 tp10 -28.8 -48.96 0.07 Allowed 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 129.386 3.075 . . . . 0.0 118.805 169.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.255 9.3 m -117.61 -147.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 CA-C-O 124.066 1.888 . . . . 0.0 109.785 -175.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.4 pt -110.93 160.77 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 124.104 1.907 . . . . 0.0 110.238 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -32.67 73.25 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.018 -1.446 . . . . 0.0 113.205 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.06 70.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.016 -1.469 . . . . 0.0 112.443 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.27 -42.52 54.84 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.967 1.712 . . . . 0.0 112.423 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.84 -37.73 71.67 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -68.1 -56.74 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.056 0 CA-C-N 119.885 1.22 . . . . 0.0 111.191 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.65 94.54 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.4 t -67.59 -46.23 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.571 1.078 . . . . 0.0 111.736 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.25 62.78 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p -92.22 4.29 53.57 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.429 ' SD ' ' OE2' ' A' ' 132' ' ' GLU . 4.6 ptt? -116.48 119.51 35.85 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 122.304 2.32 . . . . 0.0 112.185 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -78.56 148.69 33.25 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.152 -1.593 . . . . 0.0 108.72 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.6 t -9.47 79.43 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 C-N-CA 125.299 1.44 . . . . 0.0 109.001 -158.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.55 ' H ' HD22 ' A' ' 133' ' ' LEU . . . -20.46 -29.45 0.0 OUTLIER Glycine 1 N--CA 1.523 4.437 1 N-CA-C 127.783 5.873 . . . . 0.0 127.783 -144.585 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.663 0.3 OUTLIER 52.97 -125.57 2.4 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 115.581 -2.152 . . . . 0.0 111.549 -161.897 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 132' ' ' GLU 0.461 0.9 OUTLIER -136.15 132.96 36.69 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.446 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 132' ' ' GLU 2.674 5.7 m -160.27 -151.98 0.27 Allowed 'General case' 0 CA--C 1.589 2.477 0 CA-C-N 120.224 1.375 . . . . 0.0 114.489 177.022 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -143.36 158.85 43.3 Favored 'General case' 0 CA--C 1.575 1.942 0 O-C-N 120.108 -1.62 . . . . 0.0 113.662 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.39 143.87 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 C-N-CA 126.128 1.771 . . . . 0.0 110.543 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.3 m -140.09 104.5 4.85 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.1 p -118.87 147.12 44.31 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -172.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -80.71 148.13 64.58 Favored Pre-proline 0 CA--C 1.581 2.166 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.647 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -36.43 -33.06 0.12 Allowed 'Trans proline' 0 CA--C 1.567 2.144 0 N-CA-C 122.079 3.838 . . . . 0.0 122.079 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.1 -44.66 91.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -78.86 -5.96 54.89 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 116.187 -1.863 . . . . 0.0 114.328 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.43 -153.25 0.5 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 122.324 2.329 . . . . 0.0 114.288 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.283 0.1 OUTLIER -82.11 11.42 5.26 Favored 'General case' 0 CA--C 1.575 1.921 0 O-C-N 119.22 -2.175 . . . . 0.0 113.582 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.36 -38.57 45.23 Favored Glycine 0 CA--C 1.553 2.441 0 CA-C-N 124.027 3.103 . . . . 0.0 115.354 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 p -70.78 -51.58 26.06 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 118.316 1.058 . . . . 0.0 113.761 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.98 -34.48 14.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.91 141.96 12.81 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.039 1.29 . . . . 0.0 113.646 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.478 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 2.0 t -95.42 146.17 30.84 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.834 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -41.52 -43.23 5.99 Favored 'Trans proline' 0 CA--C 1.584 3.023 0 C-N-CA 123.65 2.9 . . . . 0.0 119.107 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.72 57.25 6.28 Favored 'Trans proline' 0 CA--C 1.585 3.036 0 CA-C-N 125.325 2.937 . . . . 0.0 115.425 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 61.93 33.39 17.48 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.325 3.454 . . . . 0.0 120.325 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.478 ' HB ' ' H ' ' A' ' 117' ' ' SER . 11.9 mt -82.91 117.56 68.96 Favored Pre-proline 0 CA--C 1.59 2.485 0 O-C-N 120.127 -1.608 . . . . 0.0 108.768 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -90.31 178.02 2.23 Favored 'Trans proline' 0 CA--C 1.585 3.061 0 CA-C-N 123.483 2.279 . . . . 0.0 116.179 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.41 151.19 54.69 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.072 2.515 . . . . 0.0 117.621 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.252 38.4 t-20 59.62 44.0 15.05 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -177.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.4 105.5 15.46 Favored 'General case' 0 CA--C 1.562 1.436 0 O-C-N 120.534 -1.354 . . . . 0.0 110.35 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.8 m -66.01 150.18 49.08 Favored 'General case' 0 CA--C 1.592 2.562 0 O-C-N 120.843 -1.161 . . . . 0.0 111.651 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.5 tp -132.64 157.48 44.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.552 -1.968 . . . . 0.0 111.663 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.494 HG23 ' HE3' ' A' ' 59' ' ' TRP . 22.3 m -147.05 144.03 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 O-C-N 121.043 -1.036 . . . . 0.0 112.043 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -146.97 134.68 21.11 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.977 -1.077 . . . . 0.0 109.98 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -88.21 112.97 23.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.39 152.94 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.243 -0.91 . . . . 0.0 111.136 -168.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.644 ' CB ' ' HA ' ' A' ' 101' ' ' LEU 0.777 0.2 OUTLIER -154.56 -164.25 1.78 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 116.781 2.141 . . . . 0.0 116.781 164.011 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 99' ' ' GLY . 5.6 tt -145.0 133.28 21.67 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.819 1.295 . . . . 0.0 113.376 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.13 -47.71 7.64 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.94 151.07 23.09 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.283 1.433 . . . . 0.0 108.895 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.447 ' CD2' HD11 ' A' ' 133' ' ' LEU 0.294 0.0 OUTLIER -143.21 -101.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.629 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 46' ' ' PRO 0.421 13.1 tmtt? -111.01 -132.66 0.33 Allowed 'General case' 0 CA--C 1.588 2.418 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.229 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.697 0 CA-C-N 124.631 3.378 . . . . 0.0 113.923 177.791 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.308 0 CA-C-O 118.653 -1.082 . . . . 0.0 114.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.479 0.4 OUTLIER 65.38 -63.3 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -175.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.54 107.32 5.94 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.632 0.773 . . . . 0.0 110.02 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 5.8 tp -157.53 138.92 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.116 0 CA-C-O 125.508 2.575 . . . . 0.0 113.131 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.42 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 32.1 p -144.59 136.49 13.0 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.711 166.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -46.09 88.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 124.177 3.251 . . . . 0.0 117.132 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.496 8.4 mptt 79.46 -28.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.29 -27.07 64.12 Favored 'General case' 0 CA--C 1.593 2.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.457 1.5 m-20 74.55 -60.83 0.51 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 127.902 2.481 . . . . 0.0 115.393 175.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.317 12.8 pt-20 -90.33 40.83 1.02 Allowed 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 25' ' ' SER . . . -75.89 -42.75 24.49 Favored Glycine 0 N--CA 1.507 3.373 0 O-C-N 119.286 -2.133 . . . . 0.0 115.438 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.254 60.4 t -135.5 135.45 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 CA-C-O 122.648 1.213 . . . . 0.0 113.842 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -91.41 114.19 26.65 Favored 'General case' 0 CA--C 1.584 2.27 0 CA-C-O 116.614 -1.66 . . . . 0.0 107.956 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -112.39 90.37 3.32 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 124.101 3.137 . . . . 0.0 108.205 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.87 130.33 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.436 -173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.303 1.0 OUTLIER -82.2 130.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 122.671 1.224 . . . . 0.0 113.133 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -110.81 -56.33 2.37 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.002 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.36 96.19 3.06 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.24 166.96 1.96 Allowed 'General case' 0 CA--C 1.59 2.495 0 CA-C-N 122.551 2.432 . . . . 0.0 116.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.35 -170.65 37.25 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 120.654 3.021 . . . . 0.0 120.654 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 t -81.02 15.33 1.89 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.46 34.04 68.05 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.5 p -122.6 26.83 8.11 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.8 1.24 . . . . 0.0 113.882 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.451 7.4 pt-20 40.41 -154.92 0.01 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.91 115.65 5.61 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 124.476 1.11 . . . . 0.0 111.191 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -41.26 -28.85 0.53 Allowed 'Trans proline' 0 CA--C 1.583 2.956 1 N-CA-C 122.626 4.049 . . . . 0.0 122.626 165.137 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.541 44.5 mtm 84.79 -141.56 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.29 1.1 tp -52.01 135.87 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 O-C-N 120.224 -1.548 . . . . 0.0 112.847 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.15 4.94 86.2 Favored Glycine 0 CA--C 1.553 2.442 0 CA-C-O 116.859 -2.078 . . . . 0.0 117.884 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.48 136.44 36.31 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 122.681 3.241 . . . . 0.0 112.577 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.51 98.2 11.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 136' ' ' PHE . 29.9 m -93.68 141.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -167.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.18 107.78 14.87 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 76' ' ' PHE . 3.1 m -114.11 165.95 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 123.272 1.511 . . . . 0.0 113.685 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.254 0.1 OUTLIER -132.11 113.36 13.23 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.075 167.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -105.91 161.21 14.65 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 124.019 1.866 . . . . 0.0 113.881 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.7 m -134.22 133.35 40.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 159.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.05 164.79 26.1 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 122.072 2.215 . . . . 0.0 118.048 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.596 ' HE3' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -148.34 155.98 41.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -173.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -85.1 172.19 11.44 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 123.469 1.604 . . . . 0.0 108.877 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.13 -33.82 74.0 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.301 0.2 OUTLIER -69.5 2.94 2.66 Favored 'General case' 0 CA--C 1.592 2.565 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 173.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.88 44.68 23.83 Favored Glycine 0 N--CA 1.503 3.106 0 CA-C-N 119.564 1.074 . . . . 0.0 114.174 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.9 m -120.77 119.81 33.83 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -78.98 97.24 5.98 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.152 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.01 -34.82 71.71 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.263 -2.148 . . . . 0.0 114.944 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.95 175.75 9.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -154.19 -77.1 0.11 Allowed 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.427 1.6 t 111.4 -40.05 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 128.775 2.83 . . . . 0.0 109.205 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.14 -34.81 15.06 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 169.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.95 -35.71 62.04 Favored 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -94.82 -85.01 0.32 Allowed 'General case' 0 CA--C 1.575 1.907 0 C-N-CA 124.716 1.206 . . . . 0.0 110.13 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? 175.32 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 127.29 2.236 . . . . 0.0 107.959 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -22.45 -37.92 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 1 N-CA-C 127.229 6.011 . . . . 0.0 127.229 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.441 53.2 pttt 71.53 -175.11 0.18 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.467 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.328 2.8 t80 -118.68 146.93 44.32 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.104 174.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.7 p -160.63 130.67 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 119.309 -2.119 . . . . 0.0 108.709 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.508 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.8 p90 -141.79 -173.71 3.87 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 123.216 0.607 . . . . 0.0 109.788 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.74 128.42 47.72 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 118.843 -2.411 . . . . 0.0 106.306 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.07 107.33 0.46 Allowed 'General case' 0 CA--C 1.578 2.038 0 O-C-N 121.314 -0.866 . . . . 0.0 112.536 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.61 56.32 5.56 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.024 -1.047 . . . . 0.0 114.802 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -102.17 -64.43 1.06 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 124.498 2.094 . . . . 0.0 112.963 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.63 -55.93 0.13 Allowed Glycine 0 N--CA 1.503 3.104 0 C-N-CA 128.86 3.124 . . . . 0.0 107.096 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.824 23.8 tt0 119.05 143.25 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 128.145 3.831 . . . . 0.0 116.807 162.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.347 14.1 m -79.87 -106.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.001 1 CA-C-N 105.319 -5.4 . . . . 0.0 104.962 -178.626 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -125.43 152.91 32.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 124.737 2.208 . . . . 0.0 105.538 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.27 -31.67 72.96 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 113.28 -1.782 . . . . 0.0 113.697 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.07 82.92 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.047 1.339 . . . . 0.0 111.391 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.544 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.9 m0 -70.46 -42.5 71.39 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 120.638 1.563 . . . . 0.0 112.549 172.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.0 -36.44 74.93 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 120.005 1.275 . . . . 0.0 114.185 172.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.259 1.3 mp -66.3 -56.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.274 1.397 . . . . 0.0 111.685 173.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.55 -45.31 91.12 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.285 75.8 t -65.04 -41.5 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 120.412 1.46 . . . . 0.0 112.531 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.58 64.63 Favored 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 120.336 1.426 . . . . 0.0 114.465 171.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 p -95.49 -6.97 39.39 Favored 'General case' 0 CA--C 1.588 2.411 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 38.6 mtp -96.69 123.11 40.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 121.597 1.999 . . . . 0.0 112.52 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -77.99 179.88 6.5 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.99 125.94 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.733 0 O-C-N 120.522 -1.361 . . . . 0.0 111.03 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.92 81.36 Favored Glycine 0 N--CA 1.515 3.934 0 CA-C-N 122.724 2.511 . . . . 0.0 116.901 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.63 132.1 41.46 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.474 2.137 . . . . 0.0 115.364 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.74 114.77 28.39 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.063 0.945 . . . . 0.0 111.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.2 m -136.53 159.56 41.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -109.73 127.24 54.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 123.845 1.783 . . . . 0.0 109.286 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.2 mt -92.58 118.59 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.395 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 104.53 11.93 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 7.7 p -118.49 148.56 42.49 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -89.02 142.19 30.04 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.495 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -42.54 -26.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 124.812 3.674 . . . . 0.0 121.413 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -31.94 72.96 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 121.314 1.87 . . . . 0.0 114.555 172.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -91.33 -9.75 43.83 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 125.472 1.509 . . . . 0.0 113.098 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.44 -112.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.196 1.816 . . . . 0.0 112.655 -176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.329 1.3 m-85 -113.79 21.03 15.35 Favored 'General case' 0 CA--C 1.588 2.411 0 CA-C-N 121.219 1.827 . . . . 0.0 113.751 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.2 -15.92 4.15 Favored Glycine 0 N--CA 1.501 2.99 1 N-CA-C 124.332 4.493 . . . . 0.0 124.332 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -71.69 -65.59 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.656 2.228 . . . . 0.0 112.063 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.29 10.4 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.38 160.28 36.38 Favored Glycine 0 CA--C 1.547 2.055 0 CA-C-N 122.144 2.247 . . . . 0.0 112.882 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -81.45 123.68 80.89 Favored Pre-proline 0 CA--C 1.577 2.008 0 O-C-N 120.258 -1.731 . . . . 0.0 107.736 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -33.69 -45.09 0.34 Allowed 'Trans proline' 0 CA--C 1.582 2.891 0 N-CA-C 121.99 3.804 . . . . 0.0 121.99 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -86.88 -16.97 3.32 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 CA-C-N 125.097 2.856 . . . . 0.0 118.948 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -159.09 -38.29 0.06 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.82 129.59 70.25 Favored Pre-proline 0 CA--C 1.581 2.143 0 O-C-N 120.195 -1.566 . . . . 0.0 113.897 -172.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.82 163.17 5.07 Favored 'Trans proline' 0 CA--C 1.586 3.121 0 CA-C-N 123.572 2.312 . . . . 0.0 113.202 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 8.95 0.45 Allowed 'Trans proline' 0 CA--C 1.576 2.619 0 N-CA-C 120.505 3.233 . . . . 0.0 120.505 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -139.68 62.79 1.51 Allowed 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.302 -1.499 . . . . 0.0 110.11 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.3 137.06 17.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.964 -1.71 . . . . 0.0 111.149 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.2 m -72.96 150.16 42.74 Favored 'General case' 0 CA--C 1.588 2.428 0 O-C-N 120.485 -1.385 . . . . 0.0 111.202 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.342 0.2 OUTLIER -134.78 167.33 21.06 Favored 'General case' 0 CA--C 1.574 1.895 0 O-C-N 118.685 -2.509 . . . . 0.0 109.524 176.11 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.596 HG13 ' HE3' ' A' ' 59' ' ' TRP . 1.6 p -141.22 146.35 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.846 -1.159 . . . . 0.0 112.02 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.288 0.6 OUTLIER -145.77 124.94 12.9 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.88 0.848 . . . . 0.0 110.501 169.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.41 115.25 24.7 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 t -124.26 134.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.026 0.917 . . . . 0.0 112.382 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -107.43 124.45 49.88 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 136' ' ' PHE . 57.2 tp -103.31 119.38 38.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.85 -49.12 8.68 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -170.61 170.58 6.71 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.469 1.908 . . . . 0.0 108.122 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.416 ' CD2' HD21 ' A' ' 133' ' ' LEU 0.255 5.7 p90 -154.94 -81.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 119.951 -1.718 . . . . 0.0 112.395 -175.307 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.412 77.2 tttt -119.98 -136.38 0.33 Allowed 'General case' 0 CA--C 1.594 2.644 0 C-N-CA 124.512 1.125 . . . . 0.0 108.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.351 0 O-C-N 117.465 -3.272 . . . . 0.0 112.561 -179.136 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.016 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 34' ' ' LYS 0.308 33.1 t 63.37 166.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.31 0 C-N-CA 125.822 1.649 . . . . 0.0 111.746 -177.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.432 28.2 t0 -156.45 169.3 24.94 Favored 'General case' 0 CA--C 1.577 1.992 0 O-C-N 118.036 -2.915 . . . . 0.0 107.111 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.4 -172.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 124.39 2.043 . . . . 0.0 106.531 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.607 0.5 OUTLIER -160.13 136.05 6.14 Favored Pre-proline 0 CA--C 1.584 2.254 0 O-C-N 118.785 -2.447 . . . . 0.0 115.058 167.233 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -38.92 -4.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.51 2.445 2 N-CA-C 127.996 6.114 . . . . 0.0 127.996 -173.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 75.81 1.18 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 121.546 1.976 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.306 34.0 mm-40 72.82 29.75 1.85 Allowed 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.714 -172.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.394 1.7 p30 53.15 24.71 3.76 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 119.886 3.291 . . . . 0.0 119.886 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -90.3 -35.57 15.19 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 120.117 3.376 . . . . 0.0 120.117 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.17 -53.88 4.69 Favored Glycine 0 N--CA 1.493 2.45 1 N-CA-C 123.739 4.255 . . . . 0.0 123.739 -158.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -142.75 125.29 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 124.278 0.634 . . . . 0.0 111.859 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -100.6 143.69 30.47 Favored 'General case' 0 CA--C 1.587 2.39 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.314 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 22' ' ' VAL . 1.9 tmmt? -120.61 113.64 20.54 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-N 124.054 3.116 . . . . 0.0 111.434 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.51 92.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.505 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.311 0.4 OUTLIER -76.95 135.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 120.887 -1.133 . . . . 0.0 110.26 178.072 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -121.09 -56.95 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.458 0.703 . . . . 0.0 111.898 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -118.6 99.73 6.99 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.96 142.71 52.83 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 119.178 -2.201 . . . . 0.0 112.614 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.49 163.54 42.73 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 119.99 -1.693 . . . . 0.0 116.638 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.3 p -121.34 -79.41 0.61 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.142 -176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 2.73 -85.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.204 0 N-CA-C 122.116 3.606 . . . . 0.0 122.116 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.404 ' H ' HG21 ' A' ' 98' ' ' VAL . 69.8 p -117.21 26.64 9.63 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.381 6.5 mt-10 55.24 -153.68 0.32 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 176.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -110.58 122.39 38.51 Favored Pre-proline 0 CA--C 1.572 1.801 0 O-C-N 120.559 -1.338 . . . . 0.0 108.497 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.397 0.2 OUTLIER -115.65 -87.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 N-CA-C 119.159 2.715 . . . . 0.0 119.159 -176.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -157.74 171.1 20.91 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 120.847 3.647 . . . . 0.0 120.847 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.36 132.41 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.763 0 CA-C-O 122.874 1.321 . . . . 0.0 109.932 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.85 3.39 68.34 Favored Glycine 0 CA--C 1.558 2.778 0 CA-C-O 116.836 -2.091 . . . . 0.0 118.186 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.79 141.24 56.59 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-N 122.624 3.212 . . . . 0.0 112.82 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -84.47 96.18 9.03 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.086 1.766 . . . . 0.0 108.353 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.31 135.09 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.99 100.46 8.89 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.76 164.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 127.356 2.263 . . . . 0.0 113.719 -172.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.79 124.4 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.583 160.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -115.03 156.87 24.33 Favored 'General case' 0 CA--C 1.593 2.608 0 CA-C-O 122.52 1.153 . . . . 0.0 111.058 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -130.36 138.51 50.44 Favored 'General case' 0 N--CA 1.515 2.792 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 160.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.08 140.71 8.57 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-N 123.329 2.786 . . . . 0.0 117.902 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.19 159.54 42.02 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 127.275 2.23 . . . . 0.0 115.057 -176.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -76.73 177.34 7.65 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.603 1.192 . . . . 0.0 109.594 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.345 0.0 OUTLIER -62.84 -27.06 69.07 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 176.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.9 13.97 0.94 Allowed 'General case' 0 CA--C 1.606 3.106 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.1 33.58 61.13 Favored Glycine 0 N--CA 1.511 3.663 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -91.86 109.42 20.75 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -68.0 107.13 2.58 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -81.64 -34.98 30.51 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 121.083 1.765 . . . . 0.0 112.099 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -155.84 155.48 33.03 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 124.163 1.935 . . . . 0.0 111.337 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -159.95 99.63 1.38 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.146 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -50.84 -34.28 27.21 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.71 -46.69 86.77 Favored 'General case' 0 CA--C 1.58 2.105 0 C-N-CA 125.346 1.458 . . . . 0.0 114.094 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.1 -41.48 77.4 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.418 1.087 . . . . 0.0 113.653 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -70.6 4.92 2.1 Favored 'General case' 0 CA--C 1.59 2.511 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 65.48 8.56 5.13 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 119.318 3.081 . . . . 0.0 119.318 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.12 -157.14 0.61 Allowed 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 125.436 1.494 . . . . 0.0 113.964 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -139.22 162.12 35.75 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 125.425 1.49 . . . . 0.0 109.393 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.354 2.1 t80 -108.47 149.43 28.81 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 120.944 1.702 . . . . 0.0 110.403 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.9 p -160.81 141.76 11.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 119.71 -1.869 . . . . 0.0 109.519 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 85' ' ' VAL . 9.1 p90 -155.01 177.45 11.31 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.233 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -116.63 125.77 52.27 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.21 105.83 0.1 Allowed 'General case' 0 CA--C 1.575 1.924 0 C-N-CA 124.198 0.999 . . . . 0.0 113.668 -173.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.6 44.48 93.9 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.42 23.8 tptp -124.47 -79.8 0.61 Allowed 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 118.147 0.974 . . . . 0.0 110.262 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.24 70.57 0.24 Allowed Glycine 0 N--CA 1.505 3.27 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.407 49.8 tt0 -68.14 152.99 44.64 Favored 'General case' 0 CA--C 1.56 1.33 1 CA-C-O 130.466 4.936 . . . . 0.0 118.245 -160.471 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.378 24.5 m -80.27 -126.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.645 2 CA-C-N 100.987 -7.37 . . . . 0.0 106.767 -178.3 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 89' ' ' TRP . 34.5 pt -106.54 154.06 7.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.805 2.24 . . . . 0.0 106.402 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 10.6 tmtt? -69.1 -25.48 64.44 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 112.859 -1.973 . . . . 0.0 114.475 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.69 89.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 116.528 -1.701 . . . . 0.0 111.454 165.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.522 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -71.37 -44.01 65.82 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 121.385 1.902 . . . . 0.0 112.711 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -54.44 -41.18 69.1 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 121.23 1.832 . . . . 0.0 113.868 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -66.87 -61.38 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 CA-C-N 119.714 1.143 . . . . 0.0 112.071 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.617 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -68.5 -33.43 74.13 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.27 20.1 t -72.4 -39.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.82 1.646 . . . . 0.0 110.443 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.22 -31.27 63.35 Favored 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 120.152 1.342 . . . . 0.0 114.179 167.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.6 p -78.39 -19.67 52.82 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 133' ' ' LEU 0.346 0.0 OUTLIER -90.37 163.84 14.55 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 124.701 3.409 . . . . 0.0 116.263 -179.126 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 137.88 51.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.944 -1.723 . . . . 0.0 112.257 -173.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.404 HG21 ' H ' ' A' ' 43' ' ' THR . 77.2 t -9.94 -171.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 127.922 2.489 . . . . 0.0 116.28 -173.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 25.67 -17.5 0.0 OUTLIER Glycine 0 N--CA 1.509 3.565 2 O-C-N 107.411 -9.555 . . . . 0.0 127.918 155.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.548 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.53 48.4 mt-10 -109.81 -149.61 0.44 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 123.996 3.898 . . . . 0.0 116.042 -178.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 15.3 tp -135.99 139.04 42.86 Favored 'General case' 0 CA--C 1.592 2.577 0 N-CA-C 119.917 3.303 . . . . 0.0 119.917 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.6 p -146.15 -168.11 2.91 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 122.605 1.193 . . . . 0.0 111.316 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 3.2 mtt180 -140.92 158.96 43.21 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 123.067 1.413 . . . . 0.0 112.555 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.8 mt -117.51 135.27 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.414 1.485 . . . . 0.0 109.262 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 m -127.59 102.8 7.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 15.7 p -122.0 149.99 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -83.11 141.06 42.89 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.456 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -61.61 -12.04 22.96 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 N-CA-C 119.282 2.762 . . . . 0.0 119.282 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.41 -39.95 92.62 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 121.0 1.727 . . . . 0.0 113.078 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -77.45 -6.98 55.42 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.906 1.282 . . . . 0.0 113.251 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.54 -121.47 0.17 Allowed 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CE2' HD21 ' A' ' 127' ' ' LEU 0.348 0.2 OUTLIER -85.58 7.44 23.14 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 122.057 2.208 . . . . 0.0 115.7 -178.036 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.8 -32.4 17.97 Favored Glycine 0 N--CA 1.501 2.998 0 CA-C-N 123.448 2.84 . . . . 0.0 119.455 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.1 p -77.92 84.57 4.2 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 118.464 1.132 . . . . 0.0 109.97 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.365 . . 86.43 -14.91 0.48 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.65 162.06 32.44 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 123.53 2.877 . . . . 0.0 113.438 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 3.5 t -89.51 148.34 40.07 Favored Pre-proline 0 CA--C 1.577 2.014 0 O-C-N 121.047 -1.266 . . . . 0.0 111.102 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.86 -43.55 6.83 Favored 'Trans proline' 0 CA--C 1.587 3.167 0 C-N-CA 123.456 2.771 . . . . 0.0 118.784 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.58 58.6 7.04 Favored 'Trans proline' 0 CA--C 1.586 3.081 0 CA-C-N 125.346 2.945 . . . . 0.0 115.292 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 61.18 31.12 19.59 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.328 3.455 . . . . 0.0 120.328 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.499 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -84.43 134.59 42.44 Favored Pre-proline 0 CA--C 1.596 2.736 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.36 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -90.5 157.56 4.4 Favored 'Trans proline' 0 CA--C 1.591 3.355 0 CA-C-N 125.981 3.172 . . . . 0.0 114.275 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.87 -42.39 64.06 Favored 'Trans proline' 0 CA--C 1.575 2.541 0 N-CA-C 119.732 2.935 . . . . 0.0 119.732 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.09 64.42 3.3 Favored 'General case' 0 CA--C 1.582 2.174 0 O-C-N 120.799 -1.188 . . . . 0.0 113.248 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.92 133.72 21.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.128 -1.608 . . . . 0.0 111.764 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.8 m -69.95 150.11 47.05 Favored 'General case' 0 CA--C 1.59 2.499 0 O-C-N 121.023 -1.048 . . . . 0.0 112.272 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 112' ' ' TYR . 9.8 tp -126.43 159.15 34.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 119.846 -1.784 . . . . 0.0 111.726 -173.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.98 136.1 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 O-C-N 121.003 -1.06 . . . . 0.0 110.256 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.274 0.6 OUTLIER -135.28 125.04 25.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.59 113.41 21.8 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 173.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.91 145.56 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.755 -0.591 . . . . 0.0 111.915 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 101' ' ' LEU 0.944 10.5 tt0 -151.54 -151.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 161.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -144.27 164.07 31.82 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -166.552 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.456 ' H ' HD23 ' A' ' 133' ' ' LEU . 47.8 m-85 -120.7 -50.51 2.19 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.349 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.98 152.0 10.84 Favored 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.872 1.669 . . . . 0.0 109.865 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -139.39 -93.66 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.235 -1.541 . . . . 0.0 109.803 178.493 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.436 77.3 tttt -127.91 -107.45 0.3 Allowed 'General case' 0 CA--C 1.588 2.411 0 CA-C-O 115.621 -2.133 . . . . 0.0 107.278 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 1 CA-C-N 126.37 4.168 . . . . 0.0 121.032 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.082 0 CA-C-O 119.827 -0.429 . . . . 0.0 114.094 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.523 2.7 p 55.83 -141.04 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.054 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.19 112.14 7.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.602 -1.311 . . . . 0.0 114.527 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.74 108.24 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 CA-C-O 123.551 1.643 . . . . 0.0 113.392 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.408 1.7 p -152.2 88.26 4.12 Favored Pre-proline 0 CA--C 1.59 2.484 0 O-C-N 118.146 -2.846 . . . . 0.0 105.916 161.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -83.68 56.49 5.26 Favored 'Trans proline' 0 CA--C 1.579 2.73 0 C-N-CA 123.419 2.746 . . . . 0.0 118.307 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.45 -52.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.228 -1.545 . . . . 0.0 109.407 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.05 -35.08 61.9 Favored 'General case' 0 CA--C 1.583 2.239 0 O-C-N 121.332 -0.855 . . . . 0.0 110.716 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.262 19.6 t70 120.38 132.81 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.211 0 C-N-CA 129.61 3.164 . . . . 0.0 105.67 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -9.33 73.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 128.83 2.852 . . . . 0.0 117.932 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.36 -21.87 57.72 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 121.786 3.474 . . . . 0.0 121.786 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.341 11.4 p -136.85 121.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tp -69.61 121.62 17.48 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 127.187 2.195 . . . . 0.0 112.316 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.11 102.31 11.03 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 122.393 2.36 . . . . 0.0 107.297 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 3.4 t -92.85 92.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.036 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.385 0.6 OUTLIER -65.2 130.68 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.03 -60.8 1.67 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.582 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.48 99.94 7.93 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -53.42 -74.81 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.56 -154.8 25.77 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 117.661 1.824 . . . . 0.0 117.661 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.0 p -87.72 -74.42 0.45 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.47 20.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 121.918 3.527 . . . . 0.0 121.918 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -134.7 67.64 1.5 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.501 12.7 pt-20 -33.59 -101.98 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.989 1 N-CA-C 123.774 4.731 . . . . 0.0 123.774 -170.48 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -112.16 100.01 48.0 Favored Pre-proline 0 CA--C 1.581 2.168 0 N-CA-C 118.233 2.679 . . . . 0.0 118.233 -169.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -100.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.579 2.739 0 C-N-CA 123.813 3.009 . . . . 0.0 119.905 169.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -163.11 161.04 25.0 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.253 0.4 OUTLIER -59.6 138.25 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-O 122.552 1.167 . . . . 0.0 110.897 175.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.15 89.06 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -85.61 157.06 20.46 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-N 121.836 2.818 . . . . 0.0 114.482 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -74.03 136.97 43.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.212 -1.555 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.371 1.1 t -137.81 132.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.388 0.675 . . . . 0.0 109.53 -165.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.44 117.39 26.75 Favored 'General case' 0 CA--C 1.562 1.416 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' A' ' 76' ' ' PHE . 19.4 m -128.42 166.36 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -130.73 120.84 24.41 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.135 169.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -124.71 137.45 54.35 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 29.4 m -106.98 153.47 22.52 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 160.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.71 142.75 8.98 Favored Glycine 0 CA--C 1.547 2.047 0 O-C-N 119.106 -2.246 . . . . 0.0 116.151 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.459 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -135.15 150.13 50.11 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.977 1.711 . . . . 0.0 113.088 -177.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.17 174.3 7.38 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.511 -0.743 . . . . 0.0 111.435 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.5 tp -61.34 -26.55 67.89 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.6 -5.93 13.39 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 167.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.83 58.04 Favored Glycine 0 N--CA 1.502 3.041 0 CA-C-N 120.622 1.555 . . . . 0.0 114.181 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -106.04 120.47 41.86 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -75.95 91.51 3.05 Favored 'General case' 0 CA--C 1.583 2.213 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.872 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -66.69 -32.06 73.13 Favored 'General case' 0 CA--C 1.566 1.56 0 O-C-N 119.282 -2.136 . . . . 0.0 115.516 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -149.19 158.91 44.57 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 120.248 1.386 . . . . 0.0 111.707 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 57' ' ' THR 0.356 43.3 t -135.36 -34.45 0.85 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 120.003 3.334 . . . . 0.0 120.003 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.321 60.0 p 58.31 -53.47 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 123.389 2.813 . . . . 0.0 116.717 -177.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.84 -34.32 27.43 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 128.343 2.657 . . . . 0.0 113.609 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -46.1 -42.72 14.02 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 125.241 1.416 . . . . 0.0 113.547 167.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.687 96.2 mtt180 95.02 38.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 120.023 3.342 . . . . 0.0 120.023 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.51 -56.15 4.37 Favored 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.78 166.82 23.6 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 126.409 1.884 . . . . 0.0 108.122 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -98.93 -162.06 0.92 Allowed 'General case' 0 CA--C 1.579 2.067 0 O-C-N 120.974 -1.079 . . . . 0.0 110.218 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.601 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.33 2.5 t80 -128.96 154.18 46.82 Favored 'General case' 0 CA--C 1.588 2.426 0 O-C-N 119.381 -2.074 . . . . 0.0 110.974 173.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.9 p -167.4 142.17 3.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 118.92 -2.362 . . . . 0.0 109.598 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CG ' HG11 ' A' ' 85' ' ' VAL . 6.6 p90 -153.49 -179.55 7.87 Favored 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.824 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.23 124.36 52.35 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.0 106.17 0.08 Allowed 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 59.28 49.16 81.47 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 -10.98 27.52 Favored 'General case' 0 CA--C 1.579 2.091 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.1 -37.0 3.02 Favored Glycine 0 CA--C 1.564 3.118 0 C-N-CA 124.495 1.045 . . . . 0.0 110.547 -168.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -38.6 -46.72 1.23 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 120.552 3.538 . . . . 0.0 120.552 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.505 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.261 7.6 m -117.8 -154.44 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-O 124.101 1.905 . . . . 0.0 109.0 -172.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.475 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.9 pt -101.05 162.34 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 125.09 2.376 . . . . 0.0 110.113 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -69.1 -35.01 75.98 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 112.678 -2.056 . . . . 0.0 114.154 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.64 -33.9 66.78 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 116.704 -1.617 . . . . 0.0 111.161 167.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.475 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -76.21 -47.04 25.49 Favored 'General case' 0 C--N 1.371 1.515 0 CA-C-N 121.492 1.951 . . . . 0.0 112.982 173.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.96 -32.57 69.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 121.194 1.815 . . . . 0.0 115.54 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.255 1.6 mp -65.98 -59.28 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.28 0.945 . . . . 0.0 110.046 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.33 -53.49 57.68 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.613 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.283 56.7 t -54.28 -40.6 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 120.454 1.479 . . . . 0.0 114.26 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.64 70.06 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 119.881 1.219 . . . . 0.0 113.372 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 p -90.55 18.82 5.85 Favored 'General case' 0 CA--C 1.601 2.909 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.543 ' CE ' HD22 ' A' ' 101' ' ' LEU . 56.4 mtp -119.79 150.41 40.46 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 119.226 -2.171 . . . . 0.0 116.711 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 146.87 29.91 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.838 2.903 . . . . 0.0 118.838 -171.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -45.89 137.13 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 CA-C-N 112.897 -1.956 . . . . 0.0 113.13 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.53 -43.6 1.96 Allowed Glycine 0 N--CA 1.491 2.34 0 CA-C-O 115.608 -2.774 . . . . 0.0 116.713 172.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.6 mt-10 -149.21 -175.99 5.19 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 121.966 2.883 . . . . 0.0 114.506 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.543 HD22 ' CE ' ' A' ' 96' ' ' MET 0.997 0.3 OUTLIER -155.49 -142.15 0.11 Allowed 'General case' 0 CA--C 1.604 3.05 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 172.64 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.533 ' SG ' HD23 ' A' ' 101' ' ' LEU 0.321 0.6 OUTLIER -151.41 -160.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 126.477 1.911 . . . . 0.0 113.746 -163.403 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.422 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 ptt85 -118.63 121.08 39.32 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.318 2.009 . . . . 0.0 110.124 165.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 mt -78.76 132.03 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 112.535 -2.12 . . . . 0.0 106.028 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.417 ' HA ' HG12 ' A' ' 128' ' ' VAL . 11.3 m -143.22 113.03 7.03 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . 2.679 2.7 m -160.28 -158.79 0.65 Allowed 'General case' 0 CA--C 1.59 2.493 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -97.6 122.68 54.59 Favored Pre-proline 0 CA--C 1.571 1.766 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -168.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 17.6 Cg_exo -42.59 -19.94 0.13 Allowed 'Trans proline' 0 CA--C 1.563 1.948 1 N-CA-C 122.534 4.013 . . . . 0.0 122.534 176.863 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.289 1.7 pm0 -63.03 -34.07 76.79 Favored 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 122.97 2.623 . . . . 0.0 113.098 169.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -74.29 -12.24 60.49 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 124.578 1.151 . . . . 0.0 113.799 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.51 -124.22 0.2 Allowed 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.289 0.6 OUTLIER -80.45 -4.63 54.5 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.133 2.242 . . . . 0.0 115.242 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -47.59 -17.99 0.56 Allowed Glycine 0 N--CA 1.497 2.755 1 N-CA-C 125.363 4.905 . . . . 0.0 125.363 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 t -65.69 -57.22 8.57 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 121.066 2.433 . . . . 0.0 111.379 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.46 -0.74 9.73 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 163.63 39.32 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-N 122.72 2.509 . . . . 0.0 111.82 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.528 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.7 t -85.51 112.21 42.67 Favored Pre-proline 0 CA--C 1.582 2.179 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.288 94.6 Cg_exo -31.52 -49.96 0.27 Allowed 'Trans proline' 0 CA--C 1.58 2.794 1 N-CA-C 123.702 4.462 . . . . 0.0 123.702 -174.042 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.63 -15.42 6.09 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 CA-C-N 125.211 2.897 . . . . 0.0 119.311 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -149.35 -6.89 0.35 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.528 ' HB ' ' H ' ' A' ' 117' ' ' SER . 25.9 mt -125.1 130.5 24.16 Favored Pre-proline 0 N--CA 1.507 2.401 0 CA-C-N 122.397 2.362 . . . . 0.0 113.767 -170.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -89.55 161.38 5.37 Favored 'Trans proline' 0 CA--C 1.591 3.356 0 CA-C-N 123.702 2.358 . . . . 0.0 112.116 173.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.03 -33.74 95.23 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 N-CA-C 119.888 2.996 . . . . 0.0 119.888 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -97.24 70.25 2.33 Favored 'General case' 0 CA--C 1.583 2.225 0 O-C-N 120.648 -1.283 . . . . 0.0 110.449 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.94 117.4 4.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 119.786 -1.821 . . . . 0.0 110.701 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 m -48.32 142.45 5.56 Favored 'General case' 0 CA--C 1.59 2.506 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.35 149.22 48.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 122.09 2.223 . . . . 0.0 111.194 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.459 HG23 ' HE3' ' A' ' 59' ' ' TRP . 30.6 m -144.86 146.95 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -142.53 132.32 24.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.714 -0.616 . . . . 0.0 109.83 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -95.7 98.28 10.35 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.422 HG12 ' HG3' ' A' ' 132' ' ' GLU . 3.9 t -122.81 162.46 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 -167.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.422 ' HG3' HG12 ' A' ' 131' ' ' VAL 2.899 27.9 mt-10 174.58 167.7 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 120.961 3.689 . . . . 0.0 120.961 162.105 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.98 130.56 38.51 Favored 'General case' 0 N--CA 1.49 1.554 1 N-CA-C 123.208 4.522 . . . . 0.0 123.208 -153.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.92 -51.05 9.58 Favored 'General case' 0 CA--C 1.581 2.15 0 O-C-N 121.254 -0.904 . . . . 0.0 112.022 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? 176.59 163.28 0.42 Allowed 'General case' 0 CA--C 1.582 2.202 0 C-N-CA 127.676 2.391 . . . . 0.0 106.699 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.412 ' HD1' ' H ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -141.57 -82.18 0.22 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.856 -1.778 . . . . 0.0 109.71 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.412 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 19.1 mmmt -79.79 -32.48 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.338 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 121.389 3.315 . . . . 0.0 121.389 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -81.71 130.73 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -171.36 152.05 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.332 0.2 OUTLIER -118.71 58.64 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.779 0 CA-C-O 124.157 1.932 . . . . 0.0 105.959 162.236 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.05 84.27 1.86 Allowed Pre-proline 0 CA--C 1.583 2.215 0 C-N-CA 127.65 2.38 . . . . 0.0 107.449 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.26 32.6 Cg_exo -57.78 -28.35 81.74 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.92 53.83 0.77 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.227 1.411 . . . . 0.0 107.854 175.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.278 2.8 mp0 56.4 38.67 29.91 Favored 'General case' 0 CA--C 1.59 2.504 0 O-C-N 120.324 -1.485 . . . . 0.0 113.839 -171.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -109.66 -55.06 2.48 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.399 1.1 mp0 -74.89 -24.19 58.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 120.771 3.619 . . . . 0.0 120.771 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.08 -46.03 0.71 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 120.519 2.968 . . . . 0.0 120.519 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.83 146.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.272 0 N-CA-C 118.861 2.911 . . . . 0.0 118.861 -173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -113.89 138.61 50.08 Favored 'General case' 0 CA--C 1.596 2.724 0 C-N-CA 127.369 2.268 . . . . 0.0 107.239 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -125.77 125.62 43.24 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 123.638 2.926 . . . . 0.0 109.458 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.86 119.54 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.561 -0.712 . . . . 0.0 109.568 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.565 HD13 ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -90.16 137.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-N 120.067 1.303 . . . . 0.0 111.629 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -123.47 -60.18 1.49 Allowed 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.552 1.141 . . . . 0.0 110.84 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -121.5 109.33 14.7 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -49.77 -38.27 33.38 Favored 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 119.541 3.163 . . . . 0.0 119.541 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.01 176.34 18.69 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 126.27 1.89 . . . . 0.0 115.886 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -151.56 -17.16 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.36 37.34 0.82 Allowed Glycine 0 N--CA 1.499 2.837 1 N-CA-C 123.37 4.108 . . . . 0.0 123.37 -175.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.3 p 65.69 -6.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.82 177.17 9.32 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 p -134.07 172.96 6.4 Favored Pre-proline 0 CA--C 1.59 2.496 0 C-N-CA 126.465 1.906 . . . . 0.0 109.402 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -100.61 -169.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.568 2.188 0 CA-C-N 123.788 2.388 . . . . 0.0 116.814 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -139.56 162.28 35.46 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 111.998 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 1.5 tp -61.65 136.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 O-C-N 119.34 -2.1 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.07 11.5 74.8 Favored Glycine 0 CA--C 1.561 2.912 0 N-CA-C 118.157 2.023 . . . . 0.0 118.157 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 158.94 16.83 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 120.866 2.333 . . . . 0.0 111.82 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -82.75 135.56 34.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.227 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -135.05 136.64 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 119.399 1.0 . . . . 0.0 110.603 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -117.54 109.35 16.61 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 120.575 -1.328 . . . . 0.0 107.688 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.47 173.1 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 CA-C-O 124.812 2.244 . . . . 0.0 113.221 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.62 126.88 39.46 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.96 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 143.5 47.91 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 121.624 3.935 . . . . 0.0 121.624 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.8 m -113.11 143.25 44.67 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 164.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.75 157.81 27.49 Favored Glycine 0 CA--C 1.56 2.874 0 CA-C-N 122.103 2.229 . . . . 0.0 116.037 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.44 151.94 36.09 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.283 1.433 . . . . 0.0 114.8 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.66 174.47 9.92 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.072 1.415 . . . . 0.0 109.316 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -30.17 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.89 5.66 1.47 Allowed 'General case' 0 CA--C 1.597 2.775 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 36.25 65.28 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 119.769 -1.832 . . . . 0.0 115.241 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.7 m -107.71 117.32 33.8 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -79.09 89.52 4.82 Favored 'General case' 0 CA--C 1.592 2.573 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.37 -34.59 78.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 118.81 -2.431 . . . . 0.0 115.595 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -143.02 168.33 19.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -141.55 -40.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.768 1 N-CA-C 128.206 6.372 . . . . 0.0 128.206 -170.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.251 3.9 m -141.83 -101.7 0.14 Allowed 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 75' ' ' LYS 0.312 25.5 mt -90.13 -28.1 19.18 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.318 12.3 t70 110.22 -14.45 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 127.433 2.293 . . . . 0.0 115.128 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.457 4.3 mmp_? 87.16 39.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -153.66 -66.21 0.15 Allowed 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.857 1.263 . . . . 0.0 107.625 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -130.84 -169.26 2.13 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 125.491 1.516 . . . . 0.0 108.611 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HA ' HD22 ' A' ' 70' ' ' LEU . 40.1 mmtm -74.07 157.26 36.4 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 119.818 -1.801 . . . . 0.0 112.303 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -74.3 116.5 15.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 123.343 2.792 . . . . 0.0 105.477 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -144.3 144.43 31.47 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.652 -1.28 . . . . 0.0 109.861 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CG ' HG11 ' A' ' 85' ' ' VAL . 36.5 p90 -148.76 -169.87 3.47 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.35 1.071 . . . . 0.0 112.862 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -125.41 113.97 18.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 tp -40.14 113.13 0.33 Allowed 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.79 28.97 61.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 119.526 2.57 . . . . 0.0 119.526 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -96.15 13.02 28.72 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 122.173 2.987 . . . . 0.0 117.447 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.71 -44.96 2.54 Favored Glycine 0 N--CA 1.51 3.618 0 O-C-N 120.91 -1.119 . . . . 0.0 111.052 -172.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.271 37.7 tt0 -23.45 -49.42 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 129.709 3.204 . . . . 0.0 119.641 169.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.585 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.302 17.1 m -107.97 -129.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 123.205 1.478 . . . . 0.0 108.098 -177.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.564 HG13 ' H ' ' A' ' 89' ' ' TRP . 44.8 pt -130.63 163.78 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 124.069 1.89 . . . . 0.0 108.869 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.256 8.0 tmtm? -69.31 -33.04 72.55 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.181 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.12 77.19 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.324 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.564 ' H ' HG13 ' A' ' 86' ' ' ILE . 37.2 m0 -72.06 -41.66 67.14 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.527 1.967 . . . . 0.0 112.957 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -57.9 -42.36 84.52 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 4.9 mt -64.78 -56.9 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.745 0 CA-C-N 118.841 0.746 . . . . 0.0 112.192 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.75 84.58 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.286 89.7 t -63.61 -34.9 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.343 1.428 . . . . 0.0 112.702 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.24 71.15 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 120.885 1.675 . . . . 0.0 113.051 169.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -79.77 5.23 14.06 Favored 'General case' 0 CA--C 1.592 2.59 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 18.2 mtt -91.58 139.18 30.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.305 -2.122 . . . . 0.0 115.012 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -93.22 159.69 15.17 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.13 130.35 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.95 0 O-C-N 119.122 -2.236 . . . . 0.0 111.055 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.92 -17.77 43.93 Favored Glycine 0 N--CA 1.514 3.898 0 CA-C-N 123.696 2.953 . . . . 0.0 116.857 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 34.4 tt0 -54.93 125.55 20.74 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 tp -103.96 121.69 43.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.125 0.97 . . . . 0.0 108.798 173.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.565 ' SG ' HD13 ' A' ' 36' ' ' ILE . 81.0 m -146.67 179.63 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.548 1.166 . . . . 0.0 110.96 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -136.0 127.6 28.87 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 123.815 1.769 . . . . 0.0 109.643 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.5 134.97 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.658 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 m -130.03 99.8 5.21 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.549 ' SG ' ' CD2' ' A' ' 127' ' ' LEU . 19.9 p -124.25 145.9 49.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -76.15 146.77 78.99 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 112.824 -1.989 . . . . 0.0 112.157 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -47.66 -23.47 3.78 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 N-CA-C 120.34 3.169 . . . . 0.0 120.34 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -63.83 -37.72 88.45 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.556 1.526 . . . . 0.0 115.017 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.14 -1.55 57.98 Favored 'General case' 0 CA--C 1.575 1.929 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.856 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.7 -122.34 0.17 Allowed 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 121.643 2.02 . . . . 0.0 116.264 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 127' ' ' LEU 0.284 3.4 m-85 -83.03 0.57 44.25 Favored 'General case' 0 N--CA 1.517 2.877 0 CA-C-N 121.881 2.128 . . . . 0.0 115.078 -178.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.69 18.97 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 122.571 3.788 . . . . 0.0 122.571 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -67.87 -56.74 7.96 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 119.653 1.726 . . . . 0.0 112.766 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -133.74 -4.11 2.89 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 118.641 2.83 . . . . 0.0 118.641 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.24 155.76 32.02 Favored Glycine 0 CA--C 1.545 1.961 0 CA-C-N 123.693 2.951 . . . . 0.0 111.789 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 t -86.53 128.76 55.64 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 116.879 -1.534 . . . . 0.0 108.814 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -32.99 -45.98 0.29 Allowed 'Trans proline' 0 CA--C 1.58 2.824 1 N-CA-C 124.351 4.712 . . . . 0.0 124.351 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.55 -28.83 9.67 Favored 'Trans proline' 0 CA--C 1.573 2.439 0 CA-C-N 125.783 3.101 . . . . 0.0 119.662 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -163.17 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mt -79.9 146.42 63.94 Favored Pre-proline 0 CA--C 1.595 2.683 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -170.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -102.84 174.51 0.19 Allowed 'Trans proline' 0 CA--C 1.593 3.426 0 CA-C-N 125.119 2.864 . . . . 0.0 114.756 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.34 25.44 0.47 Allowed 'Trans proline' 0 CA--C 1.579 2.765 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -147.89 60.02 1.12 Allowed 'General case' 0 CA--C 1.582 2.209 0 O-C-N 120.103 -1.623 . . . . 0.0 111.706 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.93 120.93 6.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.756 -1.84 . . . . 0.0 109.814 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 96.3 m -68.53 159.22 32.25 Favored 'General case' 0 CA--C 1.584 2.257 0 O-C-N 121.141 -0.974 . . . . 0.0 112.814 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD2' ' SG ' ' A' ' 106' ' ' CYS 0.289 0.0 OUTLIER -141.86 177.53 8.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.23 -2.169 . . . . 0.0 111.372 -177.052 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.3 148.99 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 125.392 1.477 . . . . 0.0 110.942 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.52 124.99 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.726 . . . . 0.0 109.555 172.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -87.63 118.37 27.07 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.17 141.93 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 121.242 1.837 . . . . 0.0 112.368 -172.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -116.05 110.17 18.53 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.793 0.837 . . . . 0.0 110.378 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.47 141.83 28.21 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 123.701 1.715 . . . . 0.0 111.002 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -120.57 -45.44 2.41 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -158.61 149.88 20.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.082 1.353 . . . . 0.0 109.045 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.425 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.284 0.0 OUTLIER -156.54 -90.71 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 O-C-N 121.227 -0.921 . . . . 0.0 111.717 179.791 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.425 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 43.8 tttm -79.87 47.15 0.84 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.126 0 N-CA-C 122.979 3.952 . . . . 0.0 122.979 173.567 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.862 0 N-CA-C 120.349 2.9 . . . . 0.0 120.349 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.93 178.07 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 123.59 1.662 . . . . 0.0 112.574 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -157.31 102.26 1.92 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 125.954 1.702 . . . . 0.0 106.418 171.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.389 10.1 tp -104.69 71.34 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 125.135 2.398 . . . . 0.0 115.038 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.9 p -137.61 -43.36 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 115.033 -2.413 . . . . 0.0 114.697 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.94 10.17 0.24 Allowed 'Trans proline' 0 CA--C 1.576 2.602 0 CA-C-N 126.398 3.321 . . . . 0.0 120.265 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.76 -67.3 0.35 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.542 1.137 . . . . 0.0 111.934 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.31 -11.74 58.42 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.332 10.8 t70 63.38 33.23 14.0 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.346 13.6 tp10 -66.46 -33.6 76.06 Favored 'General case' 0 CA--C 1.574 1.903 0 O-C-N 120.083 -1.635 . . . . 0.0 113.821 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 -25.43 4.61 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.07 168.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.658 1.729 . . . . 0.0 112.133 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.81 0.9 OUTLIER -165.15 -168.23 1.36 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 123.67 0.788 . . . . 0.0 112.514 157.585 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.91 130.69 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.285 1.402 . . . . 0.0 113.846 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.15 118.27 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.02 143.24 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.04 0.924 . . . . 0.0 112.78 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -127.43 -66.43 0.88 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.005 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -111.46 90.36 3.31 Favored 'General case' 0 CA--C 1.586 2.338 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -21.7 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.493 1 N-CA-C 123.207 4.521 . . . . 0.0 123.207 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.11 -142.81 8.62 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -142.27 -53.69 0.42 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.2 -51.82 0.14 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 120.973 3.149 . . . . 0.0 120.973 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.428 HG23 HG21 ' A' ' 98' ' ' VAL 0.401 9.6 t -85.42 46.68 1.32 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.759 2.504 . . . . 0.0 117.759 -176.54 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.455 24.0 mt-10 70.08 -172.6 0.17 Allowed 'General case' 0 CA--C 1.583 2.224 1 N-CA-C 123.891 4.774 . . . . 0.0 123.891 168.317 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.8 p -92.49 151.94 41.71 Favored Pre-proline 0 CA--C 1.577 2.003 0 C-N-CA 126.91 2.084 . . . . 0.0 115.523 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.26 147.8 88.16 Favored 'Trans proline' 0 CA--C 1.577 2.653 0 C-N-CA 122.599 2.199 . . . . 0.0 117.19 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.01 153.66 20.59 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.993 -1.692 . . . . 0.0 109.858 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.4 OUTLIER -58.58 131.71 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 120.148 -1.595 . . . . 0.0 112.423 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.38 7.14 85.25 Favored Glycine 0 CA--C 1.558 2.769 0 N-CA-C 118.705 2.242 . . . . 0.0 118.705 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -88.22 154.61 20.29 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 121.61 2.705 . . . . 0.0 114.344 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -80.25 139.45 36.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.518 -1.364 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.332 1.4 t -132.51 140.85 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.149 0.98 . . . . 0.0 111.23 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.77 110.97 14.34 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 76' ' ' PHE . 3.0 m -120.6 167.22 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 123.443 1.592 . . . . 0.0 114.804 -174.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.88 111.33 12.47 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -113.53 148.67 35.65 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.7 m -120.06 139.73 52.09 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 163.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.48 143.22 10.76 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 119.748 -1.845 . . . . 0.0 115.801 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.406 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -133.01 154.45 50.5 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.308 -1.946 . . . . 0.0 113.765 -175.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.2 tp -79.23 179.52 7.34 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 123.139 1.447 . . . . 0.0 108.639 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.366 0.0 OUTLIER -64.28 -25.61 68.13 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 178.081 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.97 14.32 2.29 Favored 'General case' 0 CA--C 1.603 3.004 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.33 31.65 70.38 Favored Glycine 0 N--CA 1.514 3.834 0 O-C-N 119.849 -1.782 . . . . 0.0 116.161 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -86.19 111.32 20.28 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -75.35 89.02 2.59 Favored 'General case' 0 CA--C 1.583 2.23 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -72.16 -30.69 65.24 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 119.376 -2.077 . . . . 0.0 114.408 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -151.31 149.6 29.54 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.547 2.118 . . . . 0.0 113.879 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.4 p -160.1 96.8 1.23 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 112.229 -2.26 . . . . 0.0 106.995 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 t -59.16 -36.96 76.22 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -51.92 -36.78 50.23 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.72 -66.27 0.5 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -161.14 70.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -151.61 -79.39 0.11 Allowed 'General case' 0 CA--C 1.564 1.515 0 O-C-N 120.28 -1.512 . . . . 0.0 108.285 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -167.74 -138.28 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.025 1.73 . . . . 0.0 107.982 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -112.64 -165.92 1.03 Allowed 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.636 1.574 . . . . 0.0 108.46 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.333 2.8 t80 -127.65 146.65 50.48 Favored 'General case' 0 CA--C 1.572 1.822 0 O-C-N 119.098 -2.251 . . . . 0.0 110.147 170.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.7 p -160.84 140.5 10.79 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 119.526 -1.984 . . . . 0.0 109.151 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CG ' HG11 ' A' ' 85' ' ' VAL . 6.3 p90 -149.65 -176.9 5.59 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.169 -176.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.53 124.95 42.43 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 119.051 -2.281 . . . . 0.0 105.074 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.53 109.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.46 97.95 Favored Glycine 0 N--CA 1.513 3.781 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -132.21 -73.31 0.52 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 123.73 0.812 . . . . 0.0 112.149 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.13 71.65 0.22 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 104.255 -3.538 . . . . 0.0 104.255 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.43 0.0 OUTLIER -65.05 135.33 55.46 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 108.301 -3.949 . . . . 0.0 118.969 -159.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.359 19.2 m -79.91 -108.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 1 CA-C-N 103.299 -6.319 . . . . 0.0 107.0 -177.303 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.552 HG13 ' H ' ' A' ' 89' ' ' TRP . 25.7 pt -132.06 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 123.645 1.688 . . . . 0.0 107.381 168.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -32.12 73.42 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.386 176.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.91 80.62 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.591 -1.195 . . . . 0.0 112.157 168.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.552 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.3 m0 -73.46 -43.49 60.12 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 120.377 1.444 . . . . 0.0 112.39 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -57.93 -35.66 71.39 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.603 1.547 . . . . 0.0 114.774 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.324 29.0 mt -72.68 -58.12 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-N 118.952 0.796 . . . . 0.0 112.087 175.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.7 81.15 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.48 -44.3 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 120.904 1.684 . . . . 0.0 110.692 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.5 -39.73 35.07 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 121.392 1.905 . . . . 0.0 115.136 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.8 p -91.39 6.9 43.61 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 ttt -86.68 -179.6 6.61 Favored 'General case' 0 CA--C 1.58 2.122 0 O-C-N 119.705 -1.872 . . . . 0.0 113.108 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.51 164.63 21.51 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 118.903 -2.373 . . . . 0.0 113.427 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 98' ' ' VAL . 89.1 t -53.79 31.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 N-CA-C 120.13 3.381 . . . . 0.0 120.13 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.75 -18.0 0.09 OUTLIER Glycine 0 N--CA 1.501 2.974 0 O-C-N 116.73 -3.731 . . . . 0.0 113.974 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' OE1' ' SG ' ' A' ' 102' ' ' CYS . 39.0 tt0 -43.89 143.76 1.02 Allowed 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 119.709 3.226 . . . . 0.0 119.709 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.71 123.59 50.66 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.659 1.183 . . . . 0.0 109.83 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.43 ' SG ' ' OE1' ' A' ' 100' ' ' GLU . 3.9 m -144.76 165.73 27.25 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.783 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -120.41 120.7 36.7 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 123.929 1.823 . . . . 0.0 110.26 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.481 HG22 ' SG ' ' A' ' 106' ' ' CYS . 3.9 mt -77.39 141.0 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.043 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.855 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.5 m -129.47 109.62 11.2 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.481 ' SG ' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -115.95 148.13 40.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -174.092 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -99.95 146.15 31.4 Favored Pre-proline 0 CA--C 1.579 2.08 0 C-N-CA 124.866 1.266 . . . . 0.0 110.381 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.13 -25.55 4.4 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 N-CA-C 119.738 2.938 . . . . 0.0 119.738 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.58 -38.26 86.89 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -92.54 4.49 53.46 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.848 1.259 . . . . 0.0 114.369 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -129.67 -104.75 0.3 Allowed 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 119.908 1.231 . . . . 0.0 113.762 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.388 47.2 m-85 -106.5 -3.12 21.23 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.17 -154.72 44.04 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 119.099 2.399 . . . . 0.0 119.099 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.7 m -67.9 -15.51 63.65 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.54 -30.46 11.39 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 118.934 2.938 . . . . 0.0 118.934 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 168.33 44.34 Favored Glycine 0 CA--C 1.552 2.355 0 CA-C-N 121.401 1.91 . . . . 0.0 115.074 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.15 120.4 59.84 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 116.666 -1.635 . . . . 0.0 107.674 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 77.1 Cg_exo -37.91 -41.02 1.12 Allowed 'Trans proline' 0 CA--C 1.58 2.814 1 N-CA-C 123.425 4.356 . . . . 0.0 123.425 -175.959 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.0 -30.84 66.66 Favored 'Trans proline' 0 CA--C 1.574 2.506 0 CA-C-N 125.455 2.984 . . . . 0.0 119.856 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -159.78 -27.78 0.07 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.8 mt -79.91 124.37 83.23 Favored Pre-proline 0 CA--C 1.584 2.271 0 C-N-CA 125.299 1.44 . . . . 0.0 111.983 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -95.58 178.3 0.7 Allowed 'Trans proline' 0 CA--C 1.584 3.007 0 C-N-CA 122.765 2.31 . . . . 0.0 116.07 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -53.13 125.29 17.87 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.655 2.903 . . . . 0.0 117.906 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.8 t30 56.16 62.41 2.37 Favored 'General case' 0 CA--C 1.586 2.36 0 C-N-CA 125.017 1.327 . . . . 0.0 113.935 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.04 123.21 40.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.303 -1.498 . . . . 0.0 112.417 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.5 m -67.29 159.25 29.63 Favored 'General case' 0 CA--C 1.593 2.616 0 O-C-N 121.358 -0.839 . . . . 0.0 113.163 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 111' ' ' ALA . 16.7 mt -134.34 164.32 27.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.461 -2.024 . . . . 0.0 115.151 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 59' ' ' TRP . 3.8 m -148.52 140.05 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 C-N-CA 124.639 1.176 . . . . 0.0 109.944 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.53 126.06 15.86 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.466 -1.396 . . . . 0.0 109.418 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -88.12 118.33 27.63 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.15 139.36 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.102 0.954 . . . . 0.0 111.794 -172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -116.23 124.56 50.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 tp -104.49 110.12 22.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.221 0.534 . . . . 0.0 109.735 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.7 -43.82 25.02 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -171.73 159.62 5.38 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 123.279 1.514 . . . . 0.0 109.558 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.276 8.1 p90 -152.38 -93.76 0.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -106.51 89.33 3.0 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.739 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.376 -176.753 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 N-CA-C 107.29 -2.324 . . . . 0.0 107.29 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -174.77 150.48 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 124.966 1.306 . . . . 0.0 108.757 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.61 126.67 4.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.415 -1.428 . . . . 0.0 108.3 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.376 24.7 mm -111.67 48.44 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-O 122.747 1.26 . . . . 0.0 112.035 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.29 -55.98 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 116.197 -1.858 . . . . 0.0 113.691 173.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.64 -14.42 35.64 Favored 'Trans proline' 0 CA--C 1.576 2.593 0 CA-C-N 125.337 2.942 . . . . 0.0 119.121 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -129.6 -55.03 1.16 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.622 1.569 . . . . 0.0 110.754 178.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -16.6 59.8 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.465 1.9 p30 65.24 25.05 12.27 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 120.106 3.373 . . . . 0.0 120.106 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.436 3.6 mp0 -90.02 -36.41 14.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.45 -32.9 0.64 Allowed Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -177.3 156.31 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 33' ' ' LEU 1.099 1.2 mp -155.61 -156.11 0.62 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 158.053 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HG2' ' SG ' ' A' ' 102' ' ' CYS 0.29 1.1 tmmt? -128.86 121.78 28.95 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.252 1.387 . . . . 0.0 113.359 -165.274 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 10.4 t -97.42 96.69 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.602 -178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.501 0.4 OUTLIER -55.25 132.2 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -173.547 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.89 -71.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.828 -0.545 . . . . 0.0 110.867 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -112.95 96.25 5.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.12 162.54 2.53 Favored 'General case' 0 CA--C 1.591 2.525 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.94 -174.99 50.12 Favored Glycine 0 CA--C 1.55 2.256 0 O-C-N 119.658 -1.901 . . . . 0.0 117.586 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -63.61 -43.22 97.52 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.97 54.19 0.46 Allowed Glycine 0 N--CA 1.48 1.568 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.2 p -136.7 -65.8 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.38 0.672 . . . . 0.0 110.95 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -127.04 163.45 23.72 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.9 p -122.83 142.46 37.91 Favored Pre-proline 0 CA--C 1.58 2.114 0 CA-C-N 110.134 -3.212 . . . . 0.0 109.399 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -60.6 119.82 7.22 Favored 'Trans proline' 0 CA--C 1.581 2.834 0 C-N-CA 123.143 2.562 . . . . 0.0 118.177 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.53 167.48 12.94 Favored 'General case' 0 CA--C 1.571 1.785 0 O-C-N 119.238 -2.164 . . . . 0.0 110.753 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.307 0.3 OUTLIER -59.47 132.09 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 O-C-N 120.132 -1.605 . . . . 0.0 112.187 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.48 2.62 88.91 Favored Glycine 0 CA--C 1.56 2.903 0 N-CA-C 118.558 2.183 . . . . 0.0 118.558 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.71 143.64 44.07 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.391 2.596 . . . . 0.0 113.442 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 107.3 18.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.402 1.5 t -103.43 123.67 57.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 126.762 2.025 . . . . 0.0 111.908 -166.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -111.32 109.93 20.17 Favored 'General case' 0 CA--C 1.573 1.834 0 O-C-N 120.936 -1.102 . . . . 0.0 108.026 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.63 164.48 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.321 11.4 m-70 -121.6 117.53 26.97 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 2.6 p90 -114.05 152.14 31.45 Favored 'General case' 0 CA--C 1.578 2.055 0 CA-C-O 123.369 1.556 . . . . 0.0 114.717 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -130.9 149.58 52.46 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.59 139.64 7.01 Favored Glycine 0 CA--C 1.551 2.331 0 O-C-N 118.735 -2.478 . . . . 0.0 116.681 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.4 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -134.93 151.39 50.82 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.292 1.837 . . . . 0.0 115.206 -175.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -95.34 176.17 6.3 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 121.543 -0.723 . . . . 0.0 112.288 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.271 1.8 pt? -62.96 -24.97 68.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.58 -2.9 15.66 Favored 'General case' 0 CA--C 1.595 2.694 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.87 167.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.83 36.84 61.28 Favored Glycine 0 N--CA 1.504 3.186 0 CA-C-N 121.355 1.889 . . . . 0.0 114.043 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -106.14 121.65 44.58 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -75.54 89.33 2.71 Favored 'General case' 0 CA--C 1.579 2.086 0 O-C-N 121.9 -0.5 . . . . 0.0 110.482 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -63.63 -31.83 73.11 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 119.568 -1.957 . . . . 0.0 113.767 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -153.35 156.38 38.23 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 124.474 2.083 . . . . 0.0 113.095 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 77.1 p -157.96 96.4 1.47 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.673 -2.058 . . . . 0.0 107.611 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -55.77 -34.34 65.15 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.92 -30.56 66.01 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -42.51 -51.73 4.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtm-85 -95.35 27.75 3.19 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.763 1.625 . . . . 0.0 113.644 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.283 31.6 ttpt 71.99 -13.25 0.61 Allowed 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.9 174.91 8.61 Favored 'General case' 0 CA--C 1.575 1.942 0 CA-C-O 123.745 1.736 . . . . 0.0 114.283 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -121.72 171.86 8.56 Favored 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.18 148.06 43.52 Favored 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 122.5 1.143 . . . . 0.0 108.761 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.8 t -169.37 142.97 2.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.15 -2.219 . . . . 0.0 107.398 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CG ' HG11 ' A' ' 85' ' ' VAL . 14.4 p90 -149.83 174.17 12.94 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.533 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -108.25 125.67 51.93 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.39 112.04 1.14 Allowed 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.055 -1.028 . . . . 0.0 112.236 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.16 57.04 11.27 Favored Glycine 0 N--CA 1.505 3.291 0 O-C-N 120.512 -1.368 . . . . 0.0 114.761 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.592 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.251 1.9 pptp? -106.17 -73.77 0.67 Allowed 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 123.898 1.808 . . . . 0.0 111.461 -175.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.592 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -110.33 -52.75 0.59 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 127.203 2.335 . . . . 0.0 108.346 169.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.757 22.9 tt0 116.71 140.65 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 128.209 3.862 . . . . 0.0 115.003 165.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.332 8.6 m -79.92 -108.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 1 CA-C-N 105.296 -5.411 . . . . 0.0 105.04 179.691 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.496 HG13 ' H ' ' A' ' 89' ' ' TRP 0.25 21.0 pt -120.32 154.32 23.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 124.419 2.057 . . . . 0.0 106.541 163.599 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.272 13.5 tmtt? -66.61 -29.62 69.71 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.337 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.42 77.92 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 117.122 -1.418 . . . . 0.0 111.911 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.496 ' H ' HG13 ' A' ' 86' ' ' ILE . 38.5 m0 -73.19 -46.07 52.69 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 121.043 1.747 . . . . 0.0 112.704 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.82 -37.27 73.52 Favored 'General case' 0 CA--C 1.575 1.94 0 CA-C-N 122.018 2.19 . . . . 0.0 114.335 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.288 1.8 mp -69.27 -64.94 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.994 0 CA-C-N 119.731 1.15 . . . . 0.0 111.215 175.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -63.67 -38.81 92.52 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.442 HG22 ' SD ' ' A' ' 96' ' ' MET 0.341 9.6 t -70.13 -33.08 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 120.903 1.683 . . . . 0.0 111.424 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.71 -38.06 66.6 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 121.584 1.993 . . . . 0.0 112.634 165.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 9.75 5.98 Favored 'General case' 0 CA--C 1.598 2.818 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.442 ' SD ' HG22 ' A' ' 93' ' ' VAL . 30.3 mtp -87.53 -178.59 6.16 Favored 'General case' 0 N--CA 1.511 2.59 0 CA-C-N 123.315 2.78 . . . . 0.0 116.516 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -135.95 146.8 47.68 Favored 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -175.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -51.66 123.2 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.1 -45.83 1.28 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-O 116.308 -2.384 . . . . 0.0 114.066 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 29.7 mt-10 -148.17 -173.86 4.42 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 121.399 2.6 . . . . 0.0 112.975 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.435 HD13 ' H ' ' A' ' 102' ' ' CYS 0.757 0.2 OUTLIER -157.6 -135.68 0.04 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 177.755 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -160.18 -150.08 0.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -165.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.599 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 47.5 ptt85 -120.92 130.68 53.97 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 124.441 2.067 . . . . 0.0 111.979 169.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 92' ' ' ALA . 3.6 mt -79.6 141.13 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.02 0 CA-C-N 112.912 -1.949 . . . . 0.0 107.935 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.9 m -129.79 109.84 11.26 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.582 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 2.1 p -132.49 151.79 51.78 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -171.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -87.8 142.19 32.28 Favored Pre-proline 0 CA--C 1.578 2.019 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.778 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 41.7 Cg_exo -54.67 -12.51 4.55 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 N-CA-C 120.304 3.155 . . . . 0.0 120.304 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.46 -40.8 97.78 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 120.925 1.693 . . . . 0.0 113.604 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.22 -3.34 54.88 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 124.652 1.181 . . . . 0.0 113.332 171.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.3 -114.27 0.24 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.11 8.12 45.19 Favored 'General case' 0 N--CA 1.514 2.731 0 CA-C-N 121.024 1.738 . . . . 0.0 114.866 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.82 141.22 43.04 Favored Glycine 0 N--CA 1.497 2.705 0 CA-C-N 123.231 2.741 . . . . 0.0 116.195 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.297 15.4 m 78.39 -54.57 0.48 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.309 1.044 . . . . 0.0 113.423 -174.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.3 -49.44 7.25 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.58 153.16 28.62 Favored Glycine 0 CA--C 1.547 2.035 0 CA-C-N 119.663 1.12 . . . . 0.0 114.379 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 10.8 t -82.45 107.21 8.27 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 116.275 -1.822 . . . . 0.0 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.499 1.0 OUTLIER -4.14 -99.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.588 3.184 1 C-N-CA 125.768 4.312 . . . . 0.0 122.332 -174.6 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -88.78 37.42 0.41 Allowed 'Trans proline' 0 CA--C 1.58 2.824 0 CA-C-N 127.743 3.801 . . . . 0.0 115.95 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -145.29 -30.5 0.42 Allowed 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.499 ' HB ' ' H ' ' A' ' 117' ' ' SER . 32.7 mt -130.57 137.37 30.66 Favored Pre-proline 0 N--CA 1.504 2.261 0 CA-C-N 121.471 1.941 . . . . 0.0 113.331 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.47 -175.59 2.0 Allowed 'Trans proline' 0 CA--C 1.591 3.339 0 CA-C-N 122.916 2.077 . . . . 0.0 112.829 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.59 9.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.58 2.777 0 N-CA-C 122.011 3.812 . . . . 0.0 122.011 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.85 93.4 1.26 Allowed 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 121.442 1.928 . . . . 0.0 110.752 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.38 98.15 4.01 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 122.924 2.602 . . . . 0.0 108.989 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.9 m -60.25 131.77 51.83 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.988 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' CD1' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -140.94 177.56 7.96 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 124.66 2.171 . . . . 0.0 114.612 -168.095 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG23 ' HE3' ' A' ' 59' ' ' TRP . 1.7 m -148.19 144.95 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 126.704 2.002 . . . . 0.0 108.189 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 0.5 OUTLIER -133.76 124.12 26.07 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -88.58 97.81 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 101' ' ' LEU . 2.5 t -108.23 140.95 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -175.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -126.15 119.28 27.11 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 tp -95.94 121.99 38.27 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.6 -46.6 9.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -165.13 157.23 15.46 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 123.855 1.788 . . . . 0.0 108.642 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -152.26 -95.49 0.05 Allowed 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 94.09 3.78 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 3.37 0 CA-C-O 117.63 -1.65 . . . . 0.0 114.561 -173.54 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 121.643 3.417 . . . . 0.0 121.643 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.19 154.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 CA-C-O 122.483 1.135 . . . . 0.0 110.752 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -153.14 141.33 20.48 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 121.588 0.709 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.347 19.4 pt -125.48 78.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 124.842 2.258 . . . . 0.0 110.274 174.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -137.15 -37.7 0.02 OUTLIER Pre-proline 0 CA--C 1.577 1.993 0 CA-C-O 114.431 -2.699 . . . . 0.0 116.496 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.21 93.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.91 0 CA-C-N 126.69 3.425 . . . . 0.0 112.691 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.394 74.3 mmtt 70.39 -12.03 0.55 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -174.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -77.92 -23.38 48.66 Favored 'General case' 0 CA--C 1.581 2.168 0 C-N-CA 124.99 1.316 . . . . 0.0 113.589 174.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.469 1.4 p30 64.75 7.05 3.6 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 121.282 3.808 . . . . 0.0 121.282 176.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.55 -9.2 58.54 Favored 'General case' 0 CA--C 1.584 2.267 0 CA-C-N 120.503 1.501 . . . . 0.0 114.894 176.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 -1.14 62.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -179.91 159.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 120.961 2.381 . . . . 0.0 113.755 -171.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.826 2.5 tp -148.23 -169.99 3.48 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.046 160.747 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 177.1 -175.23 0.13 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 -158.134 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG13 ' H ' ' A' ' 36' ' ' ILE 0.955 0.4 OUTLIER 104.28 -166.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.066 1 N-CA-C 126.537 5.754 . . . . 0.0 126.537 161.019 . . . . . . . . 5 4 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 35' ' ' VAL 0.392 25.0 mm -25.6 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.324 1 N-CA-C 126.134 5.605 . . . . 0.0 126.134 -167.468 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 -60.45 0.97 Allowed 'General case' 0 CA--C 1.583 2.237 0 CA-C-N 110.642 -2.981 . . . . 0.0 106.649 167.165 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -120.07 109.11 15.08 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -64.79 164.98 11.29 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.39 152.91 24.71 Favored Glycine 0 CA--C 1.548 2.125 0 O-C-N 120.402 -1.437 . . . . 0.0 112.401 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.8 p -121.09 -91.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.93 25.39 0.63 Allowed Glycine 0 N--CA 1.506 3.356 1 N-CA-C 124.184 4.434 . . . . 0.0 124.184 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 53.1 p 83.31 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.644 1.978 . . . . 0.0 109.185 -172.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.343 0.0 OUTLIER -0.8 -120.04 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.907 1 N-CA-C 123.04 4.459 . . . . 0.0 123.04 -177.383 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 15.5 p -107.46 137.49 19.67 Favored Pre-proline 0 CA--C 1.58 2.11 0 C-N-CA 124.735 1.214 . . . . 0.0 112.722 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.257 11.8 Cg_endo -109.48 -18.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.888 0 N-CA-C 115.84 1.438 . . . . 0.0 115.84 167.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.51 31.5 mtt 78.96 -155.22 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 169.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.323 1.0 OUTLIER -43.84 129.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -174.083 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.26 -10.34 71.53 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-O 116.073 -2.515 . . . . 0.0 117.305 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 123.457 3.629 . . . . 0.0 113.886 -177.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.2 tpt85 -86.49 96.09 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 0.0 109.648 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -91.27 133.02 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.583 0.753 . . . . 0.0 111.828 -172.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.71 102.13 10.45 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 102.307 -3.22 . . . . 0.0 102.307 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.97 -178.21 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-O 124.315 2.007 . . . . 0.0 113.789 -171.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.467 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -145.47 119.43 9.35 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.655 171.539 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -109.69 152.02 26.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.752 1.615 . . . . 0.0 114.128 -178.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.5 m -127.43 131.67 50.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 159.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.9 144.1 15.61 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-O 124.422 2.123 . . . . 0.0 116.124 -177.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -133.6 156.99 46.85 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 111.515 -2.342 . . . . 0.0 112.844 -175.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.05 163.24 13.03 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 121.308 -0.87 . . . . 0.0 109.157 168.182 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.268 9.1 tt -65.51 -20.92 66.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.124 -1.61 . . . . 0.0 114.937 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.74 -4.63 6.78 Favored 'General case' 0 CA--C 1.608 3.194 0 CA-C-N 119.926 1.239 . . . . 0.0 112.705 165.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.01 40.71 29.39 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.278 -1.514 . . . . 0.0 116.345 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 83.9 m -117.47 122.52 43.96 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.17 100.32 2.05 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -67.7 -38.69 84.01 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.621 -1.924 . . . . 0.0 112.105 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.44 173.28 11.22 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 125.667 2.651 . . . . 0.0 114.614 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 69' ' ' SER . 18.7 t -157.3 -91.53 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.983 1 N-CA-C 97.477 -5.009 . . . . 0.0 97.477 170.867 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 68' ' ' SER . 73.2 m 76.39 102.15 0.07 Allowed 'General case' 0 C--O 1.239 0.534 1 CA-C-O 97.027 -10.987 . . . . 0.0 103.933 171.843 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.556 HD22 ' HA ' ' A' ' 75' ' ' LYS . 9.3 mt -49.04 0.98 0.01 OUTLIER 'General case' 0 CA--C 1.598 2.807 3 O-C-N 75.771 -29.33 . . . . 0.0 121.981 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' SER 0.408 8.2 p-10 57.26 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 121.495 3.887 . . . . 0.0 121.495 176.856 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -76.93 28.88 0.13 Allowed 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.336 53.9 tttm 80.77 -52.59 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 126.414 1.886 . . . . 0.0 112.422 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.22 -160.32 0.79 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 122.307 1.051 . . . . 0.0 108.468 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HA ' HD22 ' A' ' 70' ' ' LEU . 8.7 mtmp? -65.11 156.74 30.63 Favored 'General case' 0 CA--C 1.578 2.026 0 O-C-N 120.502 -1.374 . . . . 0.0 113.939 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.481 ' H ' HD22 ' A' ' 70' ' ' LEU 0.278 17.9 t80 -65.71 151.5 46.42 Favored 'General case' 0 CA--C 1.571 1.76 0 CA-C-N 122.43 2.377 . . . . 0.0 108.885 179.179 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.5 p -160.55 143.1 12.99 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 119.946 -1.721 . . . . 0.0 112.456 -175.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CG ' HG11 ' A' ' 85' ' ' VAL . 31.4 p90 -157.2 -179.85 8.59 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.001 176.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -119.88 125.73 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 172.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.83 108.1 0.8 Allowed 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.05 56.55 6.32 Favored Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.288 -0.883 . . . . 0.0 113.547 -173.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -97.74 -65.4 0.97 Allowed 'General case' 0 N--CA 1.512 2.656 0 CA-C-O 124.933 2.302 . . . . 0.0 113.148 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.39 -49.68 0.15 Allowed Glycine 0 CA--C 1.56 2.895 0 N-CA-C 103.719 -3.752 . . . . 0.0 103.719 172.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.903 1.8 tm-20 119.99 139.43 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 127.226 3.393 . . . . 0.0 115.881 163.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.451 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.36 9.2 m -79.94 -105.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 1 CA-C-N 106.782 -4.736 . . . . 0.0 105.247 -178.351 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.47 HG13 ' H ' ' A' ' 89' ' ' TRP . 36.1 pt -122.5 154.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 124.289 1.995 . . . . 0.0 105.963 165.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.282 2.6 mptt -68.29 -30.67 69.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.15 81.78 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 115.791 -2.052 . . . . 0.0 110.617 167.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.47 ' H ' HG13 ' A' ' 86' ' ' ILE . 41.6 m0 -73.11 -45.25 58.12 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 122.698 2.499 . . . . 0.0 112.948 174.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.36 -38.31 71.25 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.289 1.859 . . . . 0.0 114.407 175.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.34 28.4 mt -69.25 -60.97 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 CA-C-N 118.997 0.817 . . . . 0.0 112.249 175.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.8 -31.25 70.98 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 117.723 2.49 . . . . 0.0 117.723 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.404 HG13 ' SD ' ' A' ' 96' ' ' MET 0.303 13.5 t -79.08 -28.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 CA-C-N 119.821 1.191 . . . . 0.0 110.933 176.01 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.45 85.58 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.879 1.672 . . . . 0.0 112.481 166.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.0 p -73.01 0.34 11.63 Favored 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 173.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.404 ' SD ' HG13 ' A' ' 93' ' ' VAL . 9.1 mtt -82.21 126.69 32.37 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 122.888 2.585 . . . . 0.0 115.889 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.86 130.49 36.81 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 173.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.0 t -9.49 80.17 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.541 4.076 0 CA-C-N 120.433 1.469 . . . . 0.0 108.92 -157.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.83 63.38 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 CA-C-N 109.748 -3.387 . . . . 0.0 119.429 -145.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.489 8.0 tp10 -29.63 -86.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 -170.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.267 27.7 tp -130.9 113.28 13.84 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.869 0.867 . . . . 0.0 110.192 169.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.6 m -135.38 170.98 15.1 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.37 1.081 . . . . 0.0 109.653 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 161.59 21.85 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 123.593 1.663 . . . . 0.0 113.989 178.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.2 mt -127.66 133.98 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.028 175.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.8 m -135.24 100.12 4.45 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 177.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.4 p -125.52 148.24 48.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 118.733 2.864 . . . . 0.0 118.733 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -63.8 143.22 98.1 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.807 -1.568 . . . . 0.0 110.612 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.08 -11.8 23.48 Favored 'Trans proline' 0 CA--C 1.578 2.696 0 CA-C-N 125.268 2.917 . . . . 0.0 116.977 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.0 -39.63 95.33 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.187 1.812 . . . . 0.0 112.391 171.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -75.71 3.92 8.83 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 169.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.68 -105.45 0.17 Allowed 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.368 1.44 . . . . 0.0 114.078 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -114.02 13.51 18.21 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 120.014 1.279 . . . . 0.0 114.116 -177.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -57.23 -25.66 54.72 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 121.479 3.352 . . . . 0.0 121.479 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.6 p -67.49 -57.34 6.7 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 119.463 1.632 . . . . 0.0 113.318 175.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.24 -15.15 7.31 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 151.74 20.38 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 122.684 2.493 . . . . 0.0 112.175 -176.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.517 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 10.1 t -75.88 119.34 76.73 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-O 116.158 -1.877 . . . . 0.0 108.172 176.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.295 96.6 Cg_exo -35.59 -47.62 0.92 Allowed 'Trans proline' 0 CA--C 1.579 2.736 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -175.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -89.95 -10.7 3.42 Favored 'Trans proline' 0 CA--C 1.578 2.679 0 CA-C-N 124.789 2.746 . . . . 0.0 118.251 177.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -144.99 -49.91 0.25 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 119.13 3.011 . . . . 0.0 119.13 -174.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.517 ' HB ' ' H ' ' A' ' 117' ' ' SER . 80.2 mt -80.82 139.28 50.18 Favored Pre-proline 0 CA--C 1.594 2.653 0 CA-C-O 116.353 -1.784 . . . . 0.0 114.975 -171.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -97.58 172.42 0.69 Allowed 'Trans proline' 0 CA--C 1.592 3.405 0 CA-C-N 125.754 3.091 . . . . 0.0 114.525 176.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -64.27 2.54 1.11 Allowed 'Trans proline' 0 CA--C 1.576 2.58 0 N-CA-C 120.272 3.143 . . . . 0.0 120.272 175.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -146.37 57.62 1.19 Allowed 'General case' 0 CA--C 1.58 2.105 0 O-C-N 119.754 -1.841 . . . . 0.0 114.237 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.32 114.46 15.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 119.745 -1.847 . . . . 0.0 106.989 173.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.7 m -59.88 130.89 48.99 Favored 'General case' 0 CA--C 1.586 2.359 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.201 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.91 156.41 18.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 122.137 2.244 . . . . 0.0 115.165 -173.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.0 t -143.68 120.23 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-N 112.294 -2.23 . . . . 0.0 107.727 -173.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 4.1 m-85 -140.7 129.92 23.61 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 119.756 -1.84 . . . . 0.0 110.367 174.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 111.99 23.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 172.145 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.46 131.95 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.39 108.54 17.74 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.645 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 tt -98.45 116.34 30.46 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.574 1.178 . . . . 0.0 109.886 -175.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.94 -51.58 7.03 Favored 'General case' 0 CA--C 1.574 1.878 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.73 -177.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 152.87 30.87 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.918 1.287 . . . . 0.0 109.962 175.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -131.65 -75.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.839 -1.163 . . . . 0.0 112.594 176.706 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.291 57.6 tttm -79.79 -57.1 3.82 Favored 'General case' 0 CA--C 1.584 2.281 0 CA-C-O 115.776 -2.059 . . . . 0.0 115.128 -177.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.017 0 CA-C-N 125.083 3.583 . . . . 0.0 119.602 -179.255 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.887 1 N-CA-C 127.638 5.815 . . . . 0.0 127.638 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.473 3.5 t 63.44 -64.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 177.225 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -155.57 157.06 36.19 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 121.749 2.068 . . . . 0.0 115.638 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.581 1.1 pt 137.01 -61.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 C-N-CA 127.247 2.219 . . . . 0.0 116.92 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 1.057 70.0 m 82.74 68.56 0.11 Allowed Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 116.984 -3.572 . . . . 0.0 114.727 -170.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -31.9 -24.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.51 2 N-CA-C 127.59 5.958 . . . . 0.0 127.59 -174.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.296 0.0 OUTLIER -69.18 -61.58 1.73 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 122.033 2.197 . . . . 0.0 111.507 176.86 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -95.95 -8.35 34.06 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.467 2.0 p30 61.85 7.73 2.14 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 118.432 2.752 . . . . 0.0 118.432 -175.057 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -90.45 -38.59 13.16 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.57 -51.03 6.77 Favored Glycine 0 N--CA 1.483 1.822 1 N-CA-C 125.188 4.835 . . . . 0.0 125.188 -157.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.75 166.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -172.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.759 1.1 tp -159.53 -153.11 0.34 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.437 163.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -157.34 137.29 12.48 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.042 2.201 . . . . 0.0 116.394 -169.311 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.4 133.37 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.45 -0.781 . . . . 0.0 109.737 174.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.513 HD13 ' SG ' ' A' ' 102' ' ' CYS 0.301 1.0 OUTLIER -75.84 133.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 O-C-N 120.522 -1.361 . . . . 0.0 113.602 -177.627 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -114.65 -51.58 2.74 Favored 'General case' 0 CA--C 1.575 1.925 0 C-N-CA 124.606 1.162 . . . . 0.0 112.015 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.09 96.15 2.95 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.62 171.06 0.22 Allowed 'General case' 0 CA--C 1.591 2.539 0 CA-C-N 122.106 2.23 . . . . 0.0 116.444 177.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.26 -172.19 22.65 Favored Glycine 0 CA--C 1.547 2.09 0 O-C-N 120.018 -1.676 . . . . 0.0 116.905 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -166.77 -69.45 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.043 0.937 . . . . 0.0 110.006 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.7 -103.5 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 120.738 3.055 . . . . 0.0 120.738 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.437 ' H ' HG21 ' A' ' 98' ' ' VAL . 43.4 p -113.38 49.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.247 1.499 . . . . 0.0 111.693 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.443 4.7 pt-20 41.14 -116.85 0.31 Allowed 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 119.598 3.185 . . . . 0.0 119.598 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -150.77 137.08 11.07 Favored Pre-proline 0 CA--C 1.577 2.009 0 C-N-CA 124.925 1.29 . . . . 0.0 113.579 -175.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.251 6.2 Cg_endo -117.19 -26.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.583 2.942 0 C-N-CA 121.782 1.655 . . . . 0.0 115.984 171.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.566 32.3 mtt 82.31 -146.47 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.402 0.3 OUTLIER -47.0 128.94 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -172.647 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.11 90.62 Favored Glycine 0 CA--C 1.56 2.857 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -174.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -79.6 144.69 33.6 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 122.635 3.217 . . . . 0.0 114.914 -178.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -75.64 131.33 39.87 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.252 0.933 . . . . 0.0 109.088 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.362 2.1 t -131.39 132.03 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 124.141 0.976 . . . . 0.0 112.217 -166.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -117.7 107.13 13.81 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.1 m -116.31 159.23 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.972 1.368 . . . . 0.0 114.296 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 16.9 m170 -116.32 123.57 47.98 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 116.806 -1.568 . . . . 0.0 109.223 166.201 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.323 0.1 OUTLIER -119.11 135.38 54.68 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.449 1.477 . . . . 0.0 114.303 176.592 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.4 m -104.18 149.17 25.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 159.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.12 144.21 11.14 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 118.622 -2.548 . . . . 0.0 115.656 178.404 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.426 ' CE3' HG12 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -136.26 149.11 48.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 112.452 -1.874 . . . . 0.0 114.866 -173.994 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.17 165.53 17.33 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 123.249 1.499 . . . . 0.0 107.721 167.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 126' ' ' THR 0.277 0.0 OUTLIER -60.5 -27.32 67.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 178.277 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -2.17 11.38 Favored 'General case' 0 CA--C 1.595 2.682 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 171.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.21 45.39 7.05 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.448 -1.407 . . . . 0.0 113.594 -176.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -117.65 113.89 22.58 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -176.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -79.9 93.03 5.59 Favored 'General case' 0 CA--C 1.585 2.311 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.794 -178.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -71.24 -30.04 65.85 Favored 'General case' 0 CA--C 1.566 1.579 0 O-C-N 119.085 -2.259 . . . . 0.0 115.403 175.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -146.86 156.34 43.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.825 1.648 . . . . 0.0 113.717 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 t -157.9 87.87 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.105 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 75' ' ' LYS . 47.2 t -53.98 -42.31 68.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 174.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 70' ' ' LEU . 4.7 mp -64.3 -39.3 93.64 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 127.523 2.329 . . . . 0.0 113.481 178.179 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.22 -48.45 81.7 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.45 1.5 . . . . 0.0 113.824 173.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -78.59 -23.44 46.01 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 176.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.348 0.1 OUTLIER 115.27 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 128.572 2.749 . . . . 0.0 111.236 -179.275 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -134.43 149.57 50.77 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -175.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.406 ' HB3' ' CB ' ' A' ' 69' ' ' SER 0.289 19.4 tptm -166.53 -83.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.112 3.745 . . . . 0.0 121.112 173.805 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.587 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.401 0.4 OUTLIER -89.02 146.7 24.69 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 -161.839 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -165.48 129.0 2.23 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 120.701 -1.249 . . . . 0.0 107.957 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CG ' HG11 ' A' ' 85' ' ' VAL . 27.2 p90 -142.06 -165.04 1.92 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 122.36 1.076 . . . . 0.0 110.323 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.283 9.5 t0 -135.03 125.75 27.14 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 172.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.0 112.06 0.52 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.177 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.8 92.76 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -174.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.306 5.6 mmtt -138.38 -80.16 0.34 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -168.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.94 76.61 0.46 Allowed Glycine 0 N--CA 1.503 3.131 1 N-CA-C 99.686 -5.365 . . . . 0.0 99.686 170.522 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.383 32.7 tp10 -78.63 157.04 28.77 Favored 'General case' 0 CA--C 1.555 1.172 1 CA-C-O 130.104 4.764 . . . . 0.0 119.5 -159.513 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.335 33.6 m -107.73 -140.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 1 CA-C-N 101.964 -6.926 . . . . 0.0 107.183 -173.288 . . . . . . . . 4 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 89' ' ' TRP . 12.2 pt -101.08 154.52 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 122.98 1.371 . . . . 0.0 109.452 170.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.517 0.0 OUTLIER -69.94 -21.27 63.28 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 175.927 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.73 85.78 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 117.692 -1.146 . . . . 0.0 111.366 165.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.453 ' H ' HG13 ' A' ' 86' ' ' ILE . 44.5 m0 -73.91 -40.25 63.28 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-N 120.399 1.454 . . . . 0.0 113.073 173.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -57.62 -37.08 72.68 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 119.924 1.238 . . . . 0.0 113.833 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.27 1.5 mp -64.05 -56.83 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 119.431 1.014 . . . . 0.0 110.836 173.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.52 94.48 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 177.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.489 HG22 ' CE ' ' A' ' 96' ' ' MET . 79.3 t -63.27 -43.94 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 119.031 0.832 . . . . 0.0 112.519 174.129 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.07 66.91 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-N 119.695 1.134 . . . . 0.0 113.931 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.0 p -92.29 24.61 3.3 Favored 'General case' 0 CA--C 1.588 2.439 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.601 ' SD ' ' HB3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -122.95 140.07 53.4 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.622 2.01 . . . . 0.0 114.874 178.588 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -90.4 168.08 12.14 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.403 1.081 . . . . 0.0 111.483 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.437 HG21 ' H ' ' A' ' 43' ' ' THR . 78.3 t -59.0 135.83 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.546 0 O-C-N 119.46 -2.025 . . . . 0.0 112.46 -176.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.38 8.8 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-N 124.152 3.16 . . . . 0.0 117.107 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.49 102.74 1.18 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 118.476 1.138 . . . . 0.0 111.999 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -98.24 131.83 44.25 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.496 1.119 . . . . 0.0 109.062 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.513 ' SG ' HD13 ' A' ' 36' ' ' ILE . 86.0 m -136.8 -169.71 2.53 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.553 1.168 . . . . 0.0 113.422 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.309 3.8 mtt180 -135.91 113.52 10.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 124.942 2.306 . . . . 0.0 108.732 172.548 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -76.97 136.15 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.744 -177.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -117.76 101.7 8.53 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 174.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 5.2 p -115.12 149.33 37.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -171.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -104.96 129.06 25.49 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.675 177.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.53 -16.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.966 0 N-CA-C 122.042 3.824 . . . . 0.0 122.042 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.33 -41.09 92.81 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 121.785 2.084 . . . . 0.0 113.244 169.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -87.08 -0.09 56.1 Favored 'General case' 0 CA--C 1.582 2.189 0 C-N-CA 125.766 1.626 . . . . 0.0 113.656 170.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 -113.35 0.22 Allowed 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -175.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -92.46 13.39 19.77 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 120.672 1.578 . . . . 0.0 113.62 -178.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.84 148.48 31.61 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 122.141 2.246 . . . . 0.0 118.084 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.276 8.3 t 73.4 -42.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.299 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.49 -56.45 2.34 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.81 143.53 14.83 Favored Glycine 0 CA--C 1.546 1.992 0 CA-C-N 119.626 1.103 . . . . 0.0 112.028 -175.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.431 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.3 t -78.75 144.76 65.18 Favored Pre-proline 0 CA--C 1.584 2.254 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.62 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -33.06 134.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.071 0 C-N-CA 124.307 3.338 . . . . 0.0 120.603 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.333 0.1 OUTLIER 21.84 46.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.475 2 N-CA-C 125.107 5.003 . . . . 0.0 125.107 -175.563 . . . . . . . . 4 3 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -164.45 -55.94 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.056 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.431 ' HB ' ' H ' ' A' ' 117' ' ' SER . 56.9 mt -84.69 136.17 39.63 Favored Pre-proline 0 CA--C 1.592 2.574 0 CA-C-O 116.279 -1.819 . . . . 0.0 112.674 -174.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -99.48 173.9 0.4 Allowed 'Trans proline' 0 CA--C 1.592 3.408 0 CA-C-N 125.943 3.158 . . . . 0.0 115.184 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.42 -18.68 39.97 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 N-CA-C 121.209 3.503 . . . . 0.0 121.209 176.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -140.2 83.12 1.9 Allowed 'General case' 0 CA--C 1.588 2.431 0 CA-C-N 120.448 1.476 . . . . 0.0 111.822 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.85 -153.58 0.56 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 119.453 -2.029 . . . . 0.0 111.081 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.417 ' H ' HD12 ' A' ' 61' ' ' LEU 0.255 65.9 m -139.3 150.87 45.93 Favored 'General case' 0 CA--C 1.591 2.53 0 O-C-N 119.098 -2.251 . . . . 0.0 109.099 173.44 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 50.9 mt -127.21 162.63 25.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.232 -2.168 . . . . 0.0 112.895 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.426 HG12 ' CE3' ' A' ' 59' ' ' TRP . 79.5 t -146.45 115.46 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.672 -2.058 . . . . 0.0 107.225 -174.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 0.8 OUTLIER -128.91 123.19 31.95 Favored 'General case' 0 N--CA 1.517 2.911 0 CA-C-N 123.13 2.695 . . . . 0.0 111.014 174.25 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.4 tm-20 -92.07 90.9 7.57 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 123.654 1.692 . . . . 0.0 107.467 175.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 1.5 p -134.47 157.59 41.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -173.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 101' ' ' LEU 1.657 16.6 mt-10 -179.06 -174.13 0.32 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.328 168.707 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.554 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 16.2 tp -106.82 145.68 31.83 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 121.111 3.745 . . . . 0.0 121.111 -165.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -92.02 -54.32 3.89 Favored 'General case' 0 CA--C 1.58 2.125 0 CA-C-N 111.887 -2.415 . . . . 0.0 108.572 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -170.58 159.08 6.57 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 126.144 1.778 . . . . 0.0 108.308 171.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.291 0.0 OUTLIER -129.38 -103.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.411 -1.43 . . . . 0.0 110.223 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.447 63.7 tttt -105.76 -96.94 0.34 Allowed 'General case' 0 CA--C 1.581 2.146 0 CA-C-O 116.02 -1.943 . . . . 0.0 110.269 177.12 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.562 0 CA-C-N 125.167 3.622 . . . . 0.0 116.647 -178.798 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 1 N-CA-C 127.171 5.629 . . . . 0.0 127.171 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 33' ' ' LEU 0.275 8.2 p -156.68 -141.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.607 -174.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.605 ' H ' HG22 ' A' ' 32' ' ' VAL 1.157 8.1 mp 130.35 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 129.159 2.984 . . . . 0.0 111.895 171.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -154.83 130.33 9.83 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 122.629 2.468 . . . . 0.0 117.403 -162.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.67 119.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 123.414 0.686 . . . . 0.0 111.143 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.283 0.7 OUTLIER -87.19 135.93 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 122.201 1.0 . . . . 0.0 112.077 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -118.64 -60.65 1.75 Allowed 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.611 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -119.69 94.64 4.47 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.08 164.4 5.15 Favored 'General case' 0 CA--C 1.594 2.643 0 O-C-N 119.385 -2.072 . . . . 0.0 113.912 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.74 170.69 45.98 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 122.357 3.703 . . . . 0.0 122.357 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -99.24 -63.88 1.09 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.547 -1.826 . . . . 0.0 107.123 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.23 102.83 1.74 Allowed Glycine 0 CA--C 1.549 2.175 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 p -51.54 -22.57 3.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.29 153.62 34.24 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 p -115.79 163.52 20.72 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 111.635 -2.529 . . . . 0.0 112.303 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.68 146.16 29.98 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 CA-C-N 123.385 2.245 . . . . 0.0 114.351 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -90.32 164.36 14.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.122 -1.611 . . . . 0.0 110.854 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.3 OUTLIER -61.4 130.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 119.297 -2.127 . . . . 0.0 111.691 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.0 15.22 79.86 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.419 2.128 . . . . 0.0 118.419 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.88 154.02 19.15 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.421 2.11 . . . . 0.0 110.998 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -84.58 124.58 31.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.753 . . . . 0.0 110.208 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.23 132.06 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.008 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.26 93.5 4.72 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 125.168 2.413 . . . . 0.0 104.88 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.04 169.37 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 110.558 -3.019 . . . . 0.0 109.12 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.449 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.335 2.9 t60 -148.49 137.45 21.68 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 159.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -122.71 152.62 40.39 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.107 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.9 m -117.51 150.79 38.37 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 159.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.6 144.97 12.1 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 118.424 -2.672 . . . . 0.0 115.655 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.433 ' HE3' HG12 ' A' ' 128' ' ' VAL . 1.9 m-90 -130.14 153.23 48.73 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 112.648 -1.776 . . . . 0.0 113.746 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.48 168.91 16.04 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 122.975 1.369 . . . . 0.0 107.388 166.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.8 -27.84 66.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -72.42 1.15 8.46 Favored 'General case' 0 CA--C 1.594 2.635 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.5 43.2 12.75 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 120.202 -1.561 . . . . 0.0 113.308 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -114.88 116.24 28.23 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -75.9 87.42 2.87 Favored 'General case' 0 CA--C 1.586 2.338 0 O-C-N 121.966 -0.459 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.91 -28.16 62.31 Favored 'General case' 0 CA--C 1.558 1.26 0 O-C-N 119.46 -2.025 . . . . 0.0 115.432 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -156.07 148.41 23.57 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 t -160.06 113.58 2.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.269 81.1 p -63.13 -38.58 91.75 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.275 65.7 mt -53.2 -42.34 66.17 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 122.318 2.326 . . . . 0.0 115.76 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -49.92 -36.73 28.67 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 -85.79 42.51 0.97 Allowed 'General case' 0 CA--C 1.585 2.313 0 C-N-CA 124.745 1.218 . . . . 0.0 114.251 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.324 34.3 ttmt 83.26 -36.72 0.08 Allowed 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.2 -175.07 4.55 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-O 124.034 1.873 . . . . 0.0 115.469 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.89 178.09 4.48 Favored 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 125.254 1.422 . . . . 0.0 113.033 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.99 164.73 11.87 Favored 'General case' 0 CA--C 1.583 2.246 0 O-C-N 120.431 -1.418 . . . . 0.0 108.9 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.5 p -167.44 133.71 2.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 118.939 -2.35 . . . . 0.0 111.111 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CG ' HG11 ' A' ' 85' ' ' VAL . 23.5 p90 -146.27 -176.3 5.11 Favored 'General case' 0 CA--C 1.573 1.827 0 CA-C-O 122.177 0.989 . . . . 0.0 112.214 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -119.26 114.31 22.19 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -40.89 113.85 0.42 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.4 95.17 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -111.5 21.17 16.46 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.27 -42.12 2.74 Favored Glycine 0 N--CA 1.51 3.586 0 O-C-N 121.147 -0.971 . . . . 0.0 112.484 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -32.81 -37.35 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 120.494 3.516 . . . . 0.0 120.494 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.254 20.6 m -123.95 -142.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 123.116 1.436 . . . . 0.0 109.662 -173.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 89' ' ' TRP . 13.7 pt -113.86 157.14 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 124.298 1.999 . . . . 0.0 108.284 170.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -64.85 -34.09 77.54 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 113.838 -1.528 . . . . 0.0 113.346 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.07 67.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.199 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.488 ' H ' HG13 ' A' ' 86' ' ' ILE . 33.0 m0 -73.17 -43.44 61.45 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 120.226 1.376 . . . . 0.0 112.214 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.83 -38.58 70.23 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 121.237 1.835 . . . . 0.0 114.928 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.319 2.2 mp -69.97 -62.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 CA-C-N 119.741 1.155 . . . . 0.0 111.44 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -66.72 -30.59 70.86 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.284 12.6 t -77.74 -34.45 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 120.036 1.289 . . . . 0.0 110.644 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.39 -38.43 66.16 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 121.224 1.829 . . . . 0.0 112.701 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.8 p -80.88 8.41 8.34 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.504 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 9.3 tpt -100.25 127.76 46.46 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 122.071 2.214 . . . . 0.0 114.814 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -82.08 166.53 19.65 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.41 128.22 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.914 0 O-C-N 120.395 -1.44 . . . . 0.0 109.938 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.49 -0.46 64.43 Favored Glycine 1 N--CA 1.517 4.054 0 CA-C-N 123.201 2.728 . . . . 0.0 117.751 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -73.48 154.5 39.89 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.55 123.39 26.43 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.335 1.054 . . . . 0.0 112.246 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 8.7 p -151.64 174.65 13.22 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -124.86 119.85 30.01 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 124.201 1.953 . . . . 0.0 111.566 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.2 mt -74.24 138.65 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-N 112.495 -2.138 . . . . 0.0 110.76 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -123.12 110.48 15.36 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 102.629 -3.101 . . . . 0.0 102.629 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 2.9 p -115.85 146.38 42.05 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -106.94 135.75 19.53 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.672 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -43.13 -24.59 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.853 1 N-CA-C 122.77 4.104 . . . . 0.0 122.77 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.39 -39.12 92.18 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 121.588 1.995 . . . . 0.0 114.293 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.44 -3.73 58.77 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 125.58 1.552 . . . . 0.0 112.79 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.27 -117.96 0.2 Allowed 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.433 ' CE2' HD21 ' A' ' 127' ' ' LEU 0.287 6.6 m-85 -92.45 16.72 11.24 Favored 'General case' 0 N--CA 1.513 2.692 0 CA-C-N 121.005 1.73 . . . . 0.0 114.334 -178.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.65 -63.23 4.61 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 123.008 2.64 . . . . 0.0 117.373 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -79.46 42.62 0.52 Allowed 'General case' 0 CA--C 1.584 2.264 0 CA-C-N 118.92 1.36 . . . . 0.0 114.236 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -171.77 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.99 136.88 6.45 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.22 0.914 . . . . 0.0 110.89 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.448 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.7 t -78.45 118.91 75.12 Favored Pre-proline 0 CA--C 1.581 2.157 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.241 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.272 42.4 Cg_exo -27.37 -51.15 0.11 Allowed 'Trans proline' 0 CA--C 1.579 2.761 1 N-CA-C 124.682 4.839 . . . . 0.0 124.682 -175.684 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.57 -30.14 12.44 Favored 'Trans proline' 0 CA--C 1.572 2.42 0 CA-C-N 125.607 3.038 . . . . 0.0 119.548 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -163.93 -8.95 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 117' ' ' SER . 19.6 mt -79.93 123.7 83.54 Favored Pre-proline 0 CA--C 1.583 2.248 0 O-C-N 119.631 -1.918 . . . . 0.0 113.299 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.76 171.09 7.23 Favored 'Trans proline' 0 CA--C 1.585 3.067 0 C-N-CA 122.547 2.165 . . . . 0.0 113.441 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.65 12.87 0.23 Allowed 'Trans proline' 0 CA--C 1.58 2.804 0 N-CA-C 120.536 3.245 . . . . 0.0 120.536 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -153.95 67.7 0.75 Allowed 'General case' 0 CA--C 1.582 2.211 0 O-C-N 119.974 -1.704 . . . . 0.0 111.644 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.16 133.89 33.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 119.797 -1.815 . . . . 0.0 110.529 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.291 23.3 m -66.05 152.05 45.51 Favored 'General case' 0 CA--C 1.594 2.639 0 O-C-N 120.703 -1.248 . . . . 0.0 112.447 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.602 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 11.8 tp -132.44 158.27 42.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 119.541 -1.974 . . . . 0.0 111.892 -170.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.433 HG12 ' HE3' ' A' ' 59' ' ' TRP . 53.9 t -143.69 124.59 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.862 -169.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.303 15.3 m-85 -136.46 124.44 22.8 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 122.286 2.312 . . . . 0.0 112.16 173.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -93.49 113.14 25.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.481 -2.012 . . . . 0.0 107.999 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.7 t -112.34 136.25 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.886 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -119.51 114.97 23.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.28 119.95 38.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.578 1.18 . . . . 0.0 109.498 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -79.73 -56.92 3.93 Favored 'General case' 0 CA--C 1.582 2.184 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.307 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -169.89 161.65 9.04 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 126.031 1.733 . . . . 0.0 109.72 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.434 ' HD1' ' H ' ' A' ' 137' ' ' LYS . 1.4 p90 -138.05 -84.89 0.29 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.784 -1.822 . . . . 0.0 110.862 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.434 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 40.0 ttpt -79.83 74.36 6.56 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 125.511 2.577 . . . . 0.0 108.308 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.567 3.299 0 CA-C-N 110.909 -2.86 . . . . 0.0 111.855 -173.778 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 1 N-CA-C 123.815 4.286 . . . . 0.0 123.815 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.324 38.2 t -139.51 133.2 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 1 CA-C-N 124.419 4.109 . . . . 0.0 116.517 -174.038 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.33 134.12 54.05 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 125.912 1.685 . . . . 0.0 109.253 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -129.24 133.09 47.36 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 124.12 3.145 . . . . 0.0 111.453 176.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 77.9 t -105.1 153.18 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.71 142.38 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.915 0 CA-C-O 122.771 1.272 . . . . 0.0 108.97 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 102' ' ' CYS . 55.6 tptt -114.32 -57.89 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.692 172.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -122.29 112.24 17.89 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.51 -62.9 1.45 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.455 -1.403 . . . . 0.0 114.241 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.1 -155.83 26.43 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 119.364 2.505 . . . . 0.0 119.364 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -91.12 -54.57 3.89 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 114.337 -0.931 . . . . 0.0 113.319 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -39.0 62.15 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.261 73.0 p 74.62 3.25 4.23 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -106.92 167.24 10.02 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 120.772 -1.205 . . . . 0.0 113.001 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.2 p -132.94 108.33 12.75 Favored Pre-proline 0 CA--C 1.577 1.982 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.59 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.353 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.6 ptm -170.83 175.47 4.48 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 120.868 1.667 . . . . 0.0 114.344 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -55.8 132.8 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 CA-C-O 122.334 1.064 . . . . 0.0 111.44 176.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.33 0.3 70.58 Favored Glycine 0 CA--C 1.563 3.079 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.08 137.88 49.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 121.437 2.618 . . . . 0.0 113.585 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -86.65 104.8 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 136' ' ' PHE . 1.5 m -105.39 131.08 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.074 0.95 . . . . 0.0 110.667 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.255 29.1 p90 -105.23 115.54 30.43 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 105.653 -1.981 . . . . 0.0 105.653 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.28 170.08 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 CA-C-O 125.04 2.352 . . . . 0.0 114.103 -170.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 70' ' ' LEU . 2.3 t60 -124.43 119.32 28.84 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 111.58 -2.555 . . . . 0.0 106.358 168.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.333 3.3 p90 -114.72 150.85 34.65 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 123.977 1.846 . . . . 0.0 113.626 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -127.63 151.71 48.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.53 138.38 6.03 Favored Glycine 0 CA--C 1.546 2.001 0 O-C-N 118.742 -2.474 . . . . 0.0 115.944 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.19 150.71 49.4 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 127.323 2.249 . . . . 0.0 112.25 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.5 tp -84.22 -172.75 4.34 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-O 123.984 1.849 . . . . 0.0 109.641 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -58.35 -37.39 75.09 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.19 21.61 0.89 Allowed 'General case' 0 CA--C 1.597 2.756 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.97 33.48 50.61 Favored Glycine 1 N--CA 1.517 4.054 0 O-C-N 120.179 -1.576 . . . . 0.0 115.798 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.7 m -86.72 109.24 19.08 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -69.04 92.36 0.52 Allowed 'General case' 0 CA--C 1.588 2.437 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -73.08 -36.08 66.75 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 119.296 -2.127 . . . . 0.0 114.598 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.65 174.95 12.57 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 123.834 1.778 . . . . 0.0 114.442 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 t -152.42 -147.15 0.22 Allowed 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 51.6 p -148.73 -66.56 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.056 -1.653 . . . . 0.0 108.701 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 55' ' ' HIS 0.317 22.3 mt -61.38 -42.35 98.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -49.99 -42.34 48.84 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.339 32.5 ptt180 -75.57 -75.38 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.545 1.138 . . . . 0.0 113.535 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -163.62 -36.7 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.925 1.29 . . . . 0.0 112.172 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -89.28 -157.15 0.43 Allowed 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -145.62 170.71 15.91 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 125.943 1.697 . . . . 0.0 108.498 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.285 3.7 t80 -114.05 154.68 27.28 Favored 'General case' 0 CA--C 1.573 1.856 0 CA-C-O 123.772 1.749 . . . . 0.0 109.125 173.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.2 p -170.9 124.08 0.63 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.802 -1.186 . . . . 0.0 108.171 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.2 p90 -143.22 164.44 30.18 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 121.813 -0.555 . . . . 0.0 111.913 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.97 128.2 49.89 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 119.168 -2.208 . . . . 0.0 106.125 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.57 110.94 1.08 Allowed 'General case' 0 CA--C 1.57 1.733 0 O-C-N 121.27 -0.894 . . . . 0.0 112.77 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 54.76 30.65 Favored Glycine 0 N--CA 1.509 3.542 0 O-C-N 120.65 -1.281 . . . . 0.0 114.606 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.637 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -99.15 -71.95 0.68 Allowed 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 124.366 2.031 . . . . 0.0 112.182 -174.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.637 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -111.23 -49.98 0.64 Allowed Glycine 0 CA--C 1.561 2.914 0 N-CA-C 104.024 -3.63 . . . . 0.0 104.024 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.778 23.8 tt0 118.89 137.78 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 127.909 3.719 . . . . 0.0 114.634 164.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.478 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.348 11.9 m -79.97 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 1 CA-C-N 105.773 -5.194 . . . . 0.0 104.454 178.25 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.554 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -132.79 157.39 43.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 124.017 1.865 . . . . 0.0 106.8 166.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -65.01 -33.11 75.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.519 -1.219 . . . . 0.0 113.123 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.26 80.49 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 117.25 -1.357 . . . . 0.0 111.938 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.554 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.0 m0 -73.94 -43.31 58.71 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.685 1.584 . . . . 0.0 112.215 172.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.41 -34.58 72.64 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 121.548 1.976 . . . . 0.0 114.267 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.303 1.5 mp -69.99 -63.25 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.004 0 CA-C-N 120.317 1.417 . . . . 0.0 111.294 174.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.16 -33.14 75.1 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.345 3.5 t -78.35 -25.92 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 CA-C-N 119.764 1.166 . . . . 0.0 111.584 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.23 90.05 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-N 121.238 1.835 . . . . 0.0 111.856 165.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.6 p -82.58 17.57 1.75 Allowed 'General case' 0 CA--C 1.596 2.718 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.536 ' SD ' HD22 ' A' ' 101' ' ' LEU . 2.2 ttt -104.68 143.31 33.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 119.26 -2.15 . . . . 0.0 116.068 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -104.13 152.95 21.5 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 119.039 2.977 . . . . 0.0 119.039 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.88 124.92 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.408 0 CA-C-O 118.478 -0.773 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.9 -55.4 0.53 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 120.683 1.583 . . . . 0.0 112.809 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.305 5.5 tt0 -158.41 -163.59 1.31 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 102' ' ' CYS 0.782 0.5 OUTLIER -162.66 -139.92 0.05 OUTLIER 'General case' 0 CA--C 1.594 2.667 0 C-N-CA 125.091 1.357 . . . . 0.0 111.622 178.414 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.614 ' H ' HD23 ' A' ' 101' ' ' LEU 0.72 51.3 t -160.03 -115.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 127.162 2.185 . . . . 0.0 107.916 175.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 54.8 ptt85 -135.32 135.15 40.55 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -173.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -89.84 132.07 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 CA-C-N 112.66 -2.063 . . . . 0.0 108.241 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.2 m -121.0 105.99 11.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 15.6 p -124.08 149.6 45.97 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -170.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -81.45 135.98 49.51 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.521 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.265 50.5 Cg_exo -57.7 -17.2 28.0 Favored 'Trans proline' 0 CA--C 1.559 1.756 0 N-CA-C 118.882 2.608 . . . . 0.0 118.882 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.62 -33.94 76.02 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 121.692 2.042 . . . . 0.0 113.907 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.57 -2.87 51.62 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 125.734 1.614 . . . . 0.0 113.462 169.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.51 -113.97 0.22 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 121.499 1.954 . . . . 0.0 113.013 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 127' ' ' LEU 0.308 2.7 m-85 -79.04 -37.55 38.74 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 121.188 1.813 . . . . 0.0 113.12 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.22 -116.15 3.29 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 121.222 3.249 . . . . 0.0 121.222 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -77.85 -31.99 51.83 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.36 -33.76 63.18 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.12 155.99 9.75 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 t -98.9 111.09 59.82 Favored Pre-proline 0 CA--C 1.58 2.117 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.285 47.6 Cg_exo -31.26 -52.0 0.27 Allowed 'Trans proline' 0 CA--C 1.581 2.843 1 N-CA-C 124.19 4.65 . . . . 0.0 124.19 -175.36 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.71 -18.54 32.46 Favored 'Trans proline' 0 CA--C 1.577 2.629 0 N-CA-C 120.494 3.229 . . . . 0.0 120.494 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -160.2 -18.81 0.06 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . 0.289 10.7 mt -79.93 -59.01 0.58 Allowed Pre-proline 0 CA--C 1.605 3.088 1 N-CA-C 124.437 4.977 . . . . 0.0 124.437 -172.262 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . 0.89 0.1 OUTLIER 34.09 -115.29 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.486 2 C-N-CA 126.843 5.029 . . . . 0.0 123.57 -172.325 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.12 99.66 1.32 Allowed 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 125.886 3.138 . . . . 0.0 118.601 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 t30 52.46 70.69 0.54 Allowed 'General case' 0 CA--C 1.593 2.629 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.55 114.52 28.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.618 -1.926 . . . . 0.0 108.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.4 m -54.0 151.52 6.71 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 72.5 mt -126.77 164.53 21.14 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 124.566 2.127 . . . . 0.0 113.791 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -144.31 113.55 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.601 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 5.7 m-85 -127.07 125.57 41.54 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 122.227 2.285 . . . . 0.0 110.839 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -93.68 96.03 9.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.362 -1.461 . . . . 0.0 108.296 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.3 138.98 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -132.18 118.44 19.56 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 96' ' ' MET . 6.9 tt -90.83 114.08 26.4 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.814 -1.179 . . . . 0.0 113.877 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.31 9.8 m-30 -76.59 -51.42 11.65 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.571 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -163.74 146.85 9.9 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 121.702 2.046 . . . . 0.0 108.353 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.526 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.267 0.1 OUTLIER -100.88 -80.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 170.188 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.526 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 14.1 mmtm -80.0 -37.03 35.07 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 177.333 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 1 N-CA-C 123.676 4.231 . . . . 0.0 123.676 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 106' ' ' CYS . 10.8 p -174.93 -173.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.194 0 CA-C-O 123.687 1.708 . . . . 0.0 110.681 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.91 2.2 mm? 178.94 165.9 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.71 2.004 . . . . 0.0 113.674 160.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 125.83 53.7 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 11.2 p -114.37 109.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 O-C-N 121.43 -0.793 . . . . 0.0 112.653 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.389 8.2 mm -48.31 133.87 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 N-CA-C 119.712 3.227 . . . . 0.0 119.712 -175.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -115.73 -59.8 1.95 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.201 -1.818 . . . . 0.0 108.867 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -143.49 103.74 4.14 Favored 'General case' 0 CA--C 1.585 2.322 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -53.26 -61.35 2.36 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 119.878 3.288 . . . . 0.0 119.878 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.74 177.42 16.23 Favored Glycine 0 CA--C 1.55 2.281 0 C-N-CA 125.22 1.391 . . . . 0.0 114.635 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 t -162.07 -12.62 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.01 -68.92 1.44 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 122.279 3.672 . . . . 0.0 122.279 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -158.83 66.83 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.768 0.794 . . . . 0.0 112.388 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.391 10.4 mt-10 60.42 -160.33 0.3 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 120.327 3.455 . . . . 0.0 120.327 174.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -97.04 170.86 6.7 Favored Pre-proline 0 CA--C 1.585 2.324 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -99.46 -166.15 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.512 0 CA-C-N 123.073 2.133 . . . . 0.0 117.149 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -130.15 169.71 14.99 Favored 'General case' 0 CA--C 1.573 1.837 0 O-C-N 121.282 -0.887 . . . . 0.0 112.999 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.95 139.18 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.166 0 O-C-N 119.211 -2.181 . . . . 0.0 109.352 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 7.01 86.89 Favored Glycine 0 CA--C 1.567 3.293 0 CA-C-O 117.497 -1.724 . . . . 0.0 117.335 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.43 146.85 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 121.531 2.665 . . . . 0.0 113.501 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -85.68 119.96 26.59 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.37 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 123.192 0.597 . . . . 0.0 111.332 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -114.5 111.99 22.27 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 76' ' ' PHE . 22.9 m -116.16 162.3 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 124.087 1.899 . . . . 0.0 114.669 -173.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.445 ' ND1' HD23 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -114.9 108.03 16.19 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.543 168.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 2.2 p90 -110.51 147.62 33.75 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 123.31 1.528 . . . . 0.0 114.747 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.8 m -131.19 144.5 51.4 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 165.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.88 144.85 12.68 Favored Glycine 0 CA--C 1.551 2.295 0 O-C-N 119.769 -1.832 . . . . 0.0 116.528 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.467 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -132.31 149.8 52.29 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.007 1.723 . . . . 0.0 114.398 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.97 169.55 18.13 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.369 1.081 . . . . 0.0 108.521 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.346 0.0 OUTLIER -61.59 -25.45 67.34 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.81 3.46 11.84 Favored 'General case' 0 CA--C 1.594 2.651 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.54 11.59 Favored Glycine 0 N--CA 1.507 3.387 0 CA-C-N 121.101 1.773 . . . . 0.0 114.343 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.9 m -115.52 115.53 26.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -78.2 96.74 5.29 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -70.09 -32.03 69.89 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.682 -1.886 . . . . 0.0 113.87 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.22 159.92 40.46 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 124.189 1.947 . . . . 0.0 115.669 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.7 t -158.82 98.75 1.51 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.6 p -54.36 -49.85 68.85 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.445 HD23 ' ND1' ' A' ' 55' ' ' HIS 0.428 0.2 OUTLIER -66.49 -44.17 83.35 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -177.839 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.38 -40.2 61.78 Favored 'General case' 0 CA--C 1.583 2.215 0 C-N-CA 124.423 1.089 . . . . 0.0 113.852 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.1 mtp85 -68.86 -14.81 63.26 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.384 0.6 OUTLIER 118.52 -41.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 129.005 2.922 . . . . 0.0 114.11 177.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.92 155.53 20.88 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -88.6 135.33 33.55 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 117.258 -1.353 . . . . 0.0 109.276 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HB3' HG23 ' A' ' 54' ' ' VAL . 6.9 t80 -83.11 151.23 25.84 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 122.872 2.578 . . . . 0.0 108.922 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.0 t -168.03 145.92 4.36 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 123.9 1.81 . . . . 0.0 108.429 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.5 p90 -152.46 179.28 8.71 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.007 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -116.26 121.99 43.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.72 109.59 0.24 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.83 37.77 60.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.383 13.9 tppt? -91.03 -8.85 47.92 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-N 120.993 2.397 . . . . 0.0 117.211 -174.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.29 65.75 1.41 Allowed Glycine 0 N--CA 1.504 3.183 0 N-CA-C 103.969 -3.652 . . . . 0.0 103.969 -169.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -156.91 -57.35 0.09 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.958 -1.121 . . . . 0.0 113.208 -164.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.524 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.281 13.9 m -98.99 -139.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 122.998 1.38 . . . . 0.0 109.462 -175.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 89' ' ' TRP . 15.9 pt -120.67 163.69 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 123.66 1.695 . . . . 0.0 110.317 173.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.263 2.2 mptt -67.8 -34.68 77.23 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.426 -1.261 . . . . 0.0 113.237 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.12 -32.42 69.82 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 117.313 -1.327 . . . . 0.0 112.607 167.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.4 ' H ' HG13 ' A' ' 86' ' ' ILE . 29.5 m0 -76.89 -42.66 38.89 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 120.955 1.707 . . . . 0.0 112.613 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -59.7 -37.1 77.92 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 120.313 1.415 . . . . 0.0 114.586 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.282 1.4 mp -66.76 -58.35 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-N 119.749 1.159 . . . . 0.0 110.801 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.36 87.94 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.413 HG22 ' SD ' ' A' ' 96' ' ' MET 0.289 92.9 t -67.22 -37.7 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.349 0.977 . . . . 0.0 112.221 172.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.75 -39.05 61.82 Favored 'General case' 0 CA--C 1.588 2.416 0 CA-C-N 121.302 1.864 . . . . 0.0 112.444 168.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.7 p -94.96 42.28 1.09 Allowed 'General case' 0 CA--C 1.597 2.769 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 133' ' ' LEU . 12.4 ttm -112.12 142.59 44.39 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 119.102 -2.249 . . . . 0.0 115.248 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -109.48 139.49 44.41 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 120.13 1.332 . . . . 0.0 113.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.7 131.55 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.399 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.393 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.46 -56.02 0.5 Allowed Glycine 0 N--CA 1.492 2.408 0 CA-C-O 117.107 -1.941 . . . . 0.0 111.329 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -150.45 -162.12 1.49 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-N 118.946 1.373 . . . . 0.0 113.737 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.469 HD13 ' HG3' ' A' ' 96' ' ' MET 0.799 0.6 OUTLIER -154.4 -126.94 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 CA-C-O 124.855 2.264 . . . . 0.0 114.026 176.159 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.5 OUTLIER -158.52 -147.78 0.18 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 124.357 2.027 . . . . 0.0 110.936 -164.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.502 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -131.76 138.56 48.64 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 124.644 2.164 . . . . 0.0 109.353 170.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.65 134.82 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 112.612 -2.085 . . . . 0.0 108.764 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.9 m -121.27 109.46 14.96 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.535 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 4.7 p -127.03 144.27 51.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -86.07 146.02 41.99 Favored Pre-proline 0 CA--C 1.574 1.902 0 CA-C-N 112.773 -2.012 . . . . 0.0 110.996 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -46.93 -26.21 4.61 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 N-CA-C 119.713 2.928 . . . . 0.0 119.713 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.57 -43.51 89.45 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.774 1.624 . . . . 0.0 114.437 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.86 -1.53 56.62 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.84 -118.35 0.23 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 120.719 1.599 . . . . 0.0 113.931 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.475 16.7 m-85 -83.8 -13.09 54.63 Favored 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 121.86 2.118 . . . . 0.0 115.595 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.82 -153.86 49.64 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.213 3.245 . . . . 0.0 121.213 171.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.8 t -85.26 62.38 7.46 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.995 1.379 . . . . 0.0 110.85 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.19 -54.69 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 126.301 1.84 . . . . 0.0 111.638 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.01 163.88 24.87 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 122.447 1.026 . . . . 0.0 113.796 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.518 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 19.7 t -72.98 143.57 84.22 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 116.827 -1.558 . . . . 0.0 110.862 176.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -49.68 126.82 17.19 Favored 'Trans proline' 0 CA--C 1.581 2.865 0 C-N-CA 122.923 2.415 . . . . 0.0 113.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.322 0.2 OUTLIER 28.58 47.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.575 2.536 0 N-CA-C 121.946 3.787 . . . . 0.0 121.946 -172.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -154.79 -47.66 0.09 Allowed 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' HB ' ' H ' ' A' ' 117' ' ' SER . 18.1 mt -104.51 150.14 38.18 Favored Pre-proline 0 N--CA 1.512 2.636 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.002 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.66 173.3 8.12 Favored 'Trans proline' 0 CA--C 1.588 3.189 0 CA-C-N 126.412 3.326 . . . . 0.0 116.015 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.18 -21.48 22.49 Favored 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 121.751 3.712 . . . . 0.0 121.751 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -158.71 92.8 1.14 Allowed 'General case' 0 CA--C 1.584 2.283 0 CA-C-N 120.852 1.66 . . . . 0.0 107.651 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.59 133.43 22.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 122.985 2.629 . . . . 0.0 112.916 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 84.7 m -66.56 150.61 48.73 Favored 'General case' 0 CA--C 1.586 2.328 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.535 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.25 0.3 OUTLIER -145.11 175.84 9.95 Favored 'General case' 0 CA--C 1.573 1.843 0 O-C-N 119.643 -1.91 . . . . 0.0 111.196 -177.703 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.467 HG23 ' HE3' ' A' ' 59' ' ' TRP . 1.9 m -145.42 146.52 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 125.805 1.642 . . . . 0.0 109.729 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.251 1.7 m-85 -135.96 125.28 24.8 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.481 -0.762 . . . . 0.0 109.745 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 55.6 mt-10 -83.42 114.0 21.15 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.37 136.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -132.41 120.67 22.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.542 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.7 OUTLIER -86.34 123.84 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.367 -1.458 . . . . 0.0 114.616 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.25 -49.48 49.5 Favored 'General case' 0 CA--C 1.587 2.383 0 O-C-N 121.701 -0.624 . . . . 0.0 112.526 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -171.29 155.73 4.38 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.74 1.616 . . . . 0.0 110.385 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.511 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.286 0.2 OUTLIER -126.6 -106.26 0.32 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.567 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.511 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 85.9 tttt -83.46 72.47 10.25 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.508 1.123 . . . . 0.0 110.904 173.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 178.45 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.11 133.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 118.291 1.045 . . . . 0.0 113.691 -173.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -109.96 141.95 42.01 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 127.119 2.168 . . . . 0.0 107.893 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB3' HG13 ' A' ' 35' ' ' VAL . 3.1 mtmp? -159.58 170.75 20.96 Favored 'General case' 0 N--CA 1.51 2.547 2 CA-C-N 126.276 4.125 . . . . 0.0 122.123 -170.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.615 ' O ' ' SG ' ' A' ' 102' ' ' CYS 1.237 3.7 m 106.0 -173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.672 1 N-CA-C 127.785 6.217 . . . . 0.0 127.785 158.351 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.701 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.643 34.3 mm -16.41 128.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.342 2 N-CA-C 131.351 7.538 . . . . 0.0 131.351 -153.931 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -142.63 -49.17 0.35 Allowed 'General case' 0 CA--C 1.584 2.257 0 C-N-CA 127.33 2.252 . . . . 0.0 109.537 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -114.77 101.93 9.52 Favored 'General case' 0 CA--C 1.578 2.033 0 C-N-CA 124.922 1.289 . . . . 0.0 108.693 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.28 174.84 0.63 Allowed 'General case' 0 CA--C 1.597 2.762 0 O-C-N 119.469 -2.019 . . . . 0.0 115.579 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.43 8.26 Favored Glycine 0 N--CA 1.486 2.017 0 O-C-N 119.856 -1.777 . . . . 0.0 116.461 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.5 p -107.37 -76.66 0.61 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.6 70.51 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.267 10.2 t -157.6 61.56 0.48 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.362 1.077 . . . . 0.0 113.179 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.264 30.3 mt-10 59.75 168.69 0.07 Allowed 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 120.855 3.65 . . . . 0.0 120.855 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 p -90.07 165.4 24.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.275 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.43 159.61 17.14 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 CA-C-N 121.919 1.721 . . . . 0.0 114.732 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -98.33 165.54 11.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.345 0.3 OUTLIER -63.73 130.24 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 119.219 -2.176 . . . . 0.0 110.574 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.17 17.61 79.88 Favored Glycine 0 CA--C 1.569 3.431 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.02 147.29 43.06 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.575 1.688 . . . . 0.0 112.256 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -81.83 114.64 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.46 146.14 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.661 0.784 . . . . 0.0 111.307 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.25 46.3 p90 -129.85 98.68 4.86 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 124.86 2.267 . . . . 0.0 111.712 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.1 m -90.81 170.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 111.562 -2.563 . . . . 0.0 112.259 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.446 ' CE1' ' HG ' ' A' ' 70' ' ' LEU . 5.1 t60 -134.55 135.82 42.58 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 164.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 6.7 p90 -128.8 142.3 51.03 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.1 m -110.96 144.91 39.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 159.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.34 140.44 7.99 Favored Glycine 0 CA--C 1.548 2.112 0 O-C-N 118.92 -2.363 . . . . 0.0 116.776 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 155.97 47.25 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.675 2.39 . . . . 0.0 112.569 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.49 -174.5 4.84 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 120.475 -1.391 . . . . 0.0 111.044 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 1.9 pt? -64.83 -26.12 68.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.68 1.98 13.18 Favored 'General case' 0 CA--C 1.601 2.93 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.417 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.22 31.82 81.86 Favored Glycine 0 N--CA 1.501 2.996 0 O-C-N 120.477 -1.389 . . . . 0.0 114.821 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -90.25 114.6 26.66 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.4 95.02 1.0 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -70.45 -31.3 68.4 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 119.519 -1.988 . . . . 0.0 114.212 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -154.23 161.18 41.99 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.839 2.257 . . . . 0.0 114.179 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.0 p -151.05 96.92 2.39 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -28.09 27.93 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 120.723 3.601 . . . . 0.0 120.723 -172.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.263 36.5 mt -70.48 -51.72 27.05 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.947 1.703 . . . . 0.0 112.062 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.18 -30.24 70.29 Favored 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -54.01 -19.92 5.52 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.35 39.0 ttmt 127.36 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 129.387 3.075 . . . . 0.0 111.952 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.3 2.7 p-10 -104.61 -142.8 0.37 Allowed 'General case' 0 CA--C 1.575 1.934 0 CA-C-O 123.076 1.417 . . . . 0.0 111.953 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -124.78 -136.5 0.28 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.528 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.404 3.1 t80 -140.25 142.58 35.76 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 118.337 -2.727 . . . . 0.0 109.095 167.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.4 p -155.4 148.75 24.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 118.479 -2.638 . . . . 0.0 109.05 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.508 ' CG ' HG11 ' A' ' 85' ' ' VAL . 30.3 p90 -157.37 -173.19 4.3 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.223 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -122.21 113.53 19.59 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -39.63 113.57 0.35 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.76 47.44 88.65 Favored Glycine 0 N--CA 1.503 3.149 0 N-CA-C 118.208 2.043 . . . . 0.0 118.208 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -109.39 6.65 24.51 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.78 58.32 2.15 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -149.97 -49.27 0.13 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.295 10.3 m -117.85 -138.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-O 123.04 1.4 . . . . 0.0 108.374 -175.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 89' ' ' TRP . 26.7 pt -122.48 163.25 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 123.767 1.746 . . . . 0.0 110.173 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.59 71.54 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.479 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.37 75.04 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.558 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.505 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.4 m0 -75.4 -41.43 56.18 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 120.725 1.602 . . . . 0.0 112.833 172.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.61 -37.99 80.07 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 119.744 1.157 . . . . 0.0 113.863 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.257 1.2 mp -64.61 -54.68 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.709 1.595 . . . . 0.0 111.208 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.71 72.1 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.2 t -60.91 -46.62 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.07 0.85 . . . . 0.0 112.327 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.8 -34.89 55.67 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 p -87.56 6.73 32.92 Favored 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.533 ' SD ' ' HG ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.35 138.05 52.68 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 123.524 2.874 . . . . 0.0 116.806 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -80.93 149.19 29.5 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 113.51 -3.138 . . . . 0.0 111.05 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.279 1.8 t -9.61 87.91 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 123.144 2.702 . . . . 0.0 110.513 -166.003 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 133' ' ' LEU . . . -3.19 -37.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 1 N-CA-C 129.839 6.696 . . . . 0.0 129.839 -140.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 61.24 -127.69 0.85 Allowed 'General case' 0 CA--C 1.605 3.075 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.739 HD13 ' H ' ' A' ' 102' ' ' CYS 1.672 0.6 OUTLIER 124.57 154.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 161.383 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.739 ' H ' HD13 ' A' ' 101' ' ' LEU . 18.8 t -160.19 -104.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.239 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -122.29 158.36 29.7 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 124.875 2.274 . . . . 0.0 116.036 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mt -131.82 114.61 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.007 0 CA-C-N 111.524 -2.58 . . . . 0.0 105.559 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -107.15 99.19 8.76 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 7.8 p -112.39 146.82 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -90.57 141.02 26.81 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.921 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.26 -22.41 8.33 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 N-CA-C 119.882 2.993 . . . . 0.0 119.882 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.99 -42.04 98.7 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.086 1.766 . . . . 0.0 114.434 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.56 0.17 39.39 Favored 'General case' 0 CA--C 1.577 2.0 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.256 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.97 -114.5 0.15 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.467 ' CD2' HD11 ' A' ' 127' ' ' LEU 0.38 24.7 m-85 -82.29 -14.11 55.91 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 120.945 1.702 . . . . 0.0 115.176 -178.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.1 -152.0 52.01 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.5 p -67.66 -22.25 65.31 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.12 -33.01 13.51 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.4 169.5 45.68 Favored Glycine 0 CA--C 1.551 2.327 0 CA-C-N 121.05 1.75 . . . . 0.0 114.71 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.473 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 6.8 t -90.42 120.14 69.06 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 116.684 -1.627 . . . . 0.0 108.799 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -37.23 -46.07 1.52 Allowed 'Trans proline' 0 CA--C 1.582 2.887 1 N-CA-C 123.32 4.316 . . . . 0.0 123.32 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.14 -20.11 19.39 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 CA-C-N 125.595 3.034 . . . . 0.0 119.534 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -159.53 -27.17 0.07 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 117' ' ' SER . 89.9 mt -79.98 126.6 79.43 Favored Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 120.183 -1.573 . . . . 0.0 111.938 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -82.68 170.7 12.62 Favored 'Trans proline' 0 CA--C 1.581 2.841 0 C-N-CA 122.365 2.043 . . . . 0.0 115.842 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.41 130.67 22.9 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 C-N-CA 122.85 2.367 . . . . 0.0 114.931 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.9 t30 58.85 60.85 2.34 Favored 'General case' 0 CA--C 1.586 2.364 0 C-N-CA 125.031 1.332 . . . . 0.0 113.413 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.23 123.73 32.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.33 -1.481 . . . . 0.0 112.451 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -59.35 156.2 13.22 Favored 'General case' 0 CA--C 1.587 2.373 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 87.8 mt -126.62 165.05 19.92 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 124.69 2.186 . . . . 0.0 114.297 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.99 106.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.77 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 2.5 m-85 -120.92 125.82 48.4 Favored 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 122.194 2.27 . . . . 0.0 109.134 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -95.43 98.72 10.76 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.52 140.57 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.346 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 50.4 mt-10 -130.3 110.15 11.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.484 ' O ' ' HA3' ' A' ' 99' ' ' GLY 0.31 25.8 tp -85.19 121.38 27.85 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 122.822 1.296 . . . . 0.0 112.779 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.3 15.3 m-30 -84.04 -64.36 1.18 Allowed 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.278 -1.514 . . . . 0.0 111.782 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.17 162.17 40.96 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.912 2.142 . . . . 0.0 110.46 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -143.5 -114.8 0.1 Allowed 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -103.4 173.1 6.45 Favored 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.623 1.569 . . . . 0.0 108.196 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 O-C-N 119.583 -1.948 . . . . 0.0 117.73 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.0 t -170.25 150.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 120.029 1.914 . . . . 0.0 112.859 -167.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.69 10.2 tp -151.84 -146.67 0.2 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.962 162.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -179.02 166.42 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.16 -1.587 . . . . 0.0 113.769 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.83 123.23 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.129 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.297 0.3 OUTLIER -89.79 139.28 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 120.25 1.386 . . . . 0.0 111.8 178.826 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.34 -69.18 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.982 -0.449 . . . . 0.0 111.219 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HB2' ' H ' ' A' ' 101' ' ' LEU . 89.8 mtt-85 -103.96 68.66 0.92 Allowed 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -38.1 -71.25 0.08 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.04 -178.4 39.44 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.5 p -83.7 -66.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.681 -0.759 . . . . 0.0 112.001 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.96 55.27 0.01 OUTLIER Glycine 0 CA--C 1.54 1.614 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 15.3 t -153.16 63.25 0.77 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.234 1.492 . . . . 0.0 112.527 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.361 46.8 mt-10 69.76 170.38 0.3 Allowed 'General case' 0 CA--C 1.576 1.972 1 N-CA-C 121.943 4.053 . . . . 0.0 121.943 175.126 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.7 p -114.33 160.0 34.49 Favored Pre-proline 0 CA--C 1.587 2.398 0 CA-C-N 111.042 -2.799 . . . . 0.0 110.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.83 129.18 30.91 Favored 'Trans proline' 0 CA--C 1.579 2.752 0 C-N-CA 122.853 2.369 . . . . 0.0 117.023 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -87.12 161.58 18.03 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 122.009 2.186 . . . . 0.0 111.363 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.343 0.4 OUTLIER -62.31 132.15 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 119.029 -2.294 . . . . 0.0 110.896 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.76 0.97 90.0 Favored Glycine 0 CA--C 1.569 3.428 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.56 152.65 20.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 121.504 2.652 . . . . 0.0 112.868 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -83.56 135.7 34.53 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.285 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -132.36 135.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.185 0.594 . . . . 0.0 109.831 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.265 33.4 p90 -115.96 105.31 12.51 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 124.038 1.875 . . . . 0.0 109.707 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.2 m -110.05 173.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 127.138 2.175 . . . . 0.0 114.55 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.257 0.1 OUTLIER -135.25 111.33 9.56 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 166.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.257 20.8 p90 -96.63 176.0 6.18 Favored 'General case' 0 CA--C 1.586 2.327 0 CA-C-O 126.291 2.948 . . . . 0.0 113.918 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.262 63.3 m -150.61 140.23 21.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.1 156.6 27.08 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 119.787 -1.82 . . . . 0.0 116.216 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -139.44 147.31 41.21 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 112.346 -1.927 . . . . 0.0 111.704 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 tp -80.64 169.11 18.07 Favored 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 122.762 1.268 . . . . 0.0 107.928 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.319 0.0 OUTLIER -59.24 -26.68 65.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.68 4.09 6.82 Favored 'General case' 0 CA--C 1.595 2.698 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.59 41.89 34.42 Favored Glycine 0 N--CA 1.506 3.339 0 O-C-N 119.804 -1.81 . . . . 0.0 114.434 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.6 m -116.67 117.31 29.46 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -77.36 97.82 5.03 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.054 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -74.0 -37.07 64.53 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.853 -2.404 . . . . 0.0 115.727 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.54 174.37 14.14 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.337 1.426 . . . . 0.0 113.93 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.4 p -159.98 -10.25 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 119.098 2.999 . . . . 0.0 119.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.3 1.6 t 71.7 -49.77 0.69 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.95 -2.344 . . . . 0.0 111.411 -168.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.6 mt -48.23 -39.33 20.9 Favored 'General case' 0 CA--C 1.581 2.14 0 C-N-CA 127.637 2.375 . . . . 0.0 113.972 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.26 -44.97 88.61 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 125.279 1.432 . . . . 0.0 113.025 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -76.69 -22.27 54.19 Favored 'General case' 0 CA--C 1.585 2.326 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.392 57.3 mtpt 106.18 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 127.648 2.379 . . . . 0.0 113.625 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.65 159.86 27.82 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.836 -1.165 . . . . 0.0 113.021 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -80.51 167.28 20.32 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 54' ' ' VAL . 12.0 t80 -98.04 155.96 16.87 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-O 123.052 1.406 . . . . 0.0 107.708 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -168.28 118.92 0.79 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 119.622 -1.924 . . . . 0.0 108.724 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.453 ' CG ' HG11 ' A' ' 85' ' ' VAL . 21.7 p90 -127.92 -174.53 3.22 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.235 1.017 . . . . 0.0 111.127 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.259 9.5 t0 -126.71 121.52 32.29 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 94' ' ' ALA . 11.6 tp -50.67 111.77 0.59 Allowed 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.58 23.42 70.46 Favored Glycine 0 CA--C 1.573 3.71 0 CA-C-O 118.218 -1.323 . . . . 0.0 116.045 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -124.65 -70.7 0.74 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 120.277 2.039 . . . . 0.0 112.952 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.81 73.35 0.3 Allowed Glycine 0 N--CA 1.508 3.443 0 N-CA-C 103.85 -3.7 . . . . 0.0 103.85 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.487 5.7 pt-20 -73.54 134.48 43.8 Favored 'General case' 0 CA--C 1.561 1.366 2 CA-C-O 129.302 4.382 . . . . 0.0 119.196 -158.503 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.453 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.353 20.8 m -80.04 -117.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 1 CA-C-N 102.564 -6.653 . . . . 0.0 108.439 -175.445 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.495 HG13 ' H ' ' A' ' 89' ' ' TRP . 18.2 pt -121.72 156.11 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 124.285 1.993 . . . . 0.0 107.775 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 8.0 tmtt? -66.94 -28.72 68.52 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.927 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.17 83.37 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 117.353 -1.308 . . . . 0.0 111.485 166.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.495 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.0 m0 -70.18 -41.59 73.54 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.866 1.666 . . . . 0.0 111.99 172.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.83 -41.26 67.18 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.766 1.621 . . . . 0.0 114.465 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -68.26 -61.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 119.582 1.083 . . . . 0.0 112.586 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.517 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -69.26 -28.45 66.33 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.271 45.5 t -79.16 -43.72 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 117.209 -1.377 . . . . 0.0 109.503 175.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -51.49 -33.45 31.43 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.161 1.8 . . . . 0.0 115.492 170.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -86.4 -12.09 50.16 Favored 'General case' 0 CA--C 1.583 2.221 0 CA-C-O 115.597 -2.144 . . . . 0.0 116.645 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -89.62 146.89 24.24 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 125.244 3.656 . . . . 0.0 115.043 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -86.94 159.97 18.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.86 125.95 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.566 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.277 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.12 -49.54 0.89 Allowed Glycine 0 N--CA 1.494 2.512 0 CA-C-O 113.939 -3.701 . . . . 0.0 108.651 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.974 4.5 pt-20 154.01 -93.73 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.417 1 N-CA-C 131.351 7.538 . . . . 0.0 131.351 164.39 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.433 ' H ' ' HB2' ' A' ' 38' ' ' ARG . 33.7 tp -79.09 122.2 25.94 Favored 'General case' 0 N--CA 1.484 1.225 1 N-CA-C 123.96 4.8 . . . . 0.0 123.96 -160.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.2 m -147.41 146.33 29.56 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.053 169.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -109.35 120.93 44.02 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.244 1.973 . . . . 0.0 110.905 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.2 mt -75.97 146.92 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.297 -2.229 . . . . 0.0 113.521 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -136.61 117.17 13.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.8 p -133.47 154.55 50.71 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -96.62 146.61 31.61 Favored Pre-proline 0 CA--C 1.581 2.152 0 CA-C-N 113.797 -1.547 . . . . 0.0 114.022 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 12.4 Cg_exo -43.25 -29.15 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 N-CA-C 121.62 3.661 . . . . 0.0 121.62 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -65.36 -39.09 91.88 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.22 1.827 . . . . 0.0 115.356 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -86.64 -7.71 58.1 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.958 1.303 . . . . 0.0 113.718 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.479 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -115.44 -133.77 0.34 Allowed 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 120.827 1.649 . . . . 0.0 112.398 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.2 4.1 49.74 Favored 'General case' 0 CA--C 1.591 2.556 0 CA-C-N 122.424 2.375 . . . . 0.0 113.411 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 108' ' ' PRO . . . -49.69 -62.14 5.09 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 122.293 3.677 . . . . 0.0 122.293 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -70.48 -39.16 74.37 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -130.04 -7.19 4.4 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.27 158.29 27.66 Favored Glycine 0 CA--C 1.55 2.241 0 CA-C-N 124.421 3.282 . . . . 0.0 113.78 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.466 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 6.1 t -82.75 137.0 44.28 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 116.777 -1.582 . . . . 0.0 109.759 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.266 43.8 Cg_exo -32.82 -45.18 0.25 Allowed 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.464 4.755 . . . . 0.0 124.464 -176.357 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 -52.99 0.08 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 0 CA-C-N 125.934 3.155 . . . . 0.0 118.929 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -152.5 3.57 0.35 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.466 ' HB ' ' H ' ' A' ' 117' ' ' SER . 51.0 mt -79.89 137.43 53.95 Favored Pre-proline 0 CA--C 1.599 2.838 0 O-C-N 119.15 -2.219 . . . . 0.0 113.705 -174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -92.63 -176.1 0.64 Allowed 'Trans proline' 0 CA--C 1.595 3.545 0 CA-C-N 125.319 2.935 . . . . 0.0 115.533 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -64.18 171.97 6.96 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 N-CA-C 118.722 2.547 . . . . 0.0 118.722 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.262 28.3 t-20 59.23 54.08 5.02 Favored 'General case' 0 CA--C 1.585 2.297 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.06 105.94 13.8 Favored 'General case' 0 CA--C 1.57 1.73 0 O-C-N 120.417 -1.427 . . . . 0.0 113.491 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 85.2 m -82.44 135.37 35.16 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.479 HD12 ' HB1' ' A' ' 111' ' ' ALA . 85.8 mt -129.93 167.45 18.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 122.694 2.497 . . . . 0.0 115.585 -171.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.29 125.79 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 CA-C-N 111.147 -2.751 . . . . 0.0 107.01 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.275 60.7 m-85 -133.0 162.11 32.58 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 119.89 -1.756 . . . . 0.0 110.977 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.68 104.23 6.25 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.81 131.85 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 122.0 0.905 . . . . 0.0 111.269 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -114.14 111.07 20.99 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.996 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 117.34 29.97 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.57 -65.62 0.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.367 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -156.85 162.36 39.69 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 121.451 1.932 . . . . 0.0 109.491 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -141.38 -98.54 0.14 Allowed 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -80.34 -43.8 20.55 Favored 'General case' 0 CA--C 1.594 2.669 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.949 173.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.649 0 CA-C-N 124.868 3.485 . . . . 0.0 121.038 178.697 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.265 0 N-CA-C 120.101 2.8 . . . . 0.0 120.101 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.02 140.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.588 5.9 tp -155.73 -142.92 0.11 Allowed 'General case' 0 CA--C 1.57 1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.148 168.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -153.45 162.8 40.92 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.193 1.473 . . . . 0.0 114.958 -170.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.1 t -107.49 104.8 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.495 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.376 2.1 mm -76.81 120.44 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-N 120.588 1.54 . . . . 0.0 112.512 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -95.1 -53.61 3.74 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.474 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -148.91 103.82 3.39 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -76.77 165.9 24.1 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 123.781 2.991 . . . . 0.0 114.344 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.75 -158.68 33.95 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.308 5.0 t -153.26 -77.69 0.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.887 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 13.88 -85.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 122.423 3.729 . . . . 0.0 122.423 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.3 t -143.81 60.34 1.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 121.739 0.781 . . . . 0.0 111.193 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.399 6.4 pt-20 28.01 -114.84 0.03 OUTLIER 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -139.17 121.39 10.24 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.732 1.213 . . . . 0.0 112.681 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -70.09 -114.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.524 0 C-N-CA 122.912 2.408 . . . . 0.0 114.861 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.7 ptm -170.24 179.94 3.3 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 tp -50.48 144.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.258 0 O-C-N 120.771 -1.206 . . . . 0.0 111.268 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.64 -10.59 64.23 Favored Glycine 0 CA--C 1.555 2.562 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -85.85 149.01 25.54 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 121.764 2.782 . . . . 0.0 113.354 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.9 tpt85 -79.94 130.55 35.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.033 -1.042 . . . . 0.0 109.488 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 2.4 t -127.84 146.04 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.272 1.029 . . . . 0.0 110.718 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.253 51.7 p90 -134.32 115.28 13.9 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 122.871 1.32 . . . . 0.0 108.493 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.17 -179.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 CA-C-O 124.087 1.899 . . . . 0.0 113.553 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.57 113.91 9.56 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.479 172.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -115.85 150.13 37.51 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -122.54 147.15 46.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 162.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.06 143.06 9.82 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 119.102 -2.249 . . . . 0.0 117.198 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -134.3 154.78 51.12 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.634 1.974 . . . . 0.0 114.915 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.24 162.59 23.48 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.297 1.6 tm? -61.81 -29.03 69.89 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.05 -2.06 4.99 Favored 'General case' 0 CA--C 1.598 2.808 0 O-C-N 120.323 -1.486 . . . . 0.0 114.934 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.97 50.18 4.48 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 120.17 -1.581 . . . . 0.0 113.98 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.4 m -128.43 115.89 18.89 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.28 112.61 14.17 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.108 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -87.59 -36.99 17.21 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 122.277 2.308 . . . . 0.0 114.303 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -151.44 155.85 39.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.5 1.619 . . . . 0.0 111.148 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.5 p -159.92 104.72 1.54 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.192 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -36.86 80.15 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.61 -34.55 67.34 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 -58.66 3.38 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -158.42 69.77 0.51 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.794 1.179 . . . . 0.0 113.108 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.05 -82.08 0.08 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 120.115 -1.616 . . . . 0.0 108.42 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.71 -157.68 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 127.356 2.262 . . . . 0.0 108.409 -174.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -88.84 -176.94 5.38 Favored 'General case' 0 CA--C 1.578 2.047 0 O-C-N 120.068 -1.645 . . . . 0.0 109.556 169.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.274 9.9 t80 -119.65 160.0 23.34 Favored 'General case' 0 CA--C 1.576 1.971 0 O-C-N 119.627 -1.921 . . . . 0.0 110.344 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 p -165.39 134.42 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 119.792 -1.818 . . . . 0.0 109.198 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.493 ' CG ' HG11 ' A' ' 85' ' ' VAL . 15.8 p90 -148.07 -178.56 6.35 Favored 'General case' 0 CA--C 1.58 2.103 0 O-C-N 121.374 -0.829 . . . . 0.0 110.977 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 -117.11 127.34 54.04 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.67 103.56 0.05 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -172.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.69 47.96 87.46 Favored Glycine 1 N--CA 1.516 4.017 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.308 0.0 OUTLIER -133.76 -78.81 0.47 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -168.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.29 71.41 0.33 Allowed Glycine 0 N--CA 1.509 3.542 1 N-CA-C 103.066 -4.014 . . . . 0.0 103.066 169.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.474 0.0 OUTLIER -66.37 141.86 57.82 Favored 'General case' 0 CA--C 1.554 1.106 2 CA-C-O 129.274 4.369 . . . . 0.0 119.564 -157.593 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.493 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.396 17.4 m -79.93 -110.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 1 CA-C-N 102.751 -6.568 . . . . 0.0 105.617 -176.959 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.469 HG13 ' H ' ' A' ' 89' ' ' TRP . 24.8 pt -125.28 156.76 34.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 124.031 1.872 . . . . 0.0 106.121 167.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.45 -28.94 68.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.115 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.17 -36.02 76.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 117.024 -1.465 . . . . 0.0 112.867 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.469 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.5 m0 -72.91 -45.23 59.32 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 120.785 1.63 . . . . 0.0 112.755 173.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . 0.288 2.7 p30 -56.7 -35.41 68.47 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 121.527 1.967 . . . . 0.0 115.497 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.272 1.6 mp -67.16 -57.77 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-N 119.45 1.023 . . . . 0.0 111.241 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.13 83.09 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 t -68.51 -41.14 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 120.43 1.468 . . . . 0.0 111.585 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.57 62.61 Favored 'General case' 0 CA--C 1.587 2.384 0 CA-C-N 120.16 1.345 . . . . 0.0 113.83 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.4 p -96.44 -3.15 44.0 Favored 'General case' 0 CA--C 1.593 2.606 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.2 ttp -103.02 132.64 49.14 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 121.944 2.157 . . . . 0.0 111.026 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -94.17 153.55 18.03 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.4 t -10.56 -31.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 1 N-CA-C 126.862 5.875 . . . . 0.0 126.862 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.17 17.73 0.22 Allowed Glycine 0 N--CA 1.493 2.449 0 CA-C-O 116.357 -2.357 . . . . 0.0 115.038 -169.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.35 0.9 OUTLIER -129.14 -174.24 3.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -176.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.13 127.51 53.25 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.438 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.6 m -139.68 165.9 26.04 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.708 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.251 6.0 mtt85 -127.84 116.89 20.86 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.581 1.658 . . . . 0.0 111.143 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.62 138.25 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.8 m -132.99 109.64 9.7 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 25.1 p -137.26 149.08 46.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.093 2.998 . . . . 0.0 119.093 -173.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -81.0 142.13 51.47 Favored Pre-proline 0 CA--C 1.577 2.01 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.743 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.55 -25.44 7.72 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 N-CA-C 120.727 3.318 . . . . 0.0 120.727 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.07 -38.68 89.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.364 1.893 . . . . 0.0 114.558 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -79.28 -7.65 58.45 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 124.953 1.301 . . . . 0.0 114.249 169.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.25 -115.84 0.24 Allowed 'General case' 0 CA--C 1.58 2.109 0 CA-C-N 120.7 1.591 . . . . 0.0 114.781 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.285 1.6 m-85 -103.33 29.51 5.56 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 122.178 2.263 . . . . 0.0 113.432 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -52.36 158.18 3.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 120.449 2.939 . . . . 0.0 120.449 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.284 9.9 t 71.1 -64.56 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.89 -15.6 16.81 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.17 177.8 49.85 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-N 122.619 2.463 . . . . 0.0 112.392 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.508 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.4 t -75.31 127.43 86.34 Favored Pre-proline 0 CA--C 1.579 2.093 0 CA-C-O 116.394 -1.765 . . . . 0.0 108.846 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 69.6 Cg_exo -38.3 -43.81 1.9 Allowed 'Trans proline' 0 CA--C 1.582 2.922 1 N-CA-C 123.0 4.192 . . . . 0.0 123.0 -176.961 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.6 -37.06 0.22 Allowed 'Trans proline' 0 CA--C 1.573 2.469 0 CA-C-N 125.491 2.997 . . . . 0.0 119.399 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -150.99 -7.34 0.26 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.508 ' HB ' ' H ' ' A' ' 117' ' ' SER . 1.5 mt -79.9 145.94 62.84 Favored Pre-proline 0 CA--C 1.595 2.678 0 CA-C-N 122.944 2.611 . . . . 0.0 112.797 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.4 160.65 48.81 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 CA-C-N 126.453 3.341 . . . . 0.0 115.497 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -62.2 129.32 26.64 Favored 'Trans proline' 0 CA--C 1.57 2.286 0 C-N-CA 122.721 2.281 . . . . 0.0 116.736 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.58 65.66 1.21 Allowed 'General case' 0 CA--C 1.592 2.579 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.5 140.18 51.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 119.642 -1.911 . . . . 0.0 111.748 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.6 m -59.99 146.46 42.51 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.408 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 6.2 tp -116.8 152.55 34.16 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.931 1.696 . . . . 0.0 112.336 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.26 130.39 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.302 -170.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.256 24.2 m-85 -138.35 161.28 37.33 Favored 'General case' 0 N--CA 1.521 3.085 0 O-C-N 119.444 -2.035 . . . . 0.0 110.435 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -126.19 104.68 8.36 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.52 135.31 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-O 122.387 1.089 . . . . 0.0 111.107 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -115.35 115.77 27.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.658 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.25 112.17 24.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -77.92 -40.09 40.79 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.23 172.11 1.95 Allowed 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.304 0.0 OUTLIER -146.13 -96.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.374 -2.079 . . . . 0.0 107.919 177.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.47 72.2 tttt -111.42 -99.42 0.41 Allowed 'General case' 0 CA--C 1.586 2.347 0 CA-C-O 116.545 -1.693 . . . . 0.0 110.019 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.22 0 CA-C-N 124.991 3.541 . . . . 0.0 113.973 -178.568 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.352 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 106' ' ' CYS . 23.4 t -169.04 144.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.587 7.8 tp -157.69 -141.92 0.09 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.988 -1.482 . . . . 0.0 111.415 165.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 29.6 mtpt -155.87 155.75 33.45 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 122.825 2.557 . . . . 0.0 115.876 -171.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.56 108.11 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 102' ' ' CYS 0.408 1.0 OUTLIER -78.83 124.75 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-N 120.274 1.397 . . . . 0.0 113.538 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -110.64 -56.48 2.35 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.059 0.933 . . . . 0.0 110.599 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.262 46.1 ttt180 -113.63 97.98 6.77 Favored 'General case' 0 CA--C 1.597 2.787 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 36' ' ' ILE . 31.0 mt-10 -37.75 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.863 1 N-CA-C 123.349 4.574 . . . . 0.0 123.349 -177.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.18 163.73 28.03 Favored Glycine 0 CA--C 1.55 2.234 0 C-N-CA 125.072 1.32 . . . . 0.0 114.696 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.343 12.4 t -146.41 -72.07 0.24 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.85 69.54 2.64 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 120.756 3.062 . . . . 0.0 120.756 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.27 71.1 p 69.7 61.84 0.27 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.383 4.7 pt-20 30.6 -113.39 0.03 OUTLIER 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -147.52 122.19 5.11 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 115.918 -1.991 . . . . 0.0 110.898 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.42 0.2 OUTLIER -114.26 -40.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.275 1 N-CA-C 125.749 5.25 . . . . 0.0 125.749 177.579 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 1.9 ptt? -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.526 3.367 2 N-CA-C 127.542 6.127 . . . . 0.0 127.542 -174.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 tp -65.71 141.0 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.03 82.43 Favored Glycine 0 CA--C 1.567 3.322 0 O-C-N 120.286 -1.509 . . . . 0.0 116.527 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' MET . 4.0 t0 -72.66 141.38 48.27 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.932 2.366 . . . . 0.0 110.625 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 -85.97 101.03 12.54 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.25 137.2 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.35 0.66 . . . . 0.0 112.416 -169.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.05 104.56 12.26 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 76' ' ' PHE . 12.2 m -108.98 160.29 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 125.754 2.692 . . . . 0.0 114.697 -172.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.482 ' CD2' HD12 ' A' ' 70' ' ' LEU . 1.6 t60 -125.05 115.69 20.92 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.705 -2.952 . . . . 0.0 105.106 167.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.331 5.7 p90 -113.95 143.93 43.9 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.728 1.251 . . . . 0.0 114.28 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -118.07 147.32 43.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 164.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.79 136.6 4.67 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 118.894 -2.379 . . . . 0.0 115.278 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.29 160.36 40.64 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 111.852 -2.174 . . . . 0.0 114.921 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.504 HD12 ' H ' ' A' ' 62' ' ' ASP . 1.0 OUTLIER -80.65 178.82 8.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -65.13 -22.62 66.96 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 60' ' ' LEU . 36.8 t70 -73.57 -6.46 46.75 Favored 'General case' 0 CA--C 1.601 2.924 0 CA-C-N 119.106 0.867 . . . . 0.0 112.704 165.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.79 47.46 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 125.59 1.567 . . . . 0.0 113.636 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -88.67 108.93 19.72 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -74.49 91.85 2.31 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -73.1 -25.94 61.05 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 119.81 -1.806 . . . . 0.0 113.592 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -151.72 154.17 35.79 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 124.693 2.187 . . . . 0.0 115.308 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.8 p -153.77 102.3 2.52 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 112.029 -2.35 . . . . 0.0 104.767 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.292 31.6 p -58.87 -67.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.482 HD12 ' CD2' ' A' ' 55' ' ' HIS 0.379 32.6 mt -61.39 -45.14 95.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.05 -40.89 24.36 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -93.91 26.83 3.0 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.339 40.3 tttp 82.44 -30.4 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.49 -170.29 2.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.19 176.66 9.36 Favored 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 126.044 1.738 . . . . 0.0 109.857 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.473 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.394 0.5 OUTLIER -132.68 146.02 51.52 Favored 'General case' 0 CA--C 1.575 1.939 0 O-C-N 119.404 -2.06 . . . . 0.0 111.853 173.737 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.1 p -165.42 150.29 8.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.297 -2.127 . . . . 0.0 109.647 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.548 ' CG ' HG11 ' A' ' 85' ' ' VAL . 27.2 p90 -159.66 -171.8 3.43 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.665 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -123.18 113.66 19.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -37.99 105.98 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.43 53.52 24.61 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 118.178 2.031 . . . . 0.0 118.178 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -7.2 23.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.59 63.06 2.17 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 -167.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -154.29 -55.45 0.1 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 112.036 -2.082 . . . . 0.0 110.307 -163.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.548 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.301 16.6 m -97.82 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.431 HD12 ' HE3' ' A' ' 107' ' ' LYS . 3.7 pt -125.64 163.2 27.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 124.459 2.076 . . . . 0.0 109.261 172.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.254 0.9 OUTLIER -68.07 -34.58 76.7 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.178 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.39 70.71 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.601 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -73.26 -46.27 50.95 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 121.136 1.789 . . . . 0.0 112.28 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.95 -35.83 69.57 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 121.361 1.891 . . . . 0.0 115.571 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.29 1.7 mp -65.22 -61.55 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.207 0 CA-C-N 119.855 1.207 . . . . 0.0 111.627 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -67.05 -35.91 80.91 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.301 6.4 t -74.27 -32.87 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.189 0 O-C-N 121.237 -0.914 . . . . 0.0 111.084 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.99 -24.72 68.04 Favored 'General case' 0 CA--C 1.577 2.008 0 CA-C-N 120.709 1.595 . . . . 0.0 113.833 166.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.0 p -97.22 8.0 45.44 Favored 'General case' 0 CA--C 1.596 2.724 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.787 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 8.6 tpt -93.71 140.32 29.78 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 119.515 -1.991 . . . . 0.0 113.346 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.24 145.61 26.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.778 . . . . 0.0 114.203 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.05 125.23 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.32 -12.91 53.49 Favored Glycine 0 N--CA 1.496 2.675 0 CA-C-O 114.972 -3.127 . . . . 0.0 117.888 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.483 67.7 mt-10 -113.16 -159.5 0.69 Allowed 'General case' 0 CA--C 1.583 2.234 0 CA-C-N 122.805 3.303 . . . . 0.0 117.434 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.0 tp -140.26 138.75 35.26 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 119.082 2.994 . . . . 0.0 119.082 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 0.8 OUTLIER -160.02 157.82 29.41 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.909 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -104.88 128.71 53.21 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.204 1.478 . . . . 0.0 113.177 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.757 HG22 ' SG ' ' A' ' 106' ' ' CYS . 11.0 mt -71.88 131.72 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.231 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.625 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.1 m -113.98 108.78 17.48 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.757 ' SG ' HG22 ' A' ' 104' ' ' ILE 0.315 11.4 p -160.16 162.92 34.01 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 120.09 3.366 . . . . 0.0 120.09 -163.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.617 ' HD2' ' HB2' ' A' ' 106' ' ' CYS 2.574 0.0 OUTLIER 134.61 -147.52 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.165 1 N-CA-C 147.669 13.581 . . . . 0.0 147.669 157.447 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.888 21.9 Cg_exo 35.09 -63.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.577 2.631 1 C-N-CA 126.206 4.604 . . . . 0.0 120.952 -162.214 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.31 -33.37 75.69 Favored 'General case' 0 CA--C 1.579 2.07 0 O-C-N 118.818 -2.426 . . . . 0.0 114.805 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -80.76 0.99 32.26 Favored 'General case' 0 CA--C 1.598 2.82 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.447 ' HB2' ' HG3' ' A' ' 107' ' ' LYS . . . -147.69 -104.86 0.09 Allowed 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 127' ' ' LEU . 3.1 m-85 -89.87 -7.53 54.01 Favored 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -176.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -45.56 -21.39 0.49 Allowed Glycine 0 N--CA 1.503 3.112 1 N-CA-C 123.868 4.307 . . . . 0.0 123.868 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.9 p -71.92 -56.12 6.26 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.603 1.702 . . . . 0.0 112.79 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.19 -0.24 3.72 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.56 153.82 27.29 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-N 123.56 2.891 . . . . 0.0 115.133 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.465 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 7.5 t -82.97 130.77 56.26 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.635 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -34.29 -47.57 0.55 Allowed 'Trans proline' 0 CA--C 1.581 2.841 1 N-CA-C 122.666 4.064 . . . . 0.0 122.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.23 -54.71 0.36 Allowed 'Trans proline' 0 CA--C 1.571 2.351 0 CA-C-N 125.682 3.065 . . . . 0.0 116.725 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -173.0 78.3 0.04 OUTLIER 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 119.344 0.975 . . . . 0.0 113.542 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -141.09 125.65 10.59 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 119.673 -1.892 . . . . 0.0 109.377 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -90.31 162.69 4.59 Favored 'Trans proline' 0 CA--C 1.589 3.264 0 CA-C-N 123.442 2.265 . . . . 0.0 112.223 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.28 -34.6 66.88 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.103 2.309 . . . . 0.0 118.103 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -89.68 56.71 3.63 Favored 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 125.981 1.712 . . . . 0.0 113.215 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.54 106.94 4.37 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.014 -1.678 . . . . 0.0 113.664 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 m -60.35 154.09 21.15 Favored 'General case' 0 CA--C 1.587 2.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 112' ' ' TYR . 29.2 mt -124.27 172.34 9.17 Favored 'General case' 0 CA--C 1.566 1.567 0 O-C-N 120.288 -1.507 . . . . 0.0 111.834 -174.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.46 123.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -123.78 120.82 33.78 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 119.937 1.244 . . . . 0.0 108.228 176.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.15 107.79 19.35 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.961 -1.087 . . . . 0.0 108.716 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -112.45 135.86 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.17 0.986 . . . . 0.0 110.892 -171.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -114.43 112.71 23.44 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.9 115.1 28.86 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.891 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -78.94 -50.21 11.54 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -169.94 159.67 7.92 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 123.833 1.777 . . . . 0.0 110.384 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.91 -87.97 0.08 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 102.76 -3.052 . . . . 0.0 102.76 -177.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -121.89 95.45 4.67 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 170.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.635 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 177.477 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.68 146.47 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 N-CA-C 119.028 2.973 . . . . 0.0 119.028 -170.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.42 136.9 52.86 Favored 'General case' 0 CA--C 1.598 2.793 0 C-N-CA 126.548 1.939 . . . . 0.0 107.539 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -124.19 118.65 27.34 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 118.291 -2.756 . . . . 0.0 108.211 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.13 136.03 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.579 -0.701 . . . . 0.0 109.613 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.22 151.43 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 122.124 0.964 . . . . 0.0 113.044 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -131.18 -63.62 0.84 Allowed 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 124.22 1.008 . . . . 0.0 110.851 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -112.79 89.86 3.19 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -35.09 -56.21 0.59 Allowed 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -151.75 17.38 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 124.63 1.109 . . . . 0.0 115.495 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 t -79.66 -34.17 40.65 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.35 45.74 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 120.429 2.932 . . . . 0.0 120.429 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.25 67.2 p 68.84 -5.88 0.95 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 118.894 2.924 . . . . 0.0 118.894 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -75.86 131.94 40.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.0 p -107.93 163.61 16.57 Favored Pre-proline 0 N--CA 1.503 2.185 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.47 166.43 25.93 Favored 'Trans proline' 0 CA--C 1.577 2.639 0 CA-C-N 122.39 1.889 . . . . 0.0 114.436 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -102.39 163.34 12.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.52 -1.363 . . . . 0.0 111.546 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.355 0.3 OUTLIER -63.16 128.51 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.179 -2.2 . . . . 0.0 110.432 178.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 4.03 84.58 Favored Glycine 0 CA--C 1.572 3.594 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.23 166.34 9.99 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 121.189 2.494 . . . . 0.0 114.35 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -108.21 101.12 10.37 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 119.926 1.239 . . . . 0.0 108.933 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.93 139.0 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 123.61 0.764 . . . . 0.0 111.05 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.28 41.6 p90 -117.32 101.12 8.16 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 124.865 2.269 . . . . 0.0 109.267 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 76' ' ' PHE . 2.1 p -102.19 170.93 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 111.076 -2.783 . . . . 0.0 112.731 -170.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.96 100.7 3.22 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 166.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -97.69 160.22 14.45 Favored 'General case' 0 CA--C 1.593 2.635 0 CA-C-O 122.724 1.249 . . . . 0.0 113.299 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -128.0 147.96 50.52 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.15 142.43 9.1 Favored Glycine 0 CA--C 1.55 2.222 0 O-C-N 119.098 -2.251 . . . . 0.0 116.464 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.569 ' CE3' HG12 ' A' ' 128' ' ' VAL . 2.0 m-90 -130.27 149.11 52.11 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.49 1.916 . . . . 0.0 115.205 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.29 171.4 12.75 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.922 1.344 . . . . 0.0 108.746 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 3.3 tt -62.56 -29.46 70.6 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.05 7.01 1.81 Allowed 'General case' 0 CA--C 1.597 2.786 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.37 66.0 Favored Glycine 0 N--CA 1.509 3.557 0 O-C-N 119.841 -1.787 . . . . 0.0 114.744 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -112.62 118.53 35.31 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -77.88 93.11 4.33 Favored 'General case' 0 CA--C 1.583 2.225 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -64.66 -30.31 71.33 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 119.151 -2.218 . . . . 0.0 114.559 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.14 152.85 31.73 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 124.513 2.102 . . . . 0.0 112.492 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.6 p -159.35 86.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 t -52.91 -40.66 63.73 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.12 -38.81 54.13 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.691 1.996 . . . . 0.0 115.694 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.68 -34.26 18.49 Favored 'General case' 0 CA--C 1.578 2.025 0 C-N-CA 125.879 1.672 . . . . 0.0 114.88 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -29.78 70.88 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.312 2.708 . . . . 0.0 118.312 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.352 58.5 tptt 131.5 -56.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 127.677 2.391 . . . . 0.0 111.695 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -98.35 174.06 6.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 123.602 1.667 . . . . 0.0 113.199 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.06 175.62 6.25 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 125.298 1.439 . . . . 0.0 114.389 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HB3' HG13 ' A' ' 54' ' ' VAL 0.345 2.3 t80 -108.49 153.27 23.57 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-O 122.989 1.376 . . . . 0.0 108.356 173.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.9 p -163.53 111.79 1.22 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 118.154 -2.841 . . . . 0.0 104.514 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.539 ' CD1' HG11 ' A' ' 85' ' ' VAL . 2.4 p90 -125.54 177.06 6.42 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.116 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.308 33.6 t70 -86.32 -139.34 0.09 Allowed 'General case' 0 CA--C 1.584 2.251 0 O-C-N 119.117 -2.24 . . . . 0.0 105.803 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 tp -141.5 109.96 5.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 118.579 -2.576 . . . . 0.0 104.265 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 48.44 16.12 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.414 14.5 tppt? -106.82 6.58 29.6 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-N 119.902 1.851 . . . . 0.0 114.441 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.1 -51.99 1.65 Allowed Glycine 0 N--CA 1.508 3.478 0 O-C-N 120.151 -1.593 . . . . 0.0 109.953 -172.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.283 52.9 tt0 -20.2 -53.82 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 120.654 3.575 . . . . 0.0 120.654 168.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 78' ' ' PHE 0.294 16.5 m -101.87 -135.61 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 123.228 1.49 . . . . 0.0 110.12 -174.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 89' ' ' TRP . 13.7 pt -126.55 162.51 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.774 1.75 . . . . 0.0 109.797 173.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -67.16 -33.61 75.79 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.172 -1.376 . . . . 0.0 113.109 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.2 73.09 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.29 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.452 ' H ' HG13 ' A' ' 86' ' ' ILE . 35.1 m0 -74.77 -42.18 58.66 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-N 120.854 1.661 . . . . 0.0 112.205 172.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.84 -38.5 85.7 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.21 1.368 . . . . 0.0 113.863 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.4 mp -68.6 -60.64 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-N 119.09 0.859 . . . . 0.0 111.615 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.05 72.94 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.311 15.5 t -74.16 -32.79 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 CA-C-N 120.344 1.429 . . . . 0.0 110.652 175.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.25 73.92 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 121.02 1.736 . . . . 0.0 112.749 166.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.8 p -83.85 8.24 15.51 Favored 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.531 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 tpt -91.95 130.3 37.73 Favored 'General case' 0 CA--C 1.579 2.072 0 O-C-N 119.483 -2.011 . . . . 0.0 112.209 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.33 135.35 41.89 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 116.423 -1.751 . . . . 0.0 109.461 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.288 3.6 t -9.65 82.84 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-O 124.729 2.204 . . . . 0.0 108.308 -161.044 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 133' ' ' LEU . . . -54.99 46.88 0.01 OUTLIER Glycine 0 N--CA 1.502 3.037 2 CA-C-N 107.532 -4.394 . . . . 0.0 123.702 -140.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 0.4 OUTLIER -29.02 -87.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -169.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.61 121.51 17.67 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.754 0.822 . . . . 0.0 112.646 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.531 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 2.4 m -149.2 167.36 26.2 Favored 'General case' 0 CA--C 1.575 1.92 0 C-N-CA 123.949 0.899 . . . . 0.0 111.779 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -131.83 133.6 44.86 Favored 'General case' 0 CA--C 1.557 1.226 0 O-C-N 119.134 -2.229 . . . . 0.0 112.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.3 mt -90.71 129.27 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 CA-C-N 112.689 -2.05 . . . . 0.0 108.862 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 106.4 14.35 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.581 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 5.0 p -129.36 147.48 51.19 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -169.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -91.69 146.25 32.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.037 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.26 82.4 Cg_endo -61.87 -14.55 37.43 Favored 'Trans proline' 0 CA--C 1.568 2.213 0 N-CA-C 118.023 2.278 . . . . 0.0 118.023 -176.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.82 -38.46 78.7 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 120.778 1.626 . . . . 0.0 114.427 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.58 2.54 52.85 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 125.632 1.573 . . . . 0.0 113.495 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.61 -113.8 0.17 Allowed 'General case' 0 CA--C 1.58 2.132 0 CA-C-N 120.774 1.624 . . . . 0.0 115.269 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.271 4.9 m-85 -88.08 0.33 56.12 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 120.953 1.706 . . . . 0.0 115.378 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.4 -19.39 1.87 Allowed Glycine 0 N--CA 1.499 2.86 1 N-CA-C 124.219 4.447 . . . . 0.0 124.219 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -71.36 -57.41 4.48 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 120.271 2.036 . . . . 0.0 111.869 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.52 0.34 2.49 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.5 157.07 33.3 Favored Glycine 0 CA--C 1.546 1.996 0 CA-C-N 123.999 3.091 . . . . 0.0 112.483 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.423 ' HB3' HD12 ' A' ' 121' ' ' ILE . 2.7 t -86.53 125.56 66.99 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-O 116.918 -1.515 . . . . 0.0 108.423 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.274 28.1 Cg_exo -26.24 -49.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.877 1 N-CA-C 124.882 4.916 . . . . 0.0 124.882 -176.334 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -46.16 1.3 Allowed 'Trans proline' 0 CA--C 1.572 2.391 0 CA-C-N 125.861 3.129 . . . . 0.0 118.977 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -152.58 -11.78 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 117' ' ' SER . 14.2 mt -79.91 144.13 59.03 Favored Pre-proline 0 CA--C 1.595 2.692 0 CA-C-N 121.858 2.117 . . . . 0.0 115.564 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -102.48 176.16 0.19 Allowed 'Trans proline' 0 CA--C 1.594 3.497 0 CA-C-N 125.278 2.921 . . . . 0.0 113.661 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.5 -37.87 5.1 Favored 'Trans proline' 0 CA--C 1.573 2.464 0 C-N-CA 122.239 1.959 . . . . 0.0 116.619 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -80.89 50.87 1.44 Allowed 'General case' 0 CA--C 1.582 2.177 0 O-C-N 120.06 -1.65 . . . . 0.0 115.202 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.28 127.91 17.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.218 -1.551 . . . . 0.0 112.831 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.1 m -80.26 161.73 24.98 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.973 -1.079 . . . . 0.0 112.817 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.581 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.3 0.5 OUTLIER -145.12 174.0 11.44 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 119.711 -1.868 . . . . 0.0 112.274 -176.569 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.569 HG12 ' CE3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -148.57 125.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 125.039 1.336 . . . . 0.0 108.005 -171.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.285 4.7 m-85 -124.13 122.85 38.94 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 120.302 1.41 . . . . 0.0 110.58 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.17 121.73 32.47 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.77 128.0 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 121.369 0.604 . . . . 0.0 111.806 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.56 100.56 9.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.453 ' HB3' ' HA3' ' A' ' 99' ' ' GLY 0.285 16.2 tp -103.99 126.81 51.4 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.687 1.232 . . . . 0.0 111.703 -174.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -86.04 -60.32 2.04 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 120.897 -1.127 . . . . 0.0 112.836 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -157.5 -178.06 7.06 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 119.939 1.245 . . . . 0.0 110.088 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.26 -60.65 0.08 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.28 58.3 tttm -79.82 -44.51 20.43 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.614 2.82 . . . . 0.0 118.614 -172.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.823 0 CA-C-N 124.774 3.443 . . . . 0.0 121.188 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.518 4.141 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 107' ' ' LYS 0.394 17.1 t -123.89 119.28 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 173.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.2 tp -89.93 122.42 32.94 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 125.251 1.42 . . . . 0.0 108.68 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -114.77 97.81 6.48 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 122.816 2.553 . . . . 0.0 108.568 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 109.318 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -86.17 145.48 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-O 121.591 0.71 . . . . 0.0 111.836 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -123.58 -53.67 1.78 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 123.568 0.747 . . . . 0.0 111.491 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -124.1 107.18 10.99 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -72.54 0.05 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.75 -156.82 28.83 Favored Glycine 0 CA--C 1.547 2.092 0 C-N-CA 125.1 1.334 . . . . 0.0 111.713 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -88.74 -7.48 56.18 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.6 -85.73 0.06 OUTLIER Glycine 0 CA--C 1.538 1.482 0 O-C-N 121.164 -0.96 . . . . 0.0 111.943 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -165.45 5.27 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -87.23 154.02 21.04 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 123.775 2.989 . . . . 0.0 115.1 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 p -128.23 164.29 38.48 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 112.974 -1.921 . . . . 0.0 113.284 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.48 -176.42 2.28 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-N 122.515 1.934 . . . . 0.0 115.775 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.5 ptp -133.92 167.34 20.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.461 -1.399 . . . . 0.0 112.426 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.279 1.5 tp -60.58 136.68 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 O-C-N 119.251 -2.155 . . . . 0.0 110.967 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.33 61.46 Favored Glycine 0 CA--C 1.559 2.787 0 N-CA-C 118.412 2.125 . . . . 0.0 118.412 -173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.85 149.13 26.58 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.63 2.215 . . . . 0.0 112.019 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -78.37 133.89 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.368 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.45 ' HB ' HD11 ' A' ' 133' ' ' LEU . 9.5 m -136.84 138.75 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 118.804 0.729 . . . . 0.0 111.57 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -116.73 102.43 9.42 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.551 -1.343 . . . . 0.0 108.543 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.2 m -102.32 167.81 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.62 117.91 17.59 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -112.18 150.85 30.26 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 m -119.05 151.6 37.94 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 157.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.07 142.32 8.86 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 118.229 -2.795 . . . . 0.0 115.459 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.411 ' CE3' HG12 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -130.25 155.07 46.89 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.027 -1.587 . . . . 0.0 115.01 -175.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.1 tp -78.48 177.01 8.86 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 123.086 1.422 . . . . 0.0 107.378 166.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -63.81 -25.8 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.75 13.74 2.0 Allowed 'General case' 0 CA--C 1.604 3.023 0 CA-C-N 119.077 0.853 . . . . 0.0 113.268 168.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.66 29.7 75.48 Favored Glycine 0 N--CA 1.509 3.541 0 O-C-N 120.034 -1.666 . . . . 0.0 116.432 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -86.74 113.9 22.97 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -74.39 85.28 1.98 Allowed 'General case' 0 CA--C 1.586 2.331 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.64 -30.78 69.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 119.66 -1.9 . . . . 0.0 115.403 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -149.57 141.24 23.53 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.575 1.179 . . . . 0.0 111.496 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.9 p -160.02 93.26 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.4 p -61.01 -35.83 77.89 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -52.92 -39.13 62.57 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.65 -41.8 44.38 Favored 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 125.034 1.334 . . . . 0.0 114.223 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -68.54 -20.12 64.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 33.9 mtmm 101.8 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 127.407 2.283 . . . . 0.0 112.118 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.1 153.31 41.77 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 123.0 1.381 . . . . 0.0 114.356 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -93.29 178.77 5.62 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.506 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.474 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.302 4.5 t80 -114.35 153.25 30.14 Favored 'General case' 0 CA--C 1.587 2.372 0 O-C-N 120.95 -1.094 . . . . 0.0 110.082 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.8 p -161.63 145.94 12.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 118.491 -2.631 . . . . 0.0 111.342 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 85' ' ' VAL . 25.6 p90 -155.22 -171.26 3.74 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -124.05 114.5 19.81 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.64 110.07 0.18 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.29 29.87 67.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -106.13 0.91 25.8 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.23 61.29 1.33 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -148.27 -51.29 0.17 Allowed 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 111.191 -2.505 . . . . 0.0 111.991 -166.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.261 13.5 m -125.9 -140.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.969 1.366 . . . . 0.0 109.756 -173.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.523 HD12 ' HZ3' ' A' ' 107' ' ' LYS . 12.6 pt -115.21 162.51 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-O 123.826 1.774 . . . . 0.0 109.88 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -65.88 -34.1 77.37 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.655 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . . . -57.1 -39.72 75.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 168.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.444 ' H ' HG13 ' A' ' 86' ' ' ILE . 32.8 m0 -70.23 -40.78 74.29 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.641 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.26 -33.78 74.09 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 119.593 1.088 . . . . 0.0 113.921 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -67.37 -59.17 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 119.925 1.238 . . . . 0.0 110.622 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.405 ' CB ' HD13 ' A' ' 104' ' ' ILE . . . -60.03 -47.0 87.67 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.332 5.2 t -60.4 -41.22 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.712 173.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.21 -39.29 56.23 Favored 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 121.506 1.957 . . . . 0.0 113.251 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -97.69 51.0 1.05 Allowed 'General case' 0 CA--C 1.593 2.624 0 C-N-CA 123.846 0.858 . . . . 0.0 112.618 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.1 ttt -138.37 152.3 48.31 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 119.479 -2.013 . . . . 0.0 113.881 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -118.53 146.08 44.83 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.558 2.799 . . . . 0.0 118.558 -172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -18.45 -29.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.756 1 N-CA-C 127.354 6.057 . . . . 0.0 127.354 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.37 -2.14 0.14 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-O 115.566 -2.797 . . . . 0.0 116.601 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 78.1 mm-40 -112.6 -145.43 0.4 Allowed 'General case' 0 N--CA 1.516 2.856 0 N-CA-C 121.012 3.708 . . . . 0.0 121.012 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 16.1 tp -133.94 140.6 46.88 Favored 'General case' 0 CA--C 1.601 2.932 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.47 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 58.8 m -142.88 -175.52 4.53 Favored 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.431 -1.418 . . . . 0.0 113.343 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -137.51 139.58 40.61 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 119.489 -2.007 . . . . 0.0 110.87 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.654 HG22 ' SG ' ' A' ' 106' ' ' CYS . 1.1 mt -106.97 128.11 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.579 0 C-N-CA 125.865 1.666 . . . . 0.0 109.168 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.8 m -119.49 114.49 22.37 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.654 ' SG ' HG22 ' A' ' 104' ' ' ILE 0.341 20.4 p -150.71 137.67 19.17 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -155.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.684 ' HG2' ' HB2' ' A' ' 110' ' ' TYR 0.765 0.0 OUTLIER -20.49 98.5 0.05 OUTLIER Pre-proline 0 CA--C 1.621 3.697 3 N-CA-C 140.664 10.987 . . . . 0.0 140.664 159.535 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.315 0.2 OUTLIER -49.62 -27.82 15.59 Favored 'Trans proline' 0 CA--C 1.589 3.27 1 O-C-N 113.337 -4.086 . . . . 0.0 118.14 173.084 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.82 -42.81 85.24 Favored 'General case' 0 CA--C 1.578 2.045 0 O-C-N 120.069 -1.644 . . . . 0.0 114.459 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.684 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 52.7 m-85 -78.11 3.87 13.91 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-O 117.367 -1.302 . . . . 0.0 113.469 171.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.452 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . . . -141.28 -103.43 0.14 Allowed 'General case' 0 CA--C 1.583 2.223 0 CA-C-N 121.943 2.156 . . . . 0.0 115.293 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.09 12.08 14.41 Favored 'General case' 0 CA--C 1.586 2.342 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -50.14 156.41 2.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 120.113 2.805 . . . . 0.0 120.113 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.283 7.8 t 73.38 -47.69 0.67 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.39 -52.83 4.16 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.03 148.52 17.89 Favored Glycine 0 CA--C 1.547 2.055 0 C-N-CA 124.35 0.976 . . . . 0.0 112.675 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.475 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.2 t -84.21 143.19 41.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.996 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.76 -39.58 57.33 Favored 'Trans proline' 0 CA--C 1.583 2.929 0 N-CA-C 120.265 3.141 . . . . 0.0 120.265 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -66.2 -62.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 CA-C-N 125.714 3.077 . . . . 0.0 116.229 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -168.57 62.64 0.06 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.475 ' HB ' ' H ' ' A' ' 117' ' ' SER . 69.3 mt -126.13 113.29 23.96 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.087 -1.633 . . . . 0.0 107.925 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.98 165.88 24.74 Favored 'Trans proline' 0 CA--C 1.583 2.946 0 C-N-CA 122.557 2.171 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.2 116.33 3.96 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.61 2.207 . . . . 0.0 112.679 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t30 67.33 53.21 0.77 Allowed 'General case' 0 CA--C 1.59 2.502 0 C-N-CA 125.423 1.489 . . . . 0.0 114.559 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.91 130.39 56.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.508 -1.37 . . . . 0.0 109.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 3.0 m -63.32 152.86 36.73 Favored 'General case' 0 CA--C 1.594 2.66 0 CA-C-N 120.552 1.524 . . . . 0.0 114.999 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.06 172.01 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 119.495 -2.003 . . . . 0.0 111.95 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.411 HG12 ' CE3' ' A' ' 59' ' ' TRP . 55.8 t -150.98 127.32 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.201 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 78.6 m-85 -142.1 127.21 18.48 Favored 'General case' 0 N--CA 1.517 2.914 0 O-C-N 119.236 -2.165 . . . . 0.0 111.198 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -98.36 101.18 12.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.407 -2.058 . . . . 0.0 106.732 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.07 140.42 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.556 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 101' ' ' LEU 1.827 30.5 tt0 -138.43 -171.71 3.11 Favored 'General case' 0 N--CA 1.524 3.232 0 CA-C-O 122.608 1.194 . . . . 0.0 109.203 164.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.532 ' H ' ' HG2' ' A' ' 132' ' ' GLU . 24.4 tp -140.94 127.07 19.54 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -162.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.82 -34.97 39.03 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 175.74 159.79 0.26 Allowed 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 127.32 2.248 . . . . 0.0 106.966 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.13 -92.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.135 -1.603 . . . . 0.0 109.593 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -81.13 55.92 2.66 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.149 0 CA-C-O 117.753 -1.582 . . . . 0.0 114.941 175.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.153 1 N-CA-C 123.933 4.333 . . . . 0.0 123.933 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.3 164.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.087 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.798 0.5 OUTLIER -163.62 -168.38 1.64 Allowed 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 120.52 1.509 . . . . 0.0 114.652 164.69 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 23.3 pttm -148.66 150.13 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 2.7 t -113.77 87.49 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 117.362 -1.304 . . . . 0.0 112.763 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.504 2.4 mm -43.95 121.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 117.195 2.295 . . . . 0.0 117.195 -177.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -106.9 -59.24 1.83 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.893 0.877 . . . . 0.0 110.166 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -142.2 106.94 4.86 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -51.33 -56.85 10.87 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 122.297 2.317 . . . . 0.0 116.342 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.63 -158.73 25.15 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 126.364 1.935 . . . . 0.0 114.63 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -78.24 2.79 17.2 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.4 45.12 95.68 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -114.44 -66.62 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.79 173.06 12.72 Favored 'General case' 0 CA--C 1.581 2.14 0 CA-C-O 122.996 1.379 . . . . 0.0 114.377 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -118.95 147.67 42.98 Favored Pre-proline 0 CA--C 1.581 2.15 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.157 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -68.09 141.72 53.74 Favored 'Trans proline' 0 CA--C 1.582 2.904 0 N-CA-C 118.318 2.392 . . . . 0.0 118.318 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -104.05 167.68 9.61 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 121.534 1.97 . . . . 0.0 112.79 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.256 2.0 tp -62.95 134.65 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.292 0 O-C-N 118.954 -2.341 . . . . 0.0 108.946 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.78 15.13 81.51 Favored Glycine 0 CA--C 1.562 3.012 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -82.95 139.64 33.24 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.374 2.087 . . . . 0.0 110.68 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 136' ' ' PHE . 1.6 tmm_? -83.03 113.35 20.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.386 2.0 t -117.99 136.75 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 C-N-CA 125.438 1.495 . . . . 0.0 112.911 -164.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -120.35 103.79 9.5 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.901 1.334 . . . . 0.0 107.815 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.461 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.6 m -107.55 164.92 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 123.481 1.61 . . . . 0.0 111.961 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.419 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.295 3.7 t60 -130.24 138.06 50.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 164.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -132.5 148.48 52.39 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.789 2.515 . . . . 0.0 117.789 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -116.59 147.62 41.68 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 162.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.9 145.59 13.47 Favored Glycine 0 CA--C 1.545 1.954 0 O-C-N 119.136 -2.227 . . . . 0.0 117.308 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.45 157.75 45.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.515 1.926 . . . . 0.0 114.466 -173.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.99 167.49 11.2 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 169.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.289 1.0 OUTLIER -61.95 -25.59 67.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -68.32 -3.73 11.98 Favored 'General case' 0 CA--C 1.595 2.696 0 CA-C-N 120.069 1.304 . . . . 0.0 112.763 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 44.19 12.41 Favored Glycine 0 N--CA 1.498 2.775 0 CA-C-N 120.334 1.424 . . . . 0.0 114.295 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.0 m -120.13 119.54 33.59 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.84 92.1 3.03 Favored 'General case' 0 CA--C 1.585 2.313 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.969 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -69.74 -30.87 68.58 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 118.891 -2.381 . . . . 0.0 114.962 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -147.0 156.61 43.17 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 125.237 2.446 . . . . 0.0 114.432 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -150.36 93.03 1.93 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.272 63.8 p -47.99 -58.73 4.05 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.635 2.458 . . . . 0.0 117.635 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.419 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 85.7 mt -51.9 -44.01 63.61 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.21 -43.87 96.91 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -136.34 35.93 2.74 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -176.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -158.95 -75.11 0.08 Allowed 'General case' 0 CA--C 1.564 1.508 0 O-C-N 120.212 -1.555 . . . . 0.0 109.834 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.13 -161.78 0.06 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 127.19 2.196 . . . . 0.0 108.913 -173.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.14 -170.5 2.76 Favored 'General case' 0 CA--C 1.591 2.526 0 O-C-N 118.935 -2.353 . . . . 0.0 107.769 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.47 1.4 t80 -123.77 148.79 46.33 Favored 'General case' 0 CA--C 1.58 2.11 0 O-C-N 118.038 -2.914 . . . . 0.0 111.14 173.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.3 p -167.07 140.89 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 118.454 -2.654 . . . . 0.0 111.973 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CG ' HG11 ' A' ' 85' ' ' VAL . 35.5 p90 -149.98 -165.44 2.27 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 121.227 0.537 . . . . 0.0 111.184 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.61 63.43 1.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.207 -1.558 . . . . 0.0 112.152 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 10.77 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.81 61.7 2.51 Favored Glycine 0 N--CA 1.511 3.664 0 O-C-N 119.767 -1.833 . . . . 0.0 112.025 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.662 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.394 0.0 OUTLIER -106.48 -85.22 0.5 Allowed 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 123.964 1.84 . . . . 0.0 111.357 -171.795 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.662 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -100.93 -43.47 2.24 Favored Glycine 0 N--CA 1.51 3.61 0 CA-C-O 124.647 2.248 . . . . 0.0 110.473 165.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 1.05 1.3 pp20? 111.49 135.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 131.605 3.962 . . . . 0.0 118.684 165.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 86' ' ' ILE 0.337 12.3 m -79.69 -99.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 109.232 -3.622 . . . . 0.0 104.428 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.535 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.3 pt -133.9 155.72 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 124.451 2.072 . . . . 0.0 105.982 165.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 13.0 tmtt? -67.35 -29.0 68.43 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.752 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.13 82.02 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 117.456 -1.259 . . . . 0.0 112.113 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.535 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.9 m0 -73.15 -43.0 62.2 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 120.882 1.674 . . . . 0.0 113.094 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.33 -36.52 71.25 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 120.034 1.288 . . . . 0.0 114.157 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.283 1.7 mp -67.68 -58.0 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 119.402 1.001 . . . . 0.0 111.452 174.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.485 ' CB ' HD13 ' A' ' 104' ' ' ILE . . . -63.16 -39.28 94.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.447 ' HA ' ' SD ' ' A' ' 96' ' ' MET . 65.2 t -63.57 -49.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.301 1.409 . . . . 0.0 111.052 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.66 -32.55 29.97 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.1 p -100.71 19.11 17.68 Favored 'General case' 0 CA--C 1.591 2.534 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 93' ' ' VAL 0.337 1.4 ptt? -115.82 -172.96 2.26 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 122.758 2.526 . . . . 0.0 116.373 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -134.88 152.32 51.65 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 66.6 t -48.17 126.83 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.83 -44.29 1.52 Allowed Glycine 0 N--CA 1.491 2.325 0 CA-C-O 115.904 -2.609 . . . . 0.0 113.455 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -145.53 -173.38 4.11 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.827 2.813 . . . . 0.0 113.264 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 102' ' ' CYS 0.704 0.2 OUTLIER -158.71 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.267 1.508 . . . . 0.0 113.97 176.242 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -160.08 -145.87 0.13 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' N ' ' SG ' ' A' ' 102' ' ' CYS 0.326 0.0 OUTLIER -122.94 113.58 19.28 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 124.952 2.31 . . . . 0.0 111.975 170.087 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.485 HD13 ' CB ' ' A' ' 92' ' ' ALA 0.316 1.4 mt -78.45 146.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 112.131 -2.304 . . . . 0.0 113.112 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 106' ' ' CYS 2.023 0.1 OUTLIER -161.05 -178.43 6.77 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 120.902 3.668 . . . . 0.0 120.902 146.969 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 111' ' ' ALA . 1.9 p -159.77 162.95 34.96 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -159.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -79.67 144.19 60.2 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-N 112.258 -2.246 . . . . 0.0 108.69 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.84 -21.35 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 N-CA-C 120.293 3.151 . . . . 0.0 120.293 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -60.23 -36.76 78.46 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.43 -3.26 58.23 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 171.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -128.7 -103.75 0.31 Allowed 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 120.483 1.492 . . . . 0.0 114.028 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.364 47.3 m-85 -106.42 -5.33 19.03 Favored 'General case' 0 N--CA 1.523 3.201 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.95 -154.83 49.28 Favored Glycine 0 N--CA 1.488 2.109 0 CA-C-N 122.462 2.392 . . . . 0.0 118.394 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -67.12 -24.57 65.93 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.63 -31.71 15.76 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.88 167.56 43.64 Favored Glycine 0 CA--C 1.552 2.382 0 CA-C-N 121.409 1.913 . . . . 0.0 114.797 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.428 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 5.9 t -86.82 114.82 60.02 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 116.843 -1.551 . . . . 0.0 107.384 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.284 85.0 Cg_exo -40.73 -49.27 4.31 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 122.202 3.885 . . . . 0.0 122.202 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.83 8.88 4.0 Favored 'Trans proline' 0 CA--C 1.577 2.646 0 CA-C-N 125.173 2.883 . . . . 0.0 118.086 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -159.09 -17.53 0.07 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.428 ' HB ' ' H ' ' A' ' 117' ' ' SER . 41.7 mt -125.17 136.63 28.42 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 121.381 1.901 . . . . 0.0 112.702 -172.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.47 170.53 13.04 Favored 'Trans proline' 0 CA--C 1.584 2.987 0 CA-C-N 122.914 2.077 . . . . 0.0 115.211 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.62 135.98 37.74 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 122.758 2.305 . . . . 0.0 114.836 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.3 t30 59.68 56.82 3.44 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 124.901 1.28 . . . . 0.0 113.334 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.56 114.8 27.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.249 -1.532 . . . . 0.0 112.194 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.2 m -68.8 144.31 54.35 Favored 'General case' 0 CA--C 1.591 2.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.716 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.466 HD12 ' HB1' ' A' ' 111' ' ' ALA . 21.3 mt -113.95 172.62 6.88 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -172.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -153.44 124.44 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.783 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.388 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 1.0 OUTLIER -141.85 130.53 22.77 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-N 124.599 3.363 . . . . 0.0 110.442 175.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -94.48 104.09 16.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.28 140.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -123.99 121.48 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.4 tp -89.25 112.4 23.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 111.955 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -81.74 -41.83 20.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -168.42 154.22 6.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.227 1.489 . . . . 0.0 109.537 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' ARG 0.275 5.8 p90 -151.45 -90.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 178.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.52 69.26 6.98 Favored 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.431 1.586 . . . . 0.0 112.194 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.829 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -178.816 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 N-CA-C 120.849 3.099 . . . . 0.0 120.849 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.36 143.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.7 tp -104.32 136.33 44.11 Favored 'General case' 0 CA--C 1.59 2.494 0 C-N-CA 127.003 2.121 . . . . 0.0 106.089 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -121.73 130.57 53.53 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 124.014 3.097 . . . . 0.0 113.406 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 4.5 t -85.75 147.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 116.613 -1.661 . . . . 0.0 110.203 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 102' ' ' CYS 0.446 0.5 OUTLIER -126.02 125.18 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-N 120.522 1.51 . . . . 0.0 110.007 170.248 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -58.75 2.05 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.611 -0.681 . . . . 0.0 111.874 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -121.94 99.26 6.35 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -56.51 174.61 0.14 Allowed 'General case' 0 CA--C 1.595 2.697 0 O-C-N 119.904 -1.748 . . . . 0.0 115.648 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.81 -165.66 37.68 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 119.215 2.446 . . . . 0.0 119.215 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -91.3 -1.81 57.55 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.69 -90.4 0.08 OUTLIER Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.653 1.569 . . . . 0.0 116.683 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 t -159.88 -25.92 0.07 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -78.75 142.95 36.6 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 p -135.67 114.05 11.09 Favored Pre-proline 0 CA--C 1.577 2.005 0 CA-C-N 109.831 -3.35 . . . . 0.0 107.528 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -67.5 -29.76 36.8 Favored 'Trans proline' 0 CA--C 1.582 2.887 0 N-CA-C 117.27 1.988 . . . . 0.0 117.27 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.524 32.2 mtt 81.29 -150.78 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.318 1.1 tp -50.5 134.17 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 O-C-N 120.585 -1.322 . . . . 0.0 113.625 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 -7.13 76.5 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 116.927 -2.041 . . . . 0.0 117.548 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -74.61 128.43 35.54 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 122.827 3.314 . . . . 0.0 112.817 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ptm85 -76.4 125.68 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.931 0.787 . . . . 0.0 109.078 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 136' ' ' PHE . 23.2 m -120.44 138.45 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.905 0.882 . . . . 0.0 112.751 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -117.18 108.06 15.21 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.7 m -119.12 160.6 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.301 6.1 m-70 -126.64 113.03 16.18 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 166.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -108.13 146.04 33.25 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.3 m -112.72 139.31 48.45 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 162.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.64 147.66 19.08 Favored Glycine 0 CA--C 1.565 3.188 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.77 171.52 20.24 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 127.93 2.492 . . . . 0.0 113.068 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -93.36 148.75 21.78 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.513 165.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.376 0.2 OUTLIER -61.74 -17.32 55.39 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.01 -28.23 66.19 Favored 'General case' 0 CA--C 1.594 2.636 0 CA-C-N 120.334 1.424 . . . . 0.0 111.823 166.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.18 52.07 0.61 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -135.34 113.19 11.0 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -68.52 120.39 14.49 Favored 'General case' 0 CA--C 1.584 2.274 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.411 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -97.46 -31.69 12.22 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 121.442 1.928 . . . . 0.0 113.498 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -154.16 165.65 35.59 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 123.24 1.495 . . . . 0.0 113.508 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -148.52 -10.38 0.36 Allowed 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.381 97.7 p 61.44 -36.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 122.846 2.566 . . . . 0.0 117.887 -176.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.81 -42.87 97.58 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 128.186 2.594 . . . . 0.0 113.746 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.71 -38.08 74.64 Favored 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.12 -21.72 63.99 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.332 33.4 ttmt 86.05 -23.57 0.15 Allowed 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 126.161 1.784 . . . . 0.0 114.7 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.266 8.3 t70 -92.87 -135.3 0.16 Allowed 'General case' 0 CA--C 1.572 1.81 0 C-N-CA 124.406 1.083 . . . . 0.0 110.477 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 168.87 21.38 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 124.743 1.217 . . . . 0.0 113.731 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.261 4.0 t80 -97.23 144.14 27.33 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.2 p -159.93 147.8 16.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.614 -2.554 . . . . 0.0 109.405 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.2 p90 -159.47 -176.58 5.86 Favored 'General case' 0 CA--C 1.589 2.447 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.278 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.54 132.66 52.55 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 118.922 -2.361 . . . . 0.0 106.307 171.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 107.84 0.63 Allowed 'General case' 0 CA--C 1.577 1.983 0 O-C-N 120.848 -1.158 . . . . 0.0 113.88 -175.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.84 6.81 Favored Glycine 0 N--CA 1.504 3.18 0 O-C-N 120.433 -1.417 . . . . 0.0 113.669 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.621 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.266 0.0 OUTLIER -107.71 -75.66 0.63 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.57 1.652 . . . . 0.0 110.812 -175.01 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.621 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -105.31 -51.95 0.85 Allowed Glycine 0 N--CA 1.502 3.097 0 CA-C-O 124.786 2.325 . . . . 0.0 108.808 167.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.723 19.8 tt0 114.75 140.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 128.376 3.941 . . . . 0.0 114.159 166.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.366 12.0 m -79.96 -100.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.106 1 CA-C-N 105.211 -5.45 . . . . 0.0 103.028 177.508 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.502 HG13 ' H ' ' A' ' 89' ' ' TRP . 41.3 pt -135.09 157.5 40.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 124.995 2.331 . . . . 0.0 105.895 165.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 12.7 tmtt? -69.39 -30.39 68.35 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 114.226 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.41 83.27 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 116.22 -1.848 . . . . 0.0 110.567 165.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.502 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.2 m0 -71.28 -44.85 64.42 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 122.074 2.216 . . . . 0.0 113.204 174.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.92 -33.37 68.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.252 1.6 mp -68.67 -58.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 120.187 1.358 . . . . 0.0 110.749 172.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.84 88.84 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.291 11.9 t -62.64 -38.06 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.235 1.379 . . . . 0.0 112.892 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.67 -34.41 64.99 Favored 'General case' 0 CA--C 1.581 2.171 0 CA-C-N 121.002 1.728 . . . . 0.0 113.804 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.7 p -84.45 -0.19 51.93 Favored 'General case' 0 CA--C 1.59 2.5 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 mtt -85.88 105.1 16.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 121.96 2.164 . . . . 0.0 114.242 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.75 141.4 49.75 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 114.779 -2.534 . . . . 0.0 106.756 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.267 1.7 t -9.64 96.13 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.54 4.032 0 CA-C-N 122.841 2.564 . . . . 0.0 112.484 -161.029 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 133' ' ' LEU . . . 18.78 -50.28 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 1 N-CA-C 129.289 6.475 . . . . 0.0 129.289 -151.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 69.24 174.35 0.29 Allowed 'General case' 0 CA--C 1.605 3.085 0 CA-C-O 123.089 1.424 . . . . 0.0 108.156 -164.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.707 HD13 ' HG3' ' A' ' 132' ' ' GLU 0.311 12.6 tp -126.45 104.42 8.15 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 123.863 1.792 . . . . 0.0 109.109 169.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.7 p -160.41 -159.29 0.68 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.767 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.776 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 2.31 0.0 OUTLIER -160.91 -139.15 0.05 Allowed 'General case' 0 CA--C 1.563 1.455 1 N-CA-C 122.603 4.297 . . . . 0.0 122.603 157.863 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 103' ' ' ARG . 8.0 mt -121.53 146.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 109.548 -3.478 . . . . 0.0 114.676 -165.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.6 m -135.48 91.32 2.71 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 13.7 p -107.41 147.75 29.99 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 -171.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -90.52 137.98 27.05 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.084 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.308 13.9 Cg_endo -54.09 -10.14 1.8 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 120.346 3.172 . . . . 0.0 120.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.35 -38.8 88.26 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 120.494 1.497 . . . . 0.0 113.695 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -86.27 -0.52 56.0 Favored 'General case' 0 CA--C 1.576 1.952 0 C-N-CA 126.059 1.743 . . . . 0.0 114.213 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.28 -111.64 0.19 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CD2' HD11 ' A' ' 127' ' ' LEU . 2.6 m-85 -93.5 0.21 56.61 Favored 'General case' 0 N--CA 1.517 2.879 0 CA-C-N 120.742 1.61 . . . . 0.0 114.952 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.69 146.16 3.6 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.928 2.731 . . . . 0.0 119.928 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.346 53.1 p 76.0 -47.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -175.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.72 -55.03 3.03 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.28 149.63 25.75 Favored Glycine 0 CA--C 1.546 1.99 0 CA-C-N 119.548 1.067 . . . . 0.0 111.471 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.45 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 7.4 t -75.44 129.19 82.68 Favored Pre-proline 0 CA--C 1.579 2.059 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.954 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.281 6.8 Cg_endo -40.43 -44.57 4.31 Favored 'Trans proline' 0 CA--C 1.579 2.763 1 N-CA-C 122.554 4.021 . . . . 0.0 122.554 -175.54 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.64 -37.07 1.87 Allowed 'Trans proline' 0 CA--C 1.572 2.396 0 CA-C-N 125.296 2.927 . . . . 0.0 118.61 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -151.48 -17.99 0.2 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 119.06 2.985 . . . . 0.0 119.06 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 117' ' ' SER . 85.5 mt -79.96 139.66 53.61 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 122.476 2.398 . . . . 0.0 114.028 -173.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -93.16 179.06 1.15 Allowed 'Trans proline' 0 CA--C 1.59 3.31 0 CA-C-N 125.332 2.94 . . . . 0.0 115.04 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -60.04 -2.9 1.92 Allowed 'Trans proline' 0 CA--C 1.576 2.607 0 N-CA-C 121.077 3.453 . . . . 0.0 121.077 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.04 92.82 1.38 Allowed 'General case' 0 CA--C 1.589 2.479 0 CA-C-N 120.991 1.723 . . . . 0.0 111.096 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.34 131.62 23.49 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 122.674 2.488 . . . . 0.0 110.216 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.0 m -74.92 128.81 36.46 Favored 'General case' 0 CA--C 1.593 2.629 0 O-C-N 120.836 -1.165 . . . . 0.0 111.63 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.474 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 71.3 mt -107.44 165.23 11.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.93 118.17 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.62 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.345 0.2 OUTLIER -140.33 107.98 5.62 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 121.035 1.743 . . . . 0.0 109.875 172.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.776 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 39.9 mt-10 -100.51 128.67 46.5 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.241 -1.537 . . . . 0.0 108.342 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.738 ' H ' ' HB2' ' A' ' 103' ' ' ARG 0.363 1.1 p -132.4 149.94 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 124.818 2.246 . . . . 0.0 116.161 -170.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.707 ' HG3' HD13 ' A' ' 101' ' ' LEU . 1.6 mp0 -102.61 120.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 111.41 -2.632 . . . . 0.0 107.007 178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 99' ' ' GLY 0.293 10.5 tp -107.96 109.32 20.78 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 121.713 2.051 . . . . 0.0 108.529 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -69.5 -55.55 9.9 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 119.726 -1.859 . . . . 0.0 114.014 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -158.6 155.25 27.94 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.737 1.732 . . . . 0.0 107.205 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.447 ' HB3' HG12 ' A' ' 52' ' ' VAL 0.255 0.0 OUTLIER -131.46 -108.86 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.244 177.114 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -102.24 83.87 2.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.623 0 N-CA-C 122.519 3.768 . . . . 0.0 122.519 -176.64 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.129 0 N-CA-C 118.221 2.048 . . . . 0.0 118.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.281 50.9 t -133.74 119.96 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.787 0.803 . . . . 0.0 111.119 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.61 139.17 37.56 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -139.86 84.7 1.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 119.476 -2.015 . . . . 0.0 106.66 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -85.89 101.24 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 115.972 -1.966 . . . . 0.0 111.7 -168.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.653 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.642 0.5 OUTLIER -65.51 133.4 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -172.47 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.48 -56.22 2.59 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.44 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -150.93 121.23 7.29 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -72.27 0.13 Allowed 'General case' 0 CA--C 1.581 2.147 0 O-C-N 119.038 -2.289 . . . . 0.0 114.409 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.98 -176.03 37.6 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 125.555 1.55 . . . . 0.0 114.488 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 t -149.91 -3.18 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.632 2.826 . . . . 0.0 118.632 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.19 -75.36 0.51 Allowed Glycine 0 N--CA 1.492 2.385 0 CA-C-N 122.095 2.225 . . . . 0.0 117.19 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.8 p -126.2 -80.73 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.341 0.57 . . . . 0.0 110.393 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -159.46 -146.92 0.15 Allowed 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.227 1.011 . . . . 0.0 110.679 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 p -94.57 168.97 10.36 Favored Pre-proline 0 CA--C 1.582 2.204 0 C-N-CA 125.443 1.497 . . . . 0.0 111.464 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -99.96 -167.1 0.08 OUTLIER 'Trans proline' 0 CA--C 1.569 2.256 0 CA-C-N 122.909 2.075 . . . . 0.0 116.196 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -137.65 146.73 44.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.06 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.609 HG23 ' H ' ' A' ' 49' ' ' GLY 0.529 0.2 OUTLIER -9.95 -123.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.807 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.609 ' H ' HG23 ' A' ' 48' ' ' ILE . . . -49.18 38.43 0.01 OUTLIER Glycine 0 N--CA 1.504 3.206 1 N-CA-C 124.042 4.377 . . . . 0.0 124.042 177.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.67 148.87 38.34 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 119.979 1.889 . . . . 0.0 112.141 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.82 134.47 41.73 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 0.9 OUTLIER -142.26 147.82 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 124.72 2.2 . . . . 0.0 112.123 -163.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.553 ' CE2' ' HG ' ' A' ' 133' ' ' LEU 0.532 4.9 p90 -79.9 -160.29 0.27 Allowed 'General case' 0 CA--C 1.589 2.462 0 C-N-CA 127.545 2.338 . . . . 0.0 114.335 168.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.908 HG23 ' HB3' ' A' ' 76' ' ' PHE 0.295 0.8 OUTLIER 157.6 147.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 127.094 2.158 . . . . 0.0 111.292 159.506 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.312 0.2 OUTLIER -127.64 111.49 13.78 Favored 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 118.592 -1.243 . . . . 0.0 107.886 164.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 37.1 p90 -101.12 174.65 5.9 Favored 'General case' 0 CA--C 1.589 2.46 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -152.91 113.89 4.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 164.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.81 136.85 8.96 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 124.652 2.251 . . . . 0.0 116.157 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.461 ' HE3' HG23 ' A' ' 128' ' ' VAL . 1.1 m-90 -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 110.615 -2.792 . . . . 0.0 112.897 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.4 tp -79.07 170.3 16.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 125.367 2.508 . . . . 0.0 108.318 168.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.255 3.1 tm? -58.82 -19.63 43.01 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 110.885 -2.87 . . . . 0.0 114.036 168.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -75.38 4.17 7.78 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 121.071 1.76 . . . . 0.0 113.038 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.27 89.45 Favored Glycine 0 N--CA 1.51 3.618 0 CA-C-N 121.41 1.914 . . . . 0.0 116.188 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -117.76 140.12 50.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -86.05 95.0 9.38 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.908 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -69.97 -35.21 74.26 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.206 -2.184 . . . . 0.0 113.929 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.65 170.17 23.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.755 1.616 . . . . 0.0 112.711 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 95.0 p -160.06 -17.57 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.29 1.3 t 69.97 -53.07 0.63 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.502 -1.999 . . . . 0.0 113.085 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.9 mt -49.99 -49.97 48.67 Favored 'General case' 0 CA--C 1.581 2.154 0 C-N-CA 127.09 2.156 . . . . 0.0 114.255 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.12 -38.45 82.25 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.553 1.168 . . . . 0.0 114.134 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -73.22 2.36 7.51 Favored 'General case' 0 CA--C 1.585 2.32 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 59.9 mttp 85.21 -18.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 175.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -120.26 175.31 6.02 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 123.442 1.592 . . . . 0.0 113.147 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -88.17 162.22 16.82 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.744 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.908 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.276 4.2 t80 -99.15 158.39 15.71 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 123.344 1.545 . . . . 0.0 107.851 173.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.4 p -170.01 144.5 2.72 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.716 -1.865 . . . . 0.0 109.214 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CG ' HG11 ' A' ' 85' ' ' VAL . 32.2 p90 -153.29 -162.23 1.43 Allowed 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.725 1.25 . . . . 0.0 110.694 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.93 118.0 14.36 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -45.13 117.15 1.27 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -174.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.82 29.77 73.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 118.41 2.124 . . . . 0.0 118.41 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -99.93 3.95 44.71 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 -172.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.2 58.88 2.02 Favored Glycine 0 N--CA 1.508 3.465 0 N-CA-C 106.301 -2.719 . . . . 0.0 106.301 -172.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -147.07 -48.95 0.18 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 111.994 -2.103 . . . . 0.0 113.121 -166.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.26 8.5 m -124.46 -148.76 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 123.571 1.653 . . . . 0.0 108.888 -174.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.37 159.02 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 124.278 1.99 . . . . 0.0 109.983 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -67.84 -31.53 71.42 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.798 -1.546 . . . . 0.0 113.402 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.68 69.92 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 117.105 -1.426 . . . . 0.0 111.764 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -74.12 -42.86 59.38 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-N 120.948 1.704 . . . . 0.0 112.514 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.74 -35.75 68.94 Favored 'General case' 0 CA--C 1.577 2.001 0 CA-C-N 119.92 1.236 . . . . 0.0 114.311 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.278 1.5 mp -65.99 -57.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 CA-C-N 120.002 1.274 . . . . 0.0 111.206 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.79 96.82 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.427 ' HA ' ' SD ' ' A' ' 96' ' ' MET 0.25 76.3 t -62.08 -46.68 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.728 1.149 . . . . 0.0 112.371 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.17 -34.24 60.0 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.7 p -94.86 -2.61 50.41 Favored 'General case' 0 CA--C 1.585 2.291 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.463 ' SD ' ' HG ' ' A' ' 101' ' ' LEU 0.262 0.8 OUTLIER -102.04 153.15 20.17 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 123.258 2.753 . . . . 0.0 115.444 -177.363 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -99.36 150.82 21.75 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 133' ' ' LEU . 63.3 t -48.15 124.43 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.594 0 C-N-CA 124.835 1.254 . . . . 0.0 112.557 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -29.12 11.62 Favored Glycine 0 N--CA 1.499 2.844 0 CA-C-O 115.051 -3.083 . . . . 0.0 115.76 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.364 2.2 tp10 -155.82 -176.3 5.88 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 123.008 3.404 . . . . 0.0 116.609 173.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.479 HD13 ' H ' ' A' ' 102' ' ' CYS 0.735 0.1 OUTLIER -159.44 -145.39 0.13 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 179.25 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -160.26 -152.41 0.29 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -170.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.5 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 12.1 ptm180 -109.29 130.5 55.49 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 123.864 1.792 . . . . 0.0 111.14 171.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.4 mt -93.81 134.65 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 112.871 -1.968 . . . . 0.0 107.329 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 m -130.16 100.43 5.41 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 9.5 p -115.45 144.97 43.04 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -172.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.15 148.84 72.05 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 116.924 -1.512 . . . . 0.0 111.474 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.267 71.7 Cg_endo -57.98 -19.06 38.46 Favored 'Trans proline' 0 C--N 1.379 2.138 0 CA-C-N 125.587 3.031 . . . . 0.0 119.095 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.38 -38.31 80.17 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 121.465 1.939 . . . . 0.0 114.407 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -79.16 -7.82 58.51 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 124.679 1.192 . . . . 0.0 114.1 169.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -121.52 -103.8 0.39 Allowed 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.735 1.607 . . . . 0.0 112.929 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.478 6.5 m-85 -106.2 -8.22 17.47 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.79 -148.21 49.12 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 t -88.74 61.9 6.2 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 122.407 1.099 . . . . 0.0 111.534 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.79 -52.8 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.406 1.483 . . . . 0.0 112.646 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.99 160.94 25.55 Favored Glycine 0 CA--C 1.544 1.873 0 C-N-CA 124.054 0.835 . . . . 0.0 114.038 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -89.24 139.29 28.58 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.021 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.64 -39.96 37.94 Favored 'Trans proline' 0 CA--C 1.586 3.122 0 N-CA-C 120.597 3.268 . . . . 0.0 120.597 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.33 -29.85 0.45 Allowed 'Trans proline' 0 CA--C 1.574 2.494 0 CA-C-N 125.425 2.973 . . . . 0.0 119.667 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -148.38 -29.34 0.3 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 119.422 3.119 . . . . 0.0 119.422 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mt -79.98 122.1 82.82 Favored Pre-proline 0 CA--C 1.585 2.326 0 CA-C-N 120.467 1.485 . . . . 0.0 113.854 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.69 177.85 2.58 Favored 'Trans proline' 0 CA--C 1.584 2.993 0 C-N-CA 123.119 2.546 . . . . 0.0 117.458 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -50.28 -19.84 4.97 Favored 'Trans proline' 0 CA--C 1.567 2.151 1 N-CA-C 122.927 4.164 . . . . 0.0 122.927 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -160.13 94.87 1.12 Allowed 'General case' 0 CA--C 1.583 2.233 0 CA-C-N 120.671 1.578 . . . . 0.0 106.885 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -147.23 141.9 26.66 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 123.001 2.637 . . . . 0.0 112.436 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -71.44 158.01 37.04 Favored 'General case' 0 CA--C 1.591 2.54 0 O-C-N 121.221 -0.924 . . . . 0.0 112.743 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.533 HD12 ' HB1' ' A' ' 111' ' ' ALA . 9.2 mt -129.18 161.35 30.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 119.555 -1.966 . . . . 0.0 112.762 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.461 HG23 ' HE3' ' A' ' 59' ' ' TRP . 12.5 m -144.04 135.97 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 110.798 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 2.4 m-85 -136.15 127.43 28.27 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.71 1.243 . . . . 0.0 109.225 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.88 102.26 14.37 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.69 152.06 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.294 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -133.97 133.2 41.07 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 53' ' ' PHE . 4.6 tt -94.8 143.74 26.21 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -106.33 -60.67 1.62 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -177.29 134.17 0.18 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 125.784 2.707 . . . . 0.0 106.682 -173.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.429 ' CE2' HD11 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -118.88 -111.66 0.34 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.6 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.401 42.0 tptt -119.65 -119.1 0.31 Allowed 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 171.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.009 0 CA-C-N 125.721 3.873 . . . . 0.0 120.977 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.374 1 N-CA-C 125.542 4.977 . . . . 0.0 125.542 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.305 67.8 t -141.52 144.98 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 123.002 3.401 . . . . 0.0 117.122 -169.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.2 135.99 48.61 Favored 'General case' 0 CA--C 1.585 2.318 0 C-N-CA 126.724 2.009 . . . . 0.0 109.703 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -128.86 112.55 14.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 123.694 2.952 . . . . 0.0 111.835 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.1 101.01 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.014 -1.053 . . . . 0.0 113.261 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.513 ' HA ' ' SG ' ' A' ' 102' ' ' CYS 0.304 2.6 mm -52.07 128.05 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -118.08 -42.57 2.8 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.707 1.203 . . . . 0.0 112.546 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -129.06 112.85 14.44 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.53 -173.01 4.14 Favored 'General case' 0 CA--C 1.598 2.802 0 CA-C-N 121.171 1.805 . . . . 0.0 115.833 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.8 158.67 36.64 Favored Glycine 0 N--CA 1.492 2.382 1 N-CA-C 123.559 4.183 . . . . 0.0 123.559 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -129.15 -72.81 0.59 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.57 114.76 3.98 Favored Glycine 0 CA--C 1.55 2.245 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -58.68 -14.41 8.36 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.7 148.29 42.83 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.0 m -148.52 96.4 3.89 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-N 110.652 -2.977 . . . . 0.0 107.096 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.441 0.5 OUTLIER -104.88 1.2 0.24 Allowed 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 119.818 2.969 . . . . 0.0 119.818 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.533 39.5 mtm 76.79 -140.19 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 164.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 1.1 tp -48.09 136.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 CA-C-O 122.157 0.979 . . . . 0.0 113.347 -174.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.91 -6.62 83.22 Favored Glycine 0 CA--C 1.551 2.344 0 CA-C-O 116.781 -2.122 . . . . 0.0 118.143 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -73.88 128.62 35.99 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 122.62 3.21 . . . . 0.0 113.762 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -78.37 112.48 15.43 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.4 138.96 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.65 104.14 11.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.49 166.29 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 CA-C-O 123.145 1.45 . . . . 0.0 112.556 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.92 113.7 17.54 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.742 170.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -117.87 151.81 36.64 Favored 'General case' 0 CA--C 1.582 2.191 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 97.4 m -127.43 143.26 51.23 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.93 143.08 11.47 Favored Glycine 0 CA--C 1.555 2.589 0 O-C-N 119.984 -1.698 . . . . 0.0 116.87 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.77 151.66 48.73 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 127.479 2.312 . . . . 0.0 112.499 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.39 175.75 9.15 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 123.465 1.603 . . . . 0.0 108.543 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 tp -60.35 -31.65 70.53 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.46 8.07 1.55 Allowed 'General case' 0 CA--C 1.596 2.713 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.59 36.05 82.36 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 119.697 -1.877 . . . . 0.0 114.808 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 m -111.1 119.57 39.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -76.49 112.29 12.85 Favored 'General case' 0 CA--C 1.588 2.442 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.779 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -85.09 -35.19 21.97 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 122.686 2.494 . . . . 0.0 113.689 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.51 158.08 43.85 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 123.469 1.604 . . . . 0.0 113.099 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 t -156.37 100.71 1.99 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.949 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 t -59.72 -40.33 87.62 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.82 -46.1 78.17 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.262 1.425 . . . . 0.0 114.411 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.32 -39.62 68.08 Favored 'General case' 0 CA--C 1.579 2.094 0 C-N-CA 124.82 1.248 . . . . 0.0 113.776 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 -13.15 47.37 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 51.4 mtmt 91.95 -35.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 126.808 2.043 . . . . 0.0 115.334 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -88.53 170.69 10.66 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 123.804 1.764 . . . . 0.0 111.997 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.74 168.66 9.53 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.577 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.278 5.9 t80 -104.83 145.26 30.63 Favored 'General case' 0 CA--C 1.574 1.892 0 O-C-N 120.44 -1.413 . . . . 0.0 109.273 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.1 p -155.66 128.18 7.83 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.814 -1.803 . . . . 0.0 110.095 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.8 p90 -143.16 -175.38 4.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 123.591 0.756 . . . . 0.0 110.194 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' LYS 0.263 13.4 t0 -128.06 124.81 37.96 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 118.796 -2.44 . . . . 0.0 105.551 174.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.9 104.92 0.09 Allowed 'General case' 0 CA--C 1.579 2.064 0 C-N-CA 124.69 1.196 . . . . 0.0 114.064 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.74 37.72 95.12 Favored Glycine 0 N--CA 1.512 3.721 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 -173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 5.0 mtpt -132.82 -70.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 124.668 1.187 . . . . 0.0 110.636 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.42 74.18 0.21 Allowed Glycine 0 N--CA 1.495 2.586 1 N-CA-C 100.782 -4.927 . . . . 0.0 100.782 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.326 47.8 tp10 -71.91 150.61 44.02 Favored 'General case' 0 CA--C 1.554 1.116 1 CA-C-O 130.25 4.833 . . . . 0.0 116.693 -165.363 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.349 31.4 m -98.46 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 1 CA-C-N 101.55 -7.114 . . . . 0.0 107.087 -174.02 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 89' ' ' TRP . 19.3 pt -110.97 159.05 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 124.418 2.056 . . . . 0.0 109.153 171.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -32.41 72.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.745 -1.57 . . . . 0.0 113.257 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.66 -35.48 74.51 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 116.826 -1.559 . . . . 0.0 111.677 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.45 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.0 m0 -77.43 -41.6 39.22 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.323 1.874 . . . . 0.0 112.378 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.66 -34.1 69.02 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 120.017 1.28 . . . . 0.0 113.885 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.2 mp -66.66 -57.08 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 120.098 1.317 . . . . 0.0 110.968 172.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.51 90.17 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.538 HG22 ' CE ' ' A' ' 96' ' ' MET . 99.6 t -63.03 -38.72 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-N 118.967 0.803 . . . . 0.0 112.906 173.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.71 -36.8 70.09 Favored 'General case' 0 CA--C 1.58 2.12 0 CA-C-N 120.282 1.401 . . . . 0.0 113.445 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -82.32 11.37 5.53 Favored 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.538 ' CE ' HG22 ' A' ' 93' ' ' VAL . 43.3 mtt -94.01 134.92 35.91 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 121.636 2.016 . . . . 0.0 116.103 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.3 163.26 15.43 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 164.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 64.5 t -57.73 131.66 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.943 0 O-C-N 117.899 -3.0 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.53 -21.19 30.48 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 124.172 3.169 . . . . 0.0 114.275 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.64 163.87 27.39 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 120.4 2.1 . . . . 0.0 113.695 176.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.671 HD13 ' H ' ' A' ' 102' ' ' CYS 1.751 0.1 OUTLIER 162.43 155.76 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.797 2.039 . . . . 0.0 113.921 168.009 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.671 ' H ' HD13 ' A' ' 101' ' ' LEU 0.345 81.9 m -143.44 178.97 7.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.998 1.319 . . . . 0.0 112.872 -167.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.479 ' HB3' ' HG2' ' A' ' 130' ' ' GLU 0.301 0.0 OUTLIER -93.64 119.53 32.77 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 124.483 2.087 . . . . 0.0 107.93 171.171 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.56 118.56 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 CA-C-N 111.489 -2.596 . . . . 0.0 108.922 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -112.15 103.26 11.42 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.3 p -119.21 141.14 49.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -171.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.01 141.97 87.21 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.295 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -60.46 -19.97 61.51 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 N-CA-C 119.35 2.788 . . . . 0.0 119.35 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.7 -33.48 75.18 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 122.62 2.463 . . . . 0.0 113.603 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.5 -7.84 54.35 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.76 -101.87 0.42 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 120.076 1.307 . . . . 0.0 111.847 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.257 0.3 OUTLIER -124.56 14.64 8.8 Favored 'General case' 0 CA--C 1.592 2.574 0 CA-C-N 120.431 1.469 . . . . 0.0 113.872 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.05 -31.17 39.85 Favored Glycine 0 N--CA 1.497 2.765 1 N-CA-C 123.105 4.002 . . . . 0.0 123.105 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.9 m -66.66 -11.81 55.52 Favored 'General case' 0 CA--C 1.585 2.319 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.61 -60.15 0.19 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 124.945 1.298 . . . . 0.0 113.284 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.73 152.6 7.22 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.533 1.54 . . . . 0.0 110.792 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 t -81.8 126.54 75.18 Favored Pre-proline 0 CA--C 1.579 2.067 0 CA-C-O 116.647 -1.644 . . . . 0.0 108.993 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -40.38 -43.69 4.07 Favored 'Trans proline' 0 CA--C 1.581 2.871 0 N-CA-C 121.733 3.705 . . . . 0.0 121.733 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.6 -9.79 6.6 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 CA-C-N 125.165 2.88 . . . . 0.0 119.042 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -160.57 -43.68 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.9 125.18 82.57 Favored Pre-proline 0 CA--C 1.58 2.105 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -88.54 171.13 5.3 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 C-N-CA 122.662 2.241 . . . . 0.0 112.301 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.85 -42.15 33.15 Favored 'Trans proline' 0 CA--C 1.574 2.519 0 N-CA-C 117.917 2.237 . . . . 0.0 117.917 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -90.76 61.34 4.74 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.462 -1.399 . . . . 0.0 112.621 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.23 113.62 5.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.044 -1.66 . . . . 0.0 111.972 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -65.06 155.79 33.59 Favored 'General case' 0 CA--C 1.591 2.553 0 C-N-CA 124.107 0.963 . . . . 0.0 112.793 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 mt -114.74 162.75 16.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 124.525 2.107 . . . . 0.0 112.297 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 114.8 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 CA-C-N 112.703 -2.044 . . . . 0.0 108.83 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 1.3 m-85 -131.38 123.9 29.2 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 122.711 2.505 . . . . 0.0 111.756 175.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.479 ' HG2' ' HB3' ' A' ' 103' ' ' ARG . 90.8 mt-10 -91.97 110.28 21.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . 0.28 1.3 p -138.31 145.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 122.343 1.068 . . . . 0.0 112.248 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 41.0 tt0 -136.23 133.58 37.2 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.813 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 tp -93.8 130.33 39.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.69 -51.67 6.3 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.536 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -164.2 154.74 15.08 Favored 'General case' 0 CA--C 1.575 1.923 0 C-N-CA 125.455 1.502 . . . . 0.0 108.522 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.266 0.0 OUTLIER -130.33 -115.15 0.24 Allowed 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 110.239 177.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -122.26 119.29 30.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 -178.396 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 117.071 1.588 . . . . 0.0 117.071 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -162.75 137.07 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.88 145.99 29.31 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 125.885 1.674 . . . . 0.0 109.041 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -130.89 125.61 33.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 122.621 2.464 . . . . 0.0 111.797 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.2 t -102.04 93.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.367 0.3 OUTLIER -79.24 134.53 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.849 -1.157 . . . . 0.0 111.54 178.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.89 -68.2 0.94 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.581 0.705 . . . . 0.0 111.101 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -99.01 95.32 7.06 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.9 167.33 11.77 Favored 'General case' 0 CA--C 1.59 2.512 0 O-C-N 120.044 -1.66 . . . . 0.0 113.749 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.57 170.92 41.83 Favored Glycine 0 CA--C 1.55 2.24 0 O-C-N 119.53 -1.981 . . . . 0.0 117.959 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 p -78.36 -70.72 0.47 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.27 54.04 0.1 Allowed Glycine 0 N--CA 1.482 1.766 0 C-N-CA 124.674 1.131 . . . . 0.0 113.727 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -140.38 17.05 2.4 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 55.74 -179.04 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 121.588 3.921 . . . . 0.0 121.588 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -116.85 120.59 33.88 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.396 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HG2' ' HB3' ' A' ' 137' ' ' LYS . 70.9 Cg_exo -66.46 -20.57 54.29 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 117.985 2.263 . . . . 0.0 117.985 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.515 8.7 mtt 80.2 -165.99 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.423 0.4 OUTLIER -39.65 125.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -169.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.79 88.41 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -76.75 142.82 40.29 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 122.857 3.329 . . . . 0.0 113.556 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' PHE . 18.4 ptp180 -73.84 137.84 44.04 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.31 -1.494 . . . . 0.0 109.778 177.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.32 2.1 t -135.27 144.51 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 119.752 1.16 . . . . 0.0 112.688 -167.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -125.87 100.99 6.63 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.84 167.1 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 127.174 2.19 . . . . 0.0 112.138 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.15 127.57 36.21 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.564 160.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -119.43 155.69 31.54 Favored 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.6 m -125.31 138.56 54.07 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 159.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.53 145.73 14.47 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 123.347 2.794 . . . . 0.0 117.93 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -134.09 153.04 52.06 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 112.625 -1.787 . . . . 0.0 114.615 -175.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.09 170.67 14.56 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 123.042 1.401 . . . . 0.0 108.642 170.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER -60.43 -26.35 66.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 178.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.68 9.63 3.29 Favored 'General case' 0 CA--C 1.593 2.631 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.1 38.38 73.27 Favored Glycine 0 N--CA 1.509 3.538 0 CA-C-N 121.341 1.882 . . . . 0.0 114.819 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 m -109.34 114.47 28.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -79.71 90.89 5.22 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -69.75 -30.88 68.57 Favored 'General case' 0 CA--C 1.559 1.306 0 O-C-N 119.696 -1.877 . . . . 0.0 114.424 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -154.47 148.11 25.3 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 121.603 2.001 . . . . 0.0 111.345 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 m -145.91 94.76 2.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.526 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 t -57.48 -39.22 75.95 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.15 -44.08 83.11 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -73.86 -42.18 61.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -61.33 -19.51 61.89 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.39 74.4 mmtt 96.63 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.177 2.191 . . . . 0.0 113.192 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.64 152.54 31.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.04 1.4 . . . . 0.0 113.665 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.05 171.45 10.72 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.493 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.252 9.2 t80 -105.23 157.72 17.09 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.092 0.949 . . . . 0.0 109.235 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.7 p -157.89 145.71 18.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 119.295 -2.128 . . . . 0.0 110.313 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 85' ' ' VAL . 23.8 p90 -155.15 -173.36 4.53 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.875 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -123.05 123.07 40.03 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -49.15 112.0 0.56 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -172.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.97 47.79 82.26 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -107.21 14.16 26.48 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.88 -42.67 2.37 Favored Glycine 0 N--CA 1.51 3.614 0 O-C-N 120.782 -1.199 . . . . 0.0 111.41 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.279 8.3 tp10 -28.8 -48.96 0.07 Allowed 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 129.386 3.075 . . . . 0.0 118.805 169.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.255 9.3 m -117.61 -147.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 CA-C-O 124.066 1.888 . . . . 0.0 109.785 -175.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.4 pt -110.93 160.77 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 124.104 1.907 . . . . 0.0 110.238 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -32.67 73.25 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.018 -1.446 . . . . 0.0 113.205 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.06 70.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.016 -1.469 . . . . 0.0 112.443 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.27 -42.52 54.84 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.967 1.712 . . . . 0.0 112.423 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.84 -37.73 71.67 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -68.1 -56.74 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.056 0 CA-C-N 119.885 1.22 . . . . 0.0 111.191 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.65 94.54 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.4 t -67.59 -46.23 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.571 1.078 . . . . 0.0 111.736 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.25 62.78 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p -92.22 4.29 53.57 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.429 ' SD ' ' OE2' ' A' ' 132' ' ' GLU . 4.6 ptt? -116.48 119.51 35.85 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 122.304 2.32 . . . . 0.0 112.185 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -78.56 148.69 33.25 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.152 -1.593 . . . . 0.0 108.72 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.6 t -9.47 79.43 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 C-N-CA 125.299 1.44 . . . . 0.0 109.001 -158.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.55 ' H ' HD22 ' A' ' 133' ' ' LEU . . . -20.46 -29.45 0.0 OUTLIER Glycine 1 N--CA 1.523 4.437 1 N-CA-C 127.783 5.873 . . . . 0.0 127.783 -144.585 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.663 0.3 OUTLIER 52.97 -125.57 2.4 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 115.581 -2.152 . . . . 0.0 111.549 -161.897 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 132' ' ' GLU 0.461 0.9 OUTLIER -136.15 132.96 36.69 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.446 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 132' ' ' GLU 2.674 5.7 m -160.27 -151.98 0.27 Allowed 'General case' 0 CA--C 1.589 2.477 0 CA-C-N 120.224 1.375 . . . . 0.0 114.489 177.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -143.36 158.85 43.3 Favored 'General case' 0 CA--C 1.575 1.942 0 O-C-N 120.108 -1.62 . . . . 0.0 113.662 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.39 143.87 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 C-N-CA 126.128 1.771 . . . . 0.0 110.543 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.3 m -140.09 104.5 4.85 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.1 p -118.87 147.12 44.31 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -172.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -80.71 148.13 64.58 Favored Pre-proline 0 CA--C 1.581 2.166 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.647 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -36.43 -33.06 0.12 Allowed 'Trans proline' 0 CA--C 1.567 2.144 0 N-CA-C 122.079 3.838 . . . . 0.0 122.079 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.1 -44.66 91.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -78.86 -5.96 54.89 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 116.187 -1.863 . . . . 0.0 114.328 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.43 -153.25 0.5 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 122.324 2.329 . . . . 0.0 114.288 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.283 0.1 OUTLIER -82.11 11.42 5.26 Favored 'General case' 0 CA--C 1.575 1.921 0 O-C-N 119.22 -2.175 . . . . 0.0 113.582 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.36 -38.57 45.23 Favored Glycine 0 CA--C 1.553 2.441 0 CA-C-N 124.027 3.103 . . . . 0.0 115.354 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 p -70.78 -51.58 26.06 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 118.316 1.058 . . . . 0.0 113.761 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.98 -34.48 14.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.91 141.96 12.81 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.039 1.29 . . . . 0.0 113.646 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.478 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 2.0 t -95.42 146.17 30.84 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.834 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -41.52 -43.23 5.99 Favored 'Trans proline' 0 CA--C 1.584 3.023 0 C-N-CA 123.65 2.9 . . . . 0.0 119.107 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.72 57.25 6.28 Favored 'Trans proline' 0 CA--C 1.585 3.036 0 CA-C-N 125.325 2.937 . . . . 0.0 115.425 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 61.93 33.39 17.48 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.325 3.454 . . . . 0.0 120.325 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.478 ' HB ' ' H ' ' A' ' 117' ' ' SER . 11.9 mt -82.91 117.56 68.96 Favored Pre-proline 0 CA--C 1.59 2.485 0 O-C-N 120.127 -1.608 . . . . 0.0 108.768 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -90.31 178.02 2.23 Favored 'Trans proline' 0 CA--C 1.585 3.061 0 CA-C-N 123.483 2.279 . . . . 0.0 116.179 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.41 151.19 54.69 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.072 2.515 . . . . 0.0 117.621 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.252 38.4 t-20 59.62 44.0 15.05 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -177.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.4 105.5 15.46 Favored 'General case' 0 CA--C 1.562 1.436 0 O-C-N 120.534 -1.354 . . . . 0.0 110.35 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.8 m -66.01 150.18 49.08 Favored 'General case' 0 CA--C 1.592 2.562 0 O-C-N 120.843 -1.161 . . . . 0.0 111.651 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.5 tp -132.64 157.48 44.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.552 -1.968 . . . . 0.0 111.663 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.494 HG23 ' HE3' ' A' ' 59' ' ' TRP . 22.3 m -147.05 144.03 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 O-C-N 121.043 -1.036 . . . . 0.0 112.043 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -146.97 134.68 21.11 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.977 -1.077 . . . . 0.0 109.98 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -88.21 112.97 23.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.39 152.94 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.243 -0.91 . . . . 0.0 111.136 -168.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.644 ' CB ' ' HA ' ' A' ' 101' ' ' LEU 0.777 0.2 OUTLIER -154.56 -164.25 1.78 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 116.781 2.141 . . . . 0.0 116.781 164.011 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 99' ' ' GLY . 5.6 tt -145.0 133.28 21.67 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.819 1.295 . . . . 0.0 113.376 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.13 -47.71 7.64 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.94 151.07 23.09 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.283 1.433 . . . . 0.0 108.895 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.447 ' CD2' HD11 ' A' ' 133' ' ' LEU 0.294 0.0 OUTLIER -143.21 -101.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.629 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 46' ' ' PRO 0.421 13.1 tmtt? -111.01 -132.66 0.33 Allowed 'General case' 0 CA--C 1.588 2.418 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.697 0 CA-C-N 124.631 3.378 . . . . 0.0 113.923 177.791 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.373 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.254 60.4 t -135.5 135.45 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 CA-C-O 122.648 1.213 . . . . 0.0 113.842 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -91.41 114.19 26.65 Favored 'General case' 0 CA--C 1.584 2.27 0 CA-C-O 116.614 -1.66 . . . . 0.0 107.956 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -112.39 90.37 3.32 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 124.101 3.137 . . . . 0.0 108.205 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.87 130.33 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.436 -173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.303 1.0 OUTLIER -82.2 130.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 122.671 1.224 . . . . 0.0 113.133 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -110.81 -56.33 2.37 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.002 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.36 96.19 3.06 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.24 166.96 1.96 Allowed 'General case' 0 CA--C 1.59 2.495 0 CA-C-N 122.551 2.432 . . . . 0.0 116.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.35 -170.65 37.25 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 120.654 3.021 . . . . 0.0 120.654 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 t -81.02 15.33 1.89 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.46 34.04 68.05 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.5 p -122.6 26.83 8.11 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.8 1.24 . . . . 0.0 113.882 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.451 7.4 pt-20 40.41 -154.92 0.01 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.91 115.65 5.61 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 124.476 1.11 . . . . 0.0 111.191 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -41.26 -28.85 0.53 Allowed 'Trans proline' 0 CA--C 1.583 2.956 1 N-CA-C 122.626 4.049 . . . . 0.0 122.626 165.137 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.541 44.5 mtm 84.79 -141.56 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.29 1.1 tp -52.01 135.87 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 O-C-N 120.224 -1.548 . . . . 0.0 112.847 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.15 4.94 86.2 Favored Glycine 0 CA--C 1.553 2.442 0 CA-C-O 116.859 -2.078 . . . . 0.0 117.884 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.48 136.44 36.31 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 122.681 3.241 . . . . 0.0 112.577 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.51 98.2 11.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 136' ' ' PHE . 29.9 m -93.68 141.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -167.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.18 107.78 14.87 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 76' ' ' PHE . 3.1 m -114.11 165.95 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 123.272 1.511 . . . . 0.0 113.685 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.254 0.1 OUTLIER -132.11 113.36 13.23 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.075 167.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -105.91 161.21 14.65 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 124.019 1.866 . . . . 0.0 113.881 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.7 m -134.22 133.35 40.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 159.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.05 164.79 26.1 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 122.072 2.215 . . . . 0.0 118.048 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.596 ' HE3' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -148.34 155.98 41.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -173.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -85.1 172.19 11.44 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 123.469 1.604 . . . . 0.0 108.877 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.13 -33.82 74.0 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.301 0.2 OUTLIER -69.5 2.94 2.66 Favored 'General case' 0 CA--C 1.592 2.565 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 173.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.88 44.68 23.83 Favored Glycine 0 N--CA 1.503 3.106 0 CA-C-N 119.564 1.074 . . . . 0.0 114.174 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.9 m -120.77 119.81 33.83 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -78.98 97.24 5.98 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.152 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.01 -34.82 71.71 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.263 -2.148 . . . . 0.0 114.944 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.95 175.75 9.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -154.19 -77.1 0.11 Allowed 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.427 1.6 t 111.4 -40.05 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 128.775 2.83 . . . . 0.0 109.205 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.14 -34.81 15.06 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 169.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.95 -35.71 62.04 Favored 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -94.82 -85.01 0.32 Allowed 'General case' 0 CA--C 1.575 1.907 0 C-N-CA 124.716 1.206 . . . . 0.0 110.13 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? 175.32 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 127.29 2.236 . . . . 0.0 107.959 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -22.45 -37.92 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 1 N-CA-C 127.229 6.011 . . . . 0.0 127.229 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.441 53.2 pttt 71.53 -175.11 0.18 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.467 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.328 2.8 t80 -118.68 146.93 44.32 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.104 174.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.7 p -160.63 130.67 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 119.309 -2.119 . . . . 0.0 108.709 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.508 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.8 p90 -141.79 -173.71 3.87 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 123.216 0.607 . . . . 0.0 109.788 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.74 128.42 47.72 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 118.843 -2.411 . . . . 0.0 106.306 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.07 107.33 0.46 Allowed 'General case' 0 CA--C 1.578 2.038 0 O-C-N 121.314 -0.866 . . . . 0.0 112.536 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.61 56.32 5.56 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.024 -1.047 . . . . 0.0 114.802 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -102.17 -64.43 1.06 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 124.498 2.094 . . . . 0.0 112.963 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.63 -55.93 0.13 Allowed Glycine 0 N--CA 1.503 3.104 0 C-N-CA 128.86 3.124 . . . . 0.0 107.096 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.824 23.8 tt0 119.05 143.25 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 128.145 3.831 . . . . 0.0 116.807 162.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.347 14.1 m -79.87 -106.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.001 1 CA-C-N 105.319 -5.4 . . . . 0.0 104.962 -178.626 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -125.43 152.91 32.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 124.737 2.208 . . . . 0.0 105.538 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.27 -31.67 72.96 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 113.28 -1.782 . . . . 0.0 113.697 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.07 82.92 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.047 1.339 . . . . 0.0 111.391 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.544 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.9 m0 -70.46 -42.5 71.39 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 120.638 1.563 . . . . 0.0 112.549 172.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.0 -36.44 74.93 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 120.005 1.275 . . . . 0.0 114.185 172.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.259 1.3 mp -66.3 -56.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.274 1.397 . . . . 0.0 111.685 173.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.55 -45.31 91.12 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.285 75.8 t -65.04 -41.5 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 120.412 1.46 . . . . 0.0 112.531 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.58 64.63 Favored 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 120.336 1.426 . . . . 0.0 114.465 171.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 p -95.49 -6.97 39.39 Favored 'General case' 0 CA--C 1.588 2.411 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 38.6 mtp -96.69 123.11 40.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 121.597 1.999 . . . . 0.0 112.52 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -77.99 179.88 6.5 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.99 125.94 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.733 0 O-C-N 120.522 -1.361 . . . . 0.0 111.03 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.92 81.36 Favored Glycine 0 N--CA 1.515 3.934 0 CA-C-N 122.724 2.511 . . . . 0.0 116.901 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.63 132.1 41.46 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.474 2.137 . . . . 0.0 115.364 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.74 114.77 28.39 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.063 0.945 . . . . 0.0 111.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.2 m -136.53 159.56 41.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -109.73 127.24 54.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 123.845 1.783 . . . . 0.0 109.286 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.2 mt -92.58 118.59 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.395 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 104.53 11.93 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 7.7 p -118.49 148.56 42.49 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -89.02 142.19 30.04 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.495 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -42.54 -26.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 124.812 3.674 . . . . 0.0 121.413 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -31.94 72.96 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 121.314 1.87 . . . . 0.0 114.555 172.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -91.33 -9.75 43.83 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 125.472 1.509 . . . . 0.0 113.098 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.44 -112.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.196 1.816 . . . . 0.0 112.655 -176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.329 1.3 m-85 -113.79 21.03 15.35 Favored 'General case' 0 CA--C 1.588 2.411 0 CA-C-N 121.219 1.827 . . . . 0.0 113.751 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.2 -15.92 4.15 Favored Glycine 0 N--CA 1.501 2.99 1 N-CA-C 124.332 4.493 . . . . 0.0 124.332 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -71.69 -65.59 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.656 2.228 . . . . 0.0 112.063 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.29 10.4 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.38 160.28 36.38 Favored Glycine 0 CA--C 1.547 2.055 0 CA-C-N 122.144 2.247 . . . . 0.0 112.882 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -81.45 123.68 80.89 Favored Pre-proline 0 CA--C 1.577 2.008 0 O-C-N 120.258 -1.731 . . . . 0.0 107.736 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -33.69 -45.09 0.34 Allowed 'Trans proline' 0 CA--C 1.582 2.891 0 N-CA-C 121.99 3.804 . . . . 0.0 121.99 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -86.88 -16.97 3.32 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 CA-C-N 125.097 2.856 . . . . 0.0 118.948 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -159.09 -38.29 0.06 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.82 129.59 70.25 Favored Pre-proline 0 CA--C 1.581 2.143 0 O-C-N 120.195 -1.566 . . . . 0.0 113.897 -172.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.82 163.17 5.07 Favored 'Trans proline' 0 CA--C 1.586 3.121 0 CA-C-N 123.572 2.312 . . . . 0.0 113.202 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 8.95 0.45 Allowed 'Trans proline' 0 CA--C 1.576 2.619 0 N-CA-C 120.505 3.233 . . . . 0.0 120.505 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -139.68 62.79 1.51 Allowed 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.302 -1.499 . . . . 0.0 110.11 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.3 137.06 17.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.964 -1.71 . . . . 0.0 111.149 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.2 m -72.96 150.16 42.74 Favored 'General case' 0 CA--C 1.588 2.428 0 O-C-N 120.485 -1.385 . . . . 0.0 111.202 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.342 0.2 OUTLIER -134.78 167.33 21.06 Favored 'General case' 0 CA--C 1.574 1.895 0 O-C-N 118.685 -2.509 . . . . 0.0 109.524 176.11 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.596 HG13 ' HE3' ' A' ' 59' ' ' TRP . 1.6 p -141.22 146.35 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.846 -1.159 . . . . 0.0 112.02 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.288 0.6 OUTLIER -145.77 124.94 12.9 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.88 0.848 . . . . 0.0 110.501 169.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.41 115.25 24.7 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 t -124.26 134.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.026 0.917 . . . . 0.0 112.382 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -107.43 124.45 49.88 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 136' ' ' PHE . 57.2 tp -103.31 119.38 38.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.85 -49.12 8.68 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -170.61 170.58 6.71 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.469 1.908 . . . . 0.0 108.122 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.416 ' CD2' HD21 ' A' ' 133' ' ' LEU 0.255 5.7 p90 -154.94 -81.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 119.951 -1.718 . . . . 0.0 112.395 -175.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.412 77.2 tttt -119.98 -136.38 0.33 Allowed 'General case' 0 CA--C 1.594 2.644 0 C-N-CA 124.512 1.125 . . . . 0.0 108.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.351 0 O-C-N 117.465 -3.272 . . . . 0.0 112.561 -179.136 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.45 1 N-CA-C 123.739 4.255 . . . . 0.0 123.739 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -142.75 125.29 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 124.278 0.634 . . . . 0.0 111.859 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -100.6 143.69 30.47 Favored 'General case' 0 CA--C 1.587 2.39 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.314 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -120.61 113.64 20.54 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-N 124.054 3.116 . . . . 0.0 111.434 -176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.51 92.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.505 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.311 0.4 OUTLIER -76.95 135.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 120.887 -1.133 . . . . 0.0 110.26 178.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -121.09 -56.95 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.458 0.703 . . . . 0.0 111.898 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -118.6 99.73 6.99 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.96 142.71 52.83 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 119.178 -2.201 . . . . 0.0 112.614 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.49 163.54 42.73 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 119.99 -1.693 . . . . 0.0 116.638 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.3 p -121.34 -79.41 0.61 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.142 -176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 2.73 -85.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.204 0 N-CA-C 122.116 3.606 . . . . 0.0 122.116 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.404 ' H ' HG21 ' A' ' 98' ' ' VAL . 69.8 p -117.21 26.64 9.63 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.381 6.5 mt-10 55.24 -153.68 0.32 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 176.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -110.58 122.39 38.51 Favored Pre-proline 0 CA--C 1.572 1.801 0 O-C-N 120.559 -1.338 . . . . 0.0 108.497 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.397 0.2 OUTLIER -115.65 -87.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 N-CA-C 119.159 2.715 . . . . 0.0 119.159 -176.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -157.74 171.1 20.91 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 120.847 3.647 . . . . 0.0 120.847 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.36 132.41 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.763 0 CA-C-O 122.874 1.321 . . . . 0.0 109.932 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.85 3.39 68.34 Favored Glycine 0 CA--C 1.558 2.778 0 CA-C-O 116.836 -2.091 . . . . 0.0 118.186 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.79 141.24 56.59 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-N 122.624 3.212 . . . . 0.0 112.82 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -84.47 96.18 9.03 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.086 1.766 . . . . 0.0 108.353 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.31 135.09 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.99 100.46 8.89 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.76 164.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 127.356 2.263 . . . . 0.0 113.719 -172.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.79 124.4 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.583 160.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -115.03 156.87 24.33 Favored 'General case' 0 CA--C 1.593 2.608 0 CA-C-O 122.52 1.153 . . . . 0.0 111.058 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -130.36 138.51 50.44 Favored 'General case' 0 N--CA 1.515 2.792 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 160.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.08 140.71 8.57 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-N 123.329 2.786 . . . . 0.0 117.902 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.19 159.54 42.02 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 127.275 2.23 . . . . 0.0 115.057 -176.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -76.73 177.34 7.65 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.603 1.192 . . . . 0.0 109.594 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.345 0.0 OUTLIER -62.84 -27.06 69.07 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 176.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.9 13.97 0.94 Allowed 'General case' 0 CA--C 1.606 3.106 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.1 33.58 61.13 Favored Glycine 0 N--CA 1.511 3.663 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -91.86 109.42 20.75 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -68.0 107.13 2.58 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -81.64 -34.98 30.51 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 121.083 1.765 . . . . 0.0 112.099 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -155.84 155.48 33.03 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 124.163 1.935 . . . . 0.0 111.337 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -159.95 99.63 1.38 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.146 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -50.84 -34.28 27.21 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.71 -46.69 86.77 Favored 'General case' 0 CA--C 1.58 2.105 0 C-N-CA 125.346 1.458 . . . . 0.0 114.094 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.1 -41.48 77.4 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.418 1.087 . . . . 0.0 113.653 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -70.6 4.92 2.1 Favored 'General case' 0 CA--C 1.59 2.511 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 65.48 8.56 5.13 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 119.318 3.081 . . . . 0.0 119.318 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.12 -157.14 0.61 Allowed 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 125.436 1.494 . . . . 0.0 113.964 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -139.22 162.12 35.75 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 125.425 1.49 . . . . 0.0 109.393 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.354 2.1 t80 -108.47 149.43 28.81 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 120.944 1.702 . . . . 0.0 110.403 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.9 p -160.81 141.76 11.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 119.71 -1.869 . . . . 0.0 109.519 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 85' ' ' VAL . 9.1 p90 -155.01 177.45 11.31 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.233 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -116.63 125.77 52.27 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.21 105.83 0.1 Allowed 'General case' 0 CA--C 1.575 1.924 0 C-N-CA 124.198 0.999 . . . . 0.0 113.668 -173.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.6 44.48 93.9 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.42 23.8 tptp -124.47 -79.8 0.61 Allowed 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 118.147 0.974 . . . . 0.0 110.262 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.24 70.57 0.24 Allowed Glycine 0 N--CA 1.505 3.27 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.407 49.8 tt0 -68.14 152.99 44.64 Favored 'General case' 0 CA--C 1.56 1.33 1 CA-C-O 130.466 4.936 . . . . 0.0 118.245 -160.471 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.378 24.5 m -80.27 -126.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.645 2 CA-C-N 100.987 -7.37 . . . . 0.0 106.767 -178.3 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 89' ' ' TRP . 34.5 pt -106.54 154.06 7.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.805 2.24 . . . . 0.0 106.402 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 10.6 tmtt? -69.1 -25.48 64.44 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 112.859 -1.973 . . . . 0.0 114.475 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.69 89.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 116.528 -1.701 . . . . 0.0 111.454 165.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.522 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -71.37 -44.01 65.82 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 121.385 1.902 . . . . 0.0 112.711 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -54.44 -41.18 69.1 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 121.23 1.832 . . . . 0.0 113.868 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -66.87 -61.38 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 CA-C-N 119.714 1.143 . . . . 0.0 112.071 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.617 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -68.5 -33.43 74.13 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.27 20.1 t -72.4 -39.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.82 1.646 . . . . 0.0 110.443 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.22 -31.27 63.35 Favored 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 120.152 1.342 . . . . 0.0 114.179 167.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.6 p -78.39 -19.67 52.82 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 133' ' ' LEU 0.346 0.0 OUTLIER -90.37 163.84 14.55 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 124.701 3.409 . . . . 0.0 116.263 -179.126 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 137.88 51.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.944 -1.723 . . . . 0.0 112.257 -173.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.404 HG21 ' H ' ' A' ' 43' ' ' THR . 77.2 t -9.94 -171.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 127.922 2.489 . . . . 0.0 116.28 -173.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 25.67 -17.5 0.0 OUTLIER Glycine 0 N--CA 1.509 3.565 2 O-C-N 107.411 -9.555 . . . . 0.0 127.918 155.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.548 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.53 48.4 mt-10 -109.81 -149.61 0.44 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 123.996 3.898 . . . . 0.0 116.042 -178.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 15.3 tp -135.99 139.04 42.86 Favored 'General case' 0 CA--C 1.592 2.577 0 N-CA-C 119.917 3.303 . . . . 0.0 119.917 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.6 p -146.15 -168.11 2.91 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 122.605 1.193 . . . . 0.0 111.316 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 3.2 mtt180 -140.92 158.96 43.21 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 123.067 1.413 . . . . 0.0 112.555 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.8 mt -117.51 135.27 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.414 1.485 . . . . 0.0 109.262 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 m -127.59 102.8 7.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 15.7 p -122.0 149.99 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -83.11 141.06 42.89 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.456 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -61.61 -12.04 22.96 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 N-CA-C 119.282 2.762 . . . . 0.0 119.282 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.41 -39.95 92.62 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 121.0 1.727 . . . . 0.0 113.078 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -77.45 -6.98 55.42 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.906 1.282 . . . . 0.0 113.251 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.54 -121.47 0.17 Allowed 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CE2' HD21 ' A' ' 127' ' ' LEU 0.348 0.2 OUTLIER -85.58 7.44 23.14 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 122.057 2.208 . . . . 0.0 115.7 -178.036 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.8 -32.4 17.97 Favored Glycine 0 N--CA 1.501 2.998 0 CA-C-N 123.448 2.84 . . . . 0.0 119.455 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.1 p -77.92 84.57 4.2 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 118.464 1.132 . . . . 0.0 109.97 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.365 . . 86.43 -14.91 0.48 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.65 162.06 32.44 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 123.53 2.877 . . . . 0.0 113.438 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 3.5 t -89.51 148.34 40.07 Favored Pre-proline 0 CA--C 1.577 2.014 0 O-C-N 121.047 -1.266 . . . . 0.0 111.102 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.86 -43.55 6.83 Favored 'Trans proline' 0 CA--C 1.587 3.167 0 C-N-CA 123.456 2.771 . . . . 0.0 118.784 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.58 58.6 7.04 Favored 'Trans proline' 0 CA--C 1.586 3.081 0 CA-C-N 125.346 2.945 . . . . 0.0 115.292 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 61.18 31.12 19.59 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.328 3.455 . . . . 0.0 120.328 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.499 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -84.43 134.59 42.44 Favored Pre-proline 0 CA--C 1.596 2.736 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.36 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -90.5 157.56 4.4 Favored 'Trans proline' 0 CA--C 1.591 3.355 0 CA-C-N 125.981 3.172 . . . . 0.0 114.275 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.87 -42.39 64.06 Favored 'Trans proline' 0 CA--C 1.575 2.541 0 N-CA-C 119.732 2.935 . . . . 0.0 119.732 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.09 64.42 3.3 Favored 'General case' 0 CA--C 1.582 2.174 0 O-C-N 120.799 -1.188 . . . . 0.0 113.248 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.92 133.72 21.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.128 -1.608 . . . . 0.0 111.764 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.8 m -69.95 150.11 47.05 Favored 'General case' 0 CA--C 1.59 2.499 0 O-C-N 121.023 -1.048 . . . . 0.0 112.272 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 112' ' ' TYR . 9.8 tp -126.43 159.15 34.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 119.846 -1.784 . . . . 0.0 111.726 -173.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.98 136.1 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 O-C-N 121.003 -1.06 . . . . 0.0 110.256 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.274 0.6 OUTLIER -135.28 125.04 25.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.59 113.41 21.8 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 173.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.91 145.56 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.755 -0.591 . . . . 0.0 111.915 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 101' ' ' LEU 0.944 10.5 tt0 -151.54 -151.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 161.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -144.27 164.07 31.82 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -166.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.456 ' H ' HD23 ' A' ' 133' ' ' LEU . 47.8 m-85 -120.7 -50.51 2.19 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.349 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.98 152.0 10.84 Favored 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.872 1.669 . . . . 0.0 109.865 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -139.39 -93.66 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.235 -1.541 . . . . 0.0 109.803 178.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.436 77.3 tttt -127.91 -107.45 0.3 Allowed 'General case' 0 CA--C 1.588 2.411 0 CA-C-O 115.621 -2.133 . . . . 0.0 107.278 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 1 CA-C-N 126.37 4.168 . . . . 0.0 121.032 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 121.786 3.474 . . . . 0.0 121.786 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.341 11.4 p -136.85 121.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tp -69.61 121.62 17.48 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 127.187 2.195 . . . . 0.0 112.316 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.11 102.31 11.03 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 122.393 2.36 . . . . 0.0 107.297 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 3.4 t -92.85 92.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.036 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.385 0.6 OUTLIER -65.2 130.68 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.03 -60.8 1.67 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.582 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.48 99.94 7.93 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -53.42 -74.81 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.56 -154.8 25.77 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 117.661 1.824 . . . . 0.0 117.661 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.0 p -87.72 -74.42 0.45 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.47 20.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 121.918 3.527 . . . . 0.0 121.918 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -134.7 67.64 1.5 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.501 12.7 pt-20 -33.59 -101.98 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.989 1 N-CA-C 123.774 4.731 . . . . 0.0 123.774 -170.48 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -112.16 100.01 48.0 Favored Pre-proline 0 CA--C 1.581 2.168 0 N-CA-C 118.233 2.679 . . . . 0.0 118.233 -169.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -100.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.579 2.739 0 C-N-CA 123.813 3.009 . . . . 0.0 119.905 169.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -163.11 161.04 25.0 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.253 0.4 OUTLIER -59.6 138.25 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-O 122.552 1.167 . . . . 0.0 110.897 175.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.15 89.06 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -85.61 157.06 20.46 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-N 121.836 2.818 . . . . 0.0 114.482 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -74.03 136.97 43.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.212 -1.555 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.371 1.1 t -137.81 132.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.388 0.675 . . . . 0.0 109.53 -165.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.44 117.39 26.75 Favored 'General case' 0 CA--C 1.562 1.416 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' A' ' 76' ' ' PHE . 19.4 m -128.42 166.36 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -130.73 120.84 24.41 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.135 169.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -124.71 137.45 54.35 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 29.4 m -106.98 153.47 22.52 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 160.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.71 142.75 8.98 Favored Glycine 0 CA--C 1.547 2.047 0 O-C-N 119.106 -2.246 . . . . 0.0 116.151 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.459 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -135.15 150.13 50.11 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.977 1.711 . . . . 0.0 113.088 -177.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.17 174.3 7.38 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.511 -0.743 . . . . 0.0 111.435 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.5 tp -61.34 -26.55 67.89 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.6 -5.93 13.39 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 167.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.83 58.04 Favored Glycine 0 N--CA 1.502 3.041 0 CA-C-N 120.622 1.555 . . . . 0.0 114.181 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -106.04 120.47 41.86 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -75.95 91.51 3.05 Favored 'General case' 0 CA--C 1.583 2.213 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.872 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -66.69 -32.06 73.13 Favored 'General case' 0 CA--C 1.566 1.56 0 O-C-N 119.282 -2.136 . . . . 0.0 115.516 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -149.19 158.91 44.57 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 120.248 1.386 . . . . 0.0 111.707 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 57' ' ' THR 0.356 43.3 t -135.36 -34.45 0.85 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 120.003 3.334 . . . . 0.0 120.003 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.321 60.0 p 58.31 -53.47 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 123.389 2.813 . . . . 0.0 116.717 -177.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.84 -34.32 27.43 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 128.343 2.657 . . . . 0.0 113.609 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -46.1 -42.72 14.02 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 125.241 1.416 . . . . 0.0 113.547 167.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.687 96.2 mtt180 95.02 38.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 120.023 3.342 . . . . 0.0 120.023 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.51 -56.15 4.37 Favored 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.78 166.82 23.6 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 126.409 1.884 . . . . 0.0 108.122 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -98.93 -162.06 0.92 Allowed 'General case' 0 CA--C 1.579 2.067 0 O-C-N 120.974 -1.079 . . . . 0.0 110.218 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.601 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.33 2.5 t80 -128.96 154.18 46.82 Favored 'General case' 0 CA--C 1.588 2.426 0 O-C-N 119.381 -2.074 . . . . 0.0 110.974 173.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.9 p -167.4 142.17 3.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 118.92 -2.362 . . . . 0.0 109.598 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CG ' HG11 ' A' ' 85' ' ' VAL . 6.6 p90 -153.49 -179.55 7.87 Favored 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.824 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.23 124.36 52.35 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.0 106.17 0.08 Allowed 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 59.28 49.16 81.47 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 -10.98 27.52 Favored 'General case' 0 CA--C 1.579 2.091 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.1 -37.0 3.02 Favored Glycine 0 CA--C 1.564 3.118 0 C-N-CA 124.495 1.045 . . . . 0.0 110.547 -168.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -38.6 -46.72 1.23 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 120.552 3.538 . . . . 0.0 120.552 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.505 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.261 7.6 m -117.8 -154.44 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-O 124.101 1.905 . . . . 0.0 109.0 -172.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.475 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.9 pt -101.05 162.34 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 125.09 2.376 . . . . 0.0 110.113 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -69.1 -35.01 75.98 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 112.678 -2.056 . . . . 0.0 114.154 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.64 -33.9 66.78 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 116.704 -1.617 . . . . 0.0 111.161 167.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.475 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -76.21 -47.04 25.49 Favored 'General case' 0 C--N 1.371 1.515 0 CA-C-N 121.492 1.951 . . . . 0.0 112.982 173.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.96 -32.57 69.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 121.194 1.815 . . . . 0.0 115.54 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.255 1.6 mp -65.98 -59.28 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.28 0.945 . . . . 0.0 110.046 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.33 -53.49 57.68 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.613 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.283 56.7 t -54.28 -40.6 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 120.454 1.479 . . . . 0.0 114.26 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.64 70.06 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 119.881 1.219 . . . . 0.0 113.372 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 p -90.55 18.82 5.85 Favored 'General case' 0 CA--C 1.601 2.909 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.543 ' CE ' HD22 ' A' ' 101' ' ' LEU . 56.4 mtp -119.79 150.41 40.46 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 119.226 -2.171 . . . . 0.0 116.711 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 146.87 29.91 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.838 2.903 . . . . 0.0 118.838 -171.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -45.89 137.13 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 CA-C-N 112.897 -1.956 . . . . 0.0 113.13 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.53 -43.6 1.96 Allowed Glycine 0 N--CA 1.491 2.34 0 CA-C-O 115.608 -2.774 . . . . 0.0 116.713 172.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.6 mt-10 -149.21 -175.99 5.19 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 121.966 2.883 . . . . 0.0 114.506 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.543 HD22 ' CE ' ' A' ' 96' ' ' MET 0.997 0.3 OUTLIER -155.49 -142.15 0.11 Allowed 'General case' 0 CA--C 1.604 3.05 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 172.64 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.533 ' SG ' HD23 ' A' ' 101' ' ' LEU 0.321 0.6 OUTLIER -151.41 -160.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 126.477 1.911 . . . . 0.0 113.746 -163.403 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.422 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 ptt85 -118.63 121.08 39.32 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.318 2.009 . . . . 0.0 110.124 165.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 mt -78.76 132.03 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 112.535 -2.12 . . . . 0.0 106.028 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.417 ' HA ' HG12 ' A' ' 128' ' ' VAL . 11.3 m -143.22 113.03 7.03 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . 2.679 2.7 m -160.28 -158.79 0.65 Allowed 'General case' 0 CA--C 1.59 2.493 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -97.6 122.68 54.59 Favored Pre-proline 0 CA--C 1.571 1.766 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -168.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 17.6 Cg_exo -42.59 -19.94 0.13 Allowed 'Trans proline' 0 CA--C 1.563 1.948 1 N-CA-C 122.534 4.013 . . . . 0.0 122.534 176.863 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.289 1.7 pm0 -63.03 -34.07 76.79 Favored 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 122.97 2.623 . . . . 0.0 113.098 169.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -74.29 -12.24 60.49 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 124.578 1.151 . . . . 0.0 113.799 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.51 -124.22 0.2 Allowed 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.289 0.6 OUTLIER -80.45 -4.63 54.5 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.133 2.242 . . . . 0.0 115.242 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -47.59 -17.99 0.56 Allowed Glycine 0 N--CA 1.497 2.755 1 N-CA-C 125.363 4.905 . . . . 0.0 125.363 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 t -65.69 -57.22 8.57 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 121.066 2.433 . . . . 0.0 111.379 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.46 -0.74 9.73 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 163.63 39.32 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-N 122.72 2.509 . . . . 0.0 111.82 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.528 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.7 t -85.51 112.21 42.67 Favored Pre-proline 0 CA--C 1.582 2.179 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.288 94.6 Cg_exo -31.52 -49.96 0.27 Allowed 'Trans proline' 0 CA--C 1.58 2.794 1 N-CA-C 123.702 4.462 . . . . 0.0 123.702 -174.042 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.63 -15.42 6.09 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 CA-C-N 125.211 2.897 . . . . 0.0 119.311 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -149.35 -6.89 0.35 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.528 ' HB ' ' H ' ' A' ' 117' ' ' SER . 25.9 mt -125.1 130.5 24.16 Favored Pre-proline 0 N--CA 1.507 2.401 0 CA-C-N 122.397 2.362 . . . . 0.0 113.767 -170.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -89.55 161.38 5.37 Favored 'Trans proline' 0 CA--C 1.591 3.356 0 CA-C-N 123.702 2.358 . . . . 0.0 112.116 173.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.03 -33.74 95.23 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 N-CA-C 119.888 2.996 . . . . 0.0 119.888 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -97.24 70.25 2.33 Favored 'General case' 0 CA--C 1.583 2.225 0 O-C-N 120.648 -1.283 . . . . 0.0 110.449 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.94 117.4 4.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 119.786 -1.821 . . . . 0.0 110.701 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 m -48.32 142.45 5.56 Favored 'General case' 0 CA--C 1.59 2.506 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.35 149.22 48.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 122.09 2.223 . . . . 0.0 111.194 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.459 HG23 ' HE3' ' A' ' 59' ' ' TRP . 30.6 m -144.86 146.95 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -142.53 132.32 24.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.714 -0.616 . . . . 0.0 109.83 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -95.7 98.28 10.35 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.422 HG12 ' HG3' ' A' ' 132' ' ' GLU . 3.9 t -122.81 162.46 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 -167.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.422 ' HG3' HG12 ' A' ' 131' ' ' VAL 2.899 27.9 mt-10 174.58 167.7 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 120.961 3.689 . . . . 0.0 120.961 162.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.98 130.56 38.51 Favored 'General case' 0 N--CA 1.49 1.554 1 N-CA-C 123.208 4.522 . . . . 0.0 123.208 -153.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.92 -51.05 9.58 Favored 'General case' 0 CA--C 1.581 2.15 0 O-C-N 121.254 -0.904 . . . . 0.0 112.022 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? 176.59 163.28 0.42 Allowed 'General case' 0 CA--C 1.582 2.202 0 C-N-CA 127.676 2.391 . . . . 0.0 106.699 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.412 ' HD1' ' H ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -141.57 -82.18 0.22 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.856 -1.778 . . . . 0.0 109.71 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.412 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 19.1 mmmt -79.79 -32.48 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.338 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.99 0 N-CA-C 120.519 2.968 . . . . 0.0 120.519 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.83 146.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.272 0 N-CA-C 118.861 2.911 . . . . 0.0 118.861 -173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -113.89 138.61 50.08 Favored 'General case' 0 CA--C 1.596 2.724 0 C-N-CA 127.369 2.268 . . . . 0.0 107.239 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -125.77 125.62 43.24 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 123.638 2.926 . . . . 0.0 109.458 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.86 119.54 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.561 -0.712 . . . . 0.0 109.568 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.565 HD13 ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -90.16 137.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-N 120.067 1.303 . . . . 0.0 111.629 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -123.47 -60.18 1.49 Allowed 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.552 1.141 . . . . 0.0 110.84 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -121.5 109.33 14.7 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -49.77 -38.27 33.38 Favored 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 119.541 3.163 . . . . 0.0 119.541 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.01 176.34 18.69 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 126.27 1.89 . . . . 0.0 115.886 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -151.56 -17.16 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.36 37.34 0.82 Allowed Glycine 0 N--CA 1.499 2.837 1 N-CA-C 123.37 4.108 . . . . 0.0 123.37 -175.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.3 p 65.69 -6.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.82 177.17 9.32 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 p -134.07 172.96 6.4 Favored Pre-proline 0 CA--C 1.59 2.496 0 C-N-CA 126.465 1.906 . . . . 0.0 109.402 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -100.61 -169.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.568 2.188 0 CA-C-N 123.788 2.388 . . . . 0.0 116.814 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -139.56 162.28 35.46 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 111.998 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 1.5 tp -61.65 136.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 O-C-N 119.34 -2.1 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.07 11.5 74.8 Favored Glycine 0 CA--C 1.561 2.912 0 N-CA-C 118.157 2.023 . . . . 0.0 118.157 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 158.94 16.83 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 120.866 2.333 . . . . 0.0 111.82 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -82.75 135.56 34.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.227 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -135.05 136.64 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 119.399 1.0 . . . . 0.0 110.603 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -117.54 109.35 16.61 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 120.575 -1.328 . . . . 0.0 107.688 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.47 173.1 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 CA-C-O 124.812 2.244 . . . . 0.0 113.221 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.62 126.88 39.46 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.96 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 143.5 47.91 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 121.624 3.935 . . . . 0.0 121.624 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.8 m -113.11 143.25 44.67 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 164.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.75 157.81 27.49 Favored Glycine 0 CA--C 1.56 2.874 0 CA-C-N 122.103 2.229 . . . . 0.0 116.037 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.44 151.94 36.09 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.283 1.433 . . . . 0.0 114.8 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.66 174.47 9.92 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.072 1.415 . . . . 0.0 109.316 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -30.17 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.89 5.66 1.47 Allowed 'General case' 0 CA--C 1.597 2.775 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 36.25 65.28 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 119.769 -1.832 . . . . 0.0 115.241 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.7 m -107.71 117.32 33.8 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -79.09 89.52 4.82 Favored 'General case' 0 CA--C 1.592 2.573 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.37 -34.59 78.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 118.81 -2.431 . . . . 0.0 115.595 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -143.02 168.33 19.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -141.55 -40.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.768 1 N-CA-C 128.206 6.372 . . . . 0.0 128.206 -170.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.251 3.9 m -141.83 -101.7 0.14 Allowed 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 75' ' ' LYS 0.312 25.5 mt -90.13 -28.1 19.18 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.318 12.3 t70 110.22 -14.45 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 127.433 2.293 . . . . 0.0 115.128 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.457 4.3 mmp_? 87.16 39.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -153.66 -66.21 0.15 Allowed 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.857 1.263 . . . . 0.0 107.625 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -130.84 -169.26 2.13 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 125.491 1.516 . . . . 0.0 108.611 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HA ' HD22 ' A' ' 70' ' ' LEU . 40.1 mmtm -74.07 157.26 36.4 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 119.818 -1.801 . . . . 0.0 112.303 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -74.3 116.5 15.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 123.343 2.792 . . . . 0.0 105.477 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -144.3 144.43 31.47 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.652 -1.28 . . . . 0.0 109.861 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CG ' HG11 ' A' ' 85' ' ' VAL . 36.5 p90 -148.76 -169.87 3.47 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.35 1.071 . . . . 0.0 112.862 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -125.41 113.97 18.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 tp -40.14 113.13 0.33 Allowed 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.79 28.97 61.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 119.526 2.57 . . . . 0.0 119.526 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -96.15 13.02 28.72 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 122.173 2.987 . . . . 0.0 117.447 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.71 -44.96 2.54 Favored Glycine 0 N--CA 1.51 3.618 0 O-C-N 120.91 -1.119 . . . . 0.0 111.052 -172.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.271 37.7 tt0 -23.45 -49.42 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 129.709 3.204 . . . . 0.0 119.641 169.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.585 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.302 17.1 m -107.97 -129.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 123.205 1.478 . . . . 0.0 108.098 -177.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.564 HG13 ' H ' ' A' ' 89' ' ' TRP . 44.8 pt -130.63 163.78 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 124.069 1.89 . . . . 0.0 108.869 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.256 8.0 tmtm? -69.31 -33.04 72.55 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.181 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.12 77.19 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.324 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.564 ' H ' HG13 ' A' ' 86' ' ' ILE . 37.2 m0 -72.06 -41.66 67.14 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.527 1.967 . . . . 0.0 112.957 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -57.9 -42.36 84.52 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 4.9 mt -64.78 -56.9 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.745 0 CA-C-N 118.841 0.746 . . . . 0.0 112.192 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.75 84.58 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.286 89.7 t -63.61 -34.9 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.343 1.428 . . . . 0.0 112.702 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.24 71.15 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 120.885 1.675 . . . . 0.0 113.051 169.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -79.77 5.23 14.06 Favored 'General case' 0 CA--C 1.592 2.59 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 18.2 mtt -91.58 139.18 30.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.305 -2.122 . . . . 0.0 115.012 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -93.22 159.69 15.17 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.13 130.35 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.95 0 O-C-N 119.122 -2.236 . . . . 0.0 111.055 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.92 -17.77 43.93 Favored Glycine 0 N--CA 1.514 3.898 0 CA-C-N 123.696 2.953 . . . . 0.0 116.857 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.462 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 34.4 tt0 -54.93 125.55 20.74 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 tp -103.96 121.69 43.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.125 0.97 . . . . 0.0 108.798 173.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.565 ' SG ' HD13 ' A' ' 36' ' ' ILE . 81.0 m -146.67 179.63 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.548 1.166 . . . . 0.0 110.96 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -136.0 127.6 28.87 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 123.815 1.769 . . . . 0.0 109.643 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.5 134.97 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.658 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 m -130.03 99.8 5.21 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.549 ' SG ' ' CD2' ' A' ' 127' ' ' LEU . 19.9 p -124.25 145.9 49.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -76.15 146.77 78.99 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 112.824 -1.989 . . . . 0.0 112.157 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -47.66 -23.47 3.78 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 N-CA-C 120.34 3.169 . . . . 0.0 120.34 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -63.83 -37.72 88.45 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.556 1.526 . . . . 0.0 115.017 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.14 -1.55 57.98 Favored 'General case' 0 CA--C 1.575 1.929 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.856 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.7 -122.34 0.17 Allowed 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 121.643 2.02 . . . . 0.0 116.264 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 127' ' ' LEU 0.284 3.4 m-85 -83.03 0.57 44.25 Favored 'General case' 0 N--CA 1.517 2.877 0 CA-C-N 121.881 2.128 . . . . 0.0 115.078 -178.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.69 18.97 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 122.571 3.788 . . . . 0.0 122.571 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -67.87 -56.74 7.96 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 119.653 1.726 . . . . 0.0 112.766 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -133.74 -4.11 2.89 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 118.641 2.83 . . . . 0.0 118.641 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.24 155.76 32.02 Favored Glycine 0 CA--C 1.545 1.961 0 CA-C-N 123.693 2.951 . . . . 0.0 111.789 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 t -86.53 128.76 55.64 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 116.879 -1.534 . . . . 0.0 108.814 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -32.99 -45.98 0.29 Allowed 'Trans proline' 0 CA--C 1.58 2.824 1 N-CA-C 124.351 4.712 . . . . 0.0 124.351 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.55 -28.83 9.67 Favored 'Trans proline' 0 CA--C 1.573 2.439 0 CA-C-N 125.783 3.101 . . . . 0.0 119.662 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -163.17 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mt -79.9 146.42 63.94 Favored Pre-proline 0 CA--C 1.595 2.683 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -170.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -102.84 174.51 0.19 Allowed 'Trans proline' 0 CA--C 1.593 3.426 0 CA-C-N 125.119 2.864 . . . . 0.0 114.756 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.34 25.44 0.47 Allowed 'Trans proline' 0 CA--C 1.579 2.765 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -147.89 60.02 1.12 Allowed 'General case' 0 CA--C 1.582 2.209 0 O-C-N 120.103 -1.623 . . . . 0.0 111.706 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.93 120.93 6.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.756 -1.84 . . . . 0.0 109.814 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 96.3 m -68.53 159.22 32.25 Favored 'General case' 0 CA--C 1.584 2.257 0 O-C-N 121.141 -0.974 . . . . 0.0 112.814 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD2' ' SG ' ' A' ' 106' ' ' CYS 0.289 0.0 OUTLIER -141.86 177.53 8.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.23 -2.169 . . . . 0.0 111.372 -177.052 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.3 148.99 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 125.392 1.477 . . . . 0.0 110.942 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.52 124.99 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.726 . . . . 0.0 109.555 172.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -87.63 118.37 27.07 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.17 141.93 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 121.242 1.837 . . . . 0.0 112.368 -172.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -116.05 110.17 18.53 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.793 0.837 . . . . 0.0 110.378 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.47 141.83 28.21 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 123.701 1.715 . . . . 0.0 111.002 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -120.57 -45.44 2.41 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -158.61 149.88 20.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.082 1.353 . . . . 0.0 109.045 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.425 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.284 0.0 OUTLIER -156.54 -90.71 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 O-C-N 121.227 -0.921 . . . . 0.0 111.717 179.791 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.425 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 43.8 tttm -79.87 47.15 0.84 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.126 0 N-CA-C 122.979 3.952 . . . . 0.0 122.979 173.567 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.07 168.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.658 1.729 . . . . 0.0 112.133 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.81 0.9 OUTLIER -165.15 -168.23 1.36 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 123.67 0.788 . . . . 0.0 112.514 157.585 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.91 130.69 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.285 1.402 . . . . 0.0 113.846 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.15 118.27 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.02 143.24 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.04 0.924 . . . . 0.0 112.78 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -127.43 -66.43 0.88 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.005 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -111.46 90.36 3.31 Favored 'General case' 0 CA--C 1.586 2.338 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -21.7 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.493 1 N-CA-C 123.207 4.521 . . . . 0.0 123.207 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.11 -142.81 8.62 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -142.27 -53.69 0.42 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.2 -51.82 0.14 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 120.973 3.149 . . . . 0.0 120.973 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.428 HG23 HG21 ' A' ' 98' ' ' VAL 0.401 9.6 t -85.42 46.68 1.32 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.759 2.504 . . . . 0.0 117.759 -176.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.455 24.0 mt-10 70.08 -172.6 0.17 Allowed 'General case' 0 CA--C 1.583 2.224 1 N-CA-C 123.891 4.774 . . . . 0.0 123.891 168.317 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.8 p -92.49 151.94 41.71 Favored Pre-proline 0 CA--C 1.577 2.003 0 C-N-CA 126.91 2.084 . . . . 0.0 115.523 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.26 147.8 88.16 Favored 'Trans proline' 0 CA--C 1.577 2.653 0 C-N-CA 122.599 2.199 . . . . 0.0 117.19 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.01 153.66 20.59 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.993 -1.692 . . . . 0.0 109.858 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.4 OUTLIER -58.58 131.71 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 120.148 -1.595 . . . . 0.0 112.423 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.38 7.14 85.25 Favored Glycine 0 CA--C 1.558 2.769 0 N-CA-C 118.705 2.242 . . . . 0.0 118.705 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -88.22 154.61 20.29 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 121.61 2.705 . . . . 0.0 114.344 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -80.25 139.45 36.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.518 -1.364 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.332 1.4 t -132.51 140.85 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.149 0.98 . . . . 0.0 111.23 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.77 110.97 14.34 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 76' ' ' PHE . 3.0 m -120.6 167.22 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 123.443 1.592 . . . . 0.0 114.804 -174.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.88 111.33 12.47 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -113.53 148.67 35.65 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.7 m -120.06 139.73 52.09 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 163.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.48 143.22 10.76 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 119.748 -1.845 . . . . 0.0 115.801 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.406 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -133.01 154.45 50.5 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.308 -1.946 . . . . 0.0 113.765 -175.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.2 tp -79.23 179.52 7.34 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 123.139 1.447 . . . . 0.0 108.639 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.366 0.0 OUTLIER -64.28 -25.61 68.13 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 178.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.97 14.32 2.29 Favored 'General case' 0 CA--C 1.603 3.004 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.33 31.65 70.38 Favored Glycine 0 N--CA 1.514 3.834 0 O-C-N 119.849 -1.782 . . . . 0.0 116.161 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -86.19 111.32 20.28 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -75.35 89.02 2.59 Favored 'General case' 0 CA--C 1.583 2.23 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -72.16 -30.69 65.24 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 119.376 -2.077 . . . . 0.0 114.408 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -151.31 149.6 29.54 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.547 2.118 . . . . 0.0 113.879 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.4 p -160.1 96.8 1.23 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 112.229 -2.26 . . . . 0.0 106.995 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 t -59.16 -36.96 76.22 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -51.92 -36.78 50.23 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.72 -66.27 0.5 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -161.14 70.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -151.61 -79.39 0.11 Allowed 'General case' 0 CA--C 1.564 1.515 0 O-C-N 120.28 -1.512 . . . . 0.0 108.285 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -167.74 -138.28 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.025 1.73 . . . . 0.0 107.982 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -112.64 -165.92 1.03 Allowed 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.636 1.574 . . . . 0.0 108.46 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.333 2.8 t80 -127.65 146.65 50.48 Favored 'General case' 0 CA--C 1.572 1.822 0 O-C-N 119.098 -2.251 . . . . 0.0 110.147 170.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.7 p -160.84 140.5 10.79 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 119.526 -1.984 . . . . 0.0 109.151 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CG ' HG11 ' A' ' 85' ' ' VAL . 6.3 p90 -149.65 -176.9 5.59 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.169 -176.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.53 124.95 42.43 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 119.051 -2.281 . . . . 0.0 105.074 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.53 109.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.46 97.95 Favored Glycine 0 N--CA 1.513 3.781 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -132.21 -73.31 0.52 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 123.73 0.812 . . . . 0.0 112.149 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.13 71.65 0.22 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 104.255 -3.538 . . . . 0.0 104.255 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.43 0.0 OUTLIER -65.05 135.33 55.46 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 108.301 -3.949 . . . . 0.0 118.969 -159.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.502 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.359 19.2 m -79.91 -108.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 1 CA-C-N 103.299 -6.319 . . . . 0.0 107.0 -177.303 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.552 HG13 ' H ' ' A' ' 89' ' ' TRP . 25.7 pt -132.06 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 123.645 1.688 . . . . 0.0 107.381 168.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -32.12 73.42 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.386 176.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.91 80.62 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.591 -1.195 . . . . 0.0 112.157 168.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.552 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.3 m0 -73.46 -43.49 60.12 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 120.377 1.444 . . . . 0.0 112.39 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -57.93 -35.66 71.39 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.603 1.547 . . . . 0.0 114.774 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.324 29.0 mt -72.68 -58.12 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-N 118.952 0.796 . . . . 0.0 112.087 175.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.7 81.15 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.48 -44.3 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 120.904 1.684 . . . . 0.0 110.692 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.5 -39.73 35.07 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 121.392 1.905 . . . . 0.0 115.136 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.8 p -91.39 6.9 43.61 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 ttt -86.68 -179.6 6.61 Favored 'General case' 0 CA--C 1.58 2.122 0 O-C-N 119.705 -1.872 . . . . 0.0 113.108 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.51 164.63 21.51 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 118.903 -2.373 . . . . 0.0 113.427 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 98' ' ' VAL . 89.1 t -53.79 31.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 N-CA-C 120.13 3.381 . . . . 0.0 120.13 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.75 -18.0 0.09 OUTLIER Glycine 0 N--CA 1.501 2.974 0 O-C-N 116.73 -3.731 . . . . 0.0 113.974 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' OE1' ' SG ' ' A' ' 102' ' ' CYS . 39.0 tt0 -43.89 143.76 1.02 Allowed 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 119.709 3.226 . . . . 0.0 119.709 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.71 123.59 50.66 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.659 1.183 . . . . 0.0 109.83 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.43 ' SG ' ' OE1' ' A' ' 100' ' ' GLU . 3.9 m -144.76 165.73 27.25 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.783 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -120.41 120.7 36.7 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 123.929 1.823 . . . . 0.0 110.26 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.481 HG22 ' SG ' ' A' ' 106' ' ' CYS . 3.9 mt -77.39 141.0 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.043 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.855 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.5 m -129.47 109.62 11.2 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.481 ' SG ' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -115.95 148.13 40.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -174.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -99.95 146.15 31.4 Favored Pre-proline 0 CA--C 1.579 2.08 0 C-N-CA 124.866 1.266 . . . . 0.0 110.381 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.13 -25.55 4.4 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 N-CA-C 119.738 2.938 . . . . 0.0 119.738 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.58 -38.26 86.89 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -92.54 4.49 53.46 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.848 1.259 . . . . 0.0 114.369 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -129.67 -104.75 0.3 Allowed 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 119.908 1.231 . . . . 0.0 113.762 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.388 47.2 m-85 -106.5 -3.12 21.23 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.17 -154.72 44.04 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 119.099 2.399 . . . . 0.0 119.099 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.7 m -67.9 -15.51 63.65 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.54 -30.46 11.39 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 118.934 2.938 . . . . 0.0 118.934 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 168.33 44.34 Favored Glycine 0 CA--C 1.552 2.355 0 CA-C-N 121.401 1.91 . . . . 0.0 115.074 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.15 120.4 59.84 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 116.666 -1.635 . . . . 0.0 107.674 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 77.1 Cg_exo -37.91 -41.02 1.12 Allowed 'Trans proline' 0 CA--C 1.58 2.814 1 N-CA-C 123.425 4.356 . . . . 0.0 123.425 -175.959 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.0 -30.84 66.66 Favored 'Trans proline' 0 CA--C 1.574 2.506 0 CA-C-N 125.455 2.984 . . . . 0.0 119.856 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -159.78 -27.78 0.07 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.8 mt -79.91 124.37 83.23 Favored Pre-proline 0 CA--C 1.584 2.271 0 C-N-CA 125.299 1.44 . . . . 0.0 111.983 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -95.58 178.3 0.7 Allowed 'Trans proline' 0 CA--C 1.584 3.007 0 C-N-CA 122.765 2.31 . . . . 0.0 116.07 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -53.13 125.29 17.87 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.655 2.903 . . . . 0.0 117.906 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.8 t30 56.16 62.41 2.37 Favored 'General case' 0 CA--C 1.586 2.36 0 C-N-CA 125.017 1.327 . . . . 0.0 113.935 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.04 123.21 40.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.303 -1.498 . . . . 0.0 112.417 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.5 m -67.29 159.25 29.63 Favored 'General case' 0 CA--C 1.593 2.616 0 O-C-N 121.358 -0.839 . . . . 0.0 113.163 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 111' ' ' ALA . 16.7 mt -134.34 164.32 27.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.461 -2.024 . . . . 0.0 115.151 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 59' ' ' TRP . 3.8 m -148.52 140.05 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 C-N-CA 124.639 1.176 . . . . 0.0 109.944 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.53 126.06 15.86 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.466 -1.396 . . . . 0.0 109.418 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -88.12 118.33 27.63 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.15 139.36 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.102 0.954 . . . . 0.0 111.794 -172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -116.23 124.56 50.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 tp -104.49 110.12 22.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.221 0.534 . . . . 0.0 109.735 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.7 -43.82 25.02 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -171.73 159.62 5.38 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 123.279 1.514 . . . . 0.0 109.558 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.276 8.1 p90 -152.38 -93.76 0.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -106.51 89.33 3.0 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.739 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.376 -176.753 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.508 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -177.3 156.31 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 33' ' ' LEU 1.099 1.2 mp -155.61 -156.11 0.62 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 158.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HG2' ' SG ' ' A' ' 102' ' ' CYS 0.29 1.1 tmmt? -128.86 121.78 28.95 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.252 1.387 . . . . 0.0 113.359 -165.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 10.4 t -97.42 96.69 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.602 -178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.501 0.4 OUTLIER -55.25 132.2 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -173.547 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.89 -71.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.828 -0.545 . . . . 0.0 110.867 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -112.95 96.25 5.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.12 162.54 2.53 Favored 'General case' 0 CA--C 1.591 2.525 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.94 -174.99 50.12 Favored Glycine 0 CA--C 1.55 2.256 0 O-C-N 119.658 -1.901 . . . . 0.0 117.586 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -63.61 -43.22 97.52 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.97 54.19 0.46 Allowed Glycine 0 N--CA 1.48 1.568 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.2 p -136.7 -65.8 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.38 0.672 . . . . 0.0 110.95 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -127.04 163.45 23.72 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.9 p -122.83 142.46 37.91 Favored Pre-proline 0 CA--C 1.58 2.114 0 CA-C-N 110.134 -3.212 . . . . 0.0 109.399 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -60.6 119.82 7.22 Favored 'Trans proline' 0 CA--C 1.581 2.834 0 C-N-CA 123.143 2.562 . . . . 0.0 118.177 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.53 167.48 12.94 Favored 'General case' 0 CA--C 1.571 1.785 0 O-C-N 119.238 -2.164 . . . . 0.0 110.753 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.307 0.3 OUTLIER -59.47 132.09 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 O-C-N 120.132 -1.605 . . . . 0.0 112.187 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.48 2.62 88.91 Favored Glycine 0 CA--C 1.56 2.903 0 N-CA-C 118.558 2.183 . . . . 0.0 118.558 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.71 143.64 44.07 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.391 2.596 . . . . 0.0 113.442 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 107.3 18.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.402 1.5 t -103.43 123.67 57.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 126.762 2.025 . . . . 0.0 111.908 -166.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -111.32 109.93 20.17 Favored 'General case' 0 CA--C 1.573 1.834 0 O-C-N 120.936 -1.102 . . . . 0.0 108.026 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.63 164.48 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.321 11.4 m-70 -121.6 117.53 26.97 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 2.6 p90 -114.05 152.14 31.45 Favored 'General case' 0 CA--C 1.578 2.055 0 CA-C-O 123.369 1.556 . . . . 0.0 114.717 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -130.9 149.58 52.46 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.59 139.64 7.01 Favored Glycine 0 CA--C 1.551 2.331 0 O-C-N 118.735 -2.478 . . . . 0.0 116.681 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.4 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -134.93 151.39 50.82 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.292 1.837 . . . . 0.0 115.206 -175.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -95.34 176.17 6.3 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 121.543 -0.723 . . . . 0.0 112.288 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.271 1.8 pt? -62.96 -24.97 68.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.58 -2.9 15.66 Favored 'General case' 0 CA--C 1.595 2.694 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.87 167.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.83 36.84 61.28 Favored Glycine 0 N--CA 1.504 3.186 0 CA-C-N 121.355 1.889 . . . . 0.0 114.043 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -106.14 121.65 44.58 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -75.54 89.33 2.71 Favored 'General case' 0 CA--C 1.579 2.086 0 O-C-N 121.9 -0.5 . . . . 0.0 110.482 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -63.63 -31.83 73.11 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 119.568 -1.957 . . . . 0.0 113.767 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -153.35 156.38 38.23 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 124.474 2.083 . . . . 0.0 113.095 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 77.1 p -157.96 96.4 1.47 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.673 -2.058 . . . . 0.0 107.611 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -55.77 -34.34 65.15 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.92 -30.56 66.01 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -42.51 -51.73 4.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtm-85 -95.35 27.75 3.19 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.763 1.625 . . . . 0.0 113.644 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.283 31.6 ttpt 71.99 -13.25 0.61 Allowed 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.9 174.91 8.61 Favored 'General case' 0 CA--C 1.575 1.942 0 CA-C-O 123.745 1.736 . . . . 0.0 114.283 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -121.72 171.86 8.56 Favored 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.18 148.06 43.52 Favored 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 122.5 1.143 . . . . 0.0 108.761 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.8 t -169.37 142.97 2.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.15 -2.219 . . . . 0.0 107.398 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CG ' HG11 ' A' ' 85' ' ' VAL . 14.4 p90 -149.83 174.17 12.94 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.533 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -108.25 125.67 51.93 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.39 112.04 1.14 Allowed 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.055 -1.028 . . . . 0.0 112.236 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.16 57.04 11.27 Favored Glycine 0 N--CA 1.505 3.291 0 O-C-N 120.512 -1.368 . . . . 0.0 114.761 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.592 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.251 1.9 pptp? -106.17 -73.77 0.67 Allowed 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 123.898 1.808 . . . . 0.0 111.461 -175.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.592 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -110.33 -52.75 0.59 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 127.203 2.335 . . . . 0.0 108.346 169.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.757 22.9 tt0 116.71 140.65 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 128.209 3.862 . . . . 0.0 115.003 165.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.332 8.6 m -79.92 -108.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 1 CA-C-N 105.296 -5.411 . . . . 0.0 105.04 179.691 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.496 HG13 ' H ' ' A' ' 89' ' ' TRP 0.25 21.0 pt -120.32 154.32 23.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 124.419 2.057 . . . . 0.0 106.541 163.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.272 13.5 tmtt? -66.61 -29.62 69.71 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.337 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.42 77.92 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 117.122 -1.418 . . . . 0.0 111.911 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.496 ' H ' HG13 ' A' ' 86' ' ' ILE . 38.5 m0 -73.19 -46.07 52.69 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 121.043 1.747 . . . . 0.0 112.704 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.82 -37.27 73.52 Favored 'General case' 0 CA--C 1.575 1.94 0 CA-C-N 122.018 2.19 . . . . 0.0 114.335 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.288 1.8 mp -69.27 -64.94 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.994 0 CA-C-N 119.731 1.15 . . . . 0.0 111.215 175.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -63.67 -38.81 92.52 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.442 HG22 ' SD ' ' A' ' 96' ' ' MET 0.341 9.6 t -70.13 -33.08 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 120.903 1.683 . . . . 0.0 111.424 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.71 -38.06 66.6 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 121.584 1.993 . . . . 0.0 112.634 165.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 9.75 5.98 Favored 'General case' 0 CA--C 1.598 2.818 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.442 ' SD ' HG22 ' A' ' 93' ' ' VAL . 30.3 mtp -87.53 -178.59 6.16 Favored 'General case' 0 N--CA 1.511 2.59 0 CA-C-N 123.315 2.78 . . . . 0.0 116.516 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -135.95 146.8 47.68 Favored 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -175.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -51.66 123.2 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.1 -45.83 1.28 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-O 116.308 -2.384 . . . . 0.0 114.066 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 29.7 mt-10 -148.17 -173.86 4.42 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 121.399 2.6 . . . . 0.0 112.975 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.435 HD13 ' H ' ' A' ' 102' ' ' CYS 0.757 0.2 OUTLIER -157.6 -135.68 0.04 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 177.755 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -160.18 -150.08 0.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -165.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.599 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 47.5 ptt85 -120.92 130.68 53.97 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 124.441 2.067 . . . . 0.0 111.979 169.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 92' ' ' ALA . 3.6 mt -79.6 141.13 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.02 0 CA-C-N 112.912 -1.949 . . . . 0.0 107.935 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.9 m -129.79 109.84 11.26 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.582 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 2.1 p -132.49 151.79 51.78 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -171.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -87.8 142.19 32.28 Favored Pre-proline 0 CA--C 1.578 2.019 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.778 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 41.7 Cg_exo -54.67 -12.51 4.55 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 N-CA-C 120.304 3.155 . . . . 0.0 120.304 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.46 -40.8 97.78 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 120.925 1.693 . . . . 0.0 113.604 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.22 -3.34 54.88 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 124.652 1.181 . . . . 0.0 113.332 171.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.3 -114.27 0.24 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.11 8.12 45.19 Favored 'General case' 0 N--CA 1.514 2.731 0 CA-C-N 121.024 1.738 . . . . 0.0 114.866 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.82 141.22 43.04 Favored Glycine 0 N--CA 1.497 2.705 0 CA-C-N 123.231 2.741 . . . . 0.0 116.195 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.297 15.4 m 78.39 -54.57 0.48 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.309 1.044 . . . . 0.0 113.423 -174.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.3 -49.44 7.25 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.58 153.16 28.62 Favored Glycine 0 CA--C 1.547 2.035 0 CA-C-N 119.663 1.12 . . . . 0.0 114.379 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 10.8 t -82.45 107.21 8.27 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 116.275 -1.822 . . . . 0.0 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.499 1.0 OUTLIER -4.14 -99.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.588 3.184 1 C-N-CA 125.768 4.312 . . . . 0.0 122.332 -174.6 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -88.78 37.42 0.41 Allowed 'Trans proline' 0 CA--C 1.58 2.824 0 CA-C-N 127.743 3.801 . . . . 0.0 115.95 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -145.29 -30.5 0.42 Allowed 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.499 ' HB ' ' H ' ' A' ' 117' ' ' SER . 32.7 mt -130.57 137.37 30.66 Favored Pre-proline 0 N--CA 1.504 2.261 0 CA-C-N 121.471 1.941 . . . . 0.0 113.331 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.47 -175.59 2.0 Allowed 'Trans proline' 0 CA--C 1.591 3.339 0 CA-C-N 122.916 2.077 . . . . 0.0 112.829 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.59 9.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.58 2.777 0 N-CA-C 122.011 3.812 . . . . 0.0 122.011 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.85 93.4 1.26 Allowed 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 121.442 1.928 . . . . 0.0 110.752 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.38 98.15 4.01 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 122.924 2.602 . . . . 0.0 108.989 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.9 m -60.25 131.77 51.83 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.988 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' CD1' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -140.94 177.56 7.96 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 124.66 2.171 . . . . 0.0 114.612 -168.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG23 ' HE3' ' A' ' 59' ' ' TRP . 1.7 m -148.19 144.95 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 126.704 2.002 . . . . 0.0 108.189 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 0.5 OUTLIER -133.76 124.12 26.07 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -88.58 97.81 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 101' ' ' LEU . 2.5 t -108.23 140.95 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -175.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -126.15 119.28 27.11 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 tp -95.94 121.99 38.27 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.6 -46.6 9.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -165.13 157.23 15.46 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 123.855 1.788 . . . . 0.0 108.642 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -152.26 -95.49 0.05 Allowed 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 94.09 3.78 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 3.37 0 CA-C-O 117.63 -1.65 . . . . 0.0 114.561 -173.54 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -179.91 159.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 120.961 2.381 . . . . 0.0 113.755 -171.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.826 2.5 tp -148.23 -169.99 3.48 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.046 160.747 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 177.1 -175.23 0.13 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 -158.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG13 ' H ' ' A' ' 36' ' ' ILE 0.955 0.4 OUTLIER 104.28 -166.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.066 1 N-CA-C 126.537 5.754 . . . . 0.0 126.537 161.019 . . . . . . . . 5 4 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 35' ' ' VAL 0.392 25.0 mm -25.6 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.324 1 N-CA-C 126.134 5.605 . . . . 0.0 126.134 -167.468 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 -60.45 0.97 Allowed 'General case' 0 CA--C 1.583 2.237 0 CA-C-N 110.642 -2.981 . . . . 0.0 106.649 167.165 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -120.07 109.11 15.08 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -64.79 164.98 11.29 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.39 152.91 24.71 Favored Glycine 0 CA--C 1.548 2.125 0 O-C-N 120.402 -1.437 . . . . 0.0 112.401 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.8 p -121.09 -91.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.93 25.39 0.63 Allowed Glycine 0 N--CA 1.506 3.356 1 N-CA-C 124.184 4.434 . . . . 0.0 124.184 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 53.1 p 83.31 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.644 1.978 . . . . 0.0 109.185 -172.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.343 0.0 OUTLIER -0.8 -120.04 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.907 1 N-CA-C 123.04 4.459 . . . . 0.0 123.04 -177.383 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 15.5 p -107.46 137.49 19.67 Favored Pre-proline 0 CA--C 1.58 2.11 0 C-N-CA 124.735 1.214 . . . . 0.0 112.722 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.257 11.8 Cg_endo -109.48 -18.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.888 0 N-CA-C 115.84 1.438 . . . . 0.0 115.84 167.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.51 31.5 mtt 78.96 -155.22 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 169.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.323 1.0 OUTLIER -43.84 129.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -174.083 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.26 -10.34 71.53 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-O 116.073 -2.515 . . . . 0.0 117.305 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 123.457 3.629 . . . . 0.0 113.886 -177.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.2 tpt85 -86.49 96.09 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 0.0 109.648 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -91.27 133.02 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.583 0.753 . . . . 0.0 111.828 -172.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.71 102.13 10.45 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 102.307 -3.22 . . . . 0.0 102.307 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.97 -178.21 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-O 124.315 2.007 . . . . 0.0 113.789 -171.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.467 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -145.47 119.43 9.35 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.655 171.539 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -109.69 152.02 26.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.752 1.615 . . . . 0.0 114.128 -178.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.5 m -127.43 131.67 50.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 159.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.9 144.1 15.61 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-O 124.422 2.123 . . . . 0.0 116.124 -177.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -133.6 156.99 46.85 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 111.515 -2.342 . . . . 0.0 112.844 -175.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.05 163.24 13.03 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 121.308 -0.87 . . . . 0.0 109.157 168.182 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.268 9.1 tt -65.51 -20.92 66.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.124 -1.61 . . . . 0.0 114.937 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.74 -4.63 6.78 Favored 'General case' 0 CA--C 1.608 3.194 0 CA-C-N 119.926 1.239 . . . . 0.0 112.705 165.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.01 40.71 29.39 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.278 -1.514 . . . . 0.0 116.345 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 83.9 m -117.47 122.52 43.96 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.17 100.32 2.05 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -67.7 -38.69 84.01 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.621 -1.924 . . . . 0.0 112.105 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.44 173.28 11.22 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 125.667 2.651 . . . . 0.0 114.614 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 69' ' ' SER . 18.7 t -157.3 -91.53 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.983 1 N-CA-C 97.477 -5.009 . . . . 0.0 97.477 170.867 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 68' ' ' SER . 73.2 m 76.39 102.15 0.07 Allowed 'General case' 0 C--O 1.239 0.534 1 CA-C-O 97.027 -10.987 . . . . 0.0 103.933 171.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.556 HD22 ' HA ' ' A' ' 75' ' ' LYS . 9.3 mt -49.04 0.98 0.01 OUTLIER 'General case' 0 CA--C 1.598 2.807 3 O-C-N 75.771 -29.33 . . . . 0.0 121.981 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' SER 0.408 8.2 p-10 57.26 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 121.495 3.887 . . . . 0.0 121.495 176.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -76.93 28.88 0.13 Allowed 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.336 53.9 tttm 80.77 -52.59 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 126.414 1.886 . . . . 0.0 112.422 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.22 -160.32 0.79 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 122.307 1.051 . . . . 0.0 108.468 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HA ' HD22 ' A' ' 70' ' ' LEU . 8.7 mtmp? -65.11 156.74 30.63 Favored 'General case' 0 CA--C 1.578 2.026 0 O-C-N 120.502 -1.374 . . . . 0.0 113.939 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.481 ' H ' HD22 ' A' ' 70' ' ' LEU 0.278 17.9 t80 -65.71 151.5 46.42 Favored 'General case' 0 CA--C 1.571 1.76 0 CA-C-N 122.43 2.377 . . . . 0.0 108.885 179.179 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.5 p -160.55 143.1 12.99 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 119.946 -1.721 . . . . 0.0 112.456 -175.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CG ' HG11 ' A' ' 85' ' ' VAL . 31.4 p90 -157.2 -179.85 8.59 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.001 176.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -119.88 125.73 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 172.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.83 108.1 0.8 Allowed 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.05 56.55 6.32 Favored Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.288 -0.883 . . . . 0.0 113.547 -173.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -97.74 -65.4 0.97 Allowed 'General case' 0 N--CA 1.512 2.656 0 CA-C-O 124.933 2.302 . . . . 0.0 113.148 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.39 -49.68 0.15 Allowed Glycine 0 CA--C 1.56 2.895 0 N-CA-C 103.719 -3.752 . . . . 0.0 103.719 172.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.903 1.8 tm-20 119.99 139.43 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 127.226 3.393 . . . . 0.0 115.881 163.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.451 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.36 9.2 m -79.94 -105.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 1 CA-C-N 106.782 -4.736 . . . . 0.0 105.247 -178.351 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.47 HG13 ' H ' ' A' ' 89' ' ' TRP . 36.1 pt -122.5 154.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 124.289 1.995 . . . . 0.0 105.963 165.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.282 2.6 mptt -68.29 -30.67 69.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.15 81.78 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 115.791 -2.052 . . . . 0.0 110.617 167.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.47 ' H ' HG13 ' A' ' 86' ' ' ILE . 41.6 m0 -73.11 -45.25 58.12 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 122.698 2.499 . . . . 0.0 112.948 174.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.36 -38.31 71.25 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.289 1.859 . . . . 0.0 114.407 175.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.34 28.4 mt -69.25 -60.97 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 CA-C-N 118.997 0.817 . . . . 0.0 112.249 175.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.8 -31.25 70.98 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 117.723 2.49 . . . . 0.0 117.723 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.404 HG13 ' SD ' ' A' ' 96' ' ' MET 0.303 13.5 t -79.08 -28.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 CA-C-N 119.821 1.191 . . . . 0.0 110.933 176.01 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.45 85.58 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.879 1.672 . . . . 0.0 112.481 166.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.0 p -73.01 0.34 11.63 Favored 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 173.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.404 ' SD ' HG13 ' A' ' 93' ' ' VAL . 9.1 mtt -82.21 126.69 32.37 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 122.888 2.585 . . . . 0.0 115.889 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.86 130.49 36.81 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 173.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.0 t -9.49 80.17 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.541 4.076 0 CA-C-N 120.433 1.469 . . . . 0.0 108.92 -157.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.83 63.38 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 CA-C-N 109.748 -3.387 . . . . 0.0 119.429 -145.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.489 8.0 tp10 -29.63 -86.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 -170.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.267 27.7 tp -130.9 113.28 13.84 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.869 0.867 . . . . 0.0 110.192 169.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.6 m -135.38 170.98 15.1 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.37 1.081 . . . . 0.0 109.653 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 161.59 21.85 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 123.593 1.663 . . . . 0.0 113.989 178.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.2 mt -127.66 133.98 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.028 175.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.8 m -135.24 100.12 4.45 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 177.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.4 p -125.52 148.24 48.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 118.733 2.864 . . . . 0.0 118.733 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -63.8 143.22 98.1 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.807 -1.568 . . . . 0.0 110.612 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.08 -11.8 23.48 Favored 'Trans proline' 0 CA--C 1.578 2.696 0 CA-C-N 125.268 2.917 . . . . 0.0 116.977 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.0 -39.63 95.33 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.187 1.812 . . . . 0.0 112.391 171.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -75.71 3.92 8.83 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 169.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.68 -105.45 0.17 Allowed 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.368 1.44 . . . . 0.0 114.078 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -114.02 13.51 18.21 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 120.014 1.279 . . . . 0.0 114.116 -177.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -57.23 -25.66 54.72 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 121.479 3.352 . . . . 0.0 121.479 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.6 p -67.49 -57.34 6.7 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 119.463 1.632 . . . . 0.0 113.318 175.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.24 -15.15 7.31 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 151.74 20.38 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 122.684 2.493 . . . . 0.0 112.175 -176.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.517 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 10.1 t -75.88 119.34 76.73 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-O 116.158 -1.877 . . . . 0.0 108.172 176.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.295 96.6 Cg_exo -35.59 -47.62 0.92 Allowed 'Trans proline' 0 CA--C 1.579 2.736 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -175.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -89.95 -10.7 3.42 Favored 'Trans proline' 0 CA--C 1.578 2.679 0 CA-C-N 124.789 2.746 . . . . 0.0 118.251 177.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -144.99 -49.91 0.25 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 119.13 3.011 . . . . 0.0 119.13 -174.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.517 ' HB ' ' H ' ' A' ' 117' ' ' SER . 80.2 mt -80.82 139.28 50.18 Favored Pre-proline 0 CA--C 1.594 2.653 0 CA-C-O 116.353 -1.784 . . . . 0.0 114.975 -171.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -97.58 172.42 0.69 Allowed 'Trans proline' 0 CA--C 1.592 3.405 0 CA-C-N 125.754 3.091 . . . . 0.0 114.525 176.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -64.27 2.54 1.11 Allowed 'Trans proline' 0 CA--C 1.576 2.58 0 N-CA-C 120.272 3.143 . . . . 0.0 120.272 175.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -146.37 57.62 1.19 Allowed 'General case' 0 CA--C 1.58 2.105 0 O-C-N 119.754 -1.841 . . . . 0.0 114.237 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.32 114.46 15.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 119.745 -1.847 . . . . 0.0 106.989 173.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.7 m -59.88 130.89 48.99 Favored 'General case' 0 CA--C 1.586 2.359 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.201 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.91 156.41 18.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 122.137 2.244 . . . . 0.0 115.165 -173.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.0 t -143.68 120.23 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-N 112.294 -2.23 . . . . 0.0 107.727 -173.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 4.1 m-85 -140.7 129.92 23.61 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 119.756 -1.84 . . . . 0.0 110.367 174.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 111.99 23.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 172.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.46 131.95 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.39 108.54 17.74 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.645 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 tt -98.45 116.34 30.46 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.574 1.178 . . . . 0.0 109.886 -175.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.94 -51.58 7.03 Favored 'General case' 0 CA--C 1.574 1.878 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.73 -177.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 152.87 30.87 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.918 1.287 . . . . 0.0 109.962 175.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -131.65 -75.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.839 -1.163 . . . . 0.0 112.594 176.706 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.291 57.6 tttm -79.79 -57.1 3.82 Favored 'General case' 0 CA--C 1.584 2.281 0 CA-C-O 115.776 -2.059 . . . . 0.0 115.128 -177.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.017 0 CA-C-N 125.083 3.583 . . . . 0.0 119.602 -179.255 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 1 N-CA-C 125.188 4.835 . . . . 0.0 125.188 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.75 166.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -172.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.759 1.1 tp -159.53 -153.11 0.34 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.437 163.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -157.34 137.29 12.48 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.042 2.201 . . . . 0.0 116.394 -169.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.4 133.37 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.45 -0.781 . . . . 0.0 109.737 174.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.513 HD13 ' SG ' ' A' ' 102' ' ' CYS 0.301 1.0 OUTLIER -75.84 133.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 O-C-N 120.522 -1.361 . . . . 0.0 113.602 -177.627 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -114.65 -51.58 2.74 Favored 'General case' 0 CA--C 1.575 1.925 0 C-N-CA 124.606 1.162 . . . . 0.0 112.015 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.09 96.15 2.95 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.62 171.06 0.22 Allowed 'General case' 0 CA--C 1.591 2.539 0 CA-C-N 122.106 2.23 . . . . 0.0 116.444 177.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.26 -172.19 22.65 Favored Glycine 0 CA--C 1.547 2.09 0 O-C-N 120.018 -1.676 . . . . 0.0 116.905 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -166.77 -69.45 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.043 0.937 . . . . 0.0 110.006 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.7 -103.5 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 120.738 3.055 . . . . 0.0 120.738 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.437 ' H ' HG21 ' A' ' 98' ' ' VAL . 43.4 p -113.38 49.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.247 1.499 . . . . 0.0 111.693 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.443 4.7 pt-20 41.14 -116.85 0.31 Allowed 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 119.598 3.185 . . . . 0.0 119.598 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -150.77 137.08 11.07 Favored Pre-proline 0 CA--C 1.577 2.009 0 C-N-CA 124.925 1.29 . . . . 0.0 113.579 -175.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.251 6.2 Cg_endo -117.19 -26.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.583 2.942 0 C-N-CA 121.782 1.655 . . . . 0.0 115.984 171.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.566 32.3 mtt 82.31 -146.47 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.402 0.3 OUTLIER -47.0 128.94 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -172.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.11 90.62 Favored Glycine 0 CA--C 1.56 2.857 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -174.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -79.6 144.69 33.6 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 122.635 3.217 . . . . 0.0 114.914 -178.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -75.64 131.33 39.87 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.252 0.933 . . . . 0.0 109.088 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.362 2.1 t -131.39 132.03 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 124.141 0.976 . . . . 0.0 112.217 -166.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -117.7 107.13 13.81 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.1 m -116.31 159.23 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.972 1.368 . . . . 0.0 114.296 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 16.9 m170 -116.32 123.57 47.98 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 116.806 -1.568 . . . . 0.0 109.223 166.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.323 0.1 OUTLIER -119.11 135.38 54.68 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.449 1.477 . . . . 0.0 114.303 176.592 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.4 m -104.18 149.17 25.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 159.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.12 144.21 11.14 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 118.622 -2.548 . . . . 0.0 115.656 178.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.426 ' CE3' HG12 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -136.26 149.11 48.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 112.452 -1.874 . . . . 0.0 114.866 -173.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.17 165.53 17.33 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 123.249 1.499 . . . . 0.0 107.721 167.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 126' ' ' THR 0.277 0.0 OUTLIER -60.5 -27.32 67.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 178.277 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -2.17 11.38 Favored 'General case' 0 CA--C 1.595 2.682 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 171.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.21 45.39 7.05 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.448 -1.407 . . . . 0.0 113.594 -176.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -117.65 113.89 22.58 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -176.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -79.9 93.03 5.59 Favored 'General case' 0 CA--C 1.585 2.311 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.794 -178.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -71.24 -30.04 65.85 Favored 'General case' 0 CA--C 1.566 1.579 0 O-C-N 119.085 -2.259 . . . . 0.0 115.403 175.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -146.86 156.34 43.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.825 1.648 . . . . 0.0 113.717 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 t -157.9 87.87 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 75' ' ' LYS . 47.2 t -53.98 -42.31 68.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 174.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 70' ' ' LEU . 4.7 mp -64.3 -39.3 93.64 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 127.523 2.329 . . . . 0.0 113.481 178.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.22 -48.45 81.7 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.45 1.5 . . . . 0.0 113.824 173.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -78.59 -23.44 46.01 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 176.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.348 0.1 OUTLIER 115.27 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 128.572 2.749 . . . . 0.0 111.236 -179.275 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -134.43 149.57 50.77 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -175.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' HB3' ' CB ' ' A' ' 69' ' ' SER 0.289 19.4 tptm -166.53 -83.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.112 3.745 . . . . 0.0 121.112 173.805 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.587 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.401 0.4 OUTLIER -89.02 146.7 24.69 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 -161.839 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -165.48 129.0 2.23 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 120.701 -1.249 . . . . 0.0 107.957 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CG ' HG11 ' A' ' 85' ' ' VAL . 27.2 p90 -142.06 -165.04 1.92 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 122.36 1.076 . . . . 0.0 110.323 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.283 9.5 t0 -135.03 125.75 27.14 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 172.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.0 112.06 0.52 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.8 92.76 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -174.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.306 5.6 mmtt -138.38 -80.16 0.34 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -168.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.94 76.61 0.46 Allowed Glycine 0 N--CA 1.503 3.131 1 N-CA-C 99.686 -5.365 . . . . 0.0 99.686 170.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.383 32.7 tp10 -78.63 157.04 28.77 Favored 'General case' 0 CA--C 1.555 1.172 1 CA-C-O 130.104 4.764 . . . . 0.0 119.5 -159.513 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.439 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.335 33.6 m -107.73 -140.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 1 CA-C-N 101.964 -6.926 . . . . 0.0 107.183 -173.288 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 89' ' ' TRP . 12.2 pt -101.08 154.52 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 122.98 1.371 . . . . 0.0 109.452 170.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.517 0.0 OUTLIER -69.94 -21.27 63.28 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 175.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.73 85.78 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 117.692 -1.146 . . . . 0.0 111.366 165.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.453 ' H ' HG13 ' A' ' 86' ' ' ILE . 44.5 m0 -73.91 -40.25 63.28 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-N 120.399 1.454 . . . . 0.0 113.073 173.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -57.62 -37.08 72.68 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 119.924 1.238 . . . . 0.0 113.833 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.27 1.5 mp -64.05 -56.83 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 119.431 1.014 . . . . 0.0 110.836 173.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.52 94.48 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 177.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.489 HG22 ' CE ' ' A' ' 96' ' ' MET . 79.3 t -63.27 -43.94 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 119.031 0.832 . . . . 0.0 112.519 174.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.07 66.91 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-N 119.695 1.134 . . . . 0.0 113.931 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.0 p -92.29 24.61 3.3 Favored 'General case' 0 CA--C 1.588 2.439 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.601 ' SD ' ' HB3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -122.95 140.07 53.4 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.622 2.01 . . . . 0.0 114.874 178.588 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -90.4 168.08 12.14 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.403 1.081 . . . . 0.0 111.483 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.437 HG21 ' H ' ' A' ' 43' ' ' THR . 78.3 t -59.0 135.83 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.546 0 O-C-N 119.46 -2.025 . . . . 0.0 112.46 -176.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.38 8.8 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-N 124.152 3.16 . . . . 0.0 117.107 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.49 102.74 1.18 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 118.476 1.138 . . . . 0.0 111.999 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -98.24 131.83 44.25 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.496 1.119 . . . . 0.0 109.062 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.513 ' SG ' HD13 ' A' ' 36' ' ' ILE . 86.0 m -136.8 -169.71 2.53 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.553 1.168 . . . . 0.0 113.422 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.309 3.8 mtt180 -135.91 113.52 10.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 124.942 2.306 . . . . 0.0 108.732 172.548 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -76.97 136.15 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.744 -177.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -117.76 101.7 8.53 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 174.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 5.2 p -115.12 149.33 37.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -171.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -104.96 129.06 25.49 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.675 177.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.53 -16.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.966 0 N-CA-C 122.042 3.824 . . . . 0.0 122.042 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.33 -41.09 92.81 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 121.785 2.084 . . . . 0.0 113.244 169.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -87.08 -0.09 56.1 Favored 'General case' 0 CA--C 1.582 2.189 0 C-N-CA 125.766 1.626 . . . . 0.0 113.656 170.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 -113.35 0.22 Allowed 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -175.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -92.46 13.39 19.77 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 120.672 1.578 . . . . 0.0 113.62 -178.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.84 148.48 31.61 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 122.141 2.246 . . . . 0.0 118.084 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.276 8.3 t 73.4 -42.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.49 -56.45 2.34 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.81 143.53 14.83 Favored Glycine 0 CA--C 1.546 1.992 0 CA-C-N 119.626 1.103 . . . . 0.0 112.028 -175.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.431 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.3 t -78.75 144.76 65.18 Favored Pre-proline 0 CA--C 1.584 2.254 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.62 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -33.06 134.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.071 0 C-N-CA 124.307 3.338 . . . . 0.0 120.603 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.333 0.1 OUTLIER 21.84 46.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.475 2 N-CA-C 125.107 5.003 . . . . 0.0 125.107 -175.563 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -164.45 -55.94 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.431 ' HB ' ' H ' ' A' ' 117' ' ' SER . 56.9 mt -84.69 136.17 39.63 Favored Pre-proline 0 CA--C 1.592 2.574 0 CA-C-O 116.279 -1.819 . . . . 0.0 112.674 -174.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -99.48 173.9 0.4 Allowed 'Trans proline' 0 CA--C 1.592 3.408 0 CA-C-N 125.943 3.158 . . . . 0.0 115.184 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.42 -18.68 39.97 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 N-CA-C 121.209 3.503 . . . . 0.0 121.209 176.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -140.2 83.12 1.9 Allowed 'General case' 0 CA--C 1.588 2.431 0 CA-C-N 120.448 1.476 . . . . 0.0 111.822 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.85 -153.58 0.56 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 119.453 -2.029 . . . . 0.0 111.081 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.417 ' H ' HD12 ' A' ' 61' ' ' LEU 0.255 65.9 m -139.3 150.87 45.93 Favored 'General case' 0 CA--C 1.591 2.53 0 O-C-N 119.098 -2.251 . . . . 0.0 109.099 173.44 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 50.9 mt -127.21 162.63 25.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.232 -2.168 . . . . 0.0 112.895 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.426 HG12 ' CE3' ' A' ' 59' ' ' TRP . 79.5 t -146.45 115.46 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.672 -2.058 . . . . 0.0 107.225 -174.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 0.8 OUTLIER -128.91 123.19 31.95 Favored 'General case' 0 N--CA 1.517 2.911 0 CA-C-N 123.13 2.695 . . . . 0.0 111.014 174.25 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.4 tm-20 -92.07 90.9 7.57 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 123.654 1.692 . . . . 0.0 107.467 175.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 1.5 p -134.47 157.59 41.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -173.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 101' ' ' LEU 1.657 16.6 mt-10 -179.06 -174.13 0.32 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.328 168.707 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.554 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 16.2 tp -106.82 145.68 31.83 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 121.111 3.745 . . . . 0.0 121.111 -165.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -92.02 -54.32 3.89 Favored 'General case' 0 CA--C 1.58 2.125 0 CA-C-N 111.887 -2.415 . . . . 0.0 108.572 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -170.58 159.08 6.57 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 126.144 1.778 . . . . 0.0 108.308 171.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.291 0.0 OUTLIER -129.38 -103.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.411 -1.43 . . . . 0.0 110.223 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.447 63.7 tttt -105.76 -96.94 0.34 Allowed 'General case' 0 CA--C 1.581 2.146 0 CA-C-O 116.02 -1.943 . . . . 0.0 110.269 177.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.562 0 CA-C-N 125.167 3.622 . . . . 0.0 116.647 -178.798 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 1 N-CA-C 126.636 5.414 . . . . 0.0 126.636 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG22 ' H ' ' A' ' 23' ' ' ASP 0.318 9.7 p -123.12 -142.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -165.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.621 ' H ' HG22 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -143.92 -175.89 4.77 Favored 'General case' 0 CA--C 1.592 2.572 0 C-N-CA 126.058 1.743 . . . . 0.0 109.158 175.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.423 0.5 OUTLIER 89.49 167.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 C-N-CA 126.222 1.809 . . . . 0.0 108.905 -175.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.8 p -119.27 120.78 30.71 Favored Pre-proline 0 CA--C 1.571 1.764 0 O-C-N 116.731 -3.731 . . . . 0.0 108.794 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -63.81 42.11 0.11 Allowed 'Trans proline' 0 CA--C 1.589 3.242 0 N-CA-C 119.971 3.027 . . . . 0.0 119.971 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.63 -62.21 0.05 Allowed 'General case' 0 CA--C 1.571 1.754 0 C-N-CA 127.257 2.223 . . . . 0.0 108.459 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -82.76 -28.07 30.62 Favored 'General case' 0 CA--C 1.582 2.197 0 O-C-N 120.726 -1.234 . . . . 0.0 113.863 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.519 0.0 OUTLIER 85.08 -22.68 0.19 Allowed 'General case' 0 CA--C 1.582 2.174 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 -177.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.27 -35.21 15.42 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 118.422 2.749 . . . . 0.0 118.422 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.3 -59.51 5.75 Favored Glycine 0 N--CA 1.479 1.551 1 N-CA-C 127.171 5.629 . . . . 0.0 127.171 -156.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 33' ' ' LEU 0.275 8.2 p -156.68 -141.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.607 -174.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.605 ' H ' HG22 ' A' ' 32' ' ' VAL 1.157 8.1 mp 130.35 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 129.159 2.984 . . . . 0.0 111.895 171.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -154.83 130.33 9.83 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 122.629 2.468 . . . . 0.0 117.403 -162.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.67 119.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 123.414 0.686 . . . . 0.0 111.143 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.283 0.7 OUTLIER -87.19 135.93 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 122.201 1.0 . . . . 0.0 112.077 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -118.64 -60.65 1.75 Allowed 'General case' 0 CA--C 1.572 1.797 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.611 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -119.69 94.64 4.47 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -61.08 164.4 5.15 Favored 'General case' 0 CA--C 1.594 2.643 0 O-C-N 119.385 -2.072 . . . . 0.0 113.912 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.74 170.69 45.98 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 122.357 3.703 . . . . 0.0 122.357 -174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -99.24 -63.88 1.09 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.547 -1.826 . . . . 0.0 107.123 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.23 102.83 1.74 Allowed Glycine 0 CA--C 1.549 2.175 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 p -51.54 -22.57 3.3 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.254 2.687 . . . . 0.0 118.254 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -63.29 153.62 34.24 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.7 p -115.79 163.52 20.72 Favored Pre-proline 0 N--CA 1.497 1.906 0 CA-C-N 111.635 -2.529 . . . . 0.0 112.303 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.68 146.16 29.98 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 CA-C-N 123.385 2.245 . . . . 0.0 114.351 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -90.32 164.36 14.38 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.122 -1.611 . . . . 0.0 110.854 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.3 OUTLIER -61.4 130.51 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 119.297 -2.127 . . . . 0.0 111.691 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.0 15.22 79.86 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.419 2.128 . . . . 0.0 118.419 -173.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.88 154.02 19.15 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 120.421 2.11 . . . . 0.0 110.998 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -84.58 124.58 31.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.753 . . . . 0.0 110.208 -174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.23 132.06 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.282 0.633 . . . . 0.0 110.008 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.26 93.5 4.72 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 125.168 2.413 . . . . 0.0 104.88 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.04 169.37 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 110.558 -3.019 . . . . 0.0 109.12 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.449 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.335 2.9 t60 -148.49 137.45 21.68 Favored 'General case' 0 CA--C 1.564 1.503 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 159.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -122.71 152.62 40.39 Favored 'General case' 0 CA--C 1.585 2.301 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.107 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.9 m -117.51 150.79 38.37 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 159.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.6 144.97 12.1 Favored Glycine 0 CA--C 1.543 1.838 0 O-C-N 118.424 -2.672 . . . . 0.0 115.655 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.433 ' HE3' HG12 ' A' ' 128' ' ' VAL . 1.9 m-90 -130.14 153.23 48.73 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 112.648 -1.776 . . . . 0.0 113.746 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.48 168.91 16.04 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 122.975 1.369 . . . . 0.0 107.388 166.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 0.0 OUTLIER -59.8 -27.84 66.94 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -72.42 1.15 8.46 Favored 'General case' 0 CA--C 1.594 2.635 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.5 43.2 12.75 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 120.202 -1.561 . . . . 0.0 113.308 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -114.88 116.24 28.23 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -75.9 87.42 2.87 Favored 'General case' 0 CA--C 1.586 2.338 0 O-C-N 121.966 -0.459 . . . . 0.0 111.742 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -72.91 -28.16 62.31 Favored 'General case' 0 CA--C 1.558 1.26 0 O-C-N 119.46 -2.025 . . . . 0.0 115.432 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -156.07 148.41 23.57 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 t -160.06 113.58 2.17 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.269 81.1 p -63.13 -38.58 91.75 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.275 65.7 mt -53.2 -42.34 66.17 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 122.318 2.326 . . . . 0.0 115.76 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -49.92 -36.73 28.67 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 173.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 -85.79 42.51 0.97 Allowed 'General case' 0 CA--C 1.585 2.313 0 C-N-CA 124.745 1.218 . . . . 0.0 114.251 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.324 34.3 ttmt 83.26 -36.72 0.08 Allowed 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.2 -175.07 4.55 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-O 124.034 1.873 . . . . 0.0 115.469 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -72.89 178.09 4.48 Favored 'General case' 0 CA--C 1.576 1.978 0 C-N-CA 125.254 1.422 . . . . 0.0 113.033 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -99.99 164.73 11.87 Favored 'General case' 0 CA--C 1.583 2.246 0 O-C-N 120.431 -1.418 . . . . 0.0 108.9 173.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.5 p -167.44 133.71 2.16 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 118.939 -2.35 . . . . 0.0 111.111 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CG ' HG11 ' A' ' 85' ' ' VAL . 23.5 p90 -146.27 -176.3 5.11 Favored 'General case' 0 CA--C 1.573 1.827 0 CA-C-O 122.177 0.989 . . . . 0.0 112.214 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -119.26 114.31 22.19 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -40.89 113.85 0.42 Allowed 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -172.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.4 95.17 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -111.5 21.17 16.46 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.27 -42.12 2.74 Favored Glycine 0 N--CA 1.51 3.586 0 O-C-N 121.147 -0.971 . . . . 0.0 112.484 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -32.81 -37.35 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 120.494 3.516 . . . . 0.0 120.494 171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.254 20.6 m -123.95 -142.43 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 123.116 1.436 . . . . 0.0 109.662 -173.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 89' ' ' TRP . 13.7 pt -113.86 157.14 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 124.298 1.999 . . . . 0.0 108.284 170.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -64.85 -34.09 77.54 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 113.838 -1.528 . . . . 0.0 113.346 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.43 -35.07 67.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.199 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.488 ' H ' HG13 ' A' ' 86' ' ' ILE . 33.0 m0 -73.17 -43.44 61.45 Favored 'General case' 0 C--N 1.362 1.143 0 CA-C-N 120.226 1.376 . . . . 0.0 112.214 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -55.83 -38.58 70.23 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 121.237 1.835 . . . . 0.0 114.928 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.319 2.2 mp -69.97 -62.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.968 0 CA-C-N 119.741 1.155 . . . . 0.0 111.44 175.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.488 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -66.72 -30.59 70.86 Favored 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.284 12.6 t -77.74 -34.45 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.833 0 CA-C-N 120.036 1.289 . . . . 0.0 110.644 175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.39 -38.43 66.16 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 121.224 1.829 . . . . 0.0 112.701 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.8 p -80.88 8.41 8.34 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.504 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 9.3 tpt -100.25 127.76 46.46 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 122.071 2.214 . . . . 0.0 114.814 -177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -82.08 166.53 19.65 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.41 128.22 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.601 2.914 0 O-C-N 120.395 -1.44 . . . . 0.0 109.938 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.49 -0.46 64.43 Favored Glycine 1 N--CA 1.517 4.054 0 CA-C-N 123.201 2.728 . . . . 0.0 117.751 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -73.48 154.5 39.89 Favored 'General case' 0 CA--C 1.577 2.011 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.55 123.39 26.43 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.335 1.054 . . . . 0.0 112.246 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 8.7 p -151.64 174.65 13.22 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -124.86 119.85 30.01 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 124.201 1.953 . . . . 0.0 111.566 173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.2 mt -74.24 138.65 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-N 112.495 -2.138 . . . . 0.0 110.76 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.8 m -123.12 110.48 15.36 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 102.629 -3.101 . . . . 0.0 102.629 172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 2.9 p -115.85 146.38 42.05 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -106.94 135.75 19.53 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.672 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -43.13 -24.59 0.5 Allowed 'Trans proline' 0 CA--C 1.561 1.853 1 N-CA-C 122.77 4.104 . . . . 0.0 122.77 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.39 -39.12 92.18 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 121.588 1.995 . . . . 0.0 114.293 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.44 -3.73 58.77 Favored 'General case' 0 CA--C 1.583 2.221 0 C-N-CA 125.58 1.552 . . . . 0.0 112.79 170.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.27 -117.96 0.2 Allowed 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.433 ' CE2' HD21 ' A' ' 127' ' ' LEU 0.287 6.6 m-85 -92.45 16.72 11.24 Favored 'General case' 0 N--CA 1.513 2.692 0 CA-C-N 121.005 1.73 . . . . 0.0 114.334 -178.084 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.65 -63.23 4.61 Favored Glycine 0 N--CA 1.5 2.949 0 CA-C-N 123.008 2.64 . . . . 0.0 117.373 176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -79.46 42.62 0.52 Allowed 'General case' 0 CA--C 1.584 2.264 0 CA-C-N 118.92 1.36 . . . . 0.0 114.236 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -171.77 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.99 136.88 6.45 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.22 0.914 . . . . 0.0 110.89 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.448 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.7 t -78.45 118.91 75.12 Favored Pre-proline 0 CA--C 1.581 2.157 0 CA-C-O 117.097 -1.43 . . . . 0.0 109.241 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.272 42.4 Cg_exo -27.37 -51.15 0.11 Allowed 'Trans proline' 0 CA--C 1.579 2.761 1 N-CA-C 124.682 4.839 . . . . 0.0 124.682 -175.684 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.57 -30.14 12.44 Favored 'Trans proline' 0 CA--C 1.572 2.42 0 CA-C-N 125.607 3.038 . . . . 0.0 119.548 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -163.93 -8.95 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 117' ' ' SER . 19.6 mt -79.93 123.7 83.54 Favored Pre-proline 0 CA--C 1.583 2.248 0 O-C-N 119.631 -1.918 . . . . 0.0 113.299 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -86.76 171.09 7.23 Favored 'Trans proline' 0 CA--C 1.585 3.067 0 C-N-CA 122.547 2.165 . . . . 0.0 113.441 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.65 12.87 0.23 Allowed 'Trans proline' 0 CA--C 1.58 2.804 0 N-CA-C 120.536 3.245 . . . . 0.0 120.536 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -153.95 67.7 0.75 Allowed 'General case' 0 CA--C 1.582 2.211 0 O-C-N 119.974 -1.704 . . . . 0.0 111.644 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.16 133.89 33.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 119.797 -1.815 . . . . 0.0 110.529 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.291 23.3 m -66.05 152.05 45.51 Favored 'General case' 0 CA--C 1.594 2.639 0 O-C-N 120.703 -1.248 . . . . 0.0 112.447 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.602 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 11.8 tp -132.44 158.27 42.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 119.541 -1.974 . . . . 0.0 111.892 -170.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.433 HG12 ' HE3' ' A' ' 59' ' ' TRP . 53.9 t -143.69 124.59 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.862 -169.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.303 15.3 m-85 -136.46 124.44 22.8 Favored 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 122.286 2.312 . . . . 0.0 112.16 173.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -93.49 113.14 25.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.481 -2.012 . . . . 0.0 107.999 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.7 t -112.34 136.25 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.886 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -119.51 114.97 23.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.28 119.95 38.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.578 1.18 . . . . 0.0 109.498 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -79.73 -56.92 3.93 Favored 'General case' 0 CA--C 1.582 2.184 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.307 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -169.89 161.65 9.04 Favored 'General case' 0 CA--C 1.592 2.573 0 C-N-CA 126.031 1.733 . . . . 0.0 109.72 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.434 ' HD1' ' H ' ' A' ' 137' ' ' LYS . 1.4 p90 -138.05 -84.89 0.29 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 119.784 -1.822 . . . . 0.0 110.862 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.434 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 40.0 ttpt -79.83 74.36 6.56 Favored 'General case' 0 CA--C 1.587 2.374 0 CA-C-O 125.511 2.577 . . . . 0.0 108.308 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.567 3.299 0 CA-C-N 110.909 -2.86 . . . . 0.0 111.855 -173.778 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.853 0 N-CA-C 119.2 2.44 . . . . 0.0 119.2 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.62 153.17 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 C-N-CA 124.038 0.935 . . . . 0.0 112.731 -176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -153.9 148.42 26.2 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.316 10.5 tp -120.86 70.09 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.016 0 CA-C-O 124.546 2.117 . . . . 0.0 108.803 173.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 t -156.17 64.58 3.77 Favored Pre-proline 0 CA--C 1.585 2.312 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.441 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.251 21.5 Cg_exo -61.49 -29.16 84.45 Favored 'Trans proline' 0 CA--C 1.573 2.463 0 CA-C-N 124.933 2.797 . . . . 0.0 117.442 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.87 52.18 0.81 Allowed 'General case' 0 CA--C 1.577 1.988 0 C-N-CA 124.948 1.299 . . . . 0.0 109.066 174.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.312 65.2 mm-40 64.62 39.09 6.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -174.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.6 -77.76 0.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 111.514 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.275 49.8 mt-10 -90.13 3.47 53.29 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 174.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.97 12.49 36.48 Favored Glycine 0 N--CA 1.484 1.839 1 N-CA-C 123.815 4.286 . . . . 0.0 123.815 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.324 38.2 t -139.51 133.2 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.914 1 CA-C-N 124.419 4.109 . . . . 0.0 116.517 -174.038 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.33 134.12 54.05 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 125.912 1.685 . . . . 0.0 109.253 175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -129.24 133.09 47.36 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 124.12 3.145 . . . . 0.0 111.453 176.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 77.9 t -105.1 153.18 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.71 142.38 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.915 0 CA-C-O 122.771 1.272 . . . . 0.0 108.97 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' N ' ' HB2' ' A' ' 102' ' ' CYS . 55.6 tptt -114.32 -57.89 2.22 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.692 172.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.6 tpt85 -122.29 112.24 17.89 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -57.51 -62.9 1.45 Allowed 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.455 -1.403 . . . . 0.0 114.241 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.1 -155.83 26.43 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 119.364 2.505 . . . . 0.0 119.364 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -91.12 -54.57 3.89 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 114.337 -0.931 . . . . 0.0 113.319 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.4 -39.0 62.15 Favored Glycine 0 CA--C 1.552 2.35 0 N-CA-C 116.753 1.461 . . . . 0.0 116.753 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.261 73.0 p 74.62 3.25 4.23 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -106.92 167.24 10.02 Favored 'General case' 0 CA--C 1.574 1.88 0 O-C-N 120.772 -1.205 . . . . 0.0 113.001 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.2 p -132.94 108.33 12.75 Favored Pre-proline 0 CA--C 1.577 1.982 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.59 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -64.71 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.571 2.353 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.6 ptm -170.83 175.47 4.48 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 120.868 1.667 . . . . 0.0 114.344 -168.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -55.8 132.8 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.983 0 CA-C-O 122.334 1.064 . . . . 0.0 111.44 176.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.33 0.3 70.58 Favored Glycine 0 CA--C 1.563 3.079 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.08 137.88 49.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 121.437 2.618 . . . . 0.0 113.585 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -86.65 104.8 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.418 HG12 ' HB3' ' A' ' 136' ' ' PHE . 1.5 m -105.39 131.08 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 124.074 0.95 . . . . 0.0 110.667 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.255 29.1 p90 -105.23 115.54 30.43 Favored 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 105.653 -1.981 . . . . 0.0 105.653 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.28 170.08 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 CA-C-O 125.04 2.352 . . . . 0.0 114.103 -170.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.497 ' CD2' HD12 ' A' ' 70' ' ' LEU . 2.3 t60 -124.43 119.32 28.84 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 111.58 -2.555 . . . . 0.0 106.358 168.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.333 3.3 p90 -114.72 150.85 34.65 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 123.977 1.846 . . . . 0.0 113.626 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.3 m -127.63 151.71 48.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 162.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.53 138.38 6.03 Favored Glycine 0 CA--C 1.546 2.001 0 O-C-N 118.742 -2.474 . . . . 0.0 115.944 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.19 150.71 49.4 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 127.323 2.249 . . . . 0.0 112.25 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.5 tp -84.22 -172.75 4.34 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-O 123.984 1.849 . . . . 0.0 109.641 173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -58.35 -37.39 75.09 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.19 21.61 0.89 Allowed 'General case' 0 CA--C 1.597 2.756 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.97 33.48 50.61 Favored Glycine 1 N--CA 1.517 4.054 0 O-C-N 120.179 -1.576 . . . . 0.0 115.798 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.7 m -86.72 109.24 19.08 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -69.04 92.36 0.52 Allowed 'General case' 0 CA--C 1.588 2.437 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -73.08 -36.08 66.75 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 119.296 -2.127 . . . . 0.0 114.598 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.65 174.95 12.57 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-O 123.834 1.778 . . . . 0.0 114.442 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.0 t -152.42 -147.15 0.22 Allowed 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 51.6 p -148.73 -66.56 0.23 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 120.056 -1.653 . . . . 0.0 108.701 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 55' ' ' HIS 0.317 22.3 mt -61.38 -42.35 98.58 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -49.99 -42.34 48.84 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.694 1.739 . . . . 0.0 115.694 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.339 32.5 ptt180 -75.57 -75.38 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.545 1.138 . . . . 0.0 113.535 176.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -163.62 -36.7 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.925 1.29 . . . . 0.0 112.172 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -89.28 -157.15 0.43 Allowed 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -175.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -145.62 170.71 15.91 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 125.943 1.697 . . . . 0.0 108.498 175.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.285 3.7 t80 -114.05 154.68 27.28 Favored 'General case' 0 CA--C 1.573 1.856 0 CA-C-O 123.772 1.749 . . . . 0.0 109.125 173.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.2 p -170.9 124.08 0.63 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.802 -1.186 . . . . 0.0 108.171 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.2 p90 -143.22 164.44 30.18 Favored 'General case' 0 CA--C 1.579 2.067 0 O-C-N 121.813 -0.555 . . . . 0.0 111.913 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -102.97 128.2 49.89 Favored 'General case' 0 CA--C 1.565 1.544 0 O-C-N 119.168 -2.208 . . . . 0.0 106.125 172.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.57 110.94 1.08 Allowed 'General case' 0 CA--C 1.57 1.733 0 O-C-N 121.27 -0.894 . . . . 0.0 112.77 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.1 54.76 30.65 Favored Glycine 0 N--CA 1.509 3.542 0 O-C-N 120.65 -1.281 . . . . 0.0 114.606 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.637 ' HG3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -99.15 -71.95 0.68 Allowed 'General case' 0 N--CA 1.509 2.485 0 CA-C-O 124.366 2.031 . . . . 0.0 112.182 -174.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.637 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -111.23 -49.98 0.64 Allowed Glycine 0 CA--C 1.561 2.914 0 N-CA-C 104.024 -3.63 . . . . 0.0 104.024 168.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.778 23.8 tt0 118.89 137.78 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 127.909 3.719 . . . . 0.0 114.634 164.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.478 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.348 11.9 m -79.97 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.949 1 CA-C-N 105.773 -5.194 . . . . 0.0 104.454 178.25 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.554 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -132.79 157.39 43.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 124.017 1.865 . . . . 0.0 106.8 166.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -65.01 -33.11 75.27 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.519 -1.219 . . . . 0.0 113.123 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.49 -37.26 80.49 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 117.25 -1.357 . . . . 0.0 111.938 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.554 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.0 m0 -73.94 -43.31 58.71 Favored 'General case' 0 C--N 1.363 1.164 0 CA-C-N 120.685 1.584 . . . . 0.0 112.215 172.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.41 -34.58 72.64 Favored 'General case' 0 CA--C 1.572 1.817 0 CA-C-N 121.548 1.976 . . . . 0.0 114.267 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.303 1.5 mp -69.99 -63.25 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.577 2.004 0 CA-C-N 120.317 1.417 . . . . 0.0 111.294 174.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.16 -33.14 75.1 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.345 3.5 t -78.35 -25.92 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 CA-C-N 119.764 1.166 . . . . 0.0 111.584 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.23 90.05 Favored 'General case' 0 CA--C 1.575 1.936 0 CA-C-N 121.238 1.835 . . . . 0.0 111.856 165.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.6 p -82.58 17.57 1.75 Allowed 'General case' 0 CA--C 1.596 2.718 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.536 ' SD ' HD22 ' A' ' 101' ' ' LEU . 2.2 ttt -104.68 143.31 33.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 119.26 -2.15 . . . . 0.0 116.068 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -104.13 152.95 21.5 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 119.039 2.977 . . . . 0.0 119.039 -171.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.88 124.92 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.408 0 CA-C-O 118.478 -0.773 . . . . 0.0 111.032 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.9 -55.4 0.53 Allowed Glycine 0 N--CA 1.488 2.163 0 CA-C-N 120.683 1.583 . . . . 0.0 112.809 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.305 5.5 tt0 -158.41 -163.59 1.31 Allowed 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 102' ' ' CYS 0.782 0.5 OUTLIER -162.66 -139.92 0.05 OUTLIER 'General case' 0 CA--C 1.594 2.667 0 C-N-CA 125.091 1.357 . . . . 0.0 111.622 178.414 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.614 ' H ' HD23 ' A' ' 101' ' ' LEU 0.72 51.3 t -160.03 -115.01 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 127.162 2.185 . . . . 0.0 107.916 175.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.53 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 54.8 ptt85 -135.32 135.15 40.55 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -173.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.7 mt -89.84 132.07 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.01 0 CA-C-N 112.66 -2.063 . . . . 0.0 108.241 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.2 m -121.0 105.99 11.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 15.6 p -124.08 149.6 45.97 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 -170.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -81.45 135.98 49.51 Favored Pre-proline 0 CA--C 1.577 1.981 0 CA-C-N 113.38 -1.737 . . . . 0.0 110.521 175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.265 50.5 Cg_exo -57.7 -17.2 28.0 Favored 'Trans proline' 0 CA--C 1.559 1.756 0 N-CA-C 118.882 2.608 . . . . 0.0 118.882 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.62 -33.94 76.02 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 121.692 2.042 . . . . 0.0 113.907 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.57 -2.87 51.62 Favored 'General case' 0 CA--C 1.576 1.972 0 C-N-CA 125.734 1.614 . . . . 0.0 113.462 169.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.51 -113.97 0.22 Allowed 'General case' 0 CA--C 1.579 2.09 0 CA-C-N 121.499 1.954 . . . . 0.0 113.013 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 127' ' ' LEU 0.308 2.7 m-85 -79.04 -37.55 38.74 Favored 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 121.188 1.813 . . . . 0.0 113.12 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 49.22 -116.15 3.29 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 121.222 3.249 . . . . 0.0 121.222 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -77.85 -31.99 51.83 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.36 -33.76 63.18 Favored 'General case' 0 CA--C 1.569 1.709 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.12 155.99 9.75 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 119.49 2.556 . . . . 0.0 119.49 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 t -98.9 111.09 59.82 Favored Pre-proline 0 CA--C 1.58 2.117 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.285 47.6 Cg_exo -31.26 -52.0 0.27 Allowed 'Trans proline' 0 CA--C 1.581 2.843 1 N-CA-C 124.19 4.65 . . . . 0.0 124.19 -175.36 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.71 -18.54 32.46 Favored 'Trans proline' 0 CA--C 1.577 2.629 0 N-CA-C 120.494 3.229 . . . . 0.0 120.494 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -160.2 -18.81 0.06 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 119.052 2.982 . . . . 0.0 119.052 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . 0.289 10.7 mt -79.93 -59.01 0.58 Allowed Pre-proline 0 CA--C 1.605 3.088 1 N-CA-C 124.437 4.977 . . . . 0.0 124.437 -172.262 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . 0.89 0.1 OUTLIER 34.09 -115.29 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.486 2 C-N-CA 126.843 5.029 . . . . 0.0 123.57 -172.325 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.12 99.66 1.32 Allowed 'Trans proline' 0 CA--C 1.575 2.537 0 CA-C-N 125.886 3.138 . . . . 0.0 118.601 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 t30 52.46 70.69 0.54 Allowed 'General case' 0 CA--C 1.593 2.629 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -109.55 114.52 28.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 119.618 -1.926 . . . . 0.0 108.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.4 m -54.0 151.52 6.71 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 72.5 mt -126.77 164.53 21.14 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 124.566 2.127 . . . . 0.0 113.791 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -144.31 113.55 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.742 0 CA-C-N 112.027 -2.351 . . . . 0.0 107.601 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.292 5.7 m-85 -127.07 125.57 41.54 Favored 'General case' 0 N--CA 1.516 2.828 0 CA-C-N 122.227 2.285 . . . . 0.0 110.839 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -93.68 96.03 9.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.362 -1.461 . . . . 0.0 108.296 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 t -106.3 138.98 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -132.18 118.44 19.56 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 96' ' ' MET . 6.9 tt -90.83 114.08 26.4 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 120.814 -1.179 . . . . 0.0 113.877 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.31 9.8 m-30 -76.59 -51.42 11.65 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.571 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -163.74 146.85 9.9 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 121.702 2.046 . . . . 0.0 108.353 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.526 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.267 0.1 OUTLIER -100.88 -80.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 170.188 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.526 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 14.1 mmtm -80.0 -37.03 35.07 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 120.134 2.814 . . . . 0.0 120.134 177.333 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.056 0 N-CA-C 106.741 -2.544 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -172.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.591 2.538 0 C-N-CA 126.218 1.807 . . . . 0.0 106.181 -177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.87 112.7 0.47 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 118.464 -2.648 . . . . 0.0 112.589 171.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.503 0.0 OUTLIER 155.96 -86.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 C-N-CA 125.79 1.636 . . . . 0.0 111.355 175.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.1 t 172.9 80.76 0.04 OUTLIER Pre-proline 0 CA--C 1.587 2.397 0 C-N-CA 130.351 3.46 . . . . 0.0 104.102 -174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -73.56 1.48 6.84 Favored 'Trans proline' 0 CA--C 1.568 2.204 1 N-CA-C 127.223 5.817 . . . . 0.0 127.223 -167.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.02 -81.17 0.1 Allowed 'General case' 0 N--CA 1.496 1.852 1 CA-C-N 126.942 4.428 . . . . 0.0 112.62 -177.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -77.45 -61.12 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 173.41 90.62 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.086 0 N-CA-C 105.094 -2.188 . . . . 0.0 105.094 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -87.56 7.61 28.86 Favored 'General case' 0 CA--C 1.577 2.012 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.24 6.48 2.11 Favored Glycine 0 N--CA 1.496 2.64 1 N-CA-C 123.676 4.231 . . . . 0.0 123.676 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.446 HG23 ' HB3' ' A' ' 106' ' ' CYS . 10.8 p -174.93 -173.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.582 2.194 0 CA-C-O 123.687 1.708 . . . . 0.0 110.681 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.91 2.2 mm? 178.94 165.9 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.71 2.004 . . . . 0.0 113.674 160.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.34 125.83 53.7 Favored 'General case' 0 CA--C 1.565 1.545 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -169.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.251 11.2 p -114.37 109.53 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.596 0 O-C-N 121.43 -0.793 . . . . 0.0 112.653 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.389 8.2 mm -48.31 133.87 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 N-CA-C 119.712 3.227 . . . . 0.0 119.712 -175.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -115.73 -59.8 1.95 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.201 -1.818 . . . . 0.0 108.867 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -143.49 103.74 4.14 Favored 'General case' 0 CA--C 1.585 2.322 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -53.26 -61.35 2.36 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 119.878 3.288 . . . . 0.0 119.878 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.74 177.42 16.23 Favored Glycine 0 CA--C 1.55 2.281 0 C-N-CA 125.22 1.391 . . . . 0.0 114.635 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 t -162.07 -12.62 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.01 -68.92 1.44 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 122.279 3.672 . . . . 0.0 122.279 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.4 t -158.83 66.83 0.43 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.768 0.794 . . . . 0.0 112.388 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.391 10.4 mt-10 60.42 -160.33 0.3 Allowed 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 120.327 3.455 . . . . 0.0 120.327 174.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 73.1 p -97.04 170.86 6.7 Favored Pre-proline 0 CA--C 1.585 2.324 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -99.46 -166.15 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.512 0 CA-C-N 123.073 2.133 . . . . 0.0 117.149 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.1 ptt? -130.15 169.71 14.99 Favored 'General case' 0 CA--C 1.573 1.837 0 O-C-N 121.282 -0.887 . . . . 0.0 112.999 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.4 tp -62.95 139.18 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.166 0 O-C-N 119.211 -2.181 . . . . 0.0 109.352 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 7.01 86.89 Favored Glycine 0 CA--C 1.567 3.293 0 CA-C-O 117.497 -1.724 . . . . 0.0 117.335 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.43 146.85 42.54 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 121.531 2.665 . . . . 0.0 113.501 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -85.68 119.96 26.59 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.37 135.53 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 C-N-CA 123.192 0.597 . . . . 0.0 111.332 -172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -114.5 111.99 22.27 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 76' ' ' PHE . 22.9 m -116.16 162.3 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 124.087 1.899 . . . . 0.0 114.669 -173.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.445 ' ND1' HD23 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -114.9 108.03 16.19 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 112.778 -2.01 . . . . 0.0 107.543 168.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 2.2 p90 -110.51 147.62 33.75 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 123.31 1.528 . . . . 0.0 114.747 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.8 m -131.19 144.5 51.4 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 165.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.88 144.85 12.68 Favored Glycine 0 CA--C 1.551 2.295 0 O-C-N 119.769 -1.832 . . . . 0.0 116.528 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.467 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -132.31 149.8 52.29 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 126.007 1.723 . . . . 0.0 114.398 -176.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.0 tp -76.97 169.55 18.13 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.369 1.081 . . . . 0.0 108.521 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.346 0.0 OUTLIER -61.59 -25.45 67.34 Favored 'General case' 0 CA--C 1.565 1.534 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 178.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.81 3.46 11.84 Favored 'General case' 0 CA--C 1.594 2.651 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.73 43.54 11.59 Favored Glycine 0 N--CA 1.507 3.387 0 CA-C-N 121.101 1.773 . . . . 0.0 114.343 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.9 m -115.52 115.53 26.64 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -78.2 96.74 5.29 Favored 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -70.09 -32.03 69.89 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.682 -1.886 . . . . 0.0 113.87 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -155.22 159.92 40.46 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 124.189 1.947 . . . . 0.0 115.669 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.7 t -158.82 98.75 1.51 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.6 p -54.36 -49.85 68.85 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.445 HD23 ' ND1' ' A' ' 55' ' ' HIS 0.428 0.2 OUTLIER -66.49 -44.17 83.35 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 -177.839 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.38 -40.2 61.78 Favored 'General case' 0 CA--C 1.583 2.215 0 C-N-CA 124.423 1.089 . . . . 0.0 113.852 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.1 mtp85 -68.86 -14.81 63.26 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 173.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.384 0.6 OUTLIER 118.52 -41.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 129.005 2.922 . . . . 0.0 114.11 177.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.92 155.53 20.88 Favored 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -88.6 135.33 33.55 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 117.258 -1.353 . . . . 0.0 109.276 174.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HB3' HG23 ' A' ' 54' ' ' VAL . 6.9 t80 -83.11 151.23 25.84 Favored 'General case' 0 CA--C 1.57 1.742 0 CA-C-N 122.872 2.578 . . . . 0.0 108.922 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.0 t -168.03 145.92 4.36 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 123.9 1.81 . . . . 0.0 108.429 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.5 p90 -152.46 179.28 8.71 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.007 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -116.26 121.99 43.66 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.72 109.59 0.24 Allowed 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.83 37.77 60.9 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.383 13.9 tppt? -91.03 -8.85 47.92 Favored 'General case' 0 CA--C 1.572 1.796 0 CA-C-N 120.993 2.397 . . . . 0.0 117.211 -174.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.29 65.75 1.41 Allowed Glycine 0 N--CA 1.504 3.183 0 N-CA-C 103.969 -3.652 . . . . 0.0 103.969 -169.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -156.91 -57.35 0.09 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.958 -1.121 . . . . 0.0 113.208 -164.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.524 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.281 13.9 m -98.99 -139.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 CA-C-O 122.998 1.38 . . . . 0.0 109.462 -175.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 89' ' ' TRP . 15.9 pt -120.67 163.69 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 CA-C-O 123.66 1.695 . . . . 0.0 110.317 173.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.263 2.2 mptt -67.8 -34.68 77.23 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.426 -1.261 . . . . 0.0 113.237 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.12 -32.42 69.82 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 117.313 -1.327 . . . . 0.0 112.607 167.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.4 ' H ' HG13 ' A' ' 86' ' ' ILE . 29.5 m0 -76.89 -42.66 38.89 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 120.955 1.707 . . . . 0.0 112.613 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -59.7 -37.1 77.92 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 120.313 1.415 . . . . 0.0 114.586 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.282 1.4 mp -66.76 -58.35 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.081 0 CA-C-N 119.749 1.159 . . . . 0.0 110.801 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.36 87.94 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.413 HG22 ' SD ' ' A' ' 96' ' ' MET 0.289 92.9 t -67.22 -37.7 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 119.349 0.977 . . . . 0.0 112.221 172.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.75 -39.05 61.82 Favored 'General case' 0 CA--C 1.588 2.416 0 CA-C-N 121.302 1.864 . . . . 0.0 112.444 168.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.7 p -94.96 42.28 1.09 Allowed 'General case' 0 CA--C 1.597 2.769 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 133' ' ' LEU . 12.4 ttm -112.12 142.59 44.39 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 119.102 -2.249 . . . . 0.0 115.248 -177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -109.48 139.49 44.41 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 120.13 1.332 . . . . 0.0 113.057 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.7 131.55 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.399 0 CA-C-O 118.22 -0.895 . . . . 0.0 112.393 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.46 -56.02 0.5 Allowed Glycine 0 N--CA 1.492 2.408 0 CA-C-O 117.107 -1.941 . . . . 0.0 111.329 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -150.45 -162.12 1.49 Allowed 'General case' 0 N--CA 1.51 2.537 0 CA-C-N 118.946 1.373 . . . . 0.0 113.737 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.469 HD13 ' HG3' ' A' ' 96' ' ' MET 0.799 0.6 OUTLIER -154.4 -126.94 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.065 0 CA-C-O 124.855 2.264 . . . . 0.0 114.026 176.159 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.5 OUTLIER -158.52 -147.78 0.18 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 124.357 2.027 . . . . 0.0 110.936 -164.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.502 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -131.76 138.56 48.64 Favored 'General case' 0 CA--C 1.56 1.346 0 CA-C-O 124.644 2.164 . . . . 0.0 109.353 170.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -97.65 134.82 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-N 112.612 -2.085 . . . . 0.0 108.764 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 49.9 m -121.27 109.46 14.96 Favored 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.535 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 4.7 p -127.03 144.27 51.07 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -86.07 146.02 41.99 Favored Pre-proline 0 CA--C 1.574 1.902 0 CA-C-N 112.773 -2.012 . . . . 0.0 110.996 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -46.93 -26.21 4.61 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 N-CA-C 119.713 2.928 . . . . 0.0 119.713 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -58.57 -43.51 89.45 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 120.774 1.624 . . . . 0.0 114.437 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.86 -1.53 56.62 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.84 -118.35 0.23 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 120.719 1.599 . . . . 0.0 113.931 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.475 16.7 m-85 -83.8 -13.09 54.63 Favored 'General case' 0 N--CA 1.517 2.884 0 CA-C-N 121.86 2.118 . . . . 0.0 115.595 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.82 -153.86 49.64 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 121.213 3.245 . . . . 0.0 121.213 171.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.8 t -85.26 62.38 7.46 Favored 'General case' 0 CA--C 1.577 1.991 0 CA-C-O 122.995 1.379 . . . . 0.0 110.85 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.19 -54.69 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 126.301 1.84 . . . . 0.0 111.638 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.01 163.88 24.87 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-O 122.447 1.026 . . . . 0.0 113.796 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.518 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 19.7 t -72.98 143.57 84.22 Favored Pre-proline 0 CA--C 1.577 1.992 0 CA-C-O 116.827 -1.558 . . . . 0.0 110.862 176.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -49.68 126.82 17.19 Favored 'Trans proline' 0 CA--C 1.581 2.865 0 C-N-CA 122.923 2.415 . . . . 0.0 113.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.322 0.2 OUTLIER 28.58 47.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.575 2.536 0 N-CA-C 121.946 3.787 . . . . 0.0 121.946 -172.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -154.79 -47.66 0.09 Allowed 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.518 ' HB ' ' H ' ' A' ' 117' ' ' SER . 18.1 mt -104.51 150.14 38.18 Favored Pre-proline 0 N--CA 1.512 2.636 0 CA-C-O 116.281 -1.819 . . . . 0.0 113.002 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.66 173.3 8.12 Favored 'Trans proline' 0 CA--C 1.588 3.189 0 CA-C-N 126.412 3.326 . . . . 0.0 116.015 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.18 -21.48 22.49 Favored 'Trans proline' 0 CA--C 1.57 2.287 0 N-CA-C 121.751 3.712 . . . . 0.0 121.751 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -158.71 92.8 1.14 Allowed 'General case' 0 CA--C 1.584 2.283 0 CA-C-N 120.852 1.66 . . . . 0.0 107.651 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.59 133.43 22.47 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 122.985 2.629 . . . . 0.0 112.916 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 84.7 m -66.56 150.61 48.73 Favored 'General case' 0 CA--C 1.586 2.328 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.535 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.25 0.3 OUTLIER -145.11 175.84 9.95 Favored 'General case' 0 CA--C 1.573 1.843 0 O-C-N 119.643 -1.91 . . . . 0.0 111.196 -177.703 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.467 HG23 ' HE3' ' A' ' 59' ' ' TRP . 1.9 m -145.42 146.52 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 125.805 1.642 . . . . 0.0 109.729 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.251 1.7 m-85 -135.96 125.28 24.8 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.481 -0.762 . . . . 0.0 109.745 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 55.6 mt-10 -83.42 114.0 21.15 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.37 136.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -132.41 120.67 22.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.542 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 0.7 OUTLIER -86.34 123.84 32.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.367 -1.458 . . . . 0.0 114.616 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -70.25 -49.48 49.5 Favored 'General case' 0 CA--C 1.587 2.383 0 O-C-N 121.701 -0.624 . . . . 0.0 112.526 172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -171.29 155.73 4.38 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.74 1.616 . . . . 0.0 110.385 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.511 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.286 0.2 OUTLIER -126.6 -106.26 0.32 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.567 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.511 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 85.9 tttt -83.46 72.47 10.25 Favored 'General case' 0 CA--C 1.579 2.08 0 C-N-CA 124.508 1.123 . . . . 0.0 110.904 173.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.673 0 N-CA-C 115.94 1.136 . . . . 0.0 115.94 178.45 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.436 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.409 0.4 OUTLIER 58.37 166.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.96 0 N-CA-C 116.674 2.102 . . . . 0.0 116.674 -176.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.438 23.6 t0 -162.14 -171.31 2.79 Favored 'General case' 0 CA--C 1.592 2.564 0 C-N-CA 125.937 1.695 . . . . 0.0 108.166 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.287 1.8 pp -75.14 62.22 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.384 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -156.53 70.15 4.83 Favored Pre-proline 0 CA--C 1.58 2.131 0 O-C-N 119.487 -2.008 . . . . 0.0 111.769 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.52 -27.69 82.34 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 N-CA-C 119.087 2.687 . . . . 0.0 119.087 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.17 44.18 0.55 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.443 1.097 . . . . 0.0 110.796 177.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.259 40.6 mm-40 68.76 58.57 0.39 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.308 -1.495 . . . . 0.0 109.688 -171.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -119.39 -70.75 0.77 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.339 21.6 mm-40 -89.99 -8.02 52.61 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 120.102 3.371 . . . . 0.0 120.102 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.81 -66.79 0.56 Allowed Glycine 0 N--CA 1.469 0.85 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.2 t -145.11 133.48 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.505 0 CA-C-N 118.291 1.045 . . . . 0.0 113.691 -173.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 tt -109.96 141.95 42.01 Favored 'General case' 0 CA--C 1.594 2.664 0 C-N-CA 127.119 2.168 . . . . 0.0 107.893 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB3' HG13 ' A' ' 35' ' ' VAL . 3.1 mtmp? -159.58 170.75 20.96 Favored 'General case' 0 N--CA 1.51 2.547 2 CA-C-N 126.276 4.125 . . . . 0.0 122.123 -170.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.615 ' O ' ' SG ' ' A' ' 102' ' ' CYS 1.237 3.7 m 106.0 -173.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.672 1 N-CA-C 127.785 6.217 . . . . 0.0 127.785 158.351 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.701 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.643 34.3 mm -16.41 128.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.342 2 N-CA-C 131.351 7.538 . . . . 0.0 131.351 -153.931 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -142.63 -49.17 0.35 Allowed 'General case' 0 CA--C 1.584 2.257 0 C-N-CA 127.33 2.252 . . . . 0.0 109.537 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -114.77 101.93 9.52 Favored 'General case' 0 CA--C 1.578 2.033 0 C-N-CA 124.922 1.289 . . . . 0.0 108.693 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -61.28 174.84 0.63 Allowed 'General case' 0 CA--C 1.597 2.762 0 O-C-N 119.469 -2.019 . . . . 0.0 115.579 174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.43 8.26 Favored Glycine 0 N--CA 1.486 2.017 0 O-C-N 119.856 -1.777 . . . . 0.0 116.461 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.5 p -107.37 -76.66 0.61 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.6 70.51 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.267 10.2 t -157.6 61.56 0.48 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.362 1.077 . . . . 0.0 113.179 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.264 30.3 mt-10 59.75 168.69 0.07 Allowed 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 120.855 3.65 . . . . 0.0 120.855 175.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 p -90.07 165.4 24.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 CA-C-N 112.888 -1.96 . . . . 0.0 114.275 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.43 159.61 17.14 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 CA-C-N 121.919 1.721 . . . . 0.0 114.732 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -98.33 165.54 11.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.389 -1.444 . . . . 0.0 112.211 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.345 0.3 OUTLIER -63.73 130.24 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 119.219 -2.176 . . . . 0.0 110.574 177.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.17 17.61 79.88 Favored Glycine 0 CA--C 1.569 3.431 0 N-CA-C 117.981 1.952 . . . . 0.0 117.981 -172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.02 147.29 43.06 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.575 1.688 . . . . 0.0 112.256 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -81.83 114.64 20.6 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -124.46 146.14 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.661 0.784 . . . . 0.0 111.307 -172.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.25 46.3 p90 -129.85 98.68 4.86 Favored 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 124.86 2.267 . . . . 0.0 111.712 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.1 m -90.81 170.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 111.562 -2.563 . . . . 0.0 112.259 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.446 ' CE1' ' HG ' ' A' ' 70' ' ' LEU . 5.1 t60 -134.55 135.82 42.58 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 164.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.313 6.7 p90 -128.8 142.3 51.03 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.1 m -110.96 144.91 39.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 159.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.34 140.44 7.99 Favored Glycine 0 CA--C 1.548 2.112 0 O-C-N 118.92 -2.363 . . . . 0.0 116.776 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -132.17 155.97 47.25 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 127.675 2.39 . . . . 0.0 112.569 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.49 -174.5 4.84 Favored 'General case' 0 CA--C 1.561 1.386 0 O-C-N 120.475 -1.391 . . . . 0.0 111.044 170.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 1.9 pt? -64.83 -26.12 68.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -75.68 1.98 13.18 Favored 'General case' 0 CA--C 1.601 2.93 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.417 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.22 31.82 81.86 Favored Glycine 0 N--CA 1.501 2.996 0 O-C-N 120.477 -1.389 . . . . 0.0 114.821 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.6 m -90.25 114.6 26.66 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -70.4 95.02 1.0 Allowed 'General case' 0 CA--C 1.583 2.246 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -70.45 -31.3 68.4 Favored 'General case' 0 CA--C 1.564 1.481 0 O-C-N 119.519 -1.988 . . . . 0.0 114.212 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -154.23 161.18 41.99 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.839 2.257 . . . . 0.0 114.179 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.0 p -151.05 96.92 2.39 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -28.09 27.93 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 120.723 3.601 . . . . 0.0 120.723 -172.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.446 ' HG ' ' CE1' ' A' ' 55' ' ' HIS 0.263 36.5 mt -70.48 -51.72 27.05 Favored 'General case' 0 CA--C 1.58 2.116 0 CA-C-N 120.947 1.703 . . . . 0.0 112.062 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.18 -30.24 70.29 Favored 'General case' 0 CA--C 1.58 2.13 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -54.01 -19.92 5.52 Favored 'General case' 0 CA--C 1.582 2.183 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 174.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.35 39.0 ttmt 127.36 -46.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 129.387 3.075 . . . . 0.0 111.952 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.3 2.7 p-10 -104.61 -142.8 0.37 Allowed 'General case' 0 CA--C 1.575 1.934 0 CA-C-O 123.076 1.417 . . . . 0.0 111.953 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -124.78 -136.5 0.28 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.528 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.404 3.1 t80 -140.25 142.58 35.76 Favored 'General case' 0 CA--C 1.58 2.107 0 O-C-N 118.337 -2.727 . . . . 0.0 109.095 167.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.4 p -155.4 148.75 24.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 118.479 -2.638 . . . . 0.0 109.05 -177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.508 ' CG ' HG11 ' A' ' 85' ' ' VAL . 30.3 p90 -157.37 -173.19 4.3 Favored 'General case' 0 CA--C 1.572 1.801 0 CA-C-N 114.364 -1.289 . . . . 0.0 113.223 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -122.21 113.53 19.59 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 103.736 -2.69 . . . . 0.0 103.736 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 tp -39.63 113.57 0.35 Allowed 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.76 47.44 88.65 Favored Glycine 0 N--CA 1.503 3.149 0 N-CA-C 118.208 2.043 . . . . 0.0 118.208 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -109.39 6.65 24.51 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.78 58.32 2.15 Favored Glycine 0 N--CA 1.508 3.462 0 N-CA-C 106.902 -2.479 . . . . 0.0 106.902 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -149.97 -49.27 0.13 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-N 112.138 -2.031 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.295 10.3 m -117.85 -138.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-O 123.04 1.4 . . . . 0.0 108.374 -175.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 89' ' ' TRP . 26.7 pt -122.48 163.25 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 CA-C-O 123.767 1.746 . . . . 0.0 110.173 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -31.59 71.54 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.479 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.09 -35.37 75.04 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 117.457 -1.259 . . . . 0.0 111.558 167.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.505 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.4 m0 -75.4 -41.43 56.18 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 120.725 1.602 . . . . 0.0 112.833 172.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -59.61 -37.99 80.07 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 119.744 1.157 . . . . 0.0 113.863 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.257 1.2 mp -64.61 -54.68 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-N 120.709 1.595 . . . . 0.0 111.208 173.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.71 72.1 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.624 2.083 . . . . 0.0 116.624 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 51.2 t -60.91 -46.62 96.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-N 119.07 0.85 . . . . 0.0 112.327 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.8 -34.89 55.67 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 29.0 p -87.56 6.73 32.92 Favored 'General case' 0 CA--C 1.585 2.303 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.533 ' SD ' ' HG ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.35 138.05 52.68 Favored 'General case' 0 N--CA 1.507 2.408 0 CA-C-N 123.524 2.874 . . . . 0.0 116.806 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -80.93 149.19 29.5 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-O 113.51 -3.138 . . . . 0.0 111.05 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.279 1.8 t -9.61 87.91 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.548 4.433 0 CA-C-N 123.144 2.702 . . . . 0.0 110.513 -166.003 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 133' ' ' LEU . . . -3.19 -37.76 0.0 OUTLIER Glycine 0 N--CA 1.497 2.749 1 N-CA-C 129.839 6.696 . . . . 0.0 129.839 -140.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 61.24 -127.69 0.85 Allowed 'General case' 0 CA--C 1.605 3.075 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -166.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.739 HD13 ' H ' ' A' ' 102' ' ' CYS 1.672 0.6 OUTLIER 124.57 154.73 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 161.383 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.739 ' H ' HD13 ' A' ' 101' ' ' LEU . 18.8 t -160.19 -104.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.239 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -122.29 158.36 29.7 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 124.875 2.274 . . . . 0.0 116.036 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mt -131.82 114.61 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.007 0 CA-C-N 111.524 -2.58 . . . . 0.0 105.559 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.4 m -107.15 99.19 8.76 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 7.8 p -112.39 146.82 37.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.31 3.078 . . . . 0.0 119.31 -170.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -90.57 141.02 26.81 Favored Pre-proline 0 CA--C 1.58 2.098 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.921 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.26 -22.41 8.33 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 N-CA-C 119.882 2.993 . . . . 0.0 119.882 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.99 -42.04 98.7 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.086 1.766 . . . . 0.0 114.434 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.56 0.17 39.39 Favored 'General case' 0 CA--C 1.577 2.0 0 CA-C-O 117.6 -1.19 . . . . 0.0 113.256 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.97 -114.5 0.15 Allowed 'General case' 0 CA--C 1.58 2.134 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.467 ' CD2' HD11 ' A' ' 127' ' ' LEU 0.38 24.7 m-85 -82.29 -14.11 55.91 Favored 'General case' 0 N--CA 1.526 3.339 0 CA-C-N 120.945 1.702 . . . . 0.0 115.176 -178.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.1 -152.0 52.01 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 118.888 2.315 . . . . 0.0 118.888 173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.5 p -67.66 -22.25 65.31 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.12 -33.01 13.51 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 118.399 2.74 . . . . 0.0 118.399 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.4 169.5 45.68 Favored Glycine 0 CA--C 1.551 2.327 0 CA-C-N 121.05 1.75 . . . . 0.0 114.71 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.473 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 6.8 t -90.42 120.14 69.06 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-O 116.684 -1.627 . . . . 0.0 108.799 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -37.23 -46.07 1.52 Allowed 'Trans proline' 0 CA--C 1.582 2.887 1 N-CA-C 123.32 4.316 . . . . 0.0 123.32 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.14 -20.11 19.39 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 CA-C-N 125.595 3.034 . . . . 0.0 119.534 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -159.53 -27.17 0.07 Allowed 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.473 ' HB ' ' H ' ' A' ' 117' ' ' SER . 89.9 mt -79.98 126.6 79.43 Favored Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 120.183 -1.573 . . . . 0.0 111.938 -175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -82.68 170.7 12.62 Favored 'Trans proline' 0 CA--C 1.581 2.841 0 C-N-CA 122.365 2.043 . . . . 0.0 115.842 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.41 130.67 22.9 Favored 'Trans proline' 0 CA--C 1.57 2.315 0 C-N-CA 122.85 2.367 . . . . 0.0 114.931 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.9 t30 58.85 60.85 2.34 Favored 'General case' 0 CA--C 1.586 2.364 0 C-N-CA 125.031 1.332 . . . . 0.0 113.413 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -129.23 123.73 32.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.33 -1.481 . . . . 0.0 112.451 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 m -59.35 156.2 13.22 Favored 'General case' 0 CA--C 1.587 2.373 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 87.8 mt -126.62 165.05 19.92 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 124.69 2.186 . . . . 0.0 114.297 -174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.99 106.15 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.77 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.28 2.5 m-85 -120.92 125.82 48.4 Favored 'General case' 0 N--CA 1.512 2.638 0 CA-C-N 122.194 2.27 . . . . 0.0 109.134 173.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -95.43 98.72 10.76 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.52 140.57 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.579 -1.192 . . . . 0.0 108.346 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 50.4 mt-10 -130.3 110.15 11.3 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.484 ' O ' ' HA3' ' A' ' 99' ' ' GLY 0.31 25.8 tp -85.19 121.38 27.85 Favored 'General case' 0 N--CA 1.51 2.529 0 CA-C-O 122.822 1.296 . . . . 0.0 112.779 -177.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . 0.3 15.3 m-30 -84.04 -64.36 1.18 Allowed 'General case' 0 CA--C 1.57 1.717 0 O-C-N 120.278 -1.514 . . . . 0.0 111.782 -175.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -150.17 162.17 40.96 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.912 2.142 . . . . 0.0 110.46 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -143.5 -114.8 0.1 Allowed 'General case' 0 CA--C 1.58 2.107 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -103.4 173.1 6.45 Favored 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.623 1.569 . . . . 0.0 108.196 170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 O-C-N 119.583 -1.948 . . . . 0.0 117.73 -179.766 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.02 1 N-CA-C 128.819 6.288 . . . . 0.0 128.819 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.397 0.3 OUTLIER 62.43 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 121.267 3.803 . . . . 0.0 121.267 171.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -152.05 138.09 18.2 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.465 0.1 OUTLIER -129.0 93.24 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 124.051 1.882 . . . . 0.0 108.873 170.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -140.91 72.87 28.07 Favored Pre-proline 0 CA--C 1.58 2.106 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.275 11.3 Cg_exo -74.95 -33.09 4.93 Favored 'Trans proline' 0 CA--C 1.571 2.374 0 CA-C-N 123.909 2.432 . . . . 0.0 117.754 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.48 61.85 0.17 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-N 120.747 1.612 . . . . 0.0 111.703 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.264 63.8 mm-40 72.46 25.29 2.76 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.095 -1.628 . . . . 0.0 114.124 -175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -80.85 -95.61 0.04 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 O-C-N 120.406 -1.434 . . . . 0.0 110.98 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.26 11.4 mm-40 -90.26 -15.03 32.09 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.47 10.18 2.84 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.0 t -170.25 150.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 CA-C-N 120.029 1.914 . . . . 0.0 112.859 -167.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.69 10.2 tp -151.84 -146.67 0.2 Allowed 'General case' 0 CA--C 1.565 1.55 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.962 162.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 pttt -179.02 166.42 1.58 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.16 -1.587 . . . . 0.0 113.769 -169.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.83 123.23 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.129 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.297 0.3 OUTLIER -89.79 139.28 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 CA-C-N 120.25 1.386 . . . . 0.0 111.8 178.826 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.34 -69.18 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.982 -0.449 . . . . 0.0 111.219 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HB2' ' H ' ' A' ' 101' ' ' LEU . 89.8 mtt-85 -103.96 68.66 0.92 Allowed 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -38.1 -71.25 0.08 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.04 -178.4 39.44 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.5 p -83.7 -66.21 0.92 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.681 -0.759 . . . . 0.0 112.001 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.96 55.27 0.01 OUTLIER Glycine 0 CA--C 1.54 1.614 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 15.3 t -153.16 63.25 0.77 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 123.234 1.492 . . . . 0.0 112.527 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.361 46.8 mt-10 69.76 170.38 0.3 Allowed 'General case' 0 CA--C 1.576 1.972 1 N-CA-C 121.943 4.053 . . . . 0.0 121.943 175.126 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.7 p -114.33 160.0 34.49 Favored Pre-proline 0 CA--C 1.587 2.398 0 CA-C-N 111.042 -2.799 . . . . 0.0 110.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.83 129.18 30.91 Favored 'Trans proline' 0 CA--C 1.579 2.752 0 C-N-CA 122.853 2.369 . . . . 0.0 117.023 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -87.12 161.58 18.03 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 122.009 2.186 . . . . 0.0 111.363 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.343 0.4 OUTLIER -62.31 132.15 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 119.029 -2.294 . . . . 0.0 110.896 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.76 0.97 90.0 Favored Glycine 0 CA--C 1.569 3.428 0 N-CA-C 117.765 1.866 . . . . 0.0 117.765 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -91.56 152.65 20.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 121.504 2.652 . . . . 0.0 112.868 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -83.56 135.7 34.53 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.285 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -132.36 135.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 123.185 0.594 . . . . 0.0 109.831 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.265 33.4 p90 -115.96 105.31 12.51 Favored 'General case' 0 CA--C 1.567 1.625 0 CA-C-O 124.038 1.875 . . . . 0.0 109.707 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.2 m -110.05 173.2 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 127.138 2.175 . . . . 0.0 114.55 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.257 0.1 OUTLIER -135.25 111.33 9.56 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 166.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.257 20.8 p90 -96.63 176.0 6.18 Favored 'General case' 0 CA--C 1.586 2.327 0 CA-C-O 126.291 2.948 . . . . 0.0 113.918 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . 0.262 63.3 m -150.61 140.23 21.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 162.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.1 156.6 27.08 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 119.787 -1.82 . . . . 0.0 116.216 174.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -139.44 147.31 41.21 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 112.346 -1.927 . . . . 0.0 111.704 -173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 tp -80.64 169.11 18.07 Favored 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 122.762 1.268 . . . . 0.0 107.928 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.319 0.0 OUTLIER -59.24 -26.68 65.09 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 178.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.68 4.09 6.82 Favored 'General case' 0 CA--C 1.595 2.698 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.59 41.89 34.42 Favored Glycine 0 N--CA 1.506 3.339 0 O-C-N 119.804 -1.81 . . . . 0.0 114.434 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.6 m -116.67 117.31 29.46 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -77.36 97.82 5.03 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-O 118.949 -0.548 . . . . 0.0 112.054 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -74.0 -37.07 64.53 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.853 -2.404 . . . . 0.0 115.727 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.54 174.37 14.14 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.337 1.426 . . . . 0.0 113.93 -178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.4 p -159.98 -10.25 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 119.098 2.999 . . . . 0.0 119.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.3 1.6 t 71.7 -49.77 0.69 Allowed 'General case' 0 N--CA 1.511 2.609 0 O-C-N 118.95 -2.344 . . . . 0.0 111.411 -168.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 28.6 mt -48.23 -39.33 20.9 Favored 'General case' 0 CA--C 1.581 2.14 0 C-N-CA 127.637 2.375 . . . . 0.0 113.972 169.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.26 -44.97 88.61 Favored 'General case' 0 CA--C 1.581 2.156 0 C-N-CA 125.279 1.432 . . . . 0.0 113.025 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -76.69 -22.27 54.19 Favored 'General case' 0 CA--C 1.585 2.326 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.392 57.3 mtpt 106.18 -41.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 127.648 2.379 . . . . 0.0 113.625 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -78.65 159.86 27.82 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.836 -1.165 . . . . 0.0 113.021 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -80.51 167.28 20.32 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 54' ' ' VAL . 12.0 t80 -98.04 155.96 16.87 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-O 123.052 1.406 . . . . 0.0 107.708 174.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 92.3 p -168.28 118.92 0.79 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 119.622 -1.924 . . . . 0.0 108.724 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.453 ' CG ' HG11 ' A' ' 85' ' ' VAL . 21.7 p90 -127.92 -174.53 3.22 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.235 1.017 . . . . 0.0 111.127 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.259 9.5 t0 -126.71 121.52 32.29 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 94' ' ' ALA . 11.6 tp -50.67 111.77 0.59 Allowed 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.58 23.42 70.46 Favored Glycine 0 CA--C 1.573 3.71 0 CA-C-O 118.218 -1.323 . . . . 0.0 116.045 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -124.65 -70.7 0.74 Allowed 'General case' 0 N--CA 1.503 2.192 0 CA-C-N 120.277 2.039 . . . . 0.0 112.952 -171.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.81 73.35 0.3 Allowed Glycine 0 N--CA 1.508 3.443 0 N-CA-C 103.85 -3.7 . . . . 0.0 103.85 171.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.487 5.7 pt-20 -73.54 134.48 43.8 Favored 'General case' 0 CA--C 1.561 1.366 2 CA-C-O 129.302 4.382 . . . . 0.0 119.196 -158.503 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.453 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.353 20.8 m -80.04 -117.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 1 CA-C-N 102.564 -6.653 . . . . 0.0 108.439 -175.445 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.495 HG13 ' H ' ' A' ' 89' ' ' TRP . 18.2 pt -121.72 156.11 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-O 124.285 1.993 . . . . 0.0 107.775 167.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 8.0 tmtt? -66.94 -28.72 68.52 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.927 176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.79 -37.17 83.37 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-O 117.353 -1.308 . . . . 0.0 111.485 166.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.495 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.0 m0 -70.18 -41.59 73.54 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.866 1.666 . . . . 0.0 111.99 172.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -53.83 -41.26 67.18 Favored 'General case' 0 CA--C 1.572 1.813 0 CA-C-N 120.766 1.621 . . . . 0.0 114.465 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -68.26 -61.0 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.967 0 CA-C-N 119.582 1.083 . . . . 0.0 112.586 175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.517 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -69.26 -28.45 66.33 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.271 45.5 t -79.16 -43.72 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 117.209 -1.377 . . . . 0.0 109.503 175.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -51.49 -33.45 31.43 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 121.161 1.8 . . . . 0.0 115.492 170.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -86.4 -12.09 50.16 Favored 'General case' 0 CA--C 1.583 2.221 0 CA-C-O 115.597 -2.144 . . . . 0.0 116.645 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -89.62 146.89 24.24 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 125.244 3.656 . . . . 0.0 115.043 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -86.94 159.97 18.84 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.86 125.95 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.566 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.277 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.12 -49.54 0.89 Allowed Glycine 0 N--CA 1.494 2.512 0 CA-C-O 113.939 -3.701 . . . . 0.0 108.651 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.974 4.5 pt-20 154.01 -93.73 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.417 1 N-CA-C 131.351 7.538 . . . . 0.0 131.351 164.39 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.433 ' H ' ' HB2' ' A' ' 38' ' ' ARG . 33.7 tp -79.09 122.2 25.94 Favored 'General case' 0 N--CA 1.484 1.225 1 N-CA-C 123.96 4.8 . . . . 0.0 123.96 -160.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.2 m -147.41 146.33 29.56 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.053 169.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -109.35 120.93 44.02 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.244 1.973 . . . . 0.0 110.905 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.2 mt -75.97 146.92 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.297 -2.229 . . . . 0.0 113.521 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.0 m -136.61 117.17 13.84 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.8 p -133.47 154.55 50.71 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 -173.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -96.62 146.61 31.61 Favored Pre-proline 0 CA--C 1.581 2.152 0 CA-C-N 113.797 -1.547 . . . . 0.0 114.022 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HB3' ' HA3' ' A' ' 113' ' ' GLY . 12.4 Cg_exo -43.25 -29.15 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 N-CA-C 121.62 3.661 . . . . 0.0 121.62 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -65.36 -39.09 91.88 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 121.22 1.827 . . . . 0.0 115.356 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -86.64 -7.71 58.1 Favored 'General case' 0 CA--C 1.576 1.969 0 C-N-CA 124.958 1.303 . . . . 0.0 113.718 171.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.479 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -115.44 -133.77 0.34 Allowed 'General case' 0 CA--C 1.573 1.839 0 CA-C-N 120.827 1.649 . . . . 0.0 112.398 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.2 4.1 49.74 Favored 'General case' 0 CA--C 1.591 2.556 0 CA-C-N 122.424 2.375 . . . . 0.0 113.411 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 108' ' ' PRO . . . -49.69 -62.14 5.09 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 122.293 3.677 . . . . 0.0 122.293 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -70.48 -39.16 74.37 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -130.04 -7.19 4.4 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.27 158.29 27.66 Favored Glycine 0 CA--C 1.55 2.241 0 CA-C-N 124.421 3.282 . . . . 0.0 113.78 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.466 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 6.1 t -82.75 137.0 44.28 Favored Pre-proline 0 CA--C 1.575 1.937 0 CA-C-O 116.777 -1.582 . . . . 0.0 109.759 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.266 43.8 Cg_exo -32.82 -45.18 0.25 Allowed 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.464 4.755 . . . . 0.0 124.464 -176.357 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.02 -52.99 0.08 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 0 CA-C-N 125.934 3.155 . . . . 0.0 118.929 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -152.5 3.57 0.35 Allowed 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.466 ' HB ' ' H ' ' A' ' 117' ' ' SER . 51.0 mt -79.89 137.43 53.95 Favored Pre-proline 0 CA--C 1.599 2.838 0 O-C-N 119.15 -2.219 . . . . 0.0 113.705 -174.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -92.63 -176.1 0.64 Allowed 'Trans proline' 0 CA--C 1.595 3.545 0 CA-C-N 125.319 2.935 . . . . 0.0 115.533 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -64.18 171.97 6.96 Favored 'Trans proline' 0 CA--C 1.578 2.705 0 N-CA-C 118.722 2.547 . . . . 0.0 118.722 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.262 28.3 t-20 59.23 54.08 5.02 Favored 'General case' 0 CA--C 1.585 2.297 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.06 105.94 13.8 Favored 'General case' 0 CA--C 1.57 1.73 0 O-C-N 120.417 -1.427 . . . . 0.0 113.491 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 85.2 m -82.44 135.37 35.16 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.479 HD12 ' HB1' ' A' ' 111' ' ' ALA . 85.8 mt -129.93 167.45 18.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 122.694 2.497 . . . . 0.0 115.585 -171.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.29 125.79 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.713 0 CA-C-N 111.147 -2.751 . . . . 0.0 107.01 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.275 60.7 m-85 -133.0 162.11 32.58 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 119.89 -1.756 . . . . 0.0 110.977 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.68 104.23 6.25 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.81 131.85 63.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 122.0 0.905 . . . . 0.0 111.269 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -114.14 111.07 20.99 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.996 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.53 117.34 29.97 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.57 -65.62 0.96 Allowed 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.367 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -156.85 162.36 39.69 Favored 'General case' 0 CA--C 1.576 1.954 0 CA-C-N 121.451 1.932 . . . . 0.0 109.491 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -141.38 -98.54 0.14 Allowed 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -80.34 -43.8 20.55 Favored 'General case' 0 CA--C 1.594 2.669 0 CA-C-O 116.624 -1.655 . . . . 0.0 114.949 173.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.649 0 CA-C-N 124.868 3.485 . . . . 0.0 121.038 178.697 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.01 0 N-CA-C 122.897 3.919 . . . . 0.0 122.897 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.51 174.67 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-O 123.074 1.416 . . . . 0.0 113.345 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -143.73 115.56 8.25 Favored 'General case' 0 CA--C 1.565 1.537 0 C-N-CA 124.296 1.038 . . . . 0.0 110.013 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.661 HD12 ' H ' ' A' ' 25' ' ' SER 0.349 2.4 pp -135.11 -66.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.661 ' H ' HD12 ' A' ' 24' ' ' ILE 1.057 0.3 OUTLIER 115.71 -117.21 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.195 0 O-C-N 116.479 -3.888 . . . . 0.0 108.182 -173.698 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -92.62 38.21 0.24 Allowed 'Trans proline' 0 CA--C 1.581 2.828 0 CA-C-N 125.612 3.04 . . . . 0.0 115.83 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.431 1.4 mmmp? 78.73 -22.13 0.3 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 118.764 -2.46 . . . . 0.0 115.56 -177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -73.9 -4.24 33.8 Favored 'General case' 0 CA--C 1.591 2.536 0 C-N-CA 123.642 0.777 . . . . 0.0 112.903 168.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.411 28.8 t0 70.93 54.33 0.25 Allowed 'General case' 0 CA--C 1.58 2.116 0 C-N-CA 126.199 1.8 . . . . 0.0 114.886 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -32.69 52.5 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 119.415 3.117 . . . . 0.0 119.415 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.8 -19.08 0.11 Allowed Glycine 0 N--CA 1.475 1.265 0 N-CA-C 120.101 2.8 . . . . 0.0 120.101 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.02 140.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 -172.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.588 5.9 tp -155.73 -142.92 0.11 Allowed 'General case' 0 CA--C 1.57 1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.148 168.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -153.45 162.8 40.92 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 123.193 1.473 . . . . 0.0 114.958 -170.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.1 t -107.49 104.8 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 113.554 -1.657 . . . . 0.0 107.495 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' ' SG ' ' A' ' 102' ' ' CYS 0.376 2.1 mm -76.81 120.44 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 CA-C-N 120.588 1.54 . . . . 0.0 112.512 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -95.1 -53.61 3.74 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.474 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -148.91 103.82 3.39 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -76.77 165.9 24.1 Favored 'General case' 0 CA--C 1.581 2.147 0 CA-C-N 123.781 2.991 . . . . 0.0 114.344 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.75 -158.68 33.95 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.308 5.0 t -153.26 -77.69 0.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 118.559 -0.734 . . . . 0.0 111.887 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 13.88 -85.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 122.423 3.729 . . . . 0.0 122.423 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.3 t -143.81 60.34 1.37 Allowed 'General case' 0 CA--C 1.574 1.866 0 CA-C-O 121.739 0.781 . . . . 0.0 111.193 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.399 6.4 pt-20 28.01 -114.84 0.03 OUTLIER 'General case' 0 CA--C 1.585 2.289 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.9 p -139.17 121.39 10.24 Favored Pre-proline 0 CA--C 1.575 1.94 0 C-N-CA 124.732 1.213 . . . . 0.0 112.681 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -70.09 -114.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.574 2.524 0 C-N-CA 122.912 2.408 . . . . 0.0 114.861 171.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 13.7 ptm -170.24 179.94 3.3 Favored 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -173.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.6 tp -50.48 144.26 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.258 0 O-C-N 120.771 -1.206 . . . . 0.0 111.268 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.64 -10.59 64.23 Favored Glycine 0 CA--C 1.555 2.562 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -85.85 149.01 25.54 Favored 'General case' 0 CA--C 1.567 1.615 0 CA-C-N 121.764 2.782 . . . . 0.0 113.354 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.9 tpt85 -79.94 130.55 35.37 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.033 -1.042 . . . . 0.0 109.488 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 2.4 t -127.84 146.04 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.272 1.029 . . . . 0.0 110.718 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.253 51.7 p90 -134.32 115.28 13.9 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 122.871 1.32 . . . . 0.0 108.493 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.17 -179.97 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.771 0 CA-C-O 124.087 1.899 . . . . 0.0 113.553 -172.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.57 113.91 9.56 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.479 172.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -115.85 150.13 37.51 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 119.846 3.276 . . . . 0.0 119.846 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 m -122.54 147.15 46.72 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 162.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.06 143.06 9.82 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 119.102 -2.249 . . . . 0.0 117.198 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -134.3 154.78 51.12 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.634 1.974 . . . . 0.0 114.915 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.24 162.59 23.48 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 164.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.297 1.6 tm? -61.81 -29.03 69.89 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.05 -2.06 4.99 Favored 'General case' 0 CA--C 1.598 2.808 0 O-C-N 120.323 -1.486 . . . . 0.0 114.934 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.97 50.18 4.48 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 120.17 -1.581 . . . . 0.0 113.98 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.4 m -128.43 115.89 18.89 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -77.28 112.61 14.17 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.108 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -87.59 -36.99 17.21 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 122.277 2.308 . . . . 0.0 114.303 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -151.44 155.85 39.44 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.5 1.619 . . . . 0.0 111.148 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.5 p -159.92 104.72 1.54 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.192 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -36.86 80.15 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.61 -34.55 67.34 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.86 -58.66 3.38 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -158.42 69.77 0.51 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 119.794 1.179 . . . . 0.0 113.108 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -155.05 -82.08 0.08 Allowed 'General case' 0 CA--C 1.568 1.644 0 O-C-N 120.115 -1.616 . . . . 0.0 108.42 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.71 -157.68 0.03 OUTLIER 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 127.356 2.262 . . . . 0.0 108.409 -174.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -88.84 -176.94 5.38 Favored 'General case' 0 CA--C 1.578 2.047 0 O-C-N 120.068 -1.645 . . . . 0.0 109.556 169.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.274 9.9 t80 -119.65 160.0 23.34 Favored 'General case' 0 CA--C 1.576 1.971 0 O-C-N 119.627 -1.921 . . . . 0.0 110.344 173.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.7 p -165.39 134.42 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 119.792 -1.818 . . . . 0.0 109.198 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.493 ' CG ' HG11 ' A' ' 85' ' ' VAL . 15.8 p90 -148.07 -178.56 6.35 Favored 'General case' 0 CA--C 1.58 2.103 0 O-C-N 121.374 -0.829 . . . . 0.0 110.977 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.265 6.4 t70 -117.11 127.34 54.04 Favored 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 173.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.67 103.56 0.05 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 115.815 1.783 . . . . 0.0 115.815 -172.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 58.69 47.96 87.46 Favored Glycine 1 N--CA 1.516 4.017 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.308 0.0 OUTLIER -133.76 -78.81 0.47 Allowed 'General case' 0 CA--C 1.561 1.402 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -168.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.29 71.41 0.33 Allowed Glycine 0 N--CA 1.509 3.542 1 N-CA-C 103.066 -4.014 . . . . 0.0 103.066 169.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.474 0.0 OUTLIER -66.37 141.86 57.82 Favored 'General case' 0 CA--C 1.554 1.106 2 CA-C-O 129.274 4.369 . . . . 0.0 119.564 -157.593 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.493 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.396 17.4 m -79.93 -110.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 1 CA-C-N 102.751 -6.568 . . . . 0.0 105.617 -176.959 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.469 HG13 ' H ' ' A' ' 89' ' ' TRP . 24.8 pt -125.28 156.76 34.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 124.031 1.872 . . . . 0.0 106.121 167.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.45 -28.94 68.31 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.31 -1.314 . . . . 0.0 114.115 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.17 -36.02 76.66 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 117.024 -1.465 . . . . 0.0 112.867 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.469 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.5 m0 -72.91 -45.23 59.32 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 120.785 1.63 . . . . 0.0 112.755 173.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . 0.288 2.7 p30 -56.7 -35.41 68.47 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 121.527 1.967 . . . . 0.0 115.497 174.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.272 1.6 mp -67.16 -57.77 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-N 119.45 1.023 . . . . 0.0 111.241 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.26 -36.13 83.09 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 t -68.51 -41.14 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 CA-C-N 120.43 1.468 . . . . 0.0 111.585 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.57 62.61 Favored 'General case' 0 CA--C 1.587 2.384 0 CA-C-N 120.16 1.345 . . . . 0.0 113.83 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.4 p -96.44 -3.15 44.0 Favored 'General case' 0 CA--C 1.593 2.606 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 19.2 ttp -103.02 132.64 49.14 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 121.944 2.157 . . . . 0.0 111.026 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -94.17 153.55 18.03 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 119.128 3.01 . . . . 0.0 119.128 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 70.4 t -10.56 -31.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.562 1 N-CA-C 126.862 5.875 . . . . 0.0 126.862 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.17 17.73 0.22 Allowed Glycine 0 N--CA 1.493 2.449 0 CA-C-O 116.357 -2.357 . . . . 0.0 115.038 -169.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.35 0.9 OUTLIER -129.14 -174.24 3.21 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 118.291 2.7 . . . . 0.0 118.291 -176.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.9 tp -106.13 127.51 53.25 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -171.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.438 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 1.6 m -139.68 165.9 26.04 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.708 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . 0.251 6.0 mtt85 -127.84 116.89 20.86 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.581 1.658 . . . . 0.0 111.143 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 mm -59.62 138.25 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.8 m -132.99 109.64 9.7 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 25.1 p -137.26 149.08 46.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 119.093 2.998 . . . . 0.0 119.093 -173.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -81.0 142.13 51.47 Favored Pre-proline 0 CA--C 1.577 2.01 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.743 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.55 -25.44 7.72 Favored 'Trans proline' 0 CA--C 1.56 1.801 0 N-CA-C 120.727 3.318 . . . . 0.0 120.727 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.07 -38.68 89.73 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 121.364 1.893 . . . . 0.0 114.558 175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -79.28 -7.65 58.45 Favored 'General case' 0 CA--C 1.581 2.161 0 C-N-CA 124.953 1.301 . . . . 0.0 114.249 169.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.25 -115.84 0.24 Allowed 'General case' 0 CA--C 1.58 2.109 0 CA-C-N 120.7 1.591 . . . . 0.0 114.781 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.285 1.6 m-85 -103.33 29.51 5.56 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 122.178 2.263 . . . . 0.0 113.432 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -52.36 158.18 3.48 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 120.449 2.939 . . . . 0.0 120.449 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.284 9.9 t 71.1 -64.56 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.89 -15.6 16.81 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.17 177.8 49.85 Favored Glycine 0 CA--C 1.548 2.127 0 CA-C-N 122.619 2.463 . . . . 0.0 112.392 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.508 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.4 t -75.31 127.43 86.34 Favored Pre-proline 0 CA--C 1.579 2.093 0 CA-C-O 116.394 -1.765 . . . . 0.0 108.846 176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 69.6 Cg_exo -38.3 -43.81 1.9 Allowed 'Trans proline' 0 CA--C 1.582 2.922 1 N-CA-C 123.0 4.192 . . . . 0.0 123.0 -176.961 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.6 -37.06 0.22 Allowed 'Trans proline' 0 CA--C 1.573 2.469 0 CA-C-N 125.491 2.997 . . . . 0.0 119.399 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -150.99 -7.34 0.26 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.014 3.338 . . . . 0.0 120.014 -175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.508 ' HB ' ' H ' ' A' ' 117' ' ' SER . 1.5 mt -79.9 145.94 62.84 Favored Pre-proline 0 CA--C 1.595 2.678 0 CA-C-N 122.944 2.611 . . . . 0.0 112.797 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.4 160.65 48.81 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 CA-C-N 126.453 3.341 . . . . 0.0 115.497 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -62.2 129.32 26.64 Favored 'Trans proline' 0 CA--C 1.57 2.286 0 C-N-CA 122.721 2.281 . . . . 0.0 116.736 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.58 65.66 1.21 Allowed 'General case' 0 CA--C 1.592 2.579 0 N-CA-C 117.08 2.252 . . . . 0.0 117.08 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -128.5 140.18 51.94 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 119.642 -1.911 . . . . 0.0 111.748 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.6 m -59.99 146.46 42.51 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.408 ' HB3' ' SG ' ' A' ' 106' ' ' CYS . 6.2 tp -116.8 152.55 34.16 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 120.931 1.696 . . . . 0.0 112.336 -173.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.26 130.39 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.302 -170.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.256 24.2 m-85 -138.35 161.28 37.33 Favored 'General case' 0 N--CA 1.521 3.085 0 O-C-N 119.444 -2.035 . . . . 0.0 110.435 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -126.19 104.68 8.36 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 102.853 -3.017 . . . . 0.0 102.853 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.52 135.31 63.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 CA-C-O 122.387 1.089 . . . . 0.0 111.107 -169.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -115.35 115.77 27.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.658 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 tt -93.25 112.17 24.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -77.92 -40.09 40.79 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.23 172.11 1.95 Allowed 'General case' 0 CA--C 1.588 2.427 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.304 0.0 OUTLIER -146.13 -96.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 119.374 -2.079 . . . . 0.0 107.919 177.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.47 72.2 tttt -111.42 -99.42 0.41 Allowed 'General case' 0 CA--C 1.586 2.347 0 CA-C-O 116.545 -1.693 . . . . 0.0 110.019 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.22 0 CA-C-N 124.991 3.541 . . . . 0.0 113.973 -178.568 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.963 1 N-CA-C 128.154 6.022 . . . . 0.0 128.154 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.438 0.3 OUTLIER 60.89 -60.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 118.592 2.812 . . . . 0.0 118.592 178.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.267 4.1 p-10 -151.49 112.43 4.27 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 174.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.489 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 4.8 tp -87.13 95.22 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 123.157 1.456 . . . . 0.0 108.905 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.6 t -141.99 89.61 8.77 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.254 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.269 31.3 Cg_exo -59.1 -27.87 86.22 Favored 'Trans proline' 0 CA--C 1.576 2.586 0 CA-C-N 122.879 2.064 . . . . 0.0 115.446 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 28' ' ' GLN 0.254 0.0 OUTLIER -150.99 -97.71 0.06 Allowed 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 170.723 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 1.7 mp0 -105.91 -0.51 25.05 Favored 'General case' 0 CA--C 1.588 2.419 0 C-N-CA 126.334 1.854 . . . . 0.0 111.497 174.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.266 16.8 t70 -54.62 -77.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -172.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.341 35.1 mt-10 -90.14 -23.87 21.23 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.54 13.04 1.15 Allowed Glycine 0 N--CA 1.506 3.352 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 106' ' ' CYS . 23.4 t -169.04 144.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.489 ' HB2' ' H ' ' A' ' 24' ' ' ILE 0.587 7.8 tp -157.69 -141.92 0.09 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.988 -1.482 . . . . 0.0 111.415 165.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HE2' ' SG ' ' A' ' 102' ' ' CYS . 29.6 mtpt -155.87 155.75 33.45 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 122.825 2.557 . . . . 0.0 115.876 -171.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.56 108.11 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 102' ' ' CYS 0.408 1.0 OUTLIER -78.83 124.75 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-N 120.274 1.397 . . . . 0.0 113.538 179.982 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -110.64 -56.48 2.35 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 122.059 0.933 . . . . 0.0 110.599 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.262 46.1 ttt180 -113.63 97.98 6.77 Favored 'General case' 0 CA--C 1.597 2.787 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 36' ' ' ILE . 31.0 mt-10 -37.75 -74.52 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.863 1 N-CA-C 123.349 4.574 . . . . 0.0 123.349 -177.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.18 163.73 28.03 Favored Glycine 0 CA--C 1.55 2.234 0 C-N-CA 125.072 1.32 . . . . 0.0 114.696 -173.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . 0.343 12.4 t -146.41 -72.07 0.24 Allowed 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.85 69.54 2.64 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 120.756 3.062 . . . . 0.0 120.756 -173.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.27 71.1 p 69.7 61.84 0.27 Allowed 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.383 4.7 pt-20 30.6 -113.39 0.03 OUTLIER 'General case' 0 CA--C 1.582 2.199 0 N-CA-C 120.679 3.585 . . . . 0.0 120.679 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.6 m -147.52 122.19 5.11 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 115.918 -1.991 . . . . 0.0 110.898 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.42 0.2 OUTLIER -114.26 -40.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.569 2.275 1 N-CA-C 125.749 5.25 . . . . 0.0 125.749 177.579 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 50' ' ' ASP . 1.9 ptt? -156.19 160.65 40.03 Favored 'General case' 0 N--CA 1.526 3.367 2 N-CA-C 127.542 6.127 . . . . 0.0 127.542 -174.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 tp -65.71 141.0 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.03 82.43 Favored Glycine 0 CA--C 1.567 3.322 0 O-C-N 120.286 -1.509 . . . . 0.0 116.527 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 47' ' ' MET . 4.0 t0 -72.66 141.38 48.27 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 120.932 2.366 . . . . 0.0 110.625 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.8 tpt85 -85.97 101.03 12.54 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -102.25 137.2 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 123.35 0.66 . . . . 0.0 112.416 -169.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.05 104.56 12.26 Favored 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 76' ' ' PHE . 12.2 m -108.98 160.29 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 125.754 2.692 . . . . 0.0 114.697 -172.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.482 ' CD2' HD12 ' A' ' 70' ' ' LEU . 1.6 t60 -125.05 115.69 20.92 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 110.705 -2.952 . . . . 0.0 105.106 167.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.331 5.7 p90 -113.95 143.93 43.9 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.728 1.251 . . . . 0.0 114.28 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m -118.07 147.32 43.38 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 164.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.79 136.6 4.67 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 118.894 -2.379 . . . . 0.0 115.278 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.29 160.36 40.64 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 111.852 -2.174 . . . . 0.0 114.921 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD12 ' H ' ' A' ' 62' ' ' ASP . 1.0 OUTLIER -80.65 178.82 8.1 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 172.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -65.13 -22.62 66.96 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 60' ' ' LEU . 36.8 t70 -73.57 -6.46 46.75 Favored 'General case' 0 CA--C 1.601 2.924 0 CA-C-N 119.106 0.867 . . . . 0.0 112.704 165.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.79 47.46 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 125.59 1.567 . . . . 0.0 113.636 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -88.67 108.93 19.72 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -74.49 91.85 2.31 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -73.1 -25.94 61.05 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 119.81 -1.806 . . . . 0.0 113.592 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -151.72 154.17 35.79 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 124.693 2.187 . . . . 0.0 115.308 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.8 p -153.77 102.3 2.52 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 112.029 -2.35 . . . . 0.0 104.767 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.292 31.6 p -58.87 -67.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.482 HD12 ' CD2' ' A' ' 55' ' ' HIS 0.379 32.6 mt -61.39 -45.14 95.58 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.05 -40.89 24.36 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -93.91 26.83 3.0 Favored 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.339 40.3 tttp 82.44 -30.4 0.1 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -82.49 -170.29 2.88 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -145.19 176.66 9.36 Favored 'General case' 0 CA--C 1.573 1.838 0 C-N-CA 126.044 1.738 . . . . 0.0 109.857 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.473 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.394 0.5 OUTLIER -132.68 146.02 51.52 Favored 'General case' 0 CA--C 1.575 1.939 0 O-C-N 119.404 -2.06 . . . . 0.0 111.853 173.737 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.1 p -165.42 150.29 8.92 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 119.297 -2.127 . . . . 0.0 109.647 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.548 ' CG ' HG11 ' A' ' 85' ' ' VAL . 27.2 p90 -159.66 -171.8 3.43 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 114.414 -1.266 . . . . 0.0 113.665 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -123.18 113.66 19.24 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -37.99 105.98 0.05 OUTLIER 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -172.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.43 53.52 24.61 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 118.178 2.031 . . . . 0.0 118.178 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.91 -7.2 23.68 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.59 63.06 2.17 Favored Glycine 0 N--CA 1.512 3.703 0 N-CA-C 104.905 -3.278 . . . . 0.0 104.905 -167.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -154.29 -55.45 0.1 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 112.036 -2.082 . . . . 0.0 110.307 -163.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.548 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.301 16.6 m -97.82 -132.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 178.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.431 HD12 ' HE3' ' A' ' 107' ' ' LYS . 3.7 pt -125.64 163.2 27.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 124.459 2.076 . . . . 0.0 109.261 172.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.254 0.9 OUTLIER -68.07 -34.58 76.7 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 113.218 -1.81 . . . . 0.0 114.178 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.39 70.71 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.601 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -73.26 -46.27 50.95 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 121.136 1.789 . . . . 0.0 112.28 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.95 -35.83 69.57 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 121.361 1.891 . . . . 0.0 115.571 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.29 1.7 mp -65.22 -61.55 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.582 2.207 0 CA-C-N 119.855 1.207 . . . . 0.0 111.627 173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -67.05 -35.91 80.91 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.301 6.4 t -74.27 -32.87 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.189 0 O-C-N 121.237 -0.914 . . . . 0.0 111.084 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.99 -24.72 68.04 Favored 'General case' 0 CA--C 1.577 2.008 0 CA-C-N 120.709 1.595 . . . . 0.0 113.833 166.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.0 p -97.22 8.0 45.44 Favored 'General case' 0 CA--C 1.596 2.724 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.787 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 8.6 tpt -93.71 140.32 29.78 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 119.515 -1.991 . . . . 0.0 113.346 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -98.24 145.61 26.46 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 119.856 -1.778 . . . . 0.0 114.203 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.4 t -50.05 125.23 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.32 -12.91 53.49 Favored Glycine 0 N--CA 1.496 2.675 0 CA-C-O 114.972 -3.127 . . . . 0.0 117.888 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.483 67.7 mt-10 -113.16 -159.5 0.69 Allowed 'General case' 0 CA--C 1.583 2.234 0 CA-C-N 122.805 3.303 . . . . 0.0 117.434 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.0 tp -140.26 138.75 35.26 Favored 'General case' 0 CA--C 1.575 1.927 0 N-CA-C 119.082 2.994 . . . . 0.0 119.082 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.787 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 0.8 OUTLIER -160.02 157.82 29.41 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.909 177.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -104.88 128.71 53.21 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 123.204 1.478 . . . . 0.0 113.177 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.757 HG22 ' SG ' ' A' ' 106' ' ' CYS . 11.0 mt -71.88 131.72 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.231 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.625 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.1 m -113.98 108.78 17.48 Favored 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.757 ' SG ' HG22 ' A' ' 104' ' ' ILE 0.315 11.4 p -160.16 162.92 34.01 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 120.09 3.366 . . . . 0.0 120.09 -163.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.617 ' HD2' ' HB2' ' A' ' 106' ' ' CYS 2.574 0.0 OUTLIER 134.61 -147.52 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.165 1 N-CA-C 147.669 13.581 . . . . 0.0 147.669 157.447 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.888 21.9 Cg_exo 35.09 -63.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.577 2.631 1 C-N-CA 126.206 4.604 . . . . 0.0 120.952 -162.214 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.31 -33.37 75.69 Favored 'General case' 0 CA--C 1.579 2.07 0 O-C-N 118.818 -2.426 . . . . 0.0 114.805 172.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -80.76 0.99 32.26 Favored 'General case' 0 CA--C 1.598 2.82 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.447 ' HB2' ' HG3' ' A' ' 107' ' ' LYS . . . -147.69 -104.86 0.09 Allowed 'General case' 0 CA--C 1.601 2.941 0 N-CA-C 115.964 1.839 . . . . 0.0 115.964 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 127' ' ' LEU . 3.1 m-85 -89.87 -7.53 54.01 Favored 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -176.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -45.56 -21.39 0.49 Allowed Glycine 0 N--CA 1.503 3.112 1 N-CA-C 123.868 4.307 . . . . 0.0 123.868 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.9 p -71.92 -56.12 6.26 Favored 'General case' 0 CA--C 1.574 1.867 0 CA-C-N 119.603 1.702 . . . . 0.0 112.79 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -132.19 -0.24 3.72 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 118.43 2.752 . . . . 0.0 118.43 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.56 153.82 27.29 Favored Glycine 0 CA--C 1.549 2.202 0 CA-C-N 123.56 2.891 . . . . 0.0 115.133 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.465 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 7.5 t -82.97 130.77 56.26 Favored Pre-proline 0 CA--C 1.577 2.019 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.635 177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -34.29 -47.57 0.55 Allowed 'Trans proline' 0 CA--C 1.581 2.841 1 N-CA-C 122.666 4.064 . . . . 0.0 122.666 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.23 -54.71 0.36 Allowed 'Trans proline' 0 CA--C 1.571 2.351 0 CA-C-N 125.682 3.065 . . . . 0.0 116.725 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -173.0 78.3 0.04 OUTLIER 'General case' 0 CA--C 1.582 2.175 0 CA-C-N 119.344 0.975 . . . . 0.0 113.542 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.465 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -141.09 125.65 10.59 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 119.673 -1.892 . . . . 0.0 109.377 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -90.31 162.69 4.59 Favored 'Trans proline' 0 CA--C 1.589 3.264 0 CA-C-N 123.442 2.265 . . . . 0.0 112.223 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -63.28 -34.6 66.88 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.103 2.309 . . . . 0.0 118.103 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -89.68 56.71 3.63 Favored 'General case' 0 CA--C 1.583 2.213 0 C-N-CA 125.981 1.712 . . . . 0.0 113.215 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.54 106.94 4.37 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.014 -1.678 . . . . 0.0 113.664 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.1 m -60.35 154.09 21.15 Favored 'General case' 0 CA--C 1.587 2.379 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 112' ' ' TYR . 29.2 mt -124.27 172.34 9.17 Favored 'General case' 0 CA--C 1.566 1.567 0 O-C-N 120.288 -1.507 . . . . 0.0 111.834 -174.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -153.46 123.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.415 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.301 0.1 OUTLIER -123.78 120.82 33.78 Favored 'General case' 0 N--CA 1.51 2.555 0 CA-C-N 119.937 1.244 . . . . 0.0 108.228 176.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.15 107.79 19.35 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.961 -1.087 . . . . 0.0 108.716 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 t -112.45 135.86 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-O 122.17 0.986 . . . . 0.0 110.892 -171.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -114.43 112.71 23.44 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.9 115.1 28.86 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.964 -1.016 . . . . 0.0 108.891 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -78.94 -50.21 11.54 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -169.94 159.67 7.92 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 123.833 1.777 . . . . 0.0 110.384 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.91 -87.97 0.08 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 102.76 -3.052 . . . . 0.0 102.76 -177.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -121.89 95.45 4.67 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 170.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.635 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 177.477 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.923 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.94 148.08 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 117.9 0.85 . . . . 0.0 111.832 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -164.75 152.1 11.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.94 2.57 . . . . 0.0 117.94 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.262 2.8 tp -126.71 61.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.989 0 CA-C-N 113.378 -1.737 . . . . 0.0 107.238 167.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 t -159.42 99.46 1.56 Allowed Pre-proline 0 CA--C 1.572 1.814 0 O-C-N 120.703 -1.248 . . . . 0.0 114.12 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -64.06 6.7 0.27 Allowed 'Trans proline' 0 CA--C 1.584 2.994 0 N-CA-C 119.915 3.006 . . . . 0.0 119.915 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.447 30.4 mmmt 94.57 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.746 2.418 . . . . 0.0 110.447 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.287 32.0 mm-40 76.59 40.98 0.2 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.24 -168.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -137.76 -93.0 0.21 Allowed 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 -173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.398 3.1 mp0 -84.5 -15.49 45.75 Favored 'General case' 0 N--CA 1.487 1.378 1 N-CA-C 122.404 4.224 . . . . 0.0 122.404 -171.146 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.4 -62.69 0.59 Allowed Glycine 0 N--CA 1.478 1.436 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.0 t -141.68 146.47 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 N-CA-C 119.028 2.973 . . . . 0.0 119.028 -170.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 45.2 tp -117.42 136.9 52.86 Favored 'General case' 0 CA--C 1.598 2.793 0 C-N-CA 126.548 1.939 . . . . 0.0 107.539 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -124.19 118.65 27.34 Favored 'General case' 0 CA--C 1.567 1.618 0 O-C-N 118.291 -2.756 . . . . 0.0 108.211 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.13 136.03 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.579 -0.701 . . . . 0.0 109.613 -176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -100.22 151.43 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 122.124 0.964 . . . . 0.0 113.044 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -131.18 -63.62 0.84 Allowed 'General case' 0 CA--C 1.572 1.799 0 C-N-CA 124.22 1.008 . . . . 0.0 110.851 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -112.79 89.86 3.19 Favored 'General case' 0 CA--C 1.583 2.25 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -35.09 -56.21 0.59 Allowed 'General case' 0 N--CA 1.518 2.95 0 N-CA-C 120.776 3.621 . . . . 0.0 120.776 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -151.75 17.38 Favored Glycine 0 CA--C 1.545 1.947 0 C-N-CA 124.63 1.109 . . . . 0.0 115.495 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 t -79.66 -34.17 40.65 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.35 45.74 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 120.429 2.932 . . . . 0.0 120.429 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.25 67.2 p 68.84 -5.88 0.95 Allowed 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 118.894 2.924 . . . . 0.0 118.894 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -75.86 131.94 40.02 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.0 p -107.93 163.61 16.57 Favored Pre-proline 0 N--CA 1.503 2.185 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.47 166.43 25.93 Favored 'Trans proline' 0 CA--C 1.577 2.639 0 CA-C-N 122.39 1.889 . . . . 0.0 114.436 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -102.39 163.34 12.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.52 -1.363 . . . . 0.0 111.546 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.355 0.3 OUTLIER -63.16 128.51 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.179 -2.2 . . . . 0.0 110.432 178.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.1 4.03 84.58 Favored Glycine 0 CA--C 1.572 3.594 0 N-CA-C 117.579 1.792 . . . . 0.0 117.579 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -65.23 166.34 9.99 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 121.189 2.494 . . . . 0.0 114.35 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -108.21 101.12 10.37 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 119.926 1.239 . . . . 0.0 108.933 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.93 139.0 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 C-N-CA 123.61 0.764 . . . . 0.0 111.05 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . 0.28 41.6 p90 -117.32 101.12 8.16 Favored 'General case' 0 CA--C 1.569 1.71 0 CA-C-O 124.865 2.269 . . . . 0.0 109.267 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 76' ' ' PHE . 2.1 p -102.19 170.93 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 CA-C-N 111.076 -2.783 . . . . 0.0 112.731 -170.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.96 100.7 3.22 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 166.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -97.69 160.22 14.45 Favored 'General case' 0 CA--C 1.593 2.635 0 CA-C-O 122.724 1.249 . . . . 0.0 113.299 -173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.3 m -128.0 147.96 50.52 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.15 142.43 9.1 Favored Glycine 0 CA--C 1.55 2.222 0 O-C-N 119.098 -2.251 . . . . 0.0 116.464 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.569 ' CE3' HG12 ' A' ' 128' ' ' VAL . 2.0 m-90 -130.27 149.11 52.11 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 126.49 1.916 . . . . 0.0 115.205 -173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.29 171.4 12.75 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 122.922 1.344 . . . . 0.0 108.746 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.287 3.3 tt -62.56 -29.46 70.6 Favored 'General case' 0 CA--C 1.565 1.521 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.05 7.01 1.81 Allowed 'General case' 0 CA--C 1.597 2.786 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 171.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.81 38.37 66.0 Favored Glycine 0 N--CA 1.509 3.557 0 O-C-N 119.841 -1.787 . . . . 0.0 114.744 -175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -112.62 118.53 35.31 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -77.88 93.11 4.33 Favored 'General case' 0 CA--C 1.583 2.225 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -64.66 -30.31 71.33 Favored 'General case' 0 CA--C 1.565 1.551 0 O-C-N 119.151 -2.218 . . . . 0.0 114.559 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.14 152.85 31.73 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 124.513 2.102 . . . . 0.0 112.492 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 93.6 p -159.35 86.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 112.441 -2.163 . . . . 0.0 108.931 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.3 t -52.91 -40.66 63.73 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.9 mt -51.12 -38.81 54.13 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.691 1.996 . . . . 0.0 115.694 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.68 -34.26 18.49 Favored 'General case' 0 CA--C 1.578 2.025 0 C-N-CA 125.879 1.672 . . . . 0.0 114.88 175.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.14 -29.78 70.88 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 118.312 2.708 . . . . 0.0 118.312 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.352 58.5 tptt 131.5 -56.53 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 127.677 2.391 . . . . 0.0 111.695 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -98.35 174.06 6.67 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 123.602 1.667 . . . . 0.0 113.199 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.06 175.62 6.25 Favored 'General case' 0 CA--C 1.569 1.694 0 C-N-CA 125.298 1.439 . . . . 0.0 114.389 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HB3' HG13 ' A' ' 54' ' ' VAL 0.345 2.3 t80 -108.49 153.27 23.57 Favored 'General case' 0 CA--C 1.59 2.503 0 CA-C-O 122.989 1.376 . . . . 0.0 108.356 173.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.9 p -163.53 111.79 1.22 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 118.154 -2.841 . . . . 0.0 104.514 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.539 ' CD1' HG11 ' A' ' 85' ' ' VAL . 2.4 p90 -125.54 177.06 6.42 Favored 'General case' 0 CA--C 1.576 1.961 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.116 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.308 33.6 t70 -86.32 -139.34 0.09 Allowed 'General case' 0 CA--C 1.584 2.251 0 O-C-N 119.117 -2.24 . . . . 0.0 105.803 172.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 tp -141.5 109.96 5.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 118.579 -2.576 . . . . 0.0 104.265 168.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.95 48.44 16.12 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 116.808 1.483 . . . . 0.0 116.808 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.414 14.5 tppt? -106.82 6.58 29.6 Favored 'General case' 0 CA--C 1.579 2.076 0 CA-C-N 119.902 1.851 . . . . 0.0 114.441 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.1 -51.99 1.65 Allowed Glycine 0 N--CA 1.508 3.478 0 O-C-N 120.151 -1.593 . . . . 0.0 109.953 -172.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.283 52.9 tt0 -20.2 -53.82 0.02 OUTLIER 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 120.654 3.575 . . . . 0.0 120.654 168.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 78' ' ' PHE 0.294 16.5 m -101.87 -135.61 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 123.228 1.49 . . . . 0.0 110.12 -174.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.452 HG13 ' H ' ' A' ' 89' ' ' TRP . 13.7 pt -126.55 162.51 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 123.774 1.75 . . . . 0.0 109.797 173.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -67.16 -33.61 75.79 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.172 -1.376 . . . . 0.0 113.109 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.06 -34.2 73.09 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.29 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.452 ' H ' HG13 ' A' ' 86' ' ' ILE . 35.1 m0 -74.77 -42.18 58.66 Favored 'General case' 0 C--N 1.363 1.189 0 CA-C-N 120.854 1.661 . . . . 0.0 112.205 172.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.84 -38.5 85.7 Favored 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 120.21 1.368 . . . . 0.0 113.863 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.4 mp -68.6 -60.64 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-N 119.09 0.859 . . . . 0.0 111.615 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.05 72.94 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.311 15.5 t -74.16 -32.79 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 CA-C-N 120.344 1.429 . . . . 0.0 110.652 175.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.25 73.92 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 121.02 1.736 . . . . 0.0 112.749 166.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 69.8 p -83.85 8.24 15.51 Favored 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.531 ' SD ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 tpt -91.95 130.3 37.73 Favored 'General case' 0 CA--C 1.579 2.072 0 O-C-N 119.483 -2.011 . . . . 0.0 112.209 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.33 135.35 41.89 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 116.423 -1.751 . . . . 0.0 109.461 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.288 3.6 t -9.65 82.84 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.542 4.13 0 CA-C-O 124.729 2.204 . . . . 0.0 108.308 -161.044 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 133' ' ' LEU . . . -54.99 46.88 0.01 OUTLIER Glycine 0 N--CA 1.502 3.037 2 CA-C-N 107.532 -4.394 . . . . 0.0 123.702 -140.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 0.4 OUTLIER -29.02 -87.0 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 119.924 3.305 . . . . 0.0 119.924 -169.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.6 tp -137.61 121.51 17.67 Favored 'General case' 0 CA--C 1.567 1.6 0 C-N-CA 123.754 0.822 . . . . 0.0 112.646 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.531 ' SG ' ' SD ' ' A' ' 96' ' ' MET . 2.4 m -149.2 167.36 26.2 Favored 'General case' 0 CA--C 1.575 1.92 0 C-N-CA 123.949 0.899 . . . . 0.0 111.779 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -131.83 133.6 44.86 Favored 'General case' 0 CA--C 1.557 1.226 0 O-C-N 119.134 -2.229 . . . . 0.0 112.122 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.3 mt -90.71 129.27 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.076 0 CA-C-N 112.689 -2.05 . . . . 0.0 108.862 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 106.4 14.35 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 103.262 -2.866 . . . . 0.0 103.262 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.581 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 5.0 p -129.36 147.48 51.19 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 -169.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -91.69 146.25 32.74 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.037 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.26 82.4 Cg_endo -61.87 -14.55 37.43 Favored 'Trans proline' 0 CA--C 1.568 2.213 0 N-CA-C 118.023 2.278 . . . . 0.0 118.023 -176.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.82 -38.46 78.7 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 120.778 1.626 . . . . 0.0 114.427 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.58 2.54 52.85 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 125.632 1.573 . . . . 0.0 113.495 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.61 -113.8 0.17 Allowed 'General case' 0 CA--C 1.58 2.132 0 CA-C-N 120.774 1.624 . . . . 0.0 115.269 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.271 4.9 m-85 -88.08 0.33 56.12 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 120.953 1.706 . . . . 0.0 115.378 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.4 -19.39 1.87 Allowed Glycine 0 N--CA 1.499 2.86 1 N-CA-C 124.219 4.447 . . . . 0.0 124.219 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -71.36 -57.41 4.48 Favored 'General case' 0 CA--C 1.573 1.853 0 CA-C-N 120.271 2.036 . . . . 0.0 111.869 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.52 0.34 2.49 Favored 'General case' 0 CA--C 1.578 2.058 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.5 157.07 33.3 Favored Glycine 0 CA--C 1.546 1.996 0 CA-C-N 123.999 3.091 . . . . 0.0 112.483 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.423 ' HB3' HD12 ' A' ' 121' ' ' ILE . 2.7 t -86.53 125.56 66.99 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-O 116.918 -1.515 . . . . 0.0 108.423 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.274 28.1 Cg_exo -26.24 -49.43 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.877 1 N-CA-C 124.882 4.916 . . . . 0.0 124.882 -176.334 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.82 -46.16 1.3 Allowed 'Trans proline' 0 CA--C 1.572 2.391 0 CA-C-N 125.861 3.129 . . . . 0.0 118.977 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -152.58 -11.78 0.17 Allowed 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 118.385 2.735 . . . . 0.0 118.385 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 117' ' ' SER . 14.2 mt -79.91 144.13 59.03 Favored Pre-proline 0 CA--C 1.595 2.692 0 CA-C-N 121.858 2.117 . . . . 0.0 115.564 -173.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -102.48 176.16 0.19 Allowed 'Trans proline' 0 CA--C 1.594 3.497 0 CA-C-N 125.278 2.921 . . . . 0.0 113.661 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.5 -37.87 5.1 Favored 'Trans proline' 0 CA--C 1.573 2.464 0 C-N-CA 122.239 1.959 . . . . 0.0 116.619 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -80.89 50.87 1.44 Allowed 'General case' 0 CA--C 1.582 2.177 0 O-C-N 120.06 -1.65 . . . . 0.0 115.202 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.28 127.91 17.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.218 -1.551 . . . . 0.0 112.831 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.1 m -80.26 161.73 24.98 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.973 -1.079 . . . . 0.0 112.817 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.581 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.3 0.5 OUTLIER -145.12 174.0 11.44 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 119.711 -1.868 . . . . 0.0 112.274 -176.569 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.569 HG12 ' CE3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -148.57 125.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 125.039 1.336 . . . . 0.0 108.005 -171.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.285 4.7 m-85 -124.13 122.85 38.94 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 120.302 1.41 . . . . 0.0 110.58 175.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.17 121.73 32.47 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 174.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.77 128.0 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 CA-C-O 121.369 0.604 . . . . 0.0 111.806 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -111.56 100.56 9.09 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.453 ' HB3' ' HA3' ' A' ' 99' ' ' GLY 0.285 16.2 tp -103.99 126.81 51.4 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.687 1.232 . . . . 0.0 111.703 -174.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -86.04 -60.32 2.04 Favored 'General case' 0 CA--C 1.561 1.393 0 O-C-N 120.897 -1.127 . . . . 0.0 112.836 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -157.5 -178.06 7.06 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 119.939 1.245 . . . . 0.0 110.088 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.26 -60.65 0.08 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 -175.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.28 58.3 tttm -79.82 -44.51 20.43 Favored 'General case' 0 CA--C 1.579 2.06 0 N-CA-C 118.614 2.82 . . . . 0.0 118.614 -172.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.823 0 CA-C-N 124.774 3.443 . . . . 0.0 121.188 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 120.476 2.95 . . . . 0.0 120.476 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.28 7.2 p -63.86 132.32 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 118.566 1.183 . . . . 0.0 110.704 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -119.64 131.62 55.5 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.426 3.1 tp -156.51 125.89 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.953 0 CA-C-O 125.196 2.427 . . . . 0.0 115.317 171.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.489 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 33.6 t -139.12 124.32 11.81 Favored Pre-proline 0 CA--C 1.585 2.289 0 CA-C-N 111.832 -2.44 . . . . 0.0 106.959 161.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -70.1 45.59 0.5 Allowed 'Trans proline' 0 CA--C 1.593 3.441 0 CA-C-N 126.319 3.292 . . . . 0.0 117.522 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 0.4 OUTLIER -172.7 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 127.705 2.402 . . . . 0.0 107.195 -176.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 1.1 mp0 -72.43 -31.67 65.68 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 124.705 1.202 . . . . 0.0 113.89 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.454 22.1 t70 77.62 -54.54 0.53 Allowed 'General case' 0 CA--C 1.575 1.94 0 C-N-CA 126.311 1.844 . . . . 0.0 111.88 -175.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -90.35 41.95 1.08 Allowed 'General case' 0 CA--C 1.579 2.06 0 O-C-N 120.193 -1.567 . . . . 0.0 114.096 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 25' ' ' SER . . . -69.91 -46.23 53.5 Favored Glycine 1 N--CA 1.518 4.141 0 CA-C-N 122.468 2.394 . . . . 0.0 112.15 177.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 107' ' ' LYS 0.394 17.1 t -123.89 119.28 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 173.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.2 tp -89.93 122.42 32.94 Favored 'General case' 0 CA--C 1.583 2.237 0 C-N-CA 125.251 1.42 . . . . 0.0 108.68 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -114.77 97.81 6.48 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 122.816 2.553 . . . . 0.0 108.568 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.279 0.2 OUTLIER -90.49 124.83 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -0.988 . . . . 0.0 109.318 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CD1' ' SG ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -86.17 145.48 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-O 121.591 0.71 . . . . 0.0 111.836 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -123.58 -53.67 1.78 Allowed 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 123.568 0.747 . . . . 0.0 111.491 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -124.1 107.18 10.99 Favored 'General case' 0 CA--C 1.588 2.414 0 N-CA-C 103.995 -2.595 . . . . 0.0 103.995 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -72.54 0.05 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 119.275 3.065 . . . . 0.0 119.275 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.75 -156.82 28.83 Favored Glycine 0 CA--C 1.547 2.092 0 C-N-CA 125.1 1.334 . . . . 0.0 111.713 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -88.74 -7.48 56.18 Favored 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.6 -85.73 0.06 OUTLIER Glycine 0 CA--C 1.538 1.482 0 O-C-N 121.164 -0.96 . . . . 0.0 111.943 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.2 t -165.45 5.27 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -87.23 154.02 21.04 Favored 'General case' 0 CA--C 1.581 2.165 0 CA-C-N 123.775 2.989 . . . . 0.0 115.1 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.9 p -128.23 164.29 38.48 Favored Pre-proline 0 CA--C 1.576 1.966 0 CA-C-N 112.974 -1.921 . . . . 0.0 113.284 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.48 -176.42 2.28 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-N 122.515 1.934 . . . . 0.0 115.775 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.5 ptp -133.92 167.34 20.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.461 -1.399 . . . . 0.0 112.426 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.279 1.5 tp -60.58 136.68 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.195 0 O-C-N 119.251 -2.155 . . . . 0.0 110.967 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.33 61.46 Favored Glycine 0 CA--C 1.559 2.787 0 N-CA-C 118.412 2.125 . . . . 0.0 118.412 -173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.85 149.13 26.58 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.63 2.215 . . . . 0.0 112.019 -177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.3 tpt85 -78.37 133.89 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.368 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.45 ' HB ' HD11 ' A' ' 133' ' ' LEU . 9.5 m -136.84 138.75 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-N 118.804 0.729 . . . . 0.0 111.57 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -116.73 102.43 9.42 Favored 'General case' 0 CA--C 1.569 1.686 0 O-C-N 120.551 -1.343 . . . . 0.0 108.543 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.2 m -102.32 167.81 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.62 117.91 17.59 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -112.18 150.85 30.26 Favored 'General case' 0 CA--C 1.581 2.156 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 m -119.05 151.6 37.94 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 157.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.07 142.32 8.86 Favored Glycine 0 N--CA 1.48 1.568 0 O-C-N 118.229 -2.795 . . . . 0.0 115.459 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.411 ' CE3' HG12 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -130.25 155.07 46.89 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 113.027 -1.587 . . . . 0.0 115.01 -175.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.1 tp -78.48 177.01 8.86 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 123.086 1.422 . . . . 0.0 107.378 166.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.363 0.0 OUTLIER -63.81 -25.8 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 178.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.75 13.74 2.0 Allowed 'General case' 0 CA--C 1.604 3.023 0 CA-C-N 119.077 0.853 . . . . 0.0 113.268 168.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.66 29.7 75.48 Favored Glycine 0 N--CA 1.509 3.541 0 O-C-N 120.034 -1.666 . . . . 0.0 116.432 -173.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 m -86.74 113.9 22.97 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -74.39 85.28 1.98 Allowed 'General case' 0 CA--C 1.586 2.331 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.64 -30.78 69.57 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 119.66 -1.9 . . . . 0.0 115.403 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -149.57 141.24 23.53 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.575 1.179 . . . . 0.0 111.496 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.9 p -160.02 93.26 1.05 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.4 p -61.01 -35.83 77.89 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -52.92 -39.13 62.57 Favored 'General case' 0 CA--C 1.582 2.18 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.65 -41.8 44.38 Favored 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 125.034 1.334 . . . . 0.0 114.223 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -68.54 -20.12 64.53 Favored 'General case' 0 CA--C 1.578 2.022 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 33.9 mtmm 101.8 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 127.407 2.283 . . . . 0.0 112.118 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.1 153.31 41.77 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-O 123.0 1.381 . . . . 0.0 114.356 176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -93.29 178.77 5.62 Favored 'General case' 0 CA--C 1.571 1.775 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.506 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.474 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.302 4.5 t80 -114.35 153.25 30.14 Favored 'General case' 0 CA--C 1.587 2.372 0 O-C-N 120.95 -1.094 . . . . 0.0 110.082 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 78.8 p -161.63 145.94 12.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 118.491 -2.631 . . . . 0.0 111.342 -177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 85' ' ' VAL . 25.6 p90 -155.22 -171.26 3.74 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -124.05 114.5 19.81 Favored 'General case' 0 CA--C 1.575 1.922 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.64 110.07 0.18 Allowed 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -173.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.29 29.87 67.88 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -106.13 0.91 25.8 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 120.404 3.483 . . . . 0.0 120.404 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.23 61.29 1.33 Allowed Glycine 0 N--CA 1.51 3.57 0 N-CA-C 105.543 -3.023 . . . . 0.0 105.543 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -148.27 -51.29 0.17 Allowed 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 111.191 -2.505 . . . . 0.0 111.991 -166.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.261 13.5 m -125.9 -140.28 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-O 122.969 1.366 . . . . 0.0 109.756 -173.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.523 HD12 ' HZ3' ' A' ' 107' ' ' LYS . 12.6 pt -115.21 162.51 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-O 123.826 1.774 . . . . 0.0 109.88 173.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -65.88 -34.1 77.37 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.655 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.486 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . . . -57.1 -39.72 75.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 168.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.444 ' H ' HG13 ' A' ' 86' ' ' ILE . 32.8 m0 -70.23 -40.78 74.29 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.641 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.26 -33.78 74.09 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 119.593 1.088 . . . . 0.0 113.921 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.268 1.5 mp -67.37 -59.17 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.885 0 CA-C-N 119.925 1.238 . . . . 0.0 110.622 172.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.405 ' CB ' HD13 ' A' ' 104' ' ' ILE . . . -60.03 -47.0 87.67 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.332 5.2 t -60.4 -41.22 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-O 117.569 -1.205 . . . . 0.0 112.712 173.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.21 -39.29 56.23 Favored 'General case' 0 CA--C 1.587 2.373 0 CA-C-N 121.506 1.957 . . . . 0.0 113.251 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 64.8 p -97.69 51.0 1.05 Allowed 'General case' 0 CA--C 1.593 2.624 0 C-N-CA 123.846 0.858 . . . . 0.0 112.618 173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.1 ttt -138.37 152.3 48.31 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 119.479 -2.013 . . . . 0.0 113.881 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -118.53 146.08 44.83 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.558 2.799 . . . . 0.0 118.558 -172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 t -18.45 -29.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.756 1 N-CA-C 127.354 6.057 . . . . 0.0 127.354 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.37 -2.14 0.14 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-O 115.566 -2.797 . . . . 0.0 116.601 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.535 78.1 mm-40 -112.6 -145.43 0.4 Allowed 'General case' 0 N--CA 1.516 2.856 0 N-CA-C 121.012 3.708 . . . . 0.0 121.012 -174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 16.1 tp -133.94 140.6 46.88 Favored 'General case' 0 CA--C 1.601 2.932 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -172.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.47 ' SG ' ' CD1' ' A' ' 36' ' ' ILE . 58.8 m -142.88 -175.52 4.53 Favored 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.431 -1.418 . . . . 0.0 113.343 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 3.4 ptt-85 -137.51 139.58 40.61 Favored 'General case' 0 CA--C 1.565 1.557 0 O-C-N 119.489 -2.007 . . . . 0.0 110.87 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.654 HG22 ' SG ' ' A' ' 106' ' ' CYS . 1.1 mt -106.97 128.11 62.07 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.579 0 C-N-CA 125.865 1.666 . . . . 0.0 109.168 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 32.8 m -119.49 114.49 22.37 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.654 ' SG ' HG22 ' A' ' 104' ' ' ILE 0.341 20.4 p -150.71 137.67 19.17 Favored 'General case' 0 CA--C 1.595 2.709 0 N-CA-C 120.828 3.64 . . . . 0.0 120.828 -155.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.684 ' HG2' ' HB2' ' A' ' 110' ' ' TYR 0.765 0.0 OUTLIER -20.49 98.5 0.05 OUTLIER Pre-proline 0 CA--C 1.621 3.697 3 N-CA-C 140.664 10.987 . . . . 0.0 140.664 159.535 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.315 0.2 OUTLIER -49.62 -27.82 15.59 Favored 'Trans proline' 0 CA--C 1.589 3.27 1 O-C-N 113.337 -4.086 . . . . 0.0 118.14 173.084 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.82 -42.81 85.24 Favored 'General case' 0 CA--C 1.578 2.045 0 O-C-N 120.069 -1.644 . . . . 0.0 114.459 171.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.684 ' HB2' ' HG2' ' A' ' 107' ' ' LYS . 52.7 m-85 -78.11 3.87 13.91 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-O 117.367 -1.302 . . . . 0.0 113.469 171.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.452 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . . . -141.28 -103.43 0.14 Allowed 'General case' 0 CA--C 1.583 2.223 0 CA-C-N 121.943 2.156 . . . . 0.0 115.293 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.09 12.08 14.41 Favored 'General case' 0 CA--C 1.586 2.342 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -50.14 156.41 2.23 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 120.113 2.805 . . . . 0.0 120.113 177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.283 7.8 t 73.38 -47.69 0.67 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.39 -52.83 4.16 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 105.03 148.52 17.89 Favored Glycine 0 CA--C 1.547 2.055 0 C-N-CA 124.35 0.976 . . . . 0.0 112.675 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.475 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.2 t -84.21 143.19 41.89 Favored Pre-proline 0 CA--C 1.577 2.006 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.996 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.76 -39.58 57.33 Favored 'Trans proline' 0 CA--C 1.583 2.929 0 N-CA-C 120.265 3.141 . . . . 0.0 120.265 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -66.2 -62.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.569 2.259 0 CA-C-N 125.714 3.077 . . . . 0.0 116.229 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -168.57 62.64 0.06 Allowed 'General case' 0 CA--C 1.581 2.157 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.475 ' HB ' ' H ' ' A' ' 117' ' ' SER . 69.3 mt -126.13 113.29 23.96 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.087 -1.633 . . . . 0.0 107.925 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.98 165.88 24.74 Favored 'Trans proline' 0 CA--C 1.583 2.946 0 C-N-CA 122.557 2.171 . . . . 0.0 115.297 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.2 116.33 3.96 Favored 'Trans proline' 0 CA--C 1.572 2.418 0 C-N-CA 122.61 2.207 . . . . 0.0 112.679 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.0 t30 67.33 53.21 0.77 Allowed 'General case' 0 CA--C 1.59 2.502 0 C-N-CA 125.423 1.489 . . . . 0.0 114.559 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.91 130.39 56.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.508 -1.37 . . . . 0.0 109.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 3.0 m -63.32 152.86 36.73 Favored 'General case' 0 CA--C 1.594 2.66 0 CA-C-N 120.552 1.524 . . . . 0.0 114.999 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.06 172.01 7.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 119.495 -2.003 . . . . 0.0 111.95 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.411 HG12 ' CE3' ' A' ' 59' ' ' TRP . 55.8 t -150.98 127.32 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.818 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.201 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 78.6 m-85 -142.1 127.21 18.48 Favored 'General case' 0 N--CA 1.517 2.914 0 O-C-N 119.236 -2.165 . . . . 0.0 111.198 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -98.36 101.18 12.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 119.407 -2.058 . . . . 0.0 106.732 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.07 140.42 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.556 -170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.605 ' HB3' ' HA ' ' A' ' 101' ' ' LEU 1.827 30.5 tt0 -138.43 -171.71 3.11 Favored 'General case' 0 N--CA 1.524 3.232 0 CA-C-O 122.608 1.194 . . . . 0.0 109.203 164.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.532 ' H ' ' HG2' ' A' ' 132' ' ' GLU . 24.4 tp -140.94 127.07 19.54 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -162.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.82 -34.97 39.03 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 175.74 159.79 0.26 Allowed 'General case' 0 CA--C 1.581 2.155 0 C-N-CA 127.32 2.248 . . . . 0.0 106.966 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.13 -92.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.135 -1.603 . . . . 0.0 109.593 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -81.13 55.92 2.66 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.149 0 CA-C-O 117.753 -1.582 . . . . 0.0 114.941 175.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 3.394 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -102.15 165.96 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.842 0 C-N-CA 125.62 1.568 . . . . 0.0 114.439 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -155.69 140.28 16.93 Favored 'General case' 0 CA--C 1.58 2.098 0 O-C-N 120.753 -1.217 . . . . 0.0 110.072 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.632 0.7 OUTLIER 101.62 -13.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 119.776 3.25 . . . . 0.0 119.776 174.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.896 49.2 m 58.21 58.76 6.48 Favored Pre-proline 0 CA--C 1.58 2.118 0 O-C-N 118.153 -2.842 . . . . 0.0 118.29 -175.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.81 74.07 4.54 Favored 'Trans proline' 0 CA--C 1.582 2.912 0 C-N-CA 123.282 2.655 . . . . 0.0 117.16 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -118.13 -89.02 0.6 Allowed 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.0 38.19 1.25 Allowed 'General case' 0 CA--C 1.593 2.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 41.3 t0 58.16 63.01 1.86 Allowed 'General case' 0 CA--C 1.589 2.447 0 O-C-N 120.32 -1.488 . . . . 0.0 110.996 -173.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.444 32.4 mt-10 -66.98 -43.35 83.24 Favored 'General case' 0 C--N 1.363 1.175 0 N-CA-C 117.12 2.266 . . . . 0.0 117.12 -174.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.48 -13.5 4.27 Favored Glycine 0 N--CA 1.503 3.153 1 N-CA-C 123.933 4.333 . . . . 0.0 123.933 171.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.3 164.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.087 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.798 0.5 OUTLIER -163.62 -168.38 1.64 Allowed 'General case' 0 N--CA 1.512 2.654 0 CA-C-N 120.52 1.509 . . . . 0.0 114.652 164.69 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 23.3 pttm -148.66 150.13 32.69 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 2.7 t -113.77 87.49 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 CA-C-O 117.362 -1.304 . . . . 0.0 112.763 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.504 2.4 mm -43.95 121.29 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 117.195 2.295 . . . . 0.0 117.195 -177.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -106.9 -59.24 1.83 Allowed 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.893 0.877 . . . . 0.0 110.166 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -142.2 106.94 4.86 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -51.33 -56.85 10.87 Favored 'General case' 0 N--CA 1.51 2.559 0 CA-C-N 122.297 2.317 . . . . 0.0 116.342 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.63 -158.73 25.15 Favored Glycine 0 CA--C 1.541 1.707 0 C-N-CA 126.364 1.935 . . . . 0.0 114.63 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -78.24 2.79 17.2 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 63.4 45.12 95.68 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 119.646 2.618 . . . . 0.0 119.646 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -114.44 -66.62 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.79 173.06 12.72 Favored 'General case' 0 CA--C 1.581 2.14 0 CA-C-O 122.996 1.379 . . . . 0.0 114.377 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -118.95 147.67 42.98 Favored Pre-proline 0 CA--C 1.581 2.15 0 CA-C-N 114.215 -1.357 . . . . 0.0 112.157 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -68.09 141.72 53.74 Favored 'Trans proline' 0 CA--C 1.582 2.904 0 N-CA-C 118.318 2.392 . . . . 0.0 118.318 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -104.05 167.68 9.61 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 121.534 1.97 . . . . 0.0 112.79 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.256 2.0 tp -62.95 134.65 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.292 0 O-C-N 118.954 -2.341 . . . . 0.0 108.946 175.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.78 15.13 81.51 Favored Glycine 0 CA--C 1.562 3.012 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -82.95 139.64 33.24 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.374 2.087 . . . . 0.0 110.68 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 136' ' ' PHE . 1.6 tmm_? -83.03 113.35 20.53 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.386 2.0 t -117.99 136.75 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.501 0 C-N-CA 125.438 1.495 . . . . 0.0 112.911 -164.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -120.35 103.79 9.5 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.901 1.334 . . . . 0.0 107.815 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.461 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.6 m -107.55 164.92 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 123.481 1.61 . . . . 0.0 111.961 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.419 ' CE1' ' HG ' ' A' ' 70' ' ' LEU 0.295 3.7 t60 -130.24 138.06 50.34 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 164.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -132.5 148.48 52.39 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 117.789 2.515 . . . . 0.0 117.789 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -116.59 147.62 41.68 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 162.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.9 145.59 13.47 Favored Glycine 0 CA--C 1.545 1.954 0 O-C-N 119.136 -2.227 . . . . 0.0 117.308 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.45 157.75 45.66 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 126.515 1.926 . . . . 0.0 114.466 -173.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.99 167.49 11.2 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 121.26 -0.9 . . . . 0.0 110.167 169.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.289 1.0 OUTLIER -61.95 -25.59 67.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 179.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -68.32 -3.73 11.98 Favored 'General case' 0 CA--C 1.595 2.696 0 CA-C-N 120.069 1.304 . . . . 0.0 112.763 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 44.19 12.41 Favored Glycine 0 N--CA 1.498 2.775 0 CA-C-N 120.334 1.424 . . . . 0.0 114.295 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.0 m -120.13 119.54 33.59 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -75.84 92.1 3.03 Favored 'General case' 0 CA--C 1.585 2.313 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.969 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -69.74 -30.87 68.58 Favored 'General case' 0 CA--C 1.566 1.562 0 O-C-N 118.891 -2.381 . . . . 0.0 114.962 175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -147.0 156.61 43.17 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 125.237 2.446 . . . . 0.0 114.432 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -150.36 93.03 1.93 Allowed 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.272 63.8 p -47.99 -58.73 4.05 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 117.635 2.458 . . . . 0.0 117.635 -174.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.419 ' HG ' ' CE1' ' A' ' 55' ' ' HIS . 85.7 mt -51.9 -44.01 63.61 Favored 'General case' 0 CA--C 1.582 2.204 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.21 -43.87 96.91 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -136.34 35.93 2.74 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.167 3.025 . . . . 0.0 119.167 -176.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -158.95 -75.11 0.08 Allowed 'General case' 0 CA--C 1.564 1.508 0 O-C-N 120.212 -1.555 . . . . 0.0 109.834 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -178.13 -161.78 0.06 Allowed 'General case' 0 CA--C 1.577 1.992 0 C-N-CA 127.19 2.196 . . . . 0.0 108.913 -173.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.14 -170.5 2.76 Favored 'General case' 0 CA--C 1.591 2.526 0 O-C-N 118.935 -2.353 . . . . 0.0 107.769 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.461 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.47 1.4 t80 -123.77 148.79 46.33 Favored 'General case' 0 CA--C 1.58 2.11 0 O-C-N 118.038 -2.914 . . . . 0.0 111.14 173.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.3 p -167.07 140.89 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 118.454 -2.654 . . . . 0.0 111.973 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.483 ' CG ' HG11 ' A' ' 85' ' ' VAL . 35.5 p90 -149.98 -165.44 2.27 Favored 'General case' 0 CA--C 1.571 1.786 0 CA-C-O 121.227 0.537 . . . . 0.0 111.184 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -132.61 63.43 1.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.207 -1.558 . . . . 0.0 112.152 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 10.77 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.81 61.7 2.51 Favored Glycine 0 N--CA 1.511 3.664 0 O-C-N 119.767 -1.833 . . . . 0.0 112.025 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.662 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.394 0.0 OUTLIER -106.48 -85.22 0.5 Allowed 'General case' 0 CA--C 1.57 1.712 0 CA-C-O 123.964 1.84 . . . . 0.0 111.357 -171.795 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.662 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -100.93 -43.47 2.24 Favored Glycine 0 N--CA 1.51 3.61 0 CA-C-O 124.647 2.248 . . . . 0.0 110.473 165.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 1.05 1.3 pp20? 111.49 135.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 131.605 3.962 . . . . 0.0 118.684 165.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG23 ' H ' ' A' ' 86' ' ' ILE 0.337 12.3 m -79.69 -99.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 109.232 -3.622 . . . . 0.0 104.428 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.535 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.3 pt -133.9 155.72 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 124.451 2.072 . . . . 0.0 105.982 165.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.284 13.0 tmtt? -67.35 -29.0 68.43 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.752 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.13 82.02 Favored 'General case' 0 CA--C 1.559 1.327 0 CA-C-O 117.456 -1.259 . . . . 0.0 112.113 165.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.535 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.9 m0 -73.15 -43.0 62.2 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 120.882 1.674 . . . . 0.0 113.094 173.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.33 -36.52 71.25 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 120.034 1.288 . . . . 0.0 114.157 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.283 1.7 mp -67.68 -58.0 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.949 0 CA-C-N 119.402 1.001 . . . . 0.0 111.452 174.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.485 ' CB ' HD13 ' A' ' 104' ' ' ILE . . . -63.16 -39.28 94.21 Favored 'General case' 0 CA--C 1.566 1.591 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.447 ' HA ' ' SD ' ' A' ' 96' ' ' MET . 65.2 t -63.57 -49.08 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 120.301 1.409 . . . . 0.0 111.052 173.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.66 -32.55 29.97 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.1 p -100.71 19.11 17.68 Favored 'General case' 0 CA--C 1.591 2.534 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 93' ' ' VAL 0.337 1.4 ptt? -115.82 -172.96 2.26 Favored 'General case' 0 N--CA 1.51 2.551 0 CA-C-N 122.758 2.526 . . . . 0.0 116.373 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -134.88 152.32 51.65 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 66.6 t -48.17 126.83 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.122 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 102.83 -44.29 1.52 Allowed Glycine 0 N--CA 1.491 2.325 0 CA-C-O 115.904 -2.609 . . . . 0.0 113.455 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -145.53 -173.38 4.11 Favored 'General case' 0 N--CA 1.507 2.385 0 CA-C-N 121.827 2.813 . . . . 0.0 113.264 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 102' ' ' CYS 0.704 0.2 OUTLIER -158.71 -133.36 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 123.267 1.508 . . . . 0.0 113.97 176.242 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -160.08 -145.87 0.13 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -169.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' N ' ' SG ' ' A' ' 102' ' ' CYS 0.326 0.0 OUTLIER -122.94 113.58 19.28 Favored 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 124.952 2.31 . . . . 0.0 111.975 170.087 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.485 HD13 ' CB ' ' A' ' 92' ' ' ALA 0.316 1.4 mt -78.45 146.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 112.131 -2.304 . . . . 0.0 113.112 176.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 106' ' ' CYS 2.023 0.1 OUTLIER -161.05 -178.43 6.77 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 120.902 3.668 . . . . 0.0 120.902 146.969 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 111' ' ' ALA . 1.9 p -159.77 162.95 34.96 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 117.37 2.359 . . . . 0.0 117.37 -159.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -79.67 144.19 60.2 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-N 112.258 -2.246 . . . . 0.0 108.69 168.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.84 -21.35 0.94 Allowed 'Trans proline' 0 CA--C 1.569 2.261 0 N-CA-C 120.293 3.151 . . . . 0.0 120.293 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -60.23 -36.76 78.46 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.43 -3.26 58.23 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 171.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -128.7 -103.75 0.31 Allowed 'General case' 0 CA--C 1.578 2.026 0 CA-C-N 120.483 1.492 . . . . 0.0 114.028 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.364 47.3 m-85 -106.42 -5.33 19.03 Favored 'General case' 0 N--CA 1.523 3.201 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.95 -154.83 49.28 Favored Glycine 0 N--CA 1.488 2.109 0 CA-C-N 122.462 2.392 . . . . 0.0 118.394 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -67.12 -24.57 65.93 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.63 -31.71 15.76 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 118.911 2.93 . . . . 0.0 118.911 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.88 167.56 43.64 Favored Glycine 0 CA--C 1.552 2.382 0 CA-C-N 121.409 1.913 . . . . 0.0 114.797 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.428 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 5.9 t -86.82 114.82 60.02 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 116.843 -1.551 . . . . 0.0 107.384 176.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.284 85.0 Cg_exo -40.73 -49.27 4.31 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 122.202 3.885 . . . . 0.0 122.202 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -87.83 8.88 4.0 Favored 'Trans proline' 0 CA--C 1.577 2.646 0 CA-C-N 125.173 2.883 . . . . 0.0 118.086 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -159.09 -17.53 0.07 Allowed 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 119.354 3.094 . . . . 0.0 119.354 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.428 ' HB ' ' H ' ' A' ' 117' ' ' SER . 41.7 mt -125.17 136.63 28.42 Favored Pre-proline 0 N--CA 1.508 2.459 0 CA-C-N 121.381 1.901 . . . . 0.0 112.702 -172.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -82.47 170.53 13.04 Favored 'Trans proline' 0 CA--C 1.584 2.987 0 CA-C-N 122.914 2.077 . . . . 0.0 115.211 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.62 135.98 37.74 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 122.758 2.305 . . . . 0.0 114.836 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.3 t30 59.68 56.82 3.44 Favored 'General case' 0 CA--C 1.586 2.337 0 C-N-CA 124.901 1.28 . . . . 0.0 113.334 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -113.56 114.8 27.0 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.249 -1.532 . . . . 0.0 112.194 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.2 m -68.8 144.31 54.35 Favored 'General case' 0 CA--C 1.591 2.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.716 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD12 ' HB1' ' A' ' 111' ' ' ALA . 21.3 mt -113.95 172.62 6.88 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -172.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.1 t -153.44 124.44 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.783 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.388 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.286 1.0 OUTLIER -141.85 130.53 22.77 Favored 'General case' 0 N--CA 1.515 2.79 0 CA-C-N 124.599 3.363 . . . . 0.0 110.442 175.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -94.48 104.09 16.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.28 140.09 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -123.99 121.48 35.37 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.4 tp -89.25 112.4 23.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.051 -1.031 . . . . 0.0 111.955 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -81.74 -41.83 20.68 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -168.42 154.22 6.86 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 123.227 1.489 . . . . 0.0 109.537 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' ARG 0.275 5.8 p90 -151.45 -90.02 0.06 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 178.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.52 69.26 6.98 Favored 'General case' 0 CA--C 1.577 2.003 0 CA-C-O 123.431 1.586 . . . . 0.0 112.194 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.829 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -178.816 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.06 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 11.5 p -63.55 151.75 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-N 119.095 1.448 . . . . 0.0 111.871 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -124.5 133.73 53.25 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 120.887 3.662 . . . . 0.0 120.887 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.292 9.8 tp -138.36 40.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.598 2.809 0 CA-C-N 113.222 -1.808 . . . . 0.0 110.085 166.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.64 -49.3 0.01 OUTLIER Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 118.049 2.611 . . . . 0.0 118.049 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -66.21 55.84 0.4 Allowed 'Trans proline' 0 CA--C 1.579 2.754 0 CA-C-N 125.235 2.905 . . . . 0.0 118.893 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.75 -85.38 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.24 24.73 9.08 Favored 'General case' 0 CA--C 1.59 2.497 0 C-N-CA 124.594 1.157 . . . . 0.0 113.95 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.0 t70 56.19 54.46 7.77 Favored 'General case' 0 CA--C 1.586 2.355 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.324 2.8 mp0 -76.37 -24.89 54.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 118.643 2.831 . . . . 0.0 118.643 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.9 -34.93 2.1 Favored Glycine 0 N--CA 1.473 1.163 0 N-CA-C 120.849 3.099 . . . . 0.0 120.849 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.7 p -153.36 143.01 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 N-CA-C 118.81 2.892 . . . . 0.0 118.81 -173.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.7 tp -104.32 136.33 44.11 Favored 'General case' 0 CA--C 1.59 2.494 0 C-N-CA 127.003 2.121 . . . . 0.0 106.089 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -121.73 130.57 53.53 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 124.014 3.097 . . . . 0.0 113.406 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 4.5 t -85.75 147.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 116.613 -1.661 . . . . 0.0 110.203 -178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 102' ' ' CYS 0.446 0.5 OUTLIER -126.02 125.18 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 CA-C-N 120.522 1.51 . . . . 0.0 110.007 170.248 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -58.75 2.05 Favored 'General case' 0 CA--C 1.57 1.725 0 O-C-N 121.611 -0.681 . . . . 0.0 111.874 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -121.94 99.26 6.35 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -56.51 174.61 0.14 Allowed 'General case' 0 CA--C 1.595 2.697 0 O-C-N 119.904 -1.748 . . . . 0.0 115.648 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.81 -165.66 37.68 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 119.215 2.446 . . . . 0.0 119.215 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -91.3 -1.81 57.55 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.69 -90.4 0.08 OUTLIER Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.653 1.569 . . . . 0.0 116.683 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 t -159.88 -25.92 0.07 Allowed 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -78.75 142.95 36.6 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 -173.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 p -135.67 114.05 11.09 Favored Pre-proline 0 CA--C 1.577 2.005 0 CA-C-N 109.831 -3.35 . . . . 0.0 107.528 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -67.5 -29.76 36.8 Favored 'Trans proline' 0 CA--C 1.582 2.887 0 N-CA-C 117.27 1.988 . . . . 0.0 117.27 173.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.524 32.2 mtt 81.29 -150.78 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.318 1.1 tp -50.5 134.17 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 O-C-N 120.585 -1.322 . . . . 0.0 113.625 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.04 -7.13 76.5 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 116.927 -2.041 . . . . 0.0 117.548 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -74.61 128.43 35.54 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-N 122.827 3.314 . . . . 0.0 112.817 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ptm85 -76.4 125.68 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.931 0.787 . . . . 0.0 109.078 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 136' ' ' PHE . 23.2 m -120.44 138.45 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.905 0.882 . . . . 0.0 112.751 -169.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -117.18 108.06 15.21 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 76' ' ' PHE . 2.7 m -119.12 160.6 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 -172.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.301 6.1 m-70 -126.64 113.03 16.18 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 166.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -108.13 146.04 33.25 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.3 m -112.72 139.31 48.45 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 162.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.64 147.66 19.08 Favored Glycine 0 CA--C 1.565 3.188 0 N-CA-C 115.733 1.053 . . . . 0.0 115.733 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.77 171.52 20.24 Favored 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 127.93 2.492 . . . . 0.0 113.068 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -93.36 148.75 21.78 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.513 165.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.376 0.2 OUTLIER -61.74 -17.32 55.39 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.01 -28.23 66.19 Favored 'General case' 0 CA--C 1.594 2.636 0 CA-C-N 120.334 1.424 . . . . 0.0 111.823 166.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.18 52.07 0.61 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 115.966 1.146 . . . . 0.0 115.966 174.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -135.34 113.19 11.0 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -68.52 120.39 14.49 Favored 'General case' 0 CA--C 1.584 2.274 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.411 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -97.46 -31.69 12.22 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 121.442 1.928 . . . . 0.0 113.498 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -154.16 165.65 35.59 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-O 123.24 1.495 . . . . 0.0 113.508 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.1 t -148.52 -10.38 0.36 Allowed 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.381 97.7 p 61.44 -36.22 0.1 Allowed 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 122.846 2.566 . . . . 0.0 117.887 -176.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.81 -42.87 97.58 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 128.186 2.594 . . . . 0.0 113.746 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -57.71 -38.08 74.64 Favored 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -61.12 -21.72 63.99 Favored 'General case' 0 CA--C 1.579 2.063 0 N-CA-C 117.087 2.255 . . . . 0.0 117.087 176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.332 33.4 ttmt 86.05 -23.57 0.15 Allowed 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 126.161 1.784 . . . . 0.0 114.7 -175.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.266 8.3 t70 -92.87 -135.3 0.16 Allowed 'General case' 0 CA--C 1.572 1.81 0 C-N-CA 124.406 1.083 . . . . 0.0 110.477 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 168.87 21.38 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 124.743 1.217 . . . . 0.0 113.731 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.457 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.261 4.0 t80 -97.23 144.14 27.33 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 169.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.2 p -159.93 147.8 16.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 118.614 -2.554 . . . . 0.0 109.405 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.2 p90 -159.47 -176.58 5.86 Favored 'General case' 0 CA--C 1.589 2.447 0 CA-C-N 114.075 -1.42 . . . . 0.0 111.278 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.54 132.66 52.55 Favored 'General case' 0 CA--C 1.569 1.675 0 O-C-N 118.922 -2.361 . . . . 0.0 106.307 171.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 107.84 0.63 Allowed 'General case' 0 CA--C 1.577 1.983 0 O-C-N 120.848 -1.158 . . . . 0.0 113.88 -175.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.29 58.84 6.81 Favored Glycine 0 N--CA 1.504 3.18 0 O-C-N 120.433 -1.417 . . . . 0.0 113.669 -175.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.621 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.266 0.0 OUTLIER -107.71 -75.66 0.63 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.57 1.652 . . . . 0.0 110.812 -175.01 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.621 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -105.31 -51.95 0.85 Allowed Glycine 0 N--CA 1.502 3.097 0 CA-C-O 124.786 2.325 . . . . 0.0 108.808 167.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.723 19.8 tt0 114.75 140.29 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 CA-C-O 128.376 3.941 . . . . 0.0 114.159 166.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.366 12.0 m -79.96 -100.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.106 1 CA-C-N 105.211 -5.45 . . . . 0.0 103.028 177.508 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.502 HG13 ' H ' ' A' ' 89' ' ' TRP . 41.3 pt -135.09 157.5 40.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 124.995 2.331 . . . . 0.0 105.895 165.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 12.7 tmtt? -69.39 -30.39 68.35 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 114.226 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.41 83.27 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 116.22 -1.848 . . . . 0.0 110.567 165.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.502 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.2 m0 -71.28 -44.85 64.42 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 122.074 2.216 . . . . 0.0 113.204 174.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -57.92 -33.37 68.72 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.252 1.6 mp -68.67 -58.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.029 0 CA-C-N 120.187 1.358 . . . . 0.0 110.749 172.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.68 -46.84 88.84 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.291 11.9 t -62.64 -38.06 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 120.235 1.379 . . . . 0.0 112.892 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.67 -34.41 64.99 Favored 'General case' 0 CA--C 1.581 2.171 0 CA-C-N 121.002 1.728 . . . . 0.0 113.804 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.7 p -84.45 -0.19 51.93 Favored 'General case' 0 CA--C 1.59 2.5 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 173.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 7.3 mtt -85.88 105.1 16.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 121.96 2.164 . . . . 0.0 114.242 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.75 141.4 49.75 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-O 114.779 -2.534 . . . . 0.0 106.756 173.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.267 1.7 t -9.64 96.13 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.54 4.032 0 CA-C-N 122.841 2.564 . . . . 0.0 112.484 -161.029 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 133' ' ' LEU . . . 18.78 -50.28 0.0 OUTLIER Glycine 0 N--CA 1.502 3.081 1 N-CA-C 129.289 6.475 . . . . 0.0 129.289 -151.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 69.24 174.35 0.29 Allowed 'General case' 0 CA--C 1.605 3.085 0 CA-C-O 123.089 1.424 . . . . 0.0 108.156 -164.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.707 HD13 ' HG3' ' A' ' 132' ' ' GLU 0.311 12.6 tp -126.45 104.42 8.15 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 123.863 1.792 . . . . 0.0 109.109 169.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 13.7 p -160.41 -159.29 0.68 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.523 -1.671 . . . . 0.0 108.767 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.776 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 2.31 0.0 OUTLIER -160.91 -139.15 0.05 Allowed 'General case' 0 CA--C 1.563 1.455 1 N-CA-C 122.603 4.297 . . . . 0.0 122.603 157.863 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.564 HG13 ' HB3' ' A' ' 103' ' ' ARG . 8.0 mt -121.53 146.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-N 109.548 -3.478 . . . . 0.0 114.676 -165.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.6 m -135.48 91.32 2.71 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 13.7 p -107.41 147.75 29.99 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 -171.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -90.52 137.98 27.05 Favored Pre-proline 0 CA--C 1.575 1.94 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.084 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.308 13.9 Cg_endo -54.09 -10.14 1.8 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 N-CA-C 120.346 3.172 . . . . 0.0 120.346 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.35 -38.8 88.26 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 120.494 1.497 . . . . 0.0 113.695 169.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -86.27 -0.52 56.0 Favored 'General case' 0 CA--C 1.576 1.952 0 C-N-CA 126.059 1.743 . . . . 0.0 114.213 169.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.28 -111.64 0.19 Allowed 'General case' 0 CA--C 1.581 2.149 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.4 ' CD2' HD11 ' A' ' 127' ' ' LEU . 2.6 m-85 -93.5 0.21 56.61 Favored 'General case' 0 N--CA 1.517 2.879 0 CA-C-N 120.742 1.61 . . . . 0.0 114.952 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.69 146.16 3.6 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.928 2.731 . . . . 0.0 119.928 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.346 53.1 p 76.0 -47.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -175.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.72 -55.03 3.03 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.28 149.63 25.75 Favored Glycine 0 CA--C 1.546 1.99 0 CA-C-N 119.548 1.067 . . . . 0.0 111.471 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.45 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 7.4 t -75.44 129.19 82.68 Favored Pre-proline 0 CA--C 1.579 2.059 0 CA-C-O 116.816 -1.564 . . . . 0.0 109.954 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.281 6.8 Cg_endo -40.43 -44.57 4.31 Favored 'Trans proline' 0 CA--C 1.579 2.763 1 N-CA-C 122.554 4.021 . . . . 0.0 122.554 -175.54 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.64 -37.07 1.87 Allowed 'Trans proline' 0 CA--C 1.572 2.396 0 CA-C-N 125.296 2.927 . . . . 0.0 118.61 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -151.48 -17.99 0.2 Allowed 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 119.06 2.985 . . . . 0.0 119.06 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' H ' ' A' ' 117' ' ' SER . 85.5 mt -79.96 139.66 53.61 Favored Pre-proline 0 CA--C 1.593 2.626 0 CA-C-N 122.476 2.398 . . . . 0.0 114.028 -173.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -93.16 179.06 1.15 Allowed 'Trans proline' 0 CA--C 1.59 3.31 0 CA-C-N 125.332 2.94 . . . . 0.0 115.04 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -60.04 -2.9 1.92 Allowed 'Trans proline' 0 CA--C 1.576 2.607 0 N-CA-C 121.077 3.453 . . . . 0.0 121.077 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -156.04 92.82 1.38 Allowed 'General case' 0 CA--C 1.589 2.479 0 CA-C-N 120.991 1.723 . . . . 0.0 111.096 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.34 131.62 23.49 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 122.674 2.488 . . . . 0.0 110.216 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.0 m -74.92 128.81 36.46 Favored 'General case' 0 CA--C 1.593 2.629 0 O-C-N 120.836 -1.165 . . . . 0.0 111.63 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.474 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 71.3 mt -107.44 165.23 11.55 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.8 t -143.93 118.17 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.627 0 CA-C-N 112.002 -2.363 . . . . 0.0 108.62 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.345 0.2 OUTLIER -140.33 107.98 5.62 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 121.035 1.743 . . . . 0.0 109.875 172.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.776 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 39.9 mt-10 -100.51 128.67 46.5 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.241 -1.537 . . . . 0.0 108.342 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.738 ' H ' ' HB2' ' A' ' 103' ' ' ARG 0.363 1.1 p -132.4 149.94 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-O 124.818 2.246 . . . . 0.0 116.161 -170.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.707 ' HG3' HD13 ' A' ' 101' ' ' LEU . 1.6 mp0 -102.61 120.41 40.51 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 111.41 -2.632 . . . . 0.0 107.007 178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 99' ' ' GLY 0.293 10.5 tp -107.96 109.32 20.78 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-N 121.713 2.051 . . . . 0.0 108.529 174.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -69.5 -55.55 9.9 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 119.726 -1.859 . . . . 0.0 114.014 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -158.6 155.25 27.94 Favored 'General case' 0 CA--C 1.57 1.746 0 CA-C-O 123.737 1.732 . . . . 0.0 107.205 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.447 ' HB3' HG12 ' A' ' 52' ' ' VAL 0.255 0.0 OUTLIER -131.46 -108.86 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.244 177.114 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -102.24 83.87 2.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.623 0 N-CA-C 122.519 3.768 . . . . 0.0 122.519 -176.64 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 1 N-CA-C 127.807 5.883 . . . . 0.0 127.807 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.69 123.35 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 1 N-CA-C 99.902 -4.11 . . . . 0.0 99.902 162.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -164.64 155.69 15.01 Favored 'General case' 0 N--CA 1.506 2.349 0 N-CA-C 120.083 3.364 . . . . 0.0 120.083 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.274 5.3 tp -161.66 142.2 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.274 0 CA-C-O 125.339 2.495 . . . . 0.0 110.65 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 p -142.76 127.85 10.08 Favored Pre-proline 0 CA--C 1.58 2.101 0 CA-C-N 112.659 -2.064 . . . . 0.0 107.686 166.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -58.74 21.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.902 1 N-CA-C 123.736 4.476 . . . . 0.0 123.736 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -145.97 -79.02 0.17 Allowed 'General case' 0 CA--C 1.57 1.732 0 O-C-N 119.99 -1.694 . . . . 0.0 108.264 177.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' H ' ' HG2' ' A' ' 27' ' ' LYS . 2.0 mp0 -99.78 81.59 2.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.303 37.1 p30 -18.95 -24.69 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.247 1 N-CA-C 126.23 5.641 . . . . 0.0 126.23 -174.392 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -90.18 26.27 1.94 Allowed 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 118.663 2.838 . . . . 0.0 118.663 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.66 -35.39 59.04 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 118.525 -2.609 . . . . 0.0 118.221 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.281 50.9 t -133.74 119.96 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.787 0.803 . . . . 0.0 111.119 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.61 139.17 37.56 Favored 'General case' 0 CA--C 1.587 2.389 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -139.86 84.7 1.99 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 119.476 -2.015 . . . . 0.0 106.66 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -85.89 101.24 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 CA-C-O 115.972 -1.966 . . . . 0.0 111.7 -168.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.653 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.642 0.5 OUTLIER -65.51 133.4 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -172.47 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -97.48 -56.22 2.59 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.44 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -150.93 121.23 7.29 Favored 'General case' 0 CA--C 1.584 2.26 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -72.27 0.13 Allowed 'General case' 0 CA--C 1.581 2.147 0 O-C-N 119.038 -2.289 . . . . 0.0 114.409 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.98 -176.03 37.6 Favored Glycine 0 CA--C 1.547 2.033 0 C-N-CA 125.555 1.55 . . . . 0.0 114.488 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 t -149.91 -3.18 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 118.632 2.826 . . . . 0.0 118.632 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.19 -75.36 0.51 Allowed Glycine 0 N--CA 1.492 2.385 0 CA-C-N 122.095 2.225 . . . . 0.0 117.19 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 76.8 p -126.2 -80.73 0.61 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.341 0.57 . . . . 0.0 110.393 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -159.46 -146.92 0.15 Allowed 'General case' 0 CA--C 1.584 2.27 0 C-N-CA 124.227 1.011 . . . . 0.0 110.679 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.2 p -94.57 168.97 10.36 Favored Pre-proline 0 CA--C 1.582 2.204 0 C-N-CA 125.443 1.497 . . . . 0.0 111.464 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -99.96 -167.1 0.08 OUTLIER 'Trans proline' 0 CA--C 1.569 2.256 0 CA-C-N 122.909 2.075 . . . . 0.0 116.196 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -137.65 146.73 44.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.898 . . . . 0.0 110.06 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.609 HG23 ' H ' ' A' ' 49' ' ' GLY 0.529 0.2 OUTLIER -9.95 -123.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.743 0 N-CA-C 117.666 2.469 . . . . 0.0 117.666 -172.807 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.609 ' H ' HG23 ' A' ' 48' ' ' ILE . . . -49.18 38.43 0.01 OUTLIER Glycine 0 N--CA 1.504 3.206 1 N-CA-C 124.042 4.377 . . . . 0.0 124.042 177.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -75.67 148.87 38.34 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-N 119.979 1.889 . . . . 0.0 112.141 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.82 134.47 41.73 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.352 0.9 OUTLIER -142.26 147.82 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 124.72 2.2 . . . . 0.0 112.123 -163.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.553 ' CE2' ' HG ' ' A' ' 133' ' ' LEU 0.532 4.9 p90 -79.9 -160.29 0.27 Allowed 'General case' 0 CA--C 1.589 2.462 0 C-N-CA 127.545 2.338 . . . . 0.0 114.335 168.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.908 HG23 ' HB3' ' A' ' 76' ' ' PHE 0.295 0.8 OUTLIER 157.6 147.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 127.094 2.158 . . . . 0.0 111.292 159.506 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.312 0.2 OUTLIER -127.64 111.49 13.78 Favored 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 118.592 -1.243 . . . . 0.0 107.886 164.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 37.1 p90 -101.12 174.65 5.9 Favored 'General case' 0 CA--C 1.589 2.46 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 -175.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 m -152.91 113.89 4.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 103.214 -2.884 . . . . 0.0 103.214 164.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.81 136.85 8.96 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-O 124.652 2.251 . . . . 0.0 116.157 -174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.461 ' HE3' HG23 ' A' ' 128' ' ' VAL . 1.1 m-90 -121.98 150.17 42.43 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 110.615 -2.792 . . . . 0.0 112.897 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 37.4 tp -79.07 170.3 16.88 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 125.367 2.508 . . . . 0.0 108.318 168.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.255 3.1 tm? -58.82 -19.63 43.01 Favored 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 110.885 -2.87 . . . . 0.0 114.036 168.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -75.38 4.17 7.78 Favored 'General case' 0 CA--C 1.597 2.753 0 CA-C-N 121.071 1.76 . . . . 0.0 113.038 169.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.99 34.27 89.45 Favored Glycine 0 N--CA 1.51 3.618 0 CA-C-N 121.41 1.914 . . . . 0.0 116.188 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -117.76 140.12 50.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -86.05 95.0 9.38 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.908 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -69.97 -35.21 74.26 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.206 -2.184 . . . . 0.0 113.929 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -156.65 170.17 23.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 120.755 1.616 . . . . 0.0 112.711 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 95.0 p -160.06 -17.57 0.06 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.29 1.3 t 69.97 -53.07 0.63 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.502 -1.999 . . . . 0.0 113.085 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 25.9 mt -49.99 -49.97 48.67 Favored 'General case' 0 CA--C 1.581 2.154 0 C-N-CA 127.09 2.156 . . . . 0.0 114.255 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.12 -38.45 82.25 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.553 1.168 . . . . 0.0 114.134 173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -73.22 2.36 7.51 Favored 'General case' 0 CA--C 1.585 2.32 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 59.9 mttp 85.21 -18.72 0.36 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 175.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -120.26 175.31 6.02 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 123.442 1.592 . . . . 0.0 113.147 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -88.17 162.22 16.82 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.744 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.908 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.276 4.2 t80 -99.15 158.39 15.71 Favored 'General case' 0 CA--C 1.587 2.379 0 CA-C-O 123.344 1.545 . . . . 0.0 107.851 173.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.4 p -170.01 144.5 2.72 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 119.716 -1.865 . . . . 0.0 109.214 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CG ' HG11 ' A' ' 85' ' ' VAL . 32.2 p90 -153.29 -162.23 1.43 Allowed 'General case' 0 CA--C 1.574 1.873 0 CA-C-O 122.725 1.25 . . . . 0.0 110.694 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -136.93 118.0 14.36 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ILE . 0.9 OUTLIER -45.13 117.15 1.27 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -174.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.82 29.77 73.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 118.41 2.124 . . . . 0.0 118.41 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -99.93 3.95 44.71 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 119.399 3.111 . . . . 0.0 119.399 -172.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.2 58.88 2.02 Favored Glycine 0 N--CA 1.508 3.465 0 N-CA-C 106.301 -2.719 . . . . 0.0 106.301 -172.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -147.07 -48.95 0.18 Allowed 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 111.994 -2.103 . . . . 0.0 113.121 -166.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.26 8.5 m -124.46 -148.76 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 CA-C-O 123.571 1.653 . . . . 0.0 108.888 -174.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 pt -105.37 159.02 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 124.278 1.99 . . . . 0.0 109.983 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -67.84 -31.53 71.42 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 113.798 -1.546 . . . . 0.0 113.402 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.81 -34.68 69.92 Favored 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 117.105 -1.426 . . . . 0.0 111.764 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -74.12 -42.86 59.38 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-N 120.948 1.704 . . . . 0.0 112.514 172.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.74 -35.75 68.94 Favored 'General case' 0 CA--C 1.577 2.001 0 CA-C-N 119.92 1.236 . . . . 0.0 114.311 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.278 1.5 mp -65.99 -57.39 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 CA-C-N 120.002 1.274 . . . . 0.0 111.206 174.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.79 96.82 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.427 ' HA ' ' SD ' ' A' ' 96' ' ' MET 0.25 76.3 t -62.08 -46.68 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 119.728 1.149 . . . . 0.0 112.371 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.17 -34.24 60.0 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 43.7 p -94.86 -2.61 50.41 Favored 'General case' 0 CA--C 1.585 2.291 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.463 ' SD ' ' HG ' ' A' ' 101' ' ' LEU 0.262 0.8 OUTLIER -102.04 153.15 20.17 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 123.258 2.753 . . . . 0.0 115.444 -177.363 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -99.36 150.82 21.75 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 -173.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.469 ' HA ' ' CD2' ' A' ' 133' ' ' LEU . 63.3 t -48.15 124.43 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.594 0 C-N-CA 124.835 1.254 . . . . 0.0 112.557 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 106.16 -29.12 11.62 Favored Glycine 0 N--CA 1.499 2.844 0 CA-C-O 115.051 -3.083 . . . . 0.0 115.76 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.364 2.2 tp10 -155.82 -176.3 5.88 Favored 'General case' 0 N--CA 1.518 2.938 0 CA-C-N 123.008 3.404 . . . . 0.0 116.609 173.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.479 HD13 ' H ' ' A' ' 102' ' ' CYS 0.735 0.1 OUTLIER -159.44 -145.39 0.13 Allowed 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.042 1.868 . . . . 0.0 116.042 179.25 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -160.26 -152.41 0.29 Allowed 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -170.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.5 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 12.1 ptm180 -109.29 130.5 55.49 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-O 123.864 1.792 . . . . 0.0 111.14 171.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.4 mt -93.81 134.65 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 112.871 -1.968 . . . . 0.0 107.329 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 m -130.16 100.43 5.41 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 9.5 p -115.45 144.97 43.04 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 -172.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -79.15 148.84 72.05 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 116.924 -1.512 . . . . 0.0 111.474 175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.267 71.7 Cg_endo -57.98 -19.06 38.46 Favored 'Trans proline' 0 C--N 1.379 2.138 0 CA-C-N 125.587 3.031 . . . . 0.0 119.095 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.38 -38.31 80.17 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-N 121.465 1.939 . . . . 0.0 114.407 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -79.16 -7.82 58.51 Favored 'General case' 0 CA--C 1.575 1.916 0 C-N-CA 124.679 1.192 . . . . 0.0 114.1 169.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -121.52 -103.8 0.39 Allowed 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.735 1.607 . . . . 0.0 112.929 -177.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.478 6.5 m-85 -106.2 -8.22 17.47 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.79 -148.21 49.12 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 121.272 3.269 . . . . 0.0 121.272 171.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 t -88.74 61.9 6.2 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 122.407 1.099 . . . . 0.0 111.534 177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.79 -52.8 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 C-N-CA 125.406 1.483 . . . . 0.0 112.646 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.99 160.94 25.55 Favored Glycine 0 CA--C 1.544 1.873 0 C-N-CA 124.054 0.835 . . . . 0.0 114.038 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -89.24 139.29 28.58 Favored Pre-proline 0 CA--C 1.576 1.955 0 CA-C-O 117.127 -1.416 . . . . 0.0 110.021 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -48.64 -39.96 37.94 Favored 'Trans proline' 0 CA--C 1.586 3.122 0 N-CA-C 120.597 3.268 . . . . 0.0 120.597 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -86.33 -29.85 0.45 Allowed 'Trans proline' 0 CA--C 1.574 2.494 0 CA-C-N 125.425 2.973 . . . . 0.0 119.667 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -148.38 -29.34 0.3 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 119.422 3.119 . . . . 0.0 119.422 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mt -79.98 122.1 82.82 Favored Pre-proline 0 CA--C 1.585 2.326 0 CA-C-N 120.467 1.485 . . . . 0.0 113.854 -172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.69 177.85 2.58 Favored 'Trans proline' 0 CA--C 1.584 2.993 0 C-N-CA 123.119 2.546 . . . . 0.0 117.458 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -50.28 -19.84 4.97 Favored 'Trans proline' 0 CA--C 1.567 2.151 1 N-CA-C 122.927 4.164 . . . . 0.0 122.927 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -160.13 94.87 1.12 Allowed 'General case' 0 CA--C 1.583 2.233 0 CA-C-N 120.671 1.578 . . . . 0.0 106.885 176.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -147.23 141.9 26.66 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 123.001 2.637 . . . . 0.0 112.436 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 93.3 m -71.44 158.01 37.04 Favored 'General case' 0 CA--C 1.591 2.54 0 O-C-N 121.221 -0.924 . . . . 0.0 112.743 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.533 HD12 ' HB1' ' A' ' 111' ' ' ALA . 9.2 mt -129.18 161.35 30.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 119.555 -1.966 . . . . 0.0 112.762 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.461 HG23 ' HE3' ' A' ' 59' ' ' TRP . 12.5 m -144.04 135.97 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 O-C-N 121.423 -0.798 . . . . 0.0 110.798 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 2.4 m-85 -136.15 127.43 28.27 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.71 1.243 . . . . 0.0 109.225 173.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.88 102.26 14.37 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.69 152.06 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.294 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -133.97 133.2 41.07 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.553 ' HG ' ' CE2' ' A' ' 53' ' ' PHE . 4.6 tt -94.8 143.74 26.21 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -106.33 -60.67 1.62 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -177.29 134.17 0.18 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-O 125.784 2.707 . . . . 0.0 106.682 -173.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.429 ' CE2' HD11 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -118.88 -111.66 0.34 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-N 111.314 -2.675 . . . . 0.0 106.6 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.401 42.0 tptt -119.65 -119.1 0.31 Allowed 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 171.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.009 0 CA-C-N 125.721 3.873 . . . . 0.0 120.977 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 10.8 p -67.08 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 118.549 1.175 . . . . 0.0 112.716 -176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -138.5 125.4 21.14 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -172.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.356 34.9 pt -126.44 56.4 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 123.834 1.778 . . . . 0.0 110.164 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 85.9 p -148.66 -38.75 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 114.537 -2.649 . . . . 0.0 116.283 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.92 89.11 0.15 Allowed 'Trans proline' 0 CA--C 1.58 2.797 0 CA-C-N 126.497 3.356 . . . . 0.0 111.581 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.427 8.4 mptt 73.22 -14.16 0.64 Allowed 'General case' 0 CA--C 1.581 2.171 0 O-C-N 119.421 -2.05 . . . . 0.0 115.231 -173.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.93 -22.83 58.37 Favored 'General case' 0 CA--C 1.587 2.384 0 C-N-CA 124.66 1.184 . . . . 0.0 112.708 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.309 24.2 t70 65.6 5.77 3.46 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 119.364 3.098 . . . . 0.0 119.364 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.03 17.38 6.95 Favored 'General case' 0 CA--C 1.584 2.259 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.05 -6.0 3.32 Favored Glycine 0 N--CA 1.477 1.374 1 N-CA-C 125.542 4.977 . . . . 0.0 125.542 173.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.305 67.8 t -141.52 144.98 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 123.002 3.401 . . . . 0.0 117.122 -169.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.2 135.99 48.61 Favored 'General case' 0 CA--C 1.585 2.318 0 C-N-CA 126.724 2.009 . . . . 0.0 109.703 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -128.86 112.55 14.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 123.694 2.952 . . . . 0.0 111.835 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -95.1 101.01 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.014 -1.053 . . . . 0.0 113.261 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.513 ' HA ' ' SG ' ' A' ' 102' ' ' CYS 0.304 2.6 mm -52.07 128.05 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -118.08 -42.57 2.8 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.707 1.203 . . . . 0.0 112.546 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -129.06 112.85 14.44 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.53 -173.01 4.14 Favored 'General case' 0 CA--C 1.598 2.802 0 CA-C-N 121.171 1.805 . . . . 0.0 115.833 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.8 158.67 36.64 Favored Glycine 0 N--CA 1.492 2.382 1 N-CA-C 123.559 4.183 . . . . 0.0 123.559 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -129.15 -72.81 0.59 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.57 114.76 3.98 Favored Glycine 0 CA--C 1.55 2.245 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -58.68 -14.41 8.36 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.17 3.026 . . . . 0.0 119.17 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -73.7 148.29 42.83 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 64.0 m -148.52 96.4 3.89 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-N 110.652 -2.977 . . . . 0.0 107.096 -176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.441 0.5 OUTLIER -104.88 1.2 0.24 Allowed 'Trans proline' 0 CA--C 1.57 2.3 0 N-CA-C 119.818 2.969 . . . . 0.0 119.818 -177.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.533 39.5 mtm 76.79 -140.19 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 164.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 1.1 tp -48.09 136.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.099 0 CA-C-O 122.157 0.979 . . . . 0.0 113.347 -174.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.91 -6.62 83.22 Favored Glycine 0 CA--C 1.551 2.344 0 CA-C-O 116.781 -2.122 . . . . 0.0 118.143 -174.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -73.88 128.62 35.99 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 122.62 3.21 . . . . 0.0 113.762 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -78.37 112.48 15.43 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.6 m -110.4 138.96 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -115.65 104.14 11.4 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.49 166.29 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 CA-C-O 123.145 1.45 . . . . 0.0 112.556 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.92 113.7 17.54 Favored 'General case' 0 N--CA 1.516 2.868 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.742 170.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -117.87 151.81 36.64 Favored 'General case' 0 CA--C 1.582 2.191 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 97.4 m -127.43 143.26 51.23 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.93 143.08 11.47 Favored Glycine 0 CA--C 1.555 2.589 0 O-C-N 119.984 -1.698 . . . . 0.0 116.87 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -127.77 151.66 48.73 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 127.479 2.312 . . . . 0.0 112.499 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.39 175.75 9.15 Favored 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 123.465 1.603 . . . . 0.0 108.543 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 tp -60.35 -31.65 70.53 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.46 8.07 1.55 Allowed 'General case' 0 CA--C 1.596 2.713 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.59 36.05 82.36 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 119.697 -1.877 . . . . 0.0 114.808 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.2 m -111.1 119.57 39.45 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -76.49 112.29 12.85 Favored 'General case' 0 CA--C 1.588 2.442 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.779 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -85.09 -35.19 21.97 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-N 122.686 2.494 . . . . 0.0 113.689 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.51 158.08 43.85 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 123.469 1.604 . . . . 0.0 113.099 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.0 t -156.37 100.71 1.99 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.949 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 t -59.72 -40.33 87.62 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.82 -46.1 78.17 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.262 1.425 . . . . 0.0 114.411 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.32 -39.62 68.08 Favored 'General case' 0 CA--C 1.579 2.094 0 C-N-CA 124.82 1.248 . . . . 0.0 113.776 173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -64.23 -13.15 47.37 Favored 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.367 51.4 mtmt 91.95 -35.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 126.808 2.043 . . . . 0.0 115.334 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -88.53 170.69 10.66 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 123.804 1.764 . . . . 0.0 111.997 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.74 168.66 9.53 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.577 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.278 5.9 t80 -104.83 145.26 30.63 Favored 'General case' 0 CA--C 1.574 1.892 0 O-C-N 120.44 -1.413 . . . . 0.0 109.273 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 99.1 p -155.66 128.18 7.83 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.814 -1.803 . . . . 0.0 110.095 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.501 ' CG ' HG11 ' A' ' 85' ' ' VAL . 7.8 p90 -143.16 -175.38 4.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 123.591 0.756 . . . . 0.0 110.194 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' LYS 0.263 13.4 t0 -128.06 124.81 37.96 Favored 'General case' 0 CA--C 1.571 1.774 0 O-C-N 118.796 -2.44 . . . . 0.0 105.551 174.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.9 104.92 0.09 Allowed 'General case' 0 CA--C 1.579 2.064 0 C-N-CA 124.69 1.196 . . . . 0.0 114.064 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.74 37.72 95.12 Favored Glycine 0 N--CA 1.512 3.721 0 N-CA-C 116.17 1.228 . . . . 0.0 116.17 -173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 5.0 mtpt -132.82 -70.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 124.668 1.187 . . . . 0.0 110.636 -174.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.42 74.18 0.21 Allowed Glycine 0 N--CA 1.495 2.586 1 N-CA-C 100.782 -4.927 . . . . 0.0 100.782 170.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.326 47.8 tp10 -71.91 150.61 44.02 Favored 'General case' 0 CA--C 1.554 1.116 1 CA-C-O 130.25 4.833 . . . . 0.0 116.693 -165.363 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.349 31.4 m -98.46 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.764 1 CA-C-N 101.55 -7.114 . . . . 0.0 107.087 -174.02 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 89' ' ' TRP . 19.3 pt -110.97 159.05 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 124.418 2.056 . . . . 0.0 109.153 171.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -32.41 72.89 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 113.745 -1.57 . . . . 0.0 113.257 176.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.66 -35.48 74.51 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 116.826 -1.559 . . . . 0.0 111.677 169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.45 ' H ' HG13 ' A' ' 86' ' ' ILE . 42.0 m0 -77.43 -41.6 39.22 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.323 1.874 . . . . 0.0 112.378 173.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -57.66 -34.1 69.02 Favored 'General case' 0 CA--C 1.578 2.025 0 CA-C-N 120.017 1.28 . . . . 0.0 113.885 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.263 1.2 mp -66.66 -57.08 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 120.098 1.317 . . . . 0.0 110.968 172.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.51 90.17 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.538 HG22 ' CE ' ' A' ' 96' ' ' MET . 99.6 t -63.03 -38.72 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-N 118.967 0.803 . . . . 0.0 112.906 173.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.71 -36.8 70.09 Favored 'General case' 0 CA--C 1.58 2.12 0 CA-C-N 120.282 1.401 . . . . 0.0 113.445 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.1 p -82.32 11.37 5.53 Favored 'General case' 0 CA--C 1.591 2.555 0 N-CA-C 115.921 1.822 . . . . 0.0 115.921 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.538 ' CE ' HG22 ' A' ' 93' ' ' VAL . 43.3 mtt -94.01 134.92 35.91 Favored 'General case' 0 CA--C 1.57 1.736 0 CA-C-N 121.636 2.016 . . . . 0.0 116.103 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -89.3 163.26 15.43 Favored 'General case' 0 CA--C 1.584 2.288 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 164.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 64.5 t -57.73 131.66 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.943 0 O-C-N 117.899 -3.0 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.53 -21.19 30.48 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 124.172 3.169 . . . . 0.0 114.275 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.64 163.87 27.39 Favored 'General case' 0 CA--C 1.566 1.595 0 CA-C-N 120.4 2.1 . . . . 0.0 113.695 176.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.671 HD13 ' H ' ' A' ' 102' ' ' CYS 1.751 0.1 OUTLIER 162.43 155.76 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.797 2.039 . . . . 0.0 113.921 168.009 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.671 ' H ' HD13 ' A' ' 101' ' ' LEU 0.345 81.9 m -143.44 178.97 7.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.998 1.319 . . . . 0.0 112.872 -167.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.479 ' HB3' ' HG2' ' A' ' 130' ' ' GLU 0.301 0.0 OUTLIER -93.64 119.53 32.77 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 124.483 2.087 . . . . 0.0 107.93 171.171 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.56 118.56 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.794 0 CA-C-N 111.489 -2.596 . . . . 0.0 108.922 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.1 m -112.15 103.26 11.42 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.3 p -119.21 141.14 49.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -171.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.01 141.97 87.21 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.295 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -60.46 -19.97 61.51 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 N-CA-C 119.35 2.788 . . . . 0.0 119.35 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.7 -33.48 75.18 Favored 'General case' 0 CA--C 1.578 2.021 0 CA-C-N 122.62 2.463 . . . . 0.0 113.603 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.5 -7.84 54.35 Favored 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.76 -101.87 0.42 Allowed 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 120.076 1.307 . . . . 0.0 111.847 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.257 0.3 OUTLIER -124.56 14.64 8.8 Favored 'General case' 0 CA--C 1.592 2.574 0 CA-C-N 120.431 1.469 . . . . 0.0 113.872 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.05 -31.17 39.85 Favored Glycine 0 N--CA 1.497 2.765 1 N-CA-C 123.105 4.002 . . . . 0.0 123.105 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.9 m -66.66 -11.81 55.52 Favored 'General case' 0 CA--C 1.585 2.319 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.61 -60.15 0.19 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 124.945 1.298 . . . . 0.0 113.284 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.73 152.6 7.22 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.533 1.54 . . . . 0.0 110.792 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 t -81.8 126.54 75.18 Favored Pre-proline 0 CA--C 1.579 2.067 0 CA-C-O 116.647 -1.644 . . . . 0.0 108.993 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -40.38 -43.69 4.07 Favored 'Trans proline' 0 CA--C 1.581 2.871 0 N-CA-C 121.733 3.705 . . . . 0.0 121.733 -177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.6 -9.79 6.6 Favored 'Trans proline' 0 CA--C 1.576 2.578 0 CA-C-N 125.165 2.88 . . . . 0.0 119.042 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -160.57 -43.68 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 118.79 2.885 . . . . 0.0 118.79 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.9 125.18 82.57 Favored Pre-proline 0 CA--C 1.58 2.105 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -88.54 171.13 5.3 Favored 'Trans proline' 0 CA--C 1.589 3.26 0 C-N-CA 122.662 2.241 . . . . 0.0 112.301 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -61.85 -42.15 33.15 Favored 'Trans proline' 0 CA--C 1.574 2.519 0 N-CA-C 117.917 2.237 . . . . 0.0 117.917 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -90.76 61.34 4.74 Favored 'General case' 0 CA--C 1.585 2.298 0 O-C-N 120.462 -1.399 . . . . 0.0 112.621 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -149.23 113.62 5.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.044 -1.66 . . . . 0.0 111.972 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -65.06 155.79 33.59 Favored 'General case' 0 CA--C 1.591 2.553 0 C-N-CA 124.107 0.963 . . . . 0.0 112.793 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.9 mt -114.74 162.75 16.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 124.525 2.107 . . . . 0.0 112.297 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 114.8 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.774 0 CA-C-N 112.703 -2.044 . . . . 0.0 108.83 -173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 1.3 m-85 -131.38 123.9 29.2 Favored 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 122.711 2.505 . . . . 0.0 111.756 175.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.479 ' HG2' ' HB3' ' A' ' 103' ' ' ARG . 90.8 mt-10 -91.97 110.28 21.63 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . 0.28 1.3 p -138.31 145.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-O 122.343 1.068 . . . . 0.0 112.248 -173.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 41.0 tt0 -136.23 133.58 37.2 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.813 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 tp -93.8 130.33 39.84 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.69 -51.67 6.3 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.536 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -164.2 154.74 15.08 Favored 'General case' 0 CA--C 1.575 1.923 0 C-N-CA 125.455 1.502 . . . . 0.0 108.522 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.266 0.0 OUTLIER -130.33 -115.15 0.24 Allowed 'General case' 0 CA--C 1.569 1.678 0 O-C-N 121.05 -1.031 . . . . 0.0 110.239 177.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptp -122.26 119.29 30.75 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 176.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 119.512 2.565 . . . . 0.0 119.512 -178.396 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 N-CA-C 116.221 1.248 . . . . 0.0 116.221 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.395 70.0 t 71.13 -36.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-O 115.395 -2.241 . . . . 0.0 113.693 -176.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.643 3.4 t0 63.62 162.17 0.11 Allowed 'General case' 0 N--CA 1.517 2.883 0 CA-C-N 123.73 2.968 . . . . 0.0 117.534 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 0.0 OUTLIER -153.52 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.583 2.234 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -178.053 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 1.439 28.7 m 100.49 64.79 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.167 0 O-C-N 119.052 -2.28 . . . . 0.0 115.178 -166.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.21 125.79 14.06 Favored 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 124.306 3.337 . . . . 0.0 110.916 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.553 6.9 mptt 88.44 -36.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.39 -6.9 55.04 Favored 'General case' 0 CA--C 1.596 2.713 0 O-C-N 121.325 -0.859 . . . . 0.0 112.051 165.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.9 t70 78.66 111.37 0.07 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-O 114.769 -2.539 . . . . 0.0 107.117 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -9.38 72.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 125.254 2.454 . . . . 0.0 117.616 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.52 -31.12 63.4 Favored Glycine 0 N--CA 1.481 1.651 0 CA-C-N 112.043 -2.344 . . . . 0.0 117.071 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 p -162.75 137.07 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.88 145.99 29.31 Favored 'General case' 0 CA--C 1.589 2.459 0 C-N-CA 125.885 1.674 . . . . 0.0 109.041 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -130.89 125.61 33.97 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 122.621 2.464 . . . . 0.0 111.797 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.2 t -102.04 93.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.367 0.3 OUTLIER -79.24 134.53 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 O-C-N 120.849 -1.157 . . . . 0.0 111.54 178.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.89 -68.2 0.94 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.581 0.705 . . . . 0.0 111.101 175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -99.01 95.32 7.06 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.9 167.33 11.77 Favored 'General case' 0 CA--C 1.59 2.512 0 O-C-N 120.044 -1.66 . . . . 0.0 113.749 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.57 170.92 41.83 Favored Glycine 0 CA--C 1.55 2.24 0 O-C-N 119.53 -1.981 . . . . 0.0 117.959 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 p -78.36 -70.72 0.47 Allowed 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -177.27 54.04 0.1 Allowed Glycine 0 N--CA 1.482 1.766 0 C-N-CA 124.674 1.131 . . . . 0.0 113.727 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 p -140.38 17.05 2.4 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 55.74 -179.04 0.04 OUTLIER 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 121.588 3.921 . . . . 0.0 121.588 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.1 p -116.85 120.59 33.88 Favored Pre-proline 0 N--CA 1.495 1.809 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.396 172.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HG2' ' HB3' ' A' ' 137' ' ' LYS . 70.9 Cg_exo -66.46 -20.57 54.29 Favored 'Trans proline' 0 CA--C 1.577 2.651 0 N-CA-C 117.985 2.263 . . . . 0.0 117.985 172.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.515 8.7 mtt 80.2 -165.99 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.423 0.4 OUTLIER -39.65 125.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 117.957 2.577 . . . . 0.0 117.957 -169.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.79 88.41 Favored Glycine 0 CA--C 1.555 2.566 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -76.75 142.82 40.29 Favored 'General case' 0 CA--C 1.573 1.858 0 CA-C-N 122.857 3.329 . . . . 0.0 113.556 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' PHE . 18.4 ptp180 -73.84 137.84 44.04 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.31 -1.494 . . . . 0.0 109.778 177.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.32 2.1 t -135.27 144.51 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 119.752 1.16 . . . . 0.0 112.688 -167.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -125.87 100.99 6.63 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.84 167.1 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 127.174 2.19 . . . . 0.0 112.138 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.15 127.57 36.21 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.564 160.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -119.43 155.69 31.54 Favored 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.6 m -125.31 138.56 54.07 Favored 'General case' 0 N--CA 1.515 2.812 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 159.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.53 145.73 14.47 Favored Glycine 0 CA--C 1.548 2.129 0 CA-C-N 123.347 2.794 . . . . 0.0 117.93 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -134.09 153.04 52.06 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 112.625 -1.787 . . . . 0.0 114.615 -175.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.09 170.67 14.56 Favored 'General case' 0 CA--C 1.564 1.519 0 CA-C-O 123.042 1.401 . . . . 0.0 108.642 170.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.309 0.0 OUTLIER -60.43 -26.35 66.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 178.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -77.68 9.63 3.29 Favored 'General case' 0 CA--C 1.593 2.631 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.1 38.38 73.27 Favored Glycine 0 N--CA 1.509 3.538 0 CA-C-N 121.341 1.882 . . . . 0.0 114.819 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 m -109.34 114.47 28.17 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -79.71 90.89 5.22 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -69.75 -30.88 68.57 Favored 'General case' 0 CA--C 1.559 1.306 0 O-C-N 119.696 -1.877 . . . . 0.0 114.424 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -154.47 148.11 25.3 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 121.603 2.001 . . . . 0.0 111.345 178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.4 m -145.91 94.76 2.53 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.526 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.5 t -57.48 -39.22 75.95 Favored 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.15 -44.08 83.11 Favored 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -73.86 -42.18 61.16 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -61.33 -19.51 61.89 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.39 74.4 mmtt 96.63 -44.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 127.177 2.191 . . . . 0.0 113.192 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.64 152.54 31.67 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 123.04 1.4 . . . . 0.0 113.665 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -87.05 171.45 10.72 Favored 'General case' 0 CA--C 1.568 1.64 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.493 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.252 9.2 t80 -105.23 157.72 17.09 Favored 'General case' 0 CA--C 1.578 2.048 0 CA-C-O 122.092 0.949 . . . . 0.0 109.235 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.7 p -157.89 145.71 18.61 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 119.295 -2.128 . . . . 0.0 110.313 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 85' ' ' VAL . 23.8 p90 -155.15 -173.36 4.53 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-N 114.37 -1.286 . . . . 0.0 113.875 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -123.05 123.07 40.03 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 tp -49.15 112.0 0.56 Allowed 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -172.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.97 47.79 82.26 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 118.078 1.991 . . . . 0.0 118.078 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -107.21 14.16 26.48 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.88 -42.67 2.37 Favored Glycine 0 N--CA 1.51 3.614 0 O-C-N 120.782 -1.199 . . . . 0.0 111.41 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.279 8.3 tp10 -28.8 -48.96 0.07 Allowed 'General case' 0 CA--C 1.568 1.651 0 C-N-CA 129.386 3.075 . . . . 0.0 118.805 169.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.255 9.3 m -117.61 -147.93 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.561 1.379 0 CA-C-O 124.066 1.888 . . . . 0.0 109.785 -175.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.4 pt -110.93 160.77 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 CA-C-O 124.104 1.907 . . . . 0.0 110.238 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -32.67 73.25 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.018 -1.446 . . . . 0.0 113.205 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.92 -35.06 70.54 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.016 -1.469 . . . . 0.0 112.443 169.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.27 -42.52 54.84 Favored 'General case' 0 C--N 1.366 1.323 0 CA-C-N 120.967 1.712 . . . . 0.0 112.423 172.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -56.84 -37.73 71.67 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.262 1.6 mp -68.1 -56.74 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.056 0 CA-C-N 119.885 1.22 . . . . 0.0 111.191 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.65 94.54 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.4 t -67.59 -46.23 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 119.571 1.078 . . . . 0.0 111.736 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.25 62.78 Favored 'General case' 0 CA--C 1.583 2.247 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.8 p -92.22 4.29 53.57 Favored 'General case' 0 CA--C 1.586 2.358 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.429 ' SD ' ' OE2' ' A' ' 132' ' ' GLU . 4.6 ptt? -116.48 119.51 35.85 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-N 122.304 2.32 . . . . 0.0 112.185 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -78.56 148.69 33.25 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 120.152 -1.593 . . . . 0.0 108.72 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.6 t -9.47 79.43 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.543 4.209 0 C-N-CA 125.299 1.44 . . . . 0.0 109.001 -158.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.55 ' H ' HD22 ' A' ' 133' ' ' LEU . . . -20.46 -29.45 0.0 OUTLIER Glycine 1 N--CA 1.523 4.437 1 N-CA-C 127.783 5.873 . . . . 0.0 127.783 -144.585 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.663 0.3 OUTLIER 52.97 -125.57 2.4 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 115.581 -2.152 . . . . 0.0 111.549 -161.897 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.644 ' HA ' ' CB ' ' A' ' 132' ' ' GLU 0.461 0.9 OUTLIER -136.15 132.96 36.69 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 121.057 3.725 . . . . 0.0 121.057 175.446 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 132' ' ' GLU 2.674 5.7 m -160.27 -151.98 0.27 Allowed 'General case' 0 CA--C 1.589 2.477 0 CA-C-N 120.224 1.375 . . . . 0.0 114.489 177.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -143.36 158.85 43.3 Favored 'General case' 0 CA--C 1.575 1.942 0 O-C-N 120.108 -1.62 . . . . 0.0 113.662 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -122.39 143.87 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 C-N-CA 126.128 1.771 . . . . 0.0 110.543 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.3 m -140.09 104.5 4.85 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.1 p -118.87 147.12 44.31 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -172.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -80.71 148.13 64.58 Favored Pre-proline 0 CA--C 1.581 2.166 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.647 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -36.43 -33.06 0.12 Allowed 'Trans proline' 0 CA--C 1.567 2.144 0 N-CA-C 122.079 3.838 . . . . 0.0 122.079 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -64.1 -44.66 91.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -78.86 -5.96 54.89 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 116.187 -1.863 . . . . 0.0 114.328 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.43 -153.25 0.5 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-N 122.324 2.329 . . . . 0.0 114.288 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.283 0.1 OUTLIER -82.11 11.42 5.26 Favored 'General case' 0 CA--C 1.575 1.921 0 O-C-N 119.22 -2.175 . . . . 0.0 113.582 178.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.36 -38.57 45.23 Favored Glycine 0 CA--C 1.553 2.441 0 CA-C-N 124.027 3.103 . . . . 0.0 115.354 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 p -70.78 -51.58 26.06 Favored 'General case' 0 CA--C 1.574 1.869 0 CA-C-N 118.316 1.058 . . . . 0.0 113.761 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.98 -34.48 14.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.91 141.96 12.81 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-N 120.039 1.29 . . . . 0.0 113.646 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.478 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 2.0 t -95.42 146.17 30.84 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.834 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -41.52 -43.23 5.99 Favored 'Trans proline' 0 CA--C 1.584 3.023 0 C-N-CA 123.65 2.9 . . . . 0.0 119.107 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.72 57.25 6.28 Favored 'Trans proline' 0 CA--C 1.585 3.036 0 CA-C-N 125.325 2.937 . . . . 0.0 115.425 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 61.93 33.39 17.48 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 120.325 3.454 . . . . 0.0 120.325 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.478 ' HB ' ' H ' ' A' ' 117' ' ' SER . 11.9 mt -82.91 117.56 68.96 Favored Pre-proline 0 CA--C 1.59 2.485 0 O-C-N 120.127 -1.608 . . . . 0.0 108.768 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -90.31 178.02 2.23 Favored 'Trans proline' 0 CA--C 1.585 3.061 0 CA-C-N 123.483 2.279 . . . . 0.0 116.179 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.41 151.19 54.69 Favored 'Trans proline' 0 CA--C 1.574 2.513 0 C-N-CA 123.072 2.515 . . . . 0.0 117.621 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.252 38.4 t-20 59.62 44.0 15.05 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -177.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.4 105.5 15.46 Favored 'General case' 0 CA--C 1.562 1.436 0 O-C-N 120.534 -1.354 . . . . 0.0 110.35 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.8 m -66.01 150.18 49.08 Favored 'General case' 0 CA--C 1.592 2.562 0 O-C-N 120.843 -1.161 . . . . 0.0 111.651 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.5 tp -132.64 157.48 44.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.552 -1.968 . . . . 0.0 111.663 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.494 HG23 ' HE3' ' A' ' 59' ' ' TRP . 22.3 m -147.05 144.03 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 O-C-N 121.043 -1.036 . . . . 0.0 112.043 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -146.97 134.68 21.11 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.977 -1.077 . . . . 0.0 109.98 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -88.21 112.97 23.36 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.39 152.94 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.243 -0.91 . . . . 0.0 111.136 -168.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.644 ' CB ' ' HA ' ' A' ' 101' ' ' LEU 0.777 0.2 OUTLIER -154.56 -164.25 1.78 Allowed 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 116.781 2.141 . . . . 0.0 116.781 164.011 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 99' ' ' GLY . 5.6 tt -145.0 133.28 21.67 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.819 1.295 . . . . 0.0 113.376 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.13 -47.71 7.64 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.94 151.07 23.09 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.283 1.433 . . . . 0.0 108.895 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.447 ' CD2' HD11 ' A' ' 133' ' ' LEU 0.294 0.0 OUTLIER -143.21 -101.32 0.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.629 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 46' ' ' PRO 0.421 13.1 tmtt? -111.01 -132.66 0.33 Allowed 'General case' 0 CA--C 1.588 2.418 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 173.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.697 0 CA-C-N 124.631 3.378 . . . . 0.0 113.923 177.791 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.308 0 CA-C-O 118.653 -1.082 . . . . 0.0 114.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.479 0.4 OUTLIER 65.38 -63.3 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -175.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.54 107.32 5.94 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.632 0.773 . . . . 0.0 110.02 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.321 5.8 tp -157.53 138.92 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.116 0 CA-C-O 125.508 2.575 . . . . 0.0 113.131 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.42 ' HB3' ' HA3' ' A' ' 31' ' ' GLY . 32.1 p -144.59 136.49 13.0 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-N 111.972 -2.376 . . . . 0.0 110.711 166.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -46.09 88.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.583 2.953 0 C-N-CA 124.177 3.251 . . . . 0.0 117.132 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.496 8.4 mptt 79.46 -28.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.29 -27.07 64.12 Favored 'General case' 0 CA--C 1.593 2.615 0 O-C-N 120.951 -1.093 . . . . 0.0 110.319 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.457 1.5 m-20 74.55 -60.83 0.51 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 127.902 2.481 . . . . 0.0 115.393 175.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.317 12.8 pt-20 -90.33 40.83 1.02 Allowed 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 25' ' ' SER . . . -75.89 -42.75 24.49 Favored Glycine 0 N--CA 1.507 3.373 0 O-C-N 119.286 -2.133 . . . . 0.0 115.438 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.254 60.4 t -135.5 135.45 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.963 0 CA-C-O 122.648 1.213 . . . . 0.0 113.842 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -91.41 114.19 26.65 Favored 'General case' 0 CA--C 1.584 2.27 0 CA-C-O 116.614 -1.66 . . . . 0.0 107.956 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -112.39 90.37 3.32 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 124.101 3.137 . . . . 0.0 108.205 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.87 130.33 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.436 -173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.303 1.0 OUTLIER -82.2 130.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 CA-C-O 122.671 1.224 . . . . 0.0 113.133 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -110.81 -56.33 2.37 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.002 175.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.36 96.19 3.06 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.24 166.96 1.96 Allowed 'General case' 0 CA--C 1.59 2.495 0 CA-C-N 122.551 2.432 . . . . 0.0 116.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.35 -170.65 37.25 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 120.654 3.021 . . . . 0.0 120.654 -175.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.0 t -81.02 15.33 1.89 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.46 34.04 68.05 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.5 p -122.6 26.83 8.11 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.8 1.24 . . . . 0.0 113.882 178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.451 7.4 pt-20 40.41 -154.92 0.01 OUTLIER 'General case' 0 CA--C 1.586 2.35 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.91 115.65 5.61 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 124.476 1.11 . . . . 0.0 111.191 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -41.26 -28.85 0.53 Allowed 'Trans proline' 0 CA--C 1.583 2.956 1 N-CA-C 122.626 4.049 . . . . 0.0 122.626 165.137 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.541 44.5 mtm 84.79 -141.56 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.29 1.1 tp -52.01 135.87 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.117 0 O-C-N 120.224 -1.548 . . . . 0.0 112.847 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.15 4.94 86.2 Favored Glycine 0 CA--C 1.553 2.442 0 CA-C-O 116.859 -2.078 . . . . 0.0 117.884 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.48 136.44 36.31 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 122.681 3.241 . . . . 0.0 112.577 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.51 98.2 11.63 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 175.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 136' ' ' PHE . 29.9 m -93.68 141.0 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -167.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -117.18 107.78 14.87 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 76' ' ' PHE . 3.1 m -114.11 165.95 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 123.272 1.511 . . . . 0.0 113.685 -175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.254 0.1 OUTLIER -132.11 113.36 13.23 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.075 167.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -105.91 161.21 14.65 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 124.019 1.866 . . . . 0.0 113.881 -175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 90.7 m -134.22 133.35 40.77 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 104.084 -2.562 . . . . 0.0 104.084 159.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.05 164.79 26.1 Favored Glycine 0 N--CA 1.482 1.74 0 CA-C-N 122.072 2.215 . . . . 0.0 118.048 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.596 ' HE3' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -148.34 155.98 41.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -173.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -85.1 172.19 11.44 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-O 123.469 1.604 . . . . 0.0 108.877 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.13 -33.82 74.0 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.301 0.2 OUTLIER -69.5 2.94 2.66 Favored 'General case' 0 CA--C 1.592 2.565 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 173.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.88 44.68 23.83 Favored Glycine 0 N--CA 1.503 3.106 0 CA-C-N 119.564 1.074 . . . . 0.0 114.174 -177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.9 m -120.77 119.81 33.83 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -78.98 97.24 5.98 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.152 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -71.01 -34.82 71.71 Favored 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.263 -2.148 . . . . 0.0 114.944 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.95 175.75 9.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 90.1 p -154.19 -77.1 0.11 Allowed 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.427 1.6 t 111.4 -40.05 0.01 OUTLIER 'General case' 0 CA--C 1.582 2.2 0 C-N-CA 128.775 2.83 . . . . 0.0 109.205 -171.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 16.4 mt -49.14 -34.81 15.06 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 169.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.95 -35.71 62.04 Favored 'General case' 0 CA--C 1.579 2.081 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 173.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -94.82 -85.01 0.32 Allowed 'General case' 0 CA--C 1.575 1.907 0 C-N-CA 124.716 1.206 . . . . 0.0 110.13 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? 175.32 -53.06 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 127.29 2.236 . . . . 0.0 107.959 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -22.45 -37.92 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.789 1 N-CA-C 127.229 6.011 . . . . 0.0 127.229 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . 0.441 53.2 pttt 71.53 -175.11 0.18 Allowed 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.467 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.328 2.8 t80 -118.68 146.93 44.32 Favored 'General case' 0 CA--C 1.577 1.987 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.104 174.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 93.7 p -160.63 130.67 5.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 119.309 -2.119 . . . . 0.0 108.709 -176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.508 ' CG ' HG11 ' A' ' 85' ' ' VAL . 5.8 p90 -141.79 -173.71 3.87 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 123.216 0.607 . . . . 0.0 109.788 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -125.74 128.42 47.72 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 118.843 -2.411 . . . . 0.0 106.306 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.07 107.33 0.46 Allowed 'General case' 0 CA--C 1.578 2.038 0 O-C-N 121.314 -0.866 . . . . 0.0 112.536 -176.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.61 56.32 5.56 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.024 -1.047 . . . . 0.0 114.802 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -102.17 -64.43 1.06 Allowed 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 124.498 2.094 . . . . 0.0 112.963 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -127.63 -55.93 0.13 Allowed Glycine 0 N--CA 1.503 3.104 0 C-N-CA 128.86 3.124 . . . . 0.0 107.096 173.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.824 23.8 tt0 119.05 143.25 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 128.145 3.831 . . . . 0.0 116.807 162.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.347 14.1 m -79.87 -106.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.001 1 CA-C-N 105.319 -5.4 . . . . 0.0 104.962 -178.626 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.544 HG13 ' H ' ' A' ' 89' ' ' TRP . 27.1 pt -125.43 152.91 32.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 124.737 2.208 . . . . 0.0 105.538 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -64.27 -31.67 72.96 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 113.28 -1.782 . . . . 0.0 113.697 176.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.58 -39.07 82.92 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 125.047 1.339 . . . . 0.0 111.391 167.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.544 ' H ' HG13 ' A' ' 86' ' ' ILE . 34.9 m0 -70.46 -42.5 71.39 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 120.638 1.563 . . . . 0.0 112.549 172.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -59.0 -36.44 74.93 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 120.005 1.275 . . . . 0.0 114.185 172.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.259 1.3 mp -66.3 -56.06 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.274 1.397 . . . . 0.0 111.685 173.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.55 -45.31 91.12 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.285 75.8 t -65.04 -41.5 92.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 120.412 1.46 . . . . 0.0 112.531 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.18 -30.58 64.63 Favored 'General case' 0 CA--C 1.582 2.182 0 CA-C-N 120.336 1.426 . . . . 0.0 114.465 171.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 p -95.49 -6.97 39.39 Favored 'General case' 0 CA--C 1.588 2.411 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 38.6 mtp -96.69 123.11 40.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 121.597 1.999 . . . . 0.0 112.52 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -77.99 179.88 6.5 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.99 125.94 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.596 2.733 0 O-C-N 120.522 -1.361 . . . . 0.0 111.03 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.11 1.92 81.36 Favored Glycine 0 N--CA 1.515 3.934 0 CA-C-N 122.724 2.511 . . . . 0.0 116.901 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.63 132.1 41.46 Favored 'General case' 0 CA--C 1.576 1.97 0 CA-C-N 120.474 2.137 . . . . 0.0 115.364 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.74 114.77 28.39 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.063 0.945 . . . . 0.0 111.321 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 17.2 m -136.53 159.56 41.43 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -109.73 127.24 54.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 123.845 1.783 . . . . 0.0 109.286 172.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.2 mt -92.58 118.59 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 112.379 -2.192 . . . . 0.0 109.395 -178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 104.53 11.93 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 7.7 p -118.49 148.56 42.49 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -89.02 142.19 30.04 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.495 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -42.54 -26.98 0.68 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 124.812 3.674 . . . . 0.0 121.413 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.72 -31.94 72.96 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 121.314 1.87 . . . . 0.0 114.555 172.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -91.33 -9.75 43.83 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 125.472 1.509 . . . . 0.0 113.098 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -118.44 -112.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.196 1.816 . . . . 0.0 112.655 -176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.329 1.3 m-85 -113.79 21.03 15.35 Favored 'General case' 0 CA--C 1.588 2.411 0 CA-C-N 121.219 1.827 . . . . 0.0 113.751 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -53.2 -15.92 4.15 Favored Glycine 0 N--CA 1.501 2.99 1 N-CA-C 124.332 4.493 . . . . 0.0 124.332 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -71.69 -65.59 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 120.656 2.228 . . . . 0.0 112.063 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.78 -2.29 10.4 Favored 'General case' 0 CA--C 1.578 2.053 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.38 160.28 36.38 Favored Glycine 0 CA--C 1.547 2.055 0 CA-C-N 122.144 2.247 . . . . 0.0 112.882 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -81.45 123.68 80.89 Favored Pre-proline 0 CA--C 1.577 2.008 0 O-C-N 120.258 -1.731 . . . . 0.0 107.736 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -33.69 -45.09 0.34 Allowed 'Trans proline' 0 CA--C 1.582 2.891 0 N-CA-C 121.99 3.804 . . . . 0.0 121.99 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -86.88 -16.97 3.32 Favored 'Trans proline' 0 CA--C 1.576 2.592 0 CA-C-N 125.097 2.856 . . . . 0.0 118.948 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -159.09 -38.29 0.06 Allowed 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.7 mt -79.82 129.59 70.25 Favored Pre-proline 0 CA--C 1.581 2.143 0 O-C-N 120.195 -1.566 . . . . 0.0 113.897 -172.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -89.82 163.17 5.07 Favored 'Trans proline' 0 CA--C 1.586 3.121 0 CA-C-N 123.572 2.312 . . . . 0.0 113.202 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.42 8.95 0.45 Allowed 'Trans proline' 0 CA--C 1.576 2.619 0 N-CA-C 120.505 3.233 . . . . 0.0 120.505 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -139.68 62.79 1.51 Allowed 'General case' 0 CA--C 1.58 2.111 0 O-C-N 120.302 -1.499 . . . . 0.0 110.11 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.3 137.06 17.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.964 -1.71 . . . . 0.0 111.149 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 88.2 m -72.96 150.16 42.74 Favored 'General case' 0 CA--C 1.588 2.428 0 O-C-N 120.485 -1.385 . . . . 0.0 111.202 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 106' ' ' CYS 0.342 0.2 OUTLIER -134.78 167.33 21.06 Favored 'General case' 0 CA--C 1.574 1.895 0 O-C-N 118.685 -2.509 . . . . 0.0 109.524 176.11 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.596 HG13 ' HE3' ' A' ' 59' ' ' TRP . 1.6 p -141.22 146.35 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.846 -1.159 . . . . 0.0 112.02 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.288 0.6 OUTLIER -145.77 124.94 12.9 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 121.88 0.848 . . . . 0.0 110.501 169.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.41 115.25 24.7 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 t -124.26 134.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 122.026 0.917 . . . . 0.0 112.382 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -107.43 124.45 49.88 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 136' ' ' PHE . 57.2 tp -103.31 119.38 38.77 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.85 -49.12 8.68 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -170.61 170.58 6.71 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.469 1.908 . . . . 0.0 108.122 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.416 ' CD2' HD21 ' A' ' 133' ' ' LEU 0.255 5.7 p90 -154.94 -81.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 119.951 -1.718 . . . . 0.0 112.395 -175.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.412 77.2 tttt -119.98 -136.38 0.33 Allowed 'General case' 0 CA--C 1.594 2.644 0 C-N-CA 124.512 1.125 . . . . 0.0 108.975 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 2.351 0 O-C-N 117.465 -3.272 . . . . 0.0 112.561 -179.136 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.016 0 N-CA-C 115.674 1.03 . . . . 0.0 115.674 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 34' ' ' LYS 0.308 33.1 t 63.37 166.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.31 0 C-N-CA 125.822 1.649 . . . . 0.0 111.746 -177.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.432 28.2 t0 -156.45 169.3 24.94 Favored 'General case' 0 CA--C 1.577 1.992 0 O-C-N 118.036 -2.915 . . . . 0.0 107.111 173.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.4 -172.08 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.908 0 CA-C-O 124.39 2.043 . . . . 0.0 106.531 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.607 0.5 OUTLIER -160.13 136.05 6.14 Favored Pre-proline 0 CA--C 1.584 2.254 0 O-C-N 118.785 -2.447 . . . . 0.0 115.058 167.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -38.92 -4.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.51 2.445 2 N-CA-C 127.996 6.114 . . . . 0.0 127.996 -173.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.37 75.81 1.18 Allowed 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 121.546 1.976 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.306 34.0 mm-40 72.82 29.75 1.85 Allowed 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 114.485 -1.234 . . . . 0.0 113.714 -172.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.394 1.7 p30 53.15 24.71 3.76 Favored 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 119.886 3.291 . . . . 0.0 119.886 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -90.3 -35.57 15.19 Favored 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 120.117 3.376 . . . . 0.0 120.117 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.17 -53.88 4.69 Favored Glycine 0 N--CA 1.493 2.45 1 N-CA-C 123.739 4.255 . . . . 0.0 123.739 -158.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.8 t -142.75 125.29 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 124.278 0.634 . . . . 0.0 111.859 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 tt -100.6 143.69 30.47 Favored 'General case' 0 CA--C 1.587 2.39 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.314 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 22' ' ' VAL . 1.9 tmmt? -120.61 113.64 20.54 Favored 'General case' 0 C--N 1.381 1.959 0 CA-C-N 124.054 3.116 . . . . 0.0 111.434 -176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.51 92.54 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.143 -0.973 . . . . 0.0 110.505 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.311 0.4 OUTLIER -76.95 135.49 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 120.887 -1.133 . . . . 0.0 110.26 178.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -121.09 -56.95 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.458 0.703 . . . . 0.0 111.898 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -118.6 99.73 6.99 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.96 142.71 52.83 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 119.178 -2.201 . . . . 0.0 112.614 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.49 163.54 42.73 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 119.99 -1.693 . . . . 0.0 116.638 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.3 p -121.34 -79.41 0.61 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 118.434 -0.793 . . . . 0.0 112.142 -176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 2.73 -85.0 0.0 OUTLIER Glycine 0 N--CA 1.504 3.204 0 N-CA-C 122.116 3.606 . . . . 0.0 122.116 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.404 ' H ' HG21 ' A' ' 98' ' ' VAL . 69.8 p -117.21 26.64 9.63 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.381 6.5 mt-10 55.24 -153.68 0.32 Allowed 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 176.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.1 m -110.58 122.39 38.51 Favored Pre-proline 0 CA--C 1.572 1.801 0 O-C-N 120.559 -1.338 . . . . 0.0 108.497 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.397 0.2 OUTLIER -115.65 -87.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.434 0 N-CA-C 119.159 2.715 . . . . 0.0 119.159 -176.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -157.74 171.1 20.91 Favored 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 120.847 3.647 . . . . 0.0 120.847 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.36 132.41 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.763 0 CA-C-O 122.874 1.321 . . . . 0.0 109.932 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.85 3.39 68.34 Favored Glycine 0 CA--C 1.558 2.778 0 CA-C-O 116.836 -2.091 . . . . 0.0 118.186 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.79 141.24 56.59 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-N 122.624 3.212 . . . . 0.0 112.82 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -84.47 96.18 9.03 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.086 1.766 . . . . 0.0 108.353 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.31 135.09 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -169.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -111.99 100.46 8.89 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.76 164.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 127.356 2.263 . . . . 0.0 113.719 -172.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.79 124.4 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.563 -1.653 . . . . 0.0 108.583 160.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -115.03 156.87 24.33 Favored 'General case' 0 CA--C 1.593 2.608 0 CA-C-O 122.52 1.153 . . . . 0.0 111.058 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.3 m -130.36 138.51 50.44 Favored 'General case' 0 N--CA 1.515 2.792 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 160.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.08 140.71 8.57 Favored Glycine 0 CA--C 1.551 2.321 0 CA-C-N 123.329 2.786 . . . . 0.0 117.902 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.19 159.54 42.02 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 127.275 2.23 . . . . 0.0 115.057 -176.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 tp -76.73 177.34 7.65 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-O 122.603 1.192 . . . . 0.0 109.594 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.345 0.0 OUTLIER -62.84 -27.06 69.07 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 176.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.9 13.97 0.94 Allowed 'General case' 0 CA--C 1.606 3.106 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 168.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.1 33.58 61.13 Favored Glycine 0 N--CA 1.511 3.663 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -91.86 109.42 20.75 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -68.0 107.13 2.58 Favored 'General case' 0 CA--C 1.579 2.085 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -81.64 -34.98 30.51 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 121.083 1.765 . . . . 0.0 112.099 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -155.84 155.48 33.03 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 124.163 1.935 . . . . 0.0 111.337 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 48.0 t -159.95 99.63 1.38 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.278 -1.783 . . . . 0.0 109.146 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -50.84 -34.28 27.21 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.71 -46.69 86.77 Favored 'General case' 0 CA--C 1.58 2.105 0 C-N-CA 125.346 1.458 . . . . 0.0 114.094 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.1 -41.48 77.4 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.418 1.087 . . . . 0.0 113.653 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -70.6 4.92 2.1 Favored 'General case' 0 CA--C 1.59 2.511 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 65.48 8.56 5.13 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 119.318 3.081 . . . . 0.0 119.318 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -113.12 -157.14 0.61 Allowed 'General case' 0 CA--C 1.574 1.898 0 C-N-CA 125.436 1.494 . . . . 0.0 113.964 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -139.22 162.12 35.75 Favored 'General case' 0 CA--C 1.573 1.844 0 C-N-CA 125.425 1.49 . . . . 0.0 109.393 175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . 0.354 2.1 t80 -108.47 149.43 28.81 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-N 120.944 1.702 . . . . 0.0 110.403 174.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.9 p -160.81 141.76 11.7 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 119.71 -1.869 . . . . 0.0 109.519 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CG ' HG11 ' A' ' 85' ' ' VAL . 9.1 p90 -155.01 177.45 11.31 Favored 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.233 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -116.63 125.77 52.27 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.21 105.83 0.1 Allowed 'General case' 0 CA--C 1.575 1.924 0 C-N-CA 124.198 0.999 . . . . 0.0 113.668 -173.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.6 44.48 93.9 Favored Glycine 0 N--CA 1.502 3.095 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.42 23.8 tptp -124.47 -79.8 0.61 Allowed 'General case' 0 CA--C 1.565 1.533 0 CA-C-N 118.147 0.974 . . . . 0.0 110.262 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -105.24 70.57 0.24 Allowed Glycine 0 N--CA 1.505 3.27 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.407 49.8 tt0 -68.14 152.99 44.64 Favored 'General case' 0 CA--C 1.56 1.33 1 CA-C-O 130.466 4.936 . . . . 0.0 118.245 -160.471 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.378 24.5 m -80.27 -126.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.645 2 CA-C-N 100.987 -7.37 . . . . 0.0 106.767 -178.3 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.522 HG13 ' H ' ' A' ' 89' ' ' TRP . 34.5 pt -106.54 154.06 7.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 124.805 2.24 . . . . 0.0 106.402 167.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.287 10.6 tmtt? -69.1 -25.48 64.44 Favored 'General case' 0 CA--C 1.572 1.795 0 CA-C-N 112.859 -1.973 . . . . 0.0 114.475 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.69 89.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 116.528 -1.701 . . . . 0.0 111.454 165.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.522 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -71.37 -44.01 65.82 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 121.385 1.902 . . . . 0.0 112.711 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -54.44 -41.18 69.1 Favored 'General case' 0 CA--C 1.576 1.955 0 CA-C-N 121.23 1.832 . . . . 0.0 113.868 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.305 1.5 mp -66.87 -61.38 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.022 0 CA-C-N 119.714 1.143 . . . . 0.0 112.071 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.617 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -68.5 -33.43 74.13 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.27 20.1 t -72.4 -39.37 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 120.82 1.646 . . . . 0.0 110.443 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.22 -31.27 63.35 Favored 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 120.152 1.342 . . . . 0.0 114.179 167.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.6 p -78.39 -19.67 52.82 Favored 'General case' 0 CA--C 1.59 2.509 0 N-CA-C 116.296 1.962 . . . . 0.0 116.296 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 133' ' ' LEU 0.346 0.0 OUTLIER -90.37 163.84 14.55 Favored 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 124.701 3.409 . . . . 0.0 116.263 -179.126 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.45 137.88 51.81 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 119.944 -1.723 . . . . 0.0 112.257 -173.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.404 HG21 ' H ' ' A' ' 43' ' ' THR . 77.2 t -9.94 -171.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.187 0 C-N-CA 127.922 2.489 . . . . 0.0 116.28 -173.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 25.67 -17.5 0.0 OUTLIER Glycine 0 N--CA 1.509 3.565 2 O-C-N 107.411 -9.555 . . . . 0.0 127.918 155.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.548 ' O ' ' HB3' ' A' ' 132' ' ' GLU 0.53 48.4 mt-10 -109.81 -149.61 0.44 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-N 123.996 3.898 . . . . 0.0 116.042 -178.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 15.3 tp -135.99 139.04 42.86 Favored 'General case' 0 CA--C 1.592 2.577 0 N-CA-C 119.917 3.303 . . . . 0.0 119.917 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 28.6 p -146.15 -168.11 2.91 Favored 'General case' 0 CA--C 1.562 1.44 0 CA-C-O 122.605 1.193 . . . . 0.0 111.316 175.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 3.2 mtt180 -140.92 158.96 43.21 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 123.067 1.413 . . . . 0.0 112.555 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 92' ' ' ALA . 1.8 mt -117.51 135.27 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.76 0 C-N-CA 125.414 1.485 . . . . 0.0 109.262 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 m -127.59 102.8 7.0 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 127' ' ' LEU . 15.7 p -122.0 149.99 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 -172.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -83.11 141.06 42.89 Favored Pre-proline 0 CA--C 1.585 2.327 0 CA-C-O 117.413 -1.279 . . . . 0.0 109.456 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -61.61 -12.04 22.96 Favored 'Trans proline' 0 CA--C 1.568 2.217 0 N-CA-C 119.282 2.762 . . . . 0.0 119.282 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -61.41 -39.95 92.62 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 121.0 1.727 . . . . 0.0 113.078 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -77.45 -6.98 55.42 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.906 1.282 . . . . 0.0 113.251 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.54 -121.47 0.17 Allowed 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CE2' HD21 ' A' ' 127' ' ' LEU 0.348 0.2 OUTLIER -85.58 7.44 23.14 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 122.057 2.208 . . . . 0.0 115.7 -178.036 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -49.8 -32.4 17.97 Favored Glycine 0 N--CA 1.501 2.998 0 CA-C-N 123.448 2.84 . . . . 0.0 119.455 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.1 p -77.92 84.57 4.2 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 118.464 1.132 . . . . 0.0 109.97 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . 0.365 . . 86.43 -14.91 0.48 Allowed 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 120.299 3.444 . . . . 0.0 120.299 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.65 162.06 32.44 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 123.53 2.877 . . . . 0.0 113.438 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 3.5 t -89.51 148.34 40.07 Favored Pre-proline 0 CA--C 1.577 2.014 0 O-C-N 121.047 -1.266 . . . . 0.0 111.102 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -41.86 -43.55 6.83 Favored 'Trans proline' 0 CA--C 1.587 3.167 0 C-N-CA 123.456 2.771 . . . . 0.0 118.784 174.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.58 58.6 7.04 Favored 'Trans proline' 0 CA--C 1.586 3.081 0 CA-C-N 125.346 2.945 . . . . 0.0 115.292 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 61.18 31.12 19.59 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 120.328 3.455 . . . . 0.0 120.328 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.499 ' HB ' ' H ' ' A' ' 117' ' ' SER . 14.9 mt -84.43 134.59 42.44 Favored Pre-proline 0 CA--C 1.596 2.736 0 CA-C-O 116.297 -1.811 . . . . 0.0 110.36 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -90.5 157.56 4.4 Favored 'Trans proline' 0 CA--C 1.591 3.355 0 CA-C-N 125.981 3.172 . . . . 0.0 114.275 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.87 -42.39 64.06 Favored 'Trans proline' 0 CA--C 1.575 2.541 0 N-CA-C 119.732 2.935 . . . . 0.0 119.732 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.09 64.42 3.3 Favored 'General case' 0 CA--C 1.582 2.174 0 O-C-N 120.799 -1.188 . . . . 0.0 113.248 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -145.92 133.72 21.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.128 -1.608 . . . . 0.0 111.764 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.8 m -69.95 150.11 47.05 Favored 'General case' 0 CA--C 1.59 2.499 0 O-C-N 121.023 -1.048 . . . . 0.0 112.272 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD21 ' CE2' ' A' ' 112' ' ' TYR . 9.8 tp -126.43 159.15 34.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 119.846 -1.784 . . . . 0.0 111.726 -173.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.98 136.1 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 O-C-N 121.003 -1.06 . . . . 0.0 110.256 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.274 0.6 OUTLIER -135.28 125.04 25.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.59 113.41 21.8 Favored 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 173.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.91 145.56 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 121.755 -0.591 . . . . 0.0 111.915 -170.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 101' ' ' LEU 0.944 10.5 tt0 -151.54 -151.01 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 161.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -144.27 164.07 31.82 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -166.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.456 ' H ' HD23 ' A' ' 133' ' ' LEU . 47.8 m-85 -120.7 -50.51 2.19 Favored 'General case' 0 CA--C 1.573 1.857 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.349 177.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.98 152.0 10.84 Favored 'General case' 0 CA--C 1.581 2.136 0 C-N-CA 125.872 1.669 . . . . 0.0 109.865 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.271 0.0 OUTLIER -139.39 -93.66 0.17 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.235 -1.541 . . . . 0.0 109.803 178.493 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.436 77.3 tttt -127.91 -107.45 0.3 Allowed 'General case' 0 CA--C 1.588 2.411 0 CA-C-O 115.621 -2.133 . . . . 0.0 107.278 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 1 CA-C-N 126.37 4.168 . . . . 0.0 121.032 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 2.082 0 CA-C-O 119.827 -0.429 . . . . 0.0 114.094 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.523 2.7 p 55.83 -141.04 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.054 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.19 112.14 7.09 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.602 -1.311 . . . . 0.0 114.527 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tp -139.74 108.24 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 CA-C-O 123.551 1.643 . . . . 0.0 113.392 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.408 1.7 p -152.2 88.26 4.12 Favored Pre-proline 0 CA--C 1.59 2.484 0 O-C-N 118.146 -2.846 . . . . 0.0 105.916 161.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -83.68 56.49 5.26 Favored 'Trans proline' 0 CA--C 1.579 2.73 0 C-N-CA 123.419 2.746 . . . . 0.0 118.307 -172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.45 -52.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.228 -1.545 . . . . 0.0 109.407 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -75.05 -35.08 61.9 Favored 'General case' 0 CA--C 1.583 2.239 0 O-C-N 121.332 -0.855 . . . . 0.0 110.716 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.262 19.6 t70 120.38 132.81 0.0 OUTLIER 'General case' 0 CA--C 1.582 2.211 0 C-N-CA 129.61 3.164 . . . . 0.0 105.67 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -9.33 73.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 128.83 2.852 . . . . 0.0 117.932 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.36 -21.87 57.72 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 121.786 3.474 . . . . 0.0 121.786 -172.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . 0.341 11.4 p -136.85 121.65 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.675 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.7 tp -69.61 121.62 17.48 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 127.187 2.195 . . . . 0.0 112.316 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -110.11 102.31 11.03 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 122.393 2.36 . . . . 0.0 107.297 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 3.4 t -92.85 92.64 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.036 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.385 0.6 OUTLIER -65.2 130.68 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.03 -60.8 1.67 Allowed 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.582 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.48 99.94 7.93 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -53.42 -74.81 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 154.56 -154.8 25.77 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 117.661 1.824 . . . . 0.0 117.661 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.0 p -87.72 -74.42 0.45 Allowed 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.47 20.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.177 0 N-CA-C 121.918 3.527 . . . . 0.0 121.918 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.3 p -134.7 67.64 1.5 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.501 12.7 pt-20 -33.59 -101.98 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.989 1 N-CA-C 123.774 4.731 . . . . 0.0 123.774 -170.48 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 p -112.16 100.01 48.0 Favored Pre-proline 0 CA--C 1.581 2.168 0 N-CA-C 118.233 2.679 . . . . 0.0 118.233 -169.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.78 -100.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.579 2.739 0 C-N-CA 123.813 3.009 . . . . 0.0 119.905 169.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -163.11 161.04 25.0 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 -173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.253 0.4 OUTLIER -59.6 138.25 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-O 122.552 1.167 . . . . 0.0 110.897 175.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.15 89.06 Favored Glycine 0 CA--C 1.558 2.752 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -85.61 157.06 20.46 Favored 'General case' 0 CA--C 1.577 1.985 0 CA-C-N 121.836 2.818 . . . . 0.0 114.482 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -74.03 136.97 43.14 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.212 -1.555 . . . . 0.0 109.738 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.371 1.1 t -137.81 132.34 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.388 0.675 . . . . 0.0 109.53 -165.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.44 117.39 26.75 Favored 'General case' 0 CA--C 1.562 1.416 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.601 HG23 ' HB3' ' A' ' 76' ' ' PHE . 19.4 m -128.42 166.36 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.259 0.3 OUTLIER -130.73 120.84 24.41 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.135 169.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.282 0.0 OUTLIER -124.71 137.45 54.35 Favored 'General case' 0 N--CA 1.511 2.595 0 N-CA-C 118.306 2.706 . . . . 0.0 118.306 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 68' ' ' SER . 29.4 m -106.98 153.47 22.52 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 160.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.71 142.75 8.98 Favored Glycine 0 CA--C 1.547 2.047 0 O-C-N 119.106 -2.246 . . . . 0.0 116.151 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.459 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -135.15 150.13 50.11 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 125.977 1.711 . . . . 0.0 113.088 -177.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.17 174.3 7.38 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.511 -0.743 . . . . 0.0 111.435 172.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.5 tp -61.34 -26.55 67.89 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 116.05 1.871 . . . . 0.0 116.05 178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -66.6 -5.93 13.39 Favored 'General case' 0 CA--C 1.597 2.774 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 167.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.83 58.04 Favored Glycine 0 N--CA 1.502 3.041 0 CA-C-N 120.622 1.555 . . . . 0.0 114.181 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -106.04 120.47 41.86 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -75.95 91.51 3.05 Favored 'General case' 0 CA--C 1.583 2.213 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.872 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -66.69 -32.06 73.13 Favored 'General case' 0 CA--C 1.566 1.56 0 O-C-N 119.282 -2.136 . . . . 0.0 115.516 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -149.19 158.91 44.57 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 120.248 1.386 . . . . 0.0 111.707 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 57' ' ' THR 0.356 43.3 t -135.36 -34.45 0.85 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 120.003 3.334 . . . . 0.0 120.003 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.321 60.0 p 58.31 -53.47 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 123.389 2.813 . . . . 0.0 116.717 -177.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -50.84 -34.32 27.43 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 128.343 2.657 . . . . 0.0 113.609 171.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -46.1 -42.72 14.02 Favored 'General case' 0 CA--C 1.589 2.471 0 C-N-CA 125.241 1.416 . . . . 0.0 113.547 167.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.687 96.2 mtt180 95.02 38.97 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 120.023 3.342 . . . . 0.0 120.023 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.51 -56.15 4.37 Favored 'General case' 0 CA--C 1.581 2.173 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 167.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.78 166.82 23.6 Favored 'General case' 0 CA--C 1.578 2.023 0 C-N-CA 126.409 1.884 . . . . 0.0 108.122 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -98.93 -162.06 0.92 Allowed 'General case' 0 CA--C 1.579 2.067 0 O-C-N 120.974 -1.079 . . . . 0.0 110.218 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.601 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.33 2.5 t80 -128.96 154.18 46.82 Favored 'General case' 0 CA--C 1.588 2.426 0 O-C-N 119.381 -2.074 . . . . 0.0 110.974 173.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.9 p -167.4 142.17 3.84 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 118.92 -2.362 . . . . 0.0 109.598 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' CG ' HG11 ' A' ' 85' ' ' VAL . 6.6 p90 -153.49 -179.55 7.87 Favored 'General case' 0 CA--C 1.583 2.231 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.824 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -113.23 124.36 52.35 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.0 106.17 0.08 Allowed 'General case' 0 CA--C 1.578 2.02 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 59.28 49.16 81.47 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 -10.98 27.52 Favored 'General case' 0 CA--C 1.579 2.091 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 122.1 -37.0 3.02 Favored Glycine 0 CA--C 1.564 3.118 0 C-N-CA 124.495 1.045 . . . . 0.0 110.547 -168.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -38.6 -46.72 1.23 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 120.552 3.538 . . . . 0.0 120.552 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.505 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.261 7.6 m -117.8 -154.44 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-O 124.101 1.905 . . . . 0.0 109.0 -172.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.475 HG13 ' H ' ' A' ' 89' ' ' TRP . 30.9 pt -101.05 162.34 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.257 0 CA-C-O 125.09 2.376 . . . . 0.0 110.113 174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -69.1 -35.01 75.98 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 112.678 -2.056 . . . . 0.0 114.154 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.64 -33.9 66.78 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-O 116.704 -1.617 . . . . 0.0 111.161 167.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.475 ' H ' HG13 ' A' ' 86' ' ' ILE . 45.6 m0 -76.21 -47.04 25.49 Favored 'General case' 0 C--N 1.371 1.515 0 CA-C-N 121.492 1.951 . . . . 0.0 112.982 173.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.96 -32.57 69.76 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 121.194 1.815 . . . . 0.0 115.54 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.255 1.6 mp -65.98 -59.28 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 CA-C-N 119.28 0.945 . . . . 0.0 110.046 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.33 -53.49 57.68 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.613 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.283 56.7 t -54.28 -40.6 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-N 120.454 1.479 . . . . 0.0 114.26 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.74 -38.64 70.06 Favored 'General case' 0 CA--C 1.581 2.146 0 CA-C-N 119.881 1.219 . . . . 0.0 113.372 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 p -90.55 18.82 5.85 Favored 'General case' 0 CA--C 1.601 2.909 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.543 ' CE ' HD22 ' A' ' 101' ' ' LEU . 56.4 mtp -119.79 150.41 40.46 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 119.226 -2.171 . . . . 0.0 116.711 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 146.87 29.91 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.838 2.903 . . . . 0.0 118.838 -171.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -45.89 137.13 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.349 0 CA-C-N 112.897 -1.956 . . . . 0.0 113.13 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.53 -43.6 1.96 Allowed Glycine 0 N--CA 1.491 2.34 0 CA-C-O 115.608 -2.774 . . . . 0.0 116.713 172.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 60.6 mt-10 -149.21 -175.99 5.19 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 121.966 2.883 . . . . 0.0 114.506 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.543 HD22 ' CE ' ' A' ' 96' ' ' MET 0.997 0.3 OUTLIER -155.49 -142.15 0.11 Allowed 'General case' 0 CA--C 1.604 3.05 0 N-CA-C 120.889 3.663 . . . . 0.0 120.889 172.64 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.533 ' SG ' HD23 ' A' ' 101' ' ' LEU 0.321 0.6 OUTLIER -151.41 -160.01 1.1 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 126.477 1.911 . . . . 0.0 113.746 -163.403 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.422 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 ptt85 -118.63 121.08 39.32 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 124.318 2.009 . . . . 0.0 110.124 165.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.5 mt -78.76 132.03 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 112.535 -2.12 . . . . 0.0 106.028 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.417 ' HA ' HG12 ' A' ' 128' ' ' VAL . 11.3 m -143.22 113.03 7.03 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . 2.679 2.7 m -160.28 -158.79 0.65 Allowed 'General case' 0 CA--C 1.59 2.493 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -97.6 122.68 54.59 Favored Pre-proline 0 CA--C 1.571 1.766 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -168.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 17.6 Cg_exo -42.59 -19.94 0.13 Allowed 'Trans proline' 0 CA--C 1.563 1.948 1 N-CA-C 122.534 4.013 . . . . 0.0 122.534 176.863 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.289 1.7 pm0 -63.03 -34.07 76.79 Favored 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 122.97 2.623 . . . . 0.0 113.098 169.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -74.29 -12.24 60.49 Favored 'General case' 0 CA--C 1.582 2.178 0 C-N-CA 124.578 1.151 . . . . 0.0 113.799 167.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.51 -124.22 0.2 Allowed 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.289 0.6 OUTLIER -80.45 -4.63 54.5 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.133 2.242 . . . . 0.0 115.242 -178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -47.59 -17.99 0.56 Allowed Glycine 0 N--CA 1.497 2.755 1 N-CA-C 125.363 4.905 . . . . 0.0 125.363 -178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 t -65.69 -57.22 8.57 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 121.066 2.433 . . . . 0.0 111.379 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.46 -0.74 9.73 Favored 'General case' 0 CA--C 1.58 2.126 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 163.63 39.32 Favored Glycine 0 CA--C 1.548 2.14 0 CA-C-N 122.72 2.509 . . . . 0.0 111.82 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.528 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 8.7 t -85.51 112.21 42.67 Favored Pre-proline 0 CA--C 1.582 2.179 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 174.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.288 94.6 Cg_exo -31.52 -49.96 0.27 Allowed 'Trans proline' 0 CA--C 1.58 2.794 1 N-CA-C 123.702 4.462 . . . . 0.0 123.702 -174.042 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.63 -15.42 6.09 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 CA-C-N 125.211 2.897 . . . . 0.0 119.311 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -149.35 -6.89 0.35 Allowed 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.528 ' HB ' ' H ' ' A' ' 117' ' ' SER . 25.9 mt -125.1 130.5 24.16 Favored Pre-proline 0 N--CA 1.507 2.401 0 CA-C-N 122.397 2.362 . . . . 0.0 113.767 -170.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -89.55 161.38 5.37 Favored 'Trans proline' 0 CA--C 1.591 3.356 0 CA-C-N 123.702 2.358 . . . . 0.0 112.116 173.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.03 -33.74 95.23 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 N-CA-C 119.888 2.996 . . . . 0.0 119.888 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -97.24 70.25 2.33 Favored 'General case' 0 CA--C 1.583 2.225 0 O-C-N 120.648 -1.283 . . . . 0.0 110.449 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.94 117.4 4.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 119.786 -1.821 . . . . 0.0 110.701 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 m -48.32 142.45 5.56 Favored 'General case' 0 CA--C 1.59 2.506 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.3 tp -125.35 149.22 48.31 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 122.09 2.223 . . . . 0.0 111.194 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.459 HG23 ' HE3' ' A' ' 59' ' ' TRP . 30.6 m -144.86 146.95 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -176.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -142.53 132.32 24.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.714 -0.616 . . . . 0.0 109.83 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -95.7 98.28 10.35 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.422 HG12 ' HG3' ' A' ' 132' ' ' GLU . 3.9 t -122.81 162.46 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 -167.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.422 ' HG3' HG12 ' A' ' 131' ' ' VAL 2.899 27.9 mt-10 174.58 167.7 0.25 Allowed 'General case' 0 CA--C 1.562 1.433 0 N-CA-C 120.961 3.689 . . . . 0.0 120.961 162.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.98 130.56 38.51 Favored 'General case' 0 N--CA 1.49 1.554 1 N-CA-C 123.208 4.522 . . . . 0.0 123.208 -153.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -79.92 -51.05 9.58 Favored 'General case' 0 CA--C 1.581 2.15 0 O-C-N 121.254 -0.904 . . . . 0.0 112.022 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? 176.59 163.28 0.42 Allowed 'General case' 0 CA--C 1.582 2.202 0 C-N-CA 127.676 2.391 . . . . 0.0 106.699 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.412 ' HD1' ' H ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -141.57 -82.18 0.22 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.856 -1.778 . . . . 0.0 109.71 -179.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.412 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 19.1 mmmt -79.79 -32.48 40.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 2.338 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 121.389 3.315 . . . . 0.0 121.389 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 t -81.71 130.73 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -171.36 152.05 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 120.282 3.438 . . . . 0.0 120.282 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.332 0.2 OUTLIER -118.71 58.64 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.779 0 CA-C-O 124.157 1.932 . . . . 0.0 105.959 162.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.05 84.27 1.86 Allowed Pre-proline 0 CA--C 1.583 2.215 0 C-N-CA 127.65 2.38 . . . . 0.0 107.449 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . 0.26 32.6 Cg_exo -57.78 -28.35 81.74 Favored 'Trans proline' 0 CA--C 1.572 2.384 0 N-CA-C 119.751 2.943 . . . . 0.0 119.751 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.92 53.83 0.77 Allowed 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 125.227 1.411 . . . . 0.0 107.854 175.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . 0.278 2.8 mp0 56.4 38.67 29.91 Favored 'General case' 0 CA--C 1.59 2.504 0 O-C-N 120.324 -1.485 . . . . 0.0 113.839 -171.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -109.66 -55.06 2.48 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.399 1.1 mp0 -74.89 -24.19 58.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 120.771 3.619 . . . . 0.0 120.771 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.08 -46.03 0.71 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 120.519 2.968 . . . . 0.0 120.519 177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.83 146.72 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.272 0 N-CA-C 118.861 2.911 . . . . 0.0 118.861 -173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.0 tp -113.89 138.61 50.08 Favored 'General case' 0 CA--C 1.596 2.724 0 C-N-CA 127.369 2.268 . . . . 0.0 107.239 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -125.77 125.62 43.24 Favored 'General case' 0 CA--C 1.565 1.552 0 CA-C-N 123.638 2.926 . . . . 0.0 109.458 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 65.4 t -94.86 119.54 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.561 -0.712 . . . . 0.0 109.568 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.565 HD13 ' SG ' ' A' ' 102' ' ' CYS . 0.3 OUTLIER -90.16 137.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-N 120.067 1.303 . . . . 0.0 111.629 178.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -123.47 -60.18 1.49 Allowed 'General case' 0 CA--C 1.573 1.83 0 C-N-CA 124.552 1.141 . . . . 0.0 110.84 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -121.5 109.33 14.7 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -49.77 -38.27 33.38 Favored 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 119.541 3.163 . . . . 0.0 119.541 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.01 176.34 18.69 Favored Glycine 0 CA--C 1.547 2.047 0 C-N-CA 126.27 1.89 . . . . 0.0 115.886 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -151.56 -17.16 0.2 Allowed 'General case' 0 N--CA 1.506 2.368 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.36 37.34 0.82 Allowed Glycine 0 N--CA 1.499 2.837 1 N-CA-C 123.37 4.108 . . . . 0.0 123.37 -175.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.3 p 65.69 -6.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.82 177.17 9.32 Favored 'General case' 0 CA--C 1.582 2.189 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 -173.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.1 p -134.07 172.96 6.4 Favored Pre-proline 0 CA--C 1.59 2.496 0 C-N-CA 126.465 1.906 . . . . 0.0 109.402 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -100.61 -169.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.568 2.188 0 CA-C-N 123.788 2.388 . . . . 0.0 116.814 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -139.56 162.28 35.46 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.089 -1.007 . . . . 0.0 111.998 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.262 1.5 tp -61.65 136.71 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 O-C-N 119.34 -2.1 . . . . 0.0 110.346 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.07 11.5 74.8 Favored Glycine 0 CA--C 1.561 2.912 0 N-CA-C 118.157 2.023 . . . . 0.0 118.157 -173.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.41 158.94 16.83 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 120.866 2.333 . . . . 0.0 111.82 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.6 tpt85 -82.75 135.56 34.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.227 -175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -135.05 136.64 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.938 0 CA-C-N 119.399 1.0 . . . . 0.0 110.603 -175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -117.54 109.35 16.61 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 120.575 -1.328 . . . . 0.0 107.688 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.47 173.1 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.952 0 CA-C-O 124.812 2.244 . . . . 0.0 113.221 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -129.62 126.88 39.46 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.96 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 143.5 47.91 Favored 'General case' 0 N--CA 1.521 3.079 0 N-CA-C 121.624 3.935 . . . . 0.0 121.624 -176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 50.8 m -113.11 143.25 44.67 Favored 'General case' 0 N--CA 1.513 2.695 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 164.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.75 157.81 27.49 Favored Glycine 0 CA--C 1.56 2.874 0 CA-C-N 122.103 2.229 . . . . 0.0 116.037 173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.44 151.94 36.09 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.283 1.433 . . . . 0.0 114.8 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.66 174.47 9.92 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 123.072 1.415 . . . . 0.0 109.316 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -30.17 71.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.89 5.66 1.47 Allowed 'General case' 0 CA--C 1.597 2.775 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.91 36.25 65.28 Favored Glycine 0 N--CA 1.507 3.402 0 O-C-N 119.769 -1.832 . . . . 0.0 115.241 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.7 m -107.71 117.32 33.8 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -79.09 89.52 4.82 Favored 'General case' 0 CA--C 1.592 2.573 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -63.37 -34.59 78.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 118.81 -2.431 . . . . 0.0 115.595 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -143.02 168.33 19.97 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -141.55 -40.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.768 1 N-CA-C 128.206 6.372 . . . . 0.0 128.206 -170.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.251 3.9 m -141.83 -101.7 0.14 Allowed 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 75' ' ' LYS 0.312 25.5 mt -90.13 -28.1 19.18 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 117.441 2.386 . . . . 0.0 117.441 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . 0.318 12.3 t70 110.22 -14.45 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.409 0 C-N-CA 127.433 2.293 . . . . 0.0 115.128 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.457 4.3 mmp_? 87.16 39.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -153.66 -66.21 0.15 Allowed 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 124.857 1.263 . . . . 0.0 107.625 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -130.84 -169.26 2.13 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 125.491 1.516 . . . . 0.0 108.611 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HA ' HD22 ' A' ' 70' ' ' LEU . 40.1 mmtm -74.07 157.26 36.4 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 119.818 -1.801 . . . . 0.0 112.303 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -74.3 116.5 15.04 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 123.343 2.792 . . . . 0.0 105.477 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.7 p -144.3 144.43 31.47 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.652 -1.28 . . . . 0.0 109.861 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CG ' HG11 ' A' ' 85' ' ' VAL . 36.5 p90 -148.76 -169.87 3.47 Favored 'General case' 0 CA--C 1.565 1.521 0 CA-C-O 122.35 1.071 . . . . 0.0 112.862 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -125.41 113.97 18.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.0 tp -40.14 113.13 0.33 Allowed 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.79 28.97 61.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 119.526 2.57 . . . . 0.0 119.526 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -96.15 13.02 28.72 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 122.173 2.987 . . . . 0.0 117.447 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.71 -44.96 2.54 Favored Glycine 0 N--CA 1.51 3.618 0 O-C-N 120.91 -1.119 . . . . 0.0 111.052 -172.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.271 37.7 tt0 -23.45 -49.42 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 129.709 3.204 . . . . 0.0 119.641 169.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.585 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.302 17.1 m -107.97 -129.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-O 123.205 1.478 . . . . 0.0 108.098 -177.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.564 HG13 ' H ' ' A' ' 89' ' ' TRP . 44.8 pt -130.63 163.78 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 124.069 1.89 . . . . 0.0 108.869 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.256 8.0 tmtm? -69.31 -33.04 72.55 Favored 'General case' 0 CA--C 1.565 1.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 114.181 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.31 -36.12 77.19 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.842 -1.551 . . . . 0.0 111.324 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.564 ' H ' HG13 ' A' ' 86' ' ' ILE . 37.2 m0 -72.06 -41.66 67.14 Favored 'General case' 0 C--N 1.369 1.436 0 CA-C-N 121.527 1.967 . . . . 0.0 112.957 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -57.9 -42.36 84.52 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.293 4.9 mt -64.78 -56.9 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.745 0 CA-C-N 118.841 0.746 . . . . 0.0 112.192 174.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.75 84.58 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.286 89.7 t -63.61 -34.9 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 CA-C-N 120.343 1.428 . . . . 0.0 112.702 175.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.39 -40.24 71.15 Favored 'General case' 0 CA--C 1.581 2.149 0 CA-C-N 120.885 1.675 . . . . 0.0 113.051 169.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -79.77 5.23 14.06 Favored 'General case' 0 CA--C 1.592 2.59 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 18.2 mtt -91.58 139.18 30.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 119.305 -2.122 . . . . 0.0 115.012 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -93.22 159.69 15.17 Favored 'General case' 0 CA--C 1.577 1.986 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 171.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 49.8 t -58.13 130.35 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.95 0 O-C-N 119.122 -2.236 . . . . 0.0 111.055 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.92 -17.77 43.93 Favored Glycine 0 N--CA 1.514 3.898 0 CA-C-N 123.696 2.953 . . . . 0.0 116.857 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' HG2' ' SG ' ' A' ' 102' ' ' CYS . 34.4 tt0 -54.93 125.55 20.74 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 tp -103.96 121.69 43.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.125 0.97 . . . . 0.0 108.798 173.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.565 ' SG ' HD13 ' A' ' 36' ' ' ILE . 81.0 m -146.67 179.63 7.43 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.548 1.166 . . . . 0.0 110.96 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -136.0 127.6 28.87 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 123.815 1.769 . . . . 0.0 109.643 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.5 134.97 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.986 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.658 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 m -130.03 99.8 5.21 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.549 ' SG ' ' CD2' ' A' ' 127' ' ' LEU . 19.9 p -124.25 145.9 49.08 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -171.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -76.15 146.77 78.99 Favored Pre-proline 0 CA--C 1.575 1.931 0 CA-C-N 112.824 -1.989 . . . . 0.0 112.157 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -47.66 -23.47 3.78 Favored 'Trans proline' 0 CA--C 1.563 1.955 0 N-CA-C 120.34 3.169 . . . . 0.0 120.34 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -63.83 -37.72 88.45 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 120.556 1.526 . . . . 0.0 115.017 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.14 -1.55 57.98 Favored 'General case' 0 CA--C 1.575 1.929 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.856 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -134.7 -122.34 0.17 Allowed 'General case' 0 CA--C 1.581 2.143 0 CA-C-N 121.643 2.02 . . . . 0.0 116.264 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 127' ' ' LEU 0.284 3.4 m-85 -83.03 0.57 44.25 Favored 'General case' 0 N--CA 1.517 2.877 0 CA-C-N 121.881 2.128 . . . . 0.0 115.078 -178.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -54.65 -20.69 18.97 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 122.571 3.788 . . . . 0.0 122.571 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -67.87 -56.74 7.96 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 119.653 1.726 . . . . 0.0 112.766 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -133.74 -4.11 2.89 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 118.641 2.83 . . . . 0.0 118.641 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.24 155.76 32.02 Favored Glycine 0 CA--C 1.545 1.961 0 CA-C-N 123.693 2.951 . . . . 0.0 111.789 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 t -86.53 128.76 55.64 Favored Pre-proline 0 CA--C 1.578 2.053 0 CA-C-O 116.879 -1.534 . . . . 0.0 108.814 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -32.99 -45.98 0.29 Allowed 'Trans proline' 0 CA--C 1.58 2.824 1 N-CA-C 124.351 4.712 . . . . 0.0 124.351 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.55 -28.83 9.67 Favored 'Trans proline' 0 CA--C 1.573 2.439 0 CA-C-N 125.783 3.101 . . . . 0.0 119.662 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -163.17 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mt -79.9 146.42 63.94 Favored Pre-proline 0 CA--C 1.595 2.683 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -170.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -102.84 174.51 0.19 Allowed 'Trans proline' 0 CA--C 1.593 3.426 0 CA-C-N 125.119 2.864 . . . . 0.0 114.756 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.34 25.44 0.47 Allowed 'Trans proline' 0 CA--C 1.579 2.765 0 N-CA-C 118.537 2.476 . . . . 0.0 118.537 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -147.89 60.02 1.12 Allowed 'General case' 0 CA--C 1.582 2.209 0 O-C-N 120.103 -1.623 . . . . 0.0 111.706 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -152.93 120.93 6.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.756 -1.84 . . . . 0.0 109.814 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 96.3 m -68.53 159.22 32.25 Favored 'General case' 0 CA--C 1.584 2.257 0 O-C-N 121.141 -0.974 . . . . 0.0 112.814 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' CD2' ' SG ' ' A' ' 106' ' ' CYS 0.289 0.0 OUTLIER -141.86 177.53 8.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.23 -2.169 . . . . 0.0 111.372 -177.052 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -151.3 148.99 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 125.392 1.477 . . . . 0.0 110.942 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -143.52 124.99 14.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.726 . . . . 0.0 109.555 172.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -87.63 118.37 27.07 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.17 141.93 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 CA-C-N 121.242 1.837 . . . . 0.0 112.368 -172.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -116.05 110.17 18.53 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.793 0.837 . . . . 0.0 110.378 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -89.47 141.83 28.21 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 123.701 1.715 . . . . 0.0 111.002 177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -120.57 -45.44 2.41 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -158.61 149.88 20.7 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.082 1.353 . . . . 0.0 109.045 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.425 ' HD1' ' H ' ' A' ' 137' ' ' LYS 0.284 0.0 OUTLIER -156.54 -90.71 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.868 0 O-C-N 121.227 -0.921 . . . . 0.0 111.717 179.791 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.425 ' H ' ' HD1' ' A' ' 136' ' ' PHE . 43.8 tttm -79.87 47.15 0.84 Allowed 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 117.936 2.569 . . . . 0.0 117.936 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.126 0 N-CA-C 122.979 3.952 . . . . 0.0 122.979 173.567 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.862 0 N-CA-C 120.349 2.9 . . . . 0.0 120.349 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -138.93 178.07 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.874 0 CA-C-O 123.59 1.662 . . . . 0.0 112.574 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -157.31 102.26 1.92 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 125.954 1.702 . . . . 0.0 106.418 171.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.389 10.1 tp -104.69 71.34 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 125.135 2.398 . . . . 0.0 115.038 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 83.9 p -137.61 -43.36 0.02 OUTLIER Pre-proline 0 CA--C 1.575 1.917 0 CA-C-O 115.033 -2.413 . . . . 0.0 114.697 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -66.94 10.17 0.24 Allowed 'Trans proline' 0 CA--C 1.576 2.602 0 CA-C-N 126.398 3.321 . . . . 0.0 120.265 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.76 -67.3 0.35 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.542 1.137 . . . . 0.0 111.934 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.31 -11.74 58.42 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.332 10.8 t70 63.38 33.23 14.0 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.346 13.6 tp10 -66.46 -33.6 76.06 Favored 'General case' 0 CA--C 1.574 1.903 0 O-C-N 120.083 -1.635 . . . . 0.0 113.821 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.07 -25.43 4.61 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 118.1 2.0 . . . . 0.0 118.1 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.07 168.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.658 1.729 . . . . 0.0 112.133 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.81 0.9 OUTLIER -165.15 -168.23 1.36 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 123.67 0.788 . . . . 0.0 112.514 157.585 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.91 130.69 29.83 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 120.285 1.402 . . . . 0.0 113.846 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.15 118.27 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.02 143.24 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.04 0.924 . . . . 0.0 112.78 -176.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -127.43 -66.43 0.88 Allowed 'General case' 0 CA--C 1.572 1.807 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.005 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -111.46 90.36 3.31 Favored 'General case' 0 CA--C 1.586 2.338 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -21.7 -51.86 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.493 1 N-CA-C 123.207 4.521 . . . . 0.0 123.207 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.11 -142.81 8.62 Favored Glycine 0 N--CA 1.482 1.742 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -142.27 -53.69 0.42 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.2 -51.82 0.14 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 120.973 3.149 . . . . 0.0 120.973 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.428 HG23 HG21 ' A' ' 98' ' ' VAL 0.401 9.6 t -85.42 46.68 1.32 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.759 2.504 . . . . 0.0 117.759 -176.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.455 24.0 mt-10 70.08 -172.6 0.17 Allowed 'General case' 0 CA--C 1.583 2.224 1 N-CA-C 123.891 4.774 . . . . 0.0 123.891 168.317 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.8 p -92.49 151.94 41.71 Favored Pre-proline 0 CA--C 1.577 2.003 0 C-N-CA 126.91 2.084 . . . . 0.0 115.523 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -65.26 147.8 88.16 Favored 'Trans proline' 0 CA--C 1.577 2.653 0 C-N-CA 122.599 2.199 . . . . 0.0 117.19 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 14.8 ptp -104.01 153.66 20.59 Favored 'General case' 0 CA--C 1.567 1.622 0 O-C-N 119.993 -1.692 . . . . 0.0 109.858 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.348 0.4 OUTLIER -58.58 131.71 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 O-C-N 120.148 -1.595 . . . . 0.0 112.423 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.38 7.14 85.25 Favored Glycine 0 CA--C 1.558 2.769 0 N-CA-C 118.705 2.242 . . . . 0.0 118.705 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -88.22 154.61 20.29 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 121.61 2.705 . . . . 0.0 114.344 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -80.25 139.45 36.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.518 -1.364 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.332 1.4 t -132.51 140.85 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 C-N-CA 124.149 0.98 . . . . 0.0 111.23 -168.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.77 110.97 14.34 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 76' ' ' PHE . 3.0 m -120.6 167.22 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 123.443 1.592 . . . . 0.0 114.804 -174.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.88 111.33 12.47 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 166.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -113.53 148.67 35.65 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.7 m -120.06 139.73 52.09 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 163.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -148.48 143.22 10.76 Favored Glycine 0 CA--C 1.544 1.873 0 O-C-N 119.748 -1.845 . . . . 0.0 115.801 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.406 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -133.01 154.45 50.5 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 112.308 -1.946 . . . . 0.0 113.765 -175.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.2 tp -79.23 179.52 7.34 Favored 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 123.139 1.447 . . . . 0.0 108.639 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.366 0.0 OUTLIER -64.28 -25.61 68.13 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 178.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.97 14.32 2.29 Favored 'General case' 0 CA--C 1.603 3.004 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 168.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.33 31.65 70.38 Favored Glycine 0 N--CA 1.514 3.834 0 O-C-N 119.849 -1.782 . . . . 0.0 116.161 -171.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -86.19 111.32 20.28 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -75.35 89.02 2.59 Favored 'General case' 0 CA--C 1.583 2.23 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -72.16 -30.69 65.24 Favored 'General case' 0 CA--C 1.561 1.369 0 O-C-N 119.376 -2.077 . . . . 0.0 114.408 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -151.31 149.6 29.54 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 124.547 2.118 . . . . 0.0 113.879 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.4 p -160.1 96.8 1.23 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 112.229 -2.26 . . . . 0.0 106.995 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 t -59.16 -36.96 76.22 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mp -51.92 -36.78 50.23 Favored 'General case' 0 CA--C 1.575 1.931 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -57.72 -66.27 0.5 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -161.14 70.51 0.38 Allowed 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -151.61 -79.39 0.11 Allowed 'General case' 0 CA--C 1.564 1.515 0 O-C-N 120.28 -1.512 . . . . 0.0 108.285 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -167.74 -138.28 0.03 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 126.025 1.73 . . . . 0.0 107.982 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -112.64 -165.92 1.03 Allowed 'General case' 0 CA--C 1.577 2.018 0 C-N-CA 125.636 1.574 . . . . 0.0 108.46 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.333 2.8 t80 -127.65 146.65 50.48 Favored 'General case' 0 CA--C 1.572 1.822 0 O-C-N 119.098 -2.251 . . . . 0.0 110.147 170.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 88.7 p -160.84 140.5 10.79 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 119.526 -1.984 . . . . 0.0 109.151 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CG ' HG11 ' A' ' 85' ' ' VAL . 6.3 p90 -149.65 -176.9 5.59 Favored 'General case' 0 CA--C 1.575 1.918 0 CA-C-N 113.851 -1.522 . . . . 0.0 112.169 -176.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.53 124.95 42.43 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 119.051 -2.281 . . . . 0.0 105.074 173.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.53 109.5 0.36 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.46 97.95 Favored Glycine 0 N--CA 1.513 3.781 0 N-CA-C 116.231 1.252 . . . . 0.0 116.231 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -132.21 -73.31 0.52 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 123.73 0.812 . . . . 0.0 112.149 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.13 71.65 0.22 Allowed Glycine 0 N--CA 1.505 3.297 0 N-CA-C 104.255 -3.538 . . . . 0.0 104.255 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.43 0.0 OUTLIER -65.05 135.33 55.46 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 108.301 -3.949 . . . . 0.0 118.969 -159.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.359 19.2 m -79.91 -108.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 1 CA-C-N 103.299 -6.319 . . . . 0.0 107.0 -177.303 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.552 HG13 ' H ' ' A' ' 89' ' ' TRP . 25.7 pt -132.06 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 123.645 1.688 . . . . 0.0 107.381 168.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -32.12 73.42 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.386 176.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.91 80.62 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 117.591 -1.195 . . . . 0.0 112.157 168.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.552 ' H ' HG13 ' A' ' 86' ' ' ILE . 36.3 m0 -73.46 -43.49 60.12 Favored 'General case' 0 C--N 1.362 1.133 0 CA-C-N 120.377 1.444 . . . . 0.0 112.39 172.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -57.93 -35.66 71.39 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.603 1.547 . . . . 0.0 114.774 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.324 29.0 mt -72.68 -58.12 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.846 0 CA-C-N 118.952 0.796 . . . . 0.0 112.087 175.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.7 81.15 Favored 'General case' 0 CA--C 1.565 1.52 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.48 -44.3 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 120.904 1.684 . . . . 0.0 110.692 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.5 -39.73 35.07 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 121.392 1.905 . . . . 0.0 115.136 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 46.8 p -91.39 6.9 43.61 Favored 'General case' 0 CA--C 1.593 2.599 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 14.6 ttt -86.68 -179.6 6.61 Favored 'General case' 0 CA--C 1.58 2.122 0 O-C-N 119.705 -1.872 . . . . 0.0 113.108 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.51 164.63 21.51 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 118.903 -2.373 . . . . 0.0 113.427 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 98' ' ' VAL . 89.1 t -53.79 31.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.481 0 N-CA-C 120.13 3.381 . . . . 0.0 120.13 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.75 -18.0 0.09 OUTLIER Glycine 0 N--CA 1.501 2.974 0 O-C-N 116.73 -3.731 . . . . 0.0 113.974 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' OE1' ' SG ' ' A' ' 102' ' ' CYS . 39.0 tt0 -43.89 143.76 1.02 Allowed 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 119.709 3.226 . . . . 0.0 119.709 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.71 123.59 50.66 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.659 1.183 . . . . 0.0 109.83 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.43 ' SG ' ' OE1' ' A' ' 100' ' ' GLU . 3.9 m -144.76 165.73 27.25 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.783 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -120.41 120.7 36.7 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 123.929 1.823 . . . . 0.0 110.26 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.481 HG22 ' SG ' ' A' ' 106' ' ' CYS . 3.9 mt -77.39 141.0 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.043 0 CA-C-N 112.828 -1.987 . . . . 0.0 111.855 -179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.5 m -129.47 109.62 11.2 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.481 ' SG ' HG22 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -115.95 148.13 40.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -174.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 48.0 tptt -99.95 146.15 31.4 Favored Pre-proline 0 CA--C 1.579 2.08 0 C-N-CA 124.866 1.266 . . . . 0.0 110.381 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.13 -25.55 4.4 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 N-CA-C 119.738 2.938 . . . . 0.0 119.738 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.58 -38.26 86.89 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -92.54 4.49 53.46 Favored 'General case' 0 CA--C 1.569 1.676 0 C-N-CA 124.848 1.259 . . . . 0.0 114.369 171.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 127' ' ' LEU . . . -129.67 -104.75 0.3 Allowed 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 119.908 1.231 . . . . 0.0 113.762 -176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . 0.388 47.2 m-85 -106.5 -3.12 21.23 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.17 -154.72 44.04 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 119.099 2.399 . . . . 0.0 119.099 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 58.7 m -67.9 -15.51 63.65 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.54 -30.46 11.39 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 118.934 2.938 . . . . 0.0 118.934 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.84 168.33 44.34 Favored Glycine 0 CA--C 1.552 2.355 0 CA-C-N 121.401 1.91 . . . . 0.0 115.074 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.15 120.4 59.84 Favored Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 116.666 -1.635 . . . . 0.0 107.674 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.25 77.1 Cg_exo -37.91 -41.02 1.12 Allowed 'Trans proline' 0 CA--C 1.58 2.814 1 N-CA-C 123.425 4.356 . . . . 0.0 123.425 -175.959 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.0 -30.84 66.66 Favored 'Trans proline' 0 CA--C 1.574 2.506 0 CA-C-N 125.455 2.984 . . . . 0.0 119.856 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -159.78 -27.78 0.07 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 116.831 2.159 . . . . 0.0 116.831 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.8 mt -79.91 124.37 83.23 Favored Pre-proline 0 CA--C 1.584 2.271 0 C-N-CA 125.299 1.44 . . . . 0.0 111.983 -174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -95.58 178.3 0.7 Allowed 'Trans proline' 0 CA--C 1.584 3.007 0 C-N-CA 122.765 2.31 . . . . 0.0 116.07 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -53.13 125.29 17.87 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.655 2.903 . . . . 0.0 117.906 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.8 t30 56.16 62.41 2.37 Favored 'General case' 0 CA--C 1.586 2.36 0 C-N-CA 125.017 1.327 . . . . 0.0 113.935 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -123.04 123.21 40.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.303 -1.498 . . . . 0.0 112.417 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 98.5 m -67.29 159.25 29.63 Favored 'General case' 0 CA--C 1.593 2.616 0 O-C-N 121.358 -0.839 . . . . 0.0 113.163 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.485 HD12 ' HB1' ' A' ' 111' ' ' ALA . 16.7 mt -134.34 164.32 27.67 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 119.461 -2.024 . . . . 0.0 115.151 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 59' ' ' TRP . 3.8 m -148.52 140.05 17.67 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 C-N-CA 124.639 1.176 . . . . 0.0 109.944 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.53 126.06 15.86 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.466 -1.396 . . . . 0.0 109.418 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -88.12 118.33 27.63 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 174.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.2 t -127.15 139.36 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.102 0.954 . . . . 0.0 111.794 -172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -116.23 124.56 50.52 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.8 tp -104.49 110.12 22.27 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.221 0.534 . . . . 0.0 109.735 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -78.7 -43.82 25.02 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 -176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -171.73 159.62 5.38 Favored 'General case' 0 CA--C 1.563 1.462 0 CA-C-O 123.279 1.514 . . . . 0.0 109.558 -174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.276 8.1 p90 -152.38 -93.76 0.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -106.51 89.33 3.0 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.739 0 CA-C-O 117.707 -1.607 . . . . 0.0 113.376 -176.753 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 N-CA-C 107.29 -2.324 . . . . 0.0 107.29 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -174.77 150.48 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 124.966 1.306 . . . . 0.0 108.757 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.61 126.67 4.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.415 -1.428 . . . . 0.0 108.3 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.376 24.7 mm -111.67 48.44 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.58 2.115 0 CA-C-O 122.747 1.26 . . . . 0.0 112.035 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.29 -55.98 0.02 OUTLIER Pre-proline 0 CA--C 1.574 1.897 0 CA-C-O 116.197 -1.858 . . . . 0.0 113.691 173.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.64 -14.42 35.64 Favored 'Trans proline' 0 CA--C 1.576 2.593 0 CA-C-N 125.337 2.942 . . . . 0.0 119.121 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER -129.6 -55.03 1.16 Allowed 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.622 1.569 . . . . 0.0 110.754 178.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.21 -16.6 59.8 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.516 2.043 . . . . 0.0 116.516 175.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.465 1.9 p30 65.24 25.05 12.27 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 120.106 3.373 . . . . 0.0 120.106 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.436 3.6 mp0 -90.02 -36.41 14.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.45 -32.9 0.64 Allowed Glycine 0 CA--C 1.538 1.508 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.4 p -177.3 156.31 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 N-CA-C 118.076 2.621 . . . . 0.0 118.076 -174.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 33' ' ' LEU 1.099 1.2 mp -155.61 -156.11 0.62 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 158.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HG2' ' SG ' ' A' ' 102' ' ' CYS 0.29 1.1 tmmt? -128.86 121.78 28.95 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 120.252 1.387 . . . . 0.0 113.359 -165.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 10.4 t -97.42 96.69 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.536 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.602 -178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 102' ' ' CYS 0.501 0.4 OUTLIER -55.25 132.2 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 -173.547 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -122.89 -71.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.828 -0.545 . . . . 0.0 110.867 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -112.95 96.25 5.84 Favored 'General case' 0 CA--C 1.575 1.941 0 N-CA-C 104.354 -2.461 . . . . 0.0 104.354 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.12 162.54 2.53 Favored 'General case' 0 CA--C 1.591 2.525 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.94 -174.99 50.12 Favored Glycine 0 CA--C 1.55 2.256 0 O-C-N 119.658 -1.901 . . . . 0.0 117.586 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.5 p -63.61 -43.22 97.52 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.97 54.19 0.46 Allowed Glycine 0 N--CA 1.48 1.568 0 N-CA-C 119.283 2.473 . . . . 0.0 119.283 176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 47.2 p -136.7 -65.8 0.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.38 0.672 . . . . 0.0 110.95 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -127.04 163.45 23.72 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.9 p -122.83 142.46 37.91 Favored Pre-proline 0 CA--C 1.58 2.114 0 CA-C-N 110.134 -3.212 . . . . 0.0 109.399 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -60.6 119.82 7.22 Favored 'Trans proline' 0 CA--C 1.581 2.834 0 C-N-CA 123.143 2.562 . . . . 0.0 118.177 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.53 167.48 12.94 Favored 'General case' 0 CA--C 1.571 1.785 0 O-C-N 119.238 -2.164 . . . . 0.0 110.753 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.307 0.3 OUTLIER -59.47 132.09 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.956 0 O-C-N 120.132 -1.605 . . . . 0.0 112.187 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.48 2.62 88.91 Favored Glycine 0 CA--C 1.56 2.903 0 N-CA-C 118.558 2.183 . . . . 0.0 118.558 -174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -74.71 143.64 44.07 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 121.391 2.596 . . . . 0.0 113.442 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 107.3 18.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.402 1.5 t -103.43 123.67 57.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 126.762 2.025 . . . . 0.0 111.908 -166.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -111.32 109.93 20.17 Favored 'General case' 0 CA--C 1.573 1.834 0 O-C-N 120.936 -1.102 . . . . 0.0 108.026 -176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.9 m -120.63 164.48 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . 0.321 11.4 m-70 -121.6 117.53 26.97 Favored 'General case' 0 N--CA 1.512 2.633 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.263 2.6 p90 -114.05 152.14 31.45 Favored 'General case' 0 CA--C 1.578 2.055 0 CA-C-O 123.369 1.556 . . . . 0.0 114.717 -178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.5 m -130.9 149.58 52.46 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 164.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.59 139.64 7.01 Favored Glycine 0 CA--C 1.551 2.331 0 O-C-N 118.735 -2.478 . . . . 0.0 116.681 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.4 ' HE3' HG23 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -134.93 151.39 50.82 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 126.292 1.837 . . . . 0.0 115.206 -175.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -95.34 176.17 6.3 Favored 'General case' 0 CA--C 1.555 1.166 0 O-C-N 121.543 -0.723 . . . . 0.0 112.288 171.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.271 1.8 pt? -62.96 -24.97 68.13 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.58 -2.9 15.66 Favored 'General case' 0 CA--C 1.595 2.694 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.87 167.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.83 36.84 61.28 Favored Glycine 0 N--CA 1.504 3.186 0 CA-C-N 121.355 1.889 . . . . 0.0 114.043 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -106.14 121.65 44.58 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -75.54 89.33 2.71 Favored 'General case' 0 CA--C 1.579 2.086 0 O-C-N 121.9 -0.5 . . . . 0.0 110.482 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -63.63 -31.83 73.11 Favored 'General case' 0 CA--C 1.565 1.535 0 O-C-N 119.568 -1.957 . . . . 0.0 113.767 174.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -153.35 156.38 38.23 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 124.474 2.083 . . . . 0.0 113.095 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 77.1 p -157.96 96.4 1.47 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.673 -2.058 . . . . 0.0 107.611 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.0 t -55.77 -34.34 65.15 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.92 -30.56 66.01 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 173.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -42.51 -51.73 4.96 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 119.387 3.106 . . . . 0.0 119.387 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mtm-85 -95.35 27.75 3.19 Favored 'General case' 0 CA--C 1.579 2.091 0 C-N-CA 125.763 1.625 . . . . 0.0 113.644 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.283 31.6 ttpt 71.99 -13.25 0.61 Allowed 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.9 174.91 8.61 Favored 'General case' 0 CA--C 1.575 1.942 0 CA-C-O 123.745 1.736 . . . . 0.0 114.283 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -121.72 171.86 8.56 Favored 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.18 148.06 43.52 Favored 'General case' 0 CA--C 1.571 1.771 0 CA-C-O 122.5 1.143 . . . . 0.0 108.761 172.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.8 t -169.37 142.97 2.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 119.15 -2.219 . . . . 0.0 107.398 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.529 ' CG ' HG11 ' A' ' 85' ' ' VAL . 14.4 p90 -149.83 174.17 12.94 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.533 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -108.25 125.67 51.93 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.39 112.04 1.14 Allowed 'General case' 0 CA--C 1.576 1.948 0 O-C-N 121.055 -1.028 . . . . 0.0 112.236 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.16 57.04 11.27 Favored Glycine 0 N--CA 1.505 3.291 0 O-C-N 120.512 -1.368 . . . . 0.0 114.761 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.592 ' HG3' ' H ' ' A' ' 83' ' ' GLY 0.251 1.9 pptp? -106.17 -73.77 0.67 Allowed 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 123.898 1.808 . . . . 0.0 111.461 -175.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.592 ' H ' ' HG3' ' A' ' 82' ' ' LYS . . . -110.33 -52.75 0.59 Allowed Glycine 0 N--CA 1.502 3.084 0 C-N-CA 127.203 2.335 . . . . 0.0 108.346 169.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.757 22.9 tt0 116.71 140.65 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 128.209 3.862 . . . . 0.0 115.003 165.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.529 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.332 8.6 m -79.92 -108.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 1 CA-C-N 105.296 -5.411 . . . . 0.0 105.04 179.691 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.496 HG13 ' H ' ' A' ' 89' ' ' TRP 0.25 21.0 pt -120.32 154.32 23.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 124.419 2.057 . . . . 0.0 106.541 163.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.272 13.5 tmtt? -66.61 -29.62 69.71 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-N 113.701 -1.591 . . . . 0.0 113.337 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.42 77.92 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 117.122 -1.418 . . . . 0.0 111.911 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.496 ' H ' HG13 ' A' ' 86' ' ' ILE . 38.5 m0 -73.19 -46.07 52.69 Favored 'General case' 0 C--N 1.363 1.181 0 CA-C-N 121.043 1.747 . . . . 0.0 112.704 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.82 -37.27 73.52 Favored 'General case' 0 CA--C 1.575 1.94 0 CA-C-N 122.018 2.19 . . . . 0.0 114.335 175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.288 1.8 mp -69.27 -64.94 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.994 0 CA-C-N 119.731 1.15 . . . . 0.0 111.215 175.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 104' ' ' ILE . . . -63.67 -38.81 92.52 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.442 HG22 ' SD ' ' A' ' 96' ' ' MET 0.341 9.6 t -70.13 -33.08 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 120.903 1.683 . . . . 0.0 111.424 177.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.71 -38.06 66.6 Favored 'General case' 0 CA--C 1.579 2.075 0 CA-C-N 121.584 1.993 . . . . 0.0 112.634 165.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 9.75 5.98 Favored 'General case' 0 CA--C 1.598 2.818 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.442 ' SD ' HG22 ' A' ' 93' ' ' VAL . 30.3 mtp -87.53 -178.59 6.16 Favored 'General case' 0 N--CA 1.511 2.59 0 CA-C-N 123.315 2.78 . . . . 0.0 116.516 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -135.95 146.8 47.68 Favored 'General case' 0 N--CA 1.51 2.574 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -175.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t -51.66 123.2 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 103.1 -45.83 1.28 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-O 116.308 -2.384 . . . . 0.0 114.066 172.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 101' ' ' LEU . 29.7 mt-10 -148.17 -173.86 4.42 Favored 'General case' 0 N--CA 1.513 2.702 0 CA-C-N 121.399 2.6 . . . . 0.0 112.975 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.435 HD13 ' H ' ' A' ' 102' ' ' CYS 0.757 0.2 OUTLIER -157.6 -135.68 0.04 OUTLIER 'General case' 0 CA--C 1.583 2.226 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 177.755 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 103' ' ' ARG . 0.1 OUTLIER -160.18 -150.08 0.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -165.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.599 ' N ' ' SG ' ' A' ' 102' ' ' CYS . 47.5 ptt85 -120.92 130.68 53.97 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 124.441 2.067 . . . . 0.0 111.979 169.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 92' ' ' ALA . 3.6 mt -79.6 141.13 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.02 0 CA-C-N 112.912 -1.949 . . . . 0.0 107.935 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.9 m -129.79 109.84 11.26 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.582 ' SG ' ' CD1' ' A' ' 127' ' ' LEU . 2.1 p -132.49 151.79 51.78 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -171.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -87.8 142.19 32.28 Favored Pre-proline 0 CA--C 1.578 2.019 0 CA-C-N 114.044 -1.434 . . . . 0.0 109.778 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . 0.298 41.7 Cg_exo -54.67 -12.51 4.55 Favored 'Trans proline' 0 CA--C 1.562 1.918 0 N-CA-C 120.304 3.155 . . . . 0.0 120.304 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.46 -40.8 97.78 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 120.925 1.693 . . . . 0.0 113.604 171.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -82.22 -3.34 54.88 Favored 'General case' 0 CA--C 1.583 2.225 0 C-N-CA 124.652 1.181 . . . . 0.0 113.332 171.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.3 -114.27 0.24 Allowed 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.11 8.12 45.19 Favored 'General case' 0 N--CA 1.514 2.731 0 CA-C-N 121.024 1.738 . . . . 0.0 114.866 -178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.82 141.22 43.04 Favored Glycine 0 N--CA 1.497 2.705 0 CA-C-N 123.231 2.741 . . . . 0.0 116.195 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.297 15.4 m 78.39 -54.57 0.48 Allowed 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 124.309 1.044 . . . . 0.0 113.423 -174.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.3 -49.44 7.25 Favored 'General case' 0 CA--C 1.568 1.672 0 N-CA-C 117.891 2.552 . . . . 0.0 117.891 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.58 153.16 28.62 Favored Glycine 0 CA--C 1.547 2.035 0 CA-C-N 119.663 1.12 . . . . 0.0 114.379 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 10.8 t -82.45 107.21 8.27 Favored Pre-proline 0 CA--C 1.582 2.176 0 CA-C-O 116.275 -1.822 . . . . 0.0 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.499 1.0 OUTLIER -4.14 -99.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.588 3.184 1 C-N-CA 125.768 4.312 . . . . 0.0 122.332 -174.6 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -88.78 37.42 0.41 Allowed 'Trans proline' 0 CA--C 1.58 2.824 0 CA-C-N 127.743 3.801 . . . . 0.0 115.95 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -145.29 -30.5 0.42 Allowed 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 118.865 2.913 . . . . 0.0 118.865 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.499 ' HB ' ' H ' ' A' ' 117' ' ' SER . 32.7 mt -130.57 137.37 30.66 Favored Pre-proline 0 N--CA 1.504 2.261 0 CA-C-N 121.471 1.941 . . . . 0.0 113.331 -172.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -85.47 -175.59 2.0 Allowed 'Trans proline' 0 CA--C 1.591 3.339 0 CA-C-N 122.916 2.077 . . . . 0.0 112.829 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -59.59 9.51 0.06 OUTLIER 'Trans proline' 0 CA--C 1.58 2.777 0 N-CA-C 122.011 3.812 . . . . 0.0 122.011 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -157.85 93.4 1.26 Allowed 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 121.442 1.928 . . . . 0.0 110.752 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.38 98.15 4.01 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 122.924 2.602 . . . . 0.0 108.989 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.9 m -60.25 131.77 51.83 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.026 -0.988 . . . . 0.0 108.988 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' CD1' ' SG ' ' A' ' 106' ' ' CYS . 0.3 OUTLIER -140.94 177.56 7.96 Favored 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 124.66 2.171 . . . . 0.0 114.612 -168.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG23 ' HE3' ' A' ' 59' ' ' TRP . 1.7 m -148.19 144.95 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.411 0 C-N-CA 126.704 2.002 . . . . 0.0 108.189 -175.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.27 0.5 OUTLIER -133.76 124.12 26.07 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 172.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -88.58 97.81 11.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 101' ' ' LEU . 2.5 t -108.23 140.95 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -175.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -126.15 119.28 27.11 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 23.3 tp -95.94 121.99 38.27 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -87.6 -46.6 9.4 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -165.13 157.23 15.46 Favored 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 123.855 1.788 . . . . 0.0 108.642 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -152.26 -95.49 0.05 Allowed 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.64 94.09 3.78 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 171.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.568 3.37 0 CA-C-O 117.63 -1.65 . . . . 0.0 114.561 -173.54 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 121.643 3.417 . . . . 0.0 121.643 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.19 154.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 CA-C-O 122.483 1.135 . . . . 0.0 110.752 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -153.14 141.33 20.48 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 121.588 0.709 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.347 19.4 pt -125.48 78.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-O 124.842 2.258 . . . . 0.0 110.274 174.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -137.15 -37.7 0.02 OUTLIER Pre-proline 0 CA--C 1.577 1.993 0 CA-C-O 114.431 -2.699 . . . . 0.0 116.496 172.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -59.21 93.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.582 2.91 0 CA-C-N 126.69 3.425 . . . . 0.0 112.691 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.394 74.3 mmtt 70.39 -12.03 0.55 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -174.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -77.92 -23.38 48.66 Favored 'General case' 0 CA--C 1.581 2.168 0 C-N-CA 124.99 1.316 . . . . 0.0 113.589 174.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.469 1.4 p30 64.75 7.05 3.6 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 121.282 3.808 . . . . 0.0 121.282 176.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -84.55 -9.2 58.54 Favored 'General case' 0 CA--C 1.584 2.267 0 CA-C-N 120.503 1.501 . . . . 0.0 114.894 176.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.49 -1.14 62.28 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 p -179.91 159.86 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 120.961 2.381 . . . . 0.0 113.755 -171.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 33' ' ' LEU 0.826 2.5 tp -148.23 -169.99 3.48 Favored 'General case' 0 CA--C 1.567 1.624 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.046 160.747 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 177.1 -175.23 0.13 Allowed 'General case' 0 N--CA 1.509 2.49 0 N-CA-C 118.708 2.855 . . . . 0.0 118.708 -158.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG13 ' H ' ' A' ' 36' ' ' ILE 0.955 0.4 OUTLIER 104.28 -166.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.066 1 N-CA-C 126.537 5.754 . . . . 0.0 126.537 161.019 . . . . . . . . 5 4 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.53 ' H ' HG13 ' A' ' 35' ' ' VAL 0.392 25.0 mm -25.6 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.324 1 N-CA-C 126.134 5.605 . . . . 0.0 126.134 -167.468 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 -60.45 0.97 Allowed 'General case' 0 CA--C 1.583 2.237 0 CA-C-N 110.642 -2.981 . . . . 0.0 106.649 167.165 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -120.07 109.11 15.08 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -64.79 164.98 11.29 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -150.39 152.91 24.71 Favored Glycine 0 CA--C 1.548 2.125 0 O-C-N 120.402 -1.437 . . . . 0.0 112.401 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.8 p -121.09 -91.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.93 25.39 0.63 Allowed Glycine 0 N--CA 1.506 3.356 1 N-CA-C 124.184 4.434 . . . . 0.0 124.184 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.305 53.1 p 83.31 73.07 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.644 1.978 . . . . 0.0 109.185 -172.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.343 0.0 OUTLIER -0.8 -120.04 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.907 1 N-CA-C 123.04 4.459 . . . . 0.0 123.04 -177.383 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . 0.255 15.5 p -107.46 137.49 19.67 Favored Pre-proline 0 CA--C 1.58 2.11 0 C-N-CA 124.735 1.214 . . . . 0.0 112.722 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.257 11.8 Cg_endo -109.48 -18.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.582 2.888 0 N-CA-C 115.84 1.438 . . . . 0.0 115.84 167.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.51 31.5 mtt 78.96 -155.22 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 169.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.323 1.0 OUTLIER -43.84 129.71 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -174.083 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.26 -10.34 71.53 Favored Glycine 0 CA--C 1.554 2.517 0 CA-C-O 116.073 -2.515 . . . . 0.0 117.305 -173.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -75.89 135.0 40.14 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 123.457 3.629 . . . . 0.0 113.886 -177.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.2 tpt85 -86.49 96.09 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 0.0 109.648 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -91.27 133.02 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 123.583 0.753 . . . . 0.0 111.828 -172.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.71 102.13 10.45 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 102.307 -3.22 . . . . 0.0 102.307 178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.97 -178.21 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.652 0 CA-C-O 124.315 2.007 . . . . 0.0 113.789 -171.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.467 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -145.47 119.43 9.35 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.655 171.539 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -109.69 152.02 26.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.752 1.615 . . . . 0.0 114.128 -178.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.5 m -127.43 131.67 50.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 159.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.9 144.1 15.61 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-O 124.422 2.123 . . . . 0.0 116.124 -177.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -133.6 156.99 46.85 Favored 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 111.515 -2.342 . . . . 0.0 112.844 -175.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.05 163.24 13.03 Favored 'General case' 0 CA--C 1.556 1.189 0 O-C-N 121.308 -0.87 . . . . 0.0 109.157 168.182 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.268 9.1 tt -65.51 -20.92 66.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.124 -1.61 . . . . 0.0 114.937 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.74 -4.63 6.78 Favored 'General case' 0 CA--C 1.608 3.194 0 CA-C-N 119.926 1.239 . . . . 0.0 112.705 165.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.01 40.71 29.39 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.278 -1.514 . . . . 0.0 116.345 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 83.9 m -117.47 122.52 43.96 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.17 100.32 2.05 Favored 'General case' 0 CA--C 1.576 1.944 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -67.7 -38.69 84.01 Favored 'General case' 0 CA--C 1.559 1.3 0 O-C-N 119.621 -1.924 . . . . 0.0 112.105 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -165.44 173.28 11.22 Favored 'General case' 0 CA--C 1.57 1.743 0 CA-C-O 125.667 2.651 . . . . 0.0 114.614 -177.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 69' ' ' SER . 18.7 t -157.3 -91.53 0.03 OUTLIER 'General case' 0 CA--C 1.577 1.983 1 N-CA-C 97.477 -5.009 . . . . 0.0 97.477 170.867 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.433 ' H ' ' HB3' ' A' ' 68' ' ' SER . 73.2 m 76.39 102.15 0.07 Allowed 'General case' 0 C--O 1.239 0.534 1 CA-C-O 97.027 -10.987 . . . . 0.0 103.933 171.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.556 HD22 ' HA ' ' A' ' 75' ' ' LYS . 9.3 mt -49.04 0.98 0.01 OUTLIER 'General case' 0 CA--C 1.598 2.807 3 O-C-N 75.771 -29.33 . . . . 0.0 121.981 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' SER 0.408 8.2 p-10 57.26 -60.47 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 121.495 3.887 . . . . 0.0 121.495 176.856 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -76.93 28.88 0.13 Allowed 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 118.243 2.683 . . . . 0.0 118.243 -177.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.336 53.9 tttm 80.77 -52.59 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 126.414 1.886 . . . . 0.0 112.422 -176.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -100.22 -160.32 0.79 Allowed 'General case' 0 CA--C 1.576 1.945 0 CA-C-O 122.307 1.051 . . . . 0.0 108.468 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HA ' HD22 ' A' ' 70' ' ' LEU . 8.7 mtmp? -65.11 156.74 30.63 Favored 'General case' 0 CA--C 1.578 2.026 0 O-C-N 120.502 -1.374 . . . . 0.0 113.939 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.481 ' H ' HD22 ' A' ' 70' ' ' LEU 0.278 17.9 t80 -65.71 151.5 46.42 Favored 'General case' 0 CA--C 1.571 1.76 0 CA-C-N 122.43 2.377 . . . . 0.0 108.885 179.179 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.5 p -160.55 143.1 12.99 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 119.946 -1.721 . . . . 0.0 112.456 -175.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CG ' HG11 ' A' ' 85' ' ' VAL . 31.4 p90 -157.2 -179.85 8.59 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.001 176.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -119.88 125.73 49.21 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 104.353 -2.462 . . . . 0.0 104.353 172.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.83 108.1 0.8 Allowed 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -172.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.05 56.55 6.32 Favored Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.288 -0.883 . . . . 0.0 113.547 -173.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -97.74 -65.4 0.97 Allowed 'General case' 0 N--CA 1.512 2.656 0 CA-C-O 124.933 2.302 . . . . 0.0 113.148 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -128.39 -49.68 0.15 Allowed Glycine 0 CA--C 1.56 2.895 0 N-CA-C 103.719 -3.752 . . . . 0.0 103.719 172.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.903 1.8 tm-20 119.99 139.43 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-O 127.226 3.393 . . . . 0.0 115.881 163.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.451 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.36 9.2 m -79.94 -105.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.965 1 CA-C-N 106.782 -4.736 . . . . 0.0 105.247 -178.351 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.47 HG13 ' H ' ' A' ' 89' ' ' TRP . 36.1 pt -122.5 154.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 124.289 1.995 . . . . 0.0 105.963 165.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.282 2.6 mptt -68.29 -30.67 69.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.59 -36.15 81.78 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 115.791 -2.052 . . . . 0.0 110.617 167.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.47 ' H ' HG13 ' A' ' 86' ' ' ILE . 41.6 m0 -73.11 -45.25 58.12 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 122.698 2.499 . . . . 0.0 112.948 174.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.36 -38.31 71.25 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 121.289 1.859 . . . . 0.0 114.407 175.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.34 28.4 mt -69.25 -60.97 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.981 0 CA-C-N 118.997 0.817 . . . . 0.0 112.249 175.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.8 -31.25 70.98 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 117.723 2.49 . . . . 0.0 117.723 179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.404 HG13 ' SD ' ' A' ' 96' ' ' MET 0.303 13.5 t -79.08 -28.67 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.901 0 CA-C-N 119.821 1.191 . . . . 0.0 110.933 176.01 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.45 85.58 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 120.879 1.672 . . . . 0.0 112.481 166.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.0 p -73.01 0.34 11.63 Favored 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 116.532 2.049 . . . . 0.0 116.532 173.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.404 ' SD ' HG13 ' A' ' 93' ' ' VAL . 9.1 mtt -82.21 126.69 32.37 Favored 'General case' 0 CA--C 1.578 2.056 0 CA-C-N 122.888 2.585 . . . . 0.0 115.889 179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -90.86 130.49 36.81 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 173.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.0 t -9.49 80.17 0.0 OUTLIER 'Isoleucine or valine' 1 N--CA 1.541 4.076 0 CA-C-N 120.433 1.469 . . . . 0.0 108.92 -157.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -60.83 63.38 0.01 OUTLIER Glycine 0 N--CA 1.51 3.591 0 CA-C-N 109.748 -3.387 . . . . 0.0 119.429 -145.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.489 8.0 tp10 -29.63 -86.86 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 118.084 2.624 . . . . 0.0 118.084 -170.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.267 27.7 tp -130.9 113.28 13.84 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.869 0.867 . . . . 0.0 110.192 169.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.6 m -135.38 170.98 15.1 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.37 1.081 . . . . 0.0 109.653 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 161.59 21.85 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 123.593 1.663 . . . . 0.0 113.989 178.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.2 mt -127.66 133.98 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.993 0 CA-C-N 113.716 -1.583 . . . . 0.0 109.028 175.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 22.8 m -135.24 100.12 4.45 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 177.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.4 p -125.52 148.24 48.96 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 118.733 2.864 . . . . 0.0 118.733 -171.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -63.8 143.22 98.1 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.807 -1.568 . . . . 0.0 110.612 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.08 -11.8 23.48 Favored 'Trans proline' 0 CA--C 1.578 2.696 0 CA-C-N 125.268 2.917 . . . . 0.0 116.977 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.0 -39.63 95.33 Favored 'General case' 0 CA--C 1.573 1.842 0 CA-C-N 121.187 1.812 . . . . 0.0 112.391 171.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -75.71 3.92 8.83 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 169.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.68 -105.45 0.17 Allowed 'General case' 0 CA--C 1.581 2.157 0 CA-C-N 120.368 1.44 . . . . 0.0 114.078 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -114.02 13.51 18.21 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-N 120.014 1.279 . . . . 0.0 114.116 -177.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -57.23 -25.66 54.72 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 121.479 3.352 . . . . 0.0 121.479 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.6 p -67.49 -57.34 6.7 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 119.463 1.632 . . . . 0.0 113.318 175.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.24 -15.15 7.31 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.8 151.74 20.38 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 122.684 2.493 . . . . 0.0 112.175 -176.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.517 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 10.1 t -75.88 119.34 76.73 Favored Pre-proline 0 CA--C 1.58 2.104 0 CA-C-O 116.158 -1.877 . . . . 0.0 108.172 176.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . 0.295 96.6 Cg_exo -35.59 -47.62 0.92 Allowed 'Trans proline' 0 CA--C 1.579 2.736 0 N-CA-C 121.884 3.763 . . . . 0.0 121.884 -175.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -89.95 -10.7 3.42 Favored 'Trans proline' 0 CA--C 1.578 2.679 0 CA-C-N 124.789 2.746 . . . . 0.0 118.251 177.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -144.99 -49.91 0.25 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 119.13 3.011 . . . . 0.0 119.13 -174.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.517 ' HB ' ' H ' ' A' ' 117' ' ' SER . 80.2 mt -80.82 139.28 50.18 Favored Pre-proline 0 CA--C 1.594 2.653 0 CA-C-O 116.353 -1.784 . . . . 0.0 114.975 -171.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -97.58 172.42 0.69 Allowed 'Trans proline' 0 CA--C 1.592 3.405 0 CA-C-N 125.754 3.091 . . . . 0.0 114.525 176.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -64.27 2.54 1.11 Allowed 'Trans proline' 0 CA--C 1.576 2.58 0 N-CA-C 120.272 3.143 . . . . 0.0 120.272 175.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -146.37 57.62 1.19 Allowed 'General case' 0 CA--C 1.58 2.105 0 O-C-N 119.754 -1.841 . . . . 0.0 114.237 178.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -130.32 114.46 15.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 119.745 -1.847 . . . . 0.0 106.989 173.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 58.7 m -59.88 130.89 48.99 Favored 'General case' 0 CA--C 1.586 2.359 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.201 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.91 156.41 18.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 122.137 2.244 . . . . 0.0 115.165 -173.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.0 t -143.68 120.23 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 CA-C-N 112.294 -2.23 . . . . 0.0 107.727 -173.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.278 4.1 m-85 -140.7 129.92 23.61 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 119.756 -1.84 . . . . 0.0 110.367 174.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.75 111.99 23.74 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 172.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.46 131.95 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.601 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.39 108.54 17.74 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.825 0.85 . . . . 0.0 109.645 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 tt -98.45 116.34 30.46 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.574 1.178 . . . . 0.0 109.886 -175.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -83.94 -51.58 7.03 Favored 'General case' 0 CA--C 1.574 1.878 0 CA-C-N 114.121 -1.4 . . . . 0.0 113.73 -177.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 152.87 30.87 Favored 'General case' 0 CA--C 1.58 2.113 0 C-N-CA 124.918 1.287 . . . . 0.0 109.962 175.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.28 0.0 OUTLIER -131.65 -75.91 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.839 -1.163 . . . . 0.0 112.594 176.706 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.291 57.6 tttm -79.79 -57.1 3.82 Favored 'General case' 0 CA--C 1.584 2.281 0 CA-C-O 115.776 -2.059 . . . . 0.0 115.128 -177.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.017 0 CA-C-N 125.083 3.583 . . . . 0.0 119.602 -179.255 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.887 1 N-CA-C 127.638 5.815 . . . . 0.0 127.638 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.473 3.5 t 63.44 -64.24 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 118.545 2.794 . . . . 0.0 118.545 177.225 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -155.57 157.06 36.19 Favored 'General case' 0 CA--C 1.573 1.836 0 CA-C-N 121.749 2.068 . . . . 0.0 115.638 177.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.581 1.1 pt 137.01 -61.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 C-N-CA 127.247 2.219 . . . . 0.0 116.92 172.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 1.057 70.0 m 82.74 68.56 0.11 Allowed Pre-proline 0 CA--C 1.582 2.192 0 O-C-N 116.984 -3.572 . . . . 0.0 114.727 -170.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -31.9 -24.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.51 2 N-CA-C 127.59 5.958 . . . . 0.0 127.59 -174.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.296 0.0 OUTLIER -69.18 -61.58 1.73 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 122.033 2.197 . . . . 0.0 111.507 176.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -95.95 -8.35 34.06 Favored 'General case' 0 CA--C 1.586 2.348 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 170.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . 0.467 2.0 p30 61.85 7.73 2.14 Favored 'General case' 0 CA--C 1.588 2.442 0 N-CA-C 118.432 2.752 . . . . 0.0 118.432 -175.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -90.45 -38.59 13.16 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 120.793 3.627 . . . . 0.0 120.793 178.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.57 -51.03 6.77 Favored Glycine 0 N--CA 1.483 1.822 1 N-CA-C 125.188 4.835 . . . . 0.0 125.188 -157.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 p -174.75 166.13 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.623 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -172.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . 0.759 1.1 tp -159.53 -153.11 0.34 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 118.221 -0.895 . . . . 0.0 112.437 163.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -157.34 137.29 12.48 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 122.042 2.201 . . . . 0.0 116.394 -169.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 p -104.4 133.37 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 O-C-N 121.45 -0.781 . . . . 0.0 109.737 174.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.513 HD13 ' SG ' ' A' ' 102' ' ' CYS 0.301 1.0 OUTLIER -75.84 133.44 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 O-C-N 120.522 -1.361 . . . . 0.0 113.602 -177.627 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -114.65 -51.58 2.74 Favored 'General case' 0 CA--C 1.575 1.925 0 C-N-CA 124.606 1.162 . . . . 0.0 112.015 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.09 96.15 2.95 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.62 171.06 0.22 Allowed 'General case' 0 CA--C 1.591 2.539 0 CA-C-N 122.106 2.23 . . . . 0.0 116.444 177.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.26 -172.19 22.65 Favored Glycine 0 CA--C 1.547 2.09 0 O-C-N 120.018 -1.676 . . . . 0.0 116.905 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 t -166.77 -69.45 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.043 0.937 . . . . 0.0 110.006 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.7 -103.5 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 120.738 3.055 . . . . 0.0 120.738 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.437 ' H ' HG21 ' A' ' 98' ' ' VAL . 43.4 p -113.38 49.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 123.247 1.499 . . . . 0.0 111.693 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.443 4.7 pt-20 41.14 -116.85 0.31 Allowed 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 119.598 3.185 . . . . 0.0 119.598 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.7 p -150.77 137.08 11.07 Favored Pre-proline 0 CA--C 1.577 2.009 0 C-N-CA 124.925 1.29 . . . . 0.0 113.579 -175.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . 0.251 6.2 Cg_endo -117.19 -26.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.583 2.942 0 C-N-CA 121.782 1.655 . . . . 0.0 115.984 171.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . 0.566 32.3 mtt 82.31 -146.47 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.402 0.3 OUTLIER -47.0 128.94 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -172.647 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.11 90.62 Favored Glycine 0 CA--C 1.56 2.857 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -174.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -79.6 144.69 33.6 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 122.635 3.217 . . . . 0.0 114.914 -178.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.5 tpt85 -75.64 131.33 39.87 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 119.252 0.933 . . . . 0.0 109.088 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.362 2.1 t -131.39 132.03 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.729 0 C-N-CA 124.141 0.976 . . . . 0.0 112.217 -166.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -117.7 107.13 13.81 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 76' ' ' PHE . 1.1 m -116.31 159.23 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 122.972 1.368 . . . . 0.0 114.296 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 16.9 m170 -116.32 123.57 47.98 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 116.806 -1.568 . . . . 0.0 109.223 166.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . 0.323 0.1 OUTLIER -119.11 135.38 54.68 Favored 'General case' 0 CA--C 1.577 2.017 0 CA-C-N 120.449 1.477 . . . . 0.0 114.303 176.592 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.4 m -104.18 149.17 25.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 102.535 -3.135 . . . . 0.0 102.535 159.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.12 144.21 11.14 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 118.622 -2.548 . . . . 0.0 115.656 178.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.426 ' CE3' HG12 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -136.26 149.11 48.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 112.452 -1.874 . . . . 0.0 114.866 -173.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 tp -85.17 165.53 17.33 Favored 'General case' 0 CA--C 1.571 1.761 0 CA-C-O 123.249 1.499 . . . . 0.0 107.721 167.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD12 ' H ' ' A' ' 126' ' ' THR 0.277 0.0 OUTLIER -60.5 -27.32 67.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 178.277 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -69.81 -2.17 11.38 Favored 'General case' 0 CA--C 1.595 2.682 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 171.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.21 45.39 7.05 Favored Glycine 0 N--CA 1.499 2.875 0 O-C-N 120.448 -1.407 . . . . 0.0 113.594 -176.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.3 m -117.65 113.89 22.58 Favored 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -176.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -79.9 93.03 5.59 Favored 'General case' 0 CA--C 1.585 2.311 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.794 -178.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -71.24 -30.04 65.85 Favored 'General case' 0 CA--C 1.566 1.579 0 O-C-N 119.085 -2.259 . . . . 0.0 115.403 175.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -146.86 156.34 43.03 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.825 1.648 . . . . 0.0 113.717 177.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 t -157.9 87.87 0.95 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 176.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 75' ' ' LYS . 47.2 t -53.98 -42.31 68.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 174.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 70' ' ' LEU . 4.7 mp -64.3 -39.3 93.64 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 127.523 2.329 . . . . 0.0 113.481 178.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -60.22 -48.45 81.7 Favored 'General case' 0 CA--C 1.572 1.808 0 C-N-CA 125.45 1.5 . . . . 0.0 113.824 173.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -78.59 -23.44 46.01 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 176.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.348 0.1 OUTLIER 115.27 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 128.572 2.749 . . . . 0.0 111.236 -179.275 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -134.43 149.57 50.77 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -175.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.406 ' HB3' ' CB ' ' A' ' 69' ' ' SER 0.289 19.4 tptm -166.53 -83.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 121.112 3.745 . . . . 0.0 121.112 173.805 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.587 ' HB3' HG23 ' A' ' 54' ' ' VAL 0.401 0.4 OUTLIER -89.02 146.7 24.69 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.963 2.579 . . . . 0.0 117.963 -161.839 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.3 p -165.48 129.0 2.23 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 120.701 -1.249 . . . . 0.0 107.957 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CG ' HG11 ' A' ' 85' ' ' VAL . 27.2 p90 -142.06 -165.04 1.92 Allowed 'General case' 0 CA--C 1.567 1.614 0 CA-C-O 122.36 1.076 . . . . 0.0 110.323 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.283 9.5 t0 -135.03 125.75 27.14 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 172.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 mt -48.0 112.06 0.52 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.8 92.76 Favored Glycine 1 N--CA 1.517 4.079 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -174.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.306 5.6 mmtt -138.38 -80.16 0.34 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -168.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.94 76.61 0.46 Allowed Glycine 0 N--CA 1.503 3.131 1 N-CA-C 99.686 -5.365 . . . . 0.0 99.686 170.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.383 32.7 tp10 -78.63 157.04 28.77 Favored 'General case' 0 CA--C 1.555 1.172 1 CA-C-O 130.104 4.764 . . . . 0.0 119.5 -159.513 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.439 HG11 ' CG ' ' A' ' 78' ' ' PHE 0.335 33.6 m -107.73 -140.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 1 CA-C-N 101.964 -6.926 . . . . 0.0 107.183 -173.288 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 89' ' ' TRP . 12.2 pt -101.08 154.52 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 122.98 1.371 . . . . 0.0 109.452 170.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.517 0.0 OUTLIER -69.94 -21.27 63.28 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 175.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.73 85.78 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 117.692 -1.146 . . . . 0.0 111.366 165.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.453 ' H ' HG13 ' A' ' 86' ' ' ILE . 44.5 m0 -73.91 -40.25 63.28 Favored 'General case' 0 C--N 1.366 1.284 0 CA-C-N 120.399 1.454 . . . . 0.0 113.073 173.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -57.62 -37.08 72.68 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-N 119.924 1.238 . . . . 0.0 113.833 173.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . 0.27 1.5 mp -64.05 -56.83 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 119.431 1.014 . . . . 0.0 110.836 173.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.52 94.48 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 177.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.489 HG22 ' CE ' ' A' ' 96' ' ' MET . 79.3 t -63.27 -43.94 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 119.031 0.832 . . . . 0.0 112.519 174.129 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.07 66.91 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-N 119.695 1.134 . . . . 0.0 113.931 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.0 p -92.29 24.61 3.3 Favored 'General case' 0 CA--C 1.588 2.439 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.601 ' SD ' ' HB3' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -122.95 140.07 53.4 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 121.622 2.01 . . . . 0.0 114.874 178.588 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -90.4 168.08 12.14 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.403 1.081 . . . . 0.0 111.483 174.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.437 HG21 ' H ' ' A' ' 43' ' ' THR . 78.3 t -59.0 135.83 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.546 0 O-C-N 119.46 -2.025 . . . . 0.0 112.46 -176.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.42 -21.38 8.8 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-N 124.152 3.16 . . . . 0.0 117.107 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -67.49 102.74 1.18 Allowed 'General case' 0 CA--C 1.569 1.691 0 CA-C-N 118.476 1.138 . . . . 0.0 111.999 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 132' ' ' GLU . 0.7 OUTLIER -98.24 131.83 44.25 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.496 1.119 . . . . 0.0 109.062 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.513 ' SG ' HD13 ' A' ' 36' ' ' ILE . 86.0 m -136.8 -169.71 2.53 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.553 1.168 . . . . 0.0 113.422 -176.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 130' ' ' GLU 0.309 3.8 mtt180 -135.91 113.52 10.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-O 124.942 2.306 . . . . 0.0 108.732 172.548 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.2 mt -76.97 136.15 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.744 -177.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -117.76 101.7 8.53 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 174.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 127' ' ' LEU . 5.2 p -115.12 149.33 37.74 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -171.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -104.96 129.06 25.49 Favored Pre-proline 0 CA--C 1.572 1.799 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.675 177.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.53 -16.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.966 0 N-CA-C 122.042 3.824 . . . . 0.0 122.042 173.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.33 -41.09 92.81 Favored 'General case' 0 CA--C 1.578 2.02 0 CA-C-N 121.785 2.084 . . . . 0.0 113.244 169.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -87.08 -0.09 56.1 Favored 'General case' 0 CA--C 1.582 2.189 0 C-N-CA 125.766 1.626 . . . . 0.0 113.656 170.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 -113.35 0.22 Allowed 'General case' 0 CA--C 1.583 2.229 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -175.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -92.46 13.39 19.77 Favored 'General case' 0 N--CA 1.521 3.118 0 CA-C-N 120.672 1.578 . . . . 0.0 113.62 -178.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.84 148.48 31.61 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 122.141 2.246 . . . . 0.0 118.084 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.276 8.3 t 73.4 -42.73 0.53 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.49 -56.45 2.34 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 117.055 2.243 . . . . 0.0 117.055 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 95.81 143.53 14.83 Favored Glycine 0 CA--C 1.546 1.992 0 CA-C-N 119.626 1.103 . . . . 0.0 112.028 -175.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.431 ' H ' ' HB ' ' A' ' 121' ' ' ILE . 4.3 t -78.75 144.76 65.18 Favored Pre-proline 0 CA--C 1.584 2.254 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.62 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -33.06 134.3 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.071 0 C-N-CA 124.307 3.338 . . . . 0.0 120.603 -177.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . 0.333 0.1 OUTLIER 21.84 46.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.475 2 N-CA-C 125.107 5.003 . . . . 0.0 125.107 -175.563 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -164.45 -55.94 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 178.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.431 ' HB ' ' H ' ' A' ' 117' ' ' SER . 56.9 mt -84.69 136.17 39.63 Favored Pre-proline 0 CA--C 1.592 2.574 0 CA-C-O 116.279 -1.819 . . . . 0.0 112.674 -174.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -99.48 173.9 0.4 Allowed 'Trans proline' 0 CA--C 1.592 3.408 0 CA-C-N 125.943 3.158 . . . . 0.0 115.184 178.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -58.42 -18.68 39.97 Favored 'Trans proline' 0 CA--C 1.575 2.563 0 N-CA-C 121.209 3.503 . . . . 0.0 121.209 176.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -140.2 83.12 1.9 Allowed 'General case' 0 CA--C 1.588 2.431 0 CA-C-N 120.448 1.476 . . . . 0.0 111.822 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.85 -153.58 0.56 Allowed 'General case' 0 CA--C 1.575 1.914 0 O-C-N 119.453 -2.029 . . . . 0.0 111.081 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.417 ' H ' HD12 ' A' ' 61' ' ' LEU 0.255 65.9 m -139.3 150.87 45.93 Favored 'General case' 0 CA--C 1.591 2.53 0 O-C-N 119.098 -2.251 . . . . 0.0 109.099 173.44 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 50.9 mt -127.21 162.63 25.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.232 -2.168 . . . . 0.0 112.895 -176.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.426 HG12 ' CE3' ' A' ' 59' ' ' TRP . 79.5 t -146.45 115.46 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.872 0 CA-C-N 112.672 -2.058 . . . . 0.0 107.225 -174.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . 0.304 0.8 OUTLIER -128.91 123.19 31.95 Favored 'General case' 0 N--CA 1.517 2.911 0 CA-C-N 123.13 2.695 . . . . 0.0 111.014 174.25 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.4 tm-20 -92.07 90.9 7.57 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 123.654 1.692 . . . . 0.0 107.467 175.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 1.5 p -134.47 157.59 41.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -173.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.702 ' HA ' ' HA ' ' A' ' 101' ' ' LEU 1.657 16.6 mt-10 -179.06 -174.13 0.32 Allowed 'General case' 0 CA--C 1.566 1.578 0 CA-C-N 113.226 -1.806 . . . . 0.0 112.328 168.707 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.554 ' HB2' ' SD ' ' A' ' 96' ' ' MET . 16.2 tp -106.82 145.68 31.83 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 121.111 3.745 . . . . 0.0 121.111 -165.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -92.02 -54.32 3.89 Favored 'General case' 0 CA--C 1.58 2.125 0 CA-C-N 111.887 -2.415 . . . . 0.0 108.572 176.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -170.58 159.08 6.57 Favored 'General case' 0 CA--C 1.579 2.066 0 C-N-CA 126.144 1.778 . . . . 0.0 108.308 171.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . 0.291 0.0 OUTLIER -129.38 -103.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.411 -1.43 . . . . 0.0 110.223 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . 0.447 63.7 tttt -105.76 -96.94 0.34 Allowed 'General case' 0 CA--C 1.581 2.146 0 CA-C-O 116.02 -1.943 . . . . 0.0 110.269 177.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.562 0 CA-C-N 125.167 3.622 . . . . 0.0 116.647 -178.798 . . . . . . . . 0 0 . 1 stop_ save_